Citrus Sinensis ID: 045343
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 813 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.960 | 0.938 | 0.480 | 0.0 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.929 | 0.866 | 0.319 | 1e-102 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.884 | 0.867 | 0.325 | 1e-100 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.915 | 0.910 | 0.320 | 2e-88 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.901 | 0.885 | 0.318 | 1e-86 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.393 | 0.389 | 0.466 | 4e-79 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.820 | 0.836 | 0.304 | 8e-79 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.931 | 0.888 | 0.283 | 1e-75 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.908 | 0.870 | 0.277 | 2e-73 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.827 | 0.771 | 0.292 | 7e-73 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 721 bits (1862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/839 (48%), Positives = 529/839 (63%), Gaps = 58/839 (6%)
Query: 3 SARLYFIFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTN---SSTWLSPSGDFAFGFRQV 59
S + + L+ QL + S NG+VPVG +LTA + SS+W SPSGDFAFGFR++
Sbjct: 5 SCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKI 64
Query: 60 DEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPA-VPRGSQVKLTADHGLVLNDPQGK 118
ND F LSI++ I KT+VW+ + VP GS+V LTAD GLV+ DP+G+
Sbjct: 65 ----QPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQ 120
Query: 119 QVWSSEIDIGTVAVGHMNDTGNFVL----ASSSSSKLWDSFSNPSDTLLPGQTMETKQGL 174
++W + + G+V+ G D GNFVL + S LW SF NP+DTLLP Q +E + L
Sbjct: 121 ELWRA-LSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNL 179
Query: 175 FSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTG---DAYDAYYISGTYDPANSSNSGYR 231
SR++ET+F +GRF RL DGNL L+ N T D Y YY S T DP +N G +
Sbjct: 180 SSRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDP---NNPGIQ 236
Query: 232 VMFNESGYMYILRRNGGRFDLTTES--VVPAADFYYRATLNFDGVFAQYFYPKNGNE--N 287
++FN+SG +Y+L+RN RF + AA FY G PK
Sbjct: 237 LVFNQSGEIYVLQRNNSRFVVKDRDPDFSIAAPFYIST-----GFLLSTIIPKEARRIVG 291
Query: 288 WSVAWSEPENICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKP 347
+ +N+C + +G+ ACG+N+ICSL +++RPKC CP+ + L D ++ YG C P
Sbjct: 292 GCLLGLCRDNMC-SPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLP 350
Query: 348 DFEL-SCWGGGQGYKKE--LFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAV 404
DFE+ +C Q + L++F L+ TNW D E + Y+E +CK SCLSDC CAAV
Sbjct: 351 DFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAV 410
Query: 405 IF---QDDCCWFKKLPLSNGMTDGRLTSKAFMKYKNK--GDDPPSVPRPPDPEDKKKRKM 459
IF +D CW KK PLS+G R S F+K +N+ D P + R KK
Sbjct: 411 IFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTGNR------AKKLDW 464
Query: 460 MNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNSPGD--------GTIETNLPCF 511
+ SVLLG+S FV F C++ + K ++N D E NL F
Sbjct: 465 LIIACSVLLGTSAFVIFDTSCSYRKT---KKSKNMMKNQARDIGRTTATTTANELNLRVF 521
Query: 512 SYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 571
+Y EL EAT +F EE+GRG+FGIVYKG + S VAVKKLDR+ D EKEFKNEV
Sbjct: 522 TYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVK 581
Query: 572 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 631
VIGQ HHKNLVRL+GFC+EGQ++++VYEFL GTLA+FLF +PSW R NIA IARG
Sbjct: 582 VIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARG 641
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
+LYLHE+CS QIIHCDIKPQNILLD+YY RISDFGLAKLL +NQ+ + T IRGTKGYV
Sbjct: 642 ILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTL-TNIRGTKGYV 700
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
APEWFRNS IT+KVDVYS+GV+LLEI+ C+K+ D+ E+ IL +WA+DC+R +L+DL
Sbjct: 701 APEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAYDCFRQGRLEDL 757
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPFSS 810
E D EA+ND++ VE+ V ++IWCIQE+ +RP M+ V QMLEGV++V PPNP P+S+
Sbjct: 758 TEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYST 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 374 bits (961), Expect = e-102, Method: Compositional matrix adjust.
Identities = 269/842 (31%), Positives = 411/842 (48%), Gaps = 86/842 (10%)
Query: 7 YFIFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTN 66
+F F L L H+ + G+ L A + W+S +G FA GF +
Sbjct: 16 FFCFFLVSLATEPHIGL---------GSKLKASEPNRAWVSANGTFAIGFTRFKP----T 62
Query: 67 DLFLLSIFYSNIPAK-TVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEI 125
D FLLSI+++ +P T+VW + ++N V + + ++L A LVL+D Q VW+S
Sbjct: 63 DRFLLSIWFAQLPGDPTIVW---SPNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNT 118
Query: 126 DIGTVAVGHMNDTGNFVLASS---SSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETN 182
V M+++GNF+L + + +W SFS PSDTLLP Q + L S S +
Sbjct: 119 SNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSR 178
Query: 183 FSRGRFQFRLLKDGN-----LVLNI-----ANLPTGDAYDAYYISGTYDPANSSNSGYRV 232
G + ++L+ L NI AN D ++G +++
Sbjct: 179 --HGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKI 236
Query: 233 MFNES--GYMYILRR---------NGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYP 281
++ ES G +Y+ + N LT V+ R L +G Y +
Sbjct: 237 VYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVL------RRLVLENNGNLRLYRWD 290
Query: 282 K--NGNENWSVAWSEPENICVNIGGEMGSGACGFNSICSLDSDRR-PKCACPKGYSLLDE 338
NG+ W W+ N C +I +G CG N +C+LD ++ C C G L +
Sbjct: 291 NDMNGSSQWVPEWAAVSNPC-DI-----AGICG-NGVCNLDRTKKNADCLCLPGSVKLPD 343
Query: 339 NDRYGSCKPDFELSCWGGGQGYKKELFDFHELQLTNWHLSDSERFRPYNEV----QCKNS 394
+ C + L + F +Q TN++ S+ +++ +C
Sbjct: 344 QENAKLCSDNSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEM 403
Query: 395 CLSDCFCAAVIFQDD----CCWFKKLPLSNGMTDGRLTSKAFMKYKNKGDDPPSVPRPPD 450
CLSDC C A ++ D CW K G D S F+K + P +
Sbjct: 404 CLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDP--GSTLFVKTRANESYPSNSNN--- 458
Query: 451 PEDKKKRKMMNATGSVLLGSSVFVNFALVCAFGLSFFF-IYKKKWIRNSPGDGTIETNLP 509
D K RK VL+ V LV G+ ++ + +K+ ++ + + I + P
Sbjct: 459 -NDSKSRKSHGLRQKVLVIPIVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSP 517
Query: 510 C-FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN 568
F+Y++L+ T+NF + +G G FG VYKG + T VAVK+LDR GE+EF
Sbjct: 518 VSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTV----AGETLVAVKRLDRALSHGEREFIT 573
Query: 569 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS----WNLRTNI 624
EV IG HH NLVRL G+C E +RLLVYE++ NG+L ++F + + + W R I
Sbjct: 574 EVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEI 633
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
A A+G+ Y HE C +IIHCDIKP+NILLDD + ++SDFGLAK++ S + T I
Sbjct: 634 AVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVV-TMI 692
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744
RGT+GY+APEW N IT K DVYS+G+LLLEI+ R++ D+ E WA+
Sbjct: 693 RGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELT 752
Query: 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV-EVSLPP 803
N V+ ++ + + + V K + V+ WCIQ++ S+RP+M +V+++LEG E++LPP
Sbjct: 753 NGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPP 812
Query: 804 NP 805
P
Sbjct: 813 MP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (943), Expect = e-100, Method: Compositional matrix adjust.
Identities = 263/809 (32%), Positives = 401/809 (49%), Gaps = 90/809 (11%)
Query: 29 TVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSI-FYSNIPAKTVVWYT 87
T+P+G+ + A ++ W SP+ F+ F N+ FL ++ F ++P +W
Sbjct: 26 TIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNS----FLAAVSFAGSVP----IWSA 77
Query: 88 DNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASSS 147
D RGS ++L L L + G VW S+ D V G + DTG F+L ++
Sbjct: 78 GTVDS-----RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNR 131
Query: 148 SSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPT 207
S +W SF NP+DT++ Q + L S G + F+L + GNL L
Sbjct: 132 SVPVWSSFDNPTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLRW----- 177
Query: 208 GDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRA 267
+ Y+ G +S+ S R+ +G + I N L +V + D+
Sbjct: 178 -NTSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESN----LLGGAEIVYSGDYGDSN 232
Query: 268 TLNF-----DGVFAQYFYPKNGNENWSVAWSEPENICVNIGGEMGSGACGFNSICSLDSD 322
T F DG Y + + WS + V G CG ICS + D
Sbjct: 233 TFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQCLV-------YGYCGNFGICSYN-D 284
Query: 323 RRPKCACP-KGYSLLDENDRYGSCKPDFELSCWGGGQGYKKELFDF-HELQLTNWHLSDS 380
P C+CP + + +D NDR CK ELS G + D H T +S
Sbjct: 285 TNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSG----NTTMLDLVHTRLFTYEDDPNS 340
Query: 381 ERFRPYNEVQCKNSCLSDCFCAAVIFQDDC---CWFKKLPLS--NGMTDGRLTSKAFMKY 435
E F C+ +CLS C A + D CW +K P S G + S +++K
Sbjct: 341 ESFFA-GSSPCRANCLSSVLCLASVSMSDGSGNCW-QKHPGSFFTGYQWPSVPSTSYVKV 398
Query: 436 KNKGDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWI 495
++ R +D + + ++ +V + A + ++
Sbjct: 399 CGP-VVANTLERATKGDDNNSKVHL-----WIVAVAVIAGLLGLVAVEIGLWWCC----C 448
Query: 496 RNSPGDGTIETNLPC----------FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRT 545
R +P GT+ ++ F+YKEL+ T +FKE++G G FG VY+GV+ T
Sbjct: 449 RKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL----T 504
Query: 546 STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 605
+ T VAVK+L+ + Q GEK+F+ EV I THH NLVRL+GFC +G++RLLVYEF+ NG+
Sbjct: 505 NRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGS 563
Query: 606 LASFLFGNLKP---SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662
L +FLF +W R NIA A+G+ YLHE+C I+HCDIKP+NIL+DD + A+
Sbjct: 564 LDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAK 623
Query: 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 722
+SDFGLAKLL ++ +++RGT+GY+APEW N IT+K DVYS+G++LLE++S ++
Sbjct: 624 VSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKR 683
Query: 723 SFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM--EALNDIKCVEKLVMVSIWCIQEDP 780
+FD+ + + WA++ + +++ + + D++ V ++V S WCIQE P
Sbjct: 684 NFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQP 743
Query: 781 SLRPTMKKVLQMLEGVVEVSLPPNPYPFS 809
RPTM KV+QMLEG+ E+ P P S
Sbjct: 744 LQRPTMGKVVQMLEGITEIKNPLCPKTIS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 267/833 (32%), Positives = 399/833 (47%), Gaps = 89/833 (10%)
Query: 15 LPFYLHL--SIAQNNGTVPVGATLTAGT-NSSTWLSPSGDFAFGFRQVDEENNTNDLFLL 71
L F++ L A + +P+G++L + SST S G F+ GF +V F
Sbjct: 15 LSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEV-----YTHAFTF 69
Query: 72 SIFYSNIPA-----KTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEID 126
S++YS A KT+VW + N D+ P R S + L D +VL D G VW ++ +
Sbjct: 70 SVWYSKTEAAAANNKTIVW-SANPDR-PVHARRSALTLQKDGNMVLTDYDGAAVWRADGN 127
Query: 127 IGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSR 185
T V + DTGN V+ S + +W SF +P+DT LP Q + L + + S
Sbjct: 128 NFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLV--PTTQSRSP 185
Query: 186 GRFQFRLLKDGNLVLNIANLP-TGDAYDAYYISGTY-DPANSSNSGYRVMFNESGYMYIL 243
G + FR D +++ I ++P D Y Y D N NS M +SG +
Sbjct: 186 GNYIFRF-SDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASS 244
Query: 244 RRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKNGNENWSV---AWSEPENICV 300
G+ L V P R TL+ DG Y + + +WSV A ++P NI
Sbjct: 245 DFADGQ-ALVASDVGPGVK--RRLTLDPDGNLRLYSM-NDSDGSWSVSMVAMTQPCNI-- 298
Query: 301 NIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGGQGY 360
G CG N IC P C+CP GY+ + + C +C Y
Sbjct: 299 -------HGLCGPNGICHYSPT--PTCSCPPGYATRNPGNWTEGCMAIVNTTC----DRY 345
Query: 361 KKELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQDDC--CWFKKLPL 418
K F L T++ SD + + C++ C+SDC C +Q+ C+ K
Sbjct: 346 DKRSMRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLF 405
Query: 419 SNGMTDGRLTSKAFMKYKN----------KGDDPPSVPRPPDPE--DKKKRKMMNATGSV 466
S ++K + D SVPR D + +K R+
Sbjct: 406 SGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKT 465
Query: 467 LLGSSV-FVNFALVCAF--------GLSFFFIYKKK------WIRNSPGDGTIETNLPCF 511
G S F + + AF ++FF+ K++ W + G + +N +
Sbjct: 466 GGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWA-SEKGYKAMTSNFRRY 524
Query: 512 SYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 571
SY+EL +AT FK E+GRG G VYKGV+ R VAVKKL+ V Q G++ F+ E+
Sbjct: 525 SYRELVKATRKFKVELGRGESGTVYKGVLEDDR----HVAVKKLENVRQ-GKEVFQAELS 579
Query: 572 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQI 628
VIG+ +H NLVR+ GFC EG +RLLV E++ NG+LA+ LF GN+ W R NIA +
Sbjct: 580 VIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGV 639
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
A+GL YLH +C +IHCD+KP+NILLD + +I+DFGL KLL S + +RGT
Sbjct: 640 AKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTL 699
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTDWA------F 740
GY+APEW + ITAKVDVYS+GV+LLE+++ + ++ G E +++L
Sbjct: 700 GYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKL 759
Query: 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
+ +D ++ + + L+ +++ C++ED S RPTM+ +Q L
Sbjct: 760 EGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 264/830 (31%), Positives = 406/830 (48%), Gaps = 97/830 (11%)
Query: 12 LFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLL 71
F + F++H S A + T+ TL+ T +S G + GF + +N F +
Sbjct: 10 FFFICFFIHGSSAVD--TISGDFTLSG---DQTIVSSDGTYEMGFFKPGSSSN----FYI 60
Query: 72 SIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVA 131
++Y + ++T++W N+D+ + S K++ + ++L+ VWS+ ++ T +
Sbjct: 61 GMWYKQL-SQTILWVA-NRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLN-STSS 117
Query: 132 VGHM----NDTGNFVL----ASSSSSKLWDSFSNPSDTLLPGQTME------TKQGLFSR 177
V + D GN VL +S S++ LW SF +P DT LPG + Q L S
Sbjct: 118 VSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSW 177
Query: 178 KSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNES 237
KS + S G F L D + I + + Y+ SG ++P + M
Sbjct: 178 KSLEDPSPGLFSLEL--DESTAYKI----LWNGSNEYWSSGPWNPQSRIFDSVPEM--RL 229
Query: 238 GYMYILRRNGGRFDLTTESVVPAADF----YYRATLNFDGVFAQYFYPKNGNENWSVAWS 293
Y+Y N F TT+S + + R ++ G Q+ + + GN+ W++ WS
Sbjct: 230 NYIY----NFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQIKQFTWLE-GNKAWNLFWS 284
Query: 294 EPENICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLL-----DENDRYGSCKPD 348
+P C CG ICS S+ P C CP+G+ + D D C
Sbjct: 285 QPRQQC------QVYRYCGSFGICSDKSE--PFCRCPQGFRPMSQKDWDLKDYSAGCVRK 336
Query: 349 FELSCWGGGQGYKKELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQD 408
EL C +G + F ++L + +SE + C ++C DC C A + +
Sbjct: 337 TELQC---SRGDINQFFRLPNMKLAD----NSEVLTRTSLSICASACQGDCSCKAYAYDE 389
Query: 409 ---DCCWFKKLPLSNGMTDGRLTSKAFMKYKNKGDDPPSVPRPPDPEDKKKRKMMNATGS 465
C + K L+ + + + D P+V +K
Sbjct: 390 GSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNNK------GLIFG 443
Query: 466 VLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKE 525
+LGS LV + ++K +R GDGT L FSY+EL+ AT NF +
Sbjct: 444 AVLGS--LGVIVLVLLVVILILRYRRRKRMRGEKGDGT----LSAFSYRELQNATKNFSD 497
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
++G G FG V+KG + ++ +AVK+L+ + Q GEK+F+ EVV IG H NLVRL
Sbjct: 498 KLGGGGFGSVFKGAL----PDSSDIAVKRLEGISQ-GEKQFRTEVVTIGTIQHVNLVRLR 552
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCS 640
GFC EG +LLVY+++ NG+L S LF N + W LR IA ARGL YLH++C
Sbjct: 553 GFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECR 612
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
IIHCDIKP+NILLD + +++DFGLAKL+ + S+ + T +RGT+GY+APEW
Sbjct: 613 DCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVL-TTMRGTRGYLAPEWISGVA 671
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK-----LDDLVEGD 755
ITAK DVYS+G++L E++S R++ + E+ WA + +D +EGD
Sbjct: 672 ITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGD 731
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNP 805
DI+ V + V+ WCIQ++ S RP M +V+Q+LEGV+EV+ PP P
Sbjct: 732 AV---DIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (759), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 160/343 (46%), Positives = 226/343 (65%), Gaps = 23/343 (6%)
Query: 484 LSFFFIYKKKWIRNSPGDGTIETN-------LPC-FSYKELEEATDNFKEEVGRGSFGIV 535
++F +KK I +P + + E N +P F+YK+L+ AT+NF ++G+G FG V
Sbjct: 448 VAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSV 507
Query: 536 YKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595
Y+G T + +AVKKL+ + Q G+KEF+ EV +IG HH +LVRL GFC EG +RL
Sbjct: 508 YEG----TLPDGSRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRL 562
Query: 596 LVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 651
L YEFL+ G+L ++F G++ W+ R NIA A+GL YLHEDC A+I+HCDIKP+
Sbjct: 563 LAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPE 622
Query: 652 NILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFG 711
NILLDD +NA++SDFGLAKL+T QS + T +RGT+GY+APEW N I+ K DVYS+G
Sbjct: 623 NILLDDNFNAKVSDFGLAKLMTREQSH-VFTTMRGTRGYLAPEWITNYAISEKSDVYSYG 681
Query: 712 VLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI-KCVEKLVM 770
++LLE+I RK++D E +AF KL D+V+G M+ ++ + V++ +
Sbjct: 682 MVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMK 741
Query: 771 VSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPFSSSMG 813
++WCIQED RP+M KV+QMLEGV V PP+ SS+MG
Sbjct: 742 TALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPS----SSTMG 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 8e-79, Method: Compositional matrix adjust.
Identities = 242/794 (30%), Positives = 373/794 (46%), Gaps = 127/794 (15%)
Query: 44 TWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVK 103
T LS F GF N + + L I Y+++P T VW N+ + + P S ++
Sbjct: 32 TILSFKAIFRLGFFST---TNGSSNWYLGISYASMPTPTHVWVA-NRIRPVSDPDSSTLE 87
Query: 104 LTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLL 163
LT+ L++++ + VW ++ ++TGN +L + S +W SF NP+DT L
Sbjct: 88 LTSTGYLIVSNLRDGVVWQTDNKQPGTDF-RFSETGNLILINDDGSPVWQSFDNPTDTWL 146
Query: 164 PGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT--YD 221
PG + + S +S + S G + RL P+ + + Y T +
Sbjct: 147 PGMNVTGLTAMTSWRSLFDPSPGFYSLRLS------------PSFNEFQLVYKGTTPYWS 194
Query: 222 PANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYY--------------RA 267
N + + V E YI R + P A F+Y R
Sbjct: 195 TGNWTGEAF-VGVPEMTIPYIYRFH------FVNPYTPTASFWYIVPPLDSVSEPRLTRF 247
Query: 268 TLNFDGVFAQYFYPKNGNENWSVAWSEPENIC--VNIGGEMGSGACGFNSICSLDSDRRP 325
+ +G QY + ++W++ W +PE+ C N+ G++G CS S+
Sbjct: 248 MVGANGQLKQYTWDPQ-TQSWNMFWLQPEDPCRVYNLCGQLG--------FCS--SELLK 296
Query: 326 KCACPKGYSLLDE-----NDRYGSCKPDFELSCWGGGQGYKKELFDF-------HELQLT 373
CAC +G+ ++ +D C+ + G G K + F+ +++++
Sbjct: 297 PCACIRGFRPRNDAAWRSDDYSDGCRRE------NGDSGEKSDTFEAVGDLRYDGDVKMS 350
Query: 374 NWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMTDGRLTSKAFM 433
+S S C +CL + C ++ K L L S +
Sbjct: 351 RLQVSKS---------SCAKTCLGNSSCVGFYHKEKSNLCKIL----------LESPNNL 391
Query: 434 KYKNKGDDPPSVPRPPDPEDKKKRKMMNATGSV-LLGSSVFVNFALVCAFGLSFFFIYKK 492
K +KG+ S+ + + GS+ +LG ++ V L+ +
Sbjct: 392 K-NSKGNISKSI-----------IILCSVVGSISVLGFTLLVPLILLKRSRKRKKTRKQD 439
Query: 493 KWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAV 552
+ DG NL FS+KEL+ AT+ F ++VG G FG V+KG T S+T VAV
Sbjct: 440 E-------DGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKG---TLPGSSTFVAV 489
Query: 553 KKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 612
K+L+R GE EF+ EV IG H NLVRL GFC E +RLLVY+++ G+L+S+L
Sbjct: 490 KRLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL-S 547
Query: 613 NLKP---SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669
P SW R IA A+G+ YLHE C IIHCDIKP+NILLD YNA++SDFGLA
Sbjct: 548 RTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLA 607
Query: 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE-- 727
KLL + S+ + T +RGT GYVAPEW IT K DVYSFG+ LLE+I R++ +
Sbjct: 608 KLLGRDFSRVLAT-MRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSD 666
Query: 728 -MGEEYAILTDWAFDCYRNEKL-----DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPS 781
+GE+ W F + ++ D +V+ + + + V ++ V+IWCIQ++
Sbjct: 667 TLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEE 726
Query: 782 LRPTMKKVLQMLEG 795
+RP M V++MLEG
Sbjct: 727 IRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 244/862 (28%), Positives = 408/862 (47%), Gaps = 105/862 (12%)
Query: 1 MASARLYFIFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVD 60
M + +++FLL +++ Q++ T+ G+TL ++ T +S F GF
Sbjct: 1 MILSVFFYMFLLHIRRLDCFVAV-QDSKTLFKGSTLINDSHGETLVSAGQRFELGF--FT 57
Query: 61 EENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQV 120
++++ L I++ N+ TVVW + ++P + R ++ D L + D +G+
Sbjct: 58 PNGSSDERRYLGIWFYNLHPLTVVWVANR--ESPVLDRSCIFTISKDGNLEVIDSKGRVY 115
Query: 121 WSSEIDIGTVAVGHM---NDTGNFVLAS--SSSSKLWDSFSNPSDTLLPGQTMETKQGLF 175
W + + +V+ M D GN VL S + ++ +W SF NP+DT LPG M+ L
Sbjct: 116 WDTGVKPSSVSAERMVKLMDNGNLVLISDGNEANVVWQSFQNPTDTFLPGMRMDENMTLS 175
Query: 176 SRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFN 235
S +S + S G F F++ ++ + I Y+ SG SG + +
Sbjct: 176 SWRSFNDPSHGNFTFQMDQEEDKQFIIWKRSM-----RYWKSGI--------SGKFIGSD 222
Query: 236 ESGYM--YILRRNGGRFDLTTESVVPAADFYY---RATLNFDGVFAQYFYPKNGNENWSV 290
E Y Y L + SV P Y R T++ G AQYF +G W+
Sbjct: 223 EMPYAISYFLSNFTETVTVHNASVPPLFTSLYTNTRFTMSSSGQ-AQYFR-LDGERFWAQ 280
Query: 291 AWSEPENICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGY--SLLDE---NDRYGSC 345
W+EP + C ACG + S +S C C G+ + L++ D G C
Sbjct: 281 IWAEPRDECSVYN------ACG--NFGSCNSKNEEMCKCLPGFRPNFLEKWVKGDFSGGC 332
Query: 346 KPDFELSCWGGGQGYKKELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVI 405
+ + C G + +++ S +F +NE +C+ CL++C C A
Sbjct: 333 SRESRI-CGKDGVVVGDMFLNLSVVEVG----SPDSQFDAHNEKECRAECLNNCQCQAYS 387
Query: 406 FQD-------DCCWFKKLPLSNGMTDGRLTSK-AFMKYKNKGDDPPSVPRPPDPEDKKKR 457
+++ CW L+N + +G L S+ F++ +VP ++ +
Sbjct: 388 YEEVDILQSNTKCWIWLEDLNN-LKEGYLGSRNVFIRV--------AVPDIGSHVERGRG 438
Query: 458 KMMNA-TGSVLLGSSVFVNFALVCAFG--LSFFFIYKKKWIRNSPG-------------- 500
+ A T VL+ F + A++ S+ F+ ++K + G
Sbjct: 439 RYGEAKTPVVLIIVVTFTSAAILVVLSSTASYVFLQRRK-VNKELGSIPRGVHLCDSERH 497
Query: 501 ------------DGTIETNLPCFSYKELEEATDNFKE--EVGRGSFGIVYKGVILTTRTS 546
D + ++P F + + AT NF ++G+G FG VYKG+
Sbjct: 498 IKELIESGRFKQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMF----PG 553
Query: 547 TTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL 606
+AVK+L R G +EFKNEVV+I + H+NLVRLLG+C G+ +LL+YE++ + +L
Sbjct: 554 DQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSL 613
Query: 607 ASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663
F+F + W +R NI IARGLLYLH+D +IIH D+K NILLD+ N +I
Sbjct: 614 DFFIFDRKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKI 673
Query: 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 723
SDFGLA++ +++ A + GT GY++PE+ + K DV+SFGV+++E IS +++
Sbjct: 674 SDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRN 733
Query: 724 FDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLR 783
E+ L A+D ++ E+ +L++ ++ + + K + V + C+QEDP+ R
Sbjct: 734 TGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDR 793
Query: 784 PTMKKVLQMLEGVVEVSLPPNP 805
PTM V+ ML G E + P P
Sbjct: 794 PTMSNVVFML-GSSEAATLPTP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 242/873 (27%), Positives = 378/873 (43%), Gaps = 134/873 (15%)
Query: 9 IFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDL 68
++L L F+L+ S N T+ G +L G N +SP F GF +
Sbjct: 9 LYLSLFLYFFLYESSMAAN-TIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHR--- 64
Query: 69 FLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIG 128
L I+Y NI K VVW + P + + ++ D LVL D + VWSS I+
Sbjct: 65 -FLGIWYGNIEDKAVVWVANR--ATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESS 121
Query: 129 TV----AVGHMNDTGNFVLASSSSSK-LWDSFSNPSDTLLPGQTMETK------QGLFSR 177
T V ++DTGNFVL+ + + + +W+SF++P+DT LP + S
Sbjct: 122 TTNNNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSW 181
Query: 178 KSETNFSRGRFQFRLLKDG--NLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFN 235
+SET+ S G + + G +VL N + SG ++ A +G M
Sbjct: 182 RSETDPSPGNYSLGVDPSGAPEIVLWEGN------KTRKWRSGQWNSA--IFTGIPNMSL 233
Query: 236 ESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKNGNE--------- 286
+ Y+Y F L++ Y+ + V ++ NG E
Sbjct: 234 LTNYLY-------GFKLSSPPD-ETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETL 285
Query: 287 -NWSVAWSEPENICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSC 345
W+ SEP++ C CG IC + C+C GY + + C
Sbjct: 286 KKWTKFQSEPDSECDQYN------RCGKFGICDMKGSN-GICSCIHGYEQVSVGNWSRGC 338
Query: 346 KPDFELSCWGGGQGYKKELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAA-- 403
+ L C + E ++L ++ + + P + C+ CL +C C A
Sbjct: 339 RRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPED---CRERCLRNCSCNAYS 395
Query: 404 -------VIFQDDCCWFKKLPLSNGMTDGRLTSKAFMKYKNKGDDPPSVPRPPDPEDKKK 456
+I+ D ++ RL D E +
Sbjct: 396 LVGGIGCMIWNQDLVDLQQFEAGGSSLHIRLA---------------------DSEVGEN 434
Query: 457 RKMMNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNS------------------ 498
RK + + +V V L+ F L + +KK + +
Sbjct: 435 RKT-----KIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKS 489
Query: 499 ---------------PGDGTIETNLPCFSYKELEEATDNF--KEEVGRGSFGIVYKGVIL 541
G + LP FS + AT++F + E+GRG FG VYKGV+
Sbjct: 490 KETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549
Query: 542 TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601
R +AVK+L G EFKNE+++I + H+NLVRLLG C EG+ ++LVYE++
Sbjct: 550 DGR----EIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYM 605
Query: 602 NNGTLASFLFGNLKPS---WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY 658
N +L FLF K + W LR +I IARGLLYLH D +IIH D+K N+LLD
Sbjct: 606 PNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAE 665
Query: 659 YNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
N +ISDFG+A++ NQ++A + GT GY++PE+ + K DVYSFGVLLLEI+
Sbjct: 666 MNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIV 725
Query: 719 SCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQE 778
S +++ + E+ L +A+ Y + + ++LV+ + + + + V++ C+Q+
Sbjct: 726 SGKRNTSLR-SSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQD 784
Query: 779 DPSLRPTMKKVLQMLEGVVEVSLPPNPYPFSSS 811
+ RP M VL MLE P F+S+
Sbjct: 785 SAAERPNMASVLLMLESDTATLAAPRQPTFTST 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 276 bits (705), Expect = 7e-73, Method: Compositional matrix adjust.
Identities = 230/787 (29%), Positives = 367/787 (46%), Gaps = 114/787 (14%)
Query: 77 NIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGK-QVWSSEIDIGTVAVGHM 135
++ + + +W + N+D +P G+ + LT V+ D + + VWS+ + V +
Sbjct: 79 HVDSGSTIW-SSNRD-SPVSSSGT-MNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRL 135
Query: 136 NDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLK- 194
D GN +L + LW+SF P+D+++ GQ ++ L S ++FS G ++F + +
Sbjct: 136 TDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGES 195
Query: 195 DGNLVLNIANLPTGDAYDAYYISGTYDPAN-SSNSGYRVMFNESGYMYILRRNGGRFDLT 253
DG + N Y+ + AN SN + + + ++ RNG +
Sbjct: 196 DGLMQWRGQN---------YWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNG-TVVVV 245
Query: 254 TESVVPAADFYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPENICVNIGGEMGSGACGF 313
++ P++DF A ++ G ++ + +N +S P + C CG
Sbjct: 246 RVALPPSSDFRV-AKMDSSG---KFIVSRFSGKNLVTEFSGPMDSC------QIPFVCGK 295
Query: 314 NSICSLD-SDRRPKCACPKGYSLLDENDRYGSCKP-----DFELSCWGGGQGYKKELFDF 367
+C+LD + C+CP + + G C P +SC + +
Sbjct: 296 LGLCNLDNASENQSCSCPDEMRM---DAGKGVCVPVSQSLSLPVSC-------EARNISY 345
Query: 368 HELQLT----NWHLSDS-ERFRPYNEVQCKNSCLSDCFCAAVIFQDDC--CW-----FKK 415
EL L + H +D E P + C + C +C C V +++ C+ F
Sbjct: 346 LELGLGVSYFSTHFTDPVEHGLPL--LACHDICSKNCSCLGVFYENTSRSCYLVKDSFGS 403
Query: 416 LPL-SNGMTDGRLTSKAFMKYKNKGDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFV 474
L L N + L + + PP + + VLL S
Sbjct: 404 LSLVKNSPENHDLIGYVKLSIRKTNAQPPG-------NNNRGGSSFPVIALVLLPCS--- 453
Query: 475 NFALVCAFGL---------SFFFIYKKKWIRNSPGD------GTIET-NLPC-FSYKELE 517
F L+ A GL + I +K+ R PG G+ LP F ++ELE
Sbjct: 454 GFFLLIALGLLWWRRCAVMRYSSIREKQVTR--PGSFESGDLGSFHIPGLPQKFEFEELE 511
Query: 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 577
+AT+NFK ++G G FG VYKG T T +AVKK+ G +EF E+ +IG
Sbjct: 512 QATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEIAIIGNIR 567
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYL 635
H NLV+L GFC G+ LLVYE++N+G+L LF P W R +IA ARGL YL
Sbjct: 568 HTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYL 627
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H C +IIHCD+KP+NILL D++ +ISDFGL+KLL +S ++ T +RGT+GY+APEW
Sbjct: 628 HSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTRGYLAPEW 686
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD------------------ 737
N+ I+ K DVYS+G++LLE++S RK+ ++ D
Sbjct: 687 ITNAAISEKADVYSYGMVLLELVSGRKNCSFR-SRSNSVTEDNNQNHSSTTTTSTGLVYF 745
Query: 738 --WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795
+A D + + +L + +E + EKLV +++ C+ E+P+LRPTM V+ M EG
Sbjct: 746 PLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEG 805
Query: 796 VVEVSLP 802
+ + P
Sbjct: 806 SIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 813 | ||||||
| 109676362 | 2037 | CCHC-type integrase [Populus trichocarpa | 0.918 | 0.366 | 0.623 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.958 | 0.972 | 0.571 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.976 | 0.993 | 0.565 | 0.0 | |
| 356575025 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.949 | 0.965 | 0.560 | 0.0 | |
| 255544746 | 800 | ATP binding protein, putative [Ricinus c | 0.937 | 0.952 | 0.574 | 0.0 | |
| 224143661 | 691 | predicted protein [Populus trichocarpa] | 0.846 | 0.995 | 0.578 | 0.0 | |
| 224057535 | 775 | predicted protein [Populus trichocarpa] | 0.937 | 0.983 | 0.563 | 0.0 | |
| 224053032 | 752 | predicted protein [Populus trichocarpa] | 0.917 | 0.992 | 0.564 | 0.0 | |
| 224073224 | 699 | predicted protein [Populus trichocarpa] | 0.848 | 0.987 | 0.554 | 0.0 | |
| 356503089 | 807 | PREDICTED: G-type lectin S-receptor-like | 0.968 | 0.975 | 0.527 | 0.0 |
| >gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 948 bits (2451), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/768 (62%), Positives = 582/768 (75%), Gaps = 21/768 (2%)
Query: 8 FIFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTND 67
+L QL +++AQ NG VP GA++TA +S +W S SG+FAFGFRQ++ + D
Sbjct: 43 LTMVLLQL-----MAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQLENK----D 93
Query: 68 LFLLSIFYSNIPAKTVVWYTDNKD--QNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEI 125
FLLSI+Y IP KTVVWY +D +PAVPRGS+++LT D GL+L DPQG Q+WSS I
Sbjct: 94 YFLLSIWYEKIPEKTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGI 153
Query: 126 DIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFS 184
G V+ G MNDTGNFVL + +S +LW+SF+NP+DTLLP Q ME + SR++ETNFS
Sbjct: 154 PPGAAVSSGVMNDTGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFS 213
Query: 185 RGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILR 244
GRFQ RLL +GNLVLN NLPT YD YY S T D +NSSNSGYR++FNESGYMYILR
Sbjct: 214 LGRFQLRLLDNGNLVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILR 273
Query: 245 RNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPK--NGNENWSVAWSEPENICVNI 302
RNG DLT ++ +P DFY+RATLNFDGVF QYFYPK +GN +WS WS+P++ICVN+
Sbjct: 274 RNGLIEDLT-KTALPTIDFYHRATLNFDGVFTQYFYPKASSGNRSWSSVWSKPDDICVNM 332
Query: 303 GGEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGGQGYKK 362
G ++GSGACG+NSIC+L +D+RP+C CP+G+SLLD+ND+YGSC PDFELSC G +
Sbjct: 333 GADLGSGACGYNSICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTE 392
Query: 363 ELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGM 422
+ +DF EL +W SD ER++P NE +C+ SCL+DC C+ IF+D C W KKLPLSNG
Sbjct: 393 DQYDFVELINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRDGC-WKKKLPLSNGR 451
Query: 423 TDGRLTSKAFMKYKNKGDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAF 482
D + KAF+K+ KG P P P P +KKK + TGSV+LG+SVFVNF LV AF
Sbjct: 452 FDIGMNGKAFLKFP-KGYVPLDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNFVLVGAF 510
Query: 483 GLSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILT 542
L+ FIY+KK + G +ETNL F+YKEL EAT++FK+EVGRG FG+VYKG I
Sbjct: 511 CLTSSFIYRKKTEKVKEGGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQA 570
Query: 543 TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 602
ST VAVKKLD+V QDGEKEFK EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+
Sbjct: 571 G--STRVVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLS 628
Query: 603 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662
NGTLA+FLFG KP+W RT IAF IARGLLYLHE+C QIIHCDIKPQNILLD+YYNAR
Sbjct: 629 NGTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNAR 688
Query: 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 722
ISDFGLAKLL ++QSK +TAIRGTKGYVAPEWFRN IT KVDVYSFGV+LLEII CR+
Sbjct: 689 ISDFGLAKLLVMDQSKT-QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRR 747
Query: 723 SFDIEMGE-EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLV 769
+ D+E+GE E +LTDWA+DCY + LD L+ D EA NDI +E+L+
Sbjct: 748 NVDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLL 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2296), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/800 (57%), Positives = 561/800 (70%), Gaps = 21/800 (2%)
Query: 1 MASARLYFIF-LLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQV 59
MA L+ F LL LP + +++Q G + VGA+L+ N+S WLSPSGDFAFGF +
Sbjct: 1 MAFPILHLSFSLLIMLPPF---AVSQTGGNITVGASLSTSENTS-WLSPSGDFAFGFHPL 56
Query: 60 DEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQ 119
LFLL+I+Y IP KT+VWY N D+ PA P GS+ LTA+ G+ L DPQG++
Sbjct: 57 ---YGNKYLFLLAIWYDKIPEKTIVWYA-NGDK-PA-PTGSKAVLTANRGISLTDPQGRE 110
Query: 120 VWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKS 179
+W SE IG VA G M D GNFVL S KLW+SF NP+DTLLP Q ++ L SR+S
Sbjct: 111 LWRSETIIGVVAYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQS 170
Query: 180 ETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGY 239
E NFS GRFQ +L DGNL L NLP+ + YY SGT +SS+ GY+V+FNESGY
Sbjct: 171 ENNFSMGRFQLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGY 230
Query: 240 MYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPK--NGNENWSVAWSEPEN 297
+YILR N F LT DFY RATLNFDG+F QY++PK GNE W+ WS+P+N
Sbjct: 231 LYILRENDQIFSLTQRVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDN 290
Query: 298 ICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGG 357
IC GSG CGFNS+C L+SDRRP C CP GYSLLD +D+YGSC+P++ SC
Sbjct: 291 ICQASFVSSGSGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDE 350
Query: 358 QGYKKELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQD-DCCWFKKL 416
++L+DF EL T+W SD +P+ E +C+ SCL+DC CA IF+ D CW KKL
Sbjct: 351 VAPVEDLYDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKL 410
Query: 417 PLSNGMTDGRLTSKAFMKYKNKGDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNF 476
PLSNG L KA +K + +P S P P +KK R + GSV LG SVFVNF
Sbjct: 411 PLSNGRVQTNLDGKALLKVRRSNVNPRS---PYFPNNKKDRDGLILVGSVFLGCSVFVNF 467
Query: 477 ALVCAFGLSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVY 536
LVCA + FFFIY+++ R DG +ETNL CF+Y+EL EAT+ FKEE+GRG+FG+VY
Sbjct: 468 LLVCAIFMCFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVY 527
Query: 537 KGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596
KGV+ S+ VAVKKL+ V +D +EFK EV VIGQTHHKNLVRLLGFC+EG RLL
Sbjct: 528 KGVVHI--GSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLL 585
Query: 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656
VYEF++NG+L+SF+F + KP W +R IAF +ARGLLYLHE+CS QIIHCDIKPQNILLD
Sbjct: 586 VYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLD 645
Query: 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 716
+YYNARISDFGLAKLL L+QS+ TAIRGTKGYVAPEWFRN +T KVDVYS+GVLLLE
Sbjct: 646 EYYNARISDFGLAKLLLLDQSQT-HTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLE 704
Query: 717 IISCRKSFDIEMG-EEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWC 775
II CR++ D + EE AILTDWA+DCYR LD LV D AL+DI+ +E+ +M++ WC
Sbjct: 705 IICCRRNVDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWC 764
Query: 776 IQEDPSLRPTMKKVLQMLEG 795
IQEDPSLRPTM+KV QMLEG
Sbjct: 765 IQEDPSLRPTMRKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2286), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/817 (56%), Positives = 576/817 (70%), Gaps = 23/817 (2%)
Query: 1 MASARLYFIF-LLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQV 59
MA L+ F LL LP + +++Q G + VGA+L+ N+S WLSPSGDFAFGF Q+
Sbjct: 1 MAFPILHLSFSLLIMLPPF---AVSQTGGNITVGASLSTSDNTS-WLSPSGDFAFGFYQL 56
Query: 60 DEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQ 119
DLFLL+I+Y IP KT+VWY N D+ PA P GS+ LTA+ G+ L DPQG++
Sbjct: 57 ---YGNKDLFLLAIWYDKIPDKTIVWYA-NGDK-PA-PTGSKAVLTANRGISLTDPQGRE 110
Query: 120 VWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKS 179
+W SE IG VA G M DTGNFVL S KLW+SF NP+DTLLP Q ++ L SR+S
Sbjct: 111 LWRSETIIGDVAYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQS 170
Query: 180 ETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGY 239
ETNFS GRFQ +L DGNLVL NLP+ + YY SGT +SS+ GY+V+FNESGY
Sbjct: 171 ETNFSMGRFQLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGY 230
Query: 240 MYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPK--NGNENWSVAWSEPEN 297
+YILR+N F LT DFY+RATLNFDGVF QY++PK GNE W+ WS+P+N
Sbjct: 231 LYILRKNDQIFSLTQRVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDN 290
Query: 298 ICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGG 357
IC GSG CGFNS+C L+SD RP C CP GYSLLD +D+YGSC+P++ SC
Sbjct: 291 ICQASSVSAGSGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDE 350
Query: 358 QGYKKELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQD-DCCWFKKL 416
++L+DF EL T+W SD +P+ E +C+ SCL+DC CA IF+ D CW KKL
Sbjct: 351 VAPVEDLYDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKL 410
Query: 417 PLSNGMTDGRLTSKAFMKYKNKGDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNF 476
PLSNG + +KA +K + +P S P P +KK R + GSV LG SVFVNF
Sbjct: 411 PLSNGRVQTIVDAKALLKVRRSNVNPRS---PYFPNNKKDRDGLILVGSVFLGCSVFVNF 467
Query: 477 ALVCAFGLSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVY 536
LVCA + FFFIY+++ R DG +ETNL CF+Y+EL EAT+ FKEE+GRG+FG+VY
Sbjct: 468 LLVCAICMGFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVY 527
Query: 537 KGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596
+GV+ S+ VAVKKL+ V +D +EFK EV VIGQTHHKNLVRLLGFC+EG RLL
Sbjct: 528 RGVVHI--GSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLL 585
Query: 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656
VYEF++NG+L+SF+F + KP W +R IAF +ARGLLYLHED +QIIHCDIKPQNILLD
Sbjct: 586 VYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILLD 643
Query: 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 716
+ NARISDFGLAKLL +Q+K TAIRGTKGYVAPEWF+N +T KVD YSFG+LLLE
Sbjct: 644 ESLNARISDFGLAKLLKTDQTKTT-TAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLE 702
Query: 717 IISCRKSFDIE-MGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWC 775
++ CRK+F+I M E +L DWA DC + KL+ LVE D EA+ D+K VE+ VMV+IWC
Sbjct: 703 LVCCRKNFEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWC 762
Query: 776 IQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPFSSSM 812
IQEDPSLRP MKKV+QMLEG V+VS+PP+P F S++
Sbjct: 763 IQEDPSLRPGMKKVVQMLEGGVQVSVPPDPSSFISTI 799
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 883 bits (2281), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/813 (56%), Positives = 576/813 (70%), Gaps = 41/813 (5%)
Query: 8 FIFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTND 67
+ L QLP+ ++ N V +G TL AG WLSPS DFAFGF Q+D ND
Sbjct: 13 ILLPLLQLPY-----VSATN--VSIGETLVAGNGGKRWLSPSEDFAFGFHQLD-----ND 60
Query: 68 LFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDI 127
L+LL+I Y NIP + +WY + NPA P+GS+++L GLVL PQG ++W+S++
Sbjct: 61 LYLLAISYQNIPRDSFIWYANG--DNPA-PKGSKLELNQYTGLVLKSPQGVELWTSQLIS 117
Query: 128 GTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGR 187
GT++ G MNDTGNF L +S LWDSFSNP+DTL+P Q ME K L SR+ E NFSRGR
Sbjct: 118 GTISYGLMNDTGNFQLLDENSQVLWDSFSNPTDTLVPTQIMEVKGTLSSRQKEANFSRGR 177
Query: 188 FQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNG 247
FQFRLL DGN VLN NLPT YDA+YIS TYD N++NSG++V+F+ SG +YIL+R+G
Sbjct: 178 FQFRLLPDGNAVLNPINLPTNYTYDAHYISATYDSTNTTNSGFQVIFDNSG-LYILKRSG 236
Query: 248 GRFDLTTESVVPAAD-FYYRATLNFDGVFAQYFYPKN--GNENWSVAWSEPENICVNI-G 303
+ +T + D +YYRAT+NFDG F YPKN N +W+V + P+NIC+N+ G
Sbjct: 237 EKVYITNPKDALSTDSYYYRATINFDGTFTISNYPKNPASNPSWTVMKTLPDNICMNLLG 296
Query: 304 GEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGGQGYKKE 363
GSG CGFNSIC+L +D+RPKC+CP+GYS LD D YGSCKP+ EL C GQ + +
Sbjct: 297 NTGGSGVCGFNSICTLKADQRPKCSCPEGYSPLDSRDEYGSCKPNLELGCGSSGQSLQGD 356
Query: 364 LFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMT 423
L+ E+ T+W +SD E ++PYN CK SCL DC CA IF+DD C+ KKLPLSNG
Sbjct: 357 LYFMKEMANTDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKLPLSNGRR 416
Query: 424 DGRLTSKAFMKYKNKGDDPPSVPRPPDP--EDKKKRK---MMNATGSVLLGSSVFVNFAL 478
D + + AF+K G PP+P E+KK +K + SVLLG SVF F L
Sbjct: 417 DRAVGASAFIKLMKNG----VSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVF--FNL 470
Query: 479 VCAFGLSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKG 538
V A + F+F Y KK +S E+NL F++ EL +ATDNFKEE+GRGS GIVYKG
Sbjct: 471 VSAVWVGFYFYYNKK---SSTNKTATESNLCSFTFAELVQATDNFKEELGRGSCGIVYKG 527
Query: 539 VILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598
T+ +AVKKLD+V +D +KEFK EV VIGQTHHK+LVRLLG+CDE Q+R+LVY
Sbjct: 528 T-----TNLATIAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRILVY 582
Query: 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY 658
EFL+NGTLA+FLFG+ KP+WN R IAF IARGL+YLHE+C QIIHCDIKPQNILLD+
Sbjct: 583 EFLSNGTLANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILLDEQ 642
Query: 659 YNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
YNARISDFGL+KLL +N+S T IRGTKGYVAP+WFR++ IT KVDVYSFGVLLLEII
Sbjct: 643 YNARISDFGLSKLLKINESHT-ETGIRGTKGYVAPDWFRSAPITTKVDVYSFGVLLLEII 701
Query: 719 SCRKSFDIEMG-EEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQ 777
CR++ D E+G EE AILTDWA+DCYR ++D L+E D EA++D +E+ VMV+IWC+Q
Sbjct: 702 CCRRNVDGEVGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIWCLQ 761
Query: 778 EDPSLRPTMKKVLQMLEGVVEVSLPPNPYPFSS 810
EDPSLRP MKKV+ MLEG+ V++PP+P P++S
Sbjct: 762 EDPSLRPPMKKVMLMLEGIAPVTIPPSPSPYTS 794
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/781 (57%), Positives = 554/781 (70%), Gaps = 19/781 (2%)
Query: 24 AQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTV 83
AQN T+ VG L A + +WLSPSGDFAFGFRQ++ +N L+LL+I Y+ I KT+
Sbjct: 23 AQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLENKN----LYLLAICYNKISDKTI 78
Query: 84 VWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVL 143
VWY + D PA P GS+V+LTAD GLVL PQGK++W S I+IG A G MNDTGNF +
Sbjct: 79 VWYANGDD--PA-PTGSKVELTADRGLVLTSPQGKEIWKSGINIGDAARGMMNDTGNFRI 135
Query: 144 ASSSSSKLWDSFSNPSDTLLPGQTMETK-QGLFSRKSETNFSRGRFQFRLLKDGNLVLNI 202
++ KLW +F +P DTLLPGQ +E + L SR ETNFSRGRFQFRL+ DGN VLN
Sbjct: 136 VNTGGEKLWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRGRFQFRLIPDGNGVLNA 195
Query: 203 ANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAAD 262
NL TGDAYDAYY + T D AN SN+G R++FNESGY+Y LR + R +T E VVP +
Sbjct: 196 NNLRTGDAYDAYYWTNTVD-ANLSNAGLRIVFNESGYLYTLRASNKRELITPERVVPTTE 254
Query: 263 FYYRATLNFDGVFAQYFYPKNG--NENWSVAWSEPENICVNIGGEMGSGACGFNSICSLD 320
+Y+R TLNFDGV QY +PKN N NWS+ +S PENIC I ++G+G CGFNS+C L+
Sbjct: 255 YYHRVTLNFDGVLTQYSHPKNSTDNGNWSIIFSAPENICFLIT-DIGTGPCGFNSVCQLN 313
Query: 321 SDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGGQGYKKELFDFHELQLTNWHLSDS 380
+D+R C CP +S +D D Y CKPDF E +DF EL T+W SD
Sbjct: 314 ADQRAICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPEDYDFLELTNTDWPTSDY 373
Query: 381 ERFRPYNEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMTDGRLTSKAFMKYKNKGD 440
ER+ YN +C+ +C+ DCFC V+F+ C W KKLPLSNG ++ +AF+K +
Sbjct: 374 ERYDSYNIEECQKACIQDCFCNVVVFRGSC-WKKKLPLSNGRQSEKVNGRAFIKVRKDDY 432
Query: 441 DPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNSPG 500
+P P P K+ + + SVLLGSSVF+NF L+ F F Y KK G
Sbjct: 433 MGRGLPPRPFPNAKEDQDSLVLVISVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQG 492
Query: 501 DGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ 560
+ ++NL CFSYKEL EAT FKEE+GRGSFGIVYKG+I +T VAVKKLDRV +
Sbjct: 493 E---KSNLRCFSYKELVEATKGFKEELGRGSFGIVYKGLI--EMGTTVPVAVKKLDRVVE 547
Query: 561 DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNL 620
GEKE+K EV IGQTHHKNLV+LLGFCDEGQ +LLVYE L+NGTLA+FLFG+ K SW
Sbjct: 548 YGEKEYKAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWKQ 607
Query: 621 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
RT IAF IARGL+YLHE+C+ QIIHCDIKPQNIL+D+YY+A+ISDFGLAKLL L+QS+
Sbjct: 608 RTQIAFGIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQTF 667
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740
T IRGTKGYVAPEWFRN IT KVD YSFGVLLLEII R+S D E+ E AILTDWA+
Sbjct: 668 -TTIRGTKGYVAPEWFRNVPITVKVDAYSFGVLLLEIICSRRSVDTEISGERAILTDWAY 726
Query: 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
DCY ++DDLVE D EAL+D+K VE+ +MV+IWCIQEDP+LRPTMK V+ MLEG+++V+
Sbjct: 727 DCYMEGRIDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQVA 786
Query: 801 L 801
+
Sbjct: 787 V 787
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2235), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/785 (57%), Positives = 547/785 (69%), Gaps = 97/785 (12%)
Query: 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWY 86
NG++PVGA +TA ++ +WLS SG+FAFGF+ ++ + D FLLSI+Y+ IP KT+VWY
Sbjct: 1 NGSMPVGAFITATDDAPSWLSSSGEFAFGFQPLEYK----DHFLLSIWYAKIPEKTIVWY 56
Query: 87 TDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASS 146
+ NPA PR S+V+L D GLVL DPQG +WSS +GTV+ G MNDTGNFVL +S
Sbjct: 57 ANG--DNPA-PRESKVELRGDSGLVLTDPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNS 113
Query: 147 SSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLP 206
+S +LW+SFSNP+DTLLP Q ME + SR++ETNFS GRFQ RLL +GNLVLN NLP
Sbjct: 114 NSFRLWESFSNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLP 173
Query: 207 TGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYR 266
T YD YY S T D +NSSNSGYR++FNESGYMYILRRNG DLT ++ +P DFY+R
Sbjct: 174 TKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLT-KTALPTIDFYHR 232
Query: 267 ATLNFDGVFAQYFYPKNGNENWSVAWSEPENICVNIGGEMGSGACGFNSICSLDSDRRPK 326
ATLNFD ++GSGACG+NSIC+L +D+RP+
Sbjct: 233 ATLNFDA-------------------------------DLGSGACGYNSICNLKADKRPE 261
Query: 327 CACPKGYSLLDENDRYGSCKPDFELSCWGGGQGYKKELFDFHELQLTNWHLSDSERFRPY 386
C CP+G+SLLD+ND+YGSC PDFELSC G ++ +DF EL +W SD ER++P
Sbjct: 262 CKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPI 321
Query: 387 NEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMTDGRLTSKAFMKYKNKGDDPPSVP 446
NE +C+ SCL+DC C+ IF+D C W KKLPLSNG D + KAF+K+
Sbjct: 322 NEDECRKSCLNDCLCSVAIFRDGC-WKKKLPLSNGRFDIGMNGKAFLKF----------- 369
Query: 447 RPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNSPGDGTIET 506
P+ K K+ G +ET
Sbjct: 370 ----PKGYKTEKV--------------------------------------KEGGSGLET 387
Query: 507 NLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEF 566
NL F+YKEL EAT++FK+EVGRG FG+VYKG I ST VAVKKLD+V QDGEKEF
Sbjct: 388 NLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTI--QAGSTRVVAVKKLDKVVQDGEKEF 445
Query: 567 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 626
K EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+NGTLA+FLFG KP+W RT IAF
Sbjct: 446 KTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIAF 505
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
IARGLLYLHE+C QIIHCDIKPQNILLD+YYNARISDFGLAKLL ++QSK +TAIRG
Sbjct: 506 GIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT-QTAIRG 564
Query: 687 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRN 745
TKGYVAPEWFRN IT KVDVYSFGV+LLEII CR++ D+E+GE E +LTDWA+DCY +
Sbjct: 565 TKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMD 624
Query: 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNP 805
LD L+ D EA NDI +E+L+ V IWCIQEDPSLRPTM+KV QMLEGVVEV PNP
Sbjct: 625 GSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNP 684
Query: 806 YPFSS 810
+P+SS
Sbjct: 685 FPYSS 689
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2212), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/806 (56%), Positives = 563/806 (69%), Gaps = 44/806 (5%)
Query: 6 LYFIFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNT 65
LYF FLLF P L +AQ NG VG +LTAG ++ WLSP+ DFAFGFRQ+D++
Sbjct: 9 LYFFFLLF--PSSL---VAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK--- 60
Query: 66 NDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEI 125
DL+LL+I+Y+ IP KT+VWY N D+ PA P+ S VKLTA+ G+VLN+PQG ++W S
Sbjct: 61 -DLYLLAIWYNKIPDKTIVWYA-NGDR-PA-PKKSTVKLTAELGVVLNNPQGGEIWKSGP 116
Query: 126 DIGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSR 185
G A G MNDTGNF++A+++ KLW SF +DTLLP Q ME L SR SETNFS+
Sbjct: 117 GNGEAAYGFMNDTGNFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQ 176
Query: 186 GRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRR 245
GRFQFRL+ DGN VLN NLPTG Y+AY+ S T D +NSSN+GY+V+FNESGY+Y+LR
Sbjct: 177 GRFQFRLIPDGNAVLNTINLPTGFPYEAYFWSKTVD-SNSSNAGYQVVFNESGYLYVLRA 235
Query: 246 NGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKN--GNENWSVAWSEPENICVNIG 303
N R LT VVPA + Y+RATL+FDGVF Y +PKN GNENWSV + PENIC +
Sbjct: 236 NNTREALTLGRVVPATENYHRATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVR 295
Query: 304 GEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGGQGYKKE 363
G GSG CG+N +C++ +D+R C CP+ +SLLD +D YG CKPDF E
Sbjct: 296 GLKGSGPCGYNGVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPE 355
Query: 364 LFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMT 423
++ L +W SD E + PYN CK +CL D FC ++F + CW K+LPLSNG
Sbjct: 356 DYELVPLTNIDWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQ 415
Query: 424 DGRLTSKAFMKYKNKGDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFG 483
+ +FMK + KG+ ++P PP P KK ++ SVLLG SVF NF LV
Sbjct: 416 GESVNGASFMKVR-KGNY--TLPGPP-PIPKKNLLVV----SVLLGGSVFFNFVLVGVVS 467
Query: 484 LSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTT 543
+FFFIY K+ R + +++NL CFSYKEL EAT+ FKEE+GRG+FGIVYKG LT
Sbjct: 468 FAFFFIYHNKFTRTPQVERAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKG--LTQ 525
Query: 544 RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603
S VA+KK+DR ++ +KEFK EV VIG FCDEGQ+R+LVYEFL+N
Sbjct: 526 IGSGVPVAIKKVDRFVKESDKEFKTEVDVIG------------FCDEGQHRMLVYEFLSN 573
Query: 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663
G LASFLFG++K SWN RT IAF IARGLLYLH++CS QIIHCDIKPQNILLD++Y+ARI
Sbjct: 574 GALASFLFGDVKLSWNQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARI 633
Query: 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 723
+DFGLAKL Q K GTKGYVAPEWFRN IT KVDVY+FGVLLLEII CR+S
Sbjct: 634 ADFGLAKLFRNPQHK-------GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRS 686
Query: 724 FDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLR 783
D E+GEE AILTDWA+DCY+ + LVE D EALND+K +E+ VMV+IWCIQEDP+LR
Sbjct: 687 VDTEVGEERAILTDWAYDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLR 746
Query: 784 PTMKKVLQMLEGVVEVSLPPNPYPFS 809
PTMK V+ MLEG+++V +PP P PFS
Sbjct: 747 PTMKMVMLMLEGIIQVPVPPCPSPFS 772
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2184), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/785 (56%), Positives = 551/785 (70%), Gaps = 39/785 (4%)
Query: 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWY 86
NG VG +LTAG ++ WLSP+ DFAFGFRQ+D++ DL+LL+I+Y+ IP KT+VWY
Sbjct: 2 NGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK----DLYLLAIWYNKIPDKTIVWY 57
Query: 87 TDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASS 146
N D+ PA P+ S VKLTA+ G+VLN+PQG ++W S G A G MNDTGNF++A++
Sbjct: 58 A-NGDR-PA-PKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANA 114
Query: 147 SSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLP 206
+ KLW SF +DTLLP Q ME L SR SETNFS+GRFQFRL+ DGN VLN NLP
Sbjct: 115 NGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLP 174
Query: 207 TGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYR 266
TG Y+AY+ S T D +NSSN+GY+V+FNESGY+Y+LR N R LT VVPA + Y+R
Sbjct: 175 TGFPYEAYFWSKTVD-SNSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHR 233
Query: 267 ATLNFDGVFAQYFYPKN--GNENWSVAWSEPENICVNIGGEMGSGACGFNSICSLDSDRR 324
ATL+FDGVF Y +PKN GNENWSV + PENIC + G GSG CG+N +C++ +D+R
Sbjct: 234 ATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVRGLKGSGPCGYNGVCTISTDKR 293
Query: 325 PKCACPKGYSLLDENDRYGSCKPDFELSCWGGGQGYKKELFDFHELQLTNWHLSDSERFR 384
C CP+ +SLLD +D YG CKPDF E ++ L +W SD E +
Sbjct: 294 AICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPEDYELVPLTNIDWPESDYEMYT 353
Query: 385 PYNEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMTDGRLTSKAFMKYKNKGDDPPS 444
PYN CK +CL D FC ++F + CW K+LPLSNG + +FMK + KG+ +
Sbjct: 354 PYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFMKVR-KGNY--T 410
Query: 445 VPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNSPGDGTI 504
+P PP P KK ++ SVLLG SVF NF LV +FFFIY K+ R + +
Sbjct: 411 LPGPP-PIPKKNLLVV----SVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVERAV 465
Query: 505 ETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK 564
++NL CFSYKEL EAT+ FKEE+GRG+FGIVYKG LT S VA+KK+DR ++ +K
Sbjct: 466 QSNLRCFSYKELMEATNGFKEELGRGAFGIVYKG--LTQIGSGVPVAIKKVDRFVKESDK 523
Query: 565 EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 624
EFK EV VIG FCDEGQ+R+LVYEFL+NG LASFLFG++K SWN RT I
Sbjct: 524 EFKTEVDVIG------------FCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQRTQI 571
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
AF IARGLLYLH++CS QIIHCDIKPQNILLD++Y+ARI+DFGLAKL Q K
Sbjct: 572 AFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLFRNPQHK------ 625
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744
GTKGYVAPEWFRN IT KVDVY+FGVLLLEII CR+S D E+GEE AILTDWA+DCY+
Sbjct: 626 -GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWAYDCYQ 684
Query: 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPN 804
+ LVE D EALND+K +E+ VMV+IWCIQEDP+LRPTMK V+ MLEG+++V +PP
Sbjct: 685 EGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPVPPC 744
Query: 805 PYPFS 809
P PFS
Sbjct: 745 PSPFS 749
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224073224|ref|XP_002304031.1| predicted protein [Populus trichocarpa] gi|222841463|gb|EEE79010.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/793 (55%), Positives = 539/793 (67%), Gaps = 103/793 (12%)
Query: 21 LSIAQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPA 80
+++AQ NG VPVGA++TA +S +WLS SG+FAFGFRQ++ + D FLLSI+Y IP
Sbjct: 1 MAVAQTNGRVPVGASITATDDSPSWLSASGEFAFGFRQLENK----DYFLLSIWYEKIPE 56
Query: 81 KTVVWYTDNKD--QNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDT 138
KTVVWY +D +PAVPRGS+V+LT D GL+L DPQG +W+S I +G V+ G MNDT
Sbjct: 57 KTVVWYAIGEDPTDDPAVPRGSKVELTDDRGLLLADPQGNLIWTSRILLGAVSSGVMNDT 116
Query: 139 GNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNL 198
GNFVL + +S +LW+SF+NP+DTLLP Q ME + SR++ETNFS GRFQ RLL +GNL
Sbjct: 117 GNFVLQNRNSERLWESFNNPTDTLLPTQIMEAGGVVSSRRTETNFSLGRFQLRLLDNGNL 176
Query: 199 VLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVV 258
VLN NL T AYD YY SGT D +NSSN+GYR++FNESGY IL R + S +
Sbjct: 177 VLNSMNLSTKFAYDDYYRSGTSDASNSSNTGYRLLFNESGY--ILWRP-----PPSPSSL 229
Query: 259 PAADFYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPENICVNIGGEMGSGACGFNSICS 318
+AD +Y ++WS WS+P++ICVN+G ++GSGACG+NSIC+
Sbjct: 230 ISADIHYI-------------------QSWSSVWSKPDDICVNMGADLGSGACGYNSICN 270
Query: 319 LDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGGGQGYKKELFDFHELQLTNWHLS 378
L +D+RP+C CP+G+SLLD+ND+YGSC PDFELSC G ++ +DF EL +W S
Sbjct: 271 LKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTS 330
Query: 379 DSERFRPYNEVQCKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMTDGRLTSKAFMKYKNK 438
D ER++P NE + C C +DC L S A +
Sbjct: 331 DYERYKPINE----DECRKSCL-------NDC----------------LCSVAIFR---- 359
Query: 439 GDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNS 498
D KKK + N + + F+ F K +
Sbjct: 360 -----------DGCWKKKLPLSNGRFDIGMNGKAFLKFP--------------KGY---- 390
Query: 499 PGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV 558
TNL F+YKEL EAT++FK+EVGRG FG+VYKG I ST VAVKKLD+V
Sbjct: 391 -------TNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAG--STRVVAVKKLDKV 441
Query: 559 FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSW 618
QDGEKEFK EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+NGTLA+FLFG KP+W
Sbjct: 442 VQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNW 501
Query: 619 NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678
RT IAF IARGLLYLHE+C QIIHCDIKPQNILLD+YYNARISDFGLAKLL ++QSK
Sbjct: 502 KQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSK 561
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTD 737
+TAIRGTKGYVAPEWFRN IT KVDVYSFGV+LLEII CR++ D+E+GE E +LTD
Sbjct: 562 T-QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTD 620
Query: 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
WA+DCY + LD L+ D EA NDI +E+L+ V IWCIQEDPSLRPTM+KV QMLEGVV
Sbjct: 621 WAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVV 680
Query: 798 EVSLPPNPYPFSS 810
EV PNP+P+SS
Sbjct: 681 EVPAAPNPFPYSS 693
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503089|ref|XP_003520344.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2075), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/814 (52%), Positives = 551/814 (67%), Gaps = 27/814 (3%)
Query: 1 MASARLYFIFLLFQLPFYLHLSIAQNNGTVPVGATLTAGTNSSTWL--SPSGDFAFGFRQ 58
MAS+ L +F LF L +AQ + +G + TAG +++ WL SPSGDFAFGF
Sbjct: 1 MASSLL--LFFLFCSVILLPFVVAQTKTNIAIGDSHTAGKSTTPWLVSSPSGDFAFGFLP 58
Query: 59 VDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGK 118
++ T D F+L I+Y+NI +T+VW+ N+D PA P+GS+V+L+AD GLVL P G
Sbjct: 59 LEA---TPDHFILCIWYANIQDRTIVWFA-NRDNKPA-PKGSKVELSADDGLVLTAPNGD 113
Query: 119 QVWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRK 178
++W++ V+ G NDTGN VL +SS W+SF + DTLLP QTME Q L S+
Sbjct: 114 KLWNTGGFTARVSSGVFNDTGNLVLLDGASSSTWESFDDYRDTLLPSQTMERGQKLSSKL 173
Query: 179 SETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESG 238
+F+ GRF+ DGNLV++ NLP+ YY SGT + +N+S++G +++F+ SG
Sbjct: 174 RRNDFNIGRFELFFQNDGNLVMHSINLPSEYVNANYYASGTIE-SNTSSAGTQLVFDRSG 232
Query: 239 YMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPK--NGNENWSVAWSEPE 296
+YILR N +++L+ + FY RATL+FDGVF Y +PK +G+ W+ WS P+
Sbjct: 233 DVYILRDNKEKYNLSDGGSISTTQFYLRATLDFDGVFTLYQHPKGSSGSVGWTPVWSHPD 292
Query: 297 NICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLLDENDRYGSCKPDFELSCWGG 356
NIC + SG CG+NSICSL +RP C CPK YSL+D ND GSCKPDF SC
Sbjct: 293 NICKDYLSAASSGVCGYNSICSLGDYKRPICKCPKWYSLVDPNDPNGSCKPDFVQSCSED 352
Query: 357 GQGYKKELFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQ-DDCCWFKK 415
+++L+DF L T+W LSD +P+ E QC+ SC+ DC C+ IF+ D CW KK
Sbjct: 353 ELSQREDLYDFEVLIDTDWPLSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKK 412
Query: 416 LPLSNGMTDGRLT-SKAFMKYKNKGDDPPSVPRPPDPEDKKKRKMMNATGSVLLGSSVFV 474
LPLSNG D L +KAFMK + D S+ PP K R + VLL S +
Sbjct: 413 LPLSNGRVDATLNGAKAFMKVRK---DNSSLVVPPIIVKKNSRNTL----IVLLSGSACL 465
Query: 475 NFALVCAFGLSFFFIY--KKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSF 532
N LV A LS F+++ KKK R +ETNL CF+Y+ELEEAT+ F++ +G+G+F
Sbjct: 466 NLILVGAICLSSFYVFWCKKKLRRVGKSGTNVETNLRCFTYEELEEATNGFEKVLGKGAF 525
Query: 533 GIVYKGVILTTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591
GIVY+GVI S T VAVK+L+ + ++ +KEFKNE+ VIG THHKNLVRLLGFC+
Sbjct: 526 GIVYEGVI--NMGSLTLVAVKRLNTFLLEEVQKEFKNELNVIGLTHHKNLVRLLGFCETQ 583
Query: 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 651
RLLVYE+++NGTLAS +F KPSW LR IA +ARGLLYLHE+CS QIIHCDIKPQ
Sbjct: 584 DERLLVYEYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKPQ 643
Query: 652 NILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFG 711
NILLDDYYNARISDFGLAK+L +NQS+ TAIRGTKGYVA EWF+N ITAKVDVYS+G
Sbjct: 644 NILLDDYYNARISDFGLAKILNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVDVYSYG 702
Query: 712 VLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMV 771
VLLLEI+SCRKS + E EE AILT+WAFDCY L DLVE D EAL+D+K +EKLVM+
Sbjct: 703 VLLLEIVSCRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVMI 762
Query: 772 SIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNP 805
++WC+QEDP LRPTM+ V QMLEGVVEV +PP P
Sbjct: 763 ALWCVQEDPGLRPTMRNVTQMLEGVVEVQIPPCP 796
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 813 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.493 | 0.488 | 0.406 | 2.4e-85 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.728 | 0.714 | 0.344 | 9.4e-82 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.573 | 0.562 | 0.369 | 6.5e-74 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.255 | 0.238 | 0.497 | 6.1e-69 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.377 | 0.361 | 0.400 | 8.5e-69 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.369 | 0.352 | 0.375 | 2.4e-67 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.383 | 0.370 | 0.386 | 8.4e-65 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.364 | 0.360 | 0.374 | 2.4e-62 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.357 | 0.343 | 0.383 | 3.3e-61 | |
| TAIR|locus:2137010 | 849 | AT4G11900 [Arabidopsis thalian | 0.856 | 0.819 | 0.276 | 2.3e-60 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 2.4e-85, Sum P(2) = 2.4e-85
Identities = 179/440 (40%), Positives = 260/440 (59%)
Query: 391 CKNSCLSDCFCAAVIFQD---DCCWFKKLPLSNGMTDGRLTSKAFMKYKNKGXXXXXXXX 447
CK C ++C C + FQ+ +C F + + T G S F+ Y
Sbjct: 363 CKEFCHNNCSCLGLFFQNSSGNCFLFDYI--GSFKTSGNGGS-GFVSYIKIASTGSGGGD 419
Query: 448 XXXXXXXXXXXMMNATGSVLLGSSVFVNFALVCAFGLSFFFIYKKKWIRNSPGDGTIETN 507
++ +++ +VF+ L+ F ++F +KK I +P + + E N
Sbjct: 420 NGEDDGKHFPYVV-----IIVVVTVFIIAVLI--F-VAFRIHKRKKMILEAPQESSEEDN 471
Query: 508 -------LPC-FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF 559
+P F+YK+L+ AT+NF ++G+G FG VY+G T + +AVKKL+ +
Sbjct: 472 FLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEG----TLPDGSRLAVKKLEGIG 527
Query: 560 QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----GNLK 615
Q G+KEF+ EV +IG HH +LVRL GFC EG +RLL YEFL+ G+L ++F G++
Sbjct: 528 Q-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586
Query: 616 PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
W+ R NIA A+GL YLHEDC A+I+HCDIKP+NILLDD +NA++SDFGLAKL+T
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735
QS T +RGT+GY+APEW N I+ K DVYS+G++LLE+I RK++D E
Sbjct: 647 QSHVF-TTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHF 705
Query: 736 TDWAFDCYRNEKLDDLVEGDMEALNDI--KCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
+AF KL D+V+G M+ + D+ + V++ + ++WCIQED RP+M KV+QML
Sbjct: 706 PSFAFKKMEEGKLMDIVDGKMKNV-DVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764
Query: 794 EGVVEVSLPPNPYPFSSSMG 813
EGV V PP+ SS+MG
Sbjct: 765 EGVFPVVQPPS----SSTMG 780
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
Identities = 222/644 (34%), Positives = 326/644 (50%)
Query: 186 GRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRR 245
G + F+L + GNL L + Y+ G +S+ S R+ +G + I
Sbjct: 161 GLYSFQLERSGNLTLR------WNTSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVSIFES 214
Query: 246 N--GGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPENICVNIG 303
N GG + + + F + L+ DG Y + + WS + V
Sbjct: 215 NLLGGAEIVYSGDYGDSNTFRF-LKLDDDGNLRIYSSASRNSGPVNAHWSAVDQCLVY-- 271
Query: 304 GEMGSGACGFNSICSLDSDRRPKCACP-KGYSLLDENDRYGSCKPDFELSCWGGGQGYKK 362
G CG ICS + D P C+CP + + +D NDR CK ELS G
Sbjct: 272 -----GYCGNFGICSYN-DTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSGNT---- 321
Query: 363 ELFDFHELQLTNWHLS-DSERFRPYNEVQCKNSCLSDCFCAAVIFQDDC---CWFKKLPL 418
+ D +L + +SE F + C+ +CLS C A + D CW +K P
Sbjct: 322 TMLDLVHTRLFTYEDDPNSESFFAGSS-PCRANCLSSVLCLASVSMSDGSGNCW-QKHPG 379
Query: 419 S--NGMTDGRLTSKAFMKYKNKGXXXXXXXXXXXXXXXXXXXMMNATGSVLLGSSVFVNF 476
S G + S +++K + +V+ G +
Sbjct: 380 SFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIVAVAVIAG---LLGL 436
Query: 477 ALVCAFGLSFFFIYKKKWIRNSPGDGTI---ETNLPC-FSYKELEEATDNFKEEVGRGSF 532
V GL + K T+ + P F+YKEL+ T +FKE++G G F
Sbjct: 437 VAV-EIGLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGF 495
Query: 533 GIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592
G VY+GV+ T+ T VAVK+L+ + Q GEK+F+ EV I THH NLVRL+GFC +G+
Sbjct: 496 GTVYRGVL----TNRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGR 550
Query: 593 NRLLVYEFLNNGTLASFLF--GNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIK 649
+RLLVYEF+ NG+L +FLF + K +W R NIA A+G+ YLHE+C I+HCDIK
Sbjct: 551 HRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIK 610
Query: 650 PQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYS 709
P+NIL+DD + A++SDFGLAKLL ++ +++RGT+GY+APEW N IT+K DVYS
Sbjct: 611 PENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYS 670
Query: 710 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--NEK--LDDLVEGDMEALNDIKCV 765
+G++LLE++S +++FD+ + + WA++ + N K LD + D D++ V
Sbjct: 671 YGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTV--DMEQV 728
Query: 766 EKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPFS 809
++V S WCIQE P RPTM KV+QMLEG+ E+ P P S
Sbjct: 729 MRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTIS 772
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
Identities = 189/512 (36%), Positives = 273/512 (53%)
Query: 311 CGFNSICSLDSDRRPKCACPKGYSLLDEND----RYGS-CKPDFELSCWGGGQGYKKELF 365
CG ICS S+ P C CP+G+ + + D Y + C EL C +G + F
Sbjct: 296 CGSFGICSDKSE--PFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQC---SRGDINQFF 350
Query: 366 DFHELQLTNWHLSDSERFRPYNEVQ-CKNSCLSDCFCAAVIFQDDCCWFKKLPLSNGMTD 424
+L N L+D+ + C ++C DC C A + + K L S +
Sbjct: 351 -----RLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYAYDEGSS--KCLVWSKDV-- 401
Query: 425 GRLTSKAFMKYKNKGXXXXXXXXXXXXXXXXXXXMMNATGSV---LLGS-SVFVNFALVC 480
L + ++G N G + +LGS V V LV
Sbjct: 402 --LNLQQLEDENSEGNIFYLRLAASDVPNVGASGKSNNKGLIFGAVLGSLGVIVLVLLVV 459
Query: 481 AFGLSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVI 540
L + ++K +R GDGT L FSY+EL+ AT NF +++G G FG V+KG +
Sbjct: 460 ILILRY---RRRKRMRGEKGDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGAL 512
Query: 541 LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600
++ +AVK+L+ + Q GEK+F+ EVV IG H NLVRL GFC EG +LLVY++
Sbjct: 513 ----PDSSDIAVKRLEGISQ-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDY 567
Query: 601 LNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 655
+ NG+L S LF N + W LR IA ARGL YLH++C IIHCDIKP+NILL
Sbjct: 568 MPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILL 627
Query: 656 DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLL 715
D + +++DFGLAKL+ + S+ + T +RGT+GY+APEW ITAK DVYS+G++L
Sbjct: 628 DSQFCPKVADFGLAKLVGRDFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLF 686
Query: 716 EIISCRKSFDIEMGEEYAILTDWAFDCYRNE-KLDDLVEGDMEA-LNDIKCVEKLVMVSI 773
E++S R++ + E+ WA + + LV+ +E DI+ V + V+
Sbjct: 687 ELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVAC 746
Query: 774 WCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNP 805
WCIQ++ S RP M +V+Q+LEGV+EV+ PP P
Sbjct: 747 WCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 6.1e-69, Sum P(4) = 6.1e-69
Identities = 107/215 (49%), Positives = 146/215 (67%)
Query: 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEV 570
F ++ELE+AT+NFK ++G G FG VYKG T T +AVKK+ G +EF E+
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEI 560
Query: 571 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQI 628
+IG H NLV+L GFC G+ LLVYE++N+G+L LF P W R +IA
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
ARGL YLH C +IIHCD+KP+NILL D++ +ISDFGL+KLL +S ++ T +RGT+
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTR 679
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 723
GY+APEW N+ I+ K DVYS+G++LLE++S RK+
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 8.5e-69, Sum P(2) = 8.5e-69
Identities = 127/317 (40%), Positives = 186/317 (58%)
Query: 500 GDGTIETNLPCFSYKELEEATDNF-KE-EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR 557
G + LP FS + AT++F KE E+GRG FG VYKGV+ R +AVK+L
Sbjct: 506 GKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE----IAVKRLSG 561
Query: 558 VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS 617
G EFKNE+++I + H+NLVRLLG C EG+ ++LVYE++ N +L FLF K +
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 618 ---WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674
W LR +I IARGLLYLH D +IIH D+K N+LLD N +ISDFG+A++
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 734
NQ++A + GT GY++PE+ + K DVYSFGVLLLEI+S +++ + E+
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGS 740
Query: 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
L +A+ Y + + ++LV+ + + + + V++ C+Q+ + RP M VL MLE
Sbjct: 741 LIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800
Query: 795 GVVEVSLPPNPYPFSSS 811
P F+S+
Sbjct: 801 SDTATLAAPRQPTFTST 817
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 2.4e-67, Sum P(2) = 2.4e-67
Identities = 119/317 (37%), Positives = 181/317 (57%)
Query: 501 DGTIETNLPCFSYKELEEATDNFKE--EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV 558
+ T + LP ++E+ AT+NF ++G+G FGIVYKG +L + +AVK+L +
Sbjct: 504 NNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE----MAVKRLSKT 559
Query: 559 FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLK 615
G EFKNEV +I + H NLVRLL C + ++L+YE+L N +L S LF N K
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619
Query: 616 PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
+W +R +I IARGLLYLH+D +IIH D+K NILLD Y +ISDFG+A++ +
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR--KSF---DIEMGE 730
+++A + GT GY++PE+ + + K DV+SFGVLLLEIIS + K F D ++
Sbjct: 680 ETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNL 739
Query: 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790
+ +W + E +D ++ + + + + + + C+QE RPTM V+
Sbjct: 740 LGCVWRNWK-EGKGLEIIDPIITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMSLVI 797
Query: 791 QMLEGVVEVSLPPNPYP 807
ML G ++P P
Sbjct: 798 LML-GSESTTIPQPKAP 813
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 8.4e-65, Sum P(2) = 8.4e-65
Identities = 125/323 (38%), Positives = 177/323 (54%)
Query: 490 YKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEE--VGRGSFGIVYKGVILTTRTST 547
Y I+ GD +LP FS+ + AT +F EE +G+G FG VYKG R
Sbjct: 492 YSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGRE-- 549
Query: 548 TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA 607
+AVK+L + G +EFKNE+++I + H+NLVRLLG C E ++L+YE++ N +L
Sbjct: 550 --IAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLD 607
Query: 608 SFLFGNLKPS---WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 664
FLF K W R + IARGLLYLH D +IIH D+K NILLD N +IS
Sbjct: 608 RFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKIS 667
Query: 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
DFG+A++ Q A + GT GY+APE+ + K DVYSFGVL+LEI+S RK+
Sbjct: 668 DFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNV 727
Query: 725 DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP 784
G ++ L +A+ + K ++++ ++ D+ + + V + C Q+ RP
Sbjct: 728 SFR-GTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRP 786
Query: 785 TMKKVLQMLEGVVEVSLPPNPYP 807
M VL MLE LPP P
Sbjct: 787 NMGSVLLMLESQTS-QLPPPRQP 808
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 2.4e-62, Sum P(3) = 2.4e-62
Identities = 115/307 (37%), Positives = 180/307 (58%)
Query: 506 TNLPCFSYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE 563
+ L F +L+ AT+NF ++G+G FG VYKG + + +AVK+L G
Sbjct: 481 SGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKE----IAVKRLTSSSVQGT 536
Query: 564 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNL 620
+EF NE+ +I + H+NL+RLLG C +G+ +LLVYE++ N +L F+F L+ W
Sbjct: 537 EEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWAT 596
Query: 621 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
R NI IARGLLYLH D +++H D+K NILLD+ N +ISDFGLA+L NQ +
Sbjct: 597 RFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDS 656
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740
++ GT GY++PE+ T + K D+YSFGVL+LEII+ ++ G++ L +A+
Sbjct: 657 TGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAW 716
Query: 741 DCYRNEKLDDLVEGDMEALNDIKCVE--KLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
D + +L++ D++ + + VE + V + + C+Q RP +K+V+ ML +
Sbjct: 717 DSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTTD 776
Query: 799 VSLPPNP 805
+ P P
Sbjct: 777 LPKPTQP 783
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 3.3e-61, Sum P(3) = 3.3e-61
Identities = 118/308 (38%), Positives = 180/308 (58%)
Query: 508 LPCFSYKELEEATDNFKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE 565
LP +K L AT+NF + +G+G FGIVYKG++L + +AVK+L ++ G E
Sbjct: 508 LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKE----IAVKRLSKMSSQGTDE 563
Query: 566 FKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPS---WNLR 621
F NEV +I + H NLVRLLG C D+G+ ++L+YE+L N +L S LF + S W R
Sbjct: 564 FMNEVRLIAKLQHINLVRLLGCCVDKGE-KMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 622
Query: 622 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681
+I IARGLLYLH+D +IIH D+K N+LLD +ISDFG+A++ +++A
Sbjct: 623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682
Query: 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741
+ GT GY++PE+ + + K DV+SFGVLLLEIIS +++ L + +
Sbjct: 683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 742
Query: 742 CYRNEKLDDLVEG-DMEALN-DIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
++ K ++V+ +++AL+ + E L + + + C+QE RP M V+ ML
Sbjct: 743 HWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGS-- 800
Query: 798 EVSLPPNP 805
E + P P
Sbjct: 801 ETTAIPQP 808
|
|
| TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 2.3e-60, Sum P(2) = 2.3e-60
Identities = 214/774 (27%), Positives = 341/774 (44%)
Query: 69 FLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEID-- 126
+LL I N+ + T K R S K++ + L+ ++ VWS+ ++
Sbjct: 97 YLLKILDGNLILHDNISAT-RKSHTEGTSRRSPQKIS-EGNLLFHET----VWSTGVNSS 150
Query: 127 IGTVAVGHMNDTGNFVLAXXXXXXXXX---XXXNPSDTLLPGQTMETKQGLF-SRKSETN 182
+ + D+GN VL +PSDT LPG + LF S +S +
Sbjct: 151 MSKDVQAVLFDSGNLVLRDGPNSSAAVLWQSFDHPSDTWLPGGKIRLGSQLFTSWESLID 210
Query: 183 FSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT-YDPANSSNSGYRVMFNESGYMY 241
S GR+ + ++ + N +Y+ SG YD S G+ + + +
Sbjct: 211 PSPGRYSLEFDPKLHSLVTVWNRSK-----SYWSSGPLYDWLQSFK-GFPEL-QGTKLSF 263
Query: 242 ILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPENICVN 301
L + T SV P + YR + G F + + ++W V S+P+N C +
Sbjct: 264 TLNMDESYI---TFSVDPQSR--YRLVMGVSGQFMLQVWHVD-LQSWRVILSQPDNRC-D 316
Query: 302 IGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLL------DENDRYGSCKPDFELSCWG 355
+ +CG IC+ ++ P C C G+ D ND G CK + L C
Sbjct: 317 V-----YNSCGSFGICN-ENREPPPCRCVPGFKREFSQGSDDSNDYSGGCKRETYLHC-- 368
Query: 356 GGQGYKK--ELFDFHELQL----TNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQDD 409
YK+ E ++L T + S FR C + C++DC C A +
Sbjct: 369 ----YKRNDEFLPIENMKLATDPTTASVLTSGTFRT-----CASRCVADCSCQAYANDGN 419
Query: 410 CC--WFKKLPLSNGMTDGRLTSKAFMKYKNKGXXXXXXXXXXXXXXXXXXXMMNATGSVL 467
C W K + D F++ + + S++
Sbjct: 420 KCLVWTKDA-FNLQQLDANKGHTFFLRLASSNISTANNRKTEHSKGKSIVLPL-VLASLV 477
Query: 468 LGSSVFVNFALVCAFGLSFFFIYKK---KWIRNSPGDGTIET---NLPCFSYKELEEATD 521
++ FV L C K+ K R G I+ N+ + ++ AT+
Sbjct: 478 ATAACFVG--LYCCISSRIRRKKKQRDEKHSRELLEGGLIDDAGENMCYLNLHDIMVATN 535
Query: 522 NF--KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 579
+F K+++G G FG VYKG + + VA+K+L + G EFKNEVV+I + HK
Sbjct: 536 SFSRKKKLGEGGFGPVYKGKL----PNGMEVAIKRLSKKSSQGLTEFKNEVVLIIKLQHK 591
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLH 636
NLVRLLG+C EG +LL+YE+++N +L LF +LK W R I RGL YLH
Sbjct: 592 NLVRLLGYCVEGDEKLLIYEYMSNKSLDGLLFDSLKSRELDWETRMKIVNGTTRGLQYLH 651
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
E +IIH D+K NILLDD N +ISDFG A++ Q I GT GY++PE+
Sbjct: 652 EYSRLRIIHRDLKASNILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGYMSPEYA 711
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756
I+ K D+YSFGVLLLEIIS +K+ ++ L + ++ + K +++ M
Sbjct: 712 LGGVISEKSDIYSFGVLLLEIISGKKATRFVHNDQKHSLIAYEWESWCETKGVSIIDEPM 771
Query: 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPFSS 810
++ + + +++ C+Q+ P RP + +++ ML + +P P FS+
Sbjct: 772 CCSYSLEEAMRCIHIALLCVQDHPKDRPMISQIVYMLSNDNTLPIPKQP-TFSN 824
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4803 | 0.9606 | 0.9387 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 813 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-41 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-11 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 90/282 (31%), Positives = 133/282 (47%), Gaps = 41/282 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKN 580
++G GSFG VYK T VAVK L + + +K+ + E+ ++ + H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKI---VAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+VRL+ ++ + LV E+ G L +L S + IA QI RGL YLH S
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW-FRNS 699
IIH D+KP+NILLD+ +I+DFGLAK L + S T GT Y+APE +
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGN 174
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNEKLD 749
KVDV+S GV+L E+++ + F I + D +E+
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
DL++ C+ +DPS RPT +++LQ
Sbjct: 235 DLIK--------------------KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 7e-51
Identities = 80/271 (29%), Positives = 119/271 (43%), Gaps = 60/271 (22%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLL 585
+G G FG VY T VA+K + + E E+ ++ + +H N+V+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKK---VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSAQII 644
G ++ + LV E+ G+L L N S + I QI GL YLH S II
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 645 HCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE-WFRNSTIT 702
H D+KP+NILLD D +++DFGL+KLLT K++ I GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 703 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762
K D++S GV+L E+ +L DL+
Sbjct: 173 EKSDIWSLGVILYEL----------------------------PELKDLIR--------- 195
Query: 763 KCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
+Q+DP RP+ K++L+ L
Sbjct: 196 -----------KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 8e-49
Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 35/277 (12%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTST-TAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 580
E++G GSFG VY T VA+K + + ++E E+ ++ + H N
Sbjct: 3 ILEKLGEGSFGKVYLAR----DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN 58
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
+VRL ++ LV E+ G L L G L QI L YLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLH-- 114
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S I+H D+KP+NILLD+ + +++DFGLA+ L+ + + T + GT Y+APE
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 699 STITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNE-KLDDLVEGD 755
VD++S GV+L E+++ + F D ++ E + + E +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP----- 225
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
EA + I+ + +DP R T ++ LQ
Sbjct: 226 -EAKDLIRK----------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 88/279 (31%), Positives = 138/279 (49%), Gaps = 32/279 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTST-TAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 580
+++G G+FG VYKG + VAVK L + + +EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 638
+V+LLG C E + +V E++ G L S+L +P +L + A QIARG+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA---IRGTKGYVAPEW 695
S IH D+ +N L+ + +ISDFGL++ L + R IR ++APE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEG 754
+ T+K DV+SFGVLL EI + +GE+ Y +++ E L+ L G
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEQPYPGMSN-------EEVLEYLKNG 219
Query: 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
C +L + + C EDP RPT +++++L
Sbjct: 220 YRLPQPP-NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 5e-47
Identities = 87/281 (30%), Positives = 141/281 (50%), Gaps = 35/281 (12%)
Query: 523 FKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 580
+++G G+FG VYKG VAVK L + + +EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHE 637
+V+LLG C E + ++V E++ G L +L +P S + + A QIARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA---IRGTKGYVAPE 694
S IH D+ +N L+ + +ISDFGL++ L + ++ IR ++APE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE 174
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVE 753
+ T+K DV+SFGVLL EI + +GEE Y +++ E L+ L +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFT--------LGEEPYPGMSN-------AEVLEYLKK 219
Query: 754 GD-MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
G + + C +L + + C EDP RPT +++++L
Sbjct: 220 GYRLPKPPN--CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 8e-47
Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTST-TAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKN 580
+++G G+FG VYKG + T T VAVK L + E+ EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHE 637
+VRLLG C +G+ +V E++ G L FL L +A QIA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE- 119
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG---YVAPE 694
S +H D+ +N L+ + +ISDFGL++ + G K ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDI---YEDDYYRKRGGGKLPIKWMAPE 174
Query: 695 WFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753
++ T+K DV+SFGVLL EI + + + EE + + D YR + ++
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELLEDGYRLPRPEN--- 228
Query: 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
C ++L + + C DP RPT ++++ L
Sbjct: 229 ----------CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 94/288 (32%), Positives = 145/288 (50%), Gaps = 44/288 (15%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVR 583
+++G G+FG VYKG + TT VAVK L + E K+F E V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKP---SWNLRTNIAFQIARGLLY 634
LLG C E + LV E++ G L +L F + + S + A QIA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA----IRGTKGY 690
L S + +H D+ +N L+ + +ISDFGL++ + + +T IR +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 691 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLD 749
+APE ++ T+K DV+SFGVLL EI + +G Y L++ E L+
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSN-------EEVLE 218
Query: 750 DLVEGDMEALND-IKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
L +G L C ++L +M+S W Q DP RPT ++++ LE
Sbjct: 219 YLRKG--YRLPKPEYCPDELYELMLSCW--QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 82/273 (30%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
E +GRGSFG VY + + +AVK L ++ + + E+ ++ H N+V
Sbjct: 6 ELLGRGSFGSVYLA---LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 583 RLLGFC-DEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
R G DE +N L ++ E+++ G+L+S L FG L +R QI GL YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLH-- 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S I+H DIK NIL+D +++DFG AK L ++ ++RGT ++APE R
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
D++S G ++E+ + + + E+G A L + + ++ E E
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWS-ELGNPMAALYKIGS----SGEPPEIPEHLSEE 232
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
D + K C++ DP RPT ++LQ
Sbjct: 233 AKDF--LRK-------CLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 80/281 (28%), Positives = 120/281 (42%), Gaps = 45/281 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+G+G FG V G + VAVK L + F E V+ H NLV
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-----VAVKCLKDD-STAAQAFLAEASVMTTLRHPNLV 63
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 640
+LLG +G +V E++ G+L +L + L + A + G+ YL E
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+H D+ +N+L+ + A++SDFGLAK + Q + ++ T APE R
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG-KLPVKWT----APEALREKK 175
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG-----D 755
+ K DV+SFG+LL EI S + Y L D+V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVVPHVEKGYR 217
Query: 756 MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
MEA C ++ VM W + DP+ RPT K++ + L
Sbjct: 218 MEAPE--GCPPEVYKVMKDCWEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 36/276 (13%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 580
+ +GRG+FG+VYKG L T VA+K++ ++ ++ K E+ ++ H N
Sbjct: 4 LGDLIGRGAFGVVYKG--LNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
+V+ +G + + ++ E+ NG+L + FG +L +Q+ +GL YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHEQ 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
+IH DIK NIL +++DFG+A LN ++ GT ++APE
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 699 STITAKVDVYSFGVLLLEIISCRKS-FDIE-MGEEYAILTDWAFDCYRNEKLDDLVEGDM 756
S + D++S G ++E+++ +D+ M + I+ D D L EG
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DHPP------LPEGIS 224
Query: 757 EALND-IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L D + C Q+DP+LRPT K++L+
Sbjct: 225 PELKDFLMQ----------CFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 5e-31
Identities = 81/292 (27%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ-TH 577
++G GSFG VY VA+K L + + KE F E+ ++ H
Sbjct: 3 RILRKLGEGSFGEVYLAR------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRTNIAFQIARGL 632
N+V+L F + + LV E+++ G+L L G L S L I QI L
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF--ILAQILSAL 114
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYN-ARISDFGLAKLLTLNQSKAI----RTAIRGT 687
YLH IIH DIKP+NILLD ++ DFGLAKLL S + + GT
Sbjct: 115 EYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 688 KGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWA 739
GY+APE + ++ D++S G+ L E+++ F+ E I+ +
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ E +A +D+ ++K + +DP R + L
Sbjct: 232 TPSLASPLSPSNPELISKAASDL--LKK-------LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 74/279 (26%), Positives = 129/279 (46%), Gaps = 38/279 (13%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTST-TAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHK 579
+++G+GSFG VY L R S +K++D + EKE + NEV ++ + +H
Sbjct: 5 IKQIGKGSFGKVY----LVRRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHP 59
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAFQIARGLLYL 635
N+++ +E +V E+ + G L+ + + Q+ L YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H S +I+H DIKPQNI L ++ DFG++K+L+ A +T + GT Y++PE
Sbjct: 120 H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVV-GTPYYLSPEL 174
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
+N K D++S G +L E+ + + F+ GE L +++G
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLEL------------ALKILKGQ 219
Query: 756 MEALNDI--KCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
+ + LV +Q+DP RP++ ++LQ
Sbjct: 220 YPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
E++G+G FG VYK + + VA+K + ++ +++ NE+ ++ + H N+V+
Sbjct: 5 LEKIGKGGFGEVYKA---RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----YLHEDC 639
G + +V EF + G+L L + + + IA+ + + LL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTE-SQIAY-VCKELLKGLEYLH--- 115
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
S IIH DIK NILL ++ DFGL+ L+ ++ R + GT ++APE
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGK 172
Query: 700 TITAKVDVYSFGVLLLE 716
K D++S G+ +E
Sbjct: 173 PYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 75/231 (32%), Positives = 115/231 (49%), Gaps = 36/231 (15%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKL-DRVFQDGEKEFKNEVV 571
E+ + F EE+G G+FG VYKG + R S T+VA+K L + ++EF+ E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 572 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------------------ 613
++ H N+V LLG C + Q +++E+L +G L FL N
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 614 LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673
L S L +IA QIA G+ YL S +H D+ +N L+ + +ISDFGL++ +
Sbjct: 121 LDCSDFL--HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 674 LN-----QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
QSK++ +R ++ PE T + D++SFGV+L EI S
Sbjct: 176 SADYYRVQSKSL-LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-28
Identities = 95/346 (27%), Positives = 154/346 (44%), Gaps = 38/346 (10%)
Query: 470 SSVFVNFALVCAFGLSFFFIYKKKWI---RNSPGDGTIETNLPCFSYKELEEATDN---- 522
+ F ++ F FI + + R DGT E F K + T N
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF--FDSKVSKSITINDILS 690
Query: 523 -FKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 579
KEE + RG G YKG + + ++ + +E+ +G+ H
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-------SEIADMGKLQHP 743
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
N+V+L+G C + L++E++ L+ L SW R IA IA+ L +LH C
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRC 800
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
S ++ ++ P+ I++D + L LL + I +A YVAPE
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETK 853
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL----DDLVEGD 755
IT K D+Y FG++L+E+++ + D E G +I+ +WA CY + L D + GD
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYSDCHLDMWIDPSIRGD 912
Query: 756 MEALNDIKCVEKLVM-VSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
+ ++N + VE VM +++ C DP+ RP VL+ LE S
Sbjct: 913 V-SVNQNEIVE--VMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 26/216 (12%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTA-VAVKKLDRVFQDGE----KEFKNEVVVIGQTH 577
F +++G G FG V +T VAVK L+ GE +F+ E+ ++
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLD 64
Query: 578 HKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLL 633
H+N+V+ G C++ G++ L+ E+L +G+L +L + + NL+ + + QI +G+
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMD 123
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ----SKAIR-TAIRGTK 688
YL S + IH D+ +NIL++ +ISDFGLAK+L ++ K + I
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF--- 177
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKS 723
+ APE R S ++ DV+SFGV L E+ + S
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 81/288 (28%), Positives = 137/288 (47%), Gaps = 43/288 (14%)
Query: 526 EVGRGSFGIVYKGVILTTRTST--TAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 582
E+G+GSFG+VY+G+ T VA+K ++ E+ EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLK--PSWNLRTNIAFQIARGL 632
RLLG GQ L+V E + G L S+L P+ +A +IA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG--- 689
YL + +H D+ +N ++ + +I DFG+ + + ++ R +G KG
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYR---KGGKGLLP 184
Query: 690 --YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
++APE ++ T K DV+SFGV+L E+ A L + + NE+
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEM---------------ATLAEQPYQGLSNEE 229
Query: 748 LDDLVEGDMEALN-DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ V D L+ C +KL+ + C Q +P +RPT +++ L+
Sbjct: 230 VLKFV-IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THH 578
F + +G GSF V + + A+K LD+ + K K E V+ + H
Sbjct: 5 FGKIIGEGSFSTVVLA---KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 579 KNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 635
+++L F DE +N V E+ NG L ++ +G+L A +I L YL
Sbjct: 62 PGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEYL 118
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ--------SKAIRTAIR-- 685
H S IIH D+KP+NILLD + +I+DFG AK+L N + I + I
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 686 --------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
GT YV+PE D+++ G ++ ++++ + F
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 71/199 (35%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+E+G G+FG V KGV L VAVK L G+KEF E V+ Q H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQ 642
L+G C +G+ +LV E G L +L + P +L +A Q+A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYLES---KH 115
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIRTAIRGTKGYVAPEWFRNST 700
+H D+ +N+LL + + A+ISDFG+++ L +A TA R + APE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA-TTAGRWPLKWYAPECINYGK 174
Query: 701 ITAKVDVYSFGVLLLEIIS 719
++K DV+S+GV L E S
Sbjct: 175 FSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 32/271 (11%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLG 586
G+GS G+VYK + + A+KK+ + K+ E+ + +V+ G
Sbjct: 10 GQGSSGVVYKVR---HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 587 -FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 645
F EG+ + V E+++ G+LA L K + IA QI +GL YLH IIH
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 646 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKV 705
DIKP N+L++ +I+DFG++K L + GT Y++PE + + +
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 706 DVYSFGVLLLEIISCRKSFDIEMGEEYAIL----TDWAFDCYRNEKLDDLVEGDMEALND 761
D++S G+ LLE +G ++ L + E + + +G +L
Sbjct: 182 DIWSLGLTLLECA---------LG-KFPFLPPGQPSFF------ELMQAICDGPPPSLPA 225
Query: 762 IKCVEKLV-MVSIWCIQEDPSLRPTMKKVLQ 791
+ + +S C+Q+DP RP+ ++LQ
Sbjct: 226 EEFSPEFRDFISA-CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 36/277 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHHKNLV 582
+G G+FG VY V L T +AVK++ QD + KE +E+ V+ H NLV
Sbjct: 8 IGGGTFGKVYTAVNLDT---GELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+ G + + E+ + GTL L G + +R Q+ GL YLH S
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLH---SH 118
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI---RGTKGYVAPEWFRN 698
I+H DIKP NI LD ++ DFG A L N + + + GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 699 STITAK---VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
D++S G ++LE+ + ++ + E+ E+ I+ G
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWS-ELDNEFQIMFHVGA-------------GH 223
Query: 756 MEALNDIKCVEKLVMVSI-WCIQEDPSLRPTMKKVLQ 791
+ D + + C++ DP RPT ++LQ
Sbjct: 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 22/204 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
E++G G+ G VYK T R + VA+KK+ R+ + ++ NE++++ H N+
Sbjct: 22 KNLEKIGEGASGEVYKA---TDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN---IAF---QIARGLLY 634
V + L +V E+++ G+L + N +R N IA+ ++ +GL Y
Sbjct: 78 VDYYD-SYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLEY 131
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
LH S +IH DIK NILL + +++DFG A LT +SK R ++ GT ++APE
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPE 186
Query: 695 WFRNSTITAKVDVYSFGVLLLEII 718
+ KVD++S G++ +E+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/203 (34%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+ ++G G FG V+ G T TT VAVK L E F E ++ + H LV+
Sbjct: 11 ERKLGAGQFGEVWMG----TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQ 65
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDC 639
L C E + +V E+++ G+L FL LR +A QIA G+ YL
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK---GYVAPEWF 696
S IH D+ +NIL+ + +I+DFGLA+L+ + TA G K + APE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKFPIKWTAPEAA 176
Query: 697 RNSTITAKVDVYSFGVLLLEIIS 719
T K DV+SFG+LL EI++
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 87/289 (30%), Positives = 134/289 (46%), Gaps = 39/289 (13%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVV 572
E+E K ++G G +G VY+GV + S T VAVK L +D +EF E V
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGV--WKKYSLT-VAVKTLK---EDTMEVEEFLKEAAV 55
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 630
+ + H NLV+LLG C ++ EF+ G L +L + N +A QI+
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK-- 688
+ YL IH D+ +N L+ + + +++DFGL++L+T TA G K
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFP 168
Query: 689 -GYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRN 745
+ APE + + K DV++FGVLL EI + I++ + Y +L YR
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KGYRM 224
Query: 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
E+ EG C K+ + C Q +PS RP+ ++ Q E
Sbjct: 225 ER----PEG---------CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 574
E++ + ++G G FG V++G+ +TT VAVK L D K+F E ++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLW----NNTTPVAVKTLKPGTMD-PKDFLAEAQIMK 56
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 632
+ H L++L C + +V E + G+L +L G + L ++A Q+A G+
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
YL + IH D+ +N+L+ + +++DFGLA+++ + +A R + + A
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTA 172
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIIS 719
PE + + K DV+SFG+LL EI++
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 28/266 (10%)
Query: 528 GRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
G G+FG VYKGV I VA+K L + KE +E V+ H ++VRLL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
G C L+ + + G L ++ N+ + L N QIA+G+ YL E +
Sbjct: 76 GIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL--NWCVQIAKGMSYLEE---KR 129
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT 702
++H D+ +N+L+ + +I+DFGLAKLL +++ + + ++A E + T
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 703 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE-GDMEALND 761
K DV+S+GV + E+++ G + ++ ++ DL+E G+
Sbjct: 190 HKSDVWSYGVTVWELMT--------FGAK-------PYEGIPAVEIPDLLEKGERLPQPP 234
Query: 762 IKCVEKLVMVSIWCIQEDPSLRPTMK 787
I C + MV + C D RPT K
Sbjct: 235 I-CTIDVYMVLVKCWMIDAESRPTFK 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 21/202 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
++G G FG V++G+ VA+K L +++F+ EV + + HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR----VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
C G+ ++ E + G+L +FL G + P +L ++A Q+A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-IDMACQVAEGMAYLEEQ--- 123
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLT----LNQSKAIRTAIRGTKGYVAPEWFR 697
IH D+ +NIL+ + +++DFGLA+L+ L+ K I + T APE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT----APEAAS 177
Query: 698 NSTITAKVDVYSFGVLLLEIIS 719
+ T + K DV+SFG+LL E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 81/299 (27%), Positives = 140/299 (46%), Gaps = 41/299 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHH 578
E+G+GSFG+VY+G + + T VAVK ++ E+ EF NE V+
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQI 628
++VRLLG +GQ L+V E + +G L S+L G P+ +A +I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
A G+ YL+ + + +H D+ +N ++ + +I DFG+ + + ++ R +G K
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGK 180
Query: 689 G-----YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743
G ++APE ++ T D++SFGV+L EI S L + +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGL 225
Query: 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLP 802
NE++ V C E++ + C Q +P +RPT +++ +L+ + S P
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 30/277 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 583
+ +G G FG V +G + VA+K L D ++ +F E ++GQ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
L G + + +++ E++ NG+L FL N K + + IA G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS----KAIRTAIRGTKGYVAPEWFRN 698
+H D+ +NIL++ ++SDFGL++ L +++ K + IR T APE
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGDME 757
T+ DV+SFG+++ E++S GE Y D + N+ + VE
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS--------YGERPYW---DMS-----NQDVIKAVEDGYR 226
Query: 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ C L + + C Q+D + RPT +++ L+
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 43/281 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHK 579
F +E+G G FG+V+ G VA+K + ++G E +F E V+ + H
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID----VAIKMI----REGAMSEDDFIEEAKVMMKLSHP 59
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLH 636
NLV+L G C + + +V E++ NG L ++L G L W L ++ + + YL
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAMEYLE 117
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK---GYVAP 693
+ IH D+ +N L+ + ++SDFGLA+ + +Q T+ +GTK + P
Sbjct: 118 SNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVKWAPP 170
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-EKLDDLV 752
E F S ++K DV+SFGVL+ E+ S K ++ + N E ++ +
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKM---------------PYERFSNSEVVESVS 215
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
G ++ + C E P RP KK+L L
Sbjct: 216 AG-YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 60/291 (20%)
Query: 522 NFK--EEVGRGSFGIVYKGVILTTRTSTTAV-AVKKLD-RVFQDGEKEFK-NEVVVIGQT 576
+FK +++G+GS+G VYK R S A+K++D E+E NE+ ++
Sbjct: 1 DFKVLKKLGKGSYGSVYK----VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 577 HHKNLVR-----LLGFCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPS---WNLRT 622
+H N++ L G N+L +V E+ G L+ + L P W
Sbjct: 57 NHPNIISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--- 107
Query: 623 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682
I Q+ RGL LHE +I+H D+K NILL +I D G++K+L +T
Sbjct: 108 -IFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKT 160
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAF 740
I GT Y+APE ++ + K D++S G LL E+ + F+ ++ Y + +
Sbjct: 161 QI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-KY 218
Query: 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
DL + + +Q P LRP K+L
Sbjct: 219 PPIPPIYSQDL--------------QNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 88/299 (29%), Positives = 137/299 (45%), Gaps = 54/299 (18%)
Query: 527 VGRGSFGIVYKG--VILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVV------VIGQT 576
+G G+FG V K V L T+ VAVK L D EK+ + V +IG+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMKMIGK- 74
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPSWNLR--- 621
HKN++ LLG C + +V E+ +G L FL P L
Sbjct: 75 -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 622 -TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
+ A+Q+ARG+ +L S + IH D+ +N+L+ + + +I+DFGLA+ +
Sbjct: 134 LVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDW 738
T R ++APE + T + DV+SFGVLL EI + S I + E + +L +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250
Query: 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
YR EK C ++L + C E PS RPT K++++ L+ ++
Sbjct: 251 ----YRMEK-------------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 33/276 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+E+G G FG+V+ G L R VA+K + E++F E V+ + H LV
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLV 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+L G C E LV+EF+ +G L+ +L + ++ T + + G+ YL
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK---GYVAPEWFR 697
+IH D+ +N L+ + ++SDFG+ + + +Q T+ GTK + +PE F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY----TSSTGTKFPVKWSSPEVFS 174
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757
S ++K DV+SFGVL+ E+ S K+ ++ N ++ + +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKT---------------PYENRSNSEVVETINAGFR 219
Query: 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
+ + + C +E P RP+ +L L
Sbjct: 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 80/275 (29%), Positives = 130/275 (47%), Gaps = 39/275 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
E +G G FG V +G + VAVK K D Q F E V+ + HHKNLV
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK-----VAVKNIKCDVTAQ----AFLEETAVMTKLHHKNLV 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCS 640
RLLG +V E ++ G L +FL + ++ + F +A G+ YL S
Sbjct: 63 RLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---S 118
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+++H D+ +NIL+ + A++SDFGLA++ S + + K + APE ++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVK-WTAPEALKHKK 173
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG-DMEAL 759
++K DV+S+GVLL E+ S ++ Y ++ E + + +G ME
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRA-------PYPKMS-------LKEVKECVEKGYRMEPP 219
Query: 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
++M S W + +P RP+ K+ + LE
Sbjct: 220 EGCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 81/289 (28%), Positives = 128/289 (44%), Gaps = 47/289 (16%)
Query: 527 VGRGSFGIVYKGVILTTRTSTT--AVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVR 583
+G G+FG VY+G+ VAVK L + E +F E +++ + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRT----NIAFQIARGLLYL 635
L+G E R ++ E + G L SFL N +PS +L A +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS-SLTMKDLLFCARDVAKGCKYL 132
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNAR---ISDFGLAKLLTLNQSKAIRTAIRGTKG--- 689
E IH DI +N LL R I+DFG+A+ + ++ R +G +
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYR---KGGRAMLP 184
Query: 690 --YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
++ PE F + T+K DV+SFGVLL EI S L + N++
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYMPYPGRTNQE 229
Query: 748 LDDLVE--GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ + V G ++ +M W Q P RP +L+ ++
Sbjct: 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCW--QHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 78/288 (27%), Positives = 141/288 (48%), Gaps = 43/288 (14%)
Query: 526 EVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 582
E+G+GSFG+VY+G+ + T VA+K ++ E+ EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 632
RLLG +GQ L++ E + G L S+L PS +A +IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG--- 689
YL+ + + +H D+ +N ++ + + +I DFG+ + + ++ R +G KG
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 184
Query: 690 --YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
+++PE ++ T DV+SFGV+L EI A L + + NE+
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGMSNEQ 229
Query: 748 -LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
L ++EG + D C + L + C Q +P +RP+ +++ ++
Sbjct: 230 VLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 77/283 (27%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAV-KKLD-RVFQDGEKE-FKNEVVVIGQTHHKNL 581
E +G+GSFG V K V R S + V K++D + EK+ +EV ++ + H N+
Sbjct: 6 ETIGKGSFGTVRK-VR---RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 582 VRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--------NIAFQIARG 631
VR D L +V E+ G LA + + R I Q+
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI----QKCKKERKYIEEEFIWRILTQLLLA 117
Query: 632 LLYLH--EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
L H D ++H D+KP NI LD N ++ DFGLAK+L + S A GT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPY 175
Query: 690 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749
Y++PE + + K D++S G L+ E+ + F L + K
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI----KEGKFR 228
Query: 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
+ LN V+ S + DP RP+ +++LQ+
Sbjct: 229 RIPYRYSSELN-------EVIKS--MLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 30/270 (11%)
Query: 527 VGRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G G FG V+KG+ I + VA+K + DR + +E + ++ +G H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
LG C G + LV + G+L + +L P N QIA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQIAKGMYYLEEHR-- 129
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
++H ++ +NILL +I+DFG+A LL + K + + ++A E
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 702 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE-GDMEALN 760
T + DV+S+GV + E++S E YA + R ++ DL+E G+ A
Sbjct: 189 THQSDVWSYGVTVWEMMSYG-------AEPYAGM--------RPHEVPDLLEKGERLAQP 233
Query: 761 DIKCVE-KLVMVSIWCIQEDPSLRPTMKKV 789
I ++ +VMV W I E+ +RPT K++
Sbjct: 234 QICTIDVYMVMVKCWMIDEN--VRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 83/286 (29%), Positives = 127/286 (44%), Gaps = 32/286 (11%)
Query: 515 ELEEATDNFKEEV--GRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 572
E E D E V G+G++GIVY L+T+ +A+K++ + E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVR---IAIKEIPERDSRYVQPLHEEIAL 58
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIA 629
H+N+V+ LG E + E + G+L++ L P + I F QI
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLT-LNQSKAIRTAIRGT 687
GL YLH++ QI+H DIK N+L++ Y +ISDFG +K L +N T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GT 172
Query: 688 KGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745
Y+APE A D++S G ++E+ + + F IE+GE A +
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQAAMFKVGMFKIHP 231
Query: 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
E + L EA N I C + DP R + +LQ
Sbjct: 232 EIPESLSA---EAKNFILR----------CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
E++G+G+FG VYKGV+ T VAVK + D +++F E ++ Q H N+V+
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI----ARGLLYLHEDC 639
L+G C + Q +V E + G+L +FL K L Q+ A G+ YL
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK----GYVAPEW 695
IH D+ +N L+ + +ISDFG+++ + I T G K + APE
Sbjct: 114 C---IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 696 FRNSTITAKVDVYSFGVLLLEIIS 719
T++ DV+S+G+LL E S
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNL 581
E +G+GSFG VYK + + + VA+K +D ++ E E + E+ + Q +
Sbjct: 7 ECIGKGSFGEVYKAID---KRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 638
+ G +G ++ E+ G+ L KP T IAF ++ GL YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
IH DIK NILL + + +++DFG++ LT SK R GT ++APE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQ 172
Query: 699 STITAKVDVYSFGVLLLEII 718
S K D++S G+ +E+
Sbjct: 173 SGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAV-AVKKLDRVFQDG--EKEFKNEVVVIGQTHHKN 580
++G+GSFG+V+K V R + V A+K++D + +E +E V+ +
Sbjct: 5 LNKIGKGSFGVVFKVV----RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHED 638
++R + +V E+ NG L L + QI GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S +I+H DIK N+ LD Y N +I D G+AKLL+ N + A T I GT Y++PE +
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA-NT-IVGTPYYLSPELCED 175
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIE 727
K DV++ GV+L E + + FD
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 60/206 (29%), Positives = 110/206 (53%), Gaps = 24/206 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLL 585
+G+G FG VY G ++ + AVK L+R+ E ++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 586 GFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAF--QIARGLLYLHEDC 639
G C EG L+V ++ +G L +F+ + N ++ I F Q+A+G+ YL
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAK------LLTLNQSKAIRTAIRGTKGYVAP 693
S + +H D+ +N +LD+ + +++DFGLA+ +++ + ++ ++A
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMAL 171
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIIS 719
E + T K DV+SFGVLL E+++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 74/286 (25%), Positives = 135/286 (47%), Gaps = 37/286 (12%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLV 582
+E +G G FG V +G + VA+K L + + + ++F +E ++GQ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 636
L G + + +++ EF+ NG L SFL F ++ LR IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK---GYVAP 693
E +H D+ +NIL++ ++SDFGL++ L + S T+ G K + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIISC--RKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
E T+ DV+S+G+++ E++S R +D+ N+ + +
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVINA 223
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
+E D + C L + + C Q+D + RP +++ L+ ++
Sbjct: 224 IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 66/214 (30%), Positives = 116/214 (54%), Gaps = 25/214 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKK--LDRVFQDGEKE-------FKNEVVVIGQTH 577
+G GSFG VY G+ +S +AVK+ L V + E+ ++ +
Sbjct: 8 IGSGSFGSVYLGM---NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 578 HKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 634
H+N+V+ LG + L ++ E++ G++A+ L +G + + L N QI +GL Y
Sbjct: 65 HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEET--LVRNFVRQILKGLNY 121
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIRTAIRGTKGY 690
LH + IIH DIK NIL+D+ +ISDFG++K L N ++ R +++G+ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 691 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
+APE + ++ T K D++S G L++E+++ + F
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 76/241 (31%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEF-KNEVVVIGQTHHKNLVR 583
+G+GSFG V T A+K L ++ + E E E ++ + +H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGK---LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 584 LL-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF---QIARGLLYLH 636
L F E +L LV E+ G L S L G F +I L YLH
Sbjct: 58 LHYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARFYAAEIVLALEYLH 110
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
S II+ D+KP+NILLD + +++DFGLAK L+ S+ GT Y+APE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEVL 165
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYA-ILT-DWAFDCYRNEKLDDLVE 753
VD +S GVLL E+++ + F E E Y IL F + + + DL+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLIS 225
Query: 754 G 754
G
Sbjct: 226 G 226
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHHKNL 581
E+G G+FG V KG+ ++ T VAVK L + + K+E++ V+ Q + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKT-VAVKILKN--DNNDPALKDELLREANVMQQLDNPYI 58
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
VR++G C E ++ +LV E G L FL N + T + Q++ G+ YL E
Sbjct: 59 VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET--- 114
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIRTAIRGTKGYVAPEWFRNS 699
+H D+ +N+LL + A+ISDFGL+K L +++ KA K Y APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNYY 173
Query: 700 TITAKVDVYSFGVLLLEIIS 719
++K DV+SFGVL+ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 16/207 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVR 583
VGRG+FGIV+ L R + + + K V Q + E +NE V+ H N++
Sbjct: 8 VGRGAFGIVH----LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSA 641
E + ++V E+ GTLA ++ + T + F QI LL LH +
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTK 120
Query: 642 QIIHCDIKPQNILLDDYYN-ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
I+H D+K QNILLD + +I DFG++K+L+ SK+ + GT Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKP 177
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIE 727
K D+++ G +L E+ S +++F+
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 33/276 (11%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
E +GRG+FG V+ G + R T VAVK + + D + +F E ++ Q H N+VR
Sbjct: 1 ERIGRGNFGEVFSGRL---RADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSA 641
L+G C + Q +V E + G +FL P ++ I A G+ YL
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK----GYVAPEWFR 697
IH D+ +N L+ + +ISDFG+++ + + + G K + APE
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757
+++ DV+SFG+LL E S YA L+ N++ + +E +
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAV-------PYANLS--------NQQTREAIEQGVR 214
Query: 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
C + + + C + DP RP+ V Q L
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 46/281 (16%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-----KEFKNEVVVIGQTHHK 579
E +G GSFG VY+G+ AVK++ K+ + E+ ++ + H
Sbjct: 6 ELLGSGSFGSVYEGL---NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHE 637
N+V+ LG E N + E + G+LA L +G+ + QI GL YLH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP--VIRLYTRQILLGLEYLH- 119
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA--IRGTKGYVAPEW 695
+H DIK NIL+D +++DFG+AK Q A +G+ ++APE
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEV 172
Query: 696 F-RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL----DD 750
+ D++S G +LE+ + + + E A + F R+++L D
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL--EGVAAV----FKIGRSKELPPIPDH 226
Query: 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L EA + I + C+Q DPSLRPT ++L+
Sbjct: 227 L---SDEAKDFI----------LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 35/276 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+++G G FG V+ G T VA+K L + E F E ++ Q H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYY----NGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRL 66
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
+ + ++ E++ NG+L FL +K + N ++A QIA G+ ++
Sbjct: 67 YAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KN 122
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK---GYVAPEWFRNS 699
IH D++ NIL+ + +I+DFGLA+L+ N+ TA G K + APE
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 178
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-EKLDDLVEGDMEA 758
T T K DV+SFG+LL EI++ + Y +T+ + +N E+ + D
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRI-------PYPGMTN--PEVIQNLERGYRMPRPDN-- 227
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C E+L + C +E P RPT + + +LE
Sbjct: 228 -----CPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 74/290 (25%), Positives = 137/290 (47%), Gaps = 53/290 (18%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLL 585
+G G FG V++G++ AVA+K L + + ++ +F +E ++GQ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
G + + +++ E++ NG L +L F + + LR IA G+ YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-----IAAGMKYLSD-- 125
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA-----IRGTKGYVAPE 694
+H D+ +NIL++ ++SDFGL+++L + T+ IR T APE
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT----APE 180
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754
T+ DV+SFG+++ E++S GE W N ++
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMS--------FGER----PYWDMS---NHEV------ 219
Query: 755 DMEALND-------IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
M+A+ND + C + + + C Q+D + RP ++ +L+ ++
Sbjct: 220 -MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 55/300 (18%)
Query: 527 VGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVR 583
+G G FG V K L R T VAVK L E ++ +E ++ Q +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL-------------FGNLKPSW---------NLR 621
L G C + LL+ E+ G+L SFL GN S+ +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 622 TNIAF--QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679
I+F QI+RG+ YL E +++H D+ +N+L+ + +ISDFGL++ + S
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW 738
R+ R ++A E + T + DV+SFGVLL EI++ G Y I +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG-------GNPYPGIAPER 237
Query: 739 AFDC----YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
F+ YR E+ ++ C E++ + + C +++P RPT + + LE
Sbjct: 238 LFNLLKTGYRMERPEN-------------CSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 523 FKEEVGRGSFGIVYKG--VILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 579
K E+G G+FG V+ G L VAVK L + D K+F+ E ++ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------IA 625
N+V+ G C EG ++V+E++ +G L FL + + L++ IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA-- 683
QIA G++YL S +H D+ +N L+ +I DFG+ S+ + T
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM--------SRDVYTTDY 177
Query: 684 --IRGTK----GYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
+ G ++ PE T + DV+SFGV+L EI +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 8e-21
Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 24/274 (8%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+++G GSFG+V +G T+ VAVK L D +F E ++ H+NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSA 641
L G ++V E G+L L + + + T + A QIA G+ YL S
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK-GYVAPEWFRNST 700
+ IH D+ +NILL +I DFGL + L N+ + + APE R T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 701 ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759
+ DV+ FGV L E+ + + + G + D + R E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE--RLERPEA--------- 225
Query: 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
C + + V + C +P+ RPT + + L
Sbjct: 226 ----CPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 8e-21
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE--FKN---EVVVIGQTHH 578
E++G G++G+VYK + + VA+KK + D E+E E+ ++ + H
Sbjct: 4 LEKLGEGTYGVVYKA---RDKKTGEIVALKK---IRLDNEEEGIPSTALREISLLKELKH 57
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLH 636
N+V+LL + LV+E+ + L +L + +I +Q+ RGL Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
S +I+H D+KPQNIL++ +++DFGLA+ + + T Y APE
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL 170
Query: 697 RNSTI-TAKVDVYSFGVLLLEII 718
S + VD++S G + E+I
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLVR 583
+G+G+FG V I+ R + A+K +++ + +N E ++ + +H LV
Sbjct: 8 IGKGAFGKVC---IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 584 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQ----------IARGL 632
L F DE +N LV + L G L ++L + F I L
Sbjct: 65 LWYSFQDE-ENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
YLH S IIH DIKP NILLD+ + I+DF +A +T + T+ GT GY+A
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMA 167
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDI 726
PE + VD +S GV E + ++ +
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-20
Identities = 44/110 (40%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 81 KTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSS-EIDIGTVAVGHMNDTG 139
+TVVW N+ NP + L +D LVL D G+ VWSS G+ V + D G
Sbjct: 2 QTVVWVA-NRL-NPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDG 59
Query: 140 NFVLASSSSSKLWDSFSNPSDTLLPGQTMETK-----QGLFSRKSETNFS 184
N VL +S LW SF +P+DTLLPGQ + L S KS T+ S
Sbjct: 60 NLVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 80/294 (27%), Positives = 128/294 (43%), Gaps = 37/294 (12%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKG-VILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVV 572
EL + F EE+G +FG +YKG + L VA+K L + + EF+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---------------GNLKPS 617
+ + HH N+V LLG + Q +++E+LN G L FL G +K S
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 618 WNLRT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
+ +IA QIA G+ YL S +H D+ +NIL+ + + +ISD GL++ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735
++ ++ PE ++ D++SFGV+L EI F + Y
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI------FSFGLQPYYGFS 231
Query: 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
+ R +L E C ++ + C QE PS RP K +
Sbjct: 232 NQEVIEMVRKRQLLPCSE---------DCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 53/292 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL---DRVFQDGEKE-------FKNEVVVIG 574
E +G G+FG VYK + +A+K++ + F ++E +EV +I
Sbjct: 6 EHLGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 575 -QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS---------WNLRTNI 624
Q H N+VR E +V + + L F +LK WN I
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWN----I 118
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
Q+ L YLH++ +I+H D+ P NI+L + I+DFGLAK Q ++ T++
Sbjct: 119 FVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSV 173
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744
GT Y PE +N K DV++FG +L ++ + + F Y
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF------------------YS 215
Query: 745 NEKLD---DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
L +VE E L + E + V C+ D RP + +V M+
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN--EVVVIGQTHHKNLV 582
++G G++G+VYK + + VA+KK+ F+ E+ ++ + +H N++
Sbjct: 5 GKIGEGTYGVVYKA---RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSA 641
+LL + LV+EF++ L + + +L + +Q+ +GL + H S
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
I+H D+KP+N+L++ +++DFGLA+ + +R YV W+R +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF--------GSPVRPYTHYVVTRWYRAPEL 169
Query: 702 -------TAKVDVYSFGVLLLEIISCRKSF 724
+ VD++S G + E++S R F
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
DNF + +G GS GIV I T +++ VAVKK+D Q + NEVV++ H N
Sbjct: 22 DNFVK-IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+V + G +V EFL G L + + T + + + L +LH +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSFLH---A 133
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+IH DIK +ILL ++SDFG ++ + R ++ GT ++APE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLP 191
Query: 701 ITAKVDVYSFGVLLLEII 718
+VD++S G++++E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 44/277 (15%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 581
E +G+GSFG VYKG+ + VA+K +D ++ E E ++ E+ V+ Q +
Sbjct: 10 ERIGKGSFGEVYKGI---DNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 638
R G +G ++ E+L G+ L KP T IA +I +GL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH-- 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S + IH DIK N+LL + + +++DFG+A LT Q K R GT ++APE +
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQ 175
Query: 699 STITAKVDVYSFGVLLLEIISCRKSF-DIE-MGEEYAILTDW--AFDCYRNEKLDDLVEG 754
S K D++S G+ +E+ D+ M + I + + ++ + VE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA 235
Query: 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
C+ +DP RPT K++L+
Sbjct: 236 --------------------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQ-THHKNLV 582
+++G G+FG VY + + VA+KK+ + F E+ EV + + H N+V
Sbjct: 5 KQLGDGTFGSVYLAR---NKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSA 641
+L E V+E++ KP S ++ +I +QI +GL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF-RNST 700
H D+KP+N+L+ +I+DFGLA+ + +S+ T T+ Y APE R+++
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRAPEILLRSTS 175
Query: 701 ITAKVDVYSFGVLLLEIISCRKSF 724
++ VD+++ G ++ E+ + R F
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 63/218 (28%), Positives = 114/218 (52%), Gaps = 34/218 (15%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL----------DRVFQDGEKEFKNEVVVIG 574
E +G+G++G VY + +TT +AVK++ D +D K ++E+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTT---GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARG 631
H N+V+ LGF + + L ++ E++ G++ S L +G + L Q+ G
Sbjct: 64 DLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ--LVRFFTEQVLEG 120
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-----RTAIRG 686
L YLH S I+H D+K N+L+D +ISDFG++K +S I +++G
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSMQG 172
Query: 687 TKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRK 722
+ ++APE + + +AKVD++S G ++LE+ + R+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 78/288 (27%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G G FG V +G + S VAVK KLD +EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 585 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGL 632
+G C E + +++ F+ +G L SFL G L L+T + F IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL----TLNQSKAIRTAIRGTK 688
YL + IH D+ +N +L + ++DFGL+K + Q + + ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK--- 180
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNE 746
++A E + T+K DV++FGV + EI + ++ +E E Y D+ R +
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY----DYLRHGNRLK 235
Query: 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ +D C+++L + C + DP RPT K+ ++LE
Sbjct: 236 QPED-------------CLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 87/308 (28%), Positives = 138/308 (44%), Gaps = 48/308 (15%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 572
Y LE F++ +G G+FG V K I A + + +D ++F E+ V
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 573 IGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA-- 629
+ + HH N++ LLG C+ L E+ +G L FL + S L T+ AF IA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 116
Query: 630 ------------------RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671
RG+ YL + Q IH D+ +NIL+ + Y A+I+DFGL++
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG 173
Query: 672 LTLNQSKAI-RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730
+ K + R +R ++A E S T DV+S+GVLL EI+S G
Sbjct: 174 QEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-------GT 222
Query: 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790
Y +T C E + L +G + C +++ + C +E P RP+ ++L
Sbjct: 223 PYCGMT-----C--AELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
Query: 791 QMLEGVVE 798
L ++E
Sbjct: 275 VSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 36/275 (13%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKK---LDRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G+FG L RT ++ V K L R+ + ++ NE+V++ H N++
Sbjct: 8 LGKGAFGEA----TLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--FQIARGLLYLHEDCSA 641
+ L+ E+ N GTL + + + FQI + Y+H+ A
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---A 120
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
I+H DIK NI L ++ DFG++K+ L ++ + GT Y++PE +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKY 178
Query: 702 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME-ALN 760
K D+++ G +L E+++ +++FD +LV ++
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFD-------------------ATNPLNLVVKIVQGNYT 219
Query: 761 DIKCV--EKLVMVSIWCIQEDPSLRPTMKKVLQML 793
+ V +L+ + +Q+DP RPT +VL
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 50/280 (17%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 581
E +G+GSFG V+KG+ RT VA+K +D ++ E E ++ E+ V+ Q +
Sbjct: 10 ERIGKGSFGEVFKGI--DNRTQQV-VAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+ G +G ++ E+L G+ L + + T + +I +GL YLH S
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLH---SE 120
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
+ IH DIK N+LL + + +++DFG+A LT Q K R GT ++APE + S
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAY 178
Query: 702 TAKVDVYSFGVLLLEIIS----------CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
+K D++S G+ +E+ R F I + +++ + K +
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFS----KPFK--EF 232
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
++ C+ +DPS RPT K++L+
Sbjct: 233 IDA--------------------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
F +E+G G FG+V G VA+K + + E EF E V+ + H+ LV
Sbjct: 8 FLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSA 641
+L G C + + +V E+++NG L ++L + K + + + G+ YL S
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SK 119
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APEWFRN 698
Q IH D+ +N L+DD ++SDFGL++ + ++ T+ G+K V PE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLY 175
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
S ++K DV++FGVL+ E+ S L ++ + N + + V +
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYS---------------LGKMPYERFNNSETVEKVSQGLRL 220
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
EK+ + C E RPT +++L +E
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 29/273 (10%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 582
E+G G+ G+V K + R + +AVK + R+ + E K E+ ++ + + +V
Sbjct: 8 ELGAGNSGVVSKVLH---RPTGKIMAVKTI-RLEIN-EAIQKQILRELDILHKCNSPYIV 62
Query: 583 RLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 639
G F + G + + E+++ G+L L R IA + +GL YLHE
Sbjct: 63 GFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEK- 119
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
+IIH D+KP NIL++ ++ DFG++ L S A GT Y+APE + +
Sbjct: 120 -HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFV--GTSSYMAPERIQGN 174
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759
+ K D++S G+ L+E+ + R + E I E L +V L
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF----------ELLQYIVNEPPPRL 224
Query: 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
K C+ +DP RP+ K++L+
Sbjct: 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+ +G G++G VYK + T A+ V KL+ D + + E+ ++ + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELV-AIKVIKLEP--GDDFEIIQQEISMLKECRHPNIV 63
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLA---SFLFGNLKPSWNLRTNIAF---QIARGLLYLH 636
G +V E+ G+L G L IA+ + +GL YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-----ELQIAYVCRETLKGLAYLH 118
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
E IH DIK NILL + + +++DFG++ LT +K R + GT ++APE
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--RKSFIGTPYWMAPEVA 173
Query: 697 ---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730
R K D+++ G I+ IE+ E
Sbjct: 174 AVERKGGYDGKCDIWALG------ITA-----IELAE 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 36/285 (12%)
Query: 527 VGRGSFGIVYKGV---ILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 582
+G G+FG VY+G IL + VAVK L + D EK EF E ++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRT-----NIAFQIARGLLYL 635
+LLG C + + ++ E + G L S+L + L T +I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 636 HEDCSAQIIHCDIKPQNILLD--DYYNAR---ISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
+ IH D+ +N L+ Y R I DFGLA+ + + +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 691 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLD 749
+APE + T + DV+SFGVL+ EI++ +G++ Y L + +
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT--------LGQQPYPALNNQEVLQHVTA--- 228
Query: 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
G ++ + C +K+ + C +DPS RPT ++ ++L+
Sbjct: 229 ---GGRLQKPEN--CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 41/299 (13%)
Query: 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTST--TAVAVKKLDRV-FQDGEKEFK 567
F L+E T +GRG FG V+ T V VK L + ++ + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 568 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------LKP---SW 618
E+ + + HKN+VRLLG C E + ++ E+ + G L FL LKP S
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 619 NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678
+ + QIA G+ +L +A+ +H D+ +N L+ ++S L+K + ++
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 737
+R A+ + ++APE + + K DV+SFGVL+ E+ + GE + L+D
Sbjct: 174 KLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT--------QGELPFYGLSD 224
Query: 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
E L+ L G +E C +L +M W + +P RP+ +++ L
Sbjct: 225 -------EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAV--NPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 24/291 (8%)
Query: 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTA-VAVKKLDRVFQDGEKEFKNEVVVIGQ 575
EE F +++G+G+FG V + +T VAVKKL + ++F+ E+ ++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 576 THHKNLVRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARG 631
H N+V+ G C G+ L LV E+L G+L +L + + + R + + QI +G
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKG 120
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS-KAIRTAIRGTKGY 690
+ YL S + +H D+ +NIL++ +I DFGL K+L ++ +R +
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 691 VAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKS------FDIEMGEEYAILTDWAFDCY 743
APE S + DV+SFGV+L E+ + KS F MG + Y
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND----KQGQMIVY 233
Query: 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
L +L++ + C ++ + C DPS RP+ ++ +E
Sbjct: 234 H---LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 77/271 (28%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
++G+G FG V+ G T TT VA+K L E F E V+ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLY 67
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSAQI 643
E + +V E+++ G+L FL G + L ++A QIA G+ Y+
Sbjct: 68 AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITA 703
+H D++ NIL+ + +++DFGLA+L+ N+ A R + + APE T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTI 182
Query: 704 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK 763
K DV+SFG+LL E+ + + + N ++ D VE +
Sbjct: 183 KSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPPE 227
Query: 764 CVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C E L + C +++P RPT + + LE
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 525 EEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHH---K 579
E +GRG++G VY+G + T R VA+K ++ D + + + EV ++ Q
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRV----VALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----YL 635
N+ + G +G ++ E+ G++ + + K I+ I R +L Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISV-IIREVLVALKYI 117
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H +IH DIK NIL+ + N ++ DFG+A LL N SK R+ GT ++APE
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEV 172
Query: 696 FRN-STITAKVDVYSFGVLLLEIIS 719
K D++S G+ + E+ +
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
F +E+G G FG+V+ G + VA+K + E++F E V+ + H LV
Sbjct: 8 FMKELGSGQFGVVHLG----KWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
+L G C + + +V EF+ NG L ++L G L L ++ + G+ YL +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL--SMCQDVCEGMEYLERN- 119
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK---GYVAPEWF 696
IH D+ +N L+ ++SDFG+ + + ++ T+ G K + PE F
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY----TSSSGAKFPVKWSPPEVF 173
Query: 697 RNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
S ++K DV+SFGVL+ E+ + + F+ + E + F YR + V
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE- 232
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
VM S W E P RPT ++L+ +
Sbjct: 233 -------------VMYSCW--HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 577
E D+F + +G GS GIV I T + + VAVKK+D Q + NEVV++ H
Sbjct: 22 EYLDSFIK-IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 637
H+N+V + G +V EFL G L + + T + + R L YLH
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYLH- 135
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR 697
+ +IH DIK +ILL ++SDFG ++ K R ++ GT ++APE
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVIS 191
Query: 698 NSTITAKVDVYSFGVLLLEII 718
+VD++S G++++E+I
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 46/275 (16%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
+G G FG VY+GV ++ AVAVK K EK F E ++ Q H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDC 639
V+L+G E +V E G L S+L N K S +L + I ++Q++ L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE--- 124
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIRTA--IRGTKGYVAPEW 695
S + +H DI +N+L+ ++ DFGL++ L ++S KA + I+ ++APE
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIK----WMAPES 179
Query: 696 FRNSTITAKVDVYSFGVLLLEIISC-RKSFD----------IEMGEE-----------YA 733
T+ DV+ FGV + EI+ K F IE GE Y+
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239
Query: 734 ILTD-WAFDCYRNEKLDDLVEGDMEALNDIKCVEK 767
++T WA+D + + +L L+DI EK
Sbjct: 240 LMTKCWAYDPSKRPRFTELK----AQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G FG V + + A KKLD+ + GE+ NE ++ + + +V
Sbjct: 1 LGKGGFGEVCA---CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 640
L + E ++ L LV +N G L ++ +P + I A QI GL +LH+
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+I++ D+KP+N+LLDD+ N RISD GLA + L K I GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKI-KGRAGTPGYMAPEVLQGEV 170
Query: 701 ITAKVDVYSFGVLLLEIISCRKSF 724
VD ++ G L E+I+ R F
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 39/289 (13%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKN----EVVVIGQTHHKN 580
VG GS+G+V K + + VA+KK F + E K K E+ ++ Q H+N
Sbjct: 9 VGEGSYGMVMK---CKHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASF-LFGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
LV L+ + LV+EF+++ L + N +R + FQI RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQILRGIEFCH--- 117
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
S IIH DIKP+NIL+ ++ DFG A+ TL + T T+ Y APE
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 700 TITAK-VDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNEKL---DDLVE 753
T + VD+++ G L+ E+++ F D ++ + Y I+ R++++ + L
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 754 GDMEALNDIKCVEKL---------VMVSIW--CIQEDPSLRPTMKKVLQ 791
G L ++K +E L +++ + C++ DP RP+ ++L
Sbjct: 236 G--MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
DNF + +G GS GIV I T ++S VAVKK+D Q + NEVV++ H+N
Sbjct: 23 DNFIK-IGEGSTGIV---CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+V + G +V EFL G L + + + + + L LH +
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLKALSVLH---A 134
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+IH DIK +ILL ++SDFG +++ R ++ GT ++APE
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 701 ITAKVDVYSFGVLLLEII 718
+VD++S G++++E++
Sbjct: 193 YGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 33/293 (11%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
K E+G G+FG V+ L VAVK L + K+F E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRT--------NIAFQ 627
+V+ G C EG ++V+E++ +G L FL + L N +IA Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGT 687
IA G++YL S +H D+ +N L+ + +I DFG+++ + +
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
++ PE T + DV+S GV+L EI + K W + NE
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ-------------PW-YQLSNNEV 231
Query: 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
++ + +G + C +++ + + C Q +P +R +K++ +L+ + + S
Sbjct: 232 IECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV----AVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+ +G++G V+ L + ST + +KK D + ++ + E ++ Q +V
Sbjct: 1 ISKGAYGRVF----LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV 56
Query: 583 RLL-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
+L F + +N LV E+L G LAS L G+L +I L YLH
Sbjct: 57 KLYYSFQGK-KNLYLVMEYLPGGDLASLLENVGSLDEDV--ARIYIAEIVLALEYLH--- 110
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKL----LTLNQSKAIR--TAIRGTKGYVAP 693
S IIH D+KP NIL+D + +++DFGL+K+ +N + + I GT Y+AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIIS 719
E + VD +S G +L E +
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHH 578
F + +G GSFG V ++ + S A+K L + V + NE ++ H
Sbjct: 4 EFIKTLGTGSFGRVM---LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
LV L G + N LV E++ G L S L + + + A Q+ L YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH-- 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAPEWFR 697
S I++ D+KP+N+LLD +I+DFG AK + RT + GT Y+APE
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV------KGRTYTLCGTPEYLAPEIIL 171
Query: 698 NSTITAKVDVYSFGVLLLEII 718
+ VD ++ G+L+ E++
Sbjct: 172 SKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-18
Identities = 74/268 (27%), Positives = 127/268 (47%), Gaps = 26/268 (9%)
Query: 527 VGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNLV 582
+G G+FG VYKG+ + T VA+K L+ G K EF +E +++ H +LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLV 72
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSA 641
RLLG C +L V + + +G L ++ + L N QIA+G++YL E
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---R 128
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
+++H D+ +N+L+ + +I+DFGLA+LL ++ + + ++A E
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 702 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761
T + DV+S+GV + E+++ G+ Y D ++ DL+E
Sbjct: 189 THQSDVWSYGVTIWELMTFG-------GKPY--------DGIPTREIPDLLEKGERLPQP 233
Query: 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
C + MV + C D RP K++
Sbjct: 234 PICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 20/199 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 581
E++G+GSFG V+KG+ RT VA+K +D ++ E E ++ E+ V+ Q +
Sbjct: 10 EKIGKGSFGEVFKGI--DNRTQKV-VAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 638
+ G + ++ E+L G+ L +P T IA +I +GL YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH-- 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S + IH DIK N+LL ++ +++DFG+A LT Q K R GT ++APE +
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQ 175
Query: 699 STITAKVDVYSFGVLLLEI 717
S +K D++S G+ +E+
Sbjct: 176 SAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK----NL 581
E+G G+FG V KGV R VA+K L + EK ++E++ + H+ +
Sbjct: 2 ELGSGNFGCVKKGV-YKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---FQIARGLLYLHED 638
VR++G C E + +LV E + G L FL G K +N+ Q++ G+ YL
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIRTAIRGTKGYVAPEWF 696
+H D+ +N+LL + + A+ISDFGL+K L + S KA R+A + + APE
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA-RSAGKWPLKWYAPECI 170
Query: 697 RNSTITAKVDVYSFGVLLLEIIS 719
+++ DV+S+G+ + E S
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQT---H 577
E+G G++G VYK + VA+KK+ E+ E+ ++ Q
Sbjct: 5 AEIGEGAYGTVYKA---RDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 578 HKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIA 629
H N+VRLL C D LV+E ++ LA++L KP ++ ++ Q+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL 117
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
RG+ +LH S +I+H D+KPQNIL+ +I+DFGLA++ + + T++ T
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLW 171
Query: 690 YVAPEWFRNSTITAKVDVYSFGVLLLEI 717
Y APE S+ VD++S G + E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 29/283 (10%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 574
E+ + ++++G G FG V+ + T T VAVK + E F E V+
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVW----MATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMK 56
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARG 631
H LV+L + + ++ EF+ G+L FL G+ +P L + + QIA G
Sbjct: 57 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEG 114
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
+ ++ + IH D++ NIL+ +I+DFGLA+++ N+ A R + +
Sbjct: 115 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWT 170
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
APE + T K DV+SFG+LL+EI++ + M I YR + +
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--LERGYRMPRPE-- 226
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C E+L + + C + P RPT + + +L+
Sbjct: 227 -----------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKN---EVVVIGQTHHKN 580
E +G+G++G VY G LT + AV +LD EKE++ EV ++ H N
Sbjct: 6 EVLGKGAYGTVYCG--LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPSWNLRTNIAFQIARGLLYLHE 637
+V+ LG C + + EF+ G+++S L FG L +P + T QI G+ YLH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---QILDGVAYLHN 120
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL---TLNQSKA-IRTAIRGTKGYVAP 693
+C ++H DIK N++L ++ DFG A+ L L+ + + + ++ GT ++AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 694 EWFRNSTITAKVDVYSFGVLLLEI 717
E S K D++S G + E+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 72/281 (25%), Positives = 132/281 (46%), Gaps = 35/281 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLL 585
+G G FG V G + VA+K L + + ++ +F +E ++GQ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
G + + ++V E++ NG+L +FL F ++ LR IA G+ YL D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG-----IASGMKYL-SDM 125
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK---GYVAPEWF 696
+H D+ +NIL++ ++SDFGL+++L + A T RG K + APE
Sbjct: 126 GY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT--RGGKIPIRWTAPEAI 181
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756
T+ DV+S+G+++ E++S + EM + I +E
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA---------------IEEGY 226
Query: 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
+ C L + + C Q+D + RP ++++ +L+ ++
Sbjct: 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTA--VAVKKLDRVFQDGEKEFKN----EVVVIGQTHH 578
VG G++G+V K R T VA+KK + +++ K EV V+ Q H
Sbjct: 7 GVVGEGAYGVVLK-----CRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLRH 59
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYL 635
+N+V L LV+E++ TL L G L P +Q+ + + Y
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYC 116
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H S IIH DIKP+NIL+ + ++ DFG A+ L + + T T+ Y APE
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPEL 172
Query: 696 FRNSTITAK-VDVYSFGVLLLEIISCRKSF 724
T K VDV++ G ++ E++ F
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 580
E +G G+ +VY + L VA+K++D Q E + EV + Q +H N
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEK---VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHE 637
+V+ G LV +L+ G+L + + IA ++ +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH- 119
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL---TLNQSKAIRTAIRGTKGYVAPE 694
S IH DIK NILL + + +I+DFG++ L K R GT ++APE
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV-RKTFVGTPCWMAPE 176
Query: 695 WFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWAFDCYRNEKLDDLV 752
K D++SFG+ +E+ + + + +LT
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA----- 231
Query: 753 EGDMEALNDIKCVEKLV--MVSIWCIQEDPSLRPTMKKVLQ 791
D K K M+S+ C+Q+DPS RPT +++L+
Sbjct: 232 --------DYKKYSKSFRKMISL-CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 27/272 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+++G G FG V+ G T T VAVK L E F E ++ + H LV+L
Sbjct: 12 KKLGNGQFGEVWMG----TWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL 66
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSAQ 642
E + +V E+++ G+L FL + L ++A Q+A G+ Y+
Sbjct: 67 YAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MN 122
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT 702
IH D++ NIL+ D +I+DFGLA+L+ N+ A R + + APE T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFT 181
Query: 703 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762
K DV+SFG+LL E+++ + + N ++ + VE
Sbjct: 182 IKSDVWSFGILLTELVTKGRV---------------PYPGMNNREVLEQVERGYRMPCPQ 226
Query: 763 KCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C L + + C ++DP RPT + + LE
Sbjct: 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 23/221 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 581
E++G G++G+VYK R + +A+KK+ R+ Q+ E E+ ++ + H N+
Sbjct: 8 EKIGEGTYGVVYKA---RDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDC 639
VRL + LV+E+L+ L + + + N R +QI RG+ Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 640 SAQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLTLNQSKAIRTAIRG--TKGYVAPEWF 696
S +++H D+KPQN+L+D NA +++DFGLA+ + +RT T Y APE
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI----PVRTFTHEVVTLWYRAPEIL 175
Query: 697 RNS-TITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 734
S + VD++S G + E+++ + F D E+ E + I
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-18
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 549 AVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVRLLGFCDEGQ---NRLL-VYEFL 601
VA+K L + E + F+ E + + +H N+V LL D G+ L V+E++
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYV 61
Query: 602 NNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---D 656
TL L G L R + Q+ L H I+H D+KPQNI++
Sbjct: 62 PGRTLREVLAADGALPAGETGR--LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 657 DYYNARISDFGLAKLLTLNQSKAIRTAIR-----GTKGYVAPEWFRNSTITAKVDVYSFG 711
+A++ DFG+ LL + + T R GT Y APE R +T D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 712 VLLLE 716
++ LE
Sbjct: 177 LIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
K E+G G+FG V+ L VAVK L + ++F+ E ++ H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----------------FGNLKPSWNLRTN 623
+VR G C EG+ L+V+E++ +G L FL G L L
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA-- 126
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI--R 681
IA QIA G++YL S +H D+ +N L+ +I DFG+++ + + R
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 682 T--AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
T IR ++ PE T + D++SFGV+L EI +
Sbjct: 184 TMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 42/217 (19%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRL 584
VG G++G V T+T VA+KKL R FQ K E+ ++ H+N++ L
Sbjct: 23 VGSGAYGQVCSAFD--TKTGRK-VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79
Query: 585 LG-FC-----DEGQNRLLVYEF----LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 634
L F ++ Q+ LV LNN + K S + + +QI RGL Y
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLMGADLNN------IVKCQKLSDDHIQFLVYQILRGLKY 133
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
+H SA IIH D+KP NI +++ +I DFGLA R GYVA
Sbjct: 134 IH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA-----------RHTDDEMTGYVATR 179
Query: 695 WFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 724
W+R I VD++S G ++ E+++ + F
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+++G G FG V+ G ++T VAVK L + + F E ++ H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYY----NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRL 66
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSAQ 642
+ + ++ E++ G+L FL + L I F QIA G+ Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---N 123
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT 702
IH D++ N+L+ + +I+DFGLA+++ N+ A R + + APE + T
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFT 182
Query: 703 AKVDVYSFGVLLLEIIS 719
K DV+SFG+LL EI++
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 8e-18
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTA-VAVKKLDRVFQDGEKE-----FKNEVVVIGQTHH 578
++G G++G VYK T VA+KK+ + EKE E+ ++ + H
Sbjct: 5 AQIGEGTYGQVYKA----RNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRH 57
Query: 579 KNLVRLLGFC-DEGQNRL-LVYEFLN---NGTLAS----FLFGNLKPSWNLRTNIAFQIA 629
N+VRL +G+ + +V+E+++ G L S F +K Q+
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-------CYMKQLL 110
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
GL YLH S I+H DIK NIL+++ +++DFGLA+ T ++ A T T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLW 166
Query: 690 YVAPEWFRNSTI-TAKVDVYSFGVLLLEIIS 719
Y PE +T +VD++S G +L E+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 28/288 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTST-TAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLV 582
+G G FG V T VAVK L R Q +K E+ ++ +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 583 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHED 638
+ G C E G+ L+ E++ G+L +L K NL + F QI G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH-- 124
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL-TLNQSKAIRTAIRGTKGYVAPEWFR 697
S IH D+ +N+LLD+ +I DFGLAK + ++ +R + A E +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 698 NSTITAKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750
+ + DV+SFGV L E++ S K F+ +G + +T +L +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT--------VVRLIE 235
Query: 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
L+E M C +++ ++ C + + RPT + ++ +L+ +
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKE---FKNEVVVIGQTHHKNL 581
+G+G+FG VY + T +AVK++ D + +KE + E+ ++ H+ +
Sbjct: 10 LGQGAFGRVYLCYDVDT---GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
V+ G + + + E++ G++ L +G L + + QI G+ YLH
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--TETVTRKYTRQILEGVEYLH--- 121
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S I+H DIK NIL D N ++ DFG +K L T+ S ++ GT +++PE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 699 STITAKVDVYSFGVLLLEIIS 719
K DV+S G ++E+++
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 31/217 (14%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQ-THHK 579
+++G+G++GIV+K + R + VA+KK+ F+ D ++ F+ E++ + + H
Sbjct: 12 LQKLGKGAYGIVWKAI---DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHP 67
Query: 580 NLVRLLGF--CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 637
N+V+LL + ++ LV+E++ A L+ + I +Q+ + L Y+H
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KRYIMYQLLKALKYIH- 124
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT---LNQSKAIRTAIRGTKGYVAPE 694
S +IH D+KP NILL+ +++DFGLA+ L+ N + T YVA
Sbjct: 125 --SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD------YVATR 176
Query: 695 WFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 724
W+R I T VD++S G +L E++ + F
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIGQTHHKN 580
+ + +G+FG VY + R++ A+K L + + + N +++ Q
Sbjct: 2 KPISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
+ +L LV E+LN G AS + G L W + IA ++ G+ LH+
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQR 116
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
IIH DIKP+N+L+D + +++DFGL++ N+ GT Y+APE
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILG 167
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
D +S G ++ E + F E +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 69/239 (28%), Positives = 107/239 (44%), Gaps = 26/239 (10%)
Query: 563 EKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNL 620
+K+ E+ + +V+ G F DE + + + E+ G+L S ++ +K
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVK-KRGG 100
Query: 621 RTN------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674
R IA + +GL YLH S +IIH DIKP NILL ++ DFG++ L
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157
Query: 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 734
+ + GT Y+APE + + DV+S G+ LLE+ R F E GE
Sbjct: 158 SLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE-GEPPLG 212
Query: 735 LTDWAFDCYR--NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ N +L D E N IK E+ C+++DP+ RPT +L+
Sbjct: 213 PIELLSYIVNMPNPELKD------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 41/211 (19%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
E++G GS+G VYK + + VA+K + V +D + E E+ ++ Q +V
Sbjct: 7 ILEKLGEGSYGSVYKA---IHKETGQVVAIKVV-PVEEDLQ-EIIKEISILKQCDSPYIV 61
Query: 583 RLLGFCDEGQNRLLVYEF----------------LNNGTLASFLFGNLKPSWNLRTNIAF 626
+ G + + +V E+ L +A+ L+ LK
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLK----------- 110
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
GL YLH S + IH DIK NILL++ A+++DFG++ LT +K T I G
Sbjct: 111 ----GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVI-G 161
Query: 687 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEI 717
T ++APE + K D++S G+ +E+
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 42/226 (18%)
Query: 526 EVGRGSFGIVYKGVI--LTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLV 582
++G+G+FG V++ L T VAVK L + D + +F+ E ++ + H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN----------------------- 619
+LLG C G+ L++E++ G L FL P
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR-SPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 620 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL------AKLLT 673
+ IA Q+A G+ YL E + +H D+ +N L+ + +I+DFGL A
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
+++ AI IR ++ PE + T + DV+++GV+L EI S
Sbjct: 188 ASENDAI--PIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 36/220 (16%)
Query: 522 NFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIG 574
NF+ E++G G++G+VYK + + VA+KK+ R+ D E E E+ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKI-RL--DTETEGVPSTAIREISLLK 54
Query: 575 QTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARG 631
+ +H N+V+LL +N+L LV+EFL+ L F+ + L + FQ+ +G
Sbjct: 55 ELNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L + H S +++H D+KPQN+L++ +++DFGLA +A +R V
Sbjct: 113 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEV 161
Query: 692 APEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 724
W+R I + VD++S G + E+++ R F
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 39/295 (13%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKL-DRVFQDGEKEFKNEVV 571
E+ +T F EE+G FG VYKG + T T AVA+K L D+ +EFK+E +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 572 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--------GNLKPSWNLRT- 622
+ + H N+V LLG + Q +++ + ++ L FL G+ +++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 623 -------NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTL 674
+I QIA G+ +L S ++H D+ +N+L+ D N +ISD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 734
+ K + ++ + +++PE + D++S+GV+L E+ S Y +
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGL 224
Query: 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
+ Y N+ + +++ C + + + C E PS RP K +
Sbjct: 225 ---QPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 8e-17
Identities = 79/271 (29%), Positives = 120/271 (44%), Gaps = 27/271 (9%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
++G+G FG V+ G T TT VA+K L E F E ++ + H LV L
Sbjct: 13 KLGQGCFGEVWMG----TWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLY 67
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSAQI 643
E + +V EF+ G+L FL L ++A QIA G+ Y+
Sbjct: 68 AVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITA 703
IH D++ NIL+ D +I+DFGLA+L+ N+ A R + + APE T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTI 182
Query: 704 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK 763
K DV+SFG+LL E+++ + + N ++ + VE
Sbjct: 183 KSDVWSFGILLTELVTKGRV---------------PYPGMVNREVLEQVERGYRMPCPQG 227
Query: 764 CVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C E L + C ++DP RPT + + LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 39/278 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
E +G+G+FG V+KG T T VAVK + + Q+ + +F +E ++ Q H N+V+
Sbjct: 1 ELLGKGNFGEVFKG----TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDC 639
L+G C + Q +V E + G SFL K L+T A A G+ YL
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLE--- 110
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK----GYVAPEW 695
S IH D+ +N L+ + +ISDFG+++ + I ++ G K + APE
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSS-SGLKQIPIKWTAPEA 165
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
+++ DV+S+G+LL E S L + N++ + VE
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS---------------LGVCPYPGMTNQQAREQVEKG 210
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
KC + + V C P RP ++ + L
Sbjct: 211 YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 586
+G+G FG V G R + AV K D Q F E V+ Q H NLV+LLG
Sbjct: 14 IGKGEFGDVMLG---DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLG 66
Query: 587 FCDEGQNRL-LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 643
E + L +V E++ G+L +L G + + + + YL +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNF 123
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITA 703
+H D+ +N+L+ + A++SDFGL K + Q + ++ T APE R +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALREKKFST 178
Query: 704 KVDVYSFGVLLLEIIS 719
K DV+SFG+LL EI S
Sbjct: 179 KSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 69/276 (25%), Positives = 127/276 (46%), Gaps = 27/276 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNL 581
+++G G+F Y+ + T T V + + E+ + E+ ++ + +H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
+R+LG E + L E++ G+++ L +G K + N Q+ RGL YLHE+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLHEN- 122
Query: 640 SAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSKA--IRTAIRGTKGYVAPEWF 696
QIIH D+K N+L+D RI+DFG A L + A + + GT ++APE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNEKLDDLVEGD 755
R DV+S G +++E+ + + ++ E A++ F + E
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATTAPSIPEHL 236
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L D V++ C++ P RP +++L+
Sbjct: 237 SPGLRD---------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 31/221 (14%)
Query: 516 LEEATDNF--KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 573
L + T F E +G G++G VYK T VA+K +D + +D E+E K E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQ---LVAIKIMD-IIEDEEEEIKEEYNIL 56
Query: 574 GQ-THHKNLVRLLG-------FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN- 623
+ ++H N+ G ++ Q L LV E G++ + G K L+
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 624 IAF---QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
IA+ + RGL YLHE+ ++IH DIK QNILL ++ DFG++ L +
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR-- 169
Query: 681 RTAIRGTKGYVAPEWF-----RNSTITAKVDVYSFGVLLLE 716
R GT ++APE +++ A+ DV+S G+ +E
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 84/318 (26%), Positives = 134/318 (42%), Gaps = 46/318 (14%)
Query: 508 LPCFSYKELEEATDNFKEEVGRGSFGIVYK----GVILTTRTSTTAVAVKKL-----DRV 558
LP EL + +G G FG V G+ VAVK L D+
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 559 FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSW 618
D E + + +IG+ HKN++ LLG C + ++ E+ + G L +L P
Sbjct: 61 LSDLVSEME-MMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 619 NLR----------------TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662
+ + A+Q+ARG+ YL S + IH D+ +N+L+ + +
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMK 174
Query: 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 722
I+DFGLA+ + T R ++APE + T + DV+SFGVLL EI +
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234
Query: 723 SFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSL 782
S + E+L L++ C +L M+ C PS
Sbjct: 235 S---------------PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQ 279
Query: 783 RPTMKKVLQMLEGVVEVS 800
RPT K++++ L+ V+ V+
Sbjct: 280 RPTFKQLVEDLDRVLTVT 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E++G+G+ G VY + + T VA+K+++ Q ++ NE++V+ + H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQE---VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
L G +V E+L G+L + + + + + L +LH S Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 137
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
H DIK NILL + +++DFG +T QSK R+ + GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 705 VDVYSFGVLLLEII 718
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQT-HH 578
F + +G G+FG V + L+ + VAVK L E+E +E+ ++ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLH 636
+N+V LLG C G L++ E+ G L +FL + L ++F Q+A+G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
S IH D+ +N+LL +I DFGLA+ + + + ++ R ++APE
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 697 RNSTITAKVDVYSFGVLLLEIIS 719
N T + DV+S+G+LL EI S
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 497 NSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD 556
+S G+ + S ELE +G G+ G VYK + R + A+K +
Sbjct: 59 SSSASGSAPSAAKSLS--ELERV-----NRIGSGAGGTVYKVI---HRPTGRLYALKVIY 108
Query: 557 RVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK 615
+D ++ E+ ++ +H N+V+ D ++ EF++ G+L G
Sbjct: 109 GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----GTHI 164
Query: 616 PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
++A QI G+ YLH I+H DIKP N+L++ N +I+DFG++++ L
Sbjct: 165 ADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LA 219
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKV-----DVYSFGVLLLEIISCRKSFDIEMGE 730
Q+ + GT Y++PE D++S GV +LE R F +G
Sbjct: 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR--FPFGVGR 277
Query: 731 EYAILTDWA----FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM 786
+ DWA C ++ + E + I C C+Q +P+ R +
Sbjct: 278 Q----GDWASLMCAICM-SQPPEAPATASREFRHFISC----------CLQREPAKRWSA 322
Query: 787 KKVLQ 791
++LQ
Sbjct: 323 MQLLQ 327
|
Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G FG V + + + A KKLD+ + GEK E ++ + + +V
Sbjct: 1 LGKGGFGEV---CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSA 641
L + + LV +N G L ++ + + I + QI G+L+LH S
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
I++ D+KP+N+LLDD N R+SD GLA + L K I T GT GY+APE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPEILKEEPY 171
Query: 702 TAKVDVYSFGVLLLEIISCRKSF 724
+ VD ++ G + E+++ R F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV---VIGQTHHKNLVR 583
+G+G FG V R + A KKL++ K ++ +V ++ + H + +V
Sbjct: 1 LGKGGFGEVSA---CQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNL---KPSWNLRTNIAF--QIARGLLYLHED 638
L + LV +N G L ++ N+ P + + QI GL +LH+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
+II+ D+KP+N+LLD+ N RISD GLA L QSK A GT G++APE +
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPELLQG 171
Query: 699 STITAKVDVYSFGVLLLEIISCRKSF 724
VD ++ GV L E+I+ R F
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-16
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVR 583
+G G++G+V V RT VA+KK+ VF D ++ + E+ ++ H+N++
Sbjct: 8 IGSGAYGVVCSAV--DKRTGRK-VAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIG 63
Query: 584 LLG-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPSWNLRTN----IAFQIARGLL 633
LL +V E + T L + K L + +QI RGL
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELM--ETDLHKVI----KSPQPLTDDHIQYFLYQILRGLK 117
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
YLH SA +IH D+KP NIL++ + +I DFGLA+ + ++ + YV
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK-----GFLTEYVVT 169
Query: 694 EWFR-------NSTITAKVDVYSFGVLLLEII 718
W+R +S T +D++S G + E++
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 71/291 (24%), Positives = 127/291 (43%), Gaps = 40/291 (13%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
K E+G G+FG V+ L+ VAVK L K+F+ E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF------------------GNLKPSWNLRT 622
+V+ G C +G ++V+E++ +G L FL G L S L
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML-- 126
Query: 623 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682
+IA QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742
++ PE T + DV+SFGV+L EI + K ++ I +C
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------EC 237
Query: 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
+ +G + + C +++ + + C Q +P R +K++ ++L
Sbjct: 238 --------ITQGRVLERPRV-CPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 77/301 (25%), Positives = 145/301 (48%), Gaps = 61/301 (20%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 581
E++G G++G+VYKG + + VA+KK+ R+ + E E+ ++ + H N+
Sbjct: 6 EKIGEGTYGVVYKGR---NKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 582 VRLLGFCDEGQNRL-LVYEFLN---NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 637
V L + ++RL L++EFL+ L S G + +++ + +QI +G+L+ H
Sbjct: 62 VCLQDVLMQ-ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL-YQILQGILFCH- 118
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG------TKGYV 691
S +++H D+KPQN+L+D+ +++DFGLA +A +R T Y
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLA--------RAFGIPVRVYTHEVVTLWYR 168
Query: 692 APEWFRNST-ITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI-------------- 734
APE S + VD++S G + E+ + + F D E+ + + I
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228
Query: 735 ---LTDW--AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
L D+ F ++ L V+ +++ + + +EK+++ DP+ R + KK
Sbjct: 229 VTSLPDYKNTFPKWKKGSLRSAVK-NLDE-DGLDLLEKMLIY-------DPAKRISAKKA 279
Query: 790 L 790
L
Sbjct: 280 L 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 2e-16
Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E++G+G+ G VY + + T VA+K+++ Q ++ NE++V+ + + N+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQE---VAIKQMNLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
L G +V E+L G+L + + + + + L +LH S Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLH---SNQVI 137
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
H DIK NILL + +++DFG +T QSK R+ + GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 705 VDVYSFGVLLLEII 718
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G G+ GIV+K T VA+KK L R+ + E+ + H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRET---GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-IAFQIARGLLYLHEDCSAQI 643
L G +LV E++ L+ L +P + + +G+ Y+H I
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TIT 702
+H D+KP N+L+ +I+DFGLA+L + + + + T+ Y APE +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYD 179
Query: 703 AKVDVYSFGVLLLEIISCRKSF----DIE 727
VD+++ G + E+++ F DIE
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 60/296 (20%)
Query: 520 TDNFKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVI 573
NFK E +G+G F +VYK VA+KK+ ++F+ + + + E+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---ICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLL 56
Query: 574 GQTHHKNLVRLL-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRT--NIAFQ 627
Q H N+++ L F + N L +V E + G L+ + F K RT Q
Sbjct: 57 KQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGT 687
+ L ++H S +I+H DIKP N+ + ++ D GL + + + A ++ GT
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGT 169
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF------------DIEMGEEYAIL 735
Y++PE + K D++S G LL E+ + + F IE +Y L
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPPL 228
Query: 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
D Y +E+L DLV CI DP RP + VLQ
Sbjct: 229 PA---DHY-SEELRDLVSR--------------------CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-16
Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E++G+G+ G VY + + T VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
L G +V E+L G+L + + + + + L +LH S Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
H DIK NILL + +++DFG +T QSK R+ + GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 705 VDVYSFGVLLLEII 718
VD++S G++ +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 65/293 (22%)
Query: 530 GSFGIVYKGVIL-TTRTSTTAVAVK---------KLDRVFQDGEKEFKNEVVVIGQTHHK 579
G+FG ++ G+++ V VK ++ + Q+ + G H+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL-------LYG-LSHQ 68
Query: 580 NLVRLLGFCDEGQNRLLV-YEFLNNGTLASFL----FGNLKPSWNLRT----NIAFQIAR 630
N++ +L C E V Y ++N G L FL G L T ++A QIA
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK--------LLTLNQSKAIRT 682
G+ YLH +IH DI +N ++D+ +I+D L++ L N+++ ++
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 740
++A E N ++ DV+SFGVLL E+++ ++ +I+ E A L D
Sbjct: 185 -------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-- 235
Query: 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
YR + I C ++L V C DP RP+ +++Q L
Sbjct: 236 --YRLAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 522 NFKEEVGRGSFGIVY----KGVILTTR---------TSTTAVAVKKL-DRVFQDGEKEFK 567
NF E++G G FG V+ G+ + + VAVK L + ++F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 568 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----------FGNLKP 616
EV ++ + N+ RLLG C ++ E++ NG L FL +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 617 SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676
S++ +A QIA G+ YL S +H D+ +N L+ Y +I+DFG+++ L +
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 677 SKAIR----TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRK 722
++ IR ++A E T K DV++FGV L EI++ CR+
Sbjct: 185 YYRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 9/193 (4%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
++G GS GIV I + S VAVK +D Q + NEVV++ H+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 645
G+ ++ EFL G L + + + + + + L YLH S +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 646 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKV 705
DIK +ILL ++SDFG ++ + K R ++ GT ++APE + +V
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 706 DVYSFGVLLLEII 718
D++S G++++E++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQ-DGEKEFKNEVVVIGQTHHKNLVR 583
+G+G FG V R + A KKL+ R+ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 640
L + E ++ L LV +N G L ++ P ++ + A +I GL LH
Sbjct: 65 L-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---R 120
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+I++ D+KP+NILLDDY + RISD GLA + + + + IR + GT GY+APE +N
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPEVVKNER 177
Query: 701 ITAKVDVYSFGVLLLEIISCRKSF 724
T D + G L+ E+I + F
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-16
Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 514 KELEEATDNFKE--EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNE 569
K + E D +++ +VG G++G V L RT VA+KKL R FQ K E
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSA--LDRRTGAK-VAIKKLYRPFQSELFAKRAYRE 64
Query: 570 VVVIGQTHHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 623
+ ++ H+N++ LL D + LV F+ GT L + K S +
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF 122
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683
+ +Q+ +GL Y+H +A IIH D+KP N+ +++ +I DFGLA+ Q+ + T
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTG 174
Query: 684 IRGTKGYVAPE----WFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
T+ Y APE W T VD++S G ++ E+++ + F
Sbjct: 175 YVVTRWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHKNL 581
+G G++GIVY+ TS VA+KK V D E++ E+ ++ H N+
Sbjct: 15 IGEGTYGIVYRA---RDTTSGEIVALKK---VRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 582 VRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHED 638
V L + LV E+ LAS L P S + + Q+ RGL YLHE+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE-WFR 697
IIH D+K N+LL D +I+DFGLA+ L T T Y APE
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLG 182
Query: 698 NSTITAKVDVYSFGVLLLEII 718
+T T +D+++ G +L E++
Sbjct: 183 CTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 527 VGRGSFGIVYK----GVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQT 576
+G G FG V G+ T VAVK L EK+ + + +IG+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK- 82
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 623
HKN++ LLG C + ++ E+ + G L +L P N
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 624 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDW 738
T R ++APE + T + DV+SFGVLL EI + S + + E + +L +
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258
Query: 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
+R +K + C +L M+ C PS RPT K++++ L+ ++
Sbjct: 259 ----HRMDKPSN-------------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
Query: 799 VS 800
++
Sbjct: 302 LT 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 38/228 (16%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 579
E++G G++G+VYK T VA+KK+ R+ + E E E+ ++ + +H
Sbjct: 5 EKIGEGTYGVVYKARDKLT---GEIVALKKI-RL--ETEDEGVPSTAIREISLLKELNHP 58
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----AFQIARGLLYL 635
N+VRLL LV+EFL+ L ++ + P L + +Q+ +G+ Y
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG------TKG 689
H S +++H D+KPQN+L+D +++DFGLA +A +R T
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLA--------RAFGVPVRTYTHEVVTLW 164
Query: 690 YVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 734
Y APE S + VD++S G + E+++ R F D E+ + + I
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 34/273 (12%)
Query: 527 VGRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G G+FG VYKG+ I VA+K L + KE +E V+ + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDCSAQ 642
LG C +L V + + G L ++ N S +L N QIA+G+ YL E +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSYLEE---VR 129
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI- 701
++H D+ +N+L+ + +I+DFGLA+LL +++ T G V +W +I
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE-----TEYHADGGKVPIKWMALESIL 184
Query: 702 ----TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757
T + DV+S+GV + E++ +F + +D ++ DL+E
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM----TFGAK-----------PYDGIPAREIPDLLEKGER 229
Query: 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790
C + M+ + C D RP ++++
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 18/217 (8%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTT---AVAVKKLDRVFQDGEKEFK-NEVVVIGQTH 577
NF +G+GSFG V+L R T A+ + K D + QD + E E V+
Sbjct: 3 NFLMVLGKGSFG----KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG 58
Query: 578 HKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 634
+ L C + +RL V E++N G L + G K A +IA GL +
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP--HAVFYAAEIAIGLFF 116
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
LH S II+ D+K N++LD + +I+DFG+ K + K RT GT Y+APE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFC-GTPDYIAPE 171
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
VD ++FGVLL E+++ + FD E +E
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G FG V R + A K+L++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEV---CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 640
L + E ++ L LV +N G L ++ P + + A +I GL LH +
Sbjct: 65 L-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
++ D+KP+NILLDDY + RISD GLA + + + ++IR + GT GY+APE N
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVLNNQR 177
Query: 701 ITAKVDVYSFGVLLLEIISCRKSF 724
T D + G L+ E+I + F
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 35/220 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKN 580
F++ +G G+FG V + +I A A+K L + ++ ++F E+ V+ + HH N
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNA-AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-------------- 626
++ LLG C+ + E+ G L FL + S L T+ AF
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 627 ------QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
+A G+ YL E Q IH D+ +N+L+ + ++I+DFGL++ + K +
Sbjct: 121 LLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177
Query: 681 -RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
R +R ++A E S T K DV+SFGVLL EI+S
Sbjct: 178 GRLPVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 84/316 (26%), Positives = 142/316 (44%), Gaps = 60/316 (18%)
Query: 527 VGRGSFGIVYK----GVILTTRTSTTAVAVKKL-----DRVFQDGEKEFKNEVV-VIGQT 576
+G G FG V + G+ + T VAVK L D+ D E E++ +IG+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--ELMKLIGK- 76
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------ 624
HKN++ LLG C + ++ E+ G L FL P + +I
Sbjct: 77 -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 625 ----AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDW 738
+ R ++APE + T + DV+SFG+L+ EI + S I + E + +L +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG 252
Query: 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV-- 796
+R +K + C +L M+ C P+ RPT K++++ L+ V
Sbjct: 253 ----HRMDKPSN-------------CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
Query: 797 ------VEVSLPPNPY 806
+++S+P Y
Sbjct: 296 AVSEEYLDLSMPFEQY 311
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLD-RVFQDGEKEF-KNEVVVIGQTHHKNLVRL 584
+G GSFG +Y + ++ + +K++D EKE K EV+++ + H N+V
Sbjct: 8 IGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLLY 634
E +V E+ + G L + N + + F QI+ GL +
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRI--------NRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 635 LHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
+H+ +I+H DIK QNI L + A++ DFG+A+ LN S + GT Y++P
Sbjct: 117 IHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSP 171
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
E +N K D++S G +L E+ + + F+
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 527 VGRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G G+FG VYKG+ I VA+K+L + KE +E V+ + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
LG C +L + + + G L ++ N+ + L N QIA+G+ YL E
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEE---R 128
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
+++H D+ +N+L+ + +I+DFGLAKLL ++ + + ++A E +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 702 TAKVDVYSFGVLLLEIISC-RKSFD-IEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759
T + DV+S+GV + E+++ K +D I E +IL EK + L + +
Sbjct: 189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------EKGERLPQPPI--- 235
Query: 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790
C + M+ + C D RP ++++
Sbjct: 236 ----CTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 52/194 (26%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E++G+G+ G V+ + VA+K+++ Q ++ NE++V+ + + N+V
Sbjct: 25 EKIGQGASGTVFTA---IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNF 81
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
L G +V E+L G+L + + + + + L +LH + Q+I
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---QVI 137
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
H DIK N+LL + +++DFG +T QSK R+ + GT ++APE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 705 VDVYSFGVLLLEII 718
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 14/178 (7%)
Query: 550 VAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNLVRLLGFCDEGQNR--LLVYEFLNNG 604
VAVK L + G + K E+ ++ +H+N+V+ G C E L+ EFL +G
Sbjct: 36 VAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 605 TLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662
+L +L N K NL+ A QI +G+ YL S Q +H D+ +N+L++ + +
Sbjct: 94 SLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 149
Query: 663 ISDFGLAKLLTLNQS-KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
I DFGL K + ++ ++ + + APE S DV+SFGV L E+++
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLV 582
+++G GSFG K +++ ++ +K+++ ++ +E + EV V+ H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGL 632
+ +E N +V ++ G L + N + + F QI L
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGVLFPEDQILDWFVQICLAL 114
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
++H+ +I+H DIK QNI L ++ DFG+A++L + + RT I GT Y++
Sbjct: 115 KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCI-GTPYYLS 169
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
PE N K D+++ G +L E+ + + +F+
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 67/226 (29%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKE--FKNEVVVIGQTHHKNLV 582
+G+GSFG K ++ + + A+K L D V +D + E V+ H L
Sbjct: 3 LGKGSFG---KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 583 RLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
L FC ++ V E+LN G L + + + A +I GL +LH
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---K 114
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
II+ D+K N+LLD + +I+DFG+ K + KA + GT Y+APE +
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQK 172
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746
VD +SFGVLL E++ + F E +E FD N+
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTT---AVAVKKLDRVFQDGEKEF-KNEVVVIGQT-HHKNL 581
+G+GSFG V+L T AV V K D + QD + E E V+ H L
Sbjct: 3 LGKGSFG----KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+L C + ++RL V E++N G L + + + A +I GL +LHE
Sbjct: 59 TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-- 115
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
II+ D+K N+LLD + +I+DFG+ K L + GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQP 172
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY---AILTD 737
VD ++ GVLL E+++ + F+ + E+ +IL D
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G FG V R + A KKL++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 640
L + E ++ L LV +N G L ++ + + + A +I GL LH++
Sbjct: 65 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+I++ D+KP+NILLDD+ + RISD GLA + Q+ R GT GY+APE +N
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNER 177
Query: 701 ITAKVDVYSFGVLLLEIISCRKSF 724
T D ++ G LL E+I+ + F
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 578
E+G G++G V+K L + VA+K++ RV Q GE+ EV V+ H
Sbjct: 8 EIGEGAYGKVFKARDL--KNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 579 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 631
N+VRL C D LV+E ++ L ++L +P T ++ FQ+ RG
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L +LH S +++H D+KPQNIL+ +++DFGLA++ + + T++ T Y
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYR 176
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
APE S+ VD++S G + E+ + F
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 44/298 (14%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVV------VIGQTHH 578
+G G FG V L AV ++ +D EK+ + V +IG+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA------------- 625
KN++ LLG C + ++ E+ + G L +L P +IA
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 626 ---FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682
+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742
R ++APE + T + DV+SFGVL+ EI + S +
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS---------------PYPG 242
Query: 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
E+L L++ C +L M+ C PS RPT K++++ L+ ++ ++
Sbjct: 243 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 43/244 (17%)
Query: 523 FKEEVGRGSFGIVY----KGVILTTRTSTTA-------VAVKKL-DRVFQDGEKEFKNEV 570
KE++G G FG V+ +G+ VAVK L V + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 571 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------FGNLKPSWNL 620
++ + + N++RLLG C ++ E++ NG L FL N PS ++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 621 RT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN--- 675
+A QIA G+ YL S +H D+ +N L+ ++Y +I+DFG+++ L
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 676 --QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 733
Q +A+ IR ++A E T DV++FGV L E+ + K + Y+
Sbjct: 186 RIQGRAV-LPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE------QPYS 234
Query: 734 ILTD 737
+L+D
Sbjct: 235 LLSD 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 583
E VG G++G VYKG T +A K+ V D E+E K E+ ++ + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 584 LLG-FCDEGQNRL-----LVYEFLNNGTLASFLF---GN-LKPSWNLRTNIAFQIARGLL 633
G F + + LV EF G++ + GN LK W I +I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLS 125
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
+LH+ ++IH DIK QN+LL + ++ DFG++ L+++ R GT ++AP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAP 180
Query: 694 EWFR-----NSTITAKVDVYSFGVLLLEI 717
E ++T K D++S G+ +E+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 29/289 (10%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVI 573
EL+ + + +G G FG + +G + VA+ L D ++ F E + +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIAR 630
GQ H N+VRL G G ++V E+++NG L SFL G L + + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM--GMLPGLAS 118
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG- 689
G+ YL E +H + +L++ +IS F L ++S+AI T + G
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172
Query: 690 -YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748
+ APE + ++ DV+SFG+++ E++S + +M + +
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---------------GQDV 217
Query: 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
VE C L + + C Q++ RP ++ +L +V
Sbjct: 218 IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 36/240 (15%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIG---QTHH 578
E+G G++G VYK S VA+K + RV Q E EV ++ H
Sbjct: 7 EIGVGAYGTVYKA---RDPHSGHFVALKSV-RV-QTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 579 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 631
N+VRL+ C D LV+E ++ L ++L P T ++ Q RG
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L +LH +C I+H D+KP+NIL+ +++DFGLA++ + + T + T Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYR 174
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIIS-----CRKSFDIEMGEEYAIL-----TDWAFD 741
APE ST VD++S G + E+ C S ++G+ + ++ DW D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G G FG V +G L S VAVK K+ + ++F +E V + + H N++RL
Sbjct: 7 LGEGEFGSVMEG-QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 585 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGL 632
+G C + +++ F+ +G L SFL G+ + + F IA G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL----TLNQSKAIRTAIRGTK 688
YL S IH D+ +N +L++ N ++DFGL+K + Q + + ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK--- 179
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEI 717
++A E + T K DV+SFGV + EI
Sbjct: 180 -WIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 27/209 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 583
E VG G++G VYKG T +A K+ V +D E+E K E+ ++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 584 LLG-FCDE---GQNR--LLVYEFLNNGTLASFLF---GN-LKPSWNLRTNIAFQIARGLL 633
G F + G + LV EF G++ + GN LK W I +I RGL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLA 135
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
+LH + ++IH DIK QN+LL + ++ DFG++ L+++ R GT ++AP
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAP 190
Query: 694 EWFR-----NSTITAKVDVYSFGVLLLEI 717
E ++T + D++S G+ +E+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 35/216 (16%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNLVRL 584
+G G+FG V K I A A+K++ + +D ++F E+ V+ + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF------------------ 626
LG C+ L E+ +G L FL + S L T+ AF
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 627 --QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-RTA 683
+ARG+ YL + Q IH D+ +NIL+ + Y A+I+DFGL++ + K + R
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
+R ++A E S T DV+S+GVLL EI+S
Sbjct: 175 VR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 514 KELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 571
+ L + TD ++ E +G+G++G VYK +T + + AVK LD + D ++E + E
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYK---VTNKKDGSLAAVKILDPI-SDVDEEIEAEYN 70
Query: 572 VIGQ-THHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--- 621
++ +H N+V+ G GQ LV E N G++ + G L L
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 622 -TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
+ I + GL +LH + +IIH D+K NILL ++ DFG++ LT ++
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLR 184
Query: 681 RTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEI 717
R GT ++APE + + A+ DV+S G+ +E+
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHK 579
E+G+G++GIV + VA+KK+ VF +E K ++ HK
Sbjct: 7 ELGQGAYGIVCS-ARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRHFRGHK 62
Query: 580 NLVRL--LGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
N+ L + G N L +YE L L + + + +QI GL Y+H
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
SA ++H D+KP N+L++ +I DFGLA+ + N + YVA W+
Sbjct: 123 ---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF----MTEYVATRWY 175
Query: 697 R-------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 732
R + T +DV+S G +L E++ + F G++Y
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF---KGKDY 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 72/239 (30%), Positives = 109/239 (45%), Gaps = 44/239 (18%)
Query: 509 PCFSYKELE----EATDNFKE--EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD- 561
P F +EL E + ++ VG G++G V T+T VAVKKL R FQ
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLR-VAVKKLSRPFQSI 57
Query: 562 -GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKP 616
K E+ ++ H+N++ LL ++ E N+ L + L G N+
Sbjct: 58 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVK 113
Query: 617 SWNLRTN----IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672
L + + +QI RGL Y+H SA IIH D+KP N+ +++ +I DFGLA+
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 168
Query: 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 724
T T GYVA W+R I VD++S G ++ E+++ R F
Sbjct: 169 --------HTDDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRL 584
+G G+FG+V+ +T VA+KK+ VFQ+ K E+ ++ H N++
Sbjct: 8 IGYGAFGVVWS---VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 585 LGFCDEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
L + V L L + S + +QI RGL YLH S
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---S 121
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
A I+H DIKP N+L++ +I DFGLA++ ++SK T T+ Y APE S
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSR 180
Query: 701 -ITAKVDVYSFGVLLLEIISCRKSF 724
T+ VD++S G + E++ R F
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTA-VAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKN 580
E +G G++G+V + T + VA+KK+ F ++ + E+ ++ H N
Sbjct: 11 ENIGSGAYGVVCSAI----DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDN 65
Query: 581 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
++ + + ++ +V + L L + + + +Q+ RGL Y+H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIRTAIRGTKGYVAPE 694
SA +IH D+KP N+L+++ RI DFG+A+ L+ + + K T T+ Y APE
Sbjct: 125 ---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 695 -WFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
T +D++S G + E++ R+ F
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G FG V R + A KKL++ + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCS 640
L + E ++ L LV +N G L ++ P ++ + I A ++ GL L +
Sbjct: 65 L-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+I++ D+KP+NILLDD + RISD GLA + + + + +R + GT GY+APE N
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPEVINNEK 177
Query: 701 ITAKVDVYSFGVLLLEIISCRKSF 724
T D + G L+ E+I + F
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 16/197 (8%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
VG G+FG V+ + R S A+K + + + E+ NE V+ + H ++R
Sbjct: 9 VGTGTFGRVHL---VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 643
L + + ++ E++ G L S+L + + S + A +I L YLH S +I
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEI 122
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAPEWFRNSTIT 702
++ D+KP+NILLD + +++DFG AK L RT + GT Y+APE ++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCGTPEYLAPEVIQSKGHN 176
Query: 703 AKVDVYSFGVLLLEIIS 719
VD ++ G+L+ E++
Sbjct: 177 KAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 47/285 (16%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHH-KNLV 582
EE+GRG++G+V K + + T +AVK++ E K ++ + ++ V
Sbjct: 7 EELGRGAYGVVDK---MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 583 RLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 633
G C E + L +F + G P ++ IA I + L
Sbjct: 64 TFYGALFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPE-DILGKIAVSIVKALE 117
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
YLH S +IH D+KP N+L++ ++ DFG++ L + +K I G K Y+AP
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA---GCKPYMAP 172
Query: 694 EWFRNSTITA----KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN--EK 747
E K DV+S G+ ++E+ A + +D ++ ++
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIEL---------------ATGR-FPYDSWKTPFQQ 216
Query: 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
L +VE L K + C++++ RP ++LQ
Sbjct: 217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+E+G G FG V G S V VK+L D + F EV + +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEA-HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHED 638
LG C E LLV EF G L ++L N ++ +A ++A GLL+LH+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA------IRGTKGYVA 692
A IH D+ +N L + +I D+GLA L T +R ++A
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR----WLA 170
Query: 693 PEW-------FRNSTITAKVDVYSFGVLLLEI 717
PE T K +++S GV + E+
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 59/212 (27%), Positives = 112/212 (52%), Gaps = 20/212 (9%)
Query: 522 NFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQTHH 578
NFK E++G G++ VYKG RT+ VA+K++ ++G E+ ++ + H
Sbjct: 1 NFKQLEKLGEGTYATVYKG---RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRTNIAFQIARGLL 633
+N+VRL +LV+E+++ L ++ G L P N + +Q+ +G+
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDP--NTVKSFTYQLLKGIA 114
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
+ HE+ +++H D+KPQN+L++ +++DFGLA+ + + + T Y AP
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 694 EWFRNS-TITAKVDVYSFGVLLLEIISCRKSF 724
+ S T + +D++S G ++ E+I+ R F
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTT---AVAVKKLDRVFQDGEKEFKN-EVVVIGQTH 577
NF +G+GSFG V+L R T A+ + K D V QD + E E V+ +
Sbjct: 3 NFLMVLGKGSFG----KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 578 HKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 634
+ L C + +RL V E++N G L + G K + A +IA GL +
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF--YAAEIAIGLFF 116
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAP 693
LH S II+ D+K N++LD + +I+DFG+ K N + T GT Y+AP
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTKTFCGTPDYIAP 170
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
E VD ++FGVLL E+++ + F+ E +E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-14
Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
LL +H S +IH DIK NILL ++ DFG +K+ S + GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
APE +R + K D++S GVLL E+++ ++ FD E EE +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV---------------MHKT 257
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM------LEGVVEV 799
+ G + L E +V+ + DP RP+ K+L M + G++E+
Sbjct: 258 LAGRYDPLPPSISPEMQEIVTA-LLSSDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
++E +G G+ G VYK L TR AV V LD + + +K+ +E+ ++ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTR-RILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62
Query: 583 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
G F E NR+ + EF++ G+L + K ++ IA + +GL YL S
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYL---WS 113
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+I+H D+KP N+L++ ++ DFG++ L +I GT Y+APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQ 169
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
DV+S G+ +E+ R + + +++ C +V+ D L
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDPPVLP 221
Query: 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790
+ EK V C+++ P RP + ++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN--------EVVVIGQTHH 578
+G G++ +VYK T VA+KK + KE K+ E+ ++ + H
Sbjct: 8 LGEGTYAVVYKAR--DKETGRI-VAIKK---IKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 579 KNLVRLLGFCDEGQNRLLVYEFL--------NNGTLASFLFGNLKPSWNLRTNIAFQIAR 630
N++ LL N LV+EF+ + ++ ++K S+ L R
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-VLTPADIK-SYML------MTLR 113
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
GL YLH S I+H D+KP N+L+ +++DFGLA+ + T T+ Y
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWY 168
Query: 691 VAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSF 724
APE + VD++S G + E++ R F
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLVR 583
E+G G+FG VYK + + A K + + E+ +F E+ ++ + H N+V
Sbjct: 12 ELGDGAFGKVYKAQ---HKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVG 66
Query: 584 LL-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDC 639
L + E + +L+ EF + G L S + + I + Q+ L +LH
Sbjct: 67 LYEAYFYENKLWILI-EFCDGGALDSIMLELERGL--TEPQIRYVCRQMLEALNFLHSH- 122
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP-----E 694
++IH D+K NILL + +++DFG++ K R GT ++AP E
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACE 178
Query: 695 WFRNSTITAKVDVYSFGVLLLEI 717
F+++ K D++S G+ L+E+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 24/277 (8%)
Query: 522 NFKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 579
NF+ E +GRG F VY+ L R V+ + + ++ E+ ++ Q +H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF--QIARGLLYL 635
N+++ L E +V E + G L+ + F K RT + Q+ + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H S +++H DIKP N+ + ++ D GL + + + A ++ GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPER 177
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
+ K D++S G LL E+ + + F G++ + + C + E+ D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFS----LCQKIEQC------D 224
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
L EKL + CI DP RP + V Q+
Sbjct: 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 56/210 (26%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 583
+++G G++ V+KG ++ + VA+K++ ++G EV ++ H N+V
Sbjct: 11 DKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
L + LV+E+L++ L +L GNL N++ FQ+ RGL Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK---R 122
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR---- 697
+I+H D+KPQN+L+++ +++DFGLA+ +K++ T + V W+R
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 174
Query: 698 ---NSTITAKVDVYSFGVLLLEIISCRKSF 724
++ + +D++ G +L E+ + R F
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 581
E++G G++G V+K R + VA+K++ R+ D E + E+ ++ + HKN+
Sbjct: 6 EKIGEGTYGTVFKAK---NRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
VRL + LV+E+ + F N + + FQ+ +GL + H S
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SH 118
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
++H D+KPQN+L++ +++DFGLA +A +R V W+R +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLA--------RAFGIPVRCYSAEVVTLWYRPPDV 170
Query: 702 -------TAKVDVYSFGVLLLEI 717
+ +D++S G + E+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 55/210 (26%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 583
E++G G++ V+KG ++ + VA+K++ ++G EV ++ H N+V
Sbjct: 12 EKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
L ++ LV+E+L+ L ++ GN+ N++ + +QI RGL Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHR---R 123
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR---- 697
+++H D+KPQN+L+++ +++DFGLA+ +K++ T + V W+R
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 175
Query: 698 ---NSTITAKVDVYSFGVLLLEIISCRKSF 724
+S + ++D++ G + E+ S R F
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 81/288 (28%), Positives = 138/288 (47%), Gaps = 50/288 (17%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHK 579
+E+G+G++G VYK +L T T +A+K++ R+ D E +F E+ ++ +
Sbjct: 5 VLDELGKGNYGSVYK--VLHRPTGVT-MAMKEI-RLELD-ESKFNQIIMELDILHKAVSP 59
Query: 580 NLVRLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNL----KPSWNLRTNIAFQIARG 631
+V G F EG VY E+++ G+L G + P LR I + + +G
Sbjct: 60 YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKG 114
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L +L E+ IIH D+KP N+L++ ++ DFG++ L + +K T I G + Y+
Sbjct: 115 LKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK---TNI-GCQSYM 168
Query: 692 APEWFR------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745
APE + N T T + DV+S G+ +LE+ R + E Y N
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--------------YAN 214
Query: 746 --EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+L +V+GD L + V+ C+ + P+ RPT ++L+
Sbjct: 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 580
F VG+GS+G V ++ RT +KKL+ + K + E ++ Q H N
Sbjct: 4 FVRVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 581 LVR--------------LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 626
+V ++GFC+ G +Y L G L P N
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGD----LYHKLKEQK------GKLLPE-NQVVEWFV 109
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
QIA L YLHE I+H D+K QN+ L ++ D G+A++L NQ T I G
Sbjct: 110 QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI-G 164
Query: 687 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
T Y++PE F N K DV++ G + E+ + + +F+
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 27/201 (13%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRL 584
VG G+FG+V + + VA+KK+ + F K E+ ++ H+N++ L
Sbjct: 18 VGMGAFGLVCSA---RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 585 LG-FCDEGQNRLLVYEFLNNGT-LASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
F ++ V E L GT L L L+ + +QI RGL Y+H SA
Sbjct: 75 SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQF--IQYFLYQILRGLKYVH---SA 127
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE----WFR 697
++H D+KP NIL+++ + +I DFGLA++ Q + T T+ Y APE W +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TGYVSTRYYRAPEIMLTWQK 182
Query: 698 NSTITAKVDVYSFGVLLLEII 718
+VD++S G + E++
Sbjct: 183 YDV---EVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 39/101 (38%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ-SKAIRTAI 684
+QI RGL Y+H SA ++H D+KP N+LL+ + +I DFGLA++ T
Sbjct: 113 YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 685 RGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSF 724
T+ Y APE NS T +D++S G +L E++S R F
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE------KEFKNEVVVIGQTHH 578
++G GS+G+V+K R + VA+KK F + E K E+ ++ Q H
Sbjct: 7 SKIGEGSYGVVFK---CRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQLKH 59
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLH 636
NLV L+ + LV+E+ ++ T+ + L N + P ++ I +Q + + + H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCH 117
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG----YVA 692
IH D+KP+NIL+ ++ DFG A++LT G YVA
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFARILT------------GPGDDYTDYVA 162
Query: 693 PEWFR-------NSTITAKVDVYSFGVLLLEIIS 719
W+R ++ VDV++ G + E+++
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 583
+++G G++ VYKG ++ + VA+K++ ++G EV ++ H N+V
Sbjct: 12 DKLGEGTYATVYKG---RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
L ++ LV+E+L+ L +L GN N++ + FQ+ RGL Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHRR--- 123
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
+++H D+KPQN+L+++ +++DFGLA+ +K+I T + V W+R I
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNE--VVTLWYRPPDI 175
Query: 702 -------TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
+ ++D++ G + E+ + R F EE
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G+G FG V + + + S VAVK K D +EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 585 LGFC--DEGQNRL----LVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGL 632
+G + RL ++ F+ +G L +FL G + L+T + F IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL----TLNQSKAIRTAIRGTK 688
YL S IH D+ +N +L++ ++DFGL+K + Q A + ++
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK--- 180
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNE 746
++A E ++ T DV++FGV + EI++ ++ +E E Y L +
Sbjct: 181 -WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-------KGN 232
Query: 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796
+L + C+E + + C +P RP+ + + LE +
Sbjct: 233 RLKQPPD----------CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 27/205 (13%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--------DRVFQDGEKEFKNEVVVIGQTHH 578
+G+GSFG V+ +T + A+K L DRV K E ++ + +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV------RTKMERDILAEVNH 57
Query: 579 KNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLY 634
+V+L F EG+ L+ +FL G L + L K ++ F ++A L +
Sbjct: 58 PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDH 113
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
LH S II+ D+KP+NILLD+ + +++DFGL+K ++ KA + GT Y+APE
Sbjct: 114 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPE 168
Query: 695 WFRNSTITAKVDVYSFGVLLLEIIS 719
T D +SFGVL+ E+++
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 18/219 (8%)
Query: 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTT---AVAVKKLDRVFQDGEKEFKN-EVVVIGQ 575
NF +G+GSFG V+L R T A+ + K D V QD + E E V+
Sbjct: 1 DFNFLMVLGKGSFG----KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL 56
Query: 576 THHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGL 632
+ L C + +RL V E++N G L + G K + A +I+ GL
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF--YAAEISVGL 114
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
+LH II+ D+K N++LD + +I+DFG+ K + RT GT Y+A
Sbjct: 115 FFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFC-GTPDYIA 169
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
PE VD +++GVLL E+++ + FD E +E
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVR 583
+GRG++GIV T VA+KK+ F D ++ + E+ ++ H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEK---VAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIA 68
Query: 584 LLGFCDEGQNR-----LLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLY 634
+ +VYE ++ L ++ S L + +Q+ RGL Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
+H SA ++H D+KP N+LL+ + +I DFGLA+ T ++ T T+ Y APE
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE 178
Query: 695 WFRNST-ITAKVDVYSFGVLLLEII 718
N + T +DV+S G + E++
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKN 568
F+ ++L++ E+GRG+FG V K + + S T +AVK++ R D +K
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK---MLHKPSGTIMAVKRI-RSTVDEKEQKRLLM 51
Query: 569 EV-VVIGQTHHKNLVRLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLK--- 615
++ VV+ + +V+ G C E L+ L+ +++ LK
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVI 104
Query: 616 PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
P + IA + L YL E+ +IIH D+KP NILLD N ++ DFG++ L
Sbjct: 105 PE-EILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--- 158
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITA---KVDVYSFGVLLLEI 717
+T G + Y+APE S + DV+S G+ L E+
Sbjct: 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVR 583
+G G FG V + ++ A+K + + + + G ++ +E ++ + +H +V+
Sbjct: 1 LGVGGFGRVEL---VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVK 57
Query: 584 LL-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
L F D+ + ++ E+ G L + L G + R IA + YLH +
Sbjct: 58 LYRTFKDK-KYIYMLMEYCLGGELWTILRDRGLF-DEYTARFYIA-CVVLAFEYLH---N 111
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
II+ D+KP+N+LLD ++ DFG AK L +S GT YVAPE N
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 737
VD +S G+LL E+++ R F + + I D
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 64/215 (29%), Positives = 93/215 (43%), Gaps = 38/215 (17%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRL 584
VG G++G V R VAVKKL R FQ + E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLH 636
L + E N L + L G N+ L + +Q+ RGL Y+H
Sbjct: 80 LDVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
SA IIH D+KP N+ +++ RI DFGLA R A GYVA W+
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLA-----------RQADDEMTGYVATRWY 181
Query: 697 RNSTI-------TAKVDVYSFGVLLLEIISCRKSF 724
R I VD++S G ++ E++ + F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 65/239 (27%), Positives = 97/239 (40%), Gaps = 42/239 (17%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKK-LDRVFQDGEKEFK----NEVVVIGQT 576
++G G+FG VYK + T VA+KK L +DG F E+ ++ +
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGR---VVALKKILMHNEKDG---FPITALREIKILKKL 64
Query: 577 HHKNLVRLLGFC-----DEGQNRLLVY--EFLNNGTLASFLFGNLKPSWNLR----TNIA 625
H N+V L+ + R VY + L+ L N PS L
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-EN--PSVKLTESQIKCYM 121
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR 685
Q+ G+ YLHE I+H DIK NIL+D+ +I+DFGLA+
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 686 GTKGY---VAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF----DIEMGE 730
GT+ Y V W+R + T VD++ G + E+ + R DI+
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 90/337 (26%), Positives = 138/337 (40%), Gaps = 90/337 (26%)
Query: 527 VGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 582
+G G+FG V + + ++S VAVK L E K +E+ ++I +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 583 RLLGFCDEGQNRLLV-YEFLNNGTL----------------------------------- 606
LLG C + L+V EF G L
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134
Query: 607 -------ASFLFGNLKPSWNLRTN--------------------IAFQIARGLLYLHEDC 639
AS LF +PS + TN +FQ+ARG+ +L
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---A 191
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
S + IH D+ +NILL + +I DFGLA+ + + + + R ++APE +
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251
Query: 700 TITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD-M 756
T + DV+SFGVLL EI S S +++ EE+ C R L +G M
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------CQR------LKDGTRM 296
Query: 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
A + +M++ W Q DP RPT ++++L
Sbjct: 297 RAPENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 65/200 (32%), Positives = 91/200 (45%), Gaps = 8/200 (4%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRL 584
+G+GSFG V+ + T A+KK D V D + E + V+ H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
+N V E+LN G L + K T A +I GL +LH S I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIV 118
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
+ D+K NILLD + +I+DFG+ K L +K GT Y+APE
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNTS 176
Query: 705 VDVYSFGVLLLEIISCRKSF 724
VD +SFGVLL E++ + F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRL 584
+G G+ GIV VAVKKL R FQ+ K E+V++ +HKN++ L
Sbjct: 29 IGSGAQGIVCAAF---DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 585 LGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
L +E Q+ LV E ++ L + L + + +Q+ G+ +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLH-- 140
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
SA IIH D+KP NI++ +I DFGLA+ N + T T+ Y APE
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILG 196
Query: 699 STITAKVDVYSFGVLLLEII 718
VD++S G ++ E++
Sbjct: 197 MGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 24/277 (8%)
Query: 522 NFKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 579
NF+ E +GRG F VY+ L V+ D + + E+ ++ Q +H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF--QIARGLLYL 635
N+++ E +V E + G L+ + F K +T + Q+ L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H S +++H DIKP N+ + ++ D GL + + + A ++ GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPER 177
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
+ K D++S G LL E+ + + F + Y++ C + E+ D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKKIEQC------D 224
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
L E+L + CI DP RP + V +
Sbjct: 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRL 584
VG G++G V + T VA+KKL R FQ K E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEK---VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHED 638
L D + + EF + + ++ +L+ + + +Q+ GL Y+H
Sbjct: 80 L---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH-- 134
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
SA IIH D+KP N+ +++ +I DFGLA R A GYV W+R
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYRA 182
Query: 699 STI-------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 732
+ VD++S G ++ E+++ + F G++Y
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK---GKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 77/320 (24%), Positives = 130/320 (40%), Gaps = 75/320 (23%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTA-------------VAVKKL-DRVFQDGEKEFKN 568
FKE++G G FG V+ ++ + T VAVK L ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 569 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------------- 613
EV ++ + N++RLLG C + ++ E++ NG L FL +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 614 ----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669
S++ ++A QIA G+ YL S +H D+ +N L+ + +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 670 KLLTLN-----QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKS 723
+ L Q +A+ IR ++A E T DV++FGV L EI+ C++
Sbjct: 186 RNLYAGDYYRIQGRAV-LPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKE- 239
Query: 724 FDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK----------CVEKLVMVSI 773
+ Y LTD + ++E E D C + L + +
Sbjct: 240 ------QPYGELTD-----------EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELML 282
Query: 774 WCIQEDPSLRPTMKKVLQML 793
C D RP+ + L
Sbjct: 283 QCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 35/273 (12%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 582
E+G GSFG VY T + VAVKK+ + +++++ EV + Q H N +
Sbjct: 28 EIGHGSFGAVY---FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 641
G + LV E+ G+ + L + KP + I +GL YLH
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE---WFRN 698
+IH DIK NILL + +++DFG A + S GT ++APE
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDE 194
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
KVDV+S G I+C IE+ E L F+ L + + D
Sbjct: 195 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPT 239
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L + + +C+Q+ P RP ++L+
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI-GQTHHKNLVR 583
E +G+G++G V+K +L + + A AVK LD + D ++E + E ++ + H N+V+
Sbjct: 24 ETIGKGTYGKVFK--VLNKKNGSKA-AVKILDPI-HDIDEEIEAEYNILKALSDHPNVVK 79
Query: 584 LLGF-----CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR----GLLY 634
G G LV E N G++ + G LK + I I GL +
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
LH + + IH D+K NILL ++ DFG++ LT ++ R GT ++APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPE 194
Query: 695 WFR-----NSTITAKVDVYSFGVLLLEI 717
+ST A+ DV+S G+ +E+
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 60/220 (27%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRL 584
+G G+ GIV T VA+KKL R FQ+ K E+V++ +HKN++ L
Sbjct: 24 IGSGAQGIVCAAYDTVT---GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 585 LG-FC-----DEGQNRLLVYEF------------LNNGTLASFLFGNLKPSWNLRTNIAF 626
L F +E Q+ LV E L++ ++ L +
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL---------------Y 125
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
Q+ G+ +LH SA IIH D+KP NI++ +I DFGLA RTA
Sbjct: 126 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----------RTAGTS 171
Query: 687 --------TKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
T+ Y APE VD++S G ++ E+I
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 54/288 (18%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHHKNL 581
++G G+ G V K T V KK+ V + + +++ ++ + +
Sbjct: 12 DLGAGNGGSVSK----VKHIPTGTVMAKKV--VHIGAKSSVRKQILRELQIMHECRSPYI 65
Query: 582 VRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
V G F +E N + EF++ G+L G + + IA + GL YL+
Sbjct: 66 VSFYGAFLNEN-NICMCMEFMDCGSLDRIYKKGGPIPV--EILGKIAVAVVEGLTYLYN- 121
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
+I+H DIKP NIL++ ++ DFG++ L +I GT Y++PE +
Sbjct: 122 -VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQG 176
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
T K DV+S G+ ++E+ + F + DD + M
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAF------------------SNIDDDGQDDPMGI 218
Query: 759 LNDIKCV--------------EKLVMVSIWCIQEDPSLRPTMKKVLQM 792
L+ ++ + E L C+ +DP+ RPT +++ M
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 48/154 (31%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+E+G G FG V G + + + V VK+L Q+ + +F E H NL+
Sbjct: 1 KEIGNGWFGKVILGEV-NSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLL 58
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHE 637
+ LG C E LLV EF G L +L + P +A +IA GLL+LH+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671
+ IH D+ +N LL +I D+GL+
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 26/204 (12%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
E+G G+FG VYK + + A K ++ ++ +++ E+ ++ +H +V+LL
Sbjct: 19 ELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 586 G-FCDEGQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
G F +G+ +++ EF G + + + G +P + I Q+ L YLH S
Sbjct: 76 GAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLH---S 128
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLA--KLLTLNQSKAIRTAIRGTKGYVAP----- 693
+IIH D+K N+LL + +++DFG++ + TL + R + GT ++AP
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR----RDSFIGTPYWMAPEVVMC 184
Query: 694 EWFRNSTITAKVDVYSFGVLLLEI 717
E +++ K D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLVR 583
+G+GSFG V + + R + A+K + + E + E V+ Q + +V
Sbjct: 1 IGKGSFGKVMQ---VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSA 641
L F + +L LV F+N G L F +L+ + A F A L L
Sbjct: 58 L-KFSFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAPEWFRNST 700
+I+ D+KP+NILLD + + DFGL K LN +T GT Y+APE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 701 ITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEY-AILTD 737
T VD ++ GVLL E+++ F D + E Y IL +
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFK-NEVVVIGQTHHKNLVR 583
+G+GSFG K ++ + S AVK K D + QD + E E ++ + +
Sbjct: 3 LGKGSFG---KVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 584 LLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
L C + +RL V EF+N G L + + + A +I L++LH+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KG 116
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR-GTKGYVAPEWFRNSTI 701
II+ D+K N+LLD + +++DFG+ K N T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTSTFCGTPDYIAPEILQEMLY 173
Query: 702 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 737
VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
E+G G+FG VYK + + A K +D ++ +++ E+ ++ H N+V+LL
Sbjct: 12 ELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-QIARGLLYLHEDCSAQII 644
N ++ EF G + + + +P + + Q L YLHE+ +II
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF-----RNS 699
H D+K NIL + +++DFG++ T + R + GT ++APE ++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDR 183
Query: 700 TITAKVDVYSFGVLLLEI 717
K DV+S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
VG GSFG + +++ S A+K +L + E K E V++ + H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAF 63
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+ + +V E+ + G L + G L P + Q+ G+ ++HE
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQMCLGVQHIHEK--- 119
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
+++H DIK +NI L ++ DFG A+LLT + A GT YV PE + N
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYYVPPEIWENMPY 177
Query: 702 TAKVDVYSFGVLLLEIISCRKSF 724
K D++S G +L E+ + + F
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 48/215 (22%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--- 580
E +G GSFG V I + + A+K L K E++ + Q H
Sbjct: 23 GETLGTGSFGRVR---IAKHKGTGEYYAIKCLK----------KREILKMKQVQHVAQEK 69
Query: 581 ----------LVRLL-GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQ 627
+V ++ F DE NR+ + EF+ G L F +L+ + ++A F
Sbjct: 70 SILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFY 123
Query: 628 IARGLL---YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-A 683
A +L YLH S II+ D+KP+N+LLD+ + +++DFG AK + RT
Sbjct: 124 HAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP------DRTFT 174
Query: 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
+ GT Y+APE ++ VD ++ GVLL E I
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL---DRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+GRG+FG V+ L T V A+K L D + ++ + E ++ +V
Sbjct: 9 IGRGAFGEVW----LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 583 RLL-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
+L F DE ++ LV E++ G L + L F IA +L L
Sbjct: 65 KLYYSFQDE-EHLYLVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVH 118
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLL--------------------------- 672
IH DIKP NIL+D + +++DFGL K +
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
Q + + GT Y+APE R + + D +S GV+L E++
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRL 584
+G+GSFG V L + AV K D V D + E + V+ + L L
Sbjct: 3 LGKGSFGKVLLAE-LKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
++ V EFLN G L + + T A +I GL +LH S II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGII 118
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
+ D+K N++LD + +I+DFG+ K ++A + GT Y+APE + T
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTFS 176
Query: 705 VDVYSFGVLLLEIISCRKSF 724
VD +SFGVLL E++ + F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 30/212 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 582
E++G GS+ VYKG+ +R + VA+K + ++G F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKGI---SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV 66
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDC 639
L + V+E+++ LA ++ G L P +N+R FQ+ RGL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP-YNVRL-FMFQLLRGLAYIHGQ- 122
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR-- 697
I+H D+KPQN+L+ +++DFGLA+ +K+I + ++ V W+R
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSE--VVTLWYRPP 172
Query: 698 -----NSTITAKVDVYSFGVLLLEIISCRKSF 724
+ ++ +D++ G + +E++ + +F
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 73/321 (22%), Positives = 132/321 (41%), Gaps = 82/321 (25%)
Query: 523 FKEEVGRGSFGIVY----KGV---------ILTTRTSTTAVAVKKL-DRVFQDGEKEFKN 568
FKE++G G FG V+ +G+ + + VAVK L + ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 569 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------------ 610
E+ ++ + N++RLL C ++ E++ NG L FL
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 611 FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
+ L +A QIA G+ YL S +H D+ +N L+ Y +I+DFG+++
Sbjct: 129 YSTLI-------FMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI-----TAKVDVYSFGVLLLEIIS-CRKSF 724
N I+G + + W +I T DV++FGV L EI++ C++
Sbjct: 179 ----NLYSGDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE-- 231
Query: 725 DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK----------CVEKLVMVSIW 774
+ Y+ L+D + ++E E D C + L + +
Sbjct: 232 -----QPYSQLSD-----------EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS 275
Query: 775 CIQEDPSLRPTMKKV-LQMLE 794
C + + RP+ +++ +LE
Sbjct: 276 CWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 525 EEVGRGSFGIVYKG----VILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
E +G+G+F ++KG V T V +K LD+ ++ + F ++ Q HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHE 637
LV G C G ++V E++ G+L ++L N + SW L +A Q+A L +L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLED 118
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI--RTAIRGTKGYVAPEW 695
+ H ++ +N+LL + + + KL S + + + +V PE
Sbjct: 119 K---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175
Query: 696 FRNS-TITAKVDVYSFGVLLLEIIS 719
N ++ D +SFG L EI S
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 48/216 (22%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL- 584
+G GSFG+VY+ + + T + VA+KK V QD ++KN E++++ +H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDT---SEKVAIKK---VLQD--PQYKNRELLIMKNLNHINIIFLK 125
Query: 585 --------------------LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 624
+ F + ++ + + NN L FL
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV----------KLY 175
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTA 683
++Q+ R L Y+H S I H D+KPQN+L+D + + ++ DFG AK L Q
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 684 IRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEII 718
R Y APE +T T +D++S G ++ E+I
Sbjct: 233 SR---FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHH-K 579
E+G G+ G VYK + + + +AVK++ R G KE ++ V+ ++H
Sbjct: 21 GEIGSGTCGQVYK---MRFKKTGHVMAVKQMRRT---GNKEENKRILMDLDVVLKSHDCP 74
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLH 636
+V+ G+ + + E + T L ++ P ++ + I + L YL
Sbjct: 75 YIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPE-DILGKMTVAIVKALHYLK 131
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
E +IH D+KP NILLD N ++ DFG++ L SKA +T G Y+APE
Sbjct: 132 E--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKA-KTRSAGCAAYMAPERI 186
Query: 697 ----RNSTITAKVDVYSFGVLLLEI 717
N + DV+S G+ L+E+
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNL 581
+G+GSFG V L + AVK L + +KE K+ + V++ H L
Sbjct: 3 IGKGSFGKVL----LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
V L + + ++L V +++N G L L A +IA L YLH S
Sbjct: 59 VGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
II+ D+KP+NILLD + ++DFGL K + SK T GT Y+APE R
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC-GTPEYLAPEVLRKQP 172
Query: 701 ITAKVDVYSFGVLLLEIIS 719
VD + G +L E++
Sbjct: 173 YDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVR 583
+G+G+FG VY + T A V+ D + KE + E+ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ-FDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 584 LLG-FCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
G D + L ++ E++ G++ L +G L S + QI G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES--VTRKYTRQILEGMSYLH--- 123
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S I+H DIK NIL D N ++ DFG +K L T+ S ++ GT +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 699 STITAKVDVYSFGVLLLEIIS 719
K DV+S G ++E+++
Sbjct: 184 EGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-11
Identities = 37/119 (31%), Positives = 50/119 (42%), Gaps = 10/119 (8%)
Query: 40 TNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRG 99
++ T +S + F GF I Y + +TVVW N+D NP V
Sbjct: 5 SSGQTLVSGNSLFELGFF-----TLIMQNDYNLILYKSSS-RTVVWVA-NRD-NP-VSDS 55
Query: 100 SQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSN 157
+ L +D LVL D G+ VWSS V + D GN V+ S + LW SF
Sbjct: 56 CTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 582
E++G GS+ VYKG ++ + VA+K + R+ ++ F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKG---KSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDC 639
L + LV+E+++ L ++ G L P N++ + FQ+ RGL Y+H+
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQ-- 121
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
I+H D+KPQN+L+ D +++DFGLA+ ++ + T Y P+ S
Sbjct: 122 -RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS 178
Query: 700 T-ITAKVDVYSFGVLLLEIISCRKSF 724
T + +D++ G + +E+I +F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 23/179 (12%)
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
+FQ+ARG+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 742
R ++APE + T + DV+SFGVLL EI S S +++ EE+ C
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF---------C 286
Query: 743 YRNEKLDDLVEGD-MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
R L EG M A +M+ W +P RPT +++++L +++ +
Sbjct: 287 RR------LKEGTRMRAPEYATPEIYSIMLDCW--HNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKE---FKNEVVVIGQTHHKNL 581
+GRG+FG VY + + +AVK++ D Q+ KE + E+ ++ H +
Sbjct: 10 LGRGAFGEVY---LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 582 VRLLGFC--DEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLH 636
V+ G C D + +L ++ E++ G++ L +G L + N+ QI +G+ YLH
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGAL--TENVTRRYTRQILQGVSYLH 123
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIRTAIRGTKGYVAPEW 695
S I+H DIK NIL D N ++ DFG +K + T+ S ++ GT +++PE
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 696 FRNSTITAKVDVYSFGVLLLEIIS 719
K DV+S ++E+++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 79/273 (28%), Positives = 116/273 (42%), Gaps = 35/273 (12%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEK--EFKNEVVVIGQTHHKNLV 582
E+G GSFG VY RT+ VA+KK+ Q EK + EV + Q H N +
Sbjct: 22 EIGHGSFGAVYFAR--DVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI 78
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 641
G LV E+ G+ + L + KP + I +GL YLH S
Sbjct: 79 EYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SH 134
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE---WFRN 698
+ IH DIK NILL + +++DFG A L++ S GT ++APE
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAMDE 188
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
KVDV+S G I+C IE+ E L F+ L + + D
Sbjct: 189 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPT 233
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L+ + C+Q+ P RP+ +++L+
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-11
Identities = 40/133 (30%), Positives = 51/133 (38%), Gaps = 18/133 (13%)
Query: 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWY 86
+ + G TL + S L G F + D I Y +TVVW
Sbjct: 1 SNPLSSGQTLVSS-GSLFEL---GFFKLIMQSRD---------YNLILYKGSS-RTVVWV 46
Query: 87 TDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLAS 145
N+D NP + L +D LV+ D G VWSS V + D GN VL
Sbjct: 47 A-NRD-NP-SGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD 103
Query: 146 SSSSKLWDSFSNP 158
S + LW SF P
Sbjct: 104 SDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQ 575
D ++ E++G G++G VYK T VA+KK R+ D E E+ ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNT---GKLVALKK-TRLEMDEEGIPPTALREISLLQM 56
Query: 576 THHKN-LVRLLGF----CDEGQNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIA--- 625
+VRLL G+ L LV+E+L++ L F+ N + P L
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 626 -FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLTLNQSKAIRTA 683
+Q+ +G+ + H ++H D+KPQN+L+D +I+D GL + ++
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 684 IRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEII 718
+ T Y APE ST + VD++S G + E+
Sbjct: 173 V--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 527 VGRGSFGIV---YKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL 581
+G G+ GIV Y V+ VA+KKL R FQ+ K E+V++ +HKN+
Sbjct: 25 IGSGAQGIVCAAYDAVL------DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 582 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
+ LL +E Q+ LV E ++ L + ++ + + +Q+ G+ +L
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 135
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H SA IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 189
Query: 696 FRNSTITAKVDVYSFGVLLLEII 718
VD++S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLL 585
+GRGS+ V V L A+ V K + V D + ++ + E V Q + + L
Sbjct: 3 IGRGSYAKVLL-VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 586 GFCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQI 643
C + ++RL V E++N G L + K P + R A +I+ L YLHE I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGI 117
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR-----TAIRGTKGYVAPEWFRN 698
I+ D+K N+LLD + +++D+G+ K + +R + GT Y+APE R
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDI 726
VD ++ GVL+ E+++ R FDI
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 21/178 (11%)
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 742
R ++APE + T + DV+SFGVLL EI S S +++ EE+ C
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 292
Query: 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
R L EG D E + + C +PS RPT ++++ L +++ +
Sbjct: 293 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKE---FKNEVVVIGQTHHKNL 581
+G+G+FG VY + + +AVK++ D + KE + E+ ++ H+ +
Sbjct: 10 LGQGAFGRVY---LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 582 VRLLGFCDEGQNRLL--VYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHE 637
V+ G + R L E + G++ L +G L + N+ QI G+ YLH
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL--TENVTRKYTRQILEGVSYLH- 123
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIRTAIRGTKGYVAPEWF 696
S I+H DIK NIL D N ++ DFG +K L T+ S ++ GT +++PE
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 697 RNSTITAKVDVYSFGVLLLEIISCR 721
K D++S G ++E+++ +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLL 585
+GRGS+ V V L A+ V K + V D + ++ + E V Q + L
Sbjct: 3 IGRGSYAKVLL-VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 586 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQI 643
C + +RL LV E++N G L + K P + R A +I L +LHE I
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHE---RGI 117
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR-----TAIRGTKGYVAPEWFRN 698
I+ D+K N+LLD + +++D+G+ K + + + GT Y+APE R
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDI 726
VD ++ GVL+ E+++ R FDI
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 37/182 (20%)
Query: 623 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682
+ ++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + + + ++
Sbjct: 218 SFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS----------FDIEMGEEY 732
R ++APE N T + DV+S+G+LL EI S S F + E Y
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY 334
Query: 733 AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
+L+ +C +E D +M S W DP RPT K+++Q+
Sbjct: 335 RMLSP---ECAPSEMYD-------------------IMKSCW--DADPLKRPTFKQIVQL 370
Query: 793 LE 794
+E
Sbjct: 371 IE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 20/220 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTT---AVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKN 580
+G+GSFG V+L T A+ V K D + QD + + + ++ + H
Sbjct: 3 LGKGSFG----KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--P 56
Query: 581 LVRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
+ L C + ++RL V E++N G L + + K A ++ L++LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
+I+ D+K NILLD + +++DFG+ K LN T GT Y+APE +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQEL 171
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 737
VD ++ GVL+ E+++ + F+ + ++ +IL D
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 38/228 (16%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FK----NEVVVIGQTHHKN 580
++G G++G VYK + + VA+KK V D EKE F E+ ++ Q +H+N
Sbjct: 14 QIGEGTYGQVYKAR---DKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 581 LVRL----------LGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPSWNLRTNIAF- 626
+V L L F + LV+E++++ G L S L ++ +F
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-----HFSEDHIKSFM 122
Query: 627 -QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR 685
Q+ GL Y H+ +H DIK NILL++ +++DFGLA+L +S+ +
Sbjct: 123 KQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 686 GTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGE 730
T Y PE +DV+S G +L E+ + + F + E+ +
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNL 581
E +G+GS+G+V + T VA+KK++ VF+ D + + E+ ++ H ++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEK---VAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDI 61
Query: 582 VRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGL 632
V + E ++ +V+E + S L +K + +L +Q+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
Y+H +A + H D+KP+NIL + +I DFGLA++ + TAI T YVA
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP----TAIFWTD-YVA 168
Query: 693 PEWFRN--------STITAKVDVYSFGVLLLEIISCRKSF 724
W+R S T +D++S G + E+++ + F
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 527 VGRGSFGIV---YKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL 581
+G G+ GIV Y ++ VA+KKL R FQ+ K E+V++ +HKN+
Sbjct: 32 IGSGAQGIVCAAYDAIL------ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 582 VRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
+ LL +E Q+ +V E ++ L + ++ + + +Q+ G+ +L
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHL 142
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H SA IIH D+KP NI++ +I DFGLA+ T S + + T+ Y APE
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRAPEV 196
Query: 696 FRNSTITAKVDVYSFGVLLLEII 718
VD++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 517 EEATDNFKE--EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVI 573
E D+F+ E+G G+ G+V K + + S +A K + + + E+ V+
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK---VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 574 GQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 632
+ + +V G F +G+ + + E ++ G+L L + + ++ + RGL
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGL 116
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
YL E QI+H D+KP NIL++ ++ DFG++ L ++ + GT+ Y++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 170
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEI 717
PE + + + + D++S G+ L+E+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 51/172 (29%), Positives = 85/172 (49%), Gaps = 21/172 (12%)
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
+ Q+A+G+ +L S IH D+ +N+LL D A+I DFGLA+ + + + ++
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 743
R ++APE + T + DV+S+G+LL EI S KS Y IL + F Y
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF--Y 325
Query: 744 RNEKLDDLVEGDMEALNDIKCVE-KLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ K G + D E +M W + +P+ RPT ++ Q+++
Sbjct: 326 KMVK-----RGYQMSRPDFAPPEIYSIMKMCWNL--EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 41/171 (23%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN--------EVVVIGQTH 577
+GRG++G VYK + A+KK G+KE E+ ++ +
Sbjct: 7 CIGRGTYGRVYKAKRKNGKD-GKEYAIKKF-----KGDKEQYTGISQSACREIALLRELK 60
Query: 578 HKNLVRLLGFCDEGQNRL--LVYEFLNNGTLASF-LFGNLK----------PSWNLRTNI 624
H+N+V L+ E ++ L++++ A L+ +K P ++ ++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVK-SL 113
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR----ISDFGLAKL 671
+QI G+ YLH + ++H D+KP NIL+ R I D GLA+L
Sbjct: 114 LWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+ VG G++G VYK L T AV + KL+ D + E+ ++ + H N+V
Sbjct: 15 QRVGSGTYGDVYKARNLHT-GELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCSA 641
G + + E+ G+L ++ P L+ IA+ + +GL YLH S
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQ--IAYVCRETLQGLAYLH---SK 125
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF---RN 698
+H DIK NILL D + +++DFG+A +T +K R + GT ++APE +N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKN 183
Query: 699 STITAKVDVYSFGVLLLEI 717
D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 44/228 (19%)
Query: 512 SYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK--NE 569
+YK+L++ +G GS+ VYKG ++ + VA+K++ R+ + F E
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGR---SKLTGQLVALKEI-RLEHEEGAPFTAIRE 53
Query: 570 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAF 626
++ H N+V L + LV+E+L+ L ++ G L N+R F
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRL-FLF 110
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
Q+ RGL Y H +++H D+KPQN+L+ + +++DFGLA+ +K++
Sbjct: 111 QLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR------AKSVP----- 156
Query: 687 TKGY---VAPEWFR------NST-ITAKVDVYSFGVLLLEIISCRKSF 724
+K Y V W+R ST + +D++ G + E+ + R F
Sbjct: 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 70/273 (25%), Positives = 120/273 (43%), Gaps = 29/273 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 582
+ +G G++G VYK + T A+ V KL + GE + E++++ H N+V
Sbjct: 15 QRIGSGTYGDVYKARNVNT-GELAAIKVIKL----EPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
G + EF G+L S + ++ + +GL YLH S
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKG 126
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF---RNS 699
+H DIK NILL D + +++DFG++ +T +K R + GT ++APE R
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKG 184
Query: 700 TITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
D+++ G+ +E+ + FD+ ++T F + KL D M+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF---QPPKLKD----KMKW 237
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
N K+ + ++P RPT +K+LQ
Sbjct: 238 SNSFHHFVKMALT------KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQ-THHKNLVR 583
+GRGS+ V + TR +KK + D E + E V ++H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKK--ELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSA 641
L C + ++RL V EF++ G L + K P + R A +I+ L +LHE
Sbjct: 61 LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHE---R 115
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR-----TAIRGTKGYVAPEWF 696
II+ D+K N+LLD + +++D+G+ K + IR + GT Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDI 726
R VD ++ GVL+ E+++ R FDI
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHK 579
+GRG FG VY R + T A+K LD+ + GE NE +++ T
Sbjct: 2 IGRGGFGEVYG-----CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 580 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
+ + + ++L + + +N G L L + S A +I GL ++H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH-- 114
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
+ +++ D+KP NILLD++ + RISD GLA + SK A GT GY+APE +
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 699 STI-TAKVDVYSFGVLLLEIISCRKSF 724
T + D +S G +L +++ F
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLV 582
+G+GSFG K ++ ++ + AVK L + +KE + + V++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHED 638
L + V +++N G L F +L+ A ++A + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLH-- 113
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S II+ D+KP+NILLD + ++DFGL K + + + GT Y+APE R
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRK 170
Query: 699 STITAKVDVYSFGVLLLEII 718
VD + G +L E++
Sbjct: 171 EPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLV 582
+G+GSFG K ++ + AVK L + KE K+ + V++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----PSWNLRTNIAFQIARGLLYLHE 637
L + V +F+N G L F +L+ P R A +IA L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAA-EIASALGYLH- 113
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR 697
S I++ D+KP+NILLD + ++DFGL K + QS T GT Y+APE R
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTT-TTFCGTPEYLAPEVIR 169
Query: 698 NSTITAKVDVYSFGVLLLEII 718
VD + G +L E++
Sbjct: 170 KQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 582
E+G GSFG VY RT+ VA+KK+ + +++++ EV + + H N +
Sbjct: 32 EIGHGSFGAVY--FARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 641
G LV E+ G+ + L + KP + I +GL YLH S
Sbjct: 89 EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE---WFRN 698
+IH DIK NILL + +++DFG A + + S GT ++APE
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDE 198
Query: 699 STITAKVDVYSFGVLLLEI 717
KVDV+S G+ +E+
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTT--AVAVKKLDR---VFQDGEKEFKNEVVVIGQT 576
NF +G GSFG VIL T + VA+K+ ++ + Q +E ++
Sbjct: 33 NFIRTLGTGSFG----RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
+H V L G + LV EF+ G +FL N + ++ A QI YL
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAPEW 695
S I++ D+KP+N+LLD +++DFG AK++ RT + GT Y+APE
Sbjct: 149 ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEYIAPEI 199
Query: 696 FRNSTITAKVDVYSFGVLLLEII 718
N D ++ G+ + EI+
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-09
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 40/230 (17%)
Query: 527 VGRGSFGIVYKG--VILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 581
+G+G G VY + + R VA+KK+ + K F E + H +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRR-----VALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNI-AF-----QIAR 630
V + C +G ++ TL S L +L +T++ AF +I
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ-------------- 676
+ Y+H S ++H D+KP NILL + I D+G A L +
Sbjct: 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 677 --SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
S I I GT Y+APE + D+Y+ GV+L ++++ +
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 48/208 (23%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 517 EEATDNFKE--EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVV--- 571
E D+F++ E+G G+ G+V+K + + + +KL + + + +N+++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK----VSHKPSGLIMARKL--IHLEIKPAIRNQIIREL 54
Query: 572 -VIGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 629
V+ + + +V G F +G+ + + E ++ G+L L + + ++ +
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 113
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
+GL YL E +I+H D+KP NIL++ ++ DFG++ L ++ + GT+
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 167
Query: 690 YVAPEWFRNSTITAKVDVYSFGVLLLEI 717
Y++PE + + + + D++S G+ L+E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 11/170 (6%)
Query: 569 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQ 627
E +++ +H +++R+ G +V ++ L ++L +P + I Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGT 687
I GL YLH + +IIH D+K +NI ++D I D G A+ + GT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLAGT 219
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS-FDIE--MGEEYAI 734
APE +K D++S G++L E+++ + F+ EEY
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQ-THHKNLVRLL 585
G G+F V K +R + A+K + + F+ E+ E+ + + + H N++RL+
Sbjct: 8 GEGTFSEVLKA---QSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 586 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT-NIAFQIARGLLYLHEDCSAQ 642
D RL LV+E L + L + G +P R + +Q+ + L ++H +
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---G 120
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE-WFRNSTI 701
I H DIKP+NIL+ D +++DFG + + SK T T+ Y APE +
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFGSCRGI---YSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 702 TAKVDVYSFGVLLLEIIS 719
K+D+++ G + EI+S
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G+FG K +++ + S A+K L + + +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
L + + ++RL V E++N G L L S + +I L YLH S +
Sbjct: 60 L-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGK 115
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT 702
I++ D+K +N++LD + +I+DFGL K + + ++T GT Y+APE ++
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 703 AKVDVYSFGVLLLEIISCRKSF 724
VD + GV++ E++ R F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 525 EEVGRGSFGIVYKGVI-------LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 577
E +G+G+F +YKGV+ + +V +K L +D F ++ Q
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLS 59
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLY 634
HK+LV+L G C +N ++V E++ G L FL N+ W L ++A Q+A L Y
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHY 116
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYN-------ARISDFGLAKLLTLNQSKAIRTAIRGT 687
L + +++H ++ +NIL+ Y ++SD G+ + + + R
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP---- 169
Query: 688 KGYVAPEWFRN--STITAKVDVYSFGVLLLEIIS 719
++APE RN +++T D +SFG LLEI S
Sbjct: 170 --WIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 26/159 (16%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FK----NEVVVIGQTHHKNL 581
+G+G+FG V+K + + VA+KK V + EKE F E+ ++ H+N+
Sbjct: 20 IGQGTFGEVFKA---RHKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 582 VRLLGFCD---EGQNR-----LLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARG 631
V L+ C NR LV+EF + LA L N + L + + G
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNG 131
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
L Y+H +I+H D+K NIL+ +++DFGLA+
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683
I+ + RGL YL E +I+H D+KP NIL++ ++ DFG++ L S A +
Sbjct: 104 ISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMA--NS 157
Query: 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEI 717
GT+ Y++PE + + T + D++S G+ L+E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGE-KEFKNEVVVIGQTHHKNL 581
+VG+G +G V+ + + + VA+K++ + +F+ E + E ++ T + L
Sbjct: 7 TQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCS 640
V+LL + + L E++ G + L NL L + A F +A +
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLG---VLSEDHARFYMAEMFEAVDALHE 119
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAK-LLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
IH D+KP+N L+D + +++DFGL+K ++T S + G+ Y+APE R
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VVGSPDYMAPEVLRGK 173
Query: 700 TITAKVDVYSFGVLLLEIIS 719
VD +S G +L E +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 582
E+G GSFG VY ++ VA+KK+ + +++++ EV + + H N +
Sbjct: 22 EIGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSA 641
+ G LV E+ G+ + L + KP + + +GL YLH S
Sbjct: 79 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE---WFRN 698
+IH D+K NILL + ++ DFG A ++ GT ++APE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDE 188
Query: 699 STITAKVDVYSFGVLLLEI 717
KVDV+S G+ +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 47/226 (20%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRL 584
+G GS G+V+ V VAVKK+ V D + K E+ +I + H N+V++
Sbjct: 13 LGCGSNGLVFSAV---DSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKV 67
Query: 585 LGFCDEGQNRL--------------LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 630
+ L +V E++ LA+ L + R +Q+ R
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLR 125
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
GL Y+H SA ++H D+KP N+ ++ + +I DFGLA+++ + S KG
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---------KG 173
Query: 690 Y----VAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKSF 724
Y + +W+R+ + T +D+++ G + E+++ + F
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 7e-09
Identities = 40/163 (24%), Positives = 64/163 (39%), Gaps = 24/163 (14%)
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
+ N ++L + +L+ +++ +G L L K S I Q+ L LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 637 EDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSKAIRTAIRGTKG------ 689
IIH DIK +N+L D + D+GL K I GT
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------------IIGTPSCYDGTL 170
Query: 690 -YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
Y +PE + D ++ GVL E+++ + F + EE
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 24/166 (14%)
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
Q+ G+ Y+H+ +I+H D+K +NI L + +I DFG+++LL S + T G
Sbjct: 114 QLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTG 167
Query: 687 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746
T Y++PE ++ +K D++S G +L E+ +F E L+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-----EGQNFLS---------- 212
Query: 747 KLDDLVEGDMEALNDIKCVE-KLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ +VEG +L + + +M S+ + +DPSLRP+ ++L+
Sbjct: 213 VVLRIVEGPTPSLPETYSRQLNSIMQSM--LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 64/250 (25%), Positives = 98/250 (39%), Gaps = 45/250 (18%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE----FKNEVVVIGQTHHKNLV 582
+GRG+FG V L + T V K+ R EKE + E ++ + +V
Sbjct: 9 IGRGAFGEVR----LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
++ + N L+ EFL G + + L +K F IA +L +
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLL-----------------------TLNQSKA 679
IH DIKP N+LLD + ++SDFGL L +N +
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 680 IRTAIR----------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 729
T R GT Y+APE F + D +S GV++ E++ F E
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 730 EE-YAILTDW 738
+E Y + +W
Sbjct: 242 QETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHK 579
+GRG FG VY R + T A+K LD+ + GE NE +++ T
Sbjct: 2 IGRGGFGEVYG-----CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 580 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
+ + + ++L + + +N G L L + S A +I GL ++H
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-- 114
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
+ +++ D+KP NILLD++ + RISD GLA + SK A GT GY+APE +
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 699 STI-TAKVDVYSFGVLLLEII 718
+ D +S G +L +++
Sbjct: 170 GVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 61/239 (25%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE----FKNEVVVIGQTHHKNLV 582
+GRG+FG V ++ + + A+KKL + + EKE + E ++ + + +V
Sbjct: 9 IGRGAFGEVR---LVQKKDTGHIYAMKKLRKS-EMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 583 RLL-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------AFQIARGLLYL 635
+L F DE L+ E+L G + + L ++ + F IA +L +
Sbjct: 65 KLYYSFQDE-NYLYLIMEYLPGGDMMTLL---------MKKDTFTEEETRFYIAETILAI 114
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL----------------------- 672
IH DIKP N+LLD + ++SDFGL L
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 673 ---TLNQSKAIRTAIR----------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
++ + T R GT Y+APE F + + D +S GV++ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLV 582
+G+GSFG K ++ + AVK L + +KE K+ + V++ H LV
Sbjct: 3 IGKGSFG---KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 583 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHED 638
L F + ++L V +++N G L L L+P A +IA L YLH
Sbjct: 60 GL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLH-- 113
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S I++ D+KP+NILLD + ++DFGL K + + GT Y+APE
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTFCGTPEYLAPEVLHK 170
Query: 699 STITAKVDVYSFGVLLLEII 718
VD + G +L E++
Sbjct: 171 QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/137 (32%), Positives = 72/137 (52%), Gaps = 12/137 (8%)
Query: 596 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653
L+ +++N G L + L+ + S +R IA +I L +LH+ II+ DIK +NI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLENI 136
Query: 654 LLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAPEWFRNSTI--TAKVDVYSF 710
LLD + ++DFGL+K + + R + GT Y+APE R + VD +S
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194
Query: 711 GVLLLEIISCRKSFDIE 727
GVL E+++ F ++
Sbjct: 195 GVLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 525 EEVGRGSFGIVYKGVI---------LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ 575
E +GRG+ +Y G++ + V +K LD +D F ++ Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGL 632
HK++V L G C ++V EF+ G L F+ L W +A Q+A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASAL 118
Query: 633 LYLHEDCSAQIIHCDIKPQNILL-----DDYYNA--RISDFGLAKLLTLNQSKAIRTAIR 685
YL ED ++H ++ +NILL D ++SD G+ + Q R
Sbjct: 119 SYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP-- 173
Query: 686 GTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEI 717
++APE +S ++ D +SFG L EI
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKN----EVVVIGQTHHKN 580
VG G++G+V K + + VA+KK F+D E +E K E+ ++ +N
Sbjct: 9 VGEGAYGVVLK---CRHKETKEIVAIKK----FKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
+V L LV+E++ L N P +R+ I +Q+ + + + H++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN- 119
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
I+H DIKP+N+L+ ++ DFG A+ L+ S A T T+ Y +PE +
Sbjct: 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 700 TITAKVDVYSFGVLLLEI 717
VD++S G +L E+
Sbjct: 177 PYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHH 578
+ K VGRG FG V ++ + + A+K + + + Q+ F+ E ++ ++
Sbjct: 4 DVKSLVGRGHFGEVQ---VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHE 637
+ +L + N LV E+ G L S L ++A F +A +L +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHS 117
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR 697
+H DIKP+N+L+D + +++DFG A LT N+ GT Y+APE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLT 176
Query: 698 ------NSTITAKVDVYSFGVLLLEIISCRKSF 724
T + D +S GV+ E+I R F
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAV----AVKKLDRVFQDGEKEFKNE---VVVIGQTHHKN 580
GRG FG V+L T + A+KK D + +D + E H
Sbjct: 8 GRGHFG----KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 581 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI---------AFQIAR 630
LV L C + ++ + V E+ G L ++ T++ A +
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLM----------MHIHTDVFSEPRAVFYAACVVL 112
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR-GTKG 689
GL YLHE+ +I++ D+K N+LLD +I+DFGL K RT+ GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPE 166
Query: 690 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 737
++APE ++ T VD + GVL+ E++ F + EE +I+ D
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+GRG+FG V ++ ++S A+K K + + + F E ++ + +V+
Sbjct: 51 IGRGAFGEVQ---LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSAQ 642
L + + +V E++ G L NL ++++ A F A +L L S
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR--TAIRGTKGYVAPEWFR--- 697
+IH D+KP N+LLD + + +++DFG + ++++ +R TA+ GT Y++PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 698 -NSTITAKVDVYSFGVLLLEII 718
+ + D +S GV L E++
Sbjct: 220 GDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G+FG K +++ + + A+K L + + +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
L + + +RL V E+ N G L L + +I L YLH S
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRD 115
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT 702
+++ DIK +N++LD + +I+DFGL K + A GT Y+APE ++
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 703 AKVDVYSFGVLLLEIISCRKSF 724
VD + GV++ E++ R F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQ-IARGLLY------LHEDCSAQIIHCD 647
LL+ E+ + G L N + L+ ++ FQ GLL+ L E S +++H D
Sbjct: 141 LLIMEYGSGGDL------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194
Query: 648 IKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDV 707
+K NI L ++ DFG +K + + S + ++ GT Y+APE + + K D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254
Query: 708 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEK 767
+S GV+L E+++ + F E I+ + Y + V M+AL D
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQRE--IMQQVLYGKY--DPFPCPVSSGMKALLDP----- 305
Query: 768 LVMVSIWCIQEDPSLRPTMKKVLQ 791
+ ++P+LRPT +++L
Sbjct: 306 -------LLSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 47/235 (20%), Positives = 95/235 (40%), Gaps = 28/235 (11%)
Query: 566 FKNEVVVIGQTHHKNLVRLLGF----CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR 621
+NE+ + + N++++ GF D+ L+ E+ G L L S+ +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK 124
Query: 622 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681
++A +GL L++ + + ++ + L+ + Y +I GL K+L+ K +
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 682 TAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 739
+ Y + + + S T K D+YS GV+L EI + + F+
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE---NLTTK------ 228
Query: 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
E D ++ + + C ++ + C D RP +K++L L
Sbjct: 229 ------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 35/106 (33%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 623 NIAFQIARGLL----YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678
A I R LL YLH IIH D+K +NI LD+ NA + DFG A L +
Sbjct: 185 EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
GT +PE AK D++S G++L E+ +
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
+I L +LH+ I++ DIK +NILLD + ++DFGL+K L++ K + G
Sbjct: 113 EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168
Query: 687 TKGYVAPEWFRNSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGE 730
T Y+APE R K VD +S G+L+ E+++ F +E GE
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 64/258 (24%), Positives = 104/258 (40%), Gaps = 47/258 (18%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE----FKNEVVVIG 574
D+F+ + +GRG+FG V L + T + K+ R EKE + E ++
Sbjct: 1 DDFESLKVIGRGAFGEVR----LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILV 56
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 634
+ +V++ + +N L+ EFL G + + L +K F IA +L
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLA 113
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL---------------------- 672
+ IH DIKP N+LLD + ++SDFGL L
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 673 -TLNQSKAIRT----------AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR 721
+N + T + GT Y+APE F + D +S GV++ E++
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 722 KSFDIEMGEE-YAILTDW 738
F E +E Y + +W
Sbjct: 234 PPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G+FG K +++ + + A+K L + + +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGL 632
L + + +RL V E+ N G L ++L F +I L
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELF----------FHLSRERVFSEDRARFYGAEIVSAL 108
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
YLH S +++ D+K +N++LD + +I+DFGL K ++ ++T GT Y+A
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLA 163
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
PE ++ VD + GV++ E++ R F
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 38/222 (17%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT---------- 576
+G G++G V K T T VA+KK+ + + + + ++G
Sbjct: 17 LGEGTYGKVEKA--YDTLTGKI-VAIKKVKII--EISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 577 ------HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 630
H+N++ L+ EG LV + + L + ++ + + I QI
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK-----LLTLNQSKAIRTAIR 685
GL LH +H D+ P NI ++ +I+DFGLA+ + SK R
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 686 G-------TKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIIS 719
T Y APE + VD++S G + E+++
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 41/139 (29%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 655
L+ +++N G L + L + + +I L +LH+ II+ DIK +NILL
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILL 138
Query: 656 DDYYNARISDFGLAK-LLTLNQSKAIRTAIRGTKGYVAPEWFR--NSTITAKVDVYSFGV 712
D + ++DFGL+K +A + GT Y+AP+ R + VD +S GV
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196
Query: 713 LLLEIISCRKSFDIEMGEE 731
L+ E+++ F ++ GE+
Sbjct: 197 LMYELLTGASPFTVD-GEK 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 527 VGRGSFGIVYK------GVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
+G+G+FG VY+ I + + V K + GE+ ++V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERN----ILVRTLLDESP 56
Query: 581 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHED 638
+ L F + + L LV ++++ G L F +L+ + A F IA +L L
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELVLALEHL 112
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL-LTLNQSKAIRTAIRGTKGYVAPE-WF 696
I++ D+KP+NILLD + + DFGL+K LT N GT Y+APE
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLL 169
Query: 697 RNSTITAKVDVYSFGVLLLEI 717
T VD +S GVL+ E+
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH----HKN 580
+E+G G FG V I T T V VK+L KE +NE + G + H N
Sbjct: 1 QEIGNGWFGKVLLSEIYTD-TGVARVVVKELKA--NASSKE-QNEFLQQGDPYRILQHPN 56
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-------IAFQIARGLL 633
+++ LG C E LLV+E+ G L S+L + W+ R + +A +IA G+
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT------AIRGT 687
++H+ +H D+ +N L ++ D+G+ + + I T +R
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLR-- 166
Query: 688 KGYVAPEW---FRNSTITAK----VDVYSFGVLLLEIISCRK 722
++APE F ITA+ +V++ GV L E+
Sbjct: 167 --WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVR 583
+G+G+FG K +++ + + A+K L + V +D E V+ + H L
Sbjct: 3 LGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 584 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
L + + +RL V E+ N G L L S + +I L YLH +
Sbjct: 60 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KN 116
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT 702
+++ D+K +N++LD + +I+DFGL K + A GT Y+APE ++
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 703 AKVDVYSFGVLLLEIISCRKSF 724
VD + GV++ E++ R F
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKE-FKNE--VVVIGQTHHKNL 581
+GRG+FG V ++ + + A+K L++ + + E F+ E V+V G
Sbjct: 9 IGRGAFGEV---AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ---W 62
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
+ L + + +N L LV ++ G L + L F + P R F IA +L +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSI 118
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR-GTKGYVAPEWFR 697
+H DIKP N+LLD + R++DFG L +NQ +++++ GT Y++PE +
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 698 N-----STITAKVDVYSFGVLLLEIISCRKSFDIE 727
+ D +S GV + E++ F E
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLV 582
+G+G +G V++ +T + A+K L + Q K E ++ H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSA 641
L+ G L+ E+L+ G L F +L+ + A F ++ L L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
II+ D+KP+NILLD + +++DFGL K ++++ T GT Y+APE S
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFC-GTIEYMAPEILMRSGH 177
Query: 702 TAKVDVYSFGVLLLEIISCRKSFDIE 727
VD +S G L+ ++++ F E
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 22/70 (31%), Positives = 33/70 (47%), Gaps = 9/70 (12%)
Query: 263 FYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPENICVNIGGEMGSGACGFNSICSLDSD 322
Y R TL+ +G ++ + N +W++ WS P++ C G CG C D +
Sbjct: 45 IYSRLTLSSEGSLERFTWIPNSQ-DWNLFWSAPKDQCDVY------GRCGPYGYC--DVN 95
Query: 323 RRPKCACPKG 332
PKC C KG
Sbjct: 96 TSPKCNCIKG 105
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 3/97 (3%)
Query: 623 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682
+ +Q+ARG+ +L S +H D+ +N+LL +I DFGLA+ + + + +
Sbjct: 241 SFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
+ ++APE ++ T DV+S+G+LL EI S
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 32/184 (17%)
Query: 550 VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 609
V +K LD +D F ++ Q H +L + G C G ++V EF+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 610 LF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR---- 662
L G + +W + +A Q+A L YL ED + ++H ++ +NILL AR
Sbjct: 107 LRKEKGRVPVAWKI--TVAQQLASALSYL-EDKN--LVHGNVCAKNILL-----ARLGLA 156
Query: 663 --------ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVL 713
+SD G++ + + R ++APE ++++ D +SFG
Sbjct: 157 EGTSPFIKLSDPGVSFTALSREERVERIP------WIAPECVPGGNSLSTAADKWSFGTT 210
Query: 714 LLEI 717
LLEI
Sbjct: 211 LLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE----FKNEVVVIGQTHHKNLV 582
+GRG+FG V L ST V KL F+ ++ F E ++ + +V
Sbjct: 51 IGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSA 641
+L + + +V E++ G L NL ++++ A F A +L L S
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSM 161
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR--TAIRGTKGYVAPEWFR-- 697
IH D+KP N+LLD + +++DFG + +N+ +R TA+ GT Y++PE +
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 698 --NSTITAKVDVYSFGVLLLEII 718
+ + D +S GV L E++
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL-LTLNQSKAIRT 682
I + R + YLHE+ +IIH DIK +NI ++ + + DFG A + +N +K
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
A GT APE VD++S G++L E+ +C S
Sbjct: 244 A--GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
++Q+A G+ +L S +H D+ +N+L+ + +I DFGLA+ + + + + +
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
++APE N+ T DV+SFG+LL EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 39/232 (16%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 583
+++G G FG V+ ++ RT R ++ EK + EV V+ + HKN+VR
Sbjct: 19 KKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 584 LLG-FCDEGQNRL-LVYEFLNNGTLASF------LFGNLKPSWNLRTNIAFQIARGLLYL 635
+ F ++ +L ++ EF + G L+ +FG ++ + +I Q+ L Y
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE--HAIVDITRQLLHALAYC 134
Query: 636 HE----DCSAQIIHCDIKPQNILLDDYYN-----------------ARISDFGLAKLLTL 674
H +++H D+KPQNI L A+I DFGL+K + +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 675 NQSKAIRTAIRGTKGYVAPEWFRNSTIT--AKVDVYSFGVLLLEIISCRKSF 724
+++ + GT Y +PE + T + K D+++ G ++ E+ S + F
Sbjct: 195 ---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+GRG+FG V ++ ++S A+K K + + + F E ++ + + +V+
Sbjct: 51 IGRGAFGEVQ---LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 584 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCS 640
L F D+ + +V E++ G L + L N + W F A +L L S
Sbjct: 108 LHYAFQDD-KYLYMVMEYMPGGDLVN-LMSNYDIPEKW-----ARFYTAEVVLALDAIHS 160
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR--TAIRGTKGYVAPEWFRN 698
IH D+KP N+LLD + +++DFG + ++ + +R TA+ GT Y++PE ++
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRCDTAV-GTPDYISPEVLKS 217
Query: 699 STITA----KVDVYSFGVLLLEII 718
+ D +S GV L E++
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVR 583
+GRG+FG V ++ + + A+K L++ + + E F+ E V+ ++ +
Sbjct: 9 IGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
L + N LV ++ G L + L F + P R F +A ++ +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQL 121
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR-GTKGYVAPEWFR--- 697
+H DIKP NIL+D + R++DFG L L + +++++ GT Y++PE +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 698 --NSTITAKVDVYSFGVLLLEIISCRKSFDIE 727
+ D +S GV + E++ F E
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 43/220 (19%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FK----NEVVVI 573
D ++ + G++G+VY+ T VA+KKL + EKE F E+ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKT---GEIVALKKLK---MEKEKEGFPITSLREINIL 58
Query: 574 GQTHHKNLVRL----LGFCDEGQNRL-LVYEF--------LNNGTLASFLFGNLKPSWNL 620
+ H N+V + +G +++ +V E+ + FL +K
Sbjct: 59 LKLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVK----- 109
Query: 621 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
+ Q+ G+ +LH++ I+H D+K N+LL++ +I DFGLA+
Sbjct: 110 --CLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY- 163
Query: 681 RTAIRGTKGYVAPE-WFRNSTITAKVDVYSFGVLLLEIIS 719
T + T Y APE + +D++S G + E+++
Sbjct: 164 -TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 622 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681
T +A Q+ + Y+H + IIH DIK +N+L++ + + DFG A + S
Sbjct: 263 TAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 716
I GT APE T VD++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 46/235 (19%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAV-AVKKLDRVFQDGEKEFKN---EVVVIG 574
+FK + +G+G G V+ L T + A+K LD+ + K E ++
Sbjct: 1 KHFKKIKLLGKGDVGRVF----LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA 56
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLL 633
H L L LV ++ G L L +P L +A F A LL
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLL 114
Query: 634 ---YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR----- 685
YLH I++ D+KP+NILL + + +SDF L+K + + +
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 686 ----------------------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
GT+ Y+APE + VD ++ G+LL E++
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVR 583
+GRG+FG V ++ + + A+K L++ + + E F+ E V+ + +
Sbjct: 9 IGRGAFGEV---AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITN 65
Query: 584 L-LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
L F DE N LV ++ G L + L F + P R F +A +L +
Sbjct: 66 LHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVLAIDSVHQ 120
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR-GTKGYVAPEWFR-- 697
+H DIKP N+LLD + R++DFG L L +++ + GT Y++PE +
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 698 ---NSTITAKVDVYSFGVLLLEII 718
+ D +S GV + E++
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 16/100 (16%)
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL----LTLNQSKA-IRTAIR- 685
L YLH + I+H D+KP N+L+ + +++DFGL+K+ LT N + I R
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 686 -------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
GT Y+APE VD ++ G++L E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 58/248 (23%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV----AVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+G G+FG V L + T A+ ++K D + ++ K E ++ + ++ +V
Sbjct: 9 LGIGAFG----EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVV 64
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+L + N V +++ G + S L + P R F IA L +
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLAR----FYIAELTLAIESVHKM 120
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLA-------------------------------- 669
IH DIKP NIL+D + +++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 670 -------KLLTLNQ------SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 716
+L TL Q + + ++ GT Y+APE T D +S GV+L E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 717 IISCRKSF 724
++ + F
Sbjct: 241 MLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 17/75 (22%), Positives = 28/75 (37%), Gaps = 10/75 (13%)
Query: 349 FELSCWGGGQGYKKELFDFHELQLTNWHLSD-SERFRPYNEVQCKNSCLSDCFCAAVIFQ 407
L+C G F +L L D + + +C+ +CLS+C C A +
Sbjct: 1 TPLNC-----GGDGSTDGFLKLPDVK--LPDNASAITAISLEECREACLSNCSCTAYAYN 53
Query: 408 DDC--CWFKKLPLSN 420
+ C L+N
Sbjct: 54 NGSGGCLLWNGLLNN 68
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 620 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN---- 675
L NI + L Y+HE I H DIKP+NI++D I D+G+A ++
Sbjct: 127 LIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 676 -QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 716
SK + RGT Y + + +T + D+ S G +L+
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 586
+ RG+FG VY G VKK D + ++ + + E + + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 587 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
N LV E+L G + S L +G ++ I+ ++A L YLH II
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-IS-EVALALDYLHRH---GII 126
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676
H D+KP N+L+ + + +++DFGL+K +TLN+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 70/254 (27%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV----AVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+G G+FG V L + T A+ ++K D + ++ K E ++ + ++ +V
Sbjct: 9 LGIGAFG----EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVV 64
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE-DCSA 641
RL + N V +++ G + S L +R I F Y+ E C+
Sbjct: 65 RLYYSFQDKDNLYFVMDYIPGGDMMSLL---------IRMGI-FPEDLARFYIAELTCAV 114
Query: 642 Q------IIHCDIKPQNILLDDYYNARISDFGLA-------------------------- 669
+ IH DIKP NIL+D + +++DFGL
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 670 -------------KLLTLNQSKA------IRTAIRGTKGYVAPEWFRNSTITAKVDVYSF 710
+L L + A + ++ GT Y+APE + T D +S
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 711 GVLLLEIISCRKSF 724
GV+L E++ + F
Sbjct: 235 GVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 4/92 (4%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQT-HH 578
F + +G G+FG V + L + VAVK L E+E +E+ ++ H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 610
KN+V LLG C G L++ E+ G L +FL
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 58/246 (23%), Positives = 98/246 (39%), Gaps = 58/246 (23%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKLDR--VFQDGE-KEFKNEVVVIGQTHHKNLV 582
+G G+FG V L + T A+ A+K L + V + K E ++ + ++ +V
Sbjct: 9 IGIGAFG----EVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+L + N V +++ G + S L G + R IA ++ + +H+
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIA-ELTCAIESVHK--- 119
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGL-------------------------------- 668
IH DIKP NIL+D + +++DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 669 ---AKLLTLNQSKAIRTAIR-------GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718
+L L + + R R GT Y+APE + T D +S GV+L E++
Sbjct: 180 IDRCRLKPLER-RRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 719 SCRKSF 724
+ F
Sbjct: 239 VGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 526 EVGRGSFGIVYKGVILTTRTST-TAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
E+GRG + V L T T T V V+ L+ ++ K +NEVV+ H N++
Sbjct: 5 EIGRGFCNLT--SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHEDC 639
G ++ F+ G+ A+ L P S L NI F RGL YLH++
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN- 120
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL----NQSKAI------RTAIRGTKG 689
IH +IK +IL+ + +S GL+ L +L ++K + T++
Sbjct: 121 --GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LP 173
Query: 690 YVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSF 724
+++PE R K D+YS G+ E+ + R F
Sbjct: 174 WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 40/164 (24%), Positives = 76/164 (46%), Gaps = 18/164 (10%)
Query: 565 EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV---YEFLNNGTLASFLFG---NLKPS- 617
+ +NE++ +G+ +H+N++++ N ++ Y+F L SF++ + K
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 618 --WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
R I Q+ + Y+H ++IH DIK +NI L+ + DFG A
Sbjct: 265 LLKQTRA-IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-K 319
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
+ +A GT +PE D++S G++LL+++S
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRL 584
+VGRG++G VYK R L ++ G E+ ++ + H N++ L
Sbjct: 8 KVGRGTYGHVYKA----KRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIAL 63
Query: 585 LG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPSWNLRT---NIAFQIARGLLY 634
F ++ L++++ + F N KP R+ ++ +QI G+ Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 635 LHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLN-QSKAIRTAIRGTKG 689
LH + ++H D+KP NIL+ + +I+D G A+L + A + T
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 690 YVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSF 724
Y APE + T +D+++ G + E+++ F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 32/148 (21%)
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD----------------DYYNARISDFG 667
I FQ L Y H + ++H D+KP+NIL++ D RI D G
Sbjct: 236 IIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE 727
+ RTAI T+ Y +PE D++S G ++ E+ + + +D
Sbjct: 294 -----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348
Query: 728 MGEEYAIL---------TDWAFDCYRNE 746
E+ L ++WA C E
Sbjct: 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEE 376
|
Length = 467 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRL 584
+VGRG++G VYK R L ++ G E+ ++ + H N++ L
Sbjct: 8 KVGRGTYGHVYKA----KRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL 63
Query: 585 LG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPSWNLR---TNIAFQIARGLLY 634
F ++ L++++ + F N KP R ++ +QI G+ Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 635 LHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLN-QSKAIRTAIRGTKG 689
LH + ++H D+KP NIL+ + +I+D G A+L + A + T
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 690 YVAPEWFRNST-ITAKVDVYSFGVLLLEIIS------CRKSFDIEMGEEY 732
Y APE + T +D+++ G + E+++ CR+ DI+ Y
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNPY 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 60/241 (24%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQ-DGEKEFKNEVVVIGQTHHKNLV 582
+G+G+FG V L + T + A+K L +F+ D K E V+ ++ +V
Sbjct: 9 IGKGAFGEVR----LVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--IAFQIARGLLYLHEDCS 640
L + Q L+ EFL G L + L ++ + F +A +L +
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHK 119
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLA-------------KL---------------- 671
IH DIKP NIL+D + ++SDFGL+ KL
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 672 ------LTLNQSKAIRTAIR----------GTKGYVAPEWFRNSTITAKVDVYSFGVLLL 715
LT++ I T + GT Y+APE F + D +S G ++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 716 E 716
E
Sbjct: 240 E 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 4/109 (3%)
Query: 506 TNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGE 563
T LP E +F + +G G+FG V + L + VAVK L E
Sbjct: 22 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE 81
Query: 564 KE-FKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 610
+E +E+ V+ +H N+V LLG C G L++ E+ G L +FL
Sbjct: 82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 10/141 (7%)
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
N+V L + + LV + G L S + L A ++ L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR-- 103
Query: 640 SAQIIHC-DIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
+ I C D+ P NILLDD + +++ F + + A+ Y APE
Sbjct: 104 --EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV---EDSCDGEAV--ENMYCAPEVGGI 156
Query: 699 STITAKVDVYSFGVLLLEIIS 719
S T D +S G +L E+++
Sbjct: 157 SEETEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 7/89 (7%)
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
++L + L+ E++ TL + S + +IA Q+A L LH+
Sbjct: 57 KVLASGESDGWSYLLMEWIEGETLD-------EVSEEEKEDIAEQLAELLAKLHQLPLLV 109
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKL 671
+ H D+ P NIL+DD I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 813 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.01 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.96 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.87 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.86 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.64 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.56 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.56 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.55 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.5 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.48 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.18 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.81 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.75 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.65 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.59 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.25 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.12 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.07 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.98 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.86 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.27 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.88 | |
| PLN02236 | 344 | choline kinase | 94.65 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.59 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.59 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.28 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.13 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.88 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=455.09 Aligned_cols=287 Identities=46% Similarity=0.757 Sum_probs=251.7
Q ss_pred CCCCCCHHHHHHHHhhcc--cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceE
Q 045343 507 NLPCFSYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 507 ~~~~~~~~el~~~~~~~~--~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 584 (813)
....|++.||..||.+|. +.||+|+||.||||.+. ++..||||++.....+..++|.+|+.++.+++|||||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence 567799999999999998 58999999999999995 448999998876433215679999999999999999999
Q ss_pred EeEeecCC-ceEEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCE
Q 045343 585 LGFCDEGQ-NRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 661 (813)
Q Consensus 585 ~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 661 (813)
+|||.+.+ +++||||||++|+|.++|+... .++|..|++|+.++|+||+|||+.+.+.|+|||||++|||||+++++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999999 4999999999999999998865 88999999999999999999999988899999999999999999999
Q ss_pred EEeeccCccccccCcccceeecc-cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH
Q 045343 662 RISDFGLAKLLTLNQSKAIRTAI-RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 740 (813)
||+|||+|+........ .... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+..|+.
T Consensus 217 KlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999765431111 1122 79999999999999999999999999999999999999988665444445889998
Q ss_pred HhhccCccccccccccc-ccccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 741 DCYRNEKLDDLVEGDME-ALNDI-KCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 741 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
..+....+.+++|+.+. ..... ++...+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88888899999999986 44443 6788899999999999999999999999999766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=386.29 Aligned_cols=252 Identities=34% Similarity=0.535 Sum_probs=209.0
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceE-EEEEEeecccccc--chhhhheeeeeeccccCCcceEEeEeecCC-ceEEE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTA-VAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLV 597 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~-vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV 597 (813)
.+.+.||+|+||+||+|.+. +.. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred hhhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 34466999999999999984 445 9999997643222 458999999999999999999999999888 79999
Q ss_pred EeecCCCchhhhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeeCCCCCCcEEEcCCC-CEEEeeccCccccc
Q 045343 598 YEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQ-IIHCDIKPQNILLDDYY-NARISDFGLAKLLT 673 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~ 673 (813)
||||++|+|.++++. ...+++..+++++.|||+||.|||++ + |||||||++||||+.++ ++||+|||+++...
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999988 57899999999999999999999965 5 99999999999999997 99999999998876
Q ss_pred cCcccceeecccccccccCccccc--CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFR--NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
... ...+...||..|||||++. ...++.|+||||||++||||+||+.||........ +.....
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~------- 260 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVV------- 260 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-------
Confidence 432 1133467999999999999 56999999999999999999999999986543111 111111
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
...+......+...+..++.+||+.||.+||++.+++..|+.+..
T Consensus 261 --~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 261 --GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 111111222367889999999999999999999999999997655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=379.55 Aligned_cols=263 Identities=30% Similarity=0.447 Sum_probs=221.4
Q ss_pred HHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 514 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
-++......+.++||+|-||+||.|.+. ....||||.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~----~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWN----GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEc----CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 3556666778899999999999999995 3347999998764 3345689999999999999999999999999889
Q ss_pred eEEEEeecCCCchhhhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 594 RLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
++||||||++|+|.++|.. ...+.....+.++.|||+|++||+ +.++|||||.++||||+++..+||+|||||+.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999999986 467889999999999999999999 55999999999999999999999999999996
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
...+.... .....-...|.|||.+....++.|+|||||||+||||+| |+.|+......+ +-+
T Consensus 353 ~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~ 415 (468)
T KOG0197|consen 353 IGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLE 415 (468)
T ss_pred cCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHH
Confidence 55443322 333445678999999999999999999999999999999 888876433221 122
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSL 801 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 801 (813)
.++...+.+.+..|+..+.++|..||+.+|++|||++.+...|+.+.....
T Consensus 416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 344455555666789999999999999999999999999999998766543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.88 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=214.7
Q ss_pred CCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEee
Q 045343 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD 589 (813)
Q Consensus 511 ~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 589 (813)
++..||+. .+.||+|..|+|||+.+. .+++.+|+|.+.... ....+++.+|++++++.+||+||+++|.|.
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk---~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHK---PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEc---CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 44455543 478999999999999985 567899999995432 334578999999999999999999999998
Q ss_pred cCCc-eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 590 EGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 590 ~~~~-~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
.... ..++||||++|||++++...+++++....+|+.+|++||.|||++ .+||||||||+|||++..|++||+|||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 8884 999999999999999999889999999999999999999999963 6999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch--hhhhhHHHHHHhhccC
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNE 746 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~ 746 (813)
++.+.+. .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+. ....+
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L----------- 290 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL----------- 290 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH-----------
Confidence 9988765 245678999999999999999999999999999999999999999765221 11111
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+..+++..........+++++.+++..||++||.+||+++|++++
T Consensus 291 -l~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 291 -LCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -HHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222333222222222578999999999999999999999999865
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=392.46 Aligned_cols=268 Identities=29% Similarity=0.477 Sum_probs=226.7
Q ss_pred HHHHHHHHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEee
Q 045343 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCD 589 (813)
Q Consensus 513 ~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~ 589 (813)
..++......+.++||+|+||+||+|...... ++...||||.|++.... ...+|++|++++..++|+|||+|+|+|.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 44666677778899999999999999876544 45678999999887655 6678999999999999999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhcc--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 655 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll 655 (813)
+++..+||+|||.+|+|.+||..+ ..++..+.+.|+.|||.|+.||-+ ..+|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhcee
Confidence 999999999999999999999532 127788999999999999999994 499999999999999
Q ss_pred cCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhh
Q 045343 656 DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 734 (813)
Q Consensus 656 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 734 (813)
.++..|||+||||++.....+.........-..+|||||.|...++++++|||||||+|||+.+ |+.|+.....++.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-- 714 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-- 714 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--
Confidence 9999999999999998776655443434455789999999999999999999999999999999 9999876554332
Q ss_pred hHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 735 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.+.+..+. + ...+..++.+++.||+.||+.+|.+||+++||-..|+.....
T Consensus 715 -----Ie~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 -----IECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -----HHHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 22222222 2 334557899999999999999999999999999999987654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=358.32 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=207.9
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc-------chhhhheeeeeeccccCCcceEEeEee
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-------EKEFKNEVVVIGQTHHKNLVRLLGFCD 589 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~ 589 (813)
....|.+.+.||+|+||.|-+|... .+++.||||.+++..... .....+|+++|++++|||||++++++.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~---~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK---KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc---ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 5566778899999999999999874 478899999997542221 223579999999999999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC---CCEEEeec
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDF 666 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Df 666 (813)
..+..|||+||+++|+|.+++-.++.+.+..-..++.|++.|+.|||+ .||+||||||+|||+..+ ..+||+||
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999999999999999999999999999999999995 499999999999999765 78999999
Q ss_pred cCccccccCcccceeecccccccccCcccccCCCC---CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhh
Q 045343 667 GLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI---TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743 (813)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 743 (813)
|+|+..... ..+...+||+.|.|||++.+... ..++|+||+||+||-+++|.+||....+... +. +..
T Consensus 324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~----eQI 394 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LK----EQI 394 (475)
T ss_pred chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HH----HHH
Confidence 999987633 22567899999999999987643 3478999999999999999999986544220 10 111
Q ss_pred ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+.... ......+..++..+|+.+||..||++|||++|++++
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111110 111233567899999999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=352.72 Aligned_cols=203 Identities=32% Similarity=0.499 Sum_probs=181.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|.+.++||+|+|++||+|.+. .++..||||.+... ..+..+-+..|+.+|+.++|+|||++++++..++..+||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~---~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHK---KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cceehhhccCcceEEEEEeEec---cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3566778999999999999986 35689999999765 333445578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC------CCEEEeeccCccc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY------YNARISDFGLAKL 671 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~------~~~kl~DfGla~~ 671 (813)
||||.+|+|.+||+.+..+++.+.+.++.|||.||++||+ .+||||||||+||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999995 599999999999999764 5689999999999
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~ 731 (813)
+.+... ....+|++-|||||++..++|+.|+|+||+|++||++++|+.||+.....+
T Consensus 165 L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 165 LQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred CCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 885432 456789999999999999999999999999999999999999998665443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=367.88 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=211.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
.+|...+.||+|||..+|++... ..+..||+|++.+. .....+.+.+||++.++|+|||||+++++|++.+..|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~---~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL---DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc---CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 55777889999999999999873 36789999999763 2334566889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||.|+|.+++|..+++.+..+++.+++.++.||+.||.|||+ .+|+|||||..|+||+++.++||+|||||..+..+
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999999999999999999999999999999995 59999999999999999999999999999998766
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
..+ ..+.+||+.|+|||++....++..+||||+||+||-||.|++||+...-.+.- ..+ +..+..-|
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-------~~I---k~~~Y~~P- 238 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-------NKI---KLNEYSMP- 238 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-------HHH---HhcCcccc-
Confidence 443 45688999999999999999999999999999999999999999865322211 000 01111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....+..+||..+|++||.+|||+++|+.+
T Consensus 239 ------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 ------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1235677899999999999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=375.49 Aligned_cols=272 Identities=25% Similarity=0.444 Sum_probs=230.3
Q ss_pred CCCCCHHHHHHHHhhc-----------ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeec
Q 045343 508 LPCFSYKELEEATDNF-----------KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQ 575 (813)
Q Consensus 508 ~~~~~~~el~~~~~~~-----------~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~ 575 (813)
+..++|+|--.|..+| .+.||.|.||+|++|.++...+....||||.|+... ++...+|..|..||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3457777666666554 457999999999999998777778899999998754 3445679999999999
Q ss_pred cccCCcceEEeEeecCCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEE
Q 045343 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 654 (813)
Q Consensus 576 l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIl 654 (813)
++||||++|.|+....+..++|+|||+||+|+.||..+ ..+++.+...++.+||.|+.||. ..++|||||.++|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence 99999999999999999999999999999999999764 67899999999999999999999 459999999999999
Q ss_pred EcCCCCEEEeeccCccccccCcccceeec--ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 655 LDDYYNARISDFGLAKLLTLNQSKAIRTA--IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 655 l~~~~~~kl~DfGla~~~~~~~~~~~~~~--~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
++.+..+|++|||++|.+..+.... .+. ..-..+|.|||.|...+++.++||||||++|||.++ |.+|+-.....+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eccceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 9999999999999999875543211 222 223569999999999999999999999999999998 999985332211
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+-+.++...+.+.+++++..|.+||+.|||+|-.+||++.+|+.+|++++.-
T Consensus 843 ----------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 843 ----------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ----------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2223455666777889999999999999999999999999999999997755
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=334.11 Aligned_cols=258 Identities=27% Similarity=0.377 Sum_probs=208.6
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeec--cccccchhhhheeeeeeccccCCcceEEe-EeecCC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQ 592 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~ 592 (813)
...+.+++.++||+|.||+|||+... .++..+|.|.++- ...+....+..|+.+|++|+|||||+.++ -+.++.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~---~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCL---LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeec---cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34466788899999999999999875 4778999998862 22334456889999999999999999999 455555
Q ss_pred c-eEEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeeCCCCCCcEEEcCCCCEEEeec
Q 045343 593 N-RLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCS-AQIIHCDIKPQNILLDDYYNARISDF 666 (813)
Q Consensus 593 ~-~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Df 666 (813)
+ +.|||||+..|+|...+++ +..+++..+++++.|++.||.++|.... .-|+||||||.||+|+.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 8999999999999998853 4678999999999999999999996322 23999999999999999999999999
Q ss_pred cCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 667 GLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
|+++++...... ....+|||.||+||.+...+++.|+||||+||++|||+.-.+||.+.. ...+. .
T Consensus 173 GL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~----~----- 238 (375)
T KOG0591|consen 173 GLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLC----K----- 238 (375)
T ss_pred hhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHH----H-----
Confidence 999998876543 456889999999999999999999999999999999999999998652 11111 1
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
++............++..+..++..|+..||+.||+...+++.+
T Consensus 239 ---KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 239 ---KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ---HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 11122222222346788999999999999999999955555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.52 Aligned_cols=242 Identities=26% Similarity=0.326 Sum_probs=202.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
...++.+.||+|+||+||.+.-. ..++.+|+|++++.. ....+...+|..+|.+++||.||+++-.|+++++++
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~---dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKK---DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEc---ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34566799999999999998765 477899999997642 233456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||+||+.||.|..+|++...+++..+.-++..|+.||.||| +.+||||||||+|||||.+|+++|+|||+++.....
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999999999999999999999999999999999 459999999999999999999999999999965443
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... ....+||+.|||||++.+..++..+|.||+|+++|||++|.+||........ .+....+.
T Consensus 179 ~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------~~~I~~~k-------- 241 (357)
T KOG0598|consen 179 GDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------YDKILKGK-------- 241 (357)
T ss_pred CCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------HHHHhcCc--------
Confidence 322 4558999999999999999999999999999999999999999986543211 11111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRP 784 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 784 (813)
+.. .+.-...+..+++...|+.||++|.
T Consensus 242 ~~~-~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPL-PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCC-CCccCCHHHHHHHHHHhccCHHHhc
Confidence 110 1112357788999999999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.19 Aligned_cols=267 Identities=28% Similarity=0.402 Sum_probs=205.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeec--cccCCcceEEeEeecCC----ce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDEGQ----NR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~ 594 (813)
.++.+.||+|+||.||||++ .++.||||++.. +....|++|-+|.+. ++|+||+++++.-..+. +.
T Consensus 212 l~l~eli~~Grfg~V~KaqL-----~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-----DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred hhhHHHhhcCccceeehhhc-----cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 34568899999999999999 568999999864 345567777777665 58999999999987666 88
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------SAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
+||+||.++|+|.+||..+ ..+|....+|+..+++||+|||++. ++.|+|||||.+||||.+|+++.|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999766 4699999999999999999999763 56799999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCC-CC-----CccchhhHHHHHHHHHhCCcCCCcc-cchhhhh-------
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST-IT-----AKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAI------- 734 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~k~DVwS~Gvvl~elltG~~p~~~~-~~~~~~~------- 734 (813)
|..+.+..........+||.+|||||++.+.- +. .+.||||+|.|||||++...-++.. .++-...
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99988766554445588999999999997642 22 3699999999999999976555421 1111111
Q ss_pred ---hHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 735 ---LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 735 ---l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
+.+.....++++....+.+.... ...+.-+++.+..||..||+.|.|+.=|.+.+..+....
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111111222222222222221 244678899999999999999999999999988776553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=320.26 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=207.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|+...++|+|+||+|||+.. +.+++.||||++....+ ...+-.++|+++|++++|+|||.|+++|.....++||+
T Consensus 4 YE~LgkvGEGSYGvV~KCrn---k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRN---KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred HhhhhccccCcceEEEEecc---CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 44456799999999999987 45889999999965432 12345789999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||++.--|.++-......+.+...+++.|+++|+.|+|. .+++||||||+||||+.++.+||+|||+|+.+.....
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 999997777776666778899999999999999999995 5999999999999999999999999999998874221
Q ss_pred ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH--------HhhccC-cc
Q 045343 679 AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNE-KL 748 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~-~~ 748 (813)
.-+.++.|..|+|||.+.+ .+|...+||||+||++.||++|.+.|.+..+-++..++.... ..+... -.
T Consensus 157 -~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 157 -NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred -hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 1466789999999999987 589999999999999999999999998776644443322211 111111 11
Q ss_pred ccccccccccccc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 749 DDLVEGDMEALND-----IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 749 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
..+.-|..+...+ .....-+++++..||+.||.+|++-++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111111 233457889999999999999999999885
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=339.94 Aligned_cols=251 Identities=27% Similarity=0.346 Sum_probs=210.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeecc-ccCCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 595 (813)
.+.|.+.||+|+|++|++|... ..++.+|||++.+. .+...+-+..|-.+|.+| .||.|++|+-.|.+...+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~---~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREK---ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred hcchhheeccccceeEEEeeec---CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4567899999999999999875 47789999999753 233445577888899999 8999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+|+||+++|+|.++|...+.+++...+.++.+|+.||+||| +.|||||||||+|||||.++++||+|||.|+.+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999 569999999999999999999999999999988654
Q ss_pred ccc---------ce--eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 676 QSK---------AI--RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 676 ~~~---------~~--~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
+.. .. ...++||..|.+||++.....+..+|+|+|||+||.|+.|.+||.+..+ +..+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--yliF--------- 296 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--YLIF--------- 296 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--HHHH---------
Confidence 322 11 1458899999999999999999999999999999999999999986543 1111
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
+++++-.... ....++.+.+|+.+.|..||.+|+|.++|.++-
T Consensus 297 ----qkI~~l~y~f--p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 ----QKIQALDYEF--PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----HHHHHhcccC--CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1111111111 123347788999999999999999999998874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=347.28 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=203.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecCC-
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ- 592 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~- 592 (813)
...+++.++||+|+||.||+|.... ....+..||||+++.... ...+.+.+|+.++.++ +|+||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 4557788999999999999997532 223456899999875322 2245688999999999 8999999999987654
Q ss_pred ceEEEEeecCCCchhhhhhcc-----------------------------------------------------------
Q 045343 593 NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------- 613 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~----------------------------------------------------------- 613 (813)
..++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccc
Q 045343 614 ---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690 (813)
Q Consensus 614 ---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 690 (813)
..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 236778889999999999999995 59999999999999999999999999999876433222212234467789
Q ss_pred cCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHH
Q 045343 691 VAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLV 769 (813)
Q Consensus 691 ~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 769 (813)
+|||++.+..++.++||||||+++|||++ |..||......+. +. .....+.... .....+..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~~~---------~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTRMR---------APENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCCCC---------CCCCCCHHHH
Confidence 99999999899999999999999999997 9999975432211 10 1111111000 0112356788
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 770 MVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 770 ~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
+++.+||+.||.+|||+.||++.|+.++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.09 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=208.9
Q ss_pred CCCCCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeE
Q 045343 508 LPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 587 (813)
Q Consensus 508 ~~~~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 587 (813)
+-.+.+++|.+- +=||.|+.|-||+|.+ .++.||||+++... ..+|+-|++|+|+||+.+.|+
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl-----~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRL-----HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeec-----cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeee
Confidence 344556666554 4599999999999998 67899999986532 346778899999999999999
Q ss_pred eecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 588 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 588 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
|...-..+||||||+.|-|...|+............+..+||.|+.|||.+ .|||||||.-||||..+..+||+|||
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999999999999999999999999999999999999965 99999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
-++...... ....+.||..|||||+|.+.+.++|+|||||||||||||||..|+....... .
T Consensus 258 TS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--I------------- 319 (904)
T KOG4721|consen 258 TSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--I------------- 319 (904)
T ss_pred chHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--e-------------
Confidence 998765331 1345789999999999999999999999999999999999999986332110 0
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
+..+=...+..+.+..+++.+.-|+++||+-.|..||++.+|+.+|+-
T Consensus 320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 000111122333445778889999999999999999999999999963
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.59 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=207.4
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccc-hhhhheeeeeeccc-cCCcceEEeEeecCC-c
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTH-HKNLVRLLGFCDEGQ-N 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~ 593 (813)
....|...++||.|.||+||+|+-. ..+..||||++++.....+ ..-.+|+..|++++ |||||+|.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~---~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSK---ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeec---CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 3456788899999999999999874 4677899999986543322 22467999999998 999999999998888 8
Q ss_pred eEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
+++|||||+. +|.++++++ ..+++..++.|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999999955 899999776 5689999999999999999999965 9999999999999999999999999999987
Q ss_pred ccCcccceeecccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc---
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL--- 748 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 748 (813)
..... -+.++.|..|+|||++. ..-|+.+.|+||+|||++|+.+-++.|.+..+-++..- +.+.+.....
T Consensus 161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K---Ic~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK---ICEVLGTPDKDSW 234 (538)
T ss_pred ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH---HHHHhCCCccccc
Confidence 65432 56788999999999875 45789999999999999999999999976654322211 1111111111
Q ss_pred --------------cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 --------------DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 --------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+.....+..... ....++.+++..|++.||.+|||++|++++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111112 367888999999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.51 Aligned_cols=267 Identities=25% Similarity=0.395 Sum_probs=217.0
Q ss_pred HHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc-chhhhheeeeeeccccCCcceEEeEeecCC
Q 045343 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 514 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 592 (813)
+|+-+..-.|.|+||+|-||+|..+.+. ....||||+++...... .++|..|+++|.+++|||||+|+|+|..++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEec----CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 3455555567899999999999999984 45899999998654433 478999999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
.+++|+|||++|+|..||..+. ...-+...+|+.|||.|++||. +.++|||||.++|+|+|.++++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccc
Confidence 9999999999999999998763 3345556779999999999999 6799999999999999999999999999999
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
-+.......+....+-..+|||+|.+...+++.++|||+||+.|||+++ ...|+.....+. ..+.....+.....
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR 762 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc
Confidence 8877777666666777899999999999999999999999999999865 667776433221 11111222222111
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.. -...+.-++..+.+++.+||+.|.++||+++++...|.+.
T Consensus 763 ~~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QV------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ce------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 1122345788999999999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.60 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=201.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCC--ceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~ 598 (813)
....+.||+|+||+||++...+ ++...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ ...+.|
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhccccCccceEEEEEEecC---CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4556889999999999998853 37889999987643222556899999999999999999999855444 589999
Q ss_pred eecCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~~~~~~ 676 (813)
||+++|+|.+++.... .+++..+.+++.||++||+||| +.+|+||||||+||||+. ++.+||+|||+++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998765 7999999999999999999999 459999999999999999 7999999999998776411
Q ss_pred -ccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 677 -SKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 677 -~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.........||+.|||||++... ....++|||||||++.||+||++||...... ..+............+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~-----~~~~~~ig~~~~~P~i--- 244 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE-----AEALLLIGREDSLPEI--- 244 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch-----HHHHHHHhccCCCCCC---
Confidence 11113457899999999999863 3345999999999999999999999753111 0111111111111111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
+...+....+++..|++.||++|||+.+++++--
T Consensus 245 ------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 245 ------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1234677889999999999999999999998863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.55 Aligned_cols=264 Identities=29% Similarity=0.428 Sum_probs=208.4
Q ss_pred HHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeec
Q 045343 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 590 (813)
Q Consensus 513 ~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 590 (813)
+-||......+.+.||+|.||+||||.+- ..||||.++.. ..+..+.|++|+.++++-+|.||+-+.|+|..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh------GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH------GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc------cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 33455555667789999999999999983 25999999753 33456789999999999999999999999988
Q ss_pred CCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+.. .+|+.+|++.+|+.+|+-. .+++....++|++|||+|+.||| .++|||||||..||||.+++.|||+|||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 877 9999999999999999864 57888899999999999999999 569999999999999999999999999998
Q ss_pred cccccCcccceeecccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
..-..-..........|...|||||++..+ +|+..+||||||+++|||++|..||.....+. .. -.+..+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-Ii------fmVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-II------FMVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-eE------EEeccc
Confidence 754322111112233477889999999654 68999999999999999999999998332221 10 011111
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.+. +++. .....+.++|.+|+..||..++++||.+.+|+..|+.++.
T Consensus 609 ~l~----pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 YLM----PDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccC----ccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 110 1111 1123567899999999999999999999999999988765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=329.01 Aligned_cols=265 Identities=25% Similarity=0.282 Sum_probs=206.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC--Cce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 594 (813)
..++-.++||+|.||.||||... .+++.||+|++.... +....-..+||.||++|.||||++|.+...+. ..+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~---~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDL---ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeec---ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 44556689999999999999874 478899999997644 22334567899999999999999999988766 579
Q ss_pred EEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 595 LLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
|||+|||++ +|.-++.. ...+++.++..++.|++.||.|+| +.+|+|||||.+|||||.+|.+||+|||||+++.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999988 66666655 568999999999999999999999 5699999999999999999999999999999888
Q ss_pred cCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH-----HhhccCc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYRNEK 747 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~ 747 (813)
...... .+..+-|..|.|||++.+. .|+..+|+||.||||.||+.|++.|.+..+.++...+-... ..|....
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 766544 5667789999999999876 69999999999999999999999998766544332211110 1111111
Q ss_pred cc--cccccc------ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LD--DLVEGD------MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~--~~~~~~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+. ..+.+. +... -.......++|+..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 111110 0000 11234567889999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.69 Aligned_cols=246 Identities=28% Similarity=0.401 Sum_probs=207.6
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
.++||+|+.|.||.+... ..+..||||++........+-+.+|+.+|+..+|+|||+++..+..++++|+|||||++
T Consensus 278 ~~kigqgaSG~vy~A~~~---~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKI---STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hhhhccccccceeeeeec---cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 368999999999998764 46678999999876555566689999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeec
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 683 (813)
|+|.|.+.... +++.++..|+.++++||+|||. .+|+|||||.+|||++.++.+||+|||+...+...+.+ ...
T Consensus 355 gsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~T 428 (550)
T KOG0578|consen 355 GSLTDVVTKTR-MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RST 428 (550)
T ss_pred Cchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--ccc
Confidence 99999886543 7899999999999999999994 59999999999999999999999999999988776654 566
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHH
Q 045343 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK 763 (813)
Q Consensus 684 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (813)
.+||+.|||||++....|++|+||||||++++||+-|.+||--+.+-....+ ... .+..+......
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia~-------ng~P~lk~~~k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IAT-------NGTPKLKNPEK 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------Hhh-------cCCCCcCCccc
Confidence 8899999999999999999999999999999999999999974332111111 011 11111122334
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 764 CVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 764 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+..+.+++.+||+.|+++|+++.|+|++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 57889999999999999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.34 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=206.2
Q ss_pred CCCCCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc---chhhhheeeeeeccccCCcceE
Q 045343 508 LPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 508 ~~~~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l 584 (813)
++.++++++...+ ...||+|++|.||+|.. +++.||||+++...... .+.+.+|+.+|.+++||||+++
T Consensus 12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred ceecCHHHcCCCC---CeEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 4455666662221 14689999999999987 57899999997643322 3567899999999999999999
Q ss_pred EeEeec----CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 585 LGFCDE----GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 585 ~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
++++.+ ....++||||+++|+|.+++.....+++....+++.|++.||.|||+ ..+++||||||+|||+++++.
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCc
Confidence 999866 34678999999999999999888889999999999999999999995 247889999999999999999
Q ss_pred EEEeeccCccccccCcccceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHH
Q 045343 661 ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 738 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 738 (813)
+||+|||+++.+.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...
T Consensus 162 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~ 233 (283)
T PHA02988 162 LKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDL 233 (283)
T ss_pred EEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHH
Confidence 9999999998654321 22457889999999976 6789999999999999999999999975432211 111
Q ss_pred HHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
+ ...+ . ....+..+++.+.+++.+||+.||++|||++||++.|+.+.
T Consensus 234 i---~~~~-~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 234 I---INKN-N--------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred H---HhcC-C--------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0 0000 0 00111234678899999999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=364.72 Aligned_cols=265 Identities=28% Similarity=0.453 Sum_probs=215.9
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCc--ceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTS--TTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 592 (813)
+......+.+.||+|+||.||+|....-..+ ...||||.+++.. .+...+|.+|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 3445556678899999999999998754433 4569999997653 445678999999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhcc-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEee
Q 045343 593 NRLLVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 665 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 665 (813)
..++++|||++|+|..||.+. ..+.....+.++.|||+|+.||++ +++|||||.++|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999754 457888999999999999999994 5999999999999999999999999
Q ss_pred ccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhc
Q 045343 666 FGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 666 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
||||+.+...+.........-...|||||.+....++.|+|||||||+|||++| |..||......+... ....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHh
Confidence 999995544433322222234568999999999999999999999999999999 888886543322111 1112
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.+ +.+.+..|++.+.++|..||+.+|++||++..|++.++.+..-
T Consensus 920 gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 22 2233556889999999999999999999999999998877654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=347.71 Aligned_cols=267 Identities=30% Similarity=0.396 Sum_probs=213.6
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceE-EEEEEeec---cccccchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTA-VAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
|......+.++||+|+||.||+|.+......... ||||..+. ......++|.+|.++|++++|+|||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 3344445668999999999999999865432233 99999885 3345567899999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
+.+++|||+|.||+|.++|.... .++..++..++.+.|.||+||| +.+++||||.++|+|++.++.+||+|||+++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999998876 5999999999999999999999 4599999999999999999999999999988
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
........ .....-..+|+|||.+....++.++|||||||++||+.+ |..|+.+....+ +..++
T Consensus 311 ~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI---------- 375 (474)
T KOG0194|consen 311 AGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKI---------- 375 (474)
T ss_pred CCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHH----------
Confidence 65411111 112235679999999999999999999999999999999 888887544321 11111
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLP 802 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 802 (813)
+....+...+...+..+..++..|+..+|++||+|.++.+.|+.+.....+
T Consensus 376 --~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 --VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 011111112224467888889999999999999999999999987765443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.67 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=207.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..|++.++||.|..++||+|... ..+..||||++....- ...+.+.+|+..|+.++||||++++..|..++.+|+|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~---p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCI---PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred cceeEEEEEeccceeEeeeeeec---ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 45788899999999999999875 3558999999964322 2257899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|.||.+||+.++++.. ..+++..+..|++++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+...
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999764 4688999999999999999999965 9999999999999999999999999988766543
Q ss_pred cccc-ee-ecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 676 QSKA-IR-TAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 676 ~~~~-~~-~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
..+. .. ...+||+.|||||++.. ..|+.|+||||||+...||.+|..||....+-.... ..+.. ....+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl------~tLqn-~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL------LTLQN-DPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH------HHhcC-CCCCc
Confidence 3221 12 45689999999999643 368999999999999999999999997554322111 11111 11111
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.-..+...........+.+++..||+.||.+|||+++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11122222334456689999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=299.50 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=206.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+|.-.++||+|.||.||+|... +.++.||||+++.... .......+|++.|+.++|+||+.|++.|.+.+...||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~---~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDT---ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEec---CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 3555688999999999999874 4778999999975422 2244678999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+|||+. +|+..+++. ..++...+..++.++++||+|||. ..|+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 999976 888888765 567889999999999999999995 599999999999999999999999999999987554
Q ss_pred ccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Ccccc--
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLDD-- 750 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~-- 750 (813)
.. .+..+-|..|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+..+-++... +.+.+.. +...+
T Consensus 156 ~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGTPTPDQWPEMT 230 (318)
T ss_pred cc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCCCCcccCcccc
Confidence 33 2333689999999999875 689999999999999999999988876655333222 2222221 11111
Q ss_pred -ccc---------ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 751 -LVE---------GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 751 -~~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
+.| +.+.. .-......+.+++..++..||.+|++++|++++=
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 111 11111 1123456679999999999999999999999763
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.75 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=205.2
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc----cc-ccchhhhheeeeeeccc-cCCcceEEeEeec
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV----FQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE 590 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 590 (813)
....|.+.+.||+|.||.|++|.... .+..||||.+... .. ...+.+.+|+.++++++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 34567788999999999999998753 4589999976553 11 23456778999999998 9999999999999
Q ss_pred CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-CCEEEeeccCc
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLA 669 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGla 669 (813)
....++||||+.+|+|.+++....++.+.....+++|++.|++||| +.+|+||||||+|||++.+ +++||+|||++
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999999999889999999999999999999999 4599999999999999999 99999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCC-CC-CccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNST-IT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... +. ..
T Consensus 169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~----~k----- 234 (370)
T KOG0583|consen 169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY----RK----- 234 (370)
T ss_pred cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH----HH-----
Confidence 98741 112255678999999999999987 76 68999999999999999999998632211 10 01
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 790 (813)
+.......+.... ...+..++.+||+.||.+|+++.+|+
T Consensus 235 ---i~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 ---IRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---HhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111111111111 67889999999999999999999999
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.55 Aligned_cols=261 Identities=21% Similarity=0.343 Sum_probs=208.6
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
|....+.+.+.||+|+||.||+|.+......+..||+|.++.... .....+.+|+.++.+++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 345667888999999999999998765555678999999875422 2235688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 595 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +++||||||+|||++.++.+|++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999764 5789999999999999999999954 99999999999999999999999999876543
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||......+. ... .....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~----~~~~~----- 225 (266)
T cd05064 159 SEAIYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA----VEDGF----- 225 (266)
T ss_pred ccchhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HHCCC-----
Confidence 221111 112335678999999999999999999999999999875 9999975433211 111 11110
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.......++..+.+++..||+.+|.+||++++|++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011223467789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=342.07 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=203.9
Q ss_pred HHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecCC
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 592 (813)
....+.+.++||+|+||.||+|.... .......||||+++... ....+.+.+|+.++..+ +||||++++++|.++.
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34457778999999999999997532 22355689999986432 22345688999999999 8999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhcc-----------------------------------------------------------
Q 045343 593 NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------- 613 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~----------------------------------------------------------- 613 (813)
..++||||+++|+|.+++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999988542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 614 ----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 614 ----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
..+++..+++++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 136788899999999999999995 5999999999999999999999999999987654332
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
........++..|+|||.+.+..++.++||||||+++|||++ |..||........ +.. ....+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~----~~~~~~~~------- 336 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK----MIKEGYRM------- 336 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH----HHHhCccC-------
Confidence 221223345678999999999999999999999999999998 8888864432211 111 11111000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
......+.++.+++.+||+.||++||++.||+++|++.
T Consensus 337 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 --LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00111246788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=319.32 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=211.6
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
.+-.|+|.+.||+|.||.|-++... ..++.||||.+++..-. +.-.+.+||+||+.|+||||+.++.+|+..+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~---~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEH---KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhc---cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 4567889999999999999998753 47889999998764333 33457899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
..|||||..+|.|.||+.....+++.+.+.++.||..|+.|+|.+ +++|||||.+|||||+++++||+|||++.++.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999999999999999999999999999999999965 99999999999999999999999999998876
Q ss_pred cCcccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
... ....++|.+-|.+||++.+.+| .+.+|-|||||+||.|+.|..||++..- ..+. .++.
T Consensus 205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv------------rQIs 266 (668)
T KOG0611|consen 205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV------------RQIS 266 (668)
T ss_pred ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH------------HHhh
Confidence 432 2567899999999999999987 5789999999999999999999986432 1111 1111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.+.... .+.+....-||+|||..||++|.|+.+|..+.-
T Consensus 267 ~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 267 RGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred cccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 222211 122345677999999999999999999998873
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.17 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=203.1
Q ss_pred HHHhhcccccceeeeeeEEEEEEecc-------------CCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTT-------------RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVR 583 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~-------------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 583 (813)
...+.+.++||+|+||.||++..... ...+..||||.+.... .....++.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 34567789999999999999986432 1234579999986532 223457899999999999999999
Q ss_pred EEeEeecCCceEEEEeecCCCchhhhhhcc-------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 045343 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644 (813)
Q Consensus 584 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iv 644 (813)
+++++.+.+..++||||+++|+|.+++... ..+++..+++++.||+.||.|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 999999999999999999999999988542 235788899999999999999995 4999
Q ss_pred eCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCc
Q 045343 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRK 722 (813)
Q Consensus 645 H~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt--G~~ 722 (813)
||||||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987654332222233456789999999988889999999999999999987 456
Q ss_pred CCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 723 SFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 723 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
||........ .............. .. ......++..+.+++.+||+.||.+|||+.||.+.|++
T Consensus 241 p~~~~~~~~~---~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQV---IENAGEFFRDQGRQ-VY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHH---HHHHHHHhhhcccc-cc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6654332211 11111111111000 00 00112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.07 Aligned_cols=252 Identities=33% Similarity=0.536 Sum_probs=197.3
Q ss_pred cccccceeeeeeEEEEEEe-ccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 523 FKEEVGRGSFGIVYKGVIL-TTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~-~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.+.||.|.||.||+|.+. ........|+||.++.... ...+++.+|++.+++++|+||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999997 4555678899999965322 2367899999999999999999999999988889999999
Q ss_pred cCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 601 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 601 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
+++|+|.++|... ..+++..+.+|+.||++||+|||+. +++|++|+++||+++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 7889999999999999999999964 8999999999999999999999999999877332222
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+ +. ..+.....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~----~~~~~~~~--------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---II----EKLKQGQR--------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HH----HHHHTTEE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc----cccccccc---------
Confidence 21233446789999999998889999999999999999999 678876442211 11 11111111
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
......++..+.+++..||+.+|++||++.+|++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111123457788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=340.63 Aligned_cols=264 Identities=25% Similarity=0.405 Sum_probs=205.2
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 591 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 591 (813)
+....+++.+.||+|+||.||+|..... ......||||+++.... .....+.+|+++++.+ +|+||++++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 4455677889999999999999986432 23446799999975322 2234688999999999 899999999999999
Q ss_pred CceEEEEeecCCCchhhhhhcc----------------------------------------------------------
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN---------------------------------------------------------- 613 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~---------------------------------------------------------- 613 (813)
...++||||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 614 ------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 614 ------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
..+++..+++++.||++||.|||+ .+|+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 136788889999999999999995 59999999999999999999999999999866443222212
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
....++..|+|||++.+..++.++||||||+++|||++ |+.||........ . ....... . .. ..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~----~~~~~~~-~----~~----~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F----YKMVKRG-Y----QM----SR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H----HHHHHcc-c----Cc----cC
Confidence 23345678999999998899999999999999999997 9999975432211 0 0111100 0 00 00
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
....+..+.+++.+||+.||.+||++.+|+++|++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1112467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=303.39 Aligned_cols=235 Identities=29% Similarity=0.331 Sum_probs=199.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.+.||.|+||.|.++... ..+..+|+|++++..-- ..+...+|..+|+.+.||.++++.+.+.+.+..+||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k---~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREK---HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhheeeeccCccceEEEEEEc---cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456688999999999998774 56889999999764322 234567899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|.|..+|+...++++...+-++.||+.||+||| +.+|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999999999999999999999999999999999 569999999999999999999999999999987533
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
..+.+||+.|+|||.++.+.+...+|.|||||++|||+.|.+||....... .+ ++++...+.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY--------~KI~~~~v~ 259 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IY--------EKILEGKVK 259 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HH--------HHHHhCccc
Confidence 456889999999999999999999999999999999999999998665411 11 223333333
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCC
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLR 783 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~R 783 (813)
.+ .-....+.+|+...|+.|-.+|
T Consensus 260 fP--~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FP--SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CC--cccCHHHHHHHHHHHhhhhHhh
Confidence 22 1234667788888888888888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.91 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=208.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|.+.+.||+|.||.||||.-+ .+.+.||+|.+.+.. ++..+.+.+|++++++++|||||.+++.|+...++++|.
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK---~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRK---YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred hhHHHHhcCCccceeeecccc---cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 556789999999999999763 467899999987642 233456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+.+ +|..+|.....++++.+..++.+++.||.||| +.+|.|||+||+|||++..+++|++|||+|+.+..+.
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 99988 99999999999999999999999999999999 5599999999999999999999999999999877543
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.+.+.+.||+-|||||.+.+.+++..+|.||+||++||+.+|++||.... +...+..... .....
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~---------d~v~~ 219 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK---------DPVKP 219 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc---------CCCCC
Confidence 33677899999999999999999999999999999999999999997432 1111111111 11111
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+.+....+..++...|++||.+|.+..+++.+
T Consensus 220 --p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 --PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 22456788899999999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.02 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=210.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.+-||.|+-|.|-.|+.. .+|+.+|||.+.+.. ......+.+|+.+|+.+.|||++++++++++.+++|||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~---~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHA---ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred eeccccccCCCCceehhhhcc---cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 456788999999999998874 578999999997642 22234588999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
.||+++|.|.+++-.++.+++.+..+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.+-.++.
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 9999999999999999999999999999999999999995 499999999999999999999999999998755432
Q ss_pred cceeecccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....+|.+.|.+||++.+.+|+ .++||||+|||||.||||+.||+.+.- ..+. ..+..+..+
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LL----lKV~~G~f~------- 230 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLL----LKVQRGVFE------- 230 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHH----HHHHcCccc-------
Confidence 24567899999999999999885 589999999999999999999984331 1111 111122111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH--hcCcCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML--EGVVEV 799 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L--~~~~~~ 799 (813)
. +...+.++.+|+.+|+..||++|.|++||+++- .+...+
T Consensus 231 -M--Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 231 -M--PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -C--CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 1 123457788999999999999999999999874 444433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=367.57 Aligned_cols=269 Identities=27% Similarity=0.517 Sum_probs=212.8
Q ss_pred CCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec
Q 045343 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 590 (813)
Q Consensus 511 ~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 590 (813)
++++++... ....+.||+|+||.||+|... .++..||||+++.... ....|++++++++|||||+++++|.+
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSI---KNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEEC---CCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc
Confidence 444454433 234467999999999999874 3568899999865322 22345788999999999999999999
Q ss_pred CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
++..++||||+++|+|.++++ .++|..+.+++.|||+||+|||+.+..+|+||||||+||+++.++.+++. |+.+.
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 999999999999999999996 37899999999999999999998778899999999999999999988876 66654
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
..... ....++..|+|||++.+..++.++|||||||++|||++|+.|++...+. ...+.+|+...........
T Consensus 831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhh
Confidence 43221 1235789999999999999999999999999999999999999654332 2234455554444444445
Q ss_pred cccccccc--cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 751 LVEGDMEA--LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 751 ~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.+++.+.. ....++..++.+++.+||+.||++||||.||+++|+++..
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 55554432 2234567788999999999999999999999999998765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.11 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=205.8
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
...+++.++||+|+||.||++... ..+..+|+|.+.... ....+++.+|++++++++|+||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK---PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 445677789999999999999874 356789999886532 2234568999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999999998888889999999999999999999952 369999999999999999999999999997654321
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC---c------
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE---K------ 747 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~------ 747 (813)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.... ........ .
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCccccCc
Confidence 2335689999999999998999999999999999999999999965432211100 00000000 0
Q ss_pred -------------------------ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 748 -------------------------LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 748 -------------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
...+................+.+++.+||+.||++|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000001113456789999999999999999999999774
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.98 Aligned_cols=245 Identities=27% Similarity=0.361 Sum_probs=206.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.++.+.||+|-||.||.|..+ +..-.||+|++.+. ..+..+++.+|+++-+.|+||||+++++++.+....+|+
T Consensus 24 feigr~LgkgkFG~vYlarek---ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREK---KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred ccccccccCCccccEeEeeec---cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 456789999999999999874 46778999999653 234457899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhh--ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||.+.|+|...|+ ...++++.....++.|+|.||.|+| .++|+||||||+|+|++..+..||+|||-+.....+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999998 5577899999999999999999999 569999999999999999999999999999865422
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh-hhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
. ....+||..|++||...+...+..+|+|++|++.||++.|.+||+.....+ +..+ . -.++..+
T Consensus 178 k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--------~---k~~~~~p 242 (281)
T KOG0580|consen 178 K----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--------R---KVDLKFP 242 (281)
T ss_pred C----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--------H---HccccCC
Confidence 1 456789999999999999999999999999999999999999998654321 1111 0 0111111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
......+.+++.+|+..+|.+|.+..|++.+-
T Consensus 243 -------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 243 -------STISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -------cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 23457788999999999999999999998763
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=325.49 Aligned_cols=265 Identities=28% Similarity=0.409 Sum_probs=221.7
Q ss_pred HHHHHHHHhhcccccceeeeeeEEEEEEecc-CCcceEEEEEEeec-cccccchhhhheeeeeeccccCCcceEEeEeec
Q 045343 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTT-RTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 590 (813)
Q Consensus 513 ~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~-~~~~~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 590 (813)
--+|.++...+.+.||.|.||.||+|+.... ++..-.||||..+. ......+.|..|..+|+.++|||||+|+|.|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 3456666677788999999999999998765 45566799999986 344556779999999999999999999999965
Q ss_pred CCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+..++|||.++-|.|..||+.+ ..++......++.||+.+|+||| +..+|||||..+|||+....-+||+|||++
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchh
Confidence 5789999999999999999875 56888888999999999999999 679999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
+.+..+.... .+...-..-|||||.+.-..++.++|||.|||++||+++ |..||.+....+ +
T Consensus 539 R~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------V 601 (974)
T KOG4257|consen 539 RYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------V 601 (974)
T ss_pred hhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------e
Confidence 9987655443 233445678999999999999999999999999999988 999997543211 1
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
--.++...+.+.+..|+..|..++.+||..+|.+||.+.|+...|..+.+
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11233334445566889999999999999999999999999998877665
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.48 Aligned_cols=258 Identities=30% Similarity=0.472 Sum_probs=206.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+.+.+.||+|+||.||+|...... .....|++|.++.... ....++.+|+.++.+++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4567789999999999999875432 2346799999864322 234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 597 VYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
+|||+++++|.+++... ..+++..++.++.|+++||.|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 99999999999998653 346788899999999999999995 49999999999999999999
Q ss_pred EEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHH
Q 045343 661 ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 739 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 739 (813)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 99999999987644332222233456788999999988889999999999999999998 9999875433221
Q ss_pred HHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
...+....... ....++.++.+++.+||+.||.+||++.||+++|+.+
T Consensus 236 ~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111111 1224568899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.57 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=208.5
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
-.+.||+|.||.||||... ..++.||+|.+.... ....++++.|+.++.+++++||.++++.+..+..++++|||+
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~---~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDN---KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred cchhccccccceeeeeeec---cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3478999999999999885 467899999997543 233467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
.+|++.+.|.....+++..+.-++.++..||.|||.+ +.+|||||+.|||+..++.+||+|||.+..+...... .
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--R 168 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc--c
Confidence 9999999999888888888888999999999999955 9999999999999999999999999999988766554 3
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
..++||+.|||||++....|+.|+||||||++.+||++|.+|+....+.. +.-++...-.....
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLD 232 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCccc
Confidence 56889999999999998899999999999999999999999997443211 11122211111222
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+...+.+++..||+.||+.||++.+++++
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3567889999999999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.05 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=207.8
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.+.||+|+||.||+|.+.....+...||||.++.... ....+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 446678899999999999999865544567899999865332 2345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++++|.+++... ..+++..+++++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999654 468999999999999999999995 599999999999999999999999999999875322
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||....... +.... ....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~-------- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGY-------- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC--------
Confidence 2211222345678999999998889999999999999999998 999885433221 11111 1100
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.......+++.+.+++.+||+.+|++||++.||+++|++++
T Consensus 226 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 226 -RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00011234577899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.43 Aligned_cols=260 Identities=23% Similarity=0.302 Sum_probs=206.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---------cc-----chhhhheeeeeeccccCCcceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---------DG-----EKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---------~~-----~~~~~~E~~~l~~l~h~niv~l 584 (813)
.+|++.++||+|.||.|-+|... .+++.||||++.+... .. .+...+||.+|++++|+|||+|
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~---~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDE---VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred hheehhhhhcCCccceEEEEeec---CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 35677789999999999998764 4778999999965311 11 1367899999999999999999
Q ss_pred EeEeecC--CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEE
Q 045343 585 LGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662 (813)
Q Consensus 585 ~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 662 (813)
+.+..+. +.+|||+|||..|.+...=-....++..+.++++.++..||+|||.+ +||||||||+|+||++++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 9998654 57899999999998765433344489999999999999999999955 999999999999999999999
Q ss_pred EeeccCccccccC---cccceeecccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhh
Q 045343 663 ISDFGLAKLLTLN---QSKAIRTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735 (813)
Q Consensus 663 l~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l 735 (813)
|+|||.+...... .........+||+.|+|||...+.. .+.+.||||+||+||-|+.|+.||-.+..-+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---- 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---- 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH----
Confidence 9999999866322 1122234478999999999987732 3568999999999999999999997543211
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
..++++...+..+...+..+.+.+|++++|++||+.|.+..+|..+.--....
T Consensus 327 -----------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 327 -----------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred -----------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 12334445555555556788999999999999999999999999988554443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=335.13 Aligned_cols=263 Identities=22% Similarity=0.353 Sum_probs=204.5
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeecccc-ccchhhhheeeeeeccc-cCCcceEEeEeecCCc
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN 593 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 593 (813)
...+.+.++||+|+||.||+|...... .....||||+++.... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 445667799999999999999864321 2345799999965322 22356889999999996 9999999999999999
Q ss_pred eEEEEeecCCCchhhhhhcc------------------------------------------------------------
Q 045343 594 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------ 613 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~------------------------------------------------------------ 613 (813)
.+|||||+++|+|.++|...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999987532
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 045343 614 ------------------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 657 (813)
Q Consensus 614 ------------------------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~ 657 (813)
..+++..+.+++.||++||.|||+ .+|+|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 136777888999999999999995 59999999999999999
Q ss_pred CCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhH
Q 045343 658 YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT 736 (813)
Q Consensus 658 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~ 736 (813)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence 99999999999987644322221223446788999999998889999999999999999997 88988643221110
Q ss_pred HHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 737 DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
......+. ........+..+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 350 ---~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 ---YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 01111110 001112345788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=327.42 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=203.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.++||+|+||.||+|... ..+..||||+++... ....+.+..|+.++.+++|+||+++++++.+++..++|
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKK---DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred cEEEEEEeecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 567789999999999999874 356789999987532 12345678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~-- 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-- 154 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc--
Confidence 9999999999999888888999999999999999999995 49999999999999999999999999999865431
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +..+ ...+.. +.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~~~~~---~~- 221 (333)
T cd05600 155 ---ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW------KETLQR---PV- 221 (333)
T ss_pred ---cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc------cccccC---CC-
Confidence 234568999999999999899999999999999999999999997654322111 1000 000000 00
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...........+.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000012345778899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.91 Aligned_cols=260 Identities=26% Similarity=0.452 Sum_probs=207.6
Q ss_pred HHHHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
...++.+.+.||+|+||.||+|..... ......||||.++..... ..+.+.+|++++++++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 345678889999999999999987533 234578999998765433 34679999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhcc--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC
Q 045343 594 RLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 659 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~ 659 (813)
.++||||+++++|.+++... ..+++..+..++.||+.|+.|||+ .+++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence 99999999999999998643 346788999999999999999995 4999999999999999999
Q ss_pred CEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHH
Q 045343 660 NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 738 (813)
Q Consensus 660 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 738 (813)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....++.. ..
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~ 236 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---EC 236 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH
Confidence 999999999986543322111223345788999999999999999999999999999998 99998654332211 11
Q ss_pred HHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
...+.... .....+..+.+++.+||+.||++||++.||++.|++
T Consensus 237 ----~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ----ITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111111 111345778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.08 Aligned_cols=265 Identities=20% Similarity=0.245 Sum_probs=202.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.+.||+|+||.||++... ..+..+|||+++... ....+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHK---ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred ceEEEEecccCCEEEEEEEEC---CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 567789999999999999874 356789999987532 223456788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||++++.|..+......+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999998887666556678999999999999999999995 59999999999999999999999999999876433221
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH---------hhccCccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD---------CYRNEKLD 749 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~~ 749 (813)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.......... ........
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 N-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred c-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 1 2335689999999999988899999999999999999999999976443221111000000 00000000
Q ss_pred cccccccccc------ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEAL------NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....+..... .....+..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000100000 011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=327.07 Aligned_cols=243 Identities=23% Similarity=0.272 Sum_probs=198.0
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.||+|+||.||++... .+++.+|||+++... ......+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREK---ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 46999999999999874 367889999987532 222345778999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~ 152 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--c
Confidence 999999999888889999999999999999999995 59999999999999999999999999998754322111 2
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+... . ....+.. . ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~----~~~~~~~--------~--~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---E----LILMEEI--------R--FP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---H----HHHcCCC--------C--CC
Confidence 3456999999999999999999999999999999999999999754322111 0 0111100 0 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 12356788999999999999999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.24 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=211.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.++||+|+||+||++.-. ..+..+|+|++++.. ....+.++.|-.+|....++.||+|+-.|.+.+.+|||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk---~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKK---DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred chhheeeccccceeEEEEEEc---cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 345578999999999998763 578899999998643 22345678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC--
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-- 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~-- 675 (813)
|||++||++..+|.....+++.....++.+++-|+.-||+. |+|||||||+|+|||..|++||+||||+.-+...
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999964 9999999999999999999999999998533110
Q ss_pred --------------------cccc---e--------------------eecccccccccCcccccCCCCCCccchhhHHH
Q 045343 676 --------------------QSKA---I--------------------RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGV 712 (813)
Q Consensus 676 --------------------~~~~---~--------------------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gv 712 (813)
.... . ....+|||.|+|||++.+..++..+|.|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 0 01247999999999999999999999999999
Q ss_pred HHHHHHhCCcCCCcccch-hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 045343 713 LLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT---MKK 788 (813)
Q Consensus 713 vl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~e 788 (813)
||||||.|-+||..+.+. ....+..|...+.. +.......+..+||.+|+. ||++|.- ++|
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 999999999999987663 34444444322211 1122334788899999998 9999975 667
Q ss_pred HHHH-------HhcCcCCCCCCCCC
Q 045343 789 VLQM-------LEGVVEVSLPPNPY 806 (813)
Q Consensus 789 vl~~-------L~~~~~~~~p~~p~ 806 (813)
|.++ .+.+.+.+.|=.|.
T Consensus 442 IK~HPfF~~v~W~~l~~~~apfvP~ 466 (550)
T KOG0605|consen 442 IKKHPFFKGVDWDHLREMPAPFVPQ 466 (550)
T ss_pred HhcCCccccCCcchhhcCCCCCCCC
Confidence 6654 34455666444443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=326.37 Aligned_cols=264 Identities=28% Similarity=0.390 Sum_probs=219.3
Q ss_pred CCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec
Q 045343 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE 590 (813)
Q Consensus 511 ~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 590 (813)
..--|+++....+.++||-|.||.||.|++++ -...||||.|+.. .-..++|..|..+|+.++|||+|+|+|+|..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeec---cceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 34445666666778899999999999999963 4568999999864 3346789999999999999999999999999
Q ss_pred CCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
+-.+|||+|||..|+|.+||... ..++--..+.++.||+.|+.||. ..++|||||.++|.|+.++..+||+|||+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999999999754 45667778899999999999999 45999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
++++..+.... .....-..-|.|||-+....++.|+|||+|||+||||.| |..|+.+..- ..+
T Consensus 412 sRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqV-------- 475 (1157)
T KOG4278|consen 412 SRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQV-------- 475 (1157)
T ss_pred hhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHH--------
Confidence 99987654322 222234567999999999999999999999999999998 8888764321 111
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
-.+++...+......|++.+.+||+.||+.+|.+||++.|+.+.+|.+..
T Consensus 476 -Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 476 -YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 22334444555566789999999999999999999999999999988654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=325.98 Aligned_cols=268 Identities=20% Similarity=0.314 Sum_probs=204.4
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
+....|++.++||+|+||.||++... .++..+|+|.++... .....++.+|++++++++|+||+++++++.+++..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHK---PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEEC---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 44566788899999999999999874 356788999876532 22335688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++||||+++++|.+++.....+++.....++.|+++||.|||+ ..+|+|+||||+|||++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999999999888888999999999999999999995 23799999999999999999999999999876533
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh-hccC-------
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC-YRNE------- 746 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-~~~~------- 746 (813)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.................. ....
T Consensus 157 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 21 23356899999999999888999999999999999999999999754321111000000000 0000
Q ss_pred c-----------------c----cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 K-----------------L----DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~-----------------~----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. . ..+...............++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 0 00000000000011134678899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.16 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=205.4
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+....+++.+.||+|++|.||+|... .+..||||.++.. ....+++.+|+.++++++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 44566788899999999999999864 3467999998653 233567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 596 LVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997654 68999999999999999999995 499999999999999999999999999998765
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... ......+..|+|||.+.+..++.++||||||++++||++ |+.||......... ...... .
T Consensus 155 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~-~---- 221 (261)
T cd05068 155 EDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQG-Y---- 221 (261)
T ss_pred CCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC-C----
Confidence 322111 111223458999999998899999999999999999999 99998654322110 111000 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
........++.+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 ----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0011123457789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=327.30 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=203.7
Q ss_pred HHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeec-CCc
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE-GQN 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 593 (813)
..+++.+.||+|+||.||+|.... ....++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 457788999999999999997543 223457899999875322 2234677899999999 89999999998865 456
Q ss_pred eEEEEeecCCCchhhhhhcc------------------------------------------------------------
Q 045343 594 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------ 613 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~------------------------------------------------------------ 613 (813)
.++++||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999988532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccC
Q 045343 614 -LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692 (813)
Q Consensus 614 -~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 692 (813)
..++|..+.+++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257899999999999999999995 4999999999999999999999999999987654332221233456778999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHH
Q 045343 693 PEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMV 771 (813)
Q Consensus 693 PE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 771 (813)
||++.+..++.++|||||||++|||++ |..||......+. +. ......... .........+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~~---------~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGTRM---------RAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999998 9999865332111 11 111111000 0011235678999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 772 SIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 772 ~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
+.+||+.+|++||++.||+++|+++++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.13 Aligned_cols=250 Identities=25% Similarity=0.275 Sum_probs=199.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+...+.||+|+||.||++... .+++.||||.+.... ......+.+|+.++.+++|+||+++++++.+++..++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe---cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 456688999999999999875 356799999986432 12234578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999999888643 468899999999999999999995 59999999999999999999999999999875432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ........ ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~--------~~ 221 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKE--------DQ 221 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhc--------cc
Confidence 21 234568999999999999999999999999999999999999997543321110 00010100 00
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
. .........+.+|+.+||+.||.+||+ +++++++
T Consensus 222 ~--~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 E--EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred c--cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 011123567889999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=319.00 Aligned_cols=261 Identities=24% Similarity=0.440 Sum_probs=208.8
Q ss_pred HHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+.+.+.||+|+||.||+|..... ..+...+++|.++.......+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 4456678999999999999986432 23456789999876554455678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 597 VYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 99999999999998643 247899999999999999999995 49999999999999999999
Q ss_pred EEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHH
Q 045343 661 ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 739 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 739 (813)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999976544322221233456788999999998899999999999999999999 9999865433221
Q ss_pred HHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.+.......... ....+..+.+++.+||+.+|++||++++|+++|+++..
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111110 11235678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.17 Aligned_cols=263 Identities=24% Similarity=0.445 Sum_probs=209.0
Q ss_pred HHHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
...+.+.+.||+|+||.||++..... ..+...+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 44566778999999999999976431 2345678999987655455667999999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccC-------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEE
Q 045343 596 LVYEFLNNGTLASFLFGNL-------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 662 (813)
+|+||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 47899999999999999999995 4999999999999999999999
Q ss_pred EeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHH
Q 045343 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 663 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||......+. . .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~----~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I----E 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----H
Confidence 999999986643322221223345778999999998889999999999999999998 8988865432211 0 1
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
....+..... ....+..+.+++.+||+.+|.+|||+.||++.|+++...
T Consensus 234 ~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111100 112346789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.69 Aligned_cols=244 Identities=25% Similarity=0.238 Sum_probs=200.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.++||+|+||.||+|... .+++.+|||++.... ....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDR---ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 567789999999999999874 356789999986432 12345688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999999888889999999999999999999995 59999999999999999999999999999876432
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... ..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~--------~~ 216 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------EKILAGK--------LE 216 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------cC
Confidence 22346899999999999988999999999999999999999999754332110 1111110 10
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
. .......+.+++.+||+.||.+||+ ++|++++
T Consensus 217 ~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 F--PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C--CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 1122457889999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.86 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=205.3
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
....+.+.++||+|++|.||+|... ..+..+++|.++.. ....+++.+|++++++++|+||+++++++..+...++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEe---cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 3445667889999999999999875 35678999998643 3335678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 597 VYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999999998653 457899999999999999999995 5999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
..... ......+..|+|||.+.+..++.++||||||+++|||++ |..|+.....++.. ......
T Consensus 157 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~------- 221 (263)
T cd05052 157 DTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKG------- 221 (263)
T ss_pred ceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCC-------
Confidence 32211 112234668999999998899999999999999999998 89998654322211 111110
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.........+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 222 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 --YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00011112357789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=326.29 Aligned_cols=246 Identities=22% Similarity=0.264 Sum_probs=201.7
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+++.+.||+|+||.||+|... .+++.||||.++... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK---GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 44678899999999999999874 356789999986532 123456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999999888888999999999999999999995 59999999999999999999999999999876432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ......+.
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~-------- 231 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGR-------- 231 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCC--------
Confidence 1234689999999999999999999999999999999999999975432110 11111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
... +......+.+++.+||+.||.+||+ +++++++
T Consensus 232 ~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 LKF--PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 110 1112456789999999999999997 6888755
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.04 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=204.2
Q ss_pred HHHhhcccccceeeeeeEEEEEEec-cCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
...+++.++||+|+||.||+|.... +......+++|.++... .....++.+|+.++++++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 3456788999999999999998632 22356789999987432 223356889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcc-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC
Q 045343 596 LVYEFLNNGTLASFLFGN-----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY 658 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~ 658 (813)
+||||+++++|.+++... ..+++...+.++.|++.||.|||+ .+++|+||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 999999999999998522 246788899999999999999995 499999999999999999
Q ss_pred CCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHH
Q 045343 659 YNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 737 (813)
Q Consensus 659 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 737 (813)
+.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+. .
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~- 236 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---I- 236 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---H-
Confidence 9999999999987654332222233446778999999988889999999999999999998 8888865432111 1
Q ss_pred HHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
+......... ........+.+++.+||+.+|.+||++.+|+++|.+
T Consensus 237 ---~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ---EMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111100 111235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.52 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=205.2
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCC-cceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
+....++..+.||+|+||.||+|.+..+.. ....||||.++... ....+++.+|+.+++.++|+||++++++|... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 344556777899999999999998753322 23458999986432 23346788999999999999999999999764 5
Q ss_pred eEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..+|+||+++|+|.+++... ..+++..+++++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 78999999999999999764 467899999999999999999995 59999999999999999999999999999877
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ....... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~--~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGE--RL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhCCC--CC
Confidence 64433221222334678999999999999999999999999999998 99998754322211 1111110 00
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.....+...+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0111234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=323.77 Aligned_cols=246 Identities=24% Similarity=0.284 Sum_probs=199.7
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||++....+...++.||||.++... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999876555678899999987532 12234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++++|.+++.....+.+..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-- 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence 9999999999888888899999999999999999995 59999999999999999999999999998754332221
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||......... .... ... .. .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~-~~~--------~~--~ 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKIL-KGK--------LN--L 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHH-cCC--------CC--C
Confidence 23456899999999999888999999999999999999999999754322110 0111 110 00 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.......+.+++.+||+.+|++|| ++.+++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 112346788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.17 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=204.1
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
....+.+.++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3455677899999999999999864 4457999987643 2235678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 597 VYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
|+||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||+++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999999653 567899999999999999999995 4999999999999999999999999999987653
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
..... .....++..|+|||.+....++.++||||||+++|||++ |+.||........ ......... .
T Consensus 156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~~~--------~ 223 (261)
T cd05072 156 NEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQRGYR--------M 223 (261)
T ss_pred Cceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHHcCCC--------C
Confidence 32211 222345678999999988889999999999999999998 9999865432211 111111000 0
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
......+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 -----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.03 Aligned_cols=243 Identities=24% Similarity=0.283 Sum_probs=197.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.||+|+||.||++... ..+..+|||+++... ......+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREK---ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 46899999999999874 467889999997532 223456788999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~ 152 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--M 152 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--c
Confidence 999999999888889999999999999999999995 59999999999999999999999999998764322111 2
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........ .+ .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-------~~~~~~~~------~~----p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEDI------KF----P 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-------HHhccCCc------cC----C
Confidence 3456899999999999889999999999999999999999999754322111 00000000 00 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
......+.+++.+||+.||.+|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12356788999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=290.80 Aligned_cols=261 Identities=25% Similarity=0.293 Sum_probs=212.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCC-----c
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----N 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~ 593 (813)
..|.+.++||+|||+-||.++.. .++..+|+|++.....++.+..++|++..++++|||+++++++...+. .
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~---s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGL---STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeeccc---CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45778899999999999998753 467789999998777677888999999999999999999999885433 4
Q ss_pred eEEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 594 RLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
.+|+++|...|+|.+.+.. ...+++..++.|+.+|++||.+||+. .+.++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999864 34689999999999999999999976 446999999999999999999999999998
Q ss_pred cccccCcccc-------eeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH
Q 045343 670 KLLTLNQSKA-------IRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 739 (813)
Q Consensus 670 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 739 (813)
....-.-... .......|.-|.|||.+. +...++++|||||||+||+|+.|..||+...+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 7654221100 012234688999999885 44678999999999999999999999974322
Q ss_pred HHhhccCccc-ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 740 FDCYRNEKLD-DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 740 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
..+.+. .+..+.+..+.....++.+.+++.+|++.||.+||++.+++..++.++
T Consensus 247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111222 233344545555557899999999999999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=304.95 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=200.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeec--cccCCcceEEeEeecCC----ce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDEGQ----NR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~ 594 (813)
..+.+.||+|.||+||+|.+ .|..||||++.. .+++.+.+|.++.+. |+|+||+.+++.-..++ .+
T Consensus 213 I~L~e~IGkGRyGEVwrG~w-----rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRW-----RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eEEEEEecCccccceeeccc-----cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 34678899999999999998 678899999864 345677888887775 59999999999876555 57
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED-----CSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+||++|.++|||.|||.. ..++....++++..+|.||+|||-+ .++.|.|||||+.|||+..++.+.|+|+|||
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999999999987 6778899999999999999999954 4678999999999999999999999999999
Q ss_pred cccccCcc--cceeecccccccccCcccccCCC----C--CCccchhhHHHHHHHHHhCC----------cCCCcccchh
Q 045343 670 KLLTLNQS--KAIRTAIRGTKGYVAPEWFRNST----I--TAKVDVYSFGVLLLEIISCR----------KSFDIEMGEE 731 (813)
Q Consensus 670 ~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~----~--~~k~DVwS~Gvvl~elltG~----------~p~~~~~~~~ 731 (813)
.....+.. .......+||.+|||||++...- + -..+||||||.|+||+.... .||..-.+.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 88765532 22234578999999999996532 2 23699999999999997432 3443221111
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
. ...+ ....+-...+...+.. ...+.+....+.++|+.||..+|..|.|+-.|.+.|.++.+.
T Consensus 444 P-s~ee-MrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 444 P-SFEE-MRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred C-CHHH-HhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 0 0000 0011111111111111 122446788899999999999999999999999999887754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.94 Aligned_cols=241 Identities=25% Similarity=0.289 Sum_probs=195.0
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
||+|+||.||++... ..+..||+|.++... ......+.+|+.++.+++|+||+++++++.+.+..++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKR---DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 799999999999874 356789999986432 23345678899999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeec
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 683 (813)
|+|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 152 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNT 152 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--ccc
Confidence 9999999888889999999999999999999995 59999999999999999999999999999864332211 234
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHH
Q 045343 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK 763 (813)
Q Consensus 684 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (813)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... . ... ....
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~-~--------~~~--~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQ-E--------PLR--FPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHc-C--------CCC--CCCc
Confidence 5689999999999999999999999999999999999999975432211 111111 0 000 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 045343 764 CVEKLVMVSIWCIQEDPSLRPT---MKKVLQM 792 (813)
Q Consensus 764 ~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 792 (813)
....+.+++.+||+.||.+||+ +.|++++
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 3467889999999999999985 5666554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=325.78 Aligned_cols=249 Identities=23% Similarity=0.274 Sum_probs=203.1
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
....+.+.+.||+|+||.||+|.... .....||+|++.... ....+.+.+|+.+++.++||||+++++++.++..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEEC--CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 44457888999999999999998642 234689999986432 2234567889999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999888889999999999999999999995 599999999999999999999999999998764
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~~----- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGII----- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC-----
Confidence 32 2345689999999999988899999999999999999999999975432211 111111110
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.. +......+.+++.+||+.||.+|+ ++++++++
T Consensus 246 ---~~--p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ---YF--PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CC--CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 111245678999999999999995 89998876
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.58 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=201.6
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCc------
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN------ 593 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 593 (813)
.+.+.||+|+||.||+|.+..+......||||+++... .....++.+|+..++.++|+||+++++++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 46688999999999999986554456789999987432 2234578899999999999999999999866554
Q ss_pred eEEEEeecCCCchhhhhhcc------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 594 RLLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
.++|+||+++++|..++... ..+++.....++.|++.||.|||+ .+++|+||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999988432 357899999999999999999995 499999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+ +... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDY----LRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC
Confidence 9987654332211222335678999999988889999999999999999999 888886443221 1111 1111
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.... ........+.+++.+||+.||.+||++.||++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 1123456889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.14 Aligned_cols=265 Identities=23% Similarity=0.384 Sum_probs=205.2
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeeccccc-cchhhhheeeeeeccc-cCCcceEEeEeec
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTH-HKNLVRLLGFCDE 590 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 590 (813)
++....+.+.++||+|+||.||+|.+.. .......||||+++..... ..+.+..|++++.++. |+||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 4455566677999999999999998743 2234568999999754222 2346889999999997 9999999999999
Q ss_pred CCceEEEEeecCCCchhhhhhcc---------------------------------------------------------
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGN--------------------------------------------------------- 613 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~--------------------------------------------------------- 613 (813)
....++|+||+++|+|.++++..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 99999999999999999998542
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 614 -----------------------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 614 -----------------------------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
..+++...++++.||+.||.|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 124667788899999999999994 599999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543222111223346788999999998889999999999999999998 888886433221
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
. + ......+. ...........+.+++..||+.+|.+||+++||++.|++++
T Consensus 350 ~--~----~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q--F----YNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--H----HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 0 01111110 00011123577899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.58 Aligned_cols=243 Identities=24% Similarity=0.264 Sum_probs=197.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.||+|+||.||++... .++..||+|.++... ......+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 46899999999999864 367889999987532 223345678999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
++|+|..++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 152 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--c
Confidence 999999999888889999999999999999999995 59999999999999999999999999998754322111 2
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.... ....+.. . ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-------~~~~~~~--------~--~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------LILMEEI--------R--FP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcCCC--------C--CC
Confidence 34568999999999999899999999999999999999999997543221110 0000000 0 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
......+.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12356788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.13 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=197.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|.+.++||+|+||.||+|... .++..||+|+++.... .....+.+|+.++++++|+||+++++++..++..++||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cceEeeEEecCCCEEEEEEEEC---CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3667789999999999999874 3567899999864322 23446788999999999999999999999988999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++ +|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 99985 888888654 457889999999999999999995 5999999999999999999999999999976543221
Q ss_pred cceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH-----hhc----cCc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CYR----NEK 747 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~----~~~ 747 (813)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.......... .+. ...
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 T--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred c--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1 233457899999998865 5688999999999999999999999976543322111100000 000 001
Q ss_pred cccccccccccc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEAL----NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......+..... ........+.+++.+||+.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111110000 001224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.89 Aligned_cols=259 Identities=26% Similarity=0.451 Sum_probs=201.5
Q ss_pred HHHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
...+++.++||+|+||.||+|..... ......+|||+++... .....++.+|+.+++.++|+||+++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 44577789999999999999986421 2345679999885432 12334688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEe
Q 045343 595 LLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 664 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 664 (813)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999998642 235788899999999999999995 499999999999999999999999
Q ss_pred eccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhh
Q 045343 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 743 (813)
Q Consensus 665 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 743 (813)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....+... . ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~----~~ 234 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---R----FV 234 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----HH
Confidence 9999986543322111122345778999999998889999999999999999999 78888644322111 1 11
Q ss_pred ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
....... .....+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 011235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.82 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=206.2
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecCC
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 592 (813)
....+++.+.||+|+||.||++...... .....+|+|.++... .....++.+|+.++.++ +|+||+++++++..+.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3445667789999999999999875432 345789999887532 22335688899999999 7999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhc----------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 593 NRLLVYEFLNNGTLASFLFG----------------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
..++||||+++|+|.+++.. ...+++..+++++.|++.||.|||+ .+|+|+||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999853 2457899999999999999999995 4999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhh
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 735 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l 735 (813)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-- 244 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-- 244 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH--
Confidence 999999999999987654332211222345678999999988889999999999999999998 88888644322211
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
........ ..........+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 245 -----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 -----KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111110 0111233567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.67 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=204.3
Q ss_pred HHHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
...+.+.++||+|+||.||+|....+ ......||||+++..... ..+.+.+|+.++.+++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 45577889999999999999987542 234578999998754322 234688899999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC
Q 045343 595 LLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY 658 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~ 658 (813)
++++||+++++|.+++... ..+++..+.+++.|++.||.|||+ .+|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 9999999999999998521 246788899999999999999995 599999999999999999
Q ss_pred CCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHH
Q 045343 659 YNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 737 (813)
Q Consensus 659 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 737 (813)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----- 235 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----- 235 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999887643322221233446789999999988889999999999999999998 8888765432211
Q ss_pred HHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
.......... .....++..+.+++..||+.+|.+||++++|++.|+.
T Consensus 236 --~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 --IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 0112346778999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.62 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=204.3
Q ss_pred HHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+.+.++||+|+||.||++.... ...++..+++|.+..........+.+|++++++++|+||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 345667899999999999997532 223566899999876655556689999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCE
Q 045343 597 VYEFLNNGTLASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 661 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 661 (813)
|+||+++++|.+++... ..+++..++.++.||+.||+|||+ .+++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 99999999999998653 247899999999999999999995 599999999999999999999
Q ss_pred EEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHH
Q 045343 662 RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 740 (813)
||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI------- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-------
Confidence 9999999976543322111222345678999999998899999999999999999998 88888643322111
Q ss_pred HhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
......... ......+..+.+++.+||+.||.+||++.||++.|++
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000000000 0111235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.18 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=199.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.++||+|+||.||++... +...+|+|.++.. ....+++.+|+.++++++|+||+++++++.+.+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec----cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 34567789999999999999774 3457999987643 233467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999998753 468899999999999999999995 4999999999999999999999999999986543221
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ... .... ....+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~---~~i----~~~~--~~~~~-- 223 (256)
T cd05114 156 TS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV---EMI----SRGF--RLYRP-- 223 (256)
T ss_pred ec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHH----HCCC--CCCCC--
Confidence 11 122335668999999998889999999999999999999 89998654322111 111 1100 00011
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
......+.+++.+||+.+|.+||++.|+++.|.
T Consensus 224 -----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 -----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=334.17 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=211.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEe-ec------CC
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFC-DE------GQ 592 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~-~~------~~ 592 (813)
..+.+.|.+|||+.||.+.+.. .+..+|+|++-...+...+.+.+|+.+|++|+ |+|||.+++.. .. .-
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecC---CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 3456889999999999999863 33889999997766777888999999999997 99999999932 11 23
Q ss_pred ceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 593 NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
+.+|.||||.+|+|-|++..+ ..|++.++++|+.|+++|+++||.. .++|||||||-|||||+.+++.||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 678999999999999999754 5699999999999999999999975 7889999999999999999999999999986
Q ss_pred ccccCcccc-----eee--cccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH
Q 045343 671 LLTLNQSKA-----IRT--AIRGTKGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 671 ~~~~~~~~~-----~~~--~~~gt~~y~aPE~l---~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 740 (813)
-........ +.. ...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 433221100 000 11258899999987 57789999999999999999999999997432
Q ss_pred HhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
...|++.....+....+...|.+||+.||+.||.+||++-+|+..+-.+...+
T Consensus 263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12355556655555678999999999999999999999999999998776553
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.16 Aligned_cols=260 Identities=23% Similarity=0.444 Sum_probs=206.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+...+.||+|+||.||+|.+..+......++||+++... ....+++..|++++++++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 44566789999999999999986554455689999986532 22345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999754 578999999999999999999995 499999999999999999999999999998765332
Q ss_pred cccee-ecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 677 SKAIR-TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 677 ~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
..... .....+..|+|||++....++.++||||||+++|||++ |+.||.....++.. ......
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~-------~~i~~~-------- 226 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-------KAINDG-------- 226 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-------HHHhcC--------
Confidence 21111 11223457999999988889999999999999999998 99998654332111 111110
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
...+.....+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 000111234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.70 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=200.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCC-cceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRT-STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+++.+.||+|+||+||+|....+.. ....+++|.+..... ....++..|+.++++++|+||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 44566899999999999998753221 123578888754322 223567788888999999999999999864 457889
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+|||+++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999999754 568999999999999999999995 489999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||..........+ ..... ....
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~--~~~~-- 232 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGE--RLAQ-- 232 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCC--cCCC--
Confidence 2221233457788999999998889999999999999999998 9999875433221111 11111 0001
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
...+...+.+++.+|+..+|.+|||+.|+++.|+.+.+
T Consensus 233 -----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 -----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11134567889999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=305.46 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=193.4
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCC-----ceEEEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NRLLVY 598 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~ 598 (813)
.+.+|.|+||.||+|++.. .+..||||+.-.. .+--.+|+++|+++.|||||+|+-+|.... ...||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred eEEEeecccceEEEEEEcC---CCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4789999999999999963 4678999997432 223457899999999999999999885432 245899
Q ss_pred eecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-CCEEEeeccCccccc
Q 045343 599 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLT 673 (813)
Q Consensus 599 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGla~~~~ 673 (813)
|||+. +|..++.+ +..++...+.-+..||.+||.|||. .+|+||||||+|+|+|.+ +.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 77777763 5667777788899999999999995 599999999999999965 999999999999987
Q ss_pred cCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc-----
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK----- 747 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 747 (813)
.++.. ..+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.++.+..+....-.+......+.
T Consensus 178 ~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 65442 345578899999999875 699999999999999999999999987665443322111111111111
Q ss_pred -------ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 -------LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 -------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..++...............+..+++.++|+.+|.+|.++.|++.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111111111223456788999999999999999999999854
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=320.54 Aligned_cols=255 Identities=21% Similarity=0.250 Sum_probs=201.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeeecc-ccCCcceEEeEeecCCceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 595 (813)
+++.++||+|+||.||++....+...+..+|+|.+.... ....+.+..|+.++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 467789999999999999876555578899999986432 12234577899999999 5999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999888889999999999999999999995 49999999999999999999999999999865433
Q ss_pred cccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....||..|+|||++.+. .++.++|||||||++|||++|+.||.......... ........ .++
T Consensus 159 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-------~~~ 228 (332)
T cd05614 159 EKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-------CDP 228 (332)
T ss_pred CCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------CCC
Confidence 2221 2345699999999999865 47889999999999999999999997543211110 00001100 001
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.. .......+.+++.+||+.||++|| ++++++++
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 PF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 112346778999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.92 Aligned_cols=272 Identities=24% Similarity=0.345 Sum_probs=199.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC-----c
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----N 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~ 593 (813)
|++.++||+|+||.||+|... .++..||||+++... .....++.+|++++++++||||+++++++.... .
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred eEEEEEEeecCCeEEEEEEEC---CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 567789999999999999874 357789999986432 223346889999999999999999999885432 4
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++||||+. ++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 799999995 6899999887889999999999999999999995 499999999999999999999999999998654
Q ss_pred cCccc-ceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH--------HHh
Q 045343 674 LNQSK-AIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDC 742 (813)
Q Consensus 674 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~ 742 (813)
..... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||............... ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 32221 11234568999999999876 57899999999999999999999999754332111100000 000
Q ss_pred hccCccccccc---ccccc---cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCC
Q 045343 743 YRNEKLDDLVE---GDMEA---LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVEV 799 (813)
Q Consensus 743 ~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~ 799 (813)
........... ..... .........+.+++.+||+.||++|||++|++++ ++++...
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 00000000000 00000 0001124567899999999999999999999965 4544443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=306.38 Aligned_cols=253 Identities=31% Similarity=0.461 Sum_probs=202.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|+||.||+|...........+|+|.++.... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998765544557899999875433 23457889999999999999999999876 4568999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce-ee
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-RT 682 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 682 (813)
++|.+++.....+++..+..++.|++.||+|||. .+++|+||||+|||++.++.+||+|||+++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999999887788999999999999999999995 4899999999999999999999999999987654332210 11
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
...++..|+|||.+.+..++.++||||||+++|||++ |..||......+ +..... ... .. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~--~~-------~~~ 220 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGE--RL-------PRP 220 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCC--cC-------CCC
Confidence 1223567999999998889999999999999999998 999987543321 111111 110 00 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
...+..+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 233567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.77 Aligned_cols=274 Identities=25% Similarity=0.375 Sum_probs=202.1
Q ss_pred HhhcccccceeeeeeEEEEEEec-cCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec--CCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 596 (813)
.+.+.+.||+|+||.||++.... ....+..|+||+++.......+.+.+|++++++++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 45667899999999999997632 234677899999876555556678999999999999999999998743 346889
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999754 468999999999999999999995 49999999999999999999999999999876543
Q ss_pred cccce-eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAI-RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
..... .....++..|+|||.+.+..++.++||||||++++||++|..++..........+............+.+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 22111 11122345699999998888999999999999999999987765322111000000000000000000001111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
..........+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=307.16 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=195.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|+||.||+|... .++..+|+|...... ......+.+|++++++++|+||+++++++......++|+||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR---ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEe---cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 47999999999999874 356789999875432 23345689999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceee
Q 045343 604 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682 (813)
Q Consensus 604 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 682 (813)
++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++.............
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999999754 467899999999999999999995 599999999999999999999999999987654321111011
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
....+..|+|||.+.+..++.++||||||+++|||++ |..|+.......... ..... ......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~~---------~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQG---------VRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHcC---------CCCCCc
Confidence 1123457999999998889999999999999999998 888886433221110 00000 000111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
...+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.08 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=207.2
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+.+.++||.|+||.||+|... .+..+++|.++........++.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~----~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWK----NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEec----CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 345778899999999999999885 3678999998765544566789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999999753 467899999999999999999995 48999999999999999999999999999876432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
... .....++..|+|||.+.+..++.++||||||+++++|++ |+.||......+... ... ..
T Consensus 158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~---~~~----~~-------- 220 (261)
T cd05148 158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD---QIT----AG-------- 220 (261)
T ss_pred ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH---HHH----hC--------
Confidence 211 123346778999999988889999999999999999998 899986543222111 110 00
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.........++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 -YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00111223457788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.26 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=206.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+++.+.||+|+||.||+|....+......|+||.++... ....++|..|+.++++++|+||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45678899999999999999987655556689999987532 23345799999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999998753 567999999999999999999995 499999999999999999999999999988665432
Q ss_pred ccceeec-cc--ccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 677 SKAIRTA-IR--GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 677 ~~~~~~~-~~--gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
....... .. .+..|+|||.+.+..++.++||||||+++||+++ |..||......+ ....+.. . .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~----~--~--- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQ----D--Y--- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHc----C--C---
Confidence 2111111 11 2457999999998899999999999999999987 999986543221 1111110 0 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
......+.+..+.+++.+||+.+|.+||++.+|+++|+++
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.95 Aligned_cols=268 Identities=25% Similarity=0.389 Sum_probs=210.1
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEec----cCCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEee
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILT----TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD 589 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~----~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 589 (813)
+....+.+.+.||+|+||.||++.... ...+...||+|.++... ....+++.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 556667788999999999999997532 22345679999986432 23345788999999999 8999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
.....++||||+++++|.+++... ..+++..+..++.||++||.|||+ .+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 999999999999999999998653 246788899999999999999995 4999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 732 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 732 (813)
++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....++.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999987654322221223345678999999988889999999999999999998 7788764332211
Q ss_pred hhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 045343 733 AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLP 802 (813)
Q Consensus 733 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 802 (813)
. ......... ......+..+.+++.+||+.+|.+||++.||++.|++++.+...
T Consensus 249 ~-------~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 249 F-------KLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred H-------HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 1 111111000 01123457788999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=335.52 Aligned_cols=250 Identities=21% Similarity=0.263 Sum_probs=200.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
|.+.+.||+|+||.||+|....+ .+..|++|++..........+.+|+.+++.++|||||++++++..++..+|||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 77889999999999999976432 2567888876544333345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 601 LNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 601 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988754 3457888999999999999999995 599999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.........||++|+|||++.+..++.++|||||||++|||++|+.||......+. ...... +....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~~~~~~-~~~~~------ 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------MQQVLY-GKYDP------ 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CCCCC------
Confidence 22223446699999999999999999999999999999999999999975432111 011110 11100
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
........+.+++.+||+.+|++||++.++++
T Consensus 291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01123467889999999999999999999874
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=312.68 Aligned_cols=267 Identities=25% Similarity=0.374 Sum_probs=201.7
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccC-----------CcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTR-----------TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~-----------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 584 (813)
....+++.++||+|+||.||++...... .....||||+++... ......+.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3456778899999999999998764221 123468999986532 2233568899999999999999999
Q ss_pred EeEeecCCceEEEEeecCCCchhhhhhccC------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 585 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
++++...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999985431 36788999999999999999995 499999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCCcccch
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGE 730 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt--G~~p~~~~~~~ 730 (813)
|++++++.+||+|||++................++..|+|||.+.+..++.++||||||++++||++ +..||.....+
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999986543322111222345678999999988889999999999999999998 55676644322
Q ss_pred hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
... ................ ......+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 240 ~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVI---ENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHH---HHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 211 1111111110000000 0111235689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.90 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=202.8
Q ss_pred hhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.+.||+|+||.||+|...... .....+++|.+..... ....++.+|+.+++.++|+||+++++.+...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 356788999999999999874322 2335788988864322 2345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 598 YEFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
+||+.+++|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 9999999999987532 246788999999999999999995 4999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 732 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 732 (813)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.....+..
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999986543322111222345678999999988889999999999999999999 9999865432221
Q ss_pred hhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 733 AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 733 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
. ...... ............+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 239 ~-------~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 F-------NLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-------HHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 111111 0001112335678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=292.78 Aligned_cols=272 Identities=22% Similarity=0.248 Sum_probs=204.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc--chhhhheeeeeeccccCCcceEEeEeec--CCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 596 (813)
++..+.|++|.||.||+|... .++..||+|+++-..+.. .-.-.+||.+|.+.+|||||.+..+... -+..+|
T Consensus 78 fe~lnrI~EGtyGiVYRakdk---~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDK---KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHhhcccCcceeEEEeccC---CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 344578999999999999874 467899999997532111 1235789999999999999999998744 457999
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||||++ +|...+... .++...++.-+..|+++|++|||. ..|+|||||++|+|+...|.+||+|||+|+.+...
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999988 778888765 478899999999999999999995 49999999999999999999999999999988765
Q ss_pred cccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc---cCccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NEKLDDL 751 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~ 751 (813)
... .+..+-|..|.|||.+.+. .|++.+|+||+|||+.||+++++.|.+...-++... +...+. +.....+
T Consensus 231 ~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 231 LKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEAIWPGY 305 (419)
T ss_pred ccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccccCCCc
Confidence 332 4667889999999999876 589999999999999999999999987655333221 222211 1111110
Q ss_pred cc--------------ccccccccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 045343 752 VE--------------GDMEALNDI-KCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNP 805 (813)
Q Consensus 752 ~~--------------~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p 805 (813)
.+ ..++..... ...+.-++|+...|..||.+|.|+.|.+++= -..+.|.|..|
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~-~F~e~P~p~~P 373 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE-YFRETPLPIDP 373 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc-ccccCCCCCCh
Confidence 00 001111111 1346678899999999999999999999763 23344444443
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=306.05 Aligned_cols=251 Identities=29% Similarity=0.415 Sum_probs=199.0
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 602 (813)
++||+|+||.||+|.+... .++..+|+|+++.... ...+++.+|+.++++++|+||+++++++. ++..++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecC-CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 3699999999999976432 3567899999864322 23457889999999999999999999885 457799999999
Q ss_pred CCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce-e
Q 045343 603 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-R 681 (813)
Q Consensus 603 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~ 681 (813)
+++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999999877788999999999999999999995 5999999999999999999999999999987654332110 1
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+. .. ....+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~----~i~~~~~~~---------~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQ----MIESGERME---------C 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHCCCCCC---------C
Confidence 12234578999999988888999999999999999998 9999975433211 11 111111100 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
....+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 113456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=304.20 Aligned_cols=266 Identities=26% Similarity=0.348 Sum_probs=206.0
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeec-----CCceEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQNRLL 596 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~l 596 (813)
.+.||+|++|.|.++... .++..||||++..... ...++..+|+++|++++|+||+.+.+.+.. -+..++
T Consensus 27 ~~~iG~GAyGvVcsA~~~---~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDK---RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred cccccCcceeeEEEEEEc---CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 578999999999999885 4568999999975433 335678899999999999999999998854 346899
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|+|+| ..+|...++.+..++.....-++.||++||.|+| +.+|+||||||+|+|++.+..+||+|||+|+......
T Consensus 104 V~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred ehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999 6699999999888999999999999999999999 5699999999999999999999999999999986543
Q ss_pred ccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc---
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV--- 752 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--- 752 (813)
.....+.++.|..|.|||++.. ..++..+||||.|||+.||++|++.|.+...-.+..+.-.......++.+..+.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 3333577889999999998754 579999999999999999999999998765433322211111111111111111
Q ss_pred -----cc-----c--ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 045343 753 -----EG-----D--MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVV 797 (813)
Q Consensus 753 -----~~-----~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 797 (813)
.. . .... -.......++|+.+||..||.+|+|++|++++ |+..-
T Consensus 260 ar~yi~slp~~p~~~f~~~-fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSI-FPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHhCCCCCCCCHHHH-cCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 10 0 0000 01334567899999999999999999999965 44443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.09 Aligned_cols=271 Identities=25% Similarity=0.354 Sum_probs=203.3
Q ss_pred hcccccceeeeeeEEEEEEec-cCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecC--CceEEE
Q 045343 522 NFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 597 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 597 (813)
.+.+.||+|+||+||++.... ...++..||+|.++.... ...+.+.+|++++++++|+||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 677899999999998876432 224667899999875422 2345788999999999999999999988654 357899
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++... .+++..++.++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999998654 58999999999999999999995 4999999999999999999999999999987654322
Q ss_pred cce-eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAI-RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
... .....++..|+|||.+....++.++||||||++++||++|+.|+.......... ............+.+.++...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccchhhhhhhhhcCC
Confidence 110 112235667999999988889999999999999999999999986432211000 000000000011111111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
........+..+.+++..||+.+|++|||+++|+++|+.+.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11122334678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.09 Aligned_cols=241 Identities=25% Similarity=0.311 Sum_probs=199.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 595 (813)
...|.++||+|.||+|+++... .+++.+|||.+++.. .+..+..+.|.+|+... +||.|++|+..+...++++
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k---~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELK---GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEc---CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3456789999999999999985 456799999998742 33345577788777776 5999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
.||||+.||++ -++.+...+++..+.-++..|+.||+|||++ +|||||||.+|||||.+|++||+|||+.+.....
T Consensus 446 fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99999999994 3344557889999999999999999999965 9999999999999999999999999999976533
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... ..+++||+.|||||++.+..|+..+|.|||||+|||||.|..||.++.+++... .++...
T Consensus 522 g~~--TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---------------sI~~d~ 584 (694)
T KOG0694|consen 522 GDR--TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---------------SIVNDE 584 (694)
T ss_pred CCc--cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHhcCC
Confidence 332 577999999999999999999999999999999999999999999776554321 111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTM 786 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 786 (813)
. .++.-.+.+...+++++|..+|++|.-+
T Consensus 585 ~--~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 V--RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C--CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 1233456788899999999999999876
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=312.59 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=205.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCC-------------cceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRT-------------STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~-------------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 584 (813)
..+++.++||+|+||.||++....... ....||+|++..... ...+++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 456778999999999999998754321 235689999875322 234578899999999999999999
Q ss_pred EeEeecCCceEEEEeecCCCchhhhhhccC-----------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 585 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
++++..+...++|+||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999997654 68899999999999999999995 4999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCCcccchh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 731 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt--G~~p~~~~~~~~ 731 (813)
+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ +..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999986544332222333456788999999988889999999999999999998 666765332211
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
................... .....+.++.+++.+||+.||.+|||+.||++.|+.
T Consensus 242 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 ---VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111111111111000 111234689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=314.23 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=204.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecCCc
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 593 (813)
...+.+.+.||+|+||.||++.... .......+|||.++.... ...+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 3456778899999999999997632 223456799998865322 2235688999999999 79999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.++|+||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+|||++.++.++|+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997543 37999999999999999999995 4999999999999999999999999999986
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||......+. +... ....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~----~~~~---- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKL----IKEG---- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHH----HHcC----
Confidence 654322111222346778999999998889999999999999999998 9999865432211 1111 1110
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
..........+.+.+++.+||+.+|++||++.||++.|+++
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00001112246789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=291.57 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=201.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc--------chhhhheeeeeecc-ccCCcceEEeEeecC
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--------EKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 591 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 591 (813)
|+-.+.||+|..++|-++... ..+...|+|++....... .++-..|+.+|+++ .||+|+++.++++.+
T Consensus 19 y~pkeilgrgvss~vrRci~k---~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHK---ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred cChHHHhcccchhhhhhhhhc---ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 444578999999999998874 466788888886432111 12346789999998 599999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.-.++|+|.|+.|.|.|+|.....++++..++|+.|+.+|+.|||. .+||||||||+|||+|++.++||+|||+|..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999999999999999999999999999999999994 5999999999999999999999999999998
Q ss_pred cccCcccceeecccccccccCcccccC------CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRN------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
+.++.. ....+||++|+|||.+.. ..|+..+|+|++||+||.|+.|.+||.... +..+. +...+
T Consensus 173 l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlML----R~Ime 242 (411)
T KOG0599|consen 173 LEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLML----RMIME 242 (411)
T ss_pred cCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHH----HHHHh
Confidence 876654 456789999999998853 357889999999999999999999996321 11111 11111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
++.. ...+.-.+.+....+|+.+||+.||.+|.|++|++++
T Consensus 243 Gkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 243 GKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111 0111123456788999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=324.81 Aligned_cols=259 Identities=21% Similarity=0.251 Sum_probs=197.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..|.+.++||+|+||.||++... ..++.||||+... ..+.+|++++++++||||+++++++..+...++|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~---~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDN---KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEEC---CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 34777899999999999999874 3567899997532 35678999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|++. ++|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9985 6888888877788999999999999999999995 49999999999999999999999999999754322111
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch-----hhhhhHHHHHHhhcc--C-----
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-----EYAILTDWAFDCYRN--E----- 746 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~--~----- 746 (813)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....+ ..+...... .
T Consensus 239 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l-~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 239 K-YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI-KLIIRRSGTHPNEFPID 316 (391)
T ss_pred c-cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH-HHHHHHhcCChhhcCcc
Confidence 1 23457999999999999989999999999999999999999887532210 00111 001100000 0
Q ss_pred ---cccccc---------ccccc--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 ---KLDDLV---------EGDME--ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ---~~~~~~---------~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+.... .+... .......+..+.+++.+||+.||.+|||++|++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000 00011345678899999999999999999999964
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.96 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=192.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.++||+|+||.||+|... .+++.||||.+..... ...+.+.+|++++++++|+||+++++++.++...++|||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHR---PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HhhhhhccCCCCeEEEEEEEC---CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 345688999999999999874 3567899999864322 224568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+. ....+..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~- 224 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP- 224 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc-
Confidence 9999998654 234677788999999999999995 49999999999999999999999999999876533211
Q ss_pred eeecccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.....||..|+|||.+... ..+.++|||||||++|||++|+.||......+...+.... ... .
T Consensus 225 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~-~------- 292 (353)
T PLN00034 225 -CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMS-Q------- 292 (353)
T ss_pred -ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hcc-C-------
Confidence 2345689999999988532 2356899999999999999999999743322211111100 000 0
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...........+.+++.+||+.||++||++.||+++
T Consensus 293 --~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 --PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112345678999999999999999999999987
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.77 Aligned_cols=242 Identities=25% Similarity=0.276 Sum_probs=196.7
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 602 (813)
+.||+|+||.||++....++..+..+|||+++.... .....+..|++++++++|+||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 579999999999998765556788999999975322 223456789999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceee
Q 045343 603 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682 (813)
Q Consensus 603 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 682 (813)
+|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--ee
Confidence 99999999888889999999999999999999995 59999999999999999999999999999865433221 23
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccH
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 762 (813)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||......... . ... .... . ...
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~---~i~-~~~~--------~--~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---T---MIL-KAKL--------G--MPQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---H---HHH-cCCC--------C--CCC
Confidence 456899999999999888999999999999999999999999754322111 0 110 1000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 045343 763 KCVEKLVMVSIWCIQEDPSLRPTMKK 788 (813)
Q Consensus 763 ~~~~~l~~l~~~Cl~~dP~~RPt~~e 788 (813)
.....+.+++.+||+.||.+||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23467889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.39 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=214.2
Q ss_pred ccccceeeeeeEEEEEEeccC-CcceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 524 KEEVGRGSFGIVYKGVILTTR-TSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
.++||+|+||+||||.+.-.. .-..+||||++... ..+...++.+|+.+|.++.|+||++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 478999999999999886442 22357999998654 3344678999999999999999999999998776 88999999
Q ss_pred CCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 602 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 602 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+.|.|.||++. +..+..+..+.|..|||+||.|||++ +++||||..+|||+..-.++||.|||+++.+..+.....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 99999999975 46788889999999999999999965 999999999999999999999999999999987766543
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....-.+-|||-|.+....++.++|||||||.+||++| |..|++....++. .++++...+..
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~geRLs 920 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKGERLS 920 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhccccCC
Confidence 444455678999999999999999999999999999999 9999876554433 23333333444
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
++..+...+..++.+||..|+..||+++++...+.++..
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 566788999999999999999999999999988766543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=318.18 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=196.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||++... ..++.||||.++... ....+.+..|..++.++ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELK---KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 46899999999999874 356789999997532 12234577899999888 799999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-- 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc--
Confidence 9999999999888889999999999999999999995 59999999999999999999999999998753222111
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh--hhhhHHHHHHhhccCcccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+......... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IRI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CCC
Confidence 234578999999999999999999999999999999999999997432111 1111111111111111 111
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPT------MKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 792 (813)
+......+.+++.+||+.||.+||+ +.+++++
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1123467889999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.87 Aligned_cols=244 Identities=23% Similarity=0.266 Sum_probs=197.3
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.||+|+||.||++... ..+..+|+|.++... .....++..|++++..++|+||+++.+++...+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46899999999999864 367889999987532 122345678999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
++|+|.+++.....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 153 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence 999999999888889999999999999999999994 158999999999999999999999999998754322211 2
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
....||..|+|||++.+..++.++|||||||++|||++|+.||.....+.... ....... .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~-------~i~~~~~------~~----p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMEEI------RF----P 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH-------HHhcCCC------CC----C
Confidence 33569999999999999899999999999999999999999997543322111 0000000 00 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
......+.+++.+||+.||.+|+ ++.+++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12346788999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.39 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=199.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.+.||+|+||.||+|... ....+|||.++.. .....++.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~----~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec----CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 34567889999999999999764 3346999988643 233467899999999999999999999999988999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+.+++|.+++... ..+++..+++++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999999764 468999999999999999999995 4999999999999999999999999999886543321
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .... ......
T Consensus 156 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~~------- 220 (256)
T cd05113 156 TS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEKV----SQGLRL------- 220 (256)
T ss_pred ee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----hcCCCC-------
Confidence 11 112335678999999988889999999999999999999 9999864432211 1111 111000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.......+.+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001123578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.23 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=196.3
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecC------Cce
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------QNR 594 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 594 (813)
+.+.||+|+||.||+|...... ....+|||.++.. .....+.+.+|++++++++|+||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCC-CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 5688999999999999875332 2346899987643 223345688899999999999999999987432 246
Q ss_pred EEEEeecCCCchhhhhhc------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 595 LLVYEFLNNGTLASFLFG------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
++|+||+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 2347899999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ + ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcCC
Confidence 987654322111122345678999999998889999999999999999999 788886433211 1 11111111
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
... ........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 1112356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=324.06 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=197.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.++||+|+||+||+|... ..++.+|||++.... ......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKV---DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred ceEEEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 456789999999999999874 366789999986532 22345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++..+..++.||+.||.|||. .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999999888888999999999999999999995 5999999999999999999999999999764321100
Q ss_pred c---------------------------------------------ceeecccccccccCcccccCCCCCCccchhhHHH
Q 045343 678 K---------------------------------------------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGV 712 (813)
Q Consensus 678 ~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gv 712 (813)
. .......||..|+|||.+.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0012346999999999999888999999999999
Q ss_pred HHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHH--hcccCCCCCCCHHHHH
Q 045343 713 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIW--CIQEDPSLRPTMKKVL 790 (813)
Q Consensus 713 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~evl 790 (813)
++|||++|+.||......+... ....... .............+.+++.+ |+..++..||++.|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL------KVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH------HHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999997654322110 0000000 00001111224566677766 5667777899999999
Q ss_pred HH
Q 045343 791 QM 792 (813)
Q Consensus 791 ~~ 792 (813)
++
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=309.08 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=205.8
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 592 (813)
+....+.+.++||+|+||.||+|...... .....|++|.+.... .....++.+|+.++..++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 34456677899999999999999876432 345789999986432 223446889999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhcc----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEE
Q 045343 593 NRLLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 662 (813)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 999999999999999998642 236788999999999999999995 5999999999999999999999
Q ss_pred EeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHH
Q 045343 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 663 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....++.. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~---- 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---K---- 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---H----
Confidence 999999987654332211233446789999999988889999999999999999998 88888644332211 1
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
......... .....+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 233 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVIDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 111235788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=317.52 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=195.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||++... ..++.+|+|.++... ....+.+..|+.++.++ +|+||+++++++...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK---KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 46999999999999874 356789999987532 12234577888888776 799999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-- 152 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-- 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence 9999999999888889999999999999999999995 49999999999999999999999999998754322111
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh--hhhhHHHHHHhhccCcccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....||..|+|||++.+..++.++||||||+++|||++|+.||....... ......+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------R- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------C-
Confidence 234568999999999999999999999999999999999999996322111 01111111111111111 1
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPT------MKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~~ 792 (813)
.+......+.+++.+||+.||.+||+ +.+++++
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11123467789999999999999998 5676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.08 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=202.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+++.++||+|+||.||+|... .++..+|+|+++.........+.+|+.++.+++|+||+++++.+..++..++|+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNL---HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEEC---CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45677899999999999999874 356789999987544444556888999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++.....+++..+..++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||+++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999999877788999999999999999999995 49999999999999999999999999999876432211
Q ss_pred ceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....++..|+|||.+. ...++.++||||||++++||++|+.|+.......... ..... ....+.
T Consensus 163 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~---~~~~~~ 230 (267)
T cd06646 163 --RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKS---NFQPPK 230 (267)
T ss_pred --cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecC---CCCCCC
Confidence 22345888999999884 3457889999999999999999999985332211100 00000 000011
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
... .......+.+++.+||+.+|++||++++|+++|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 112357889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.10 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=194.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.+.||+|+||+||++... ..++.+|||+++... ......+.+|+.++.+++|+||+++++.+.+....++|
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKK---DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 456789999999999999864 356789999987532 12234678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999876532110
Q ss_pred c---------------------------------ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCC
Q 045343 678 K---------------------------------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724 (813)
Q Consensus 678 ~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~ 724 (813)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346999999999999999999999999999999999999999
Q ss_pred CcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 045343 725 DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCI--QEDPSLRPTMKKVLQM 792 (813)
Q Consensus 725 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPt~~evl~~ 792 (813)
......+.. . ..... . ..+..+ ......+.+.+++.+++ ..++..||+++||+++
T Consensus 237 ~~~~~~~~~---~---~i~~~-~-~~~~~p-----~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETY---K---KVMNW-K-ETLIFP-----PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHH---H---HHHcC-c-CcccCC-----CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 754432211 0 00000 0 001001 01112345556666533 3344567999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.79 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=195.4
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|... ..+..+|||.++... ....+.+..|.+++..+ +|+||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELK---GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 46999999999999874 356789999987532 22234567788888765 799999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++++|..++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-- 152 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence 9999999999888889999999999999999999995 49999999999999999999999999998764322211
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||..|+|||++.+..++.++||||||+++|||++|+.||......+.. . ..... . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~---~i~~~-~---~~~------- 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---E---SILHD-D---VLY------- 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---H---HHHcC-C---CCC-------
Confidence 23456899999999999989999999999999999999999999765432211 0 11111 0 000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRP-------TMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~evl~~ 792 (813)
.......+.+++..||+.||.+|| ++.+++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111246788999999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.27 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=203.4
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCC-cceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
....++.++||+|+||+||+|....+.. ....||+|.++... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 3456677899999999999998653322 12358999986432 2234578889999999999999999999975 4578
Q ss_pred EEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+++||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999764 568999999999999999999995 5999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||....... +.... ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~---- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLL----EKGERL---- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HCCCcC----
Confidence 322211122335678999999998889999999999999999998 888886433221 11111 111000
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
.........+.+++..||+.||++||++.|+++.|+.+...+
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011123567889999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=315.58 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=194.7
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|... .+++.||||.++... ....+.+..|..++..+ +|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLK---ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEc---CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 46999999999999874 356789999987532 22334567788888766 699999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-- 152 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-- 152 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--
Confidence 9999999999888889999999999999999999995 59999999999999999999999999998764322211
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~~~---~~------- 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILNDEV---VY------- 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHhcCCC---CC-------
Confidence 23456899999999999889999999999999999999999999754432211 11111100 00
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTM------KKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 792 (813)
.......+.+++.+||+.||.+||++ ++++++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11234678899999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=314.04 Aligned_cols=264 Identities=27% Similarity=0.395 Sum_probs=205.4
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccC----CcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEee
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD 589 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 589 (813)
+....+.+.++||+|+||.||++...... .....+|+|.++... .....++.+|++++.++ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 44566888899999999999999764321 233579999987532 23345688899999999 7999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
.....++|+||+++|+|.+++... ..+++..+++++.|++.||+|||+ .+++|+||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHhe
Confidence 999999999999999999999653 247899999999999999999995 4999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 732 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 732 (813)
+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 999999999999999986643221111122234568999999998889999999999999999998 8888864432211
Q ss_pred hhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 733 AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 733 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
. ........ ..........+.+++.+||+.+|.+||++.+|++.|+.++.
T Consensus 252 ~-------~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 252 F-------KLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred H-------HHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1 11111110 00111235678899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.56 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=198.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.+.||+|+||.||+|... ....+|+|.+... .....++.+|++++++++|+||+++++++.+....++|+|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEec----CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 4567889999999999999763 3457899987643 2234568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999753 467999999999999999999995 48999999999999999999999999999865432211
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .. .... ..
T Consensus 157 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~-----~~---- 219 (256)
T cd05059 157 S-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ES----VSAG-----YR---- 219 (256)
T ss_pred c-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HH----HHcC-----Cc----
Confidence 1 111224457999999998899999999999999999999 88888654322111 10 0000 00
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.......+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011122467899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.11 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=192.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeecc---ccCCcceEEeEee-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT---HHKNLVRLLGFCD----- 589 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~----- 589 (813)
.|++.++||+|+||.||+|.... ..+..||||+++..... ....+.+|+.+++++ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcC--CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 36677899999999999998642 24578999988643221 223455666666555 6999999999885
Q ss_pred cCCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
.....++|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 3446899999996 5888888653 457899999999999999999995 499999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh-hhHHHHHHhhccC
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWAFDCYRNE 746 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~ 746 (813)
+++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.. .+.... .....+
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~~~~~ 231 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLPGEE 231 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCChh
Confidence 998754331 123456899999999998888999999999999999999999999865432211 111000 000000
Q ss_pred ccc-------ccccccccc---cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLD-------DLVEGDMEA---LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~-------~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... ......... .......+.+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000000000 0001234667899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.70 Aligned_cols=255 Identities=31% Similarity=0.458 Sum_probs=203.6
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
++...++++.++||+|+||.||+|... ++..+|+|.+.... ....++.+|+.++++++|+||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 355678889999999999999999864 45779999987532 33467899999999999999999999874 4678
Q ss_pred EEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 595 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 9999999999999998653 467899999999999999999994 59999999999999999999999999999876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
....... .....++..|+|||.+....++.++||||||++++||++ |+.||......+.. .. .....
T Consensus 153 ~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~---- 220 (260)
T cd05067 153 EDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI---QN----LERGY---- 220 (260)
T ss_pred CCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH---HH----HHcCC----
Confidence 5322211 223345678999999988889999999999999999999 99999754322111 10 00000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
........+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 -----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000111234679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.11 Aligned_cols=257 Identities=28% Similarity=0.407 Sum_probs=199.7
Q ss_pred HHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+.+.+.||+|++|.||+|...... .....|++|...... ......+..|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 34566789999999999999885311 145678999876432 223456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccC-------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC---CEEEee
Q 045343 596 LVYEFLNNGTLASFLFGNL-------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISD 665 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~D 665 (813)
+||||+++++|.+++.... .+++..+++++.||++||+|||+ .+++|+||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999986542 57899999999999999999995 4899999999999998654 599999
Q ss_pred ccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhc
Q 045343 666 FGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 666 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.....++.. .... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~~~~---~ 236 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---EFVT---G 236 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH---c
Confidence 999987643221111112233568999999998899999999999999999997 99998754332211 1100 0
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
... .......+..+.+++.+|++.+|++||++.+|+++|+
T Consensus 237 ~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 0111233567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.80 Aligned_cols=259 Identities=23% Similarity=0.412 Sum_probs=205.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.+.||+|+||.||+|...........+|+|.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667899999999999999876544456689999986532 22345789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+|||++.++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999764 467999999999999999999995 599999999999999999999999999998765432
Q ss_pred ccce-eecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 677 SKAI-RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 677 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....++..|+|||.+.+..++.++||||||+++||+++ |..||......+. ..... ..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~----~~-------- 225 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE----EG-------- 225 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh----CC--------
Confidence 2111 111223568999999998889999999999999999887 9999865432211 11111 00
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.........+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 -YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00011123356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=323.73 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=203.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
|.+.+.||+|+||+||+|... .+++.||||+++... ......+.+|+.++..++|+||+++++++.+++..++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEEC---CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 567789999999999999874 357889999987532 13345688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc-
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ- 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~- 676 (813)
|||+++++|.+++.....+++..++.++.||+.||+|||. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 9999999999999888889999999999999999999995 599999999999999999999999999998765432
Q ss_pred --------------------------ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch
Q 045343 677 --------------------------SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730 (813)
Q Consensus 677 --------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~ 730 (813)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123356899999999999999999999999999999999999999765432
Q ss_pred hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 045343 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT-MKKVLQM 792 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 792 (813)
... ....... .....+......+.+.+++..|++ +|.+||+ +++++++
T Consensus 237 ~~~------~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETY------NKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 0000000 000001111135778899999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.53 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=203.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.++||+|+||.||+|... .++..||||.++... ......+.+|++++++++|+||+++++++.+.+..++
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCL---LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEe---CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 3567789999999999999874 356789999875421 2223468889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 597 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
|+||+++++|.+++.. ...+++..+..++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999988853 3457888999999999999999995 49999999999999999999999999998876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....++..|+|||.+.+...+.++|+||||+++|||++|+.|+........ .+. .......
T Consensus 157 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~----~~~~~~~----- 224 (267)
T cd08228 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC----QKIEQCD----- 224 (267)
T ss_pred cchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH----HHHhcCC-----
Confidence 543221 2234578899999999888899999999999999999999999864332111 111 1111100
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.+. .........+.+++.+||+.+|++||++.||++.|+++
T Consensus 225 ~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 000 11123457789999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.67 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=194.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|++.++||+|+||.||+|... .++..+|||+++.... .....+.+|+.++++++|+||+++++++.+++..++||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cceEeeeEEecCCEEEEEEEEC---CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4667889999999999999874 3567899999865432 22345778999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+. ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 9996 567776654 4568899999999999999999995 4999999999999999999999999999875432211
Q ss_pred cceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cc------
Q 045343 678 KAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EK------ 747 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~------ 747 (813)
. .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+ ......... ..
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 159 T--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QL-ERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred c--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HH-HHHHHHhCCCChhhccchhh
Confidence 1 233457899999998865 4578899999999999999999999975432111 11 111110000 00
Q ss_pred cccccccccc--ccc-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDME--ALN-------DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~--~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......... ... .......+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000 000 01123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.66 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=202.7
Q ss_pred HHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
....+.+.++||+|+||.||+|.... .......||+|.++.... ....++.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34567788999999999999997642 223456899998764321 223457889999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhcc----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 594 RLLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
.++||||+++|+|.+++... ..+++..+.+++.|++.||.|||+ .+|+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999642 234677888999999999999995 49999999999999999999999
Q ss_pred eeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHh
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++.. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~~---- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---KF---- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----
Confidence 99999986543322111122335678999999998889999999999999999998 78888643322211 11
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
........ ........+.+++.+||+.+|.+|||+.++++.|+..+
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11110000 01123578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=290.35 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=203.9
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeec--cccccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
....|++.++||+|.|+.||++... ..++..|+|.+.. .+..+.+++.+|+.|-+.|+|||||+|.....+..-.
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~---~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhc---cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 3456778899999999999998763 4666777776632 2334667889999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc---CCCCEEEeeccCccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKL 671 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGla~~ 671 (813)
+||+|+|.|++|..-+-.+...++......++||+++|.|+|. .+|||||+||+|++|- ...-+||+|||+|..
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999999998777666677888889999999999999995 5999999999999994 455699999999998
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
+... .......||++|||||++...+++..+|||+.||+||-||.|..||..+.... + ++.+..+..+
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l----ye~I~~g~yd-- 230 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L----YEQIKAGAYD-- 230 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H----HHHHhccccC--
Confidence 8722 22456789999999999999999999999999999999999999998644321 1 1111111111
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+....-....++..+|+++||..||.+|.|+.|.+++
T Consensus 231 ----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 ----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111112346778899999999999999999998865
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.29 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=201.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+.||+|+||.||+|....+. ....+++|.++... ....+.+.+|++++.++ +||||+++++++.+....++|+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCC-CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 567789999999999999875432 23457888876422 22345688999999999 7999999999999999999999
Q ss_pred eecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEE
Q 045343 599 EFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662 (813)
Q Consensus 599 e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 662 (813)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 999999999998643 247788999999999999999995 4999999999999999999999
Q ss_pred EeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHH
Q 045343 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 663 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|+|||++........ ......+..|+|||.+.+..++.++||||||+++|||++ |..||......+.. .
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-------~ 229 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-------E 229 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------H
Confidence 999999864321111 111223557999999988889999999999999999998 99999654322110 1
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLP 802 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 802 (813)
..... ............+.+++.+||+.+|.+||++.++++.|+++.....+
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11110 00001112356788999999999999999999999999887765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.05 Aligned_cols=263 Identities=24% Similarity=0.389 Sum_probs=206.2
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccC-CcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeec-CCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 593 (813)
....+.+.+.||+|+||.||+|...... .....|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3456777899999999999999986321 136789999886432 2234568889999999999999999998866 567
Q ss_pred eEEEEeecCCCchhhhhhcc--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEee
Q 045343 594 RLLVYEFLNNGTLASFLFGN--------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 665 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 665 (813)
.++++||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998643 457899999999999999999995 4999999999999999999999999
Q ss_pred ccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhc
Q 045343 666 FGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 666 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ +.... .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL----K 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH----H
Confidence 999987654332221223346778999999988889999999999999999999 999997543221 11111 1
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.+. .......+++.+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 234 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 000111235678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.96 Aligned_cols=245 Identities=27% Similarity=0.327 Sum_probs=194.3
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
||+|+||+||++... .+++.+|||++..... ...+.+..|+.++++++|+||+++.+++..+...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMR---ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEc---cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 799999999999874 3567899999864321 1234567899999999999999999999999999999999999
Q ss_pred Cchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 604 GTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 604 gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++..+......
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~- 153 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK- 153 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-
Confidence 999988743 3468899999999999999999995 49999999999999999999999999999876543221
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... . .... +......
T Consensus 154 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-~~~~--------~~~~~~~-- 219 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-LKQR--------ILNDSVT-- 219 (280)
T ss_pred -ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H-HHHh--------hcccCCC--
Confidence 233568999999999999999999999999999999999999997543211100 0 0000 0011000
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.....+..+.+++.+||+.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1113456788999999999999999 78888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.51 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=201.8
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|++|.||+|.+.........+|||.++.... ...+++..|+.++++++|+||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999999865444455799999976544 445678999999999999999999999988 889999999999
Q ss_pred CchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc-e
Q 045343 604 GTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-I 680 (813)
Q Consensus 604 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~ 680 (813)
++|.+++.... .+++...+.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++.+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 68999999999999999999995 599999999999999999999999999998775432211 1
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......+.. ..... .. ... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~---~~--~~~-------~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL---KKIDK---EG--ERL-------E 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHh---cC--CcC-------C
Confidence 123457789999999998899999999999999999999 99998644332211 11100 00 000 0
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.....+..+.+++.+|++.+|.+||++.+|++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.38 Aligned_cols=242 Identities=28% Similarity=0.341 Sum_probs=192.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeec-cccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|... ..+..||||.++... ......+..|..++.. ++||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELK---GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 46999999999999874 356789999987532 2223445667777765 4899999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--
Confidence 9999999999887788999999999999999999995 49999999999999999999999999998754322111
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ..... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~~----i~~~~------~~~---- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF---QS----IRMDN------PCY---- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH---HH----HHhCC------CCC----
Confidence 23456899999999999989999999999999999999999999754322111 11 11000 000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMK-KVLQ 791 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 791 (813)
.......+.+++.+||+.||.+||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 112345678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=322.03 Aligned_cols=254 Identities=19% Similarity=0.249 Sum_probs=200.0
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
...+++.+.||+|+||.||++... ..+..+|||.++... ....+.+.+|+.+++.++|+||+++++++.+++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456778899999999999999874 356789999986421 22334577899999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999988654 57888888999999999999995 5999999999999999999999999999987653
Q ss_pred CcccceeecccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
..... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 195 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~--- 264 (370)
T cd05596 195 NGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKN--- 264 (370)
T ss_pred CCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC---
Confidence 32211 2345699999999998654 3788999999999999999999999754432110 01111000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSL--RPTMKKVLQM 792 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 792 (813)
.+..+.....+..+.+++.+||+.+|.+ ||+++|++++
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111111234577889999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.84 Aligned_cols=267 Identities=28% Similarity=0.415 Sum_probs=207.9
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccC----CcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEe
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFC 588 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 588 (813)
++....+.+.+.||+|+||.||++...... .....||+|.++... ....+++.+|+++++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 455667888999999999999999764322 123478999886432 22346788999999999 799999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
.++...++++||+++|+|.+++... ..+++..+..++.||++||.|||+ .+++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 9999999999999999999998642 246788999999999999999995 599999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986643322111122334567999999999889999999999999999998 888886543222
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
.. .......... ........+.+++.+||+.+|.+||++.|+++.|+.+....
T Consensus 245 ~~-------~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 LF-------KLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HH-------HHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 1111111000 11123567889999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.04 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=201.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCC-cceEEeEeecCC---
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQ--- 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~--- 592 (813)
..++..++||+|+||+||+|.... .+..||+|++....+ .......+|+.++++++|+| ||+|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 345556789999999999999853 568999999976543 23455789999999999999 999999998877
Q ss_pred ---ceEEEEeecCCCchhhhhhccC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEee
Q 045343 593 ---NRLLVYEFLNNGTLASFLFGNL----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 665 (813)
Q Consensus 593 ---~~~lV~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 665 (813)
..+||+||++. +|..++.... .++...+..++.||++||+|||+ .+|+||||||+||||++++.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeec
Confidence 78899999855 8888886543 46678899999999999999995 4999999999999999999999999
Q ss_pred ccCccccccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 666 FGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 666 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
||+|+...-.... .+..++|..|.|||++.+. .|+...||||+||++.||++++..|.+..+.+.. ..+.+.+.
T Consensus 164 FGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql---~~If~~lG 238 (323)
T KOG0594|consen 164 FGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL---FRIFRLLG 238 (323)
T ss_pred cchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHHHcC
Confidence 9999966532221 3445689999999999887 6899999999999999999999999876653322 12222221
Q ss_pred c---Ccccc---ccccc-----cccccc--H---HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 N---EKLDD---LVEGD-----MEALND--I---KCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~---~~~~~---~~~~~-----~~~~~~--~---~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. +.... +.+.. ...... . .......+++.+||+.+|.+|.|++.++.+
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 11111 11111 000000 0 111467899999999999999999999987
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.37 Aligned_cols=251 Identities=33% Similarity=0.494 Sum_probs=204.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc-chhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
+.||+|+||.||++........+..++||.++...... .+++.+|++++.+++|+||+++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47999999999999986432347789999997643332 56789999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 604 GTLASFLFGN---------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 604 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 778999999999999999999995 5999999999999999999999999999988765
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
...........++..|+|||.+....++.++||||||++++||++ |..||......+. . .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---L----EYLRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHHcCC------
Confidence 432222334557889999999988889999999999999999999 6999875532211 1 1111100
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
........+..+.+++.+||+.+|.+||++.|++++|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111223578899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.36 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=204.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+.+.+.||+|+||.||++... .++..++||.+.... .....++.+|+.+++.++|+||+++++++.+++..++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeec---CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 4567789999999999999864 356789999876422 1223568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 597 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
+|||+++++|.+++.. ...+++..++.++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999998863 3567899999999999999999995 49999999999999999999999999998876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....++..|+|||++.+..++.++|+||||+++|||++|..||.....+... +.. . +....
T Consensus 157 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~----~-----~~~~~ 224 (267)
T cd08229 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK----K-----IEQCD 224 (267)
T ss_pred ccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hhh----h-----hhcCC
Confidence 433221 22346888999999999888999999999999999999999998643322111 100 0 00000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.+.. ......+.+.+++.+||+.+|.+||||.+|++.++++.
T Consensus 225 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111 11234678899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.85 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=201.0
Q ss_pred HHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecC-C
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-Q 592 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 592 (813)
...+.+.+.||+|+||.||+|.... ....++.||||+++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 4567888999999999999997532 223567899999975322 2234678899999999 689999999988654 4
Q ss_pred ceEEEEeecCCCchhhhhhcc-----------------------------------------------------------
Q 045343 593 NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------- 613 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~----------------------------------------------------------- 613 (813)
..++|+||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999988542
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeeccc
Q 045343 614 --------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR 685 (813)
Q Consensus 614 --------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 685 (813)
..+++..+.+++.||++||+|||+ .+|+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 135778888999999999999995 599999999999999999999999999998754332211122234
Q ss_pred ccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHH
Q 045343 686 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKC 764 (813)
Q Consensus 686 gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (813)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ +. ........... ....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~~~~---------~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTRMRA---------PDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCCCCC---------CCCC
Confidence 5678999999988889999999999999999997 8888864332111 10 11111110000 0012
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 765 VEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 765 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
...+.+++..||+.+|.+||++.||+++|+.+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.13 Aligned_cols=242 Identities=26% Similarity=0.315 Sum_probs=191.2
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeec-cccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|... ..+..||||.++... ....+.+..|..++.. .+|+||+++++++..++..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELK---GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999874 356789999987532 1223344556666654 4899999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~ 152 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence 9999999999888889999999999999999999995 5999999999999999999999999999986543221 1
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ... .... +. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i-~~~~------~~----~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSI-LNDR------PH----F 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HcCC------CC----C
Confidence 33456899999999999988999999999999999999999999754332111 010 0000 00 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMK-KVLQ 791 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 791 (813)
+......+.+++.+||+.||.+||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 112346678999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.23 Aligned_cols=253 Identities=29% Similarity=0.440 Sum_probs=200.8
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+.+.++||+|+||.||+|... +...||+|+++.. ....+++.+|++++++++|+||+++++++.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec----CCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 355788899999999999999764 2346999998753 2234578999999999999999999998754 567999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999753 457899999999999999999995 59999999999999999999999999999876533
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. ......
T Consensus 156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~-------- 219 (262)
T cd05071 156 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG-------- 219 (262)
T ss_pred cccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcC--------
Confidence 2211 122346678999999988889999999999999999999 88888644322110 110000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.......+.++.+.+++.+|++.+|++||++.++++.|+..
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00011223467789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.72 Aligned_cols=241 Identities=26% Similarity=0.319 Sum_probs=191.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeec-cccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|... ..+..||||.++... ......+..|..++.. .+|+||+++++++.+++..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELK---GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 46999999999999874 356789999987532 2233446667777765 4899999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 9999999999888888999999999999999999995 5999999999999999999999999999875322211 1
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ .+ ..... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~----~~~~~------~~~~---- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE----SIRVD------TPHY---- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhC------CCCC----
Confidence 3346689999999999999999999999999999999999999975432211 11 11100 0001
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMK-KVL 790 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 790 (813)
.......+.+++.+||+.||.+||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111346778999999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.19 Aligned_cols=252 Identities=20% Similarity=0.256 Sum_probs=198.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.+.||+|+||+||++... ..++.||||++.... ......+.+|+.++..++|+||+++++.+.+++..++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred ceEEEEEEecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 456789999999999999874 356789999997532 22334578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999999888889999999999999999999995 4999999999999999999999999999876532211
Q ss_pred cc------------------------------------eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 045343 678 KA------------------------------------IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR 721 (813)
Q Consensus 678 ~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~ 721 (813)
.. ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011245899999999999989999999999999999999999
Q ss_pred cCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 045343 722 KSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT---MKKVLQM 792 (813)
Q Consensus 722 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 792 (813)
.||......+.. . ...... .. +.........+.+.+++.+|+. +|.+|++ +.|++++
T Consensus 237 ~Pf~~~~~~~~~---~---~i~~~~--~~-----~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETY---R---KIINWK--ET-----LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHH---H---HHHcCC--Cc-----cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999754432110 0 010000 00 0001111234677888888986 9999998 9888874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.54 Aligned_cols=252 Identities=23% Similarity=0.245 Sum_probs=196.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
|.+.++||+|+||+||++... ..++.||||++.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKK---DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred ceEeEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 456789999999999999874 366789999986432 22345678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999999888888999999999999999999995 5999999999999999999999999999964321100
Q ss_pred c---------------------------------------------ceeecccccccccCcccccCCCCCCccchhhHHH
Q 045343 678 K---------------------------------------------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGV 712 (813)
Q Consensus 678 ~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gv 712 (813)
. .......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246899999999999989999999999999
Q ss_pred HHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCC---CCHHHH
Q 045343 713 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLR---PTMKKV 789 (813)
Q Consensus 713 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ev 789 (813)
++|||++|+.||......+... ...... .. +...........+.+++.+||+ +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~~~--~~-----~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYR------KIINWR--ET-----LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHH------HHHccC--Cc-----cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999997544322110 000000 00 0001111234667889999997 66665 699999
Q ss_pred HHH
Q 045343 790 LQM 792 (813)
Q Consensus 790 l~~ 792 (813)
+++
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.69 Aligned_cols=258 Identities=29% Similarity=0.445 Sum_probs=199.8
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 596 (813)
..+++.+.||+|+||.||+|....+ .....+++|+++... ....+++.+|++++.++ +|+||+++++++.+++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccC-CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 4567789999999999999987532 223457888776432 23345688899999999 89999999999999999999
Q ss_pred EEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 597 VYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
|+||+++++|.+++... ..+++..++.++.||++||+|||+ .+++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 99999999999998643 246888999999999999999995 59999999999999999999
Q ss_pred EEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHH
Q 045343 661 ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 739 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 739 (813)
+||+|||+++....... ......+..|+|||.+.+..++.++||||||++++||+| |..||......+.. .
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~-- 234 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E-- 234 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---H--
Confidence 99999999864321111 111224567999999988889999999999999999998 99998644322111 0
Q ss_pred HHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
..... ............+.+++.+||+.+|++||++.+++++|+++.+-
T Consensus 235 --~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 --KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred --HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01100 00001112345788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.54 Aligned_cols=267 Identities=24% Similarity=0.329 Sum_probs=214.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.++.+.||+|.-|+||++.+. ..+...|+|++.+.. .+...+.+.|-+||+.++||.|+.|++.++.++-.+||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~---~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELR---GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHcCCCCceeEEEEEec---CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 445688999999999999985 345899999997643 33445678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc-
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL- 674 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~- 674 (813)
||||+||+|...++.+ ..+++..++-++..++-||+||| ..|||+|||||+||||.++|++-|+||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999998765 57899999999999999999999 56999999999999999999999999998753310
Q ss_pred --------------------------------Cccc---------------------ceeecccccccccCcccccCCCC
Q 045343 675 --------------------------------NQSK---------------------AIRTAIRGTKGYVAPEWFRNSTI 701 (813)
Q Consensus 675 --------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~l~~~~~ 701 (813)
.... .....++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0000 00123579999999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCC
Q 045343 702 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPS 781 (813)
Q Consensus 702 ~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 781 (813)
+.++|.|+|||++||||.|..||.+...++. +..++...+..+...+.+..+.+||++.|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999987664432 2333444444444446678899999999999999
Q ss_pred CCCC----HHHHHHH--Hhc----CcCCCCCCC-CCCC
Q 045343 782 LRPT----MKKVLQM--LEG----VVEVSLPPN-PYPF 808 (813)
Q Consensus 782 ~RPt----~~evl~~--L~~----~~~~~~p~~-p~~~ 808 (813)
+|.- +.||.++ .++ ++....||. |.+.
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~ 415 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV 415 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence 9998 8888765 233 444444544 5544
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.15 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=199.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+++.++||+|+||.||+|... ++..+|+|.++... ...+.+.+|+.++++++|+|++++++++. ....++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 345778899999999999999764 44569999987532 23467899999999999999999999885 4568999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999998753 4578999999999999999999954 8999999999999999999999999999876433
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+. .... ...
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~-------- 219 (260)
T cd05070 156 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQV----ERG-------- 219 (260)
T ss_pred cccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----HcC--------
Confidence 2111 122335668999999988889999999999999999999 8888865432211 1111 000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
.........+..+.+++.+|++.+|.+|||+.++.+.|++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001112335678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.80 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=203.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+++.+.||+|+||.||+|.. .++.|+||.++.... ..+++.+|+.++++++|+||+++++++......++|+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4567789999999999999986 467899999976533 4567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999997654 68999999999999999999995 499999999999999999999999999998764321
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
. ....+..|+|||.+....++.++||||||++++||++ |..||.....+. +. ..........
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~~----- 219 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PHVEKGYRME----- 219 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhcCCCCC-----
Confidence 1 2234668999999988889999999999999999997 999886443221 11 1111110000
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.....++.+.+++.+||+.+|.+||++.|++++|+.+
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 ----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112357788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.45 Aligned_cols=274 Identities=24% Similarity=0.398 Sum_probs=206.5
Q ss_pred HHhhcccccceeeeeeEEEEEEecc-CCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeec--CCce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTT-RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~-~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 594 (813)
..+.+.+.||+|+||.||++..... ...+..+|||.++..... ..+++.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 3456678999999999999987532 345788999999754332 35679999999999999999999999877 5578
Q ss_pred EEEEeecCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
++|+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997654 68999999999999999999995 599999999999999999999999999998876
Q ss_pred cCcccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... ......++..|+|||.+.+..++.++||||||++++||++|+.|+............. .........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHHH
Confidence 332211 1112335567999999988889999999999999999999999886432211000000 00000000000011
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
...........++..+.+++.+||+.+|.+|||+.||+++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111223457789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.34 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=196.7
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCC
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
+||+|+||.||+|.+... ..+..||||.+..... ...+++.+|+.++++++|+||+++++++. .+..++|+||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~-~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecC-CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 489999999999987432 2456799999865432 22356889999999999999999999885 45789999999999
Q ss_pred chhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce-ee
Q 045343 605 TLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-RT 682 (813)
Q Consensus 605 sL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 682 (813)
+|.+++.. ...+++..+++++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......... ..
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999975 4578999999999999999999995 4999999999999999999999999999986544322111 11
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
...++..|+|||.+.+..++.++||||||+++||+++ |..||......+.. ....... ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~---------~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGK---------RLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCC---------CCCCC
Confidence 1224578999999988889999999999999999996 99998754332211 1111111 01111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
..+.+.+.+++..||+.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23457888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.43 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=195.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||+||++... ..++.+|||+++.... ...+.+..|+.++.++ +|+||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK---KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 46999999999999874 3567899999975321 2234577888888888 699999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-- 152 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--
Confidence 9999999999887889999999999999999999995 49999999999999999999999999998753322111
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....................... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~-- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IRI-- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CCC--
Confidence 3345699999999999999999999999999999999999999964332211111111111111111 110
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTM------KKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 792 (813)
+......+.+++.+||+.||.+|+++ .+++++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11234667899999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.44 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=192.5
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|+||.||+|.... ......+++|+++.... .....+.+|+.++++++|+||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcC-CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 469999999999998743 33456799998865432 2334688899999999999999999999999999999999999
Q ss_pred Cchhhhhhcc-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 604 GTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 604 gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+|.+++... ...++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999999643 245677888999999999999995 59999999999999999999999999999764433221
Q ss_pred ceeecccccccccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNS-------TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~-------~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
.......++..|+|||++... .++.++||||||+++|||++ |+.||......+... . .. .+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~---~~-~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y---TV-REQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H---Hh-hcccCC
Confidence 112234577889999998642 35789999999999999996 999996543222110 0 00 111111
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
+.++.... ...+.+.+++..|+ .+|++|||++||++.|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222111 22456778999998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.97 Aligned_cols=265 Identities=24% Similarity=0.378 Sum_probs=201.0
Q ss_pred HHhhcccccceeeeeeEEEEEEec-------------cCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILT-------------TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~-------------~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 584 (813)
..+.+.++||+|+||.||++.... ...+...+|+|+++... .....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 346788999999999999985421 12244579999987542 2234578999999999999999999
Q ss_pred EeEeecCCceEEEEeecCCCchhhhhhccC-----------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 585 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999986532 35678899999999999999995 4999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCCCcccchh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE 731 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt--G~~p~~~~~~~~ 731 (813)
|++.++.++|+|||+++.+.............++..|+|||......++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999987643322111222334678999999888889999999999999999998 667776433222
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
.. ................ .....++..+.+++.+||+.||.+||++.||++.|++
T Consensus 242 ~~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VI---ENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1011111110000000 0112245788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.08 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=199.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
++..+.||+|+||+||++... .++..||||+++... ......+.+|+.++++++|+||+++++.+..++..++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEc---CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 566789999999999999874 356789999986432 12234577899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999888643 468999999999999999999995 49999999999999999999999999999875432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... +..........
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~-------- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ-------- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc--------
Confidence 21 22346899999999999888999999999999999999999999754332111 00011000000
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
..........+.+++..||+.||.+|| ++++++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001123456788999999999999999 88899765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.37 Aligned_cols=247 Identities=25% Similarity=0.297 Sum_probs=196.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecccc-CCcceEEeEeecCCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~l 596 (813)
+.+.+.||+|+||.||+|... ..++.||||+++... ....+.+..|.+++..++| ++|+++++++.+.+..++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 467789999999999999874 356789999987532 2234567788888888876 568889999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999999888888999999999999999999995 499999999999999999999999999987533221
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ..... .
T Consensus 156 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~----i~~~~--------~ 218 (324)
T cd05587 156 KT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QS----IMEHN--------V 218 (324)
T ss_pred Cc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HH----HHcCC--------C
Confidence 11 23456899999999999999999999999999999999999999754322111 10 01100 0
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTM-----KKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 792 (813)
. ........+.+++.+||+.||.+|++. .+++++
T Consensus 219 ~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 S--YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred C--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 011234678899999999999999976 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=313.75 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=209.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCc-eE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-RL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~ 595 (813)
..|+..+.+|+|+||.++..... .+...+++|++.... ....+....|+.++++++|||||.+.+.+.+++. .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk---~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK---SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc---cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 35677899999999999987664 466789999986532 2333457889999999999999999999999988 99
Q ss_pred EEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 596 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
|||+|++||+|.+.+... ..++++.+.+++.|++.|+.|||+ ..|+|||||+.|||++.+..+||.|||+|+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999999764 467899999999999999999995 499999999999999999999999999999988
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
+.... .....||+.|+.||.+.+.+|..|+|||||||++|||++-+++|....... +. .. +..
T Consensus 158 ~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li---~k---------i~~ 220 (426)
T KOG0589|consen 158 PEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI---LK---------INR 220 (426)
T ss_pred Cchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH---HH---------Hhh
Confidence 76532 456789999999999999999999999999999999999999998654321 11 11 111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ..+.+..+..++..++..|++.+|..||++.+++.+
T Consensus 221 ~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 122334567889999999999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.23 Aligned_cols=254 Identities=26% Similarity=0.507 Sum_probs=195.0
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeec-CCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~ 602 (813)
+.||+|+||.||+|...........+|||++.... ....+.+.+|+.+++.++|+||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999976544556789999985432 2234578889999999999999999998754 456889999999
Q ss_pred CCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc--
Q 045343 603 NGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-- 679 (813)
Q Consensus 603 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 679 (813)
+++|.+++... ..+++..+..++.||++||+|||+ .+++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 456788889999999999999995 499999999999999999999999999997654321111
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
......++..|+|||.+.+..++.++||||||+++|||++| ..|+......+ +... ...... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~---~~~~~~---~------- 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY---LLQGRR---L------- 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---HhcCCC---C-------
Confidence 01123457789999999888899999999999999999995 45554322111 1111 111100 0
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
......+..+.+++..||+.+|++||++.||++.|+.+.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001123467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=320.09 Aligned_cols=268 Identities=19% Similarity=0.214 Sum_probs=203.5
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
.+....|++.++||+|+||.||++... +...+..|+||.+... +...+|++++++++|+||+++++++......
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~-~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKH-GDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEc-CCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 344456888899999999999999753 2335678999987542 3456899999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++|||++. ++|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999986 6888888777789999999999999999999995 4999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc-----
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD----- 749 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----- 749 (813)
...........||..|+|||++.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 433222334579999999999999999999999999999999999999997543321111101111111100000
Q ss_pred ---------cc---cccccccc---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 ---------DL---VEGDMEAL---NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ---------~~---~~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ..+..... ........+.+++.+||+.||++|||+.|++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000000 001224567889999999999999999999987
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=329.46 Aligned_cols=252 Identities=24% Similarity=0.308 Sum_probs=199.8
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCC----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ---- 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---- 592 (813)
..|.+.+.||+|+||+||++... .+++.||||.+... .......+.+|+.++..++|+||+++...+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRV---SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEc---CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 35778899999999999999864 35779999998643 2233456788999999999999999988764432
Q ss_pred ----ceEEEEeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEe
Q 045343 593 ----NRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 664 (813)
Q Consensus 593 ----~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 664 (813)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 267999999999999998643 467899999999999999999995 599999999999999999999999
Q ss_pred eccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 665 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .... .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~~-~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHKT-L 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH-h
Confidence 99999876543332223446799999999999998999999999999999999999999975432211 1111 1
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...... ........+.+++..||+.||.+||++.+++++
T Consensus 259 ~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111110 111345678899999999999999999999875
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.87 Aligned_cols=247 Identities=24% Similarity=0.299 Sum_probs=195.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 596 (813)
+++.+.||+|+||.||+|... ..+..+|||.++... ....+.+..|..++..+ +|++|+++++++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 456789999999999999874 356789999987532 12233456677777766 58999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999999999888889999999999999999999995 499999999999999999999999999997543222
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .. ..
T Consensus 156 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~i~----~~--------~~ 218 (323)
T cd05616 156 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QSIM----EH--------NV 218 (323)
T ss_pred Cc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---HHHH----hC--------CC
Confidence 11 23456899999999999999999999999999999999999999754432111 1110 11 00
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTM-----KKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 792 (813)
. .+......+.+++.+||+.+|.+|++. .++.++
T Consensus 219 ~--~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 A--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred C--CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0 011235678899999999999999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=310.14 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=201.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.+.||+|+||.||++... ..+..+++|.++... .....++.+|++++.+++|+||+++++++.+++..++|+|
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHR---PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEc---CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 456789999999999999874 356788999876432 2223568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+++.....+++..+..++.|+++||.|||+ ..+++|+||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 99999999999888888999999999999999999995 2489999999999999999999999999987654321
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC-c-----------
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE-K----------- 747 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~----------- 747 (813)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...................... .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 233568899999999988889999999999999999999999986443221111000000000000 0
Q ss_pred ---------ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 748 ---------LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 748 ---------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
...+................+.+++.+||+.+|++||++.+|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000000112345789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.30 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=195.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||++... .++..+|||.++... ......+..|..++..+ +|+||+++++++...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELK---GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999874 356789999987532 22334567788888777 799999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|..++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 9999999999888889999999999999999999995 59999999999999999999999999998753322211
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........ . .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------~~i~~~~~--------~--~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------QSILEDEV--------R--Y 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCC--------C--C
Confidence 23346899999999999999999999999999999999999999754322111 11111100 0 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTM-----KKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 792 (813)
.......+.+++.+||+.||.+||++ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11235678899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=318.09 Aligned_cols=251 Identities=22% Similarity=0.241 Sum_probs=199.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.+.||+|+||+||++... ..+..+|||+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred ceEEEEEEeccCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 567789999999999999874 3567899999875322 2345688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++|+|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999999775 678999999999999999999995 599999999999999999999999999998765433
Q ss_pred ccceeecccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFR------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~------~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... ...........
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~ 229 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRFLK 229 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCccC
Confidence 22 123346899999999986 456778999999999999999999999754332110 11111110000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+........+.+++..|++ +|.+||++.+++++
T Consensus 230 -------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 -------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01111235678889999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.94 Aligned_cols=245 Identities=24% Similarity=0.276 Sum_probs=192.6
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheee---eeeccccCCcceEEeEeecCCceE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV---VIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
.+.+.||+|+||.||+|... .+++.||||+++... ....+.+..|++ ++++++|+||+++++++...+..+
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 46789999999999999874 356789999997532 122234555554 456778999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++++|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999999988754 468999999999999999999995 59999999999999999999999999998754322
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..... ..
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~-~~-------- 217 (324)
T cd05589 155 GDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVN-DE-------- 217 (324)
T ss_pred CCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CC--------
Confidence 211 23456899999999999989999999999999999999999999754332111 00000 00
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.. ........+.+++.+||+.||.+|| ++.+++++
T Consensus 218 ~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 VR--YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00 0112356788999999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.17 Aligned_cols=238 Identities=26% Similarity=0.276 Sum_probs=189.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheee-eeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||+||+|... .+++.||||++..... ...+++..|.. +++.++|+||+++++.+.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 46999999999999874 4678899999865321 12234444544 46778999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 9999999999888889999999999999999999995 4999999999999999999999999999875432211 1
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...... . ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~-~--------~~~~-- 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNILN-K--------PLRL-- 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHHc-C--------CCCC--
Confidence 3345689999999999998999999999999999999999999975432211 001110 0 0110
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMK 787 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 787 (813)
.......+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112356788999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.71 Aligned_cols=260 Identities=26% Similarity=0.343 Sum_probs=197.8
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCC-----ce
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NR 594 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~ 594 (813)
++.++||+|+||.||++... .++..||||++..... ...+++.+|+.+++.++|+||+++++++...+ ..
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDP---RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred cccceeeeCCCEEEEEEEEC---CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 45688999999999999864 3577899999864321 23456889999999999999999999998776 78
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++|+||+. ++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999986 5788888777889999999999999999999995 5999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc---
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD--- 750 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 750 (813)
..... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+...........
T Consensus 156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 156 DESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD---LITDLLGTPSLEAMRS 231 (372)
T ss_pred Ccccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCCHHHHHH
Confidence 32221 2334578999999998774 47899999999999999999999997654322111 0111100000000
Q ss_pred --------cc----cc-ccc--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 751 --------LV----EG-DME--ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 751 --------~~----~~-~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+. .+ ... ........+.+.+++.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 00 000 00011235678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.00 Aligned_cols=250 Identities=29% Similarity=0.447 Sum_probs=194.5
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 602 (813)
+.||+|+||.||+|.+..+. ....+++|.++... ....+.+.+|++++.++ +|+||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 46899999999999885321 22457888886432 23345788999999999 79999999999999999999999999
Q ss_pred CCchhhhhhccC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeec
Q 045343 603 NGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 666 (813)
Q Consensus 603 ~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 666 (813)
+++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 999999986432 46789999999999999999995 59999999999999999999999999
Q ss_pred cCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 667 GLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
|+++....... ......+..|+|||++....++.++||||||++++||++ |..||......+. . .....
T Consensus 157 gl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~----~~~~~ 226 (270)
T cd05047 157 GLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y----EKLPQ 226 (270)
T ss_pred CCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---H----HHHhC
Confidence 99863321111 111224567999999988889999999999999999997 9999864322111 0 11111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.. ...........+.+++.+|++.+|.+|||+.++++.|++++
T Consensus 227 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 00011123457889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.76 Aligned_cols=266 Identities=25% Similarity=0.372 Sum_probs=204.1
Q ss_pred HHHhhcccccceeeeeeEEEEEEec-cCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecC--Cc
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QN 593 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 593 (813)
..++.+.++||+|+||.||++.... ....+..||+|.++... ....+.+.+|++++++++|+||+++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3456778899999999999997642 23467789999986432 22345789999999999999999999998775 56
Q ss_pred eEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 88999999999999999654 457999999999999999999995 49999999999999999999999999999876
Q ss_pred ccCccc-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh---------hhhhHHHHHHh
Q 045343 673 TLNQSK-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE---------YAILTDWAFDC 742 (813)
Q Consensus 673 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~---------~~~l~~~~~~~ 742 (813)
...... .......++..|+|||.+.+..++.++||||||+++|||++++.|........ ....... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-VRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-HHH
Confidence 543221 11223456778999999988889999999999999999999876643221100 0000000 000
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.... .........+..+.+++.+||+.+|.+||+++++++.|+++
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 00111123467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.69 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=194.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.++||+|+||+||+|... ..++.+|||++.... ......+.+|+.++++++|+||+++++.+.+++..++|
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKV---DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEEC---CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 456789999999999999874 356789999986532 22345688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999999887788999999999999999999995 4999999999999999999999999999753321000
Q ss_pred ---------------------------------------------cceeecccccccccCcccccCCCCCCccchhhHHH
Q 045343 678 ---------------------------------------------KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGV 712 (813)
Q Consensus 678 ---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gv 712 (813)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999999999999999999
Q ss_pred HHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 045343 713 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT---MKKV 789 (813)
Q Consensus 713 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev 789 (813)
++|||++|+.||......+... ...... .....+........+.+++.+++ .+|.+|++ +.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQM------KVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHH------HHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999997544321110 000000 00000111122455667776665 49999997 8887
Q ss_pred HHH
Q 045343 790 LQM 792 (813)
Q Consensus 790 l~~ 792 (813)
+++
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=309.65 Aligned_cols=255 Identities=28% Similarity=0.348 Sum_probs=212.1
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc---chhhhheeeeeeccc-cCCcceEEeEeec
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTH-HKNLVRLLGFCDE 590 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 590 (813)
+-....|++.++||+|.||.||++.... ++..+|+|.+.+..... ...+.+|+.+|++++ |||||.+.+.+++
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 3344567888999999999999998853 47889999997654433 357899999999998 9999999999999
Q ss_pred CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC----CCCEEEeec
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD----YYNARISDF 666 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Df 666 (813)
....++|||++.+|.|.+.+... .+++.....++.||+.++.|||. .+|+||||||+|+|+.. ++.+|++||
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999999999776 48999999999999999999994 69999999999999963 357999999
Q ss_pred cCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 667 GLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
|++...... ......+||+.|+|||++....++..+||||+||++|.|++|.+||.......... .....
T Consensus 184 Gla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~ 253 (382)
T KOG0032|consen 184 GLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG 253 (382)
T ss_pred CCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC
Confidence 999988762 22567889999999999999999999999999999999999999998776433221 11111
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ......-....+.+.++++.++..||.+|+|+.+++++
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 11111222457788999999999999999999999997
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=300.01 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=190.1
Q ss_pred cccceeeeeeEEEEEEeccC---------CcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 525 EEVGRGSFGIVYKGVILTTR---------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~---------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+.||+|+||.||+|.+..+. .....|++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999864221 123468889876544444557888999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC-------EEEeecc
Q 045343 596 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-------ARISDFG 667 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~-------~kl~DfG 667 (813)
+|+||+++++|..++... ..+++..+++++.||++||+|||+ .+|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988753 568999999999999999999995 59999999999999986654 8999999
Q ss_pred CccccccCcccceeecccccccccCccccc-CCCCCCccchhhHHHHHHHHH-hCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+......+...+ ..
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--------~~ 223 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--------YE 223 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--------Hh
Confidence 98765322 2234788899999886 456889999999999999998 58887754322111100 00
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
... .. .......+.+++.+||+.||.+||++.+|++.|+
T Consensus 224 ~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 00 0112457889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.59 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=200.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccch--hhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.+.||+|+||+||++... .++..+|+|.+......... ....|+.++++++|+||+++++++.+....++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK---KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET---TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC---CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccc
Confidence 467889999999999999885 35678999999765332222 2345999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++.....+++..+..++.||++||.+||+. +|+|+||||+||+++.++.++|+|||.+...... .
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~ 152 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--N 152 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--T
T ss_pred cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--c
Confidence 9999999999999778889999999999999999999964 9999999999999999999999999999864211 1
Q ss_pred ceeecccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.......++..|+|||++. +...+.++||||+|+++++|++|+.|+................. ... .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-------~~~-~~~~~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-------RPL-PSSSQ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-------THH-HHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-------ccc-ccccc
Confidence 1234566899999999998 78899999999999999999999999986522111111100000 000 00000
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++..||+.||++||++.+++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000113789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.57 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=201.2
Q ss_pred HHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+++.++||+|+||.||++..... ......+|+|.++... ....+++.+|+.++++++|+||+++++++.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 4466778999999999999986421 2356789999986532 223456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcc----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 596 LVYEFLNNGTLASFLFGN----------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
+|+||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhhe
Confidence 999999999999998632 236788889999999999999995 4999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY 732 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 732 (813)
++++++.++|+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |..||.....++.
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876543321111122234667999999988899999999999999999998 8888864332211
Q ss_pred hhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 733 AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 733 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
. .....+.... .....+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 242 ------~-~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 ------I-YYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------H-HHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1111111110 011235678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.89 Aligned_cols=253 Identities=19% Similarity=0.255 Sum_probs=197.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+++.+.||+|+||.||++... ..+..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 45677889999999999999874 356789999986421 122345788999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999998654 57888999999999999999995 59999999999999999999999999999876433
Q ss_pred cccceeecccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
.... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......... ........
T Consensus 196 ~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~---- 264 (370)
T cd05621 196 GMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKN---- 264 (370)
T ss_pred Ccee-cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCc----
Confidence 2211 23456999999999987643 778999999999999999999999754322110 01110000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSL--RPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 792 (813)
.+..+........+.+++..|++.++.+ |+++.|++++
T Consensus 265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111112233567788889999765543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.50 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=202.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEecc----CCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTT----RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 591 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 591 (813)
...+.+.++||+|+||.||++..... ......+|+|.++... .....++..|++++.++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 34566789999999999999975321 1245678999887432 22345688899999999 699999999999998
Q ss_pred CceEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 655 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll 655 (813)
...++|+||+++|+|.+++... ..+++..+.+++.||+.||.|||+ .+++|+||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 8999999999999999998643 347889999999999999999995 499999999999999
Q ss_pred cCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhh
Q 045343 656 DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 734 (813)
Q Consensus 656 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 734 (813)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~- 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF- 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999987643222111112234567999999988889999999999999999999 88888644322211
Q ss_pred hHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 735 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.......... .....+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 247 ------~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 ------KLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ------HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111111000 112335678899999999999999999999999988663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.53 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=206.3
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
....+++.++||+|+||+||++... ..+..+|+|++.... ....+++.+|+++++.++|+||+++++++......+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHI---PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEc---CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 4456778899999999999999874 356789999876432 233467889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++++|.+++.....+++.....++.+++.+|.|||+ ..+++|+||||+||++++++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999999999877788999999999999999999995 247999999999999999999999999998754322
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh-----hhhhHHHHHHhhccCcccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~ 750 (813)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+ ...+........
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 226 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV------- 226 (284)
T ss_pred c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-------
Confidence 1 223468999999999988889999999999999999999999997544321 111111111111
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
............+..+.+++.+|++.||.+||++.||+++.
T Consensus 227 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 --QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111112456788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=296.69 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=195.7
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
+.||+|+||.||+|... ++..+|+|.++..... ....+.+|++++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 46999999999999863 5678999988654322 234688999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceee
Q 045343 604 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682 (813)
Q Consensus 604 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 682 (813)
++|.+++... ..+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SG 152 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CC
Confidence 9999998653 457899999999999999999995 499999999999999999999999999997644322111 11
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
...++..|+|||++.+..++.++||||||+++||+++ |..||......... . ....... ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~----~~~~~~~---------~~~~ 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---E----QVEKGYR---------MSCP 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---H----HHHcCCC---------CCCC
Confidence 2234568999999998889999999999999999998 99998654322110 0 0111000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.64 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=196.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
|.+.++||+|+||.||++... ..++.+|||.+.... ......+.+|+.++++++|+||+++++.+.+++..++|
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKV---DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEEC---CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 567789999999999999874 357889999986432 12335578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999999888888999999999999999999995 4999999999999999999999999999753321000
Q ss_pred -----------------------------------------cceeecccccccccCcccccCCCCCCccchhhHHHHHHH
Q 045343 678 -----------------------------------------KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLE 716 (813)
Q Consensus 678 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~e 716 (813)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000113469999999999999999999999999999999
Q ss_pred HHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 045343 717 IISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP---TMKKVLQM 792 (813)
Q Consensus 717 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 792 (813)
|++|+.||......+... ....... .............+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~~~~------~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQL------KVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHH------HHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997654322111 0000000 0000111123456677777765 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=299.26 Aligned_cols=248 Identities=27% Similarity=0.360 Sum_probs=201.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+.||+|++|.||++... .++..+++|.+... .....+++.+|++++++++|+||+++++++.+++..++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRK---ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEc---CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 456789999999999999874 35678999988642 2334567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++++|.+++... ..+++..++.++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999999764 567899999999999999999995 599999999999999999999999999988765432
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....++..|+|||++.+..++.++|+||||++++||++|+.||........ . .....+....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~~~~~~------ 220 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---I----LKIIRGVFPP------ 220 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHcCCCCC------
Confidence 21 2334578899999999998899999999999999999999999975442111 0 0011111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.+|++||++.+++++
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 ---VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=301.56 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=205.4
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
....+.+.++||+|+||.||+|...........|+||...... ....+.+.+|+.++++++|+||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 4455678899999999999999875443345679999886543 2334578999999999999999999999865 5578
Q ss_pred EEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|+||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999764 457999999999999999999995 5999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
..... .....++..|+|||.+....++.++||||||++++||++ |..||......+.. .. . .... ..
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~---~-~~~~--~~-- 227 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GR---I-ENGE--RL-- 227 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH---H-HcCC--cC--
Confidence 32211 122334568999999988889999999999999999996 99999754332211 00 0 0000 00
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
......+..+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111335678899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=302.19 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=195.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.+.||+|+||.||+|... ..+..+|+|.+... .....+++.+|++++++++|+||+++++++...+..++|+|
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHL---LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred chheeeeccCCCeEEEEEEEc---CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 456789999999999999874 35678999998643 22234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99999997553 46788889999999999999995 499999999999999999999999999998654322
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....................... .+.+
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--- 220 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL--- 220 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC---
Confidence 2335689999999999988899999999999999999999999965332111100000001100000 0000
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+|++.+|.+||+++|++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111234678899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=298.23 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=198.7
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+++.++||+|++|.||++... ....+++|.+... ....+.+.+|+.++++++|+|++++++++. .+..++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWN----GTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEc----CCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 345777889999999999999874 3346899987643 223456889999999999999999999875 4568899
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999999754 347899999999999999999995 48999999999999999999999999999876433
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....++..|+|||.+.+...+.++||||||+++|||++ |+.||......+. .... ... ..
T Consensus 156 ~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~-~~----- 221 (260)
T cd05069 156 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV----ERG-YR----- 221 (260)
T ss_pred cccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC-CC-----
Confidence 2111 122346678999999988889999999999999999999 8988875432211 1111 000 00
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
.......+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00111345778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=301.73 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=188.7
Q ss_pred ccceeeeeeEEEEEEecc---------------------CCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceE
Q 045343 526 EVGRGSFGIVYKGVILTT---------------------RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~---------------------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 584 (813)
.||+|+||.||+|.+..+ ......|++|.+.........++.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999986421 12234689998865444344578889999999999999999
Q ss_pred EeEeecCCceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----
Q 045343 585 LGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---- 659 (813)
Q Consensus 585 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~---- 659 (813)
+++|.+....++||||+++|+|..++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 4678999999999999999999995 5999999999999997543
Q ss_pred ---CEEEeeccCccccccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHH-hCCcCCCcccchhhhh
Q 045343 660 ---NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAI 734 (813)
Q Consensus 660 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~ell-tG~~p~~~~~~~~~~~ 734 (813)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999998654321 12346788999998865 56889999999999999995 6898886543322111
Q ss_pred hHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 735 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
. .... ... . ......+.+++.+||+.+|++||++.+|++.|.
T Consensus 233 ---~----~~~~--~~~-----~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 ---F----YEKK--HRL-----P----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---H----HHhc--cCC-----C----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 0000 000 0 011246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=298.89 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=197.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee-cCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD-EGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV 597 (813)
..+.+.+.||+|+||.||++.. .+..+++|.++.. ...+.+.+|+.++++++|+|++++++++. +++..++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 4567789999999999999976 4667899988643 23457889999999999999999999764 55678999
Q ss_pred EeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999987543 47899999999999999999995 49999999999999999999999999998765432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||....... +... ...+...
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~~----- 218 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM----- 218 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcCCCC-----
Confidence 2 12234568999999998889999999999999999998 998886432211 1111 1111000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
......+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01113457788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=305.33 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=201.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.++||+|++|.||+|... ..+..+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEEC---CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4566788999999999999863 3567899999876544445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+++.. ..+++..+..++.|++.||+|||. .+|+|+||||+||+++.++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 9999999999864 357899999999999999999995 49999999999999999999999999998865433221
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....+++.|+|||.+.+...+.++|||||||++|||++|+.||.......... ...... ... . .
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~~~~~~-~~~-----~--~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG-TPE-----L--Q 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------HHhcCC-CCC-----C--C
Confidence 223458889999999998888999999999999999999999997544321110 000000 000 0 0
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.+|++||++.||+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 112334678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=299.03 Aligned_cols=255 Identities=31% Similarity=0.476 Sum_probs=203.9
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+....+.+.++||+|+||.||++... +...++||.++.. ....+++.+|+.++++++|+||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 34456778899999999999999864 3467999998753 234567899999999999999999999999889999
Q ss_pred EEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 596 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999999999764 3689999999999999999999954 89999999999999999999999999998765
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... ......+..|+|||.+.+..++.++||||||++++||++ |+.||......... .... .. .
T Consensus 155 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~---~~--~---- 221 (261)
T cd05034 155 DDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---EQVE---RG--Y---- 221 (261)
T ss_pred chhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH---cC--C----
Confidence 322111 112234568999999998889999999999999999999 99998644322111 1100 00 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
........+..+.+++.+|++.+|.+||+++++++.|+.
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000111225678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.07 Aligned_cols=240 Identities=25% Similarity=0.275 Sum_probs=189.8
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheee-eeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||+||++... .++..+|||++.... ....+++..|.. +++.++|+||+++++.+..++..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 46999999999999864 367889999986532 122334555554 46778999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|..++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 152 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-- 152 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC--
Confidence 9999999999888889999999999999999999995 59999999999999999999999999998754322111
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+. ...... .. +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~-~~--------~~~-- 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILH-KP--------LVL-- 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHc-CC--------ccC--
Confidence 2345689999999999999999999999999999999999999975432211 011111 10 000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 789 (813)
.......+.+++.+|++.+|.+||++.+.
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 11234667899999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=298.67 Aligned_cols=251 Identities=21% Similarity=0.277 Sum_probs=200.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-----ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+...+.||+|++|.||++... ..+..+++|.+..... ...+.+.+|++++++++|+||+++++++.+++..+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~---~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDV---DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred ccccceecCCCceEEEEEEEc---CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 456789999999999999864 3567899998864321 12346888999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+|+||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999999887788999999999999999999995 49999999999999999999999999999865432
Q ss_pred cccce-eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAI-RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
..... .....++..|+|||++.+..++.++||||||+++|||++|+.||......... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~------ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQPTN------ 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccCCC------
Confidence 21110 12345788999999999988999999999999999999999998644322110 011010000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..........+.+++.+||+.+|.+|||+.+++++
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112345678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=307.15 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=199.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCc-ceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTS-TTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
++..+.||+|+||.||+|....+... ...+|+|.+..... ....++.+|+.++++++|+||+++++++... ...+++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 34567899999999999987543221 23578888764322 2233688899999999999999999998754 467999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999998764 367899999999999999999995 4999999999999999999999999999987654332
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .. ..... ...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~----~~~~~--~~~---- 231 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DL----LEKGE--RLP---- 231 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHCCC--CCC----
Confidence 211222345678999999998889999999999999999998 88988654322211 11 11110 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
....+...+.+++..||..+|++||++.++++.|+.+.+-
T Consensus 232 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 ---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0112345788999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.66 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=196.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+|.+.++||+|+||.||+|... ..+..||||.++.... .....+.+|+.++++++|+||+++++++..++..++||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred ceEEEEEecccCCEEEEEEEec---CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 4667789999999999999874 3567899999875432 22345778999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++ +|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99985 777777544 457889999999999999999995 4999999999999999999999999999976543221
Q ss_pred cceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH--------HhhccC-c
Q 045343 678 KAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNE-K 747 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~-~ 747 (813)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ...... .
T Consensus 160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1 223457889999998865 467899999999999999999999997654322211110000 000000 0
Q ss_pred ccccccccccc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEA----LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....-.+.... .........+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 0011234677899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.67 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=191.2
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
||+|+||.||++... ..+..+|+|++.... ....+.+..|++++++++|+||+++++.+.++...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVK---NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEc---cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 799999999999874 357889999986421 11233456799999999999999999999999999999999999
Q ss_pred Cchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 604 GTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 604 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++........ .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~ 151 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---I 151 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---e
Confidence 9999888543 357889999999999999999995 5999999999999999999999999999987653321 2
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ......... . .... ..
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~-~--------~~~~-~~ 219 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLE-D--------EVKF-EH 219 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhc-c--------cccc-cc
Confidence 3356899999999999888999999999999999999999999753321110 011111110 0 0000 01
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
......+.+++..||+.||++||++.|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 123567899999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=299.06 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=201.5
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+..+.+.+.++||+|+||.||++... ....+++|.++.. ....+.+.+|+.++++++|+||+++.+++.+ ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec----CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 44566788899999999999999764 3456999987643 2234578899999999999999999999887 7789
Q ss_pred EEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 596 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 999999999999999753 457888999999999999999995 499999999999999999999999999997654
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....++..|+|||.+....++.++|+||||+++|++++ |+.||....... +.... ....
T Consensus 154 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~----- 220 (260)
T cd05073 154 DNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGY----- 220 (260)
T ss_pred CCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCC-----
Confidence 322111 222345678999999988889999999999999999999 898986543211 11111 1100
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
........+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 221 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 ----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000111335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=312.02 Aligned_cols=241 Identities=26% Similarity=0.302 Sum_probs=189.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhhee-eeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEV-VVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||++... .++..+|+|.+.... .....++..|. .+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHK---AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 46999999999999874 356789999986432 11223344443 356778999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++++|.+++.....+.+.....++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~-- 152 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-- 152 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC--
Confidence 9999999999888888888999999999999999995 59999999999999999999999999999754322211
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... .. ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~---~i~-~~--------~~~--~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---D---NIL-NK--------PLQ--L 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---H---HHH-hC--------CcC--C
Confidence 33456999999999999999999999999999999999999999754322110 0 000 00 000 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 790 (813)
.......+.+++.+||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 112356788999999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.42 Aligned_cols=241 Identities=25% Similarity=0.306 Sum_probs=192.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccc-cCCcceEEeEeecCCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 596 (813)
+++.+.||+|+||.||++... .++..||||+++... ....+.+..|..++..+. |++|+++.+++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 467789999999999999874 357789999987532 223345677888888775 5778889999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999999888889999999999999999999995 499999999999999999999999999987543222
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .. ..
T Consensus 156 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~----~~--------~~ 218 (323)
T cd05615 156 VT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQSIM----EH--------NV 218 (323)
T ss_pred cc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hC--------CC
Confidence 11 2345689999999999998899999999999999999999999975433211 11110 00 00
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTM 786 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 786 (813)
. ........+.+++.+||+.+|.+|++.
T Consensus 219 ~--~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 S--YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C--CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 011234677899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.74 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=210.7
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
.+.|+||+|.||.|++|.+....++...||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....||+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3458999999999999999887777788999999865443 56789999999999999999999999887 788999999
Q ss_pred cCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 601 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 601 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
++.|||.+.|+.. ..+.......++.|||.||.||. ++++|||||..+|+||-....+||+|||+.+-+..++..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999999863 45678888899999999999999 569999999999999999999999999999988766554
Q ss_pred ceeec-ccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 679 AIRTA-IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 679 ~~~~~-~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
..+.. ..-...|.|||.+...+++.++|||+|||.+|||+| |..|+-+..+... -+.+|...
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----------------L~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----------------LKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------------HHhccccc
Confidence 43333 335678999999999999999999999999999999 7788765443211 11223233
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
+......+++.++++++.||..+|.+|||+..|.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3334556899999999999999999999999997443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.71 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=201.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.++||+|+||.||+|... ..+..+|+|.++.........+.+|+.+++.++|+||+++++.+..++..++|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV---NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc---CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35677789999999999999874 356789999987544444456788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++.....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999998888899999999999999999999954 9999999999999999999999999998765432211
Q ss_pred ceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....|+..|+|||++. ...++.++|||||||++|||++|+.|+.......... . . .... ...+.
T Consensus 163 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~--~----~-~~~~---~~~~~ 230 (267)
T cd06645 163 --RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L----M-TKSN---FQPPK 230 (267)
T ss_pred --cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH--h----h-hccC---CCCCc
Confidence 23456899999999874 4457889999999999999999999986433211110 0 0 0000 00000
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ........+.+++.+||+.+|++||++++|+++
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 011234568899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=301.51 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=205.1
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCC-cceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRT-STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
...+++.+.||+|+||.||+|....+.. ....+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3556778999999999999998754322 234689998865432 234578899999999999999999999987 7889
Q ss_pred EEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|+||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999764 468999999999999999999995 5999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
...........++..|+|||.+....++.++|+||||++++|+++ |+.||.....++.. .. ..... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~--~~-- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---DL----LEKGE--RL-- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH----HhCCC--CC--
Confidence 332221122224568999999988889999999999999999999 99998754332211 11 11100 00
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.....+...+.+++..||..+|.+||++.++++.|+.+..
T Consensus 231 -----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 -----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111234568899999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.89 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=199.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+++.++||+|+||.||+|... ..+..+++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK---ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC---CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 566788999999999999874 35678899998655444556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
+++++|..++.. ...+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~- 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccccc-
Confidence 999999998765 4568999999999999999999995 49999999999999999999999999998765432211
Q ss_pred eeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.....++..|+|||++. +..++.++|||||||++|||++|+.||......+. . ...... ....+.
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~~~~~~-~~~~~~-- 229 (282)
T cd06643 160 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAKS-EPPTLA-- 229 (282)
T ss_pred -cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--H----HHHhhc-CCCCCC--
Confidence 23346889999999984 34577899999999999999999999875432111 0 011000 000000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
........+.+++.+||+.+|.+||++.+++++-
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1112356788999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.96 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=197.3
Q ss_pred cccceeeeeeEEEEEEeccC---CcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTR---TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|...... .....++||.+.... .....++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999875321 233678999876432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-----CEEEeeccC
Q 045343 601 LNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-----NARISDFGL 668 (813)
Q Consensus 601 ~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~DfGl 668 (813)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 346889999999999999999995 5899999999999999877 899999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH----HhcCC
Confidence 986643322211223345678999999998899999999999999999998 9999864432211 110 00000
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
........+..+.+++.+||+.+|.+||++++|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001112345778899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.85 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=204.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+.+.+.||+|+||.||+|... .++..+++|.++... ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEc---CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567889999999999999885 356789999886321 2224578899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 597 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
||||+++++|.+++.. ...+++..+..++.++++||.|||+ .+|+|+||+|+||+++.++.++|+|||+++..
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999998853 3457899999999999999999995 49999999999999999999999999998865
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .. ......+....
T Consensus 157 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~-~~~~~~~~~~~-- 227 (267)
T cd08224 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SL-CKKIEKCDYPP-- 227 (267)
T ss_pred cCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH----HH-HhhhhcCCCCC--
Confidence 433211 2234578899999999888899999999999999999999999864332110 00 01111111110
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.........+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus 228 ------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 ------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111134567889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.17 Aligned_cols=254 Identities=29% Similarity=0.415 Sum_probs=189.4
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|+||.||+|..... .....+++|.+.... .....++.+|+.+++.++|+||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 4699999999999976433 345678999876432 22235678899999999999999999999999999999999999
Q ss_pred CchhhhhhccC-----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 604 GTLASFLFGNL-----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 604 gsL~~~l~~~~-----~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+|.+++.... ..++...+.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999996542 24677888999999999999995 49999999999999999999999999998754332211
Q ss_pred ceeecccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRN-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~-------~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||......+. +. .... +....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~-~~~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVR-EQDIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhh-ccCcc
Confidence 11122345678999998743 356789999999999999999 7778764432211 10 1111 11111
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
+..+... ......+.+++..|+ .||++||+++||++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1122111 123466677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=309.49 Aligned_cols=238 Identities=24% Similarity=0.273 Sum_probs=188.2
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheee-eeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|... .++..+|+|.+..... ....++..|.. +++.++|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK---SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 46999999999999874 3567899999864321 12234445544 57788999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++++|..++.....+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 9999999999887888899999999999999999995 5999999999999999999999999999875422211 1
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... +.. ... .. ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~-~~--------~~~--~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD---NIL-HK--------PLQ--L 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH---HHh-cC--------CCC--C
Confidence 234568999999999998889999999999999999999999997543211 100 111 11 010 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMK 787 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 787 (813)
.......+.+++.+||+.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112346788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.28 Aligned_cols=256 Identities=18% Similarity=0.239 Sum_probs=198.0
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
....+++.+.||+|+||.||++... ..++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.++..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3456778899999999999999874 356789999986421 1223457789999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++||||+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999999998654 47888889999999999999995 599999999999999999999999999998765
Q ss_pred cCcccceeecccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
...... .....||+.|+|||++.... ++.++|||||||++|||++|+.||........ ..........
T Consensus 194 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~- 265 (371)
T cd05622 194 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHKNS- 265 (371)
T ss_pred cCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCc-
Confidence 332211 23456999999999987543 78899999999999999999999975433211 0111111000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSL--RPTMKKVLQML 793 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~L 793 (813)
............+.+++..||+.++.+ ||++.|++++.
T Consensus 266 ------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 ------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 001111234567888999999854443 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.99 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=196.8
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|+||.||++... .++.|++|.++..... ..+++.+|++++++++|+||+++++++.+....++|+||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEe----CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 47999999999999874 3678999988754332 345789999999999999999999999999999999999999
Q ss_pred Cchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceee
Q 045343 604 GTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682 (813)
Q Consensus 604 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 682 (813)
++|.+++.. ...+++..+..++.+++.+|.|||+. +++||||||+||+++.++.+||+|||++.............
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999999865 35678999999999999999999954 99999999999999999999999999998654221111111
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
....+..|+|||.+.+..++.++|+||||+++|||++ |..||.......... ..... ... ...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-------~~~~~--~~~-------~~~ 217 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-------RIESG--YRM-------PAP 217 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-------HHhcC--CCC-------CCC
Confidence 2234567999999988889999999999999999999 888886443221111 00000 000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
...+..+.+++.+|++.+|.+||++.||++.|+.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.59 Aligned_cols=256 Identities=23% Similarity=0.418 Sum_probs=199.3
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC------c
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------N 593 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 593 (813)
.+.+.||+|+||.||+|.+......+..+|||.++... ....+++.+|++++++++|+||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999987665667899999886432 223456889999999999999999999886533 2
Q ss_pred eEEEEeecCCCchhhhhhcc------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 594 RLLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
.++++||+.+|+|.+++... ..+++...++++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 47889999999999887432 246888999999999999999995 499999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
+++...............++..|++||.+....++.++||||||+++|||++ |+.||......+ +..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~~~ 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---KGN 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---cCC
Confidence 9987654322211223345678999999988889999999999999999999 888886443211 111110 111
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
... ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0112356899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.93 Aligned_cols=243 Identities=24% Similarity=0.404 Sum_probs=190.1
Q ss_pred cccceeeeeeEEEEEEeccCC----cceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRT----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|....... ....+++|.+........+++.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998753221 2345888887654444456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC--------EEEeeccCccc
Q 045343 601 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--------ARISDFGLAKL 671 (813)
Q Consensus 601 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~DfGla~~ 671 (813)
+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999764 457999999999999999999995 59999999999999987765 69999999875
Q ss_pred cccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCC-cCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
.... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+.......... .... ..
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~--~~ 222 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED--RH 222 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc--cc
Confidence 5432 224578899999999864 5788999999999999999985 5554322211110 0000 00
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
. + .......+.+++.+||+.+|++|||++++++.|+
T Consensus 223 ~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 Q-----L----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-----C----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 1112356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.70 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=194.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecC------C
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG------Q 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~ 592 (813)
.+++.+.||+|+||.||+|... ..++.+|+|.+... .....++..|+.++.++ +|+||+++++++... .
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEc---CCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566788999999999999874 35678999998653 23445788899999998 699999999998653 3
Q ss_pred ceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 593 NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998763 467899999999999999999995 499999999999999999999999999998
Q ss_pred ccccCcccceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
........ .....|+..|+|||++. ...++.++|||||||++|||++|+.||.......... .. ..
T Consensus 160 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~-~~ 230 (272)
T cd06637 160 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI-PR 230 (272)
T ss_pred eccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HH-hc
Confidence 65432211 23456889999999986 3357889999999999999999999996433211110 00 00
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...... ........+.+++.+||+.+|.+|||+.|++++
T Consensus 231 ~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 NPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 101111 111234678899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=330.33 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=200.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
|++.++||+|+||.||+|... ..++.||||+++.... ...+++.+|++++++++||||+++++++.+++..++|
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~---~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDP---VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred eEEEEEEecCCCEEEEEEEEC---CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 567789999999999999874 3567899999864322 2235688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeec
Q 045343 598 YEFLNNGTLASFLFGN-----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 666 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 666 (813)
|||+++++|.+++... ...++..+++++.||++||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEec
Confidence 9999999999988531 234577788999999999999995 49999999999999999999999999
Q ss_pred cCccccccCcc----------------cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch
Q 045343 667 GLAKLLTLNQS----------------KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730 (813)
Q Consensus 667 Gla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~ 730 (813)
|+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99987621110 00012346999999999999999999999999999999999999999753322
Q ss_pred hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcC
Q 045343 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVVE 798 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~ 798 (813)
.... . . .+.++. ......+.+..+.+++.+|++.||++|| +++++++.|+..+.
T Consensus 238 ki~~------~----~---~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KISY------R----D---VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh------h----h---hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 0 0 000000 0001113456788999999999999995 67778788876554
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.91 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=201.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+...+.||+|+||+||+|...... .....+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 3456678999999999999875432 24567999988654332 34578999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccC---------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 597 VYEFLNNGTLASFLFGNL---------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999997654 68999999999999999999995 499999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
+++......... .....++..|+|||.+.+...+.++||||||+++++|++ |..||......... ......
T Consensus 163 ~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~-------~~~~~~ 234 (275)
T cd05046 163 LSKDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL-------NRLQAG 234 (275)
T ss_pred cccccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH-------HHHHcC
Confidence 987543222111 223345778999999988888999999999999999999 78888543221110 111111
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.... ......+..+.+++.+||+.+|.+||++.|++++|.
T Consensus 235 ~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 011134568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.38 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=188.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecC--------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-------- 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------- 591 (813)
.|.+.+.||+|+||.||+|... ..+..||||++... .....+|+.++++++|+||+++++++...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICI---DTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEEC---CCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3667889999999999999874 35678999988542 22345799999999999999999976332
Q ss_pred CceEEEEeecCCCchhhhhh----ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeec
Q 045343 592 QNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDF 666 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Df 666 (813)
...++||||+++ +|.+++. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 5666553 34678899999999999999999995 5999999999999999654 7999999
Q ss_pred cCccccccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 667 GLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||......+... . .......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~-i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--R-IIQVLGT 289 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHhCC
Confidence 99987654322 2235689999999998654 68999999999999999999999997654322111 0 0111000
Q ss_pred C---------------cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 E---------------KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~---------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ....+....+........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000000111111111234678999999999999999999999955
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=309.40 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=195.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.+.||+|+||+||++... ..++.+|||.+.... ......+.+|+.++..++|+||+++++++.+++..++|
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMK---HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 567789999999999999874 356789999986421 12234578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999976 4678899999999999999999995 599999999999999999999999999998765432
Q ss_pred ccceeecccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
... .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ...........
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~- 228 (331)
T cd05624 157 TVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEERFQ- 228 (331)
T ss_pred cee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCCccc-
Confidence 211 233569999999999875 45788999999999999999999999754322110 01111100000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSL--RPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 792 (813)
.... ....++.+.+++.+|+..++.+ |+++++++++
T Consensus 229 ~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 0123567888898888765544 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.70 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=200.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+...+.||+|+||.||+|... ..+..||+|.++... ....+.+.+|++++++++|+||+++++++..+...++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN---RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc---CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 44566688999999999999874 356789999886432 23345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+||+++++|.+++.. ..+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999999998864 467899999999999999999995 5999999999999999999999999999987653321
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. .....++..|+|||.+.+..++.++||||||++++||++|+.|+......... ....... .+
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~-----~~--- 219 (277)
T cd06642 157 K--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNS-----PP--- 219 (277)
T ss_pred h--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCC-----CC---
Confidence 1 22345788999999999888999999999999999999999998643221110 0000000 01
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......+..+.+++.+||+.+|.+||++.+|+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112345678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.48 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=201.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.+.++||.|++|.||+|... .++..|+||.+........+.+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDV---ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEc---CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 556688999999999999763 36778999998765445556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++++|.+++... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 171 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-- 171 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence 9999999988654 58999999999999999999995 49999999999999999999999999998865543221
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||........... .. ......+. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~----~~~~~~~~-------~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA----TNGTPELQ-------N 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----hcCCcccC-------C
Confidence 2234588899999999988899999999999999999999999976543221110 00 00000000 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+||+.+|.+||++.+|+++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11234678899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.05 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=188.5
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|+||.||+|....+ .....+++|.++... ....+.+.+|+.+++.++||||+++++.|.+....++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTD-TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcC-CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999976433 234567777765432 23346789999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 604 GTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 604 gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+|.+++... ...++..+..++.||++||+|||+ .+++|+||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999753 345667788999999999999995 499999999999999999999999999986432221111
Q ss_pred eeecccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRN-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~-------~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
......++..|+|||++.. ..++.++||||||+++|||++ |..||......+ .+ ..... +....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~----~~~~~-~~~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VL----NHVIK-DQQVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHh-hccccc
Confidence 1233457889999998753 245779999999999999997 566775432211 11 11111 111222
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.++.+.. ...+.+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2332221 23466778888999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.98 Aligned_cols=250 Identities=27% Similarity=0.469 Sum_probs=199.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.+.||+|+||.||++... .+..+++|.++.. .....++.+|++++++++|+|++++++++......++|+|
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 4567789999999999999874 3457999988643 2234578999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++++|.+++... ..+++..++.++.|++.+|+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999998764 4678999999999999999999954 8999999999999999999999999998765432211
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. .....++.+|+|||.+.+..++.++||||||+++|||++ |+.||........ . ...... .....+.
T Consensus 157 ~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~--~~~~~~~-- 224 (256)
T cd05112 157 S-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---V----ETINAG--FRLYKPR-- 224 (256)
T ss_pred c-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---H----HHHhCC--CCCCCCC--
Confidence 1 112235678999999998889999999999999999998 9999864432211 0 111110 0111111
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
...+.+.+++.+||+.+|++||++.|++++|.
T Consensus 225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=293.97 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=203.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+++.+.||.|+||.||+|.... .+..+++|.+........+.+.+|+.++++++|+||+++++++..+...+++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 45677899999999999998743 456799999876555556788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 99999999998776 788999999999999999999995 49999999999999999999999999999876543211
Q ss_pred ceeecccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~---~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.|+........... ....... ...
T Consensus 158 --~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~~---~~~ 225 (262)
T cd06613 158 --RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNFP---PPK 225 (262)
T ss_pred --cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccCC---Ccc
Confidence 2334678899999999776 788999999999999999999999975432211110 0000000 000
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+. .....+..+.+++.+||+.+|.+|||+.+|+.+
T Consensus 226 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 122346778999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=315.00 Aligned_cols=260 Identities=21% Similarity=0.207 Sum_probs=193.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.+.||+|+||.||++.... .++.||||... ...+.+|++++++++|+|||++++++..+...++|||
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECC---CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45667899999999999998753 46789999642 2346789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
++. ++|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||||+.++.+||+|||+++........
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 985 6888887654 568999999999999999999995 49999999999999999999999999999876543322
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCccc-chh----hhhhHHHHHHhh-ccCcccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM-GEE----YAILTDWAFDCY-RNEKLDDLV 752 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~-~~~----~~~l~~~~~~~~-~~~~~~~~~ 752 (813)
.......||..|+|||++.+..++.++|||||||+||||++|..++.... ... ...+...+.... .........
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 22334569999999999999999999999999999999999886653221 111 011111111100 000000000
Q ss_pred c----------------cccc---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 E----------------GDME---ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~----------------~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. +... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000 00001123467899999999999999999999976
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.29 Aligned_cols=259 Identities=25% Similarity=0.308 Sum_probs=191.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeecc---ccCCcceEEeEeec-----
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT---HHKNLVRLLGFCDE----- 590 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----- 590 (813)
|++.++||+|+||+||+|... .+++.||+|.++..... ....+.+|+.+++++ +|+||+++++++..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred ceEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 567789999999999999874 35778999988653221 223456677766665 69999999998854
Q ss_pred CCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
....++|+||+++ +|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 2357999999985 888888653 357899999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc---c
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---N 745 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~ 745 (813)
++....... .....++..|+|||++.+..++.++|||||||++|||++|++||......... .. ...... .
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~--~~-~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GK-IFDLIGLPPE 228 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH--HH-HHHHhCCCCh
Confidence 987653321 23346789999999999888999999999999999999999999754332111 01 111000 0
Q ss_pred Ccccc-------ccccccc---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDD-------LVEGDME---ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~-------~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..... ...+... .....+..+.+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000000 00111345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.19 Aligned_cols=253 Identities=20% Similarity=0.224 Sum_probs=194.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.++||+|+||+||++... ..++.+|+|.+.+.. ......+.+|+.++..++|+||+++++.+.+.+..++|
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEEC---CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 567789999999999999874 356789999986421 12233478899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999976 4678999999999999999999995 599999999999999999999999999997654332
Q ss_pred ccceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ...........+
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~~ 229 (332)
T cd05623 157 TVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKERFQF 229 (332)
T ss_pred cce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCccccC
Confidence 211 23356999999999986 345788999999999999999999999754322111 111111000000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQED--PSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPt~~evl~~ 792 (813)
.. ........+.+++.+|+..+ +..|+++.|++++
T Consensus 230 -p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -PA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 01123567778888877554 4447899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.02 Aligned_cols=197 Identities=23% Similarity=0.397 Sum_probs=159.0
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec--CCceEEEEeec
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFL 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~ 601 (813)
.++||+|+||+||+|..... ..++.+|+|.++.. .....+.+|+.++++++|+||+++++++.. +...++|+||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccC-CCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 46899999999999986432 35678999998643 223467889999999999999999998854 44678999998
Q ss_pred CCCchhhhhhcc---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE----cCCCCEEEeeccC
Q 045343 602 NNGTLASFLFGN---------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGL 668 (813)
Q Consensus 602 ~~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfGl 668 (813)
.+ +|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 777776421 247888999999999999999995 499999999999999 4567899999999
Q ss_pred ccccccCccc-ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcc
Q 045343 669 AKLLTLNQSK-AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIE 727 (813)
Q Consensus 669 a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~ 727 (813)
++........ .......+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876543221 112345689999999998764 5889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.73 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=193.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
..||+|+||.||+|... .++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||++++
T Consensus 14 ~~lg~g~~g~v~~~~~~---~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 14 VVLGKGTYGIVYAARDL---STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred EEEecCCceEEEEeEec---CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 47999999999999874 356789999887654455667899999999999999999999999999999999999999
Q ss_pred chhhhhhcc-CCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCccccccCcccce
Q 045343 605 TLASFLFGN-LKP--SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 605 sL~~~l~~~-~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+|.+++... ..+ ++..+..++.||++||+|||+ .+|+|+||||+||+++. ++.++|+|||++.........
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-- 165 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-- 165 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--
Confidence 999999764 344 788888999999999999995 59999999999999976 679999999998765432221
Q ss_pred eecccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....++..|+|||++.... ++.++||||||+++|+|++|+.||.......... +..... .. .+.
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~--~~-----~~~--- 232 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMF--KI-----HPE--- 232 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhh--cc-----CCC---
Confidence 22345789999999986643 7889999999999999999999986432211110 000000 00 000
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......+.+.+++.+||+.+|.+|||+.|++++
T Consensus 233 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 -IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111235678899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=322.23 Aligned_cols=262 Identities=20% Similarity=0.245 Sum_probs=190.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc------cCCcceEEeEeecC-
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH------HKNLVRLLGFCDEG- 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~- 591 (813)
..|.+.++||+|+||+||+|... ..+..||||+++... ...+++..|+.++++++ |.+++++++++..+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDR---KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEc---CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 45677889999999999999874 356789999986432 22334555666666654 45688999988765
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC------------
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY------------ 659 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~------------ 659 (813)
.+.++|||++ +++|.+++.....+++..+..++.||+.||.|||++ .+|+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4678999987 778888888778899999999999999999999952 4899999999999998665
Q ss_pred ----CEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhh
Q 045343 660 ----NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735 (813)
Q Consensus 660 ----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l 735 (813)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999987643221 2346799999999999999999999999999999999999999976543222211
Q ss_pred HHHHHHhhc--------cCccccc----------cccc-c------cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 045343 736 TDWAFDCYR--------NEKLDDL----------VEGD-M------EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790 (813)
Q Consensus 736 ~~~~~~~~~--------~~~~~~~----------~~~~-~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 790 (813)
.......+. ......+ .++. + ...........+.+|+.+||+.||.+|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 111000000 0000000 0000 0 0000111235678999999999999999999999
Q ss_pred HH
Q 045343 791 QM 792 (813)
Q Consensus 791 ~~ 792 (813)
++
T Consensus 437 ~H 438 (467)
T PTZ00284 437 TH 438 (467)
T ss_pred cC
Confidence 74
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=293.40 Aligned_cols=241 Identities=28% Similarity=0.468 Sum_probs=190.1
Q ss_pred cccceeeeeeEEEEEEeccC-------CcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 525 EEVGRGSFGIVYKGVILTTR-------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.||+|+||.||+|.+.... .....+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986432 11245788877643322 5678999999999999999999999988 778999
Q ss_pred EeecCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-------CEEEeeccCc
Q 045343 598 YEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-------NARISDFGLA 669 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-------~~kl~DfGla 669 (813)
+||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+|+||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998665 78999999999999999999995 5999999999999999887 7999999999
Q ss_pred cccccCcccceeecccccccccCcccccCC--CCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
...... ....++..|+|||++... .++.++||||||+++|||++ |..|+......+... .+...
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~~ 222 (259)
T cd05037 156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQ 222 (259)
T ss_pred cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhcC
Confidence 865431 223466789999999876 78899999999999999999 566665432211110 00000
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.. .. ......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 223 --~~-----~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 --HR-----LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --CC-----CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 011267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.16 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=201.7
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..|.+.+.||+|+||.||++... ..+..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDI---ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEEC---CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 45667789999999999999863 357789999987654445566888999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999864 457888999999999999999995 49999999999999999999999999998765443221
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ..... . .+..
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~-~-----~~~~-- 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN-G-----TPEL-- 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccC-C-----CCCC--
Confidence 223457889999999998889999999999999999999999997543211100 00000 0 0000
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112234667899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.49 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=201.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+++.+.||+|+||.||+|.... .+..+++|.++.... .+++.+|++++++++|+||+++++++.++...++++|
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 45677899999999999998752 467899999875422 5689999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999975 4578999999999999999999995 49999999999999999999999999999876543221
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+.......... ..... ......
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~-----~~~~~~- 220 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNK-----PPPTLS- 220 (256)
T ss_pred --cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccC-----CCCCCC-
Confidence 223457889999999999899999999999999999999999997543221110 00000 000000
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.+|++|||+.||+++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 112234678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.96 Aligned_cols=249 Identities=27% Similarity=0.306 Sum_probs=196.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
++..+.||+|+||+||++... ..++.+|||.++..... ..+.+.+|+.++++++|+|++++++.+.+.+..++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc---CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 455678999999999999875 35679999998653211 224567899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999999988643 358899999999999999999995 59999999999999999999999999998765432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ...... .... .
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~-----~~~~-~ 223 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVK-----EVQE-E 223 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhh-----hhhh-h
Confidence 21 1234689999999999998999999999999999999999999975432111000 000000 0000 0
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQ 791 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 791 (813)
........+.+++..||+.||++||| ++|+++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 ----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01123456889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.11 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=199.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc---------chhhhheeeeeeccccCCcceEEeEeecC
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG---------EKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
+.+.+.||+|++|.||+|... ..+..+|+|.+....... .+.+.+|+.++++++|+||+++++++.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNA---SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA 78 (267)
T ss_pred ccccceeecCCCeEEEEEEec---CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Confidence 346678999999999999864 356789999886432221 24578899999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+..++|+||+++++|.+++.....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999999999887888999999999999999999995 4999999999999999999999999999987
Q ss_pred cccCccc----ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 672 LTLNQSK----AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 672 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ + ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~-~~-- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I----FKI-GE-- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H----HHH-hc--
Confidence 6532111 011234578899999999988899999999999999999999999975432111 0 000 00
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...+. ........+.+++.+||+.+|.+||++.||+++
T Consensus 227 ---~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ---NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00111 112345778899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=309.79 Aligned_cols=263 Identities=25% Similarity=0.282 Sum_probs=201.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-c-----CCcceEEeEeecC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-H-----KNLVRLLGFCDEG 591 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~ 591 (813)
..+|++.+.||+|.||.|-|+... +.++.||||+++... .-..+...|+.+|..++ | -|+|+++++|...
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~---~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDH---KTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEEEecccccceeEEEEec---CCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 337788999999999999999875 467899999998642 33456778999999996 4 3799999999999
Q ss_pred CceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC--CCCEEEeecc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFG 667 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~DfG 667 (813)
++.+||+|.+ ..+|.++|+.+ ..++...++.|+.||+.||.+||+ .+|||+||||+||||.+ ...+||+|||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999987 45999999876 468899999999999999999995 59999999999999974 3479999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH-------
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF------- 740 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~------- 740 (813)
.|...... ...+..+..|+|||++.+.+|+.++||||||||+.||++|.+.|.++...++......+.
T Consensus 337 SSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 337 SSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99875533 235667889999999999999999999999999999999988887665433322111110
Q ss_pred -Hhh-------cc----------Cc-----------------ccccccc-ccc---ccccHHHHHHHHHHHHHhcccCCC
Q 045343 741 -DCY-------RN----------EK-----------------LDDLVEG-DME---ALNDIKCVEKLVMVSIWCIQEDPS 781 (813)
Q Consensus 741 -~~~-------~~----------~~-----------------~~~~~~~-~~~---~~~~~~~~~~l~~l~~~Cl~~dP~ 781 (813)
+.. .. .. ..+...+ ..+ .......-+.+.+++.+||+.||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 000 00 00 0000000 000 001113345689999999999999
Q ss_pred CCCCHHHHHHHH
Q 045343 782 LRPTMKKVLQML 793 (813)
Q Consensus 782 ~RPt~~evl~~L 793 (813)
+|+|..+++++=
T Consensus 492 ~R~tp~qal~Hp 503 (586)
T KOG0667|consen 492 ERITPAQALNHP 503 (586)
T ss_pred hcCCHHHHhcCc
Confidence 999999999763
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=304.72 Aligned_cols=253 Identities=20% Similarity=0.227 Sum_probs=193.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
|++.+.||+|+||+||++... ..+..||||.+... .....+.+.+|+.++..++|+||+++++++.+++..++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMK---NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred ceEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 567889999999999999875 35678999998642 122334578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999975 4578899999999999999999995 599999999999999999999999999987654332
Q ss_pred ccceeecccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ...........+
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~ 229 (331)
T cd05597 157 TVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQF 229 (331)
T ss_pred Ccc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcccC
Confidence 211 223468999999999863 45788999999999999999999999754322110 011111100011
Q ss_pred ccccccccccHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQE--DPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPt~~evl~~ 792 (813)
.. .....++.+.+++.+|+.. ++..||++.+++++
T Consensus 230 ~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0112356677888877754 44448899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=296.91 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=200.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+++.+.||+|++|.||+|... .++..||+|++.... ....+.+.+|+.++++++|+||+++++++..+...++||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNR---ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred eeeeeeecccCCeEEEEEEEC---CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 566788999999999999874 356789999886432 223356789999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||++++.|..++.....+++..++.++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 999999999888777788999999999999999999995 59999999999999999999999999999876543221
Q ss_pred ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH-H-------hhccCc-c
Q 045343 679 AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-D-------CYRNEK-L 748 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-~-------~~~~~~-~ 748 (813)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+......... . .+.... .
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 223457889999999876 457889999999999999999999997554322211100000 0 000000 0
Q ss_pred ccccccccccccc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 DDLVEGDMEALND-----IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....+....... ......+.+++.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 1225678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.29 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=196.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.+.||+|+||.||++... ..+..+|||.++... ......+.+|+.++.+++|+||+++++.+.+++..++|
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKK---DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 456789999999999999874 356789999986432 22345678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999999888889999999999999999999995 5999999999999999999999999999875532110
Q ss_pred c---------------------------------ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCC
Q 045343 678 K---------------------------------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724 (813)
Q Consensus 678 ~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~ 724 (813)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346999999999999999999999999999999999999999
Q ss_pred CcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 045343 725 DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT---MKKVLQM 792 (813)
Q Consensus 725 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 792 (813)
.......... ...... ..+ ..+......+.+.+++.+++. ||.+|++ +.|++++
T Consensus 237 ~~~~~~~~~~------~i~~~~--~~~-----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETYR------KVMNWK--ETL-----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHH------HHHcCC--Cce-----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 7554322110 000000 000 000111134567777777664 9999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=296.97 Aligned_cols=250 Identities=26% Similarity=0.304 Sum_probs=197.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+...+.||+|+||+||++... .+++.+|+|.++.... .....+.+|++++++++|+||+++.+.+..++..++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR---ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC---CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 345678999999999999875 3577899999864321 2234577899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999999888653 468999999999999999999995 59999999999999999999999999999765432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......... . ......... ..
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~-~~~~~~~~~--~~---- 223 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--E-VDRRVLETE--EV---- 223 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHhhhccc--cc----
Confidence 11 223468999999999998889999999999999999999999997543221110 0 011010000 00
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
........+.+++..|++.||++||+ +.+++++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 ----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11123456789999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=294.80 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=198.4
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc----------cchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD----------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
...+.||+|+||.||+|... .++..+|||.++..... ..+.+..|+.++++++|+||+++++++...
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNV---TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred eecceecccCceEEEEEeec---CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 44678999999999999864 35678999987532111 123577899999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+..++|+||+++++|.+++.....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999999887888999999999999999999995 4999999999999999999999999999986
Q ss_pred cccCcccceeecccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
..............++..|+|||.+.... ++.++|+||||++++|+++|..|+......+. ........ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNKR-SA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhccc-cC
Confidence 54322221123356889999999987654 78899999999999999999999863322110 01111111 11
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+... ........+.+++..||+.+|.+||++.+|+++
T Consensus 231 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 112345788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.26 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=201.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.+.||.|++|.||+|... .++..+++|.+.... ......+.+|+.++++++|+||+++++++.++...++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDK---RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEEC---CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 566788999999999999874 357889999986532 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 99999999998765 78999999999999999999995 48999999999999999999999999999877643221
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..........+.+
T Consensus 155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------~~~~~~~~~~~~~------ 220 (274)
T cd06609 155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------FLIPKNNPPSLEG------ 220 (274)
T ss_pred -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------HHhhhcCCCCCcc------
Confidence 23346788999999999888999999999999999999999999754321110 0011111111110
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......+.+++.+||+.+|++|||+++++++
T Consensus 221 --~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 --NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0135678899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=307.05 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=189.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|.+.+.||+|+||.||+|... ..+..||+|.... .....|+.++++++|+||+++++++.+....++|+|
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKP---GQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEEC---CCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4677899999999999999874 3566899997432 234568899999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
++. ++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 985 577777754 4678999999999999999999995 4999999999999999999999999999975432211
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCC-Ccccch--hh-----hhhHHHHHHh-hccCccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGE--EY-----AILTDWAFDC-YRNEKLD 749 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~-~~~~~~--~~-----~~l~~~~~~~-~~~~~~~ 749 (813)
.....||..|+|||++.+..++.++|||||||++|||+++..++ ...... .. ..+....... .......
T Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23456899999999999989999999999999999999965554 322111 00 0111100000 0000000
Q ss_pred ---------ccccc---------cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 ---------DLVEG---------DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ---------~~~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..++. .............+.+++.+||+.||.+|||+.||+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00000 00000011223456679999999999999999999875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=296.52 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=199.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..|++.++||+|+||.||+|... ..+..+++|.+........+.+.+|+.++++++|+||+++++.+..+...++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK---ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC---CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 34677889999999999999874 356789999987655555667889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++++|..++.. ...+++..+..++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999888754 4568999999999999999999995 4999999999999999999999999999875432211
Q ss_pred cceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
. .....++..|+|||.+. ...++.++|||||||++|||++|+.||........ . ..... ...
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~-~~~---- 232 (292)
T cd06644 166 R--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAK-SEP---- 232 (292)
T ss_pred c--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--H----HHHhc-CCC----
Confidence 1 22345788999999984 34567899999999999999999999865432111 0 01100 000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+.. .........+.+++.+||+.+|++||++.+++++
T Consensus 233 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 -PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0111334678899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=309.22 Aligned_cols=263 Identities=25% Similarity=0.306 Sum_probs=193.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ---- 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---- 592 (813)
..|.+.+.||+|+||.||++... ..+..||||++.... .....++.+|+.+++.++|+||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDT---VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEc---CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45677899999999999999864 357889999986432 233456788999999999999999999986443
Q ss_pred --ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 593 --NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 593 --~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
..++||||+++ +|...+. ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46999999976 4555553 347788899999999999999995 499999999999999999999999999997
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hH-------------
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT------------- 736 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~------------- 736 (813)
....... .....+|..|+|||++.+..++.++||||||+++|||++|+.||.......... +.
T Consensus 172 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 6543221 234568999999999999999999999999999999999999997543211100 00
Q ss_pred --HHHHHhhcc-C-----cccccccccc---cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 737 --DWAFDCYRN-E-----KLDDLVEGDM---EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 737 --~~~~~~~~~-~-----~~~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
......... . ...+...... ...........+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000 0 0000000000 0000112246688999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=307.35 Aligned_cols=262 Identities=25% Similarity=0.284 Sum_probs=193.8
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC-----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG----- 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 591 (813)
..|.+.+.||+|+||.||++... ..++.||||++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEEC---CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45677889999999999999864 356789999986532 22345678899999999999999999987543
Q ss_pred -CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 592 -QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 592 -~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
...++||||+++ +|.+++.. .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999975 66666643 47788899999999999999995 599999999999999999999999999998
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHH------------
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD------------ 737 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~------------ 737 (813)
....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+... +..
T Consensus 175 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 6543221 234568999999999999999999999999999999999999997543321110 000
Q ss_pred ---HHHHhhcc-Ccc-----cccccccc---cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 738 ---WAFDCYRN-EKL-----DDLVEGDM---EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 738 ---~~~~~~~~-~~~-----~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........ ... .++..... ...........+.+++.+||+.||.+|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000 00000000 000011124578899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=308.49 Aligned_cols=262 Identities=25% Similarity=0.293 Sum_probs=193.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC-----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG----- 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 591 (813)
..|.+.+.||+|+||.||++... ..++.+|||++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEec---CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35667789999999999999764 356789999986532 22335677899999999999999999988543
Q ss_pred -CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 592 -QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 592 -~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
...++||||+++ +|.+.+.. .+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 346999999975 56665543 47888899999999999999995 599999999999999999999999999998
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh-hhHH------------
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTD------------ 737 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~------------ 737 (813)
....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+.. ....
T Consensus 168 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6543221 23456899999999999989999999999999999999999999754321110 0000
Q ss_pred ---HHHHhhcc-Ccccccc------ccccc--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 738 ---WAFDCYRN-EKLDDLV------EGDME--ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 738 ---~~~~~~~~-~~~~~~~------~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........ .....+. +.... ..........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000000 00000 00111234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.50 Aligned_cols=245 Identities=29% Similarity=0.466 Sum_probs=195.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.+.||+|+||.||++.. .+..+|+|.++.. .....+.+|+.++++++|+|++++++++..+ ..++|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 4567889999999999999864 5667999998643 2345788999999999999999999998654 579999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++++|.+++... ..+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 999999999999754 357899999999999999999995 599999999999999999999999999987643221
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+.. .......
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~-------- 214 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKGY-------- 214 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCCC--------
Confidence 12234567999999988889999999999999999998 99998654322211 1111110
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
........+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000111335778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.38 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=196.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|.+.++||+|+||.||+|... ..+..||+|.++.... .....+.+|+.++++++|+||+++++++..+...++|+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSK---LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEc---CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4667789999999999999874 3567899999864322 22345778999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||++ ++|.+++.. ...+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 9997 588888765 3567899999999999999999995 5999999999999999999999999999976543221
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc---cCcccccc-
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NEKLDDLV- 752 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~- 752 (813)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+... ....... ......+.
T Consensus 160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILS 234 (301)
T ss_pred c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhc
Confidence 1 2233568899999988654 57889999999999999999999997554322111 1111100 00000000
Q ss_pred --------cccccc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 --------EGDMEA----LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 --------~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+.... .........+.+++.+||+.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0011234578899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=292.91 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=197.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc------ccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
+...+.||+|+||+||+|... ++..+|||.++.... .....+.+|++++++++|+||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI 77 (265)
T ss_pred ccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence 345678999999999999753 567899998864321 1124588899999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++|+||+++++|.+++.....+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999999877788999999999999999999995 4899999999999999999999999999876532
Q ss_pred Ccc----cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 675 NQS----KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 675 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
... ........++..|+|||.+.+..++.++||||||++++||++|+.||.......... ...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~~~---~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF------YIGAHR---G 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH------Hhhhcc---C
Confidence 111 111223458899999999998889999999999999999999999997433211110 000000 0
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
. .+.. .......+.+++.+||+.+|.+||++.|+++
T Consensus 226 ~-~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 L-MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0011 1124567899999999999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=293.53 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=201.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+...++||.|+||.||+|... ..+..||||.++... ......+.+|+.++++++|+||+++++++.++...++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc---cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 34556688999999999999874 356789999886432 23345788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++.. ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999999999865 457888899999999999999995 5999999999999999999999999999977654322
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. .....++..|+|||.+.+..++.++|+||||+++|||++|..|+.......... .... ...
T Consensus 157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~---------~~~ 218 (277)
T cd06640 157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPK---------NNP 218 (277)
T ss_pred c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhc---------CCC
Confidence 1 223457889999999988889999999999999999999999987543221110 0000 001
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+..+.+++.+||+.+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122456788899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=291.40 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=198.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.++||+|+||.||++... ..+..+++|.++... ....+.+.+|+.++++++|+||+++++.+.++...++|+|
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHV---NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEc---CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 457789999999999999874 356789999886432 2334568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 600 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 600 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|+++++|.+++... ..+++...+.++.||+.||.|||+ .+|+|+||||+||++++++.++|+|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999988642 457889999999999999999995 4999999999999999999999999999976643221
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. .....++..|+|||++.+..++.++|+||||+++|+|++|+.||........ ... ........+
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~------ 220 (255)
T cd08219 156 Y--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILK-VCQGSYKPL------ 220 (255)
T ss_pred c--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHH-HhcCCCCCC------
Confidence 1 2335688899999999988899999999999999999999999975432111 001 111111111
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+||+.||++||++.||+..
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=297.32 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=203.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+++.+.||+|+||.||+|... .++..|+||+++... ....+.+.+|++++++++|+||+++++++..++..++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK---ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC---CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 3567789999999999999874 346789999886532 22345788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+||++++.|..++.....+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999988887777667789999999999999999999964 999999999999999999999999999987665432
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---------C-
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---------E- 746 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~- 746 (813)
.. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.............. .
T Consensus 156 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 11 2335678899999999888 7899999999999999999999998754332211110000000000 0
Q ss_pred ----ccccccccc-ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 ----KLDDLVEGD-MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ----~~~~~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......+.. .........+..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000 0000111236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=309.45 Aligned_cols=242 Identities=23% Similarity=0.259 Sum_probs=187.7
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeecc---ccCCcceEEeEeecCCceEEEEee
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQT---HHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
||+|+||+||+|... ..+..||||++...... ....+..|..++.+. +|+||+++++.+.+.+..++||||
T Consensus 1 lG~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKK---DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEEC---CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 799999999999874 35678999998643211 122344555666554 699999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 9999999999888889999999999999999999995 49999999999999999999999999998764322211
Q ss_pred eecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||......+. ......+.. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~-~~~------- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGKV-RFP------- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCCC-CCC-------
Confidence 2345689999999998765 478999999999999999999999975432211 011111110 000
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRP----TMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~~ 792 (813)
.......+.+++.+||+.||.+|| ++.+++++
T Consensus 218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 012346778999999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=302.71 Aligned_cols=262 Identities=17% Similarity=0.184 Sum_probs=193.2
Q ss_pred ccccccee--eeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 523 FKEEVGRG--SFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 523 ~~~~LG~G--~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.++||+| +|++||++... .++..||||+++... ....+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK---PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeec---ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 56789999 78999999874 467899999986532 222345778999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999999653 458899999999999999999995 599999999999999999999999998654432111
Q ss_pred c-c----ceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc-----
Q 045343 677 S-K----AIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR----- 744 (813)
Q Consensus 677 ~-~----~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 744 (813)
. . .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... . ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~-~~~~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-L-EKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-H-HHhcCCccccccc
Confidence 1 0 00112346778999999976 45889999999999999999999999743221100 0 00000000
Q ss_pred ----cCcc----------ccccc------------ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 ----NEKL----------DDLVE------------GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ----~~~~----------~~~~~------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+.+ ..+.+ ..............+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 00000 000001112345678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=307.17 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=197.7
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEee--cc--ccccchhhhheeeeeeccccCCcceEEeEeecCCc--eE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN--RL 595 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~--~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~ 595 (813)
.|.++||+|+|-+||||.+. .++..||--.++ +. .....+.|..|+.+|+.|+|+|||+++.+..+... ..
T Consensus 43 k~~evLGrGafKtVYka~De---~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDE---EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeecccc---ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 35578999999999999873 456666543332 11 22334679999999999999999999999877665 78
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~~~~ 674 (813)
+|+|.+..|+|..|+....+.+.+.+.+|+.||++||.|||.+ .++|+|||||-.||+|+ ..|.+||+|+|||..+..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999999999999999999999999999999999987 88999999999999997 568999999999998875
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... ...|||.|||||.+. ..|++.+||||||++|+||+|+..|+..-....+ +-+.+..-.....+.++-
T Consensus 199 s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~kV~-- 269 (632)
T KOG0584|consen 199 SHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSKVK-- 269 (632)
T ss_pred cccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhccC--
Confidence 5432 367999999999987 6899999999999999999999999974332211 111111112222222222
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..++.++|.+||.. ..+|||+.|+++.
T Consensus 270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 ----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 35678999999999 9999999999953
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.85 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=201.3
Q ss_pred hcccccceeeeeeEEEEEEeccC-CcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTR-TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.||+|+||.||++...... .....||+|.++..... ..+.+..|+.++.+++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 35688999999999999986432 22478999999754332 45678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCC--CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 600 FLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|+++++|.+++..... +++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999976544 8999999999999999999995 4999999999999999999999999999987654422
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....++..|+|||.+.+..++.++||||||++++||++ |+.||......... . ........
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~---~----~~~~~~~~------- 223 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL---E----YLKKGYRL------- 223 (258)
T ss_pred cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHhcCCCC-------
Confidence 21 112336789999999988889999999999999999998 78887653221111 1 11111100
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
......+..+.+++.+|++.+|++|||+.|+++.|
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112457789999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=300.71 Aligned_cols=196 Identities=23% Similarity=0.400 Sum_probs=158.3
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee--cCCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~ 602 (813)
.+||+|+||.||+|..... ..+..+|+|.++.. .....+.+|++++++++|+||+++++++. .+...++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-KDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCC-CccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 5799999999999986432 35678999988643 22346788999999999999999999884 3456799999987
Q ss_pred CCchhhhhhc---------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE----cCCCCEEEeeccCc
Q 045343 603 NGTLASFLFG---------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLA 669 (813)
Q Consensus 603 ~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfGla 669 (813)
+ +|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 66666532 1247888999999999999999995 599999999999999 56678999999999
Q ss_pred cccccCccc-ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcc
Q 045343 670 KLLTLNQSK-AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIE 727 (813)
Q Consensus 670 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~ 727 (813)
+........ .......+|..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 112345689999999998764 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=294.65 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=200.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+++.++||.|+||.||++... .++..+++|..+.......+.+..|+.++++++|+||+++++.+..+...++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHK---ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEc---CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 4677889999999999999874 2567899999876544455678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999998764 5689999999999999999999954 9999999999999999999999999998765432211
Q ss_pred ceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||........ +.. . .....
T Consensus 160 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~----~-~~~~~----- 225 (280)
T cd06611 160 --RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLK----I-LKSEP----- 225 (280)
T ss_pred --cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHH----H-hcCCC-----
Confidence 23345889999999875 34567899999999999999999999975432211 111 0 00000
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+.+. ........+.+++..||+.+|.+||++.+|+++
T Consensus 226 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000 111234678899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=298.60 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=199.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
++++.++||+|+||.||+|... ..++.+|+|++...... ..+.+.+|++++++++|+||+++++++..+...++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEEC---CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 3567789999999999999874 34678999987643222 245688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+||+++++|..+......+++..++.++.||++||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999999999888776678999999999999999999995 4999999999999999999999999999987654332
Q ss_pred cceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhh-hhhHHHHHHh-------hccCcc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDC-------YRNEKL 748 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~-------~~~~~~ 748 (813)
. .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+. ..+....... ......
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 156 V--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred c--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 1 233457889999998865 4577899999999999999999999865433211 1110000000 000000
Q ss_pred -cccccccccc-----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 -DDLVEGDMEA-----LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 -~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....+.... .........+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 0011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=290.23 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=202.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.+.||+|+||.||.+... .++..+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRT---EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred ceEeeEecccCCceEEEEEEc---CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 567789999999999988764 35678999987643 2334457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++++|.+++... ..+++..+..++.|++++|.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999999764 467899999999999999999995 489999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. ......++..|+|||.+.+...+.++||||||++++||++|+.||......+. ..... .+....
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~~------ 220 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNYTP------ 220 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCCCC------
Confidence 2 12345689999999999888889999999999999999999999975432211 11111 111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
........+.+++.+||+.+|.+||++.++++++
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 ---VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0123356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=292.53 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=198.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----------cccchhhhheeeeeec-cccCCcceEEeEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----------QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCD 589 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~ 589 (813)
+.+.+.||+|+||.||+|....+ .+..+|||.+.... .....++..|+.++.+ ++|+||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 45678899999999999998532 45789999875321 1122346678887764 79999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEee
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 665 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 665 (813)
++...++||||+++++|.+++.. ...+++..+++++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988743 3467899999999999999999995 24799999999999999999999999
Q ss_pred ccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 666 FGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 666 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... . ....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---~----~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---T----KIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---H----HHhh
Confidence 99998765433 133456889999999999888999999999999999999999998644321110 0 0011
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
...... ........+.+++.+||+.||++||++.||..+|++
T Consensus 228 ~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111100 111234678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.35 Aligned_cols=260 Identities=23% Similarity=0.271 Sum_probs=197.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-----cchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+++.+.||+|++|.||+|... .++..|+||+++..... ....+..|++++++++|+||+++++++.+.+..+
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDK---ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78 (298)
T ss_pred ceeeeeeeeccccEEEEEEEC---CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEE
Confidence 456788999999999999874 34678999999754322 2345678999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+||||+ +++|.+++.... .+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.++|+|||+++....
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999999 999999997765 78999999999999999999995 4999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc--------
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-------- 745 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 745 (813)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|..+|......+.. .. .......
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GK-IFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HH-HHHHcCCCchhhhhh
Confidence 3211 222346788999998855 45788999999999999999998877654432111 00 1110000
Q ss_pred -Cccccccccccccc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 -EKLDDLVEGDMEAL-----NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 -~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.............. ........+.+++.+||+.+|.+|||+.||+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 011235778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=293.37 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=192.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-----ccchhhhheeeeeeccccCCcceEEeEeecC--Cc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QN 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 593 (813)
+...+.||+|+||.||+|... ..+..+++|++..... ...+.+.+|+.++++++|+||+++++++.+. ..
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDV---DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred ccccceecCCCCEEEEEEEEc---CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 455688999999999999874 3567899998864321 1234578899999999999999999988653 56
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++++||+++++|.+++.....+++...+.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 78999999999999999887778999999999999999999994 599999999999999999999999999998664
Q ss_pred cCccc-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSK-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~-----~ 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP-----T 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-----C
Confidence 32111 111234578899999999988899999999999999999999999974422111 01110000 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+.. .....+.+.+++ +||..+|++||+++||+++
T Consensus 227 ~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1111 112234555666 6888999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.68 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=208.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..|.+.+.||+|.|..|-++... -.|..||||++.+..-. ....+..|++.|+.++|||||+|+.+......+||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHV---FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhh---cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 34667788999999999887664 36789999999764322 23467889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE-cCCCCEEEeeccCcccccc
Q 045343 597 VYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL-DDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 597 V~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll-~~~~~~kl~DfGla~~~~~ 674 (813)
|+|.-++|+|.|||- +...+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+.+
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999985 45789999999999999999999995 599999999999876 5678999999999988877
Q ss_pred CcccceeecccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.+. ....+|...|-|||++.+..|+ +++||||||||||.|++|+.||+...+.+. +..++|
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImD 233 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMD 233 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhc
Confidence 654 4567899999999999998886 579999999999999999999986554332 223334
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
-.... +.....++.+||..||+.||.+|.+.+||+..-
T Consensus 234 CKYtv--PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 234 CKYTV--PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred ccccC--chhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 33221 234678999999999999999999999998653
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.16 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=198.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC-ceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV 597 (813)
|++.+.||+|++|.||++... .+++.+++|++.... ....+.+.+|++++++++|+|++++++.+...+ ..++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEc---CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 567899999999999999874 345789999986432 223456888999999999999999999876544 57899
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++++|.+++... ..+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999999753 457999999999999999999995 49999999999999999999999999999876433
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....+++.|+|||.+.+..++.++||||||++++||++|+.||........ ..... .+....
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~~----- 221 (257)
T cd08223 156 CDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGKLPP----- 221 (257)
T ss_pred CCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcCCCC-----
Confidence 221 2345688999999999998899999999999999999999999874332111 11111 111110
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+|++.+|++||++.+++++
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=291.74 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=199.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-----cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+...+.||+|++|.||+|... .++..|++|.+.... .+..+++.+|+.++++++|+||+++++++..+...+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNL---DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY 78 (258)
T ss_pred ccccceeeecCCceEEEEEEc---CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEE
Confidence 345688999999999999874 356789999886532 123457889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+|+||+++++|.+++.....+++..+..++.||++||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999999877778999999999999999999995 49999999999999999999999999998876443
Q ss_pred cccceeecccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||........ . ...........+
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~----~~~~~~~~~~~~--- 223 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--V----FKIGRSKELPPI--- 223 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--H----HHHHhcccCCCc---
Confidence 2 123455888999999987766 88999999999999999999999965432111 0 111010111110
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....+.+.+++.+||+.+|.+||++.+++++
T Consensus 224 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 ------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11235678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.83 Aligned_cols=245 Identities=28% Similarity=0.388 Sum_probs=197.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
..||+|+||.||++... ..+..||||++........+.+.+|+.++++++|+||+++++.+..++..++||||++++
T Consensus 28 ~~lg~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 28 IKIGEGSTGIVCIATEK---HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hcccCCCCeEEEEEEEC---CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 56999999999999764 356789999987654445567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecc
Q 045343 605 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684 (813)
Q Consensus 605 sL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 684 (813)
+|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||++++++.++|+|||++......... ....
T Consensus 105 ~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 178 (292)
T cd06658 105 ALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL 178 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence 99998854 457899999999999999999995 49999999999999999999999999998765432221 2234
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHH
Q 045343 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKC 764 (813)
Q Consensus 685 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (813)
.++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ... ....+.... ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------~~~-----~~~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------RIR-----DNLPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHH-----hcCCCcccc--cccc
Confidence 58899999999988889999999999999999999999997543221110 000 001111111 1123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 765 VEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 765 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...+.+++.+|++.||.+|||++|++++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=294.59 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=194.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+.||+|++|.||+|... ..+..||||+++... ....+.+.+|+.++++++|+||+++++++.++...++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNK---KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred ceEeeEecccCceEEEEEEEC---CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 456789999999999999874 356789999986432 222356888999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||++ ++|.+++... ..+++..+..++.||++||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 6888887542 468899999999999999999995 59999999999999999999999999999765432
Q ss_pred cccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHHHHH----Hhhcc-C--
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWAF----DCYRN-E-- 746 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~----~~~~~-~-- 746 (813)
... .....++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ...... ..+.. .
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 155 VRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred ccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 211 2233568899999988654 57889999999999999999999997543321110 000000 00000 0
Q ss_pred -----cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 -----KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 -----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........... ........++.+++.+||+.||.+|||+.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 0011235677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=326.25 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=197.1
Q ss_pred HHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeec-
Q 045343 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE- 590 (813)
Q Consensus 514 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~- 590 (813)
.+.....|.+.++||+|+||+||++... ..+..+|+|.+... .......+..|+.++++++|||||++++++.+
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk---~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHK---RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEEC---CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3444456788899999999999999875 35678899988643 22234568899999999999999999998854
Q ss_pred -CCceEEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcC----CCCeeeCCCCCCcEEEcC----
Q 045343 591 -GQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC----SAQIIHCDIKPQNILLDD---- 657 (813)
Q Consensus 591 -~~~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~----~~~ivH~dlk~~NIll~~---- 657 (813)
....+|||||+++++|.++|.. ...+++..++.|+.||+.||.|||... ..+|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 3468999999999999999864 256899999999999999999999642 146999999999999964
Q ss_pred -------------CCCEEEeeccCccccccCcccceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCc
Q 045343 658 -------------YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRK 722 (813)
Q Consensus 658 -------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~ 722 (813)
...+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23489999999987643221 234568999999999854 458899999999999999999999
Q ss_pred CCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 723 SFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 723 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
||........ + . ..+... +.+. .......+.+|+..||+.+|.+||++.|+++
T Consensus 242 PF~~~~~~~q--l---i-~~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFSQ--L---I-SELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHHH--H---H-HHHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9975432111 1 1 111110 0000 0123467889999999999999999999994
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=304.29 Aligned_cols=259 Identities=25% Similarity=0.312 Sum_probs=191.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecC------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 591 (813)
.|.+.+.||+|+||.||+|... ..+..||||++..... ...+++.+|+.++++++|+||+++++++...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDT---RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhheecccCCCeEEEEEEEC---CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4666789999999999999874 3567899999864321 2234577899999999999999999987533
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
...++++|++ +++|.+++.. ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3568999987 7788887753 468999999999999999999995 4999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh-hhHHHH-------HHh
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWA-------FDC 742 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~-------~~~ 742 (813)
.... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.... ...
T Consensus 168 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 168 ADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred cCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 5432 233568999999999877 46889999999999999999999999754321110 000000 000
Q ss_pred hccCc-------ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRNEK-------LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...+. +........... .....+.+.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000000000 00123457899999999999999999999966
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.42 Aligned_cols=244 Identities=27% Similarity=0.382 Sum_probs=199.5
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCCc
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 605 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 605 (813)
+||+|.||+||-|.+. .....+|||.+........+-+.+||.+-++++|.|||+++|.+.++...-+.||.++|||
T Consensus 582 VLGKGTYG~VYA~RD~---~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM---DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccc---cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999774 3557799999876544455568899999999999999999999999999999999999999
Q ss_pred hhhhhhcc-CCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCccccccCccccee
Q 045343 606 LASFLFGN-LKP--SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 606 L~~~l~~~-~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
|.++|... +++ ++.+.--+.+||++||.|||+. .|||||||-.||||+ -.|.+||+|||-++++..- ....
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~T 733 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCT 733 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Cccc
Confidence 99999765 444 7888888999999999999965 999999999999997 5689999999999887532 2235
Q ss_pred ecccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
..+-||..|||||++..+ .|..++|||||||.+.||.||++||..........+ .-+.. ....+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------kVGmy------KvHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------KVGMY------KVHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------hhcce------ecCCC
Confidence 567899999999999765 488999999999999999999999975443222211 11100 11122
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
.+.+...+...++++|+.+||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 34466788899999999999999999999985
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=286.03 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=208.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
..+.++||+|+||.|||+.. ++.+..+|||++.- +.+.+++..|+.+|++.+.+++|+++|.+.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH---~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIH---RESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHH---hccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 44568999999999999987 46889999999864 45678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|.-|+..+++.. ++++.+.++..++...++||+|||. ..-+|||||+.||||+.+|.+||+|||.|..+.....+
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 999999999975 4788999999999999999999995 47799999999999999999999999999877644332
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc-cccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV-EGDMEA 758 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~ 758 (813)
.....||+-|||||++..-.|+.++||||||+...||..|++|+..--+- ..+.-+. .+.-..
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RAIFMIPTKPPPTF 249 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------------ceeEeccCCCCCCC
Confidence 34567999999999999999999999999999999999999998633211 1111111 111122
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+.+.+.++-++++.||.++|++|-|+.+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2345678899999999999999999999988876
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.16 Aligned_cols=251 Identities=22% Similarity=0.241 Sum_probs=198.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.+.||+|++|.||++... ..+..+|||.+...... ..+.+.+|++++.+++|+||+++++.+.+....++|
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLK---GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred eEEeeeecCCccEEEEEEEEc---CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 456688999999999999875 25678999998753222 345688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+.+++|.+++... ..+++..+..++.|+++||+|||. .+++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999998754 568899999999999999999995 59999999999999999999999999998765322
Q ss_pred ccc---------------------------ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCccc
Q 045343 676 QSK---------------------------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 728 (813)
Q Consensus 676 ~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~ 728 (813)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 00112357889999999998889999999999999999999999997543
Q ss_pred chhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 045343 729 GEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT----MKKVLQM 792 (813)
Q Consensus 729 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~~ 792 (813)
..... . .. .+..............+.+++.+||+.+|++||+ ++|++++
T Consensus 237 ~~~~~--~----~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETF--S----NI---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHH--H----HH---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 32111 0 00 0111111111124678999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.95 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=198.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.+++.+.||+|+||.||++... ..+..+|+|.++... .....++.+|+.++.+++|+||+++++.+......++|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHR---PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEc---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 3677899999999999999874 356789999886432 223457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||+++++|..++... ..+++..+..++.|++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999988763 368999999999999999999995 248999999999999999999999999998765432
Q ss_pred cccceeecccccccccCcccccCCC------CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNST------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~------~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
. .....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||........... . .
T Consensus 157 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~-~-------- 220 (286)
T cd06622 157 L----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---L-S-------- 220 (286)
T ss_pred c----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---H-H--------
Confidence 1 22345788999999985543 47899999999999999999999965332111100 0 0
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+..... ..........+.+++.+||+.+|.+||++.+++++
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 AIVDGDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHhhcCC-CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0111000 00112356778899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.05 Aligned_cols=245 Identities=25% Similarity=0.362 Sum_probs=197.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
.+||+|+||.||++... .++..|+||.+........+.+.+|+.++..++|+||+++++++..++..++|+||++++
T Consensus 27 ~~ig~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 27 IKIGEGSTGIVCIAREK---HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhcCCCCceeEEEEEEc---CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 47999999999999874 356789999986544444567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecc
Q 045343 605 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684 (813)
Q Consensus 605 sL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 684 (813)
+|..++.. ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... ....
T Consensus 104 ~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 177 (297)
T cd06659 104 ALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL 177 (297)
T ss_pred CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence 99987754 467899999999999999999995 49999999999999999999999999998765433221 2335
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHH
Q 045343 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKC 764 (813)
Q Consensus 685 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (813)
.++..|+|||.+.+..++.++||||||++++||++|+.||......+... ......... .. .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~-----~~--~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-------RLRDSPPPK-----LK--NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhccCCCC-----cc--ccCCC
Confidence 68899999999998889999999999999999999999997543322110 001100000 00 01123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 765 VEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 765 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...+.+++.+||+.+|.+||++.+++++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 4568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.13 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=200.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|...+.||+|+||.||+|... .++..+++|.++..... ..+++.+|+.++++++|+||+++++++...+..++|+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNL---DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred ceeeeEeecCCCcEEEEEEEC---CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 456789999999999999874 35678999998754332 4567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++.....+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999999887778999999999999999999995 49999999999999999999999999999876543221
Q ss_pred ce--eecccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 679 AI--RTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 679 ~~--~~~~~gt~~y~aPE~l~~~~---~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.. .....++..|+|||++.... .+.++||||||++++|+++|+.||......... ..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~~~-~~~~----- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFHVG-AGHK----- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHHHh-cCCC-----
Confidence 10 11345788999999998766 888999999999999999999999643221110 00000 0000
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
+... ........+.+++.+||+.+|.+||++.|+++
T Consensus 225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011 11123567789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.52 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=199.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeec--CCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 596 (813)
|++.+.||.|+||.||++... ..+..+++|.+... .....+++.+|++++++++|+||+++++++.. +...++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRK---SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred ceeeeeeccCCCeEEEEeeec---CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 456788999999999999874 35678999988642 22334568889999999999999999998754 445789
Q ss_pred EEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 597 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
+|||+++++|.+++.. ...+++..++.++.||++||.|||..+ ..+++|+||||+||++++++.+||+|||++.
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 9999999999999865 357899999999999999999999443 4599999999999999999999999999998
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
........ .....++..|+|||.+.+..++.++|+||||+++++|++|+.|+.....+. +... ........
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~~ 229 (265)
T cd08217 159 ILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKEGKFRR 229 (265)
T ss_pred cccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----HhcCCCCC
Confidence 76543321 223468999999999998889999999999999999999999997543211 1111 11111111
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+|++.+|.+||++.+|+++
T Consensus 230 ---------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ---------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=294.50 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=194.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|.+.++||+|+||.||+|... ..+..+++|+++... ......+.+|+.++++++|+||+++++++.+....++|+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~---~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred ceeEEEecccCCeEEEEEEEC---CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 556789999999999999874 356789999986432 222346788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++ +|.+++.. ...+++..++.++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 99974 77777654 5678999999999999999999995 4999999999999999999999999999986543221
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC------cccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE------KLDD 750 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~ 750 (813)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ .+ .......... ....
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhh
Confidence 1 2234578899999998765 468899999999999999999988643322111 00 0001000000 0000
Q ss_pred cccc----ccc-----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 751 LVEG----DME-----ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 751 ~~~~----~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+. ... ........+.+.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 000 00111245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.51 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=199.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|.+.+.||+|+||.+|++... .+++.+++|++... .....+++.+|+.++++++|+||+++++++.+.+..++|+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSK---EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred ceEEEEeccCCceEEEEEEEc---CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 566789999999999999874 35678999998643 2233457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++++|.+++... ..+++..+++++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999998654 357899999999999999999995 499999999999999999999999999998664332
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....++..|+|||++.+...+.++|+||||+++++|++|+.|+......+. ...... +...
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~-~~~~------- 219 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIR-GSYP------- 219 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhc-CCCC-------
Confidence 11 1234578899999999988899999999999999999999999875432211 111111 1000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++.+||+.+|.+||++.+|+++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 --PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112345678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=291.94 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=201.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.+.||+|++|.||++... .++..+++|.+.... ....+++.+|++++++++|+||+++++.+..+...++|+|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHR---PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEc---CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 456788999999999999874 356789999987543 2344578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++++|.+++... ..+++..+..++.|++++|+|||. ..+++|+||||+||++++++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999999999765 778899999999999999999995 159999999999999999999999999998766432211
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
...++..|+|||.+.+..++.++||||||+++++|++|+.||......... ......... ......
T Consensus 158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~---------~~~~~~ 223 (265)
T cd06605 158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIV---------NEPPPR 223 (265)
T ss_pred ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHh---------cCCCCC
Confidence 156788999999999889999999999999999999999999654211110 001111111 100000
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++..||..+|.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0111145678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.56 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=194.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-----ccchhhhheeeeeeccccCCcceEEeEeecC--Cc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QN 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 593 (813)
+.+.+.||+|+||.||+|... .++..|+||.+..... ...+.+.+|+.++++++|+||+++++++.+. ..
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDA---DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred ceEeeEEecCCceEEEEEEEc---CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 456789999999999999874 3567899998753211 1234678899999999999999999988664 45
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++|+||+++++|.+++.....+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 78999999999999999877778899999999999999999995 489999999999999999999999999998654
Q ss_pred cCccc-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSK-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ . .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~~~------ 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--I----FKIATQP------ 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--H----HHHhcCC------
Confidence 32111 112234588899999999888899999999999999999999999974422111 0 0110000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
............+.+++.+|+. +|.+||+++||+++
T Consensus 226 ---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0011122345677888899985 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.94 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=199.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc------ccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
+...+.||+|++|.||++... .++..+|+|.++.... ...+++.+|++++++++|+||+++++++.+.+..
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDV---KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHF 78 (268)
T ss_pred ccccceecCcCceEEEEEEEc---CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeE
Confidence 345578999999999999763 3567899998864321 1245688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLT 673 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~ 673 (813)
++|+||+++++|.+++.....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++ .+||+|||++....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 9999999999999999887788999999999999999999995 4999999999999998775 59999999998765
Q ss_pred cCccc--ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 674 LNQSK--AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 674 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
..... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||........... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~---- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATT---- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccCC----
Confidence 43211 112234578899999999888899999999999999999999999864332111110 111000000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...........+.+++.+||+.+|.+||++.|++++
T Consensus 229 -----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 -----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 011122345778899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.86 Aligned_cols=255 Identities=18% Similarity=0.244 Sum_probs=199.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.+.||+|+||.||++... ..++.|+||.+.... ....+.+.+|+++++.++|+||+++++.+.+++..++|
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHK---ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred ceEeeEeecCCCeeEEEEEEC---CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 456789999999999999874 356789999886542 12234678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++.....+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999999888888999999999999999999995 4999999999999999999999999999874211100
Q ss_pred c-------------ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 678 K-------------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 678 ~-------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
. .......++..|+|||.+....++.++|+||||+++|||++|+.||.....++. .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~------~~~~-~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQV-I 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-H
Confidence 0 001123578899999999888899999999999999999999999974432211 0010 0
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
.+. ...+.. ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDD---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcc---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 000100 01235678899999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=288.68 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=199.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.++||+|+||.||+|... ..+..+|||.+.... ....+.+.+|+.++.+++|+||+++++++..+...++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDN---RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEEC---CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 34566788999999999999763 356789999876432 22335688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+||+++++|.+++.. ..+++..+..++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999999998864 457899999999999999999995 5999999999999999999999999999876643321
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. .....++..|+|||.+.+...+.++|+||||+++++|++|..|+......... ........ +.
T Consensus 157 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-----~~-- 220 (277)
T cd06641 157 K--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-------FLIPKNNP-----PT-- 220 (277)
T ss_pred h--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH-------HHHhcCCC-----CC--
Confidence 1 22345788999999998888899999999999999999999998643321110 00011000 00
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.+|.+||++.+++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 --LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111335678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=291.73 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=193.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEee-----cCCc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD-----EGQN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~ 593 (813)
++++.+.||+|+||.||++... ..+..+++|.++.. .....++.+|+.++.++ +|+||+++++++. .+..
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~---~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNK---KNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEEC---CCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 4566789999999999999874 35678999987642 22345688899999999 6999999999884 3456
Q ss_pred eEEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 594 RLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
.++||||+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCce
Confidence 8999999999999998753 3467888999999999999999995 59999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
+........ .....|+..|+|||.+.. ..++.++|||||||++|||++|+.|+........ +. . ..
T Consensus 172 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~----~-~~ 242 (286)
T cd06638 172 AQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF----K-IP 242 (286)
T ss_pred eecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh----h-cc
Confidence 876432211 233468999999998853 4478899999999999999999999865432111 00 0 00
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
......... .......+.+++.+||+.+|++|||+.||++++
T Consensus 243 ~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000111 111345788999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=285.90 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=205.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.+.||+|++|.||++... ..+..++||++..... ...+++.+|+.++.+++|+||+++++++......++|+|
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~---~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHK---PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 456789999999999999885 3577899999875433 345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+++.....+++..++.++.|+++||+|||+ ..+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 99999999999887888999999999999999999994 159999999999999999999999999999876543322
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.|+..........+.... . ......
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~-~~~~~~--------- 222 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---C-DGPPPS--------- 222 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---h-cCCCCC---------
Confidence 12345788999999999888999999999999999999999999755321111111111 1 110000
Q ss_pred ccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIK-CVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... .+..+.+++.+||+.+|++||++.|++++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112 46789999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=289.70 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=197.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccc---cCCcceEEeEeecCCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 596 (813)
|++.+.||+|+||.||+|... .++..++||.+.... ....+++.+|+.++++++ |+|++++++++.++...++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHV---PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhheeccCCceEEEEEEc---CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 456788999999999999874 356789999886432 233456888999998886 9999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++... .+++...+.++.|+++||.|||+ .+|+|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999998654 68899999999999999999995 499999999999999999999999999998765443
Q ss_pred ccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. .....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||......... ...... ..+.
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~-----~~~~ 221 (277)
T cd06917 156 SK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKS-----KPPR 221 (277)
T ss_pred cc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccC-----CCCC
Confidence 21 2334688899999988654 4688999999999999999999999754321110 000000 0111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+. .......+.+++.+||+.||.+||++.|++++
T Consensus 222 ~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11 11135678899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=292.37 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=201.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.+.||+|+||.||++... .++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV---ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc---CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 45667789999999999999764 356789999986544444567889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999999998654 57889999999999999999995 49999999999999999999999999998765443221
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....++..|+|||.+....++.++||||||+++||+++|+.||.......... .... .+....
T Consensus 172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~--------~~~~~~ 235 (293)
T cd06647 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPEL 235 (293)
T ss_pred --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc--------CCCCCC
Confidence 223458889999999988889999999999999999999999997543221100 0000 000000
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111234678899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=290.48 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=199.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|.+.+.||+|++|.||+|... .++..|+||++.... ....+.+.+|+.++++++|+||+++++++..+...++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDR---ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred ceEEeecccCCCcEEEEEEEC---CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 567789999999999999874 356789999987543 223457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+ +++|.+++.. ...+++..++.++.||+++|+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999 9999999864 4568999999999999999999995 4999999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC----------
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE---------- 746 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 746 (813)
.. .....++..|+|||.+.+. .++.++||||+|++++||++|.++|......+.. ......+...
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 RL-YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred Cc-cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccC
Confidence 11 2234688999999998654 4688999999999999999998877654332111 1111111000
Q ss_pred --ccccccccccc----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 --KLDDLVEGDME----ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 --~~~~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....+..+... .....+....+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00001235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=284.98 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=198.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.+.||+|++|.||++... ..+..++||.+... .....+.+.+|++++++++|+||+++++.+..++..++|+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRK---ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred ceEEEEecccCceEEEEEEEc---CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 567789999999999999874 35678999988643 2233457889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-CCEEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGla~~~~~~ 675 (813)
||+++++|.+++... ..+++..+.+++.+++++|.|||+ .+++|+||||+||+++++ ..+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999999764 457899999999999999999995 499999999999999855 46899999999876543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. .....++..|+|||.+.+...+.++||||||+++++|++|+.||........ ...... .....+
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~-~~~~~~---- 221 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMS-GTFAPI---- 221 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHh-cCCCCC----
Confidence 22 2234578899999999988889999999999999999999999875432211 111110 001111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+||+.+|.+|||+.|++++
T Consensus 222 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 -----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=289.32 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=198.2
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
.+.||+|++|.||++... ..+..+++|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 24 ~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 24 FVKIGEGSTGIVCIATDK---STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred ceEeccCCCeEEEEEEEC---CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 468999999999999864 35678999998755444456688999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeec
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 683 (813)
++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... ...
T Consensus 101 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~ 174 (285)
T cd06648 101 GALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKS 174 (285)
T ss_pred CCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--ccc
Confidence 999999877 568899999999999999999995 49999999999999999999999999988765432211 223
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHH
Q 045343 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK 763 (813)
Q Consensus 684 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (813)
..|+..|+|||.+.+..++.++||||||++++||++|+.||......... ........ +... ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~-------~~~~~~~~-----~~~~--~~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-------KRIRDNLP-----PKLK--NLHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH-------HHHHhcCC-----CCCc--cccc
Confidence 45889999999998888999999999999999999999998654321110 00111100 0111 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 764 CVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 764 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....+.+++.+||+.+|++||++.+++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 35678999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=299.52 Aligned_cols=241 Identities=26% Similarity=0.349 Sum_probs=197.8
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
++||+|+||-||-+... .+...||||++.-. ......++..|+..|.+++|||+|.+.|++..+...|||||||
T Consensus 32 rEIGHGSFGAVYfArd~---~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred HHhcCCccceeEEeecc---CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH
Confidence 57999999999999875 36678999998632 2222346889999999999999999999999999999999999
Q ss_pred CCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 602 NNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 602 ~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
-| |-.|++. ..+++.+-.+..|..+.+.||+||| +.+.||||||+.||||++.|.|||+|||.|....+.
T Consensus 109 lG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 109 LG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred hc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 55 6667664 4567888899999999999999999 559999999999999999999999999999887653
Q ss_pred eecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
..++||+.|||||+|. .+.|+-|+||||||+...||...++|.-...... .+-.+......
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---------------ALYHIAQNesP 243 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------------ALYHIAQNESP 243 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---------------HHHHHHhcCCC
Confidence 3467999999999884 4679999999999999999999999875322111 01112222223
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.....+.+..++.++..||++-|.+|||..+++++-
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 334568899999999999999999999999998874
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=290.02 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=192.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|.+.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISR---INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEc---CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3556789999999999999874 3467899999865432 22345788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 566666543 4567888889999999999999995 4999999999999999999999999999976433211
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---C------c
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---E------K 747 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~------~ 747 (813)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||+........ +.+ .+..... . .
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 159 T--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LEK-IWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HHH-HHHHcCCCChhhhhhhhh
Confidence 1 1233468899999998764 5788999999999999999999999754432111 111 1110000 0 0
Q ss_pred c----cccc----cccccc-cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 L----DDLV----EGDMEA-LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~----~~~~----~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. .... ...... .........+.+++.+|++.||.+|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 0000 000000 0011124677899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=286.43 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=201.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.+.||.|+||+||+|... .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICL---PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEc---CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 567789999999999999864 256789999986432 2245678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
++++++|.+++... ..+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999753 458899999999999999999995 599999999999999999999999999998765433
Q ss_pred cc--ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 677 SK--AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 677 ~~--~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.. .......++..|+|||.+... ..+.++|+||||++++||++|+.||........ +. ..... . .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~----~~~~~-~-----~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LM----LTLQN-D-----P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HH----HHhcC-C-----C
Confidence 22 112334688999999998877 788999999999999999999999975433210 10 11110 0 0
Q ss_pred ccccccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 GDMEALN-DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+...... .......+.+++.+||+.||++||++.+|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011000 12345778899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=291.69 Aligned_cols=244 Identities=25% Similarity=0.269 Sum_probs=199.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
|.+.+.||+|+||.||++.... .++.+|+|.++... ....+.+.+|++++++++|+||+++++++.++...++|
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 5677899999999999998753 56789999986432 12345688899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++.....+++..+..++.||++||.|||+ .+++|+||+|+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999999888889999999999999999999995 59999999999999999999999999999876543
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......... ...... ...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~--------~~~ 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY-------EKILEG--------KVR 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcC--------Ccc
Confidence 22345889999999998888899999999999999999999999754321100 000010 000
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
. .......+.+++.+||+.||.+|+ +++|++++
T Consensus 217 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 F--PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred C--CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 112256788999999999999999 77777744
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=290.78 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=193.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeec------C
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE------G 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~ 591 (813)
..+++.+.||+|+||.||+|... ..+..+|+|.+.... ....++..|+.++.++ +|+||+++++++.. .
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEc---CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 34566789999999999999874 356789999886532 2345688899999988 69999999999853 4
Q ss_pred CceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+..+++|||+++|+|.+++... ..+++..+..++.||++||.|||+ .+|+|+||||+||++++++.++|+|||++
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 5689999999999999998653 457888889999999999999995 49999999999999999999999999998
Q ss_pred cccccCcccceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
......... .....|+..|+|||.+. ...++.++||||||+++|||++|+.||.......... ..
T Consensus 169 ~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~~-- 238 (282)
T cd06636 169 AQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------LI-- 238 (282)
T ss_pred hhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------hH--
Confidence 765432211 23356889999999885 3457889999999999999999999996433211100 00
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....... ......+..+.+++.+||+.||.+||++.|++++
T Consensus 239 ----~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 ----PRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----hhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0000000 1111345678999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=286.89 Aligned_cols=243 Identities=25% Similarity=0.285 Sum_probs=188.1
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeee---eeccccCCcceEEeEeecCCceEEEEe
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVV---IGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.||+|+||.||++... .++..+|||.+..... .....+.+|..+ +...+|+||+.+++++..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEEC---CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 4899999999999874 3577899998864321 112223444433 333479999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+++.....+++..+..++.|++.||.|||. .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999999999888889999999999999999999995 599999999999999999999999999987554321
Q ss_pred eeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....|+..|+|||.+.+ ..++.++||||||++++||++|+.||..........+... .. .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~------~~~~~--- 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL------TVNVE--- 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----hh------cCCcC---
Confidence 223458999999998864 5678999999999999999999999975433221111110 00 00001
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
........+.+++..||+.||.+|| +++|++++
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1122456788999999999999999 69999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=287.80 Aligned_cols=255 Identities=26% Similarity=0.327 Sum_probs=197.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecC--CceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 597 (813)
+++.++||.|++|.||++... ..+..+|+|.+..... ....++.+|++++++++|+||+++++++.+. ...++|
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLK---NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred eEEEEEeccCCceEEEEEEEC---CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 345688999999999999985 3567899999874322 3346789999999999999999999988543 468999
Q ss_pred EeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 598 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 3457889999999999999999995 499999999999999999999999999987654
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch--hhhhhHHHHHHhhccCccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~ 751 (813)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.....+ ....+..+... .....+
T Consensus 157 ~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 228 (287)
T cd06621 157 NSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL 228 (287)
T ss_pred ccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh
Confidence 322 12345788999999999889999999999999999999999999765321 11111111111 000111
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+. ........+.+.+++.+||+.+|.+|||+.||+++
T Consensus 229 ~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 01112346788999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=291.73 Aligned_cols=246 Identities=26% Similarity=0.323 Sum_probs=193.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+.+.+.||+|+||.||+|... ..+..|++|++..... ...+++.+|+++++.++|+||+++.+++.+++..++
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDV---RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEc---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3666788999999999999874 3567899998864322 223468899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|+||+. |+|.+++. ....+++..+..++.|++.||.|||. .+|+|+||+|+||++++++.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 999997 56666654 34568999999999999999999995 59999999999999999999999999998765432
Q ss_pred cccceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ ....... ..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~-~~---- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-DS---- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcC-CC----
Confidence 2345788999999874 35678899999999999999999999864432111 0010000 00
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.........+.+.+++.+||+.+|++||++.+|+++.
T Consensus 232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 ----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0011123467789999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.00 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=196.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+...+.||+|+||.||++... .++..+|+|++..... ...+++.+|++++++++|+|++++++++.+++..++
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV---RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc---CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 3556688999999999999874 3567899999864322 223468889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|+||+.+ +|.+++.. ...+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++......
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9999975 67676643 4668999999999999999999995 49999999999999999999999999998754422
Q ss_pred cccceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
....++..|+|||++. ...++.++||||||+++|||++|+.||......... ....... .
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~-~---- 241 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE-S---- 241 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhcc-C----
Confidence 2345788999999974 456888999999999999999999998654321110 0010100 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
...........+.+++.+||+.+|.+||++.+|++++......
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0011123456789999999999999999999999987654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=289.55 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=193.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.+++.+.||+|++|.||+|... .++..||||.+...... ....+.+|++++++++|+||+++++++.+++..++||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSK---LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEc---CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 4567789999999999999874 35678999998653222 2345678999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++ +|.+++... ..+++.....++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 99985 898888653 467899999999999999999995 4999999999999999999999999999875432211
Q ss_pred cceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cccccc--
Q 045343 678 KAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLDDL-- 751 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~-- 751 (813)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... + ......... +.....
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-L-HKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-H-HHHHHhcCCCChhhhhhhhh
Confidence 1 122346788999998865 45788999999999999999999999654321110 0 101111000 000000
Q ss_pred -----------c-cccccc-cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 -----------V-EGDMEA-LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 -----------~-~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ...+.. .........+.+++.+||+.+|.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000000 0011113677899999999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=288.96 Aligned_cols=260 Identities=24% Similarity=0.290 Sum_probs=197.3
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC--CceEEE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 597 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 597 (813)
++.++||+|++|.||+|... ..+..+++|++.... ......+.+|++++++++|+|++++++++... ...++|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNK---KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred eeeEEeccCCCeEEEEEEEC---CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 46788999999999999874 346789999997653 22335688899999999999999999999887 789999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+||+++ +|.+++... ..+++..++.++.||++||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 999975 888888665 578999999999999999999995 499999999999999999999999999998765443
Q ss_pred ccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc---cCccc---
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NEKLD--- 749 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~--- 749 (813)
... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... ....... .....
T Consensus 155 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVS 230 (287)
T ss_pred ccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccc
Confidence 211 223356788999998765 457899999999999999999999997654322111 1111100 00000
Q ss_pred cc-----------ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DL-----------VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~-----------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+ ....+.......++..+.+++.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00000000011126788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=274.88 Aligned_cols=269 Identities=23% Similarity=0.314 Sum_probs=208.6
Q ss_pred CCCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEe
Q 045343 510 CFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFC 588 (813)
Q Consensus 510 ~~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~ 588 (813)
.-+++|+.+-|. +.||+|+++.|-.++.. ..+..+|||++.+.......+..+|++++.+.+ |+||++|+++|
T Consensus 72 ~g~F~d~YkLt~---e~LGeGAyasVqtcv~i---~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 72 SGKFEDMYKLTS---ELLGEGAYASVQTCVSI---QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred cchHHHHHHhHH---HHhcCccceeeeeeeee---ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 345666666654 67999999999888764 367889999999887777888999999999985 99999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC---EEEee
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISD 665 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~D 665 (813)
+++...|||||-|.+|+|..+|+.+..+++.+..++.++||.||.+|| .++|.||||||+|||...... +||+|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeec
Confidence 999999999999999999999999999999999999999999999999 569999999999999975543 89999
Q ss_pred ccCccccccCcc-----cceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh--
Q 045343 666 FGLAKLLTLNQS-----KAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-- 733 (813)
Q Consensus 666 fGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-- 733 (813)
|.+..-...... .......+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+..+++-.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 998765432211 11123457899999999773 345889999999999999999999999876553210
Q ss_pred --hhHHHHHHhhccCcccccccccccccc--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 734 --ILTDWAFDCYRNEKLDDLVEGDMEALN--DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 734 --~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
......... ..+.+-++..+.+. -...+.+..+++...+..++.+|.++..+++
T Consensus 303 rGe~Cr~CQ~~----LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNK----LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHH----HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000111110 11111112221111 1245677788999999999999999999987
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=287.88 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=201.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+++.+.||+|++|.||+|.... .+..+++|+++.... ..+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred chHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4556789999999999998752 467899999875433 456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
+++++|.+++.... .+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK- 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh-
Confidence 99999999998776 88999999999999999999995 59999999999999999999999999998765432211
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....++..|++||.+.+..++.++||||||+++|+|++|+.|+.......... .. .........
T Consensus 173 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~~~------- 237 (286)
T cd06614 173 -RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LI-TTKGIPPLK------- 237 (286)
T ss_pred -hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhcCCCCCc-------
Confidence 223457889999999988889999999999999999999999987543321110 00 000011100
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.+|.+||++.+|+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011235678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=287.70 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=192.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecC-----Cce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-----QNR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~ 594 (813)
+.+.+.||+|+||.||++... .+++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++... ...
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~---~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNK---KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred eEEEEEeecCCCeEEEEEEEC---CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 556688999999999999874 356789999886432 2345677889999988 799999999998653 358
Q ss_pred EEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 595 LLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
++|+||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 999999999999998853 3568899999999999999999995 499999999999999999999999999988
Q ss_pred ccccCcccceeecccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
........ .....++..|+|||.+... .++.++|||||||++|||++|+.||........ +. .. ..
T Consensus 177 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~----~~-~~ 247 (291)
T cd06639 177 QLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF----KI-PR 247 (291)
T ss_pred hccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH----HH-hc
Confidence 65432211 2234578899999988643 367899999999999999999999875432111 10 11 00
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....+.+ ..+....+.+++.+||+.+|++||++.|++++
T Consensus 248 ~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111111 11234578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=287.48 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=196.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCC-----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ----- 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~----- 592 (813)
..+++.+.||+|++|.||+|... ..+..+++|.++... ...+++.+|+.+++++ +|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHK---KTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hheeheeeecCCCCeEEEEEEEC---CCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45667899999999999999874 346789999887543 2346789999999999 6999999999996644
Q ss_pred -ceEEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 593 -NRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 593 -~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 48999999999999998864 3578899999999999999999995 599999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
++......... .....++..|+|||.+.. ..++.++||||||+++++|++|+.||........ +. ..
T Consensus 159 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~ 230 (275)
T cd06608 159 VSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF----KI 230 (275)
T ss_pred cceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH----Hh
Confidence 98765433221 233458889999998753 3467889999999999999999999964322111 10 10
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ...... . .......+.+.+++.+||..||++|||+.+++++
T Consensus 231 ~-~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 P-RNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred h-ccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 000001 1 1112346788999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=288.43 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=193.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
++..+.||.|++|.||+|... ..+..|+||+++... ......+.+|++++++++|+||+++++++.+++..++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred ceeeeeecCCCceEEEEEEEC---CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 456688999999999999874 356789999886432 222356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+. ++|.+++.. ...+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 9996 688888854 3567899999999999999999995 499999999999999999999999999987654322
Q ss_pred ccceeecccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC---------
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE--------- 746 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 746 (813)
.. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ +.... ......
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIF-RTLGTPDEVVWPGVT 229 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCChhhhhhhh
Confidence 11 12234678999999887654 58899999999999999999999975433211 11100 000000
Q ss_pred -------cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 -------KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
............. .......+.+++.+||+.||.+|||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 01224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=288.01 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=195.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecC--CceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 595 (813)
.+++.+.||+|+||.||+|... .+++.++||.++..... ....+.+|+.++.+++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDK---KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEEC---CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 4667789999999999999874 35678999998643221 223567899999999999999999998777 7899
Q ss_pred EEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|+||+.+ +|.+++... ..+++..++.++.||++||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99999974 898888654 458999999999999999999995 4999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhh-hhHHHH-------HHhh--
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWA-------FDCY-- 743 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~-------~~~~-- 743 (813)
.... .....++..|+|||.+.+. ..+.++|+||||++++||++|+.||......... .+.... +..+
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3211 2234578899999998754 4688999999999999999999999754432111 000000 0000
Q ss_pred -cc---CcccccccccccccccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 -RN---EKLDDLVEGDMEALNDI-KCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 -~~---~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ..........+...... ...+.+.+++..||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00000000001000111 135678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=288.82 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=189.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeee-eeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+++.+.||+|+||.||++... .++..||||+++.... ....++..|+.+ ++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHV---PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred ceEEEEecccCCeEEEEEEEc---CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 456789999999999999874 4578999999875422 223445556654 55668999999999999999999999
Q ss_pred eecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 599 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 599 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||++ ++|.+++.. ...+++..++.++.||+.||+|||+ ..+++||||||+||+++.++.+||+|||+++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9997 678777643 3467899999999999999999995 23899999999999999999999999999986543
Q ss_pred CcccceeecccccccccCcccccC----CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
... .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..+. .... .....
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~----~~~~-~~~~~ 227 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK----QVVE-EPSPQ 227 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH----HHHh-cCCCC
Confidence 211 223457889999998865 446889999999999999999999986422111 0110 0000 00000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+ .....++.+.+++.+||+.+|.+||++.+++++
T Consensus 228 ~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 L--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred C--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011235678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=317.65 Aligned_cols=264 Identities=26% Similarity=0.405 Sum_probs=209.6
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCc----ceEEEEEEeeccccc-cchhhhheeeeeecc-ccCCcceEEeEe
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTS----TTAVAVKKLDRVFQD-GEKEFKNEVVVIGQT-HHKNLVRLLGFC 588 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~ 588 (813)
|+....-.+.+.||+|.||.|++|........ ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 34444445667999999999999987644433 578999999865433 456799999999998 699999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhccC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
.+....++|.||+..|+|.++|.... .++....+.++.|||.|++||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999997654 37788899999999999999994 589999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecc-cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccch
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAI-RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 730 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~ 730 (813)
||+..+..+||+|||+|+.............. .-...|||||.+....++.|+|||||||+||||+| |..|+......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999976544333211111 12456999999999999999999999999999999 88888642111
Q ss_pred hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
+ .+ .+.+. ...+...+..+.+++.++|+.||+.+|++||++.++++.++..
T Consensus 529 ~--~l----~~~l~---------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 E--EL----LEFLK---------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H--HH----HHHHh---------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 11 11112 2222233445678999999999999999999999999999873
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=279.45 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=202.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+...+.||+|++|.||++... .++..+++|++........+++.+|++++++++|+|++++++++..+...++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHK---RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEEC---CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 345688999999999999874 25678999999765444567799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
+++++|.+++... ..+++..+..++.|++++|.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999999776 678999999999999999999995 5999999999999999999999999999987654432
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....++..|+|||.+.....+.++||||||+++++|++|+.|+........... . .......+..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~-~~~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------I-ATNGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------H-HhcCCCCcCc------
Confidence 2234578899999999888889999999999999999999999875432111100 0 0011111111
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+||+.||.+|||+.|++++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11125678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=287.65 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=195.0
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
++.++||.|++|.||+|... .++..|+||++.... ....+.+.+|++++++++|+|++++++++.+++..++|||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDK---LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred chheEecCCCCeEEEEEEEc---CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 45688999999999999874 356789999986432 2223568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 600 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|++ ++|.+++.... .+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||+++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 995 68999987655 78999999999999999999995 4999999999999999999999999999976543221
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc--------Cc-
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN--------EK- 747 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--------~~- 747 (813)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ +.......... ..
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 1 1223468899999988654 568899999999999999999999975433211 00000000000 00
Q ss_pred ------ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 ------LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......... .........+.+++.+||+.+|.+|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 0011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=292.50 Aligned_cols=252 Identities=22% Similarity=0.366 Sum_probs=199.6
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccc-cCCcceEEeEeecCCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 593 (813)
....|++.++||+||.+.|||+... +...+|+|++... ..+....|.+|+..|.+|+ |.+||+|++|-..+..
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 3455777899999999999998753 5567888877532 2334566999999999995 9999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCC--CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+||||||- ..+|..+|..... ..| .+..+..|++.++.++|++ +|||.||||.|+|+-.. .+||+|||+|..
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~a 508 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANA 508 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcc
Confidence 99999975 5699999987643 234 7778899999999999977 99999999999999764 899999999999
Q ss_pred cccCcccceeecccccccccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNS-----------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 740 (813)
+..+.........+||..||+||.+... +.+.++||||+|||||+|+.|+.||..... . +
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~--~-- 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q--I-- 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H--H--
Confidence 9888776666778999999999988422 356799999999999999999999963211 0 0
Q ss_pred HhhccCccccccccccccccc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 741 DCYRNEKLDDLVEGDMEALND-IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.++..+.++..+...+ .....++.++|..||+.||.+||+..|++++
T Consensus 580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233344443221111 1122349999999999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=279.31 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=203.6
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecC--CceEEE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 597 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 597 (813)
...+.||+|++|.||+|... .++..+++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDK---DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred eeeeEeeecCceEEEEEEEC---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 45678999999999999874 3567899999865432 3456789999999999999999999999888 889999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+||+++++|.+++.....+++..+..++.|++++|+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999999887789999999999999999999995 5999999999999999999999999999987765432
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
........++..|+|||.+.....+.++||||||+++++|++|..||........ .............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~------- 224 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKIGSSGEPPE------- 224 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHhccccCCCcC-------
Confidence 1112334588899999999888899999999999999999999999975541110 0111111011111
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+|++.+|.+||++.|++++
T Consensus 225 --~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 --IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111235789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=284.38 Aligned_cols=247 Identities=26% Similarity=0.299 Sum_probs=200.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.+.||.|+||.||++... ..+..+++|.+..... ...+.+.+|++++++++||||+++++.+.++...++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEc---cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 567789999999999999874 3567899999875321 3356789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+||+.+++|.+++.....+++..+..++.||++||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 9999999999999877788999999999999999999995 4999999999999999999999999999887654321
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.....++..|+|||.+.+...+.++|+||||+++|+|++|+.|+..........+ ...... ..
T Consensus 156 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~--~~-------- 218 (258)
T cd05578 156 ---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET--AD-------- 218 (258)
T ss_pred ---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc--cc--------
Confidence 2334578899999999988899999999999999999999999976543211111 111110 00
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTM--KKVL 790 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl 790 (813)
.......+..+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00111235788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=293.32 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=196.8
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeecc-ccCCcceEEeEeecC--C
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG--Q 592 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~ 592 (813)
...+.+.+.||+|+||.||+|... ..+..++||++... .......+..|+.+++++ +|+||+++++++... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR---RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc---CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 455777899999999999999874 35678999988542 122334577899999999 999999999998654 3
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++|+||++ ++|..++... .+++..+..++.||+.||+|||+ .+|+|+||||+||+++.++.+||+|||+++..
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 6899999997 5898888766 77899999999999999999995 59999999999999999999999999999876
Q ss_pred ccCccc---ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHHHH-------H
Q 045343 673 TLNQSK---AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA-------F 740 (813)
Q Consensus 673 ~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~-------~ 740 (813)
...... .......++..|+|||.+.+ ...+.++||||||+++|||++|+.||.......... +.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543221 11234568899999998765 457889999999999999999999997543322110 00000 0
Q ss_pred Hhhc----cCccccccccccc--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 741 DCYR----NEKLDDLVEGDME--ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 741 ~~~~----~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+. ...+..+...... ..........+.+++.+||+.+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 0000000000000 00001235678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=282.87 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=195.9
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
||.|++|.||++... ..+..+++|.+..... ...+.+.+|+.++++++|+||+++++.+.+++..++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVK---SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEEC---CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 799999999999874 3567899999864321 2345688999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeec
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 683 (813)
++|.+++.....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||+++....... ...
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~ 151 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWT 151 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccc
Confidence 9999999887788999999999999999999995 5999999999999999999999999999987654321 223
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHH
Q 045343 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK 763 (813)
Q Consensus 684 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (813)
..++..|++||.+....++.++|+||||+++|||++|..||.....+..... ..... ..........
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY----NDILK---------GNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH----HHHhc---------cCCCCCCCcc
Confidence 4578899999999888899999999999999999999999975542111111 11110 0000011112
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 045343 764 CVEKLVMVSIWCIQEDPSLRPT-----MKKVLQ 791 (813)
Q Consensus 764 ~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 791 (813)
....+.+++.+||+.+|.+||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2578899999999999999999 667665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=287.99 Aligned_cols=266 Identities=18% Similarity=0.202 Sum_probs=185.8
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccch-----------hhhheeeeeeccccCCcceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-----------EFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l 584 (813)
+....+.+.+.||+|+||.||+|....+......+++|........... ....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3445677889999999999999987543222455666654322111100 11122334556789999999
Q ss_pred EeEeecCC----ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 585 LGFCDEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 585 ~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
++.+.... ..++++|++.. ++.+.+......++..+..++.|+++||+|||+ .+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence 99765543 23567776543 566666555556788899999999999999995 49999999999999999999
Q ss_pred EEEeeccCccccccCccc-----ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhh
Q 045343 661 ARISDFGLAKLLTLNQSK-----AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l 735 (813)
++|+|||+++.+..+... .......||+.|+|||++.+..++.++|||||||+++||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432211 112234699999999999999999999999999999999999999976532211100
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
....+. +..+..+.... ....+.+.+++..|++.+|++||++.++++.|+
T Consensus 245 -~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 -AAKCDF-----IKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -HhHHHH-----HHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000000 01111111111 123577889999999999999999999998874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=287.39 Aligned_cols=241 Identities=28% Similarity=0.330 Sum_probs=196.8
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
-+.||+|+||.||-+... .+++.+|.|++.+. ..+++....+|-.+|++++.+.||.+--.++..+.++||+..
T Consensus 190 ~RvlGkGGFGEV~acqvr---aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVR---ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eEEEecccccceeEEEEe---cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 368999999999998875 47889999988653 234455678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 601 LNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 601 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|.||+|.-+|.+.. .+++...+-++.+|+.||++||++ +||+|||||+|||||+.|+++|+|+|+|..+...+.
T Consensus 267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~- 342 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP- 342 (591)
T ss_pred ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc-
Confidence 99999999998765 789999999999999999999955 999999999999999999999999999998775543
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
....+||.||||||++.+..|+...|.|||||++|||+.|+.||........ .+++++.+-.. ..
T Consensus 343 --~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk------------~eEvdrr~~~~-~~ 407 (591)
T KOG0986|consen 343 --IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK------------REEVDRRTLED-PE 407 (591)
T ss_pred --cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh------------HHHHHHHHhcc-hh
Confidence 3345899999999999999999999999999999999999999974332110 01111111000 01
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTM 786 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 786 (813)
..+...++++.++.+..|+.||.+|.--
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1223456778888888999999999744
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.74 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=191.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccc-cCCcceEEeEeecC--CceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEG--QNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~l 596 (813)
|.+.++||+|+||.||+|... .++..+|+|+++.... ........|+.++.++. |+||+++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR---KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEc---CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 356788999999999999874 3567899999875322 22234457888888885 99999999999887 78999
Q ss_pred EEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|+||++ ++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++. +.+||+|||+++.....
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 999997 577777765 3578999999999999999999995 49999999999999999 99999999999876433
Q ss_pred cccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh-hhHHH-------HHHhhccC
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------AFDCYRNE 746 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~-------~~~~~~~~ 746 (813)
.. .....++..|+|||.+.. ..++.++|||||||++|||++|..||......+.. ..... ........
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 22 123457889999997654 45788999999999999999999999754432110 00000 00000000
Q ss_pred ccccccccccc----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDDLVEGDME----ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+... .......+..+.+++.+||+.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 00011346889999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=295.44 Aligned_cols=267 Identities=25% Similarity=0.338 Sum_probs=199.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC-----Cc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 593 (813)
|.+.+.||+|+||+||++... ..+..||||+++... .....++.+|+.+++.++|+||+++++++... ..
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNS---ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred eeEEEEeccCCCeEEEEEEec---CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 556788999999999999874 367899999986532 22344677899999999999999999988644 34
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++|+||+. ++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 799999996 6899998887889999999999999999999995 499999999999999999999999999998764
Q ss_pred cCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH--------hhc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD--------CYR 744 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~ 744 (813)
..... .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||................. ...
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 160 EKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 33211 233457889999998865 4688999999999999999999999975432211110000000 000
Q ss_pred cCcccccc-------cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 045343 745 NEKLDDLV-------EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVV 797 (813)
Q Consensus 745 ~~~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 797 (813)
.....+.+ +..... ........+.+++.+||+.+|++|||++|++++ ++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000 000000 011345678999999999999999999999988 66543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=287.96 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=191.9
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEe
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.++||+|+||.||++... ..+..+|||++.... ......+.+|+.++.++. |+||+++++++..+...++++|
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHK---PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHHHHhCCCCceEEEEEEEC---CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 34578999999999999874 356889999986432 223456888999999996 9999999999999999999999
Q ss_pred ecCCCchhhh---hh--ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 600 FLNNGTLASF---LF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 600 ~~~~gsL~~~---l~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
|+.. +|.++ +. ....+++....+++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 44443 22 23568899999999999999999995 24899999999999999999999999999976543
Q ss_pred CcccceeecccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ........... .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~-~---- 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG-D---- 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC-C----
Confidence 321 1233578899999999776 688999999999999999999999864321 00111111110 0
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+.+...........+.+++.+||+.+|++|||+++|+++
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111112356788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=311.18 Aligned_cols=268 Identities=19% Similarity=0.275 Sum_probs=185.9
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEE------------------Eeeccccccchhhhheeeeeecccc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVK------------------KLDRVFQDGEKEFKNEVVVIGQTHH 578 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h 578 (813)
....|++.++||+|+||+||++.+... .+...++| +++. ......++.+|+.++++++|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCC
Confidence 345688889999999999999876432 11111111 1111 11223467899999999999
Q ss_pred CCcceEEeEeecCCceEEEEeecCCCchhhhhhcc-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 579 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
+||+++++++...+..++|+|++. ++|.+++... ..........++.||+.||.|||+ .+|+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHE
Confidence 999999999999999999999985 4666666432 223456677899999999999995 5999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCC-Ccccchhh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEY 732 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~-~~~~~~~~ 732 (813)
|++.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++ ........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 99999999999999998765432211 23456999999999999999999999999999999999987544 32222211
Q ss_pred hhhHHHHHHhh-ccCcc-------cccccc--------ccc-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 733 AILTDWAFDCY-RNEKL-------DDLVEG--------DME-ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 733 ~~l~~~~~~~~-~~~~~-------~~~~~~--------~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+.+...... ..+.. .+.++. .+. ..........+.+++.+||+.||.+|||+.|++++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111111000 00000 000000 000 00001123456788999999999999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=272.56 Aligned_cols=284 Identities=23% Similarity=0.277 Sum_probs=205.5
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCc-ceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeec-CCce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTS-TTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~-~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 594 (813)
..|+...+||+|.+|.|||++-.+++.. .+.+|||+++..... ......+|+.+++.++|+||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 3467778999999999999976554421 347999999764321 23457889999999999999999999876 7788
Q ss_pred EEEEeecCCCchhhhhhcc-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC----CCEEEee
Q 045343 595 LLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY----YNARISD 665 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~D 665 (813)
+|++||.++ +|.++|+.+ ..++...+..|+.||+.|+.|||+ ..|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 666666432 457888999999999999999995 499999999999999877 8999999
Q ss_pred ccCccccccCcccc-eeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchh------hhhhHH
Q 045343 666 FGLAKLLTLNQSKA-IRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTD 737 (813)
Q Consensus 666 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~------~~~l~~ 737 (813)
||+++.+.+.-... .....+-|..|.|||.+.+. .|++++|||+.|||+.||++-.+.|....... ......
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999886543221 13345689999999999876 58999999999999999999998886543210 111112
Q ss_pred HHHHhhccCc------ccccccc-------c--cccccc-H-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 738 WAFDCYRNEK------LDDLVEG-------D--MEALND-I-------KCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 738 ~~~~~~~~~~------~~~~~~~-------~--~~~~~~-~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.+.+.+.... +.++.+. . ...... . ...+...+|+..+|+.||.+|.|+++.+++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~- 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP- 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-
Confidence 2222221110 1111111 0 000000 0 0122367899999999999999999998875
Q ss_pred cCcCCCCCCCCCC
Q 045343 795 GVVEVSLPPNPYP 807 (813)
Q Consensus 795 ~~~~~~~p~~p~~ 807 (813)
-..+.+.||.|+.
T Consensus 339 yF~~d~lpp~pt~ 351 (438)
T KOG0666|consen 339 YFTEDPLPPLPTS 351 (438)
T ss_pred ccccCCCCCCccc
Confidence 3455667777753
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=283.78 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=197.5
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
||+|+||.||++... ..+..+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++|+||+++
T Consensus 1 lg~g~~~~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKK---STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEEC---CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 689999999999874 3467899999865322 3345688899999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc-----
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK----- 678 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~----- 678 (813)
++|.+++.....+++..+..++.||++||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999999877788999999999999999999995 49999999999999999999999999998765433210
Q ss_pred -ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 679 -AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 679 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.......++..|+|||.......+.++||||||++++||++|+.||.....++.. .. ...+.. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~-~~~~~~--------~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QN-ILNGKI--------E 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HhcCCc--------C
Confidence 1123345788999999998888899999999999999999999999754432211 00 010000 0
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
..........+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0011112577899999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=295.04 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=195.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecC-----Cc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 593 (813)
.|.+.++||+|+||.||+|... .++..||||+++... ......+.+|+.++++++|+||+++++++... ..
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEc---CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4667789999999999999874 356789999986422 22335578899999999999999999987543 35
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++|+||+.+ +|..++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 7999999975 77776643 468899999999999999999995 499999999999999999999999999998764
Q ss_pred cCcccc-eeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Ccc
Q 045343 674 LNQSKA-IRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKL 748 (813)
Q Consensus 674 ~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~ 748 (813)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHHH
Confidence 322211 1223468899999998754 46889999999999999999999999654321110 001111110 000
Q ss_pred cccccc-------------cccc-cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 045343 749 DDLVEG-------------DMEA-LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVV 797 (813)
Q Consensus 749 ~~~~~~-------------~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 797 (813)
..+... .... .........+.+++.+||+.+|++|||+.|++++ ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 0000 0001235678899999999999999999999987 65544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=293.13 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=203.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
-.+++.+||.|+||.|||++.. ..+...|-|.+........+++.-||+||+...||+||+|++.|..++.++++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nk---et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNK---ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcc---cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3566788999999999999874 3455677888877777777889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||.||-.+.++-. ...+.+.++.-++.|++.||.||| +..|||||||+.|||++-+|.++|+|||.+.........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 9999999988755 467899999999999999999999 459999999999999999999999999998654332211
Q ss_pred ceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
...+.||+.|||||+.. ..+|+.++||||||+.|.||..+.+|......... +. .+.... .
T Consensus 187 --RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--ll-----KiaKSe-----P 252 (1187)
T KOG0579|consen 187 --RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL-----KIAKSE-----P 252 (1187)
T ss_pred --hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HH-----HHhhcC-----C
Confidence 34577999999999874 46799999999999999999999998764332111 00 000111 1
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+.+ ..+..+...+.+++.+||..||..||++.+++++
T Consensus 253 PTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 PTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Ccc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 111 1234567889999999999999999999999876
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=284.65 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=195.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+++.++||+|++|.||+|... .++..||||+++..... ..+.+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNR---TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred ceEeeeeccCCceEEEEEEEC---CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 456789999999999999874 35778999998754322 34567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|+++ +|.+++... ..+++..+..++.||++||.|||+ .+++|+||||+||++++++.++|+|||+++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 888887643 357899999999999999999995 499999999999999999999999999997654322
Q ss_pred ccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHHHH-------HHhhc-cC
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA-------FDCYR-NE 746 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~-------~~~~~-~~ 746 (813)
.. .....++..|++||.+.+. .++.++||||||+++|||++|+.||......+... +.... +..+. ..
T Consensus 155 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 155 NT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 11 1234568899999988654 56889999999999999999999997554322111 00000 00000 00
Q ss_pred cccc----cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDD----LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~----~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... ..+... ..........+.+++.+|++.||.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 233 EYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 000000 00011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=285.61 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=196.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
.+||+|+||.||++... .++..||||++..........+.+|+.++++++|+||+++++.+...+..++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVK---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEc---CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 67999999999999874 367899999986544445566889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecc
Q 045343 605 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684 (813)
Q Consensus 605 sL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 684 (813)
+|.+++.. ..+++.....++.|++.+|+|||+ .+++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 103 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 103 ALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 99998754 357899999999999999999995 49999999999999999999999999998765433211 2234
Q ss_pred cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHH
Q 045343 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKC 764 (813)
Q Consensus 685 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (813)
.++..|+|||.+.+..++.++|+||||+++|||++|..||.......... ...... ...... ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~~~---------~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNL---------PPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhhC---------CcccCC--cccC
Confidence 58899999999988888999999999999999999999987543321111 000000 001100 1123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 765 VEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 765 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...+.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 4567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.00 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=192.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCC-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 592 (813)
.|.+.++||+|+||.||+|... .++..||||.+...... ....+.+|++++++++|+||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHK---KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred heEEEEEeecCCCEEEEEEEEC---CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4677789999999999999874 35788999988643221 2234567999999999999999999986654
Q ss_pred ---ceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 593 ---NRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 593 ---~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
..++|+||+.+ +|.+++... ..+++..++.++.||++||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 34999999975 777777554 4689999999999999999999954 999999999999999999999999999
Q ss_pred ccccccCccc--ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 669 AKLLTLNQSK--AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 669 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.....................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9876433221 111234578889999988664 4688999999999999999999999765433222111111110000
Q ss_pred Cccccc---------cccc-----cc-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDL---------VEGD-----ME-ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~---------~~~~-----~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+..... ..+. .. ..........+.+++.+||+.||.+|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000 00 00000123567799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.20 Aligned_cols=264 Identities=23% Similarity=0.271 Sum_probs=194.7
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCC--
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-- 592 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-- 592 (813)
....+++.+.||+|+||.||+|... .++..||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC---CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3455677899999999999999985 3567899999865322 22345778999999999999999999987655
Q ss_pred --------ceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 593 --------NRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 593 --------~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
..++|+||+++ +|.+++.. ...+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999987 66666654 3568999999999999999999995 49999999999999999999999
Q ss_pred eeccCccccccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
+|||++.......... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+... . ....
T Consensus 158 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~--~-~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE--L-ISRL 233 (302)
T ss_pred CcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHH
Confidence 9999998765432211 122345778999998865 357889999999999999999999997543321111 1 1111
Q ss_pred hcc---Ccccccc--------c------ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRN---EKLDDLV--------E------GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~---~~~~~~~--------~------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... .....+. + ....... ...+..+.+++..||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0000000 0 0000000 1135678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=289.40 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=194.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecC--CceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 595 (813)
+.+.++||+|+||.||+|..... ..+..+|||.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 45678899999999999998531 256899999987632 23345678899999999999999999999887 7899
Q ss_pred EEEeecCCCchhhhhhcc-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC----CCCEEEeec
Q 045343 596 LVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD----YYNARISDF 666 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Df 666 (813)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 565555321 367889999999999999999995 59999999999999999 999999999
Q ss_pred cCccccccCccc-ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhh-------hhhHH
Q 045343 667 GLAKLLTLNQSK-AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-------AILTD 737 (813)
Q Consensus 667 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~-------~~l~~ 737 (813)
|++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.||.....+.. ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999876433221 112234578899999988664 578999999999999999999999975443220 01111
Q ss_pred HHHHhhcc------------Cccccccc---------ccccccccH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 738 WAFDCYRN------------EKLDDLVE---------GDMEALNDI--KCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 738 ~~~~~~~~------------~~~~~~~~---------~~~~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ...+.. .......+ ..+...... .....+.+++.+||+.||++|||+.|++++
T Consensus 237 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 I-FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred H-HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 010000 00000000 000000000 234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.97 Aligned_cols=259 Identities=21% Similarity=0.243 Sum_probs=202.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeeecc-ccCCcceEEeEeecCCceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 595 (813)
+.+.+.||+|++|.||++.......++..+|||.++... ....+.+.+|+.++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456789999999999999876555567889999986432 12234678899999999 5999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++++|.+++.....+++..+..++.|++++|.|||+ .+++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 999999999999999877788999999999999999999995 59999999999999999999999999998876543
Q ss_pred cccceeecccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.... .....++..|+|||.+.+.. .+.++||||||++++||++|..||........ ........... .
T Consensus 159 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~-------~ 228 (288)
T cd05583 159 EEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS-------K 228 (288)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc-------C
Confidence 3221 22345889999999987665 78899999999999999999999864322110 00111111100 0
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.. ........+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 229 ~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 PP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 1112345678999999999999999998888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=281.27 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=197.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+.||+|+||.||+|... .++..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAK---SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred ceEEEEecCCCcceEEEEEEc---CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 456789999999999999885 356779999986431 223456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~~~ 675 (813)
||+++++|.+++.... .+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999986543 57899999999999999999995 4999999999999999875 4699999999876533
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....|+..|+|||++.+..++.++|+||||++++||++|..|+....... ....... .....+
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~---- 222 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYFAPI---- 222 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccCCCC----
Confidence 211 223458889999999988889999999999999999999999986443211 1111111 111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+|++.+|++|||+.||+++
T Consensus 223 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=285.55 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=191.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccc-cCCcceEEeEeecCCc----
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN---- 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~---- 593 (813)
+++.+.||+|+||.||+|... .++..||||+++.... .....+.+|+.++++++ |+||+++++++...+.
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~---~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDK---NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred ceEeeEecccCCeEEEEEEEC---CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 556788999999999999874 3567899998765322 22356788999999995 6999999999977665
Q ss_pred -eEEEEeecCCCchhhhhhcc-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeec
Q 045343 594 -RLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDF 666 (813)
Q Consensus 594 -~~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Df 666 (813)
.++||||+++ +|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 788887542 357899999999999999999995 59999999999999998 899999999
Q ss_pred cCccccccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 667 GLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 667 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
|+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||......... ... ......
T Consensus 156 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~-~~~~~~ 230 (295)
T cd07837 156 GLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHI-FKLLGT 230 (295)
T ss_pred ccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH-HHHhCC
Confidence 998865432211 122346788999998865 45789999999999999999999999754332110 000 010000
Q ss_pred C---ccccc---cc----cccc----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 E---KLDDL---VE----GDME----ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~---~~~~~---~~----~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ..... .+ +... ..........+.+++.+||+.||.+||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000 00 0000 00011245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.91 Aligned_cols=262 Identities=24% Similarity=0.303 Sum_probs=194.5
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC-----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG----- 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 591 (813)
..|...+.||+|+||.||++... .++..||||.+.... ....+++.+|+.++++++|+||+++++++...
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDT---VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEEC---CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 44666789999999999999874 356789999986432 22334677899999999999999999988543
Q ss_pred -CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 592 -QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 592 -~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
...++|+||+.+ +|.+.+... +++..+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999964 787777544 7888999999999999999995 499999999999999999999999999998
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhh-hhhHH-----------H
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTD-----------W 738 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~-~~l~~-----------~ 738 (813)
....... .....++..|+|||.+.+..++.++||||||+++++|++|+.||........ ..+.. .
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 7643321 2234578899999999999999999999999999999999999975432110 00000 0
Q ss_pred ----HHHhhccC------cccccccccc----cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 739 ----AFDCYRNE------KLDDLVEGDM----EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 739 ----~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........ ...++..... ...........+.+++.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0001111000 000011345678899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.69 Aligned_cols=271 Identities=23% Similarity=0.291 Sum_probs=195.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC------
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------ 592 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 592 (813)
+...+.||+|+||.||+|... .++..||||++.... ......+.+|+.++++++|+||+++++++....
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDK---RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeC---CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 345578999999999999874 356789999986432 222345788999999999999999999986543
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++|+||+.. +|..++. ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 46899999864 6666542 357899999999999999999995 49999999999999999999999999998765
Q ss_pred ccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH--------HHhh
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCY 743 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~ 743 (813)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ....
T Consensus 168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 168 DAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 322 223457889999999876 46888999999999999999999999754321111000000 0000
Q ss_pred ccCccccccc-------ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCCCCCC
Q 045343 744 RNEKLDDLVE-------GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVEVSLPPNPY 806 (813)
Q Consensus 744 ~~~~~~~~~~-------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~p~~p~ 806 (813)
.......... ..+.. ........+.+++.+||+.||.+||++.|++++ ++...+.+..+.|.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~ 313 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQ 313 (342)
T ss_pred cccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCC
Confidence 0000000000 00000 001124568899999999999999999999966 77776654444443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=286.63 Aligned_cols=262 Identities=27% Similarity=0.284 Sum_probs=193.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecC--CceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 595 (813)
.+++.+.||+|+||.||+|... ..+..||+|+++..... ....+.+|+.++++++|+||+++++++.+. +..+
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDT---TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEEC---CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4567789999999999999874 35678999998643221 123466899999999999999999998655 4689
Q ss_pred EEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|+||+.+ +|.+++.. ...+++..++.++.||++||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999975 78777764 3668999999999999999999995 4999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC---cc--
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE---KL-- 748 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~-- 748 (813)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ........ ..
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~ 235 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPNESIWPG 235 (309)
T ss_pred ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChhhchh
Confidence 3211 222345788999999865 4578999999999999999999999975543221111 11110000 00
Q ss_pred -------c--ccccccccc--cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 749 -------D--DLVEGDMEA--LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 749 -------~--~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
. .+....... .......+.+.+++.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 000000000 00011356778999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=281.27 Aligned_cols=243 Identities=28% Similarity=0.337 Sum_probs=192.2
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
||+|+||+||++... ..++.+++|.+.... ......+.+|++++++++|+||+++++.+...+..++|+||+++
T Consensus 1 lg~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVK---ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEc---CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 699999999999764 356789999886432 12234567899999999999999999999999999999999999
Q ss_pred CchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 604 GTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 604 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........ .
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 151 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---I 151 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---c
Confidence 99999997654 68899999999999999999995 4999999999999999999999999999876543211 2
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh-hhhhHHHHHHhhccCcccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ...+. .. .... ....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~----~~~~------~~~~ 217 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK----RR----TLEM------AVEY 217 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH----hc----cccc------cccC
Confidence 23457889999999988889999999999999999999999996543211 11110 00 0000 0001
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.......+.+++.+||+.+|.+|| ++.+++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 112356788999999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=288.14 Aligned_cols=260 Identities=24% Similarity=0.300 Sum_probs=191.1
Q ss_pred ccccee--eeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRG--SFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G--~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
++||+| +||+||++... ..+..||||.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT---PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEc---CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 467776 89999999863 467899999986432 22345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 601 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 601 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
+.+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999998754 457889999999999999999995 59999999999999999999999999865433221111
Q ss_pred c-e----eecccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh-h-------
Q 045343 679 A-I----RTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC-Y------- 743 (813)
Q Consensus 679 ~-~----~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-~------- 743 (813)
. . .....++..|+|||++.+. .++.++||||||++++||++|+.||......... ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccc
Confidence 0 0 0112345679999999764 4788999999999999999999999754321110 0000000 0
Q ss_pred ------------------------ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 ------------------------RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+....+.......+...+.+++++||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000001111111222233456788999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=293.03 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=198.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeec----CC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQ 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~ 592 (813)
..+++.+.||+|+||.||+|... ..+..|++|++..... ...+.+.+|+.++++++|+||+++++++.. ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT---RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 34566788999999999999875 3567899999875322 234567789999999999999999998753 34
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++|+||+. ++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 6799999996 6899999877789999999999999999999995 49999999999999999999999999999876
Q ss_pred ccCccc--ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH--------HH
Q 045343 673 TLNQSK--AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FD 741 (813)
Q Consensus 673 ~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~ 741 (813)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 433221 11123468889999999865 45789999999999999999999999754332111100000 00
Q ss_pred hhccCccccccccc-cccc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 742 CYRNEKLDDLVEGD-MEAL-----NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 742 ~~~~~~~~~~~~~~-~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
......+.+..+.. .... ........+.+++.+||+.+|.+||++.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000010000000 0000 0012357789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=286.11 Aligned_cols=250 Identities=25% Similarity=0.308 Sum_probs=194.8
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
...++...+.||+|+||.||+|... ..+..++||.+.... ....+++.+|+++++.++|+|++++++++.....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEc---CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 3344556688999999999999874 356789999886421 2223467789999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 RLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.++|+||+. |+|.+++. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999999997 57777664 34567899999999999999999995 49999999999999999999999999998765
Q ss_pred ccCcccceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
... ....++..|+|||.+. ....+.++||||||+++|||++|+.|+......+.. ..... ...
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-~~~- 231 (308)
T cd06634 166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NES- 231 (308)
T ss_pred cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHhh-cCC-
Confidence 432 2345788999999874 345788999999999999999999998643221111 00000 000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
...........+.+++.+||+.+|.+||++.+++++-.
T Consensus 232 -------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 -------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00111234567889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=279.91 Aligned_cols=250 Identities=21% Similarity=0.264 Sum_probs=195.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-----ccccchhhhheeeeeeccccCCcceEEeEeecC--Cc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-----FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QN 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 593 (813)
+.+.+.||+|+||.||+|... ..+..+++|.+... .....+.+.+|++++++++|+||+++++++.+. ..
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDA---DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEc---CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 566789999999999999874 35678999987431 112335688999999999999999999998664 35
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++|+||+++++|.+++.....+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 78999999999999999877778999999999999999999995 499999999999999999999999999998654
Q ss_pred cCcc-cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQS-KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
.... ........++..|+|||.+.+...+.++|+||||++++||++|+.||........ . .........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~---- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--I----FKIATQPTK---- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--H----HHHHcCCCC----
Confidence 3211 1112234588999999999988899999999999999999999999974322111 0 111111000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+.+++.+|++ +|.+||+..+++.+
T Consensus 228 -----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 -----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11122345778899999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=277.04 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=201.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+.||+|++|.||++... ..+..+++|.+..... .....+.+|++++++++|+|++++++++.+++..++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNL---ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEc---CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 456789999999999999874 3567899999876433 34457899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++.....+++..+..++.|++.+|.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 999999999999887889999999999999999999994 59999999999999999999999999999876543321
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....++..|+|||.+.+...+.++|||+||+++++|++|+.|+........ . .... ......
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~----~~~~-~~~~~~-------- 218 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--L----FRIV-QDDHPP-------- 218 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--H----HHHh-ccCCCC--------
Confidence 2234578899999999888889999999999999999999999874432110 0 0000 000000
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......+.+.+++.+||+.+|++||++.+++..
T Consensus 219 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 219 -LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 011235678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=289.10 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=195.7
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc--------------chhhhheeeeeeccccCCcceEEeEe
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--------------EKEFKNEVVVIGQTHHKNLVRLLGFC 588 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~ 588 (813)
+.+.||+|+||+||+|... ..++.||||+++...... ...+.+|++++++++|+||+++++++
T Consensus 13 ~~~~ig~G~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDT---LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY 89 (335)
T ss_pred hhhcccCCCceeEEEEEEC---CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence 4567999999999999864 356789999886532211 12467899999999999999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
..++..++||||+. ++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 90 VEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred ecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999997 6899999887788999999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCc------------ccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhh
Q 045343 669 AKLLTLNQ------------SKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735 (813)
Q Consensus 669 a~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l 735 (813)
+....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-- 243 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL-- 243 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 98665111 00111223467889999998764 4688999999999999999999999765432211
Q ss_pred HHHHHHhhccCc---ccc------------cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 736 TDWAFDCYRNEK---LDD------------LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 736 ~~~~~~~~~~~~---~~~------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
..+........ ... ........ ........+.+++..||+.+|++||+++|++.+-
T Consensus 244 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 244 -GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred -HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 11111111000 000 00000000 0012356788999999999999999999999754
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=283.59 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=191.7
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+++.++||+|++|.||+|... .+++.++||++..... ...+.+.+|++++++++|+||+++++++..+...++|+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred eEEEEEecCCCCEEEEEEEec---CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 566789999999999999874 3567899998864322 23356888999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~~~~~ 675 (813)
||++ ++|.+++.... .+++.....++.||+.||+|||+ .+++|+||+|+||+++. ++.+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9996 57777775443 35778888999999999999995 49999999999999985 567999999999765432
Q ss_pred cccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC---c----
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE---K---- 747 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~---- 747 (813)
... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+... . ........ .
T Consensus 157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--K-IFRILGTPNEETWPGV 231 (294)
T ss_pred ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhCCCChhhcccc
Confidence 111 1234568899999988664 57889999999999999999999997543321110 0 00000000 0
Q ss_pred --cccccc--ccccc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 --LDDLVE--GDMEA----LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 --~~~~~~--~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+..... +.... .......+.+.+++.+|++.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0011235678899999999999999999999864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=277.78 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=189.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeee-eeccccCCcceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.||+|+||.||+|... ..+..||||.++.... .....+..|..+ ....+|+|++++++++..++..++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEec---CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 57999999999999874 3567899999864321 112233444433 3455899999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++++|.+++.....+++..+..++.||+.||.|||. .+++|+||+|+||+++.++.+||+|||+++....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999999999887788999999999999999999995 5999999999999999999999999999876432
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....++..|+|||.+.+..++.++||||||+++|||++|..||......... ......... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-------DNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcccC------CCCcc
Confidence 12345788999999998888899999999999999999999999754332111 101011000 00001
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
.......+.+++.+||+.+|++||++.++.+.|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1124577899999999999999998766655553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=278.62 Aligned_cols=246 Identities=27% Similarity=0.355 Sum_probs=200.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+++.++||+|++|.||++... .++..+++|.+.... .....++.+|+.++++++|+||+++++++.+....++|+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRL---SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred ceEeeeecCCCceeEEEEEEC---CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 456789999999999999764 356789999986532 223456788999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 599 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 599 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||+++++|.+++.. ...+++..+..++.|++.||+|||. .+++|+||+|+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999999865 3567899999999999999999994 5999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.. .....++..|+|||.+.+..++.++|+||||++++||++|+.||.....++.. ..........
T Consensus 156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~---- 220 (256)
T cd08530 156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRGKYPP---- 220 (256)
T ss_pred CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCCCC----
Confidence 41 22345788999999999988999999999999999999999999754332111 0111111111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+|++.+|++||++.|++++
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 -----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112345778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=282.23 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=198.1
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.||+|++|.||++... .++..+++|++...... ....+..|+.++++++|+||+++++++..+...++|+|
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDK---LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred ccceeeecCCCceEEEEEcC---CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 45678999999999999874 35778999998654322 34568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++ +|.+++.. ...+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.++|+|||.+.........
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 9975 88877765 3578999999999999999999995 49999999999999999999999999999877654311
Q ss_pred ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cccccccc-
Q 045343 679 AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLDDLVE- 753 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~- 753 (813)
.....++..|+|||.+.+. ..+.++|+||||+++|+|++|+.||......+.... ..+.+.. .....+.+
T Consensus 155 --~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 --YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred --ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhh
Confidence 2234578889999998776 788999999999999999999999965443221100 0010000 00000000
Q ss_pred ----------cccc--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 ----------GDME--ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ----------~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... ..........+.+++..||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=281.62 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=194.3
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEe
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.||+|++|+||+|... ..++.++||++...... ......+|+..+.+++ |+||+++++++.+++..++|||
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNK---ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred eeheeeccCCceEEEEEEEC---CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 56788999999999999984 24678999998654221 2223456888899998 9999999999999999999999
Q ss_pred ecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 600 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|+ +++|.+++.... .+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99 889999887654 78999999999999999999995 4999999999999999999999999999987653221
Q ss_pred cceeecccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHH---------HHHHhhccC
Q 045343 678 KAIRTAIRGTKGYVAPEWFR-NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD---------WAFDCYRNE 746 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~---------~~~~~~~~~ 746 (813)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||......+... ... |........
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 22345788999999875 4457899999999999999999999986554322110 000 000000000
Q ss_pred ccccccc----ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDDLVE----GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....... ..+..... .....+.+++.+||+.+|++|||++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000001 114678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.56 Aligned_cols=241 Identities=20% Similarity=0.249 Sum_probs=185.8
Q ss_pred hcccc--cceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEE
Q 045343 522 NFKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 522 ~~~~~--LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.+.+. ||+|+||.||++... ..+..+++|.+....... . |+.....+ +|+||+++++.+...+..++||
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHK---PTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred ccccceeecCCCceEEEEEEEc---CCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 44455 499999999999864 356789999876432111 1 22122212 6999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~ 677 (813)
||+++++|.+++.....+++..+..++.||++||.|||+ .+++|+||||+||+++.++ .++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 999999999999887789999999999999999999995 4899999999999999988 9999999998765432
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
....++..|+|||++.+..++.++||||||++++||++|+.||.....+. .....+.... . ....
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~--------~~~~ 228 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--Q--------KKLP 228 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--c--------ccCC
Confidence 22357899999999998889999999999999999999999997443221 1111111110 0 0000
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPT-MKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 792 (813)
........+.+++.+||+.+|.+||+ ++|++++
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 229 --FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --cccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 01134577899999999999999996 6888753
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=281.58 Aligned_cols=255 Identities=22% Similarity=0.258 Sum_probs=198.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc----ccchhhhheeeeeecc-ccCCcceEEeEeecCCceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ----DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 595 (813)
+++.+.||+|+||.||++.......++..||+|.+..... ...+++.+|+++++++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 4567899999999999998754445678899999865321 2235678899999999 5999999999999988999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+|+||+++++|.+++.....+++..+..++.|+++||.|||+ .+++||||+|+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 999999999999999888888999999999999999999995 59999999999999999999999999999876443
Q ss_pred cccceeecccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.... .....|+..|+|||.+... ..+.++||||||+++|+|++|+.|+........ ............
T Consensus 159 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~------- 228 (290)
T cd05613 159 EVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE------- 228 (290)
T ss_pred cccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC-------
Confidence 2211 2234588899999998753 467899999999999999999999864322110 111111111100
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
+. ........+.+++.+||+.+|.+|| ++.+++.+
T Consensus 229 ~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 1112346788999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=290.69 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=204.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC-----c
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----N 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~ 593 (813)
+.+.+.||+|++|.||+|... ..+..++||++.... ....+.+.+|+.++++++|+||+++++++.... .
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDK---RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeC---CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 567789999999999999874 346789999987643 334467889999999999999999999987765 7
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++|+||+. ++|.+++.....+++..++.++.||++||+|||. .+|+|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 899999998 4899998877789999999999999999999995 599999999999999999999999999998765
Q ss_pred cCccc-ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc-------
Q 045343 674 LNQSK-AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR------- 744 (813)
Q Consensus 674 ~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------- 744 (813)
..... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHh
Confidence 44210 112334578899999999887 78999999999999999999999997654322111 0111100
Q ss_pred ----cCcccccccc-cccc-----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 045343 745 ----NEKLDDLVEG-DMEA-----LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVV 797 (813)
Q Consensus 745 ----~~~~~~~~~~-~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 797 (813)
.......+.. .... .........+.+++.+||+.+|.+||++.+++++ ++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000000000 0000 0011235678999999999999999999999986 55544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.45 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=206.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
...|.+.+.||+|.|++|..+.... .+..||||.+++.... ....+.+|+++|..++|||||+++.+.+....++
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3446677899999999999998864 5778999998764322 2234789999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+.+|.+.++|..+.+..+.....++.|+..+++|||. ..|+|||||++||||+.+.++||+|||++..+...
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999999998888889999999999999999994 59999999999999999999999999999988744
Q ss_pred cccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.. ....+|++.|.|||+..+..+ .+++|+||+|++||-|++|..||++..-.+ .-...+..
T Consensus 209 ~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------------Lr~rvl~g 270 (596)
T KOG0586|consen 209 LM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------------LRPRVLRG 270 (596)
T ss_pred cc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------------ccchheee
Confidence 32 456789999999999998876 578999999999999999999998543211 01112222
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.++.... ...++.++++++|..+|.+|++++++.+.-
T Consensus 271 k~rIp~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 271 KYRIPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eecccce--eechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 2222222 245677899999999999999999998653
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.70 Aligned_cols=259 Identities=25% Similarity=0.313 Sum_probs=192.5
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeecc---ccCCcceEEeEeecCCc---
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT---HHKNLVRLLGFCDEGQN--- 593 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~--- 593 (813)
++.+.||+|+||.||+|.... .+..+|||+++..... ....+.+|+.++.++ +|+||+++++++...+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred eEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 466889999999999999842 4678999998643221 123466677766655 59999999999987776
Q ss_pred --eEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 594 --RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 594 --~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
.+++|||+.+ +|.+++... ..+++..++.++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 788888654 358999999999999999999995 49999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc-
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL- 748 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 748 (813)
........ .....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+.. .............
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHh
Confidence 87654322 12334788999999999888999999999999999999999998765432211 1111000000000
Q ss_pred --------ccccccccc---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 --------DDLVEGDME---ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 --------~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......... .....+....+.+++.+||+.||.+||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 00111345677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=275.76 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=201.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+.||+|+||.||++... .++..+++|++..... ...+++.+|++++++++|+|++++++.+..+...++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRK---SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEc---CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 456788999999999999874 2567899999875432 34556889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 599 EFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 599 e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999999999763 6789999999999999999999954 999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
... ......+++.|+|||.+....++.++|+||+|+++++|++|+.|+....... + .... .......+
T Consensus 156 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~---~~~~-~~~~~~~~--- 223 (258)
T cd08215 156 TVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L---ALKI-LKGQYPPI--- 223 (258)
T ss_pred Ccc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H---HHHH-hcCCCCCC---
Confidence 431 1233468889999999988889999999999999999999999986543211 1 1111 11111111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+||+.+|.+||++.|++++
T Consensus 224 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=283.16 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=191.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+.+.||+|+||.||+|... ..+..+|||.++... .....++..|+.++.+.. |+||+++++++.++...++|
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFK---KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred hheeeeEeeccCCeEEEEEEEC---CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3567789999999999999874 246789999987532 223345666777666664 99999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+.+ +|.+++.. ...+++..+..++.||++||+|||+ ..+|+||||+|+||++++++.+||+|||++..+....
T Consensus 93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 999854 66666654 4578899999999999999999995 2489999999999999999999999999998764332
Q ss_pred ccceeecccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.....+. ..+. ..... ....+
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~-~~~~~- 239 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT----KILQE-EPPSL- 239 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH----HHhcC-CCCCC-
Confidence 2 12234778999999987654 7889999999999999999999996432211 1110 11111 00000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
. ......+++.+++.+||+.||.+||++.+++++-
T Consensus 240 ----~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 ----P--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ----C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 0112356789999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=283.44 Aligned_cols=244 Identities=26% Similarity=0.328 Sum_probs=190.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+...++||+|+||.||+|... ..+..+++|++..... ...+.+.+|++++++++|+|++++++++.+.+..++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS---HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC---CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 334567999999999999864 3567899999864322 2234578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+. ++|.+++.. ...+++..+..++.||+.+|.|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 99996 567676654 4568999999999999999999995 4999999999999999999999999999864322
Q ss_pred ccceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.....++..|+|||++. ...++.++||||||+++|||++|..|+......... ...... .....
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~~~~~-- 240 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-DSPTL-- 240 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CCCCC--
Confidence 22346888999999984 456788999999999999999999998654321111 000000 01110
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.+|.+||++.+++++
T Consensus 241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111234568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=278.28 Aligned_cols=243 Identities=24% Similarity=0.281 Sum_probs=187.9
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheee---eeeccccCCcceEEeEeecCCceEEEEe
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVV---VIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.||+|+||.||++... ..++.||||.+...... ....+..|.. .++...|+||+++++++.+.+..++|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEe---cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 4899999999999864 35678999988643211 1122334433 3444579999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+++.....+++..+..++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999999999887889999999999999999999995 499999999999999999999999999987654321
Q ss_pred eeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....|+..|+|||.+.+. .++.++||||||+++|||++|+.||............ .... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~~~~-- 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TMAVEL-- 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh------ccCCCC--
Confidence 2234689999999998754 6889999999999999999999999754322111110 0000 000111
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
....+..+.+++.+|++.+|.+|| ++.+++++
T Consensus 219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112357788999999999999999 99999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.98 Aligned_cols=260 Identities=17% Similarity=0.193 Sum_probs=191.1
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.+.+|.|+++.||++.. ++..+|||++... .....+.+..|++++++++|+||+++++++.+.+..+++|||
T Consensus 6 i~~~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhHhhcCCceEEEEEecC-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 344556666666666543 6789999998653 233446789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 601 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 601 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
+++++|.+++... ..+++.....++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999999999753 457888999999999999999995 49999999999999999999999999988755322111
Q ss_pred -----ceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhh----cc--
Q 045343 679 -----AIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY----RN-- 745 (813)
Q Consensus 679 -----~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~~-- 745 (813)
.......++..|+|||++.. ..++.++||||||++++||++|+.||....... .+.+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCc
Confidence 00122346778999999866 357889999999999999999999997543211 1111000000 00
Q ss_pred -----Ccccc----cccc----cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 -----EKLDD----LVEG----DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 -----~~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..... ..++ .............+.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0000 01111122345678899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=280.88 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=200.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 596 (813)
|.+.+.||+|+||.||++... .++..+++|.+... .....+.+.+|++++++++ |+||+++++++..++..++
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEK---ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred ceEeeeecCCCceEEEEEEEc---CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 567789999999999999874 36778999988642 1233456888999999998 9999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++.....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999999888889999999999999999999995 499999999999999999999999999998765332
Q ss_pred cc------------------ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHH
Q 045343 677 SK------------------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 738 (813)
Q Consensus 677 ~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 738 (813)
.. .......++..|+|||.......+.++||||||++++++++|+.||....... .+ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~-~- 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF-Q- 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH-H-
Confidence 11 11223457889999999988889999999999999999999999997543211 00 0
Q ss_pred HHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 045343 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM----KKVLQM 792 (813)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~~ 792 (813)
... .... .......+.+.+++.+||+.+|.+||++ ++++++
T Consensus 233 --~~~---------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 --KIL---------KLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred --HHH---------hcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 000 0000 0111235778999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=291.59 Aligned_cols=200 Identities=29% Similarity=0.444 Sum_probs=171.6
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc-chhhhheeeeeeccccCCcceEEeEeecCC------ce
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------NR 594 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 594 (813)
...+.||+|+||.||+|... +.|+.||||.++...... .+...+|+++|++++|+|||++++.-++.. ..
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnk---etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNK---ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eehhhhcCCccceeeeeccc---ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34578999999999999863 578999999997643322 345788999999999999999999876544 56
Q ss_pred EEEEeecCCCchhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc--C--CCCEEEeecc
Q 045343 595 LLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--D--YYNARISDFG 667 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~--~--~~~~kl~DfG 667 (813)
.+|||||.+|||...|... ..+++.+.+.++.+++.||.|||++ +|+||||||.||++- . .-..||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999753 5789999999999999999999976 999999999999993 2 3347999999
Q ss_pred CccccccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccch
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~ 730 (813)
.|+.+..+. .....+||..|++||.+.. +.++..+|.|||||++||.+||..||....+.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999887554 2567889999999999985 78899999999999999999999999876554
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=282.91 Aligned_cols=267 Identities=23% Similarity=0.263 Sum_probs=191.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCC----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ---- 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---- 592 (813)
..+.+.++||+|+||.||+|... .++..++||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQI---KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEEC---CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 34667789999999999999874 35678999988643222 2345778999999999999999999875433
Q ss_pred ----ceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 593 ----NRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 593 ----~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
..++|+||+.+ +|...+.. ...+++..+..++.|+++||.|||. .+|+|+||||+||++++++.+||+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999876 56665544 4578999999999999999999995 599999999999999999999999999
Q ss_pred CccccccCcccc---------eeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHH
Q 045343 668 LAKLLTLNQSKA---------IRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 737 (813)
Q Consensus 668 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 737 (813)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998654322111 01223568889999987654 57899999999999999999999997544322111100
Q ss_pred HHHHhhccC------cccccc----cccccc---cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 738 WAFDCYRNE------KLDDLV----EGDMEA---LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 738 ~~~~~~~~~------~~~~~~----~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......... .+.... ...... .......+.+.+++.+||+.||.+|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000000 000000 000000 0001223678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=260.50 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=191.9
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-ccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEee
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+...||.|..|.|+|.... ..+..+|||.+... ..+..+++...+.++.+-+ +|.||+.+|+|..+...++.||.
T Consensus 96 ~l~dlGsGtcG~V~k~~~r---s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFR---STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hHHhhcCCCccceEEEEEc---ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4578999999999999885 46789999998653 2334456777777776654 89999999999999999999998
Q ss_pred cCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|.- .++.++.. ...+++...-++...+++||.||.+ ..+|+|||+||+|||+|+.|++|++|||++-++-....
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 854 34444433 3557888888999999999999986 57999999999999999999999999999987754332
Q ss_pred eeecccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.+...|-+.|||||.+.- .+|+-++||||||+.|+||.||..||.....+-.. +.. .+.++ . +.+
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-ltk----vln~e--P----P~L 315 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LTK----VLNEE--P----PLL 315 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HHH----HHhcC--C----CCC
Confidence 344568889999999854 46888999999999999999999999865443211 111 11110 1 111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ....+..+.+++..||++|+.+||...+++++
T Consensus 316 ~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Cc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 12256788999999999999999999998865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=276.90 Aligned_cols=261 Identities=26% Similarity=0.341 Sum_probs=197.2
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.||+|++|.||+|+.. ..+..+++|.+.... ....+.+..|+.++++++|+||+++++++.+....++|+|
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDK---KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred eeehcccccCcceEEEeeec---CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 45678999999999999875 346789999987643 2234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|++ ++|.+++... ..+++..+.+++.|+++||.|||+. +|+|+||+|+||++++++.++|+|||+++........
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 998 5899999776 5789999999999999999999964 9999999999999999999999999999876543221
Q ss_pred ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhh-hhHHH-------HHHhhc-----
Q 045343 679 AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------AFDCYR----- 744 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~-------~~~~~~----- 744 (813)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+.. .+... .+....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1223457789999998776 7899999999999999999999999754432111 00000 000000
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
............. .........+.+++..||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000 0001225678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=275.25 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=190.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|.+.++||+|+||.||++...........+++|..... ......++..|+.++++++||||+++++++.+.+..++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 56778999999999999987543222223333333221 1122335677889999999999999999999999999999
Q ss_pred eecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 599 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 599 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||+++++|.+++.. ...+++..++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998853 3568999999999999999999995 59999999999999976 4699999999987643
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....++..|+|||.+.+..++.++|+||||+++++|++|..||....... ...... .....
T Consensus 158 ~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~-~~~~~----- 223 (260)
T cd08222 158 SCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIV-EGPTP----- 223 (260)
T ss_pred Cccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-cCCCC-----
Confidence 3221 223457889999999988888999999999999999999999986432111 000100 01000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ........+.+++.+||+.+|++||++.|++++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0 112345688899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=284.39 Aligned_cols=266 Identities=23% Similarity=0.292 Sum_probs=192.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeecc-ccCCcceEEeEeecC----Cc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG----QN 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~ 593 (813)
+.+.+.||+|+||.||++..... ..+..+|||++..... ...+.+.+|+.+++++ +|+||+++++++... ..
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCC-CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 45678999999999999987532 1267899999864322 1235678899999998 599999999976432 35
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++++||+. ++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678888876 6899999888889999999999999999999995 499999999999999999999999999998765
Q ss_pred cCccc--ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH--------HHh
Q 045343 674 LNQSK--AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDC 742 (813)
Q Consensus 674 ~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~ 742 (813)
..... .......|+..|+|||.+.+ ..++.++||||||+++++|++|+.||............... ...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 33221 11223568999999998765 46889999999999999999999999754322111000000 000
Q ss_pred hccCcc-------cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRNEKL-------DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+..... .......... ........+.+++.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0000000000 001124678899999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.21 Aligned_cols=266 Identities=23% Similarity=0.267 Sum_probs=191.7
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecC-------
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------- 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 591 (813)
..+.+.+.||+|+||.||+|... ..+..|++|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~---~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS---DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC---CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 34667789999999999999874 35778999998765555556788999999999999999999876543
Q ss_pred -------CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEE
Q 045343 592 -------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARI 663 (813)
Q Consensus 592 -------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl 663 (813)
...++|+||++ ++|.+++.. ..+++.....++.||++||.|||+ .+|+||||||+||+++ ++..+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 34789999997 588887754 357899999999999999999995 4999999999999997 5567899
Q ss_pred eeccCccccccCcccc-eeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH
Q 045343 664 SDFGLAKLLTLNQSKA-IRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 741 (813)
+|||+++.+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+..........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998654321111 1122357889999998754 4678899999999999999999999975433111100000000
Q ss_pred hhccCc-------ccc-ccccccccc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 742 CYRNEK-------LDD-LVEGDMEAL-----NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 742 ~~~~~~-------~~~-~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....+. ... ......... ........+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 000 000000000 001234678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=303.77 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=183.7
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEee--------------
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD-------------- 589 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------------- 589 (813)
+.||+||||.|||+..+ -+++.+|||++.... ......+.+|+.++++|+|||||+++....
T Consensus 485 ~lLGkGGFG~VvkVRNK---lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNK---LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHhcCCCCceEEEEeec---ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 57999999999999874 588999999997542 233456889999999999999999986400
Q ss_pred --------------------------------------------------------------------------------
Q 045343 590 -------------------------------------------------------------------------------- 589 (813)
Q Consensus 590 -------------------------------------------------------------------------------- 589 (813)
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence
Q ss_pred ------------------cC-------CceEEEEeecCCCchhhhhhccCCC-CHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 045343 590 ------------------EG-------QNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSAQI 643 (813)
Q Consensus 590 ------------------~~-------~~~~lV~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~gl~yLH~~~~~~i 643 (813)
+. ..+||=||||+...|.+++..+... .....++++.+|++||+|+|+. +|
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---gi 718 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GI 718 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ce
Confidence 00 1236778888888888887666544 4667889999999999999954 89
Q ss_pred eeCCCCCCcEEEcCCCCEEEeeccCccccc----------------cCcccceeecccccccccCcccccCC---CCCCc
Q 045343 644 IHCDIKPQNILLDDYYNARISDFGLAKLLT----------------LNQSKAIRTAIRGTKGYVAPEWFRNS---TITAK 704 (813)
Q Consensus 644 vH~dlk~~NIll~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~k 704 (813)
|||||||.||+||++..+||+|||+|.... ........+..+||.-|+|||++.+. +|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 00111124567899999999999765 49999
Q ss_pred cchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCC
Q 045343 705 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP 784 (813)
Q Consensus 705 ~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 784 (813)
+|+||+|||++||+. ||...++.. . +...++.+.+..- + ....+....-..+++++++.||.+||
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa-~-----iL~~LR~g~iP~~--~----~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERA-S-----ILTNLRKGSIPEP--A----DFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHH-H-----HHHhcccCCCCCC--c----ccccccchHHHHHHHHHhcCCCccCC
Confidence 999999999999986 465443211 1 1122222222221 0 11122344556899999999999999
Q ss_pred CHHHHHHH
Q 045343 785 TMKKVLQM 792 (813)
Q Consensus 785 t~~evl~~ 792 (813)
|+.|+++.
T Consensus 864 tA~eLL~s 871 (1351)
T KOG1035|consen 864 TATELLNS 871 (1351)
T ss_pred CHHHHhhc
Confidence 99999864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=263.96 Aligned_cols=246 Identities=24% Similarity=0.262 Sum_probs=197.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccc---hhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+|.+.||+|.||.|.++.-+ ..++.+|+|++++..--.. ..-..|-++|+..+||.+..|.-.|...++++.|
T Consensus 170 FdfLKvLGkGTFGKVIL~rEK---at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREK---ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred hhHHHHhcCCccceEEEEeec---ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 356789999999999987663 5778999999986432222 2345678899999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+.+|.|.-+|.....+++...+-+-..|+.||.|||+ .+||+||||.+|.|||.+|++||+|||+.+..-....
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 9999999999999999999999888899999999999994 5999999999999999999999999999876433222
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
....++||+.|+|||++....|...+|.|.+||+||||++|+.||.....+.-..+ +. -..++
T Consensus 324 --t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL-------Il--------~ed~k 386 (516)
T KOG0690|consen 324 --TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL-------IL--------MEDLK 386 (516)
T ss_pred --eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH-------HH--------hhhcc
Confidence 25678999999999999999999999999999999999999999985443221111 11 11111
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQ 791 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 791 (813)
. +.....+...|+...|.+||.+|. .+.||.+
T Consensus 387 F--Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 387 F--PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred C--CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1 112345667788888999999996 3455544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=283.82 Aligned_cols=266 Identities=25% Similarity=0.297 Sum_probs=194.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 592 (813)
.|.+.+.||+|+||.||++... .++..||||++.... ....+.+.+|+.++++++|+||+++++++..+.
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDR---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEEC---CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3556788999999999999864 357789999985422 122346788999999999999999999986554
Q ss_pred -ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 593 -NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 593 -~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
..++|+||+ +++|.+++.. ..+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999998 7788888764 468899999999999999999995 5999999999999999999999999999986
Q ss_pred cccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhh-hhhHHH-------HHHh
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW-------AFDC 742 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~-~~l~~~-------~~~~ 742 (813)
.... .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||........ ...... ....
T Consensus 168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 168 TDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 5432 223457889999999876 4578899999999999999999999975432111 000000 0000
Q ss_pred hccCcccc-------cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH--HHHhcCcCC
Q 045343 743 YRNEKLDD-------LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL--QMLEGVVEV 799 (813)
Q Consensus 743 ~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl--~~L~~~~~~ 799 (813)
+....... .....+. .........+.+++.+|++.||.+|||+.+++ ..++...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 00000000 0000000 00112345688999999999999999999999 444554433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=311.07 Aligned_cols=248 Identities=28% Similarity=0.385 Sum_probs=201.6
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
...||.|.||.||-+... .+|...|+|-++... ....+...+|+.++..++|||+|+.+|+-.+.+..+|.||||
T Consensus 1240 g~~Ig~G~fG~VYtavN~---~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNL---DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred ccccCCcceeeeEEeecC---CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 357999999999999875 467788999776432 334566889999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc--c
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK--A 679 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~--~ 679 (813)
++|+|.+.+......++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|+.+.++... .
T Consensus 1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999999999888888888888999999999999965 9999999999999999999999999999988765311 1
Q ss_pred eeecccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH-hhccCccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-CYRNEKLDDLVEGD 755 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~---~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~ 755 (813)
.....+||+-|||||.+.+.+ ...+.||||+|||++||+||++|+.....+ |+.- .+..+...++.+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~Pq~P~-- 1464 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHKPQIPE-- 1464 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCCCCCch--
Confidence 123567999999999997643 566899999999999999999999744321 2211 122222222211
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
....+-.+++..||+.||.+|-++.|++++-
T Consensus 1465 -------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1465 -------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred -------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2456778999999999999998888887763
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=284.46 Aligned_cols=259 Identities=25% Similarity=0.301 Sum_probs=189.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC------C
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------Q 592 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 592 (813)
+.+.+.||+|+||.||+|... .++..||||+++... ....+.+.+|+.++++++|+||+++++++... .
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEc---CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 445678999999999999864 356789999986532 22245678899999999999999999988543 3
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 467788876 78998877654 58999999999999999999995 49999999999999999999999999998765
Q ss_pred ccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHHH-------HHHhh
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCY 743 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~ 743 (813)
... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... +... ....+
T Consensus 171 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 171 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 322 223457889999998866 467889999999999999999999996543221110 0000 00000
Q ss_pred ccCccc-------ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 744 RNEKLD-------DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 744 ~~~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
...... ........ .........+.+++.+|++.||.+||++.+++++=
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred ccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000000 00000000 00001345688999999999999999999999663
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=259.75 Aligned_cols=259 Identities=22% Similarity=0.234 Sum_probs=198.5
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeec----CCceEEEEe
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE----GQNRLLVYE 599 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e 599 (813)
++||-|-.|.|-.+..+ ..+...|+|+|.+. ...++|+++--+. .|+|||.++++++. ...+++|||
T Consensus 68 qvLG~GinGkV~~C~~k---~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHK---RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEEEec---cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 57999999999988775 35667899998643 2446677665444 59999999998853 346789999
Q ss_pred ecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc---CCCCEEEeeccCcccccc
Q 045343 600 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLLTL 674 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGla~~~~~ 674 (813)
.|+||.|...++.+. .++++++..|+.||+.|+.||| +.+|.||||||+|+|.. .+..+||+|||+|+.-..
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999998764 5899999999999999999999 56999999999999996 466799999999987653
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
... ....+-|+.|.|||++...+++...|+||+||++|-||+|.+||...-+.. +..+.-.++..+
T Consensus 217 ~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispgMk~rI~~g 282 (400)
T KOG0604|consen 217 PGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGMKRRIRTG 282 (400)
T ss_pred Ccc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChhHHhHhhcc
Confidence 222 344567999999999999999999999999999999999999998544311 011111122222
Q ss_pred cccccc--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCCC
Q 045343 755 DMEALN--DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPF 808 (813)
Q Consensus 755 ~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~ 808 (813)
....+. -...++...++++.+|..+|.+|.|+.|++.+=--....-.|..|..-
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST 338 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence 222111 124577888999999999999999999999775433344445555443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=268.78 Aligned_cols=237 Identities=28% Similarity=0.309 Sum_probs=192.7
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
||+|+||.||++... .++..+++|.+...... ....+..|+.++++++|+||+++++.+..+...++||||+++
T Consensus 1 lg~G~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKK---DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEEC---CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 699999999999874 25678999988653221 344788999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeec
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 683 (813)
++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~ 152 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNT 152 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--ccC
Confidence 9999999888788999999999999999999995 59999999999999999999999999999876543211 234
Q ss_pred ccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHH
Q 045343 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIK 763 (813)
Q Consensus 684 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 763 (813)
..++..|++||.+.+...+.++|+||||+++|||++|+.||....... ... .... .... ....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~---------~~~~--~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE---KILK---------DPLR--FPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHhc---------CCCC--CCCC
Confidence 567889999999988888999999999999999999999996543211 100 1100 0010 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHH
Q 045343 764 CVEKLVMVSIWCIQEDPSLRPTMKK 788 (813)
Q Consensus 764 ~~~~l~~l~~~Cl~~dP~~RPt~~e 788 (813)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2577889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=271.15 Aligned_cols=266 Identities=25% Similarity=0.314 Sum_probs=204.1
Q ss_pred CCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccc----cchhhhheeeeeeccccCCcce
Q 045343 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQD----GEKEFKNEVVVIGQTHHKNLVR 583 (813)
Q Consensus 511 ~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~----~~~~~~~E~~~l~~l~h~niv~ 583 (813)
|.-.-.....|-+...||+|||+.|||+.+. .+.+.||||+-... .++ -.+...+|..|-+.|.|+.||+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl---~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDL---TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhccc---chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 3333344556667788999999999999875 36678999975421 111 1234678999999999999999
Q ss_pred EEeEee-cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc---CCC
Q 045343 584 LLGFCD-EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYY 659 (813)
Q Consensus 584 l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~---~~~ 659 (813)
+++++. +.+.++-|+||+++.+|+-||+.+...++++.+.|++||+.||.||.+. +++|||-||||.||||. .-|
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 999985 5567899999999999999999999999999999999999999999976 88999999999999995 457
Q ss_pred CEEEeeccCccccccCccc-----ceeecccccccccCcccccC----CCCCCccchhhHHHHHHHHHhCCcCCCcccch
Q 045343 660 NARISDFGLAKLLTLNQSK-----AIRTAIRGTKGYVAPEWFRN----STITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730 (813)
Q Consensus 660 ~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~ 730 (813)
.+||.|||+++.+..+... .......||..|++||++-- .+++.|+||||.|||+|..+.|+.||......
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 8999999999998754332 12344679999999998843 35788999999999999999999999765432
Q ss_pred hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
.... ....+-.. ..+..+.......+...+|++||+..-++|....++..
T Consensus 691 QdIL---------qeNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 QDIL---------QENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHH---------hhhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2111 11111110 01112222334567789999999999999998887764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=280.28 Aligned_cols=260 Identities=24% Similarity=0.298 Sum_probs=191.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeec-CCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l 596 (813)
.|.+.+.||+|+||.||++... .++..+|||++.... ....+.+..|+.++++++||||+++++++.. ....++
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQ---LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ceEEEEeecccCCeEEEEEEEC---CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 3556789999999999999864 367789999875422 2234568889999999999999999998865 567899
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|+||+ +++|.+++.. ..+++.....++.|+++||.|||+ .+|+|+||+|+||++++++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 99998 5688888764 356788888999999999999995 59999999999999999999999999998754322
Q ss_pred ccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh-hHHHH-------HHhhccCc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA-------FDCYRNEK 747 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~-------~~~~~~~~ 747 (813)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... +.+.. ......+.
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 123457889999998866 568899999999999999999999996543211110 00000 00000000
Q ss_pred cccccc-cccccccc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVE-GDMEALND-----IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~-~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..++.. ........ ......+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000000 1234688999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=281.38 Aligned_cols=241 Identities=25% Similarity=0.313 Sum_probs=196.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 597 (813)
..|++...+|.|+|+.|-++... .+.+..+||++.+. ..+-.+|+.++.+. +|+||+++.+.+.++.+.++|
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~---~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESS---PTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred hhhccccccCCCCccceeeeecc---ccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 34667788999999999998875 35667889988654 33456778777666 699999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE-cCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL-DDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll-~~~~~~kl~DfGla~~~~~~~ 676 (813)
||.+.++.|.+.+....... ..+..|+.+|+.++.|||. .+++||||||+|||+ ++.++++|+|||.++....+
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999888887776665 7888899999999999995 499999999999999 58999999999999987655
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
....+-|..|.|||++....+++++|+||||++||+||+|+.||........ +...+.....
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~i~~~~~-------- 531 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTRIQMPKF-------- 531 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHhhcCCcc--------
Confidence 1223468899999999999999999999999999999999999975543311 1111111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
....++...+|+.+||+.||.+||+|.++..+=
T Consensus 532 ----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 532 ----SECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred ----ccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 124567889999999999999999999998763
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.63 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=198.3
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeec
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE 590 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 590 (813)
-+.....+|..+||+|+||.|-++.. ++....+|||++++.. ..+.+--+.|-++|+.. +-|.++++..++..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaer---kgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAER---KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecc---cCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 34445568999999999999998865 3466789999997642 12222245677777766 57889999999999
Q ss_pred CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
.++++.||||+.+|+|--++++-.++.+..+.-++..||-||-+|| +.+|++||||..|||||.+|++||+|||+.+
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999999999999889999999999999999999999 5699999999999999999999999999998
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
.--.+. ......+||+.|+|||++..++|+..+|.|||||+||||+.|.+||+++.+++-.. .
T Consensus 499 Eni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------a 561 (683)
T KOG0696|consen 499 ENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------A 561 (683)
T ss_pred ccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------H
Confidence 643322 22456899999999999999999999999999999999999999999776543221 1
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCC
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT 785 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 785 (813)
+.+....- +...+.+...+....|.+.|.+|.-
T Consensus 562 I~ehnvsy--PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 IMEHNVSY--PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHccCcC--cccccHHHHHHHHHHhhcCCccccC
Confidence 22222221 2234567778888889999999853
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=283.10 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=192.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCc-----
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----- 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 593 (813)
|.+.+.||+|++|.||+|.... .+..+|||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred eEEEEEeccCCceEEEEEEECC---CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 5567899999999999998853 56789999986431 2233557789999999999999999998766554
Q ss_pred -eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 -RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 -~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||. .+|+|+||||+||++++++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 5699888865 468999999999999999999995 59999999999999999999999999999875
Q ss_pred ccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhh-hhhHHH-------HHHhh
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW-------AFDCY 743 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~-~~l~~~-------~~~~~ 743 (813)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..+... ....+
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 432 223457889999998865 3678899999999999999999999975433211 000000 00000
Q ss_pred ccCcccccccc-------cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 RNEKLDDLVEG-------DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 ~~~~~~~~~~~-------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.. ..... .....+.+.+++.+||+.+|.+|||+.||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000 00000 01125678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=299.52 Aligned_cols=269 Identities=20% Similarity=0.243 Sum_probs=211.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
...+++.+.||+|+||.|..+... ..++.+|.|++.+. ......-|++|-.+|..-+.+=|+.+.-.|.++..+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k---~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHK---STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEee---ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 345667899999999999998875 46789999999763 233344588999999888899999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
|+|||||+||+|-.++....++++..++-++..|.-||.-|| +.|+|||||||.|||||..|++||+|||..-.+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999999988778999999999999999999999 57999999999999999999999999999988876
Q ss_pred CcccceeecccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
+..-. ....+|||.|++||++.. +.|++.+|.||+||++|||+.|..||..+.-.+ ..........
T Consensus 228 dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve------TY~KIm~hk~-- 298 (1317)
T KOG0612|consen 228 DGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE------TYGKIMNHKE-- 298 (1317)
T ss_pred CCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH------HHHHHhchhh--
Confidence 54432 456789999999999953 468899999999999999999999998654211 1111111111
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH-------hcCcCCCCCCCCCC
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT---MKKVLQML-------EGVVEVSLPPNPYP 807 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~L-------~~~~~~~~p~~p~~ 807 (813)
.+..+...+.++...+||+..+. +|+.|.. ++++..+- +.|.+...|-.|..
T Consensus 299 -----~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 299 -----SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred -----hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 11122223456778888887654 7788887 88888763 44556665555544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=264.72 Aligned_cols=221 Identities=21% Similarity=0.182 Sum_probs=175.9
Q ss_pred eeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCCchhhh
Q 045343 530 GSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 609 (813)
Q Consensus 530 G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 609 (813)
|.+|.||++... .+++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~---~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDT---RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEc---cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999874 456789999986532 233344444455799999999999999999999999999999999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeeccccccc
Q 045343 610 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689 (813)
Q Consensus 610 l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 689 (813)
+.....+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 9877778999999999999999999995 59999999999999999999999999988665432 122345678
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHH
Q 045343 690 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLV 769 (813)
Q Consensus 690 y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 769 (813)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... .. ...+ .+ +......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~--~~~~---~~----~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT--HTTL---NI----PEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc--cccc---CC----cccCCHHHH
Confidence 999999988888999999999999999999998765321100 00 0000 00 112346788
Q ss_pred HHHHHhcccCCCCCCCHH
Q 045343 770 MVSIWCIQEDPSLRPTMK 787 (813)
Q Consensus 770 ~l~~~Cl~~dP~~RPt~~ 787 (813)
+++.+|++.||.+||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=259.73 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=200.1
Q ss_pred ccccceeeeeeEEEEEEeccC--CcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeec-CCceEEEEe
Q 045343 524 KEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYE 599 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 599 (813)
...+-+|.||.||+|.+...+ .+.+.|-||.++... +-....+..|..++..+.|||+..+.+++.+ .+..+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 446889999999999876432 233456777765432 2223457788888888899999999999855 457899999
Q ss_pred ecCCCchhhhhhc--------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 600 FLNNGTLASFLFG--------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 600 ~~~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
++.-|+|..||.. ...++-.+...++.|++.|++|||. .+|||.||..+|.+||+..++||+|-.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence 9999999999972 1344566677889999999999995 4999999999999999999999999999998
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
+.+.+.............||+||.+.+..++..+|||||||+||||+| |+.|+..-.+.+.. .
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----------------~ 509 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----------------H 509 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----------------H
Confidence 876655443333445678999999999999999999999999999999 88888654443321 1
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
.+....+..++.++++++..+|.-||..+|++||++++++.-|.+
T Consensus 510 ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 122233444566789999999999999999999999999998865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=274.52 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=195.2
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
.|.||.|.||+||-|+.. ..|+.||||.+.+. ....+.++++|+.||++++||.||.+.-.|+..++.++|||-+
T Consensus 569 devLGSGQFG~VYgg~hR---ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHR---KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceec---ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 368999999999999885 57889999999764 2345577999999999999999999999999999999999999
Q ss_pred CCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCEEEeeccCccccccCcc
Q 045343 602 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 602 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGla~~~~~~~~ 677 (813)
.+.=|+-+|.. ..++++..-.-++.||+.||.|||. ++|+|+||||+||||.. --++||+|||.|+.+.....
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 77666666654 4678888888899999999999995 59999999999999964 35799999999999875433
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
....+||+.|+|||++.++.|...-|+||.|||+|--|+|..||..+.+- ...++.+.-++....
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~P---------- 787 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNP---------- 787 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCCc----------
Confidence 45678999999999999999999999999999999999999999744321 111111111111111
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
-.+.....+++|...||..-.+|-+.+..+.
T Consensus 788 ---W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 ---WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ---hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1234566778888888888888888876553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-31 Score=256.76 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=196.3
Q ss_pred CCCCCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeec-cccCCcceEE
Q 045343 508 LPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQ-THHKNLVRLL 585 (813)
Q Consensus 508 ~~~~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~ 585 (813)
+-.|+-.+|+.. .+||.|+||+|+|-.. ++.++..|||+++.... ...+++..|.++..+ -+.||||+++
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~h---k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLH---KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhc---CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 344665555543 5799999999999876 46789999999986544 445678888776544 4799999999
Q ss_pred eEeecCCceEEEEeecCCCchhhhh---h--ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 586 GFCDEGQNRLLVYEFLNNGTLASFL---F--GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 586 g~~~~~~~~~lV~e~~~~gsL~~~l---~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
|.+..+...++.||.|+- ||+.+- + .+..+++...-+|....++||.||.+ ...|+|||+||+||||+..|.
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 999999999999999853 555443 2 34678888888999999999999997 478999999999999999999
Q ss_pred EEEeeccCccccccCcccceeecccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHH
Q 045343 661 ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 738 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 738 (813)
+||+|||+...+..+-. .+.-.|-..|||||.+... .++-++||||||+.|+|+.||+.|+..-.. +.+.
T Consensus 207 vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeq 278 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQ 278 (361)
T ss_pred EeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHH
Confidence 99999999877654322 2334577789999999643 488999999999999999999999863221 1111
Q ss_pred HHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+.... .+.-..+.. .....+....+..++..|+.+|..+||...++.++
T Consensus 279 l~~Vv-~gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LCQVV-IGDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHH-cCCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111 111111111 11123567889999999999999999999988753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=297.11 Aligned_cols=145 Identities=27% Similarity=0.352 Sum_probs=128.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.++||+|+||.||+|... ..++.||||+++.... .....+..|+.++..++|+||+++++.+......+|
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKK---NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 3567789999999999999874 3577899999865321 123568889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
||||+.+++|.+++.....+++..++.++.||+.||.|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999877788999999999999999999995 499999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=263.62 Aligned_cols=270 Identities=22% Similarity=0.293 Sum_probs=206.3
Q ss_pred CCCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-c-CC----cce
Q 045343 510 CFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-H-KN----LVR 583 (813)
Q Consensus 510 ~~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~n----iv~ 583 (813)
.+...+.....|.+.+.+|+|.||.|-.+.... .+..||||+++... .-.+..+-|+++++++. + |+ +|.
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 455566777888889999999999999988753 46889999998753 23445677999999983 2 22 788
Q ss_pred EEeEeecCCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC----
Q 045343 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---- 657 (813)
Q Consensus 584 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---- 657 (813)
+.+++.-..+.++|+|.+ |-|+.++|..+ ..++...++.|+.|+++++++||+ .+++|-||||+|||+.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceE
Confidence 889999999999999987 55999999876 467889999999999999999995 59999999999999931
Q ss_pred ----------------CCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 045343 658 ----------------YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR 721 (813)
Q Consensus 658 ----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~ 721 (813)
+..+||+|||.|....... ..++.|..|.|||++.+-.++.++||||+||||.|+.+|.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 3468999999998866543 4567899999999999999999999999999999999999
Q ss_pred cCCCcccchhhhhhHHHHHHhh--------------ccCcc-----------cccccccc----cccccHHHHHHHHHHH
Q 045343 722 KSFDIEMGEEYAILTDWAFDCY--------------RNEKL-----------DDLVEGDM----EALNDIKCVEKLVMVS 772 (813)
Q Consensus 722 ~p~~~~~~~~~~~l~~~~~~~~--------------~~~~~-----------~~~~~~~~----~~~~~~~~~~~l~~l~ 772 (813)
..|+.....+...+.+.+.... ..+.+ ....++.. .......+...|++|+
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9998765433222211111100 00000 00111000 0111235567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 045343 773 IWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 773 ~~Cl~~dP~~RPt~~evl~~ 792 (813)
..||..||.+|+|+.|++++
T Consensus 387 ~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHccCccccccHHHHhcC
Confidence 99999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=250.01 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=194.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecC------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 591 (813)
+|+-..+||+|.||+||++... ..++.||+|+.--. .+.-.....+|+.+|..++|+|++.++..|...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~---n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSK---NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhc---CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3444468999999999999764 35566888875321 122233567899999999999999999988432
Q ss_pred --CceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 592 --QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 592 --~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
...+||++++++ +|.-+|... .+++..++.+++.++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 237999999987 777777765 688999999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCcc--cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 669 AKLLTLNQS--KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 669 a~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
++.+..... ...-+..+-|..|++||.+.+. .++++.|||.-||+|.||.|+.+.+..........+..........
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987653322 1112345568999999998775 6899999999999999999999988876554433332222111111
Q ss_pred Ccccc--------------cccccccccc----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 746 EKLDD--------------LVEGDMEALN----DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 746 ~~~~~--------------~~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
+...+ +.....+... .-...++.++|+..++..||.+|+++++++.+-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11111 1111100000 001123677899999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=254.09 Aligned_cols=239 Identities=30% Similarity=0.372 Sum_probs=193.4
Q ss_pred eeeeEEEEEEeccCCcceEEEEEEeecccccc-chhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCCchhhh
Q 045343 531 SFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 609 (813)
Q Consensus 531 ~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 609 (813)
+||.||+|... .++..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDK---KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999884 346789999997654433 57899999999999999999999999999999999999999999999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeeccccccc
Q 045343 610 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689 (813)
Q Consensus 610 l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 689 (813)
+.....+++..++.++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+........ .....++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~ 151 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTPE 151 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCcC
Confidence 98766689999999999999999999964 999999999999999999999999999988764321 234557889
Q ss_pred ccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHH
Q 045343 690 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLV 769 (813)
Q Consensus 690 y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 769 (813)
|++||.+.....+.++|||+||+++++|++|..|+....... .+ ............ . ........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~----~~~~~~~~~~~~-~------~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--EL----FKKIGKPKPPFP-P------PEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH----HHHHhccCCCCc-c------ccccCCHHHH
Confidence 999999988888999999999999999999999987532211 11 111111111000 0 0000456889
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 045343 770 MVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 770 ~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=227.36 Aligned_cols=260 Identities=21% Similarity=0.289 Sum_probs=192.3
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
-|+||+|.+|+||||... ...+.||+|+++... +.......+|+-+++.++|+|||++++....+..+.||+|||
T Consensus 7 mekigegtygtvfkarn~---~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred HHhhcCCcceeeEecccC---CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 478999999999999764 467899999986432 233456789999999999999999999999999999999999
Q ss_pred CCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 602 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 602 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
.. +|..+... +..++.+..+.++.|+++||.++|. ..+.||||||+|.||+.+|++|++|||+++-+.-.-. .
T Consensus 84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr--c 157 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C 157 (292)
T ss_pred hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence 54 67777654 5678899999999999999999994 5999999999999999999999999999987653321 1
Q ss_pred eecccccccccCcccccCCC-CCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcc---ccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKL---DDLVEGD 755 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~~~ 755 (813)
....+-|..|.+|+++.+.+ +++..|+||-||++.|+.. |++.|.+....++..-.-+......++.. .++.|..
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 23345788999999998765 7899999999999999987 66666554433332222222222222222 1222211
Q ss_pred cccccc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALND---------IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.-.... ......=.+++...+.-+|.+|.++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111110 1112233567777788899999999998765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=274.63 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=176.7
Q ss_pred HhhcccccceeeeeeEEEEEEecc-------------CCcceEEEEEEeeccccccchhh--------------hheeee
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTT-------------RTSTTAVAVKKLDRVFQDGEKEF--------------KNEVVV 572 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~-------------~~~~~~vavK~l~~~~~~~~~~~--------------~~E~~~ 572 (813)
.+.+.++||+|+||+||+|.+... ...++.||||++........++| ..|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 456678999999999999975321 12456799999865332222223 335556
Q ss_pred eeccccCCc-----ceEEeEeec--------CCceEEEEeecCCCchhhhhhcc------------------------CC
Q 045343 573 IGQTHHKNL-----VRLLGFCDE--------GQNRLLVYEFLNNGTLASFLFGN------------------------LK 615 (813)
Q Consensus 573 l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~------------------------~~ 615 (813)
+.+++|.++ ++++++|.. ....+|||||+++++|.++++.. ..
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 666766554 677887743 34689999999999999988642 12
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCccc
Q 045343 616 PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695 (813)
Q Consensus 616 l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 695 (813)
++|..++.++.|++++|.|||+ .+|+||||||+|||++.++.+||+|||+++.+....... .....+++.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhh
Confidence 3577888999999999999995 489999999999999999999999999997654332111 112235789999998
Q ss_pred ccCCCC----------------------CCccchhhHHHHHHHHHhCCc-CCCcccch--h----hhhhHHHHHHhhccC
Q 045343 696 FRNSTI----------------------TAKVDVYSFGVLLLEIISCRK-SFDIEMGE--E----YAILTDWAFDCYRNE 746 (813)
Q Consensus 696 l~~~~~----------------------~~k~DVwS~Gvvl~elltG~~-p~~~~~~~--~----~~~l~~~~~~~~~~~ 746 (813)
+..... ..+.||||+||+++||++|.. |+...... + ...+..| ......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~ 459 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQ 459 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hhhccc
Confidence 854321 134799999999999999875 55422110 0 0011111 111111
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDP---SLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~~ 792 (813)
...........+...+++.++|..+| .+|+|++|+++|
T Consensus 460 --------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 --------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111112235678899999998765 689999999876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=273.23 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=202.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEee-----cCCc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD-----EGQN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~ 593 (813)
+.+|.+.||.|.+|.||++... ..++..|||++.-. ....+++..|.++++.+ .|||++.++|++. .++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~---~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHV---KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeee---ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3567899999999999999875 35667788877543 44566788899999988 6999999999984 3567
Q ss_pred eEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 594 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+|||||||.+||..|+++.. .++.|..+..|+..++.|+.|||. ..++|||||-.|||++.++.+||.|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 99999999999999998764 577899999999999999999995 4999999999999999999999999999988
Q ss_pred cccCcccceeecccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
+...... .....||+.|||||++... .++.++|+||||++..||.-|.+|+....+..
T Consensus 173 ldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------------- 235 (953)
T KOG0587|consen 173 LDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------------- 235 (953)
T ss_pred eeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------------
Confidence 7754433 3456799999999999543 46778999999999999999999986432211
Q ss_pred ccccc-ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDDL-VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+..+ -.|...........+.+.++|..||.+|-++||++.+++++
T Consensus 236 aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 12222333355788999999999999999999999998864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-30 Score=267.14 Aligned_cols=245 Identities=21% Similarity=0.247 Sum_probs=199.5
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeec---cccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
..||-|+||.|=++.... +....|+|.+++ ......+.+..|-++|...+.+.||+|+-.|.+....|+.||-|
T Consensus 426 aTLGvGgFGRVELV~~~~---~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNS---QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhcccCccceEEEEEecc---cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 469999999999887743 222456665543 33444566888999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccccee
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 681 (813)
-||.|...|..+..++..+..-++..+.+|++||| +.+||+|||||+|.+||.+|-+||.|||+|+.+..+.. .
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---T 576 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---T 576 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---e
Confidence 99999999999999999999999999999999999 56999999999999999999999999999999876543 4
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
-.++||+.|.|||++.++..+..+|.||||+++|||++|++||....+-..-.+. .. -++.+ ..+
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------Lk-Gid~i-------~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------LK-GIDKI-------EFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------Hh-hhhhh-------hcc
Confidence 5689999999999999999999999999999999999999999876542211110 00 01111 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQML 793 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~L 793 (813)
....+...+++++....+|.+|.- +.+|.++-
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 233566778888888999999986 67777663
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=279.57 Aligned_cols=262 Identities=21% Similarity=0.193 Sum_probs=165.0
Q ss_pred HhhcccccceeeeeeEEEEEEecc-CCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeE------eecCC
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTT-RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF------CDEGQ 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~ 592 (813)
.+.+.++||+|+||.||+|.+..+ ...+..||||++..... .+....| .+.+..+.+++.++.. +.++.
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 456778999999999999998532 11267899998764211 1111111 1111122222222211 34566
Q ss_pred ceEEEEeecCCCchhhhhhccCC--------------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLK--------------------PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
..++|+||+.+++|.+++..... .....+..++.||+.||+|||+ .+|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHH
Confidence 89999999999999998864321 1123456789999999999995 499999999999
Q ss_pred EEEcC-CCCEEEeeccCccccccCcccceeecccccccccCcccccCC----------------------CCCCccchhh
Q 045343 653 ILLDD-YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS----------------------TITAKVDVYS 709 (813)
Q Consensus 653 Ill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~k~DVwS 709 (813)
||++. ++.+||+|||+++.+....... .....++++|+|||.+... .+..++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99985 6799999999998665432221 3446789999999965322 2345679999
Q ss_pred HHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc----ccccc--cHHHHHHHHHHHHHhcccCCCCC
Q 045343 710 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD----MEALN--DIKCVEKLVMVSIWCIQEDPSLR 783 (813)
Q Consensus 710 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~l~~l~~~Cl~~dP~~R 783 (813)
|||+||||+++..+.+.........+... ............+. +.... .........+|+.+||+.||.+|
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRN---DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhc---CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999997766542211100000000 00000000001110 00000 00112345689999999999999
Q ss_pred CCHHHHHHH
Q 045343 784 PTMKKVLQM 792 (813)
Q Consensus 784 Pt~~evl~~ 792 (813)
||+.|++++
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-29 Score=275.51 Aligned_cols=240 Identities=31% Similarity=0.398 Sum_probs=184.7
Q ss_pred cccceeeee-eEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEeecC
Q 045343 525 EEVGRGSFG-IVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG-~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 602 (813)
+.+|.|..| .||+|.. +++.||||++-.. ...-.++|+..|+.- +|+|||+.++.-.+....|+..|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-----EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred HHcccCCCCcEEEEEee-----CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 468999887 5799998 7889999998432 233467899888877 6999999999989999999999998
Q ss_pred CCchhhhhhcc--CC--CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-----CCCEEEeeccCccccc
Q 045343 603 NGTLASFLFGN--LK--PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLT 673 (813)
Q Consensus 603 ~gsL~~~l~~~--~~--l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~DfGla~~~~ 673 (813)
..+|.+++... .. ..-...+.+..|+++||+||| +.+||||||||.||||+. ...++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 55999999764 11 111344678899999999999 679999999999999975 2579999999999988
Q ss_pred cCcccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 674 LNQSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 674 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
.+.+.. ......||.||+|||++....-+.++||+|+||++|+.++| .+||...-..+...+ .....+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeee
Confidence 765432 13456799999999999998888899999999999999995 899974432211111 011111111
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ...++ +..+||.+|++++|..||++.+|+.+
T Consensus 736 ~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 E-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred c-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 11122 77899999999999999999999753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=242.90 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=196.4
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCC-----ceEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NRLL 596 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 596 (813)
.+.||.|+||.||.+.++ .+++.||.|++..... ...+.+.+|+++|..++|.|++..++...-.. ++++
T Consensus 58 DRPIGYGAFGVVWsVTDP---RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDP---RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCcccccceeEEEeccCC---CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 478999999999998875 4788999999876432 23467889999999999999999888764332 5678
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
++|.|.. +|..++-....++-..+.-+..||++||.||| +.+|.||||||.|.|++.+..+||+|||+++....++
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8888754 78888877788888888889999999999999 5699999999999999999999999999999877666
Q ss_pred ccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc----------
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---------- 745 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------- 745 (813)
... ++..+-|..|.|||++.+. .|+...||||.||++.||+..+..|....+-+...+. .+++..
T Consensus 211 ~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI---tdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 211 RLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI---IDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH---HHHhCCCcHHHHHHHh
Confidence 554 4555678999999999876 5899999999999999999999988776554333221 111111
Q ss_pred -Cccccccc-----cccc---cccc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 746 -EKLDDLVE-----GDME---ALND-IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 746 -~~~~~~~~-----~~~~---~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
+....++. +... ...+ .....+..++...++..||++|.+..+.+.++
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11011111 1110 0001 11223445677778999999999999998876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=239.06 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=192.4
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeecc-ccCCcceEEeEeecCCceEEE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+.||+|+|..|-.+.+. ...+.+|+|++++..-. +..=.+.|-.+..+- +||.+|.|..++..+..+++|
T Consensus 253 ~ll~vigrgsyakvl~~~~~---~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLK---KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred eeeeeecCcchhhhhheehc---ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 45688999999999998875 35678999988764222 222345666666655 699999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
.||+++|+|--+++.+.+++++..+-+...|+-||.|||+ .+|++||||..|||||..|++||+|+|+.+.--....
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 9999999999999999999999999999999999999995 4999999999999999999999999999886433222
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch-hhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
....++||+.|.|||++.+..|...+|.|++||+|+||+.|+.||+....+ ......+...+.+.+ ..+
T Consensus 407 --~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------kqi 476 (593)
T KOG0695|consen 407 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------KQI 476 (593)
T ss_pred --ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------hcc
Confidence 256789999999999999999999999999999999999999999854321 111222222232222 222
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPT 785 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 785 (813)
+.+.+ .+.+...++..-|++||.+|.-
T Consensus 477 riprs--lsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 RIPRS--LSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccce--eehhhHHHHHHhhcCCcHHhcC
Confidence 22112 2345567778889999999853
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-28 Score=218.97 Aligned_cols=103 Identities=38% Similarity=0.580 Sum_probs=74.0
Q ss_pred CCeeEEEecCCCCCCCCC--CceEEEEeeCccEEEeCCCCCEEeee-ccCCCc--eeEEEEecCcCEEEEecCCcccccc
Q 045343 80 AKTVVWYTDNKDQNPAVP--RGSQVKLTADHGLVLNDPQGKQVWSS-EIDIGT--VAVGHMNDTGNFVLASSSSSKLWDS 154 (813)
Q Consensus 80 ~~tvvWvanr~~~~~~~~--~~~~l~~~~~g~l~l~~~~~~~~wst-~~~~~~--~~~~~l~d~Gnlvl~~~~~~~~WqS 154 (813)
++||||+|||+. +..+ ...+|.|+.||||+|++..|++||+| ++.+.+ ...|+|+|+|||||++..+++||||
T Consensus 1 ~~tvvW~an~~~--p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S 78 (114)
T PF01453_consen 1 PRTVVWVANRNS--PLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQS 78 (114)
T ss_dssp ---------TTE--EEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEES
T ss_pred Cccccccccccc--ccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEee
Confidence 379999999993 3223 45899999999999999999999999 555544 6899999999999999999999999
Q ss_pred cccCcCcccCCCcccc----c--cceeecCCCCCCC
Q 045343 155 FSNPSDTLLPGQTMET----K--QGLFSRKSETNFS 184 (813)
Q Consensus 155 FD~PTDTlLpg~~l~~----~--~~L~S~~s~~dps 184 (813)
|||||||+||||+|+. . ..++||++.+|||
T Consensus 79 f~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 FDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred cCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999876 2 3599999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=220.94 Aligned_cols=194 Identities=27% Similarity=0.414 Sum_probs=161.1
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-ccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEeec
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
.++||+|++|.|=+-.+. ..+...|||++... ..+..++..+|+.+..+- .+|.+|+++|........++.||.|
T Consensus 51 i~elGrGayG~vekmrh~---~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHI---QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhcCCccchhhheeec---cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 468999999998776663 57889999999753 334456778888876664 7999999999998889999999998
Q ss_pred CCCchhhhh----hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 602 NNGTLASFL----FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 602 ~~gsL~~~l----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+- ||+.+- ......++...-+|+..+.+||.|||+ ...++|||+||+||||+.+|++|++|||++-.+..+-.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 54 676653 455778899999999999999999997 47899999999999999999999999999987764432
Q ss_pred cceeecccccccccCcccccC----CCCCCccchhhHHHHHHHHHhCCcCCCc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRN----STITAKVDVYSFGVLLLEIISCRKSFDI 726 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~----~~~~~k~DVwS~Gvvl~elltG~~p~~~ 726 (813)
.+...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.|++.
T Consensus 205 ---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 ---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 222446778999998853 3688999999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-27 Score=248.70 Aligned_cols=194 Identities=22% Similarity=0.328 Sum_probs=167.4
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--------cccchhhhheeeeeeccc---cCCcceEEeEeec
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDE 590 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 590 (813)
...+++|.|+||.|+.++.+ .+...|+||.+.+.. ....-....||+||..++ |+||++++++|++
T Consensus 564 ttlq~lG~GAyGkV~lai~K---~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHK---ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred eeeeeccccccceEEEeeec---ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 34568999999999999985 357789999886531 122234678999999997 9999999999999
Q ss_pred CCceEEEEeec-CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 591 GQNRLLVYEFL-NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 591 ~~~~~lV~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
++..+|++|-. ++.+|.+++.-+..+++.+..-|+.||+.|++|||.+ +|||||||-+||.++.+|-+||+|||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 99999999975 4569999999999999999999999999999999954 9999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCC
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFD 725 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~ 725 (813)
.+...+. ...++||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 718 a~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8876543 345789999999999999886 556899999999999998877764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=245.93 Aligned_cols=199 Identities=24% Similarity=0.366 Sum_probs=169.2
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.||-|+||+|-++.-. .....+|.|.|++.. .......++|-.||..-..+=||+|+-.|.+++.+|+||+|+
T Consensus 635 k~iGvGAFGeV~Lv~Kv---DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKV---DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeec---chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence 46999999999987543 246788999987632 222345788999999999999999999999999999999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc-------
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL------- 674 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~------- 674 (813)
+||++-.+|.....+.+...+-++..+..|+++.| ..|+|||||||.|||||.+|++||+||||..-++.
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999999999999999999999999999999 66999999999999999999999999999653321
Q ss_pred --Ccc-------------------------------cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 045343 675 --NQS-------------------------------KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR 721 (813)
Q Consensus 675 --~~~-------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~ 721 (813)
+.. .......+||+.|+|||++....++.-+|.||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 000 00012357999999999999999999999999999999999999
Q ss_pred cCCCcccc
Q 045343 722 KSFDIEMG 729 (813)
Q Consensus 722 ~p~~~~~~ 729 (813)
.||-....
T Consensus 869 ~pf~~~tp 876 (1034)
T KOG0608|consen 869 PPFLADTP 876 (1034)
T ss_pred CCccCCCC
Confidence 99976654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=224.96 Aligned_cols=211 Identities=36% Similarity=0.557 Sum_probs=182.1
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCCc
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 605 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 605 (813)
||+|.+|.||++.... .+..++||++...... ..+.+.+|+..++.++|++++++++++......++++|++++++
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999998842 4678999998754322 24678999999999999999999999999999999999999999
Q ss_pred hhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCccccccCcccceeec
Q 045343 606 LASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAIRTA 683 (813)
Q Consensus 606 L~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 683 (813)
|.+++... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99998765 5788999999999999999999954 9999999999999999 89999999999987654321 1223
Q ss_pred ccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccH
Q 045343 684 IRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762 (813)
Q Consensus 684 ~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 762 (813)
..+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577889999999877 788999999999999998
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 763 KCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 763 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
..+.+++..|++.+|.+||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5677899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=203.50 Aligned_cols=114 Identities=31% Similarity=0.474 Sum_probs=99.7
Q ss_pred ceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeCccEEEe
Q 045343 34 ATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLN 113 (813)
Q Consensus 34 ~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~g~l~l~ 113 (813)
+.|..++ +|+|++|.|++|||.+.. .. ..+.+|||.+++ +++||.||++. |....+.|.|+.||+|+|+
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~---q~-~dgnlv~~~~~~-~~~vW~snt~~---~~~~~~~l~l~~dGnLvl~ 70 (116)
T cd00028 2 NPLSSGQ---TLVSSGSLFELGFFKLIM---QS-RDYNLILYKGSS-RTVVWVANRDN---PSGSSCTLTLQSDGNLVIY 70 (116)
T ss_pred cCcCCCC---EEEeCCCcEEEecccCCC---CC-CeEEEEEEeCCC-CeEEEECCCCC---CCCCCEEEEEecCCCeEEE
Confidence 3566776 999999999999999852 21 489999999887 89999999983 3566789999999999999
Q ss_pred CCCCCEEeeeccCC-CceeEEEEecCcCEEEEecCCcccccccccC
Q 045343 114 DPQGKQVWSSEIDI-GTVAVGHMNDTGNFVLASSSSSKLWDSFSNP 158 (813)
Q Consensus 114 ~~~~~~~wst~~~~-~~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~P 158 (813)
|.+|.+||+|++.+ .+..+|+|+|+|||||++.++++||||||||
T Consensus 71 ~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 71 DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred cCCCcEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 99999999999886 5567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=228.25 Aligned_cols=268 Identities=26% Similarity=0.316 Sum_probs=192.0
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEee------cCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD------EGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~~~l 596 (813)
+.+|.|.- .|--+.+ .-.++.||+|++... .....++..+|..++..++|+||++++.++. +-.+.++
T Consensus 23 ~p~~~g~~-~v~~a~D---~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~ 98 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFD---QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYL 98 (369)
T ss_pred cccCCCCc-eEEecch---hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHH
Confidence 35666666 3333332 235678999998653 2334567889999999999999999999983 2346799
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+|. .+|...+. ..++-+....|..|++.|+.||| +.+|+||||||+||++..+..+||.|||+|+....+
T Consensus 99 v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 99 VMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 999995 47777776 56778889999999999999999 569999999999999999999999999999876554
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh-hh---------------hhHHHHH
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YA---------------ILTDWAF 740 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~-~~---------------~l~~~~~ 740 (813)
...+.++.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+..--+ .. .+...+.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 23677889999999999999889999999999999999999998886432110 00 0111111
Q ss_pred Hhhcc------Ccccccc-cccc--cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hh---cCcCCCCCCCC
Q 045343 741 DCYRN------EKLDDLV-EGDM--EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LE---GVVEVSLPPNP 805 (813)
Q Consensus 741 ~~~~~------~~~~~~~-~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~---~~~~~~~p~~p 805 (813)
..... -...+++ |... ....+......+.+++.+||..||++|.++++++++ ++ .-.++++|+.|
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 11110 0001111 1100 011111234567889999999999999999999986 33 33345555554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=214.60 Aligned_cols=258 Identities=20% Similarity=0.348 Sum_probs=189.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeecCC--ceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQ--NRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~ 595 (813)
..|++.+++|+|-+++||.|.... +...++||.++.. ..+.+.+|+.+|..+. |+||++|++...+.. ...
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccC---CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 346788999999999999997542 5567899998754 4567899999999997 999999999987655 568
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~~~~ 674 (813)
||+||+.+.+...+. ..++...+...+.++++||.|+| +.||+|||+||.|++||. .-.++|+|+|+|.+..+
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999997765543 34566678889999999999999 679999999999999995 56799999999999887
Q ss_pred CcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH--------HHhh--
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCY-- 743 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~-- 743 (813)
..... ..+.+..|.-||.+-. +.++..-|+|||||+|.+|+..+.||-...+.... +...+ ...+
T Consensus 186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHHHHHH
Confidence 65433 2345667888998854 45788999999999999999999998543321111 11100 0000
Q ss_pred ----ccCcccccccccc--------cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 ----RNEKLDDLVEGDM--------EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 ----~~~~~~~~~~~~~--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......++.... ......-...+.++++...|..|-.+|||++|.+.+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0111111111110 011111224678899999999999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=241.83 Aligned_cols=250 Identities=25% Similarity=0.308 Sum_probs=202.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
|++...+|.|.+|.|||+... ..+...|||.++.......+-.+.|+-+++..+|+|||.++|.+...+..++.|||
T Consensus 17 yellqrvgsgTygdvyKaRd~---~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDK---RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred hhheeeecCCcccchhhhccc---ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 556788999999999999875 46778999999887777778889999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+.+|+|.+.-+-...+++.++....+...+|++||| +.+=+|||||-.|||+++.+.+|++|||.+-.+...-.+
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K-- 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK-- 168 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhhh--
Confidence 999999999999999999999999999999999999 558899999999999999999999999998766543222
Q ss_pred eecccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc-cc
Q 045343 681 RTAIRGTKGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG-DM 756 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l---~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~ 756 (813)
...+.||+.|||||+. ....+..++|||++|+...|+-.-.+|.....+.....+ . .....++ .+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------m----TkS~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------M----TKSGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------h----hccCCCCCcc
Confidence 3456799999999987 345689999999999999999776666432221111100 0 0111111 11
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
+ ......+.+.++++.|+-.+|.+||+++.+++
T Consensus 238 k--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 K--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred c--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 12356788999999999999999999987664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=220.58 Aligned_cols=198 Identities=30% Similarity=0.459 Sum_probs=171.3
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
.+.+.||.|++|.||++.... .+..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 456889999999999998852 4678999998765443 466788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
+++++|.+++..... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 999999999987666 89999999999999999999954 9999999999999999999999999999887644211
Q ss_pred eeecccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCcCCCc
Q 045343 680 IRTAIRGTKGYVAPEWF-RNSTITAKVDVYSFGVLLLEIISCRKSFDI 726 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvvl~elltG~~p~~~ 726 (813)
......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12334578889999998 666778899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=227.44 Aligned_cols=137 Identities=26% Similarity=0.374 Sum_probs=111.6
Q ss_pred HHHHHH-HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-----c---CCcce
Q 045343 513 YKELEE-ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----H---KNLVR 583 (813)
Q Consensus 513 ~~el~~-~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~ 583 (813)
.-|... +.|.+.++||=|.|++||++.+. ...+.||+|+.+.. +.-.+....||++|++++ | ..||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDt---q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDT---QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeec---cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 344445 78888999999999999999875 35678999998764 333456788999999883 3 35999
Q ss_pred EEeEee----cCCceEEEEeecCCCchhhhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 584 LLGFCD----EGQNRLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 584 l~g~~~----~~~~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
|+++|. .+.+.+||+|++ |.+|..+|.. ...++...+.+|++||+.||.|||.+ .+|||-||||+|||+.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 999995 466899999998 5566666653 36789999999999999999999986 5999999999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=236.10 Aligned_cols=268 Identities=22% Similarity=0.241 Sum_probs=205.2
Q ss_pred CCCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc------cCCcce
Q 045343 510 CFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH------HKNLVR 583 (813)
Q Consensus 510 ~~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~ 583 (813)
.+.+-|+....|++.--.|+|-|++|-+|... ..+..||||++... +.-.+.=+.|+++|++|+ .-|.++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~---~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQ---ARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeecccc---CCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35677899999999999999999999999874 34569999999753 223344567999999995 357999
Q ss_pred EEeEeecCCceEEEEeecCCCchhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-C
Q 045343 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-Y 659 (813)
Q Consensus 584 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-~ 659 (813)
|+-.|.+.++++||+|-+ ..+|.+.|..- ..+..+.+..+++|+.-||.+|. ..+|+|.||||.|||+.+. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcc
Confidence 999999999999999976 56889998653 46788899999999999999999 5699999999999999865 5
Q ss_pred CEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH
Q 045343 660 NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 739 (813)
Q Consensus 660 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 739 (813)
.+||||||.|.....++ .+.+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+........ ..
T Consensus 575 iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr---l~ 647 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR---LF 647 (752)
T ss_pred eeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH---HH
Confidence 68999999998766543 345556778999999999999999999999999999999999997653322111 11
Q ss_pred HHh--------hccCc----------------ccc-----------cccc------ccc-----ccccHHHHHHHHHHHH
Q 045343 740 FDC--------YRNEK----------------LDD-----------LVEG------DME-----ALNDIKCVEKLVMVSI 773 (813)
Q Consensus 740 ~~~--------~~~~~----------------~~~-----------~~~~------~~~-----~~~~~~~~~~l~~l~~ 773 (813)
.++ +..+. ... .+.| .+. ..........+.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 110 00000 000 0111 000 1112355678899999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 045343 774 WCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 774 ~Cl~~dP~~RPt~~evl~~ 792 (813)
.||..||++|.|..+++++
T Consensus 728 kml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHhccChhhcCCHHHHhcC
Confidence 9999999999999998875
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=194.05 Aligned_cols=112 Identities=32% Similarity=0.479 Sum_probs=97.0
Q ss_pred ceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeCccEEEe
Q 045343 34 ATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLN 113 (813)
Q Consensus 34 ~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~g~l~l~ 113 (813)
+.|..++ +|+|++|.|++|||.+.. . .++.+|||++.+ +++||+||++ .|+..++.|.|+.||+|+|+
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~---q--~dgnlV~~~~~~-~~~vW~snt~---~~~~~~~~l~l~~dGnLvl~ 69 (114)
T smart00108 2 NTLSSGQ---TLVSGNSLFELGFFTLIM---Q--NDYNLILYKSSS-RTVVWVANRD---NPVSDSCTLTLQSDGNLVLY 69 (114)
T ss_pred cccCCCC---EEecCCCcEeeeccccCC---C--CCEEEEEEECCC-CcEEEECCCC---CCCCCCEEEEEeCCCCEEEE
Confidence 3566666 899999999999998752 2 479999999887 8999999998 33444588999999999999
Q ss_pred CCCCCEEeeeccC-CCceeEEEEecCcCEEEEecCCccccccccc
Q 045343 114 DPQGKQVWSSEID-IGTVAVGHMNDTGNFVLASSSSSKLWDSFSN 157 (813)
Q Consensus 114 ~~~~~~~wst~~~-~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~ 157 (813)
+.+|.+||+|++. +.+..+++|+|+|||||++..+++|||||||
T Consensus 70 ~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 70 DGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred eCCCCEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 9999999999987 4556789999999999999999999999997
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=224.69 Aligned_cols=264 Identities=24% Similarity=0.313 Sum_probs=192.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 599 (813)
+...++||+|.|++||++.+.........||+|.+... .....+.+|+++|..+. +.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 34567899999999999998754346788999998653 34567899999999994 9999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCccccccCc--
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQ-- 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~~~~~~-- 676 (813)
|+++....++..+ ++...+..++..+.+||.++|. .|||||||||+|+|.+ ..+.-.|.|||+|......+
T Consensus 116 ~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 9999998888754 4578888999999999999995 5999999999999997 45778999999987221000
Q ss_pred ----------------------------------------ccceeecccccccccCcccccC-CCCCCccchhhHHHHHH
Q 045343 677 ----------------------------------------SKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLL 715 (813)
Q Consensus 677 ----------------------------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~ 715 (813)
.........||+||.|||++.. ...++++||||-|||++
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0000112359999999999865 45789999999999999
Q ss_pred HHHhCCcCCCcccchhhhhhH------HHHHH--hhccCc--cc----------------cc-ccccc-------ccccc
Q 045343 716 EIISCRKSFDIEMGEEYAILT------DWAFD--CYRNEK--LD----------------DL-VEGDM-------EALND 761 (813)
Q Consensus 716 elltG~~p~~~~~~~~~~~l~------~~~~~--~~~~~~--~~----------------~~-~~~~~-------~~~~~ 761 (813)
.+++++.||-....+...... ....+ ....+. +. .+ +..-. .....
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 999999999644332111100 00000 000000 00 00 00000 00011
Q ss_pred HH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 762 IK-CVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 762 ~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+ .+..+++++.+|+..||.+|.|++|.+++
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 12 23478899999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=259.88 Aligned_cols=197 Identities=18% Similarity=0.226 Sum_probs=140.7
Q ss_pred ecccc-CCcceEEeEe-------ecCCceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 045343 574 GQTHH-KNLVRLLGFC-------DEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644 (813)
Q Consensus 574 ~~l~h-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iv 644 (813)
+.++| .||++++++| .+.+..++++|++ +++|.++|.. ...+++..++.++.||++||.|||+ .+|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 45667 6888999987 3334567888887 5699999965 3568999999999999999999995 5999
Q ss_pred eCCCCCCcEEEcC-------------------CCCEEEeeccCccccccCcc--------------cceeeccccccccc
Q 045343 645 HCDIKPQNILLDD-------------------YYNARISDFGLAKLLTLNQS--------------KAIRTAIRGTKGYV 691 (813)
Q Consensus 645 H~dlk~~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~ 691 (813)
||||||+||||+. ++.+||+|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566666776654211000 00011235788999
Q ss_pred CcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHH
Q 045343 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMV 771 (813)
Q Consensus 692 aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 771 (813)
|||++.+..++.++|||||||+||||++|..|+..... .+...... ...+.. ........++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI-----LLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh-----hhcCHHHHHH
Confidence 99999999999999999999999999998887642211 11010000 011100 1112345678
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 045343 772 SIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 772 ~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+.+||+++|.+||+|.||+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=204.84 Aligned_cols=253 Identities=19% Similarity=0.287 Sum_probs=184.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeE-eecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGF-CDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~l 596 (813)
..|++.+.||+|.||.+-++.+. +....+++|-+... ....++|.+|..---.| .|.||+.-++. |+..+-.+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr---~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHR---QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeecc---CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 34677889999999999988774 56678999988764 34467899988765556 58999987764 566677889
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc--CCCCEEEeeccCcccccc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLAKLLTL 674 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~DfGla~~~~~ 674 (813)
++||++-|+|..-+... .+.+....+++.|++.||.|+| +.++||||||.+||||- +...+||+|||+.+..+.
T Consensus 100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999999887653 4567778889999999999999 56999999999999993 345799999999886543
Q ss_pred CcccceeecccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
.- ....-+..|.+||..... ...+.+|||.||++++.++||+.|++.....+.. .|.+..+..+...
T Consensus 176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRKNP 247 (378)
T ss_pred ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcccCc
Confidence 21 122345678999977543 3567899999999999999999999844332221 2333333333332
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.+.+. . ....+.+..+.++-+.++|++|--..++.++.
T Consensus 248 ~~P~~-----F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKK-----F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchh-----h-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 22111 1 12345667777888999999996555555543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=200.17 Aligned_cols=166 Identities=23% Similarity=0.189 Sum_probs=125.5
Q ss_pred Cchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceee
Q 045343 604 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682 (813)
Q Consensus 604 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 682 (813)
|+|.+++... ..+++..++.++.||++||.|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 5689999999999999999999965 3 999999999999999 99998764322
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccH
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 762 (813)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....... .... .... ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~-~~~~-----~~~~--~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGM-PADD-----PRDR--SNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHh-ccCC-----cccc--ccHH
Confidence 257899999999999999999999999999999999999996443211 1111111110 0000 0000 0111
Q ss_pred HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 763 KCVE--KLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 763 ~~~~--~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.... .+.+++.+||+.+|.+||++.|+++++..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2222 689999999999999999999999998654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=204.23 Aligned_cols=256 Identities=19% Similarity=0.327 Sum_probs=194.3
Q ss_pred HHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEee--ccccccchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 514 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
.-+.-...++..+|.+...|+.|+|.+ ++..+++|++. .......++|.+|.-.|+.+.||||+.++|.|...
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrw-----qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRW-----QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccc-----cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 334444556778899999999999998 44456666664 33344457899999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
.+..++..||+-|+|...|+... ..+..+..+++.+||+|++|||.- .+-|..--|....|+||++.+++|+= +-+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~ 337 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADT 337 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccc
Confidence 99999999999999999998764 457788999999999999999964 33344557999999999999888751 111
Q ss_pred cccccCcccceeecccccccccCcccccCCCCC---CccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT---AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
++... .....-.+.|++||.++.++.+ ..+|+|||.+++|||.|...||..-..-+....
T Consensus 338 kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----------- 400 (448)
T KOG0195|consen 338 KFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----------- 400 (448)
T ss_pred eeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----------
Confidence 11110 1222346789999999887654 469999999999999999999975544322110
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
+.-..++...+...+..+.+++.-|++.||.+||.++.|+-+||+++
T Consensus 401 ----ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 ----IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11111222223345678899999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-21 Score=205.45 Aligned_cols=166 Identities=22% Similarity=0.121 Sum_probs=125.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-----cccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
..|.+.+.||+|+||+||+|..... .+..+|||++.... ....+.+.+|+++|++++|+|+++.+.. ...
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 4477789999999999999987532 45668999875321 1124468999999999999999853322 245
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC-CCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDI-KPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dl-k~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.+|||||+++++|... .... ...++.+++++|.|||+ .+|+|||| ||+|||++.++.+||+|||+++.+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 7999999999999632 1111 24678899999999995 49999999 999999999999999999999977
Q ss_pred ccCcccce------eecccccccccCcccccCC
Q 045343 673 TLNQSKAI------RTAIRGTKGYVAPEWFRNS 699 (813)
Q Consensus 673 ~~~~~~~~------~~~~~gt~~y~aPE~l~~~ 699 (813)
........ .....+++.|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54321111 1345688889999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=195.23 Aligned_cols=261 Identities=20% Similarity=0.209 Sum_probs=191.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc----CCcceEEeEe-ecCCce
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH----KNLVRLLGFC-DEGQNR 594 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~ 594 (813)
.+.+.++||+|+||.||++...... ...+|+|............+..|..++..+.+ +++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 5677899999999999999875332 45788887765433333368888888888873 6889999988 477778
Q ss_pred EEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-----CCEEEeecc
Q 045343 595 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-----YNARISDFG 667 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~DfG 667 (813)
++||+.. +.+|.++.... ..++..+.++|+.|++.+|.+||+ .+++||||||.|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999875 77999987433 678999999999999999999995 599999999999999754 469999999
Q ss_pred Ccc--ccccCccc------ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch-hhhhhHHH
Q 045343 668 LAK--LLTLNQSK------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDW 738 (813)
Q Consensus 668 la~--~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~-~~~~l~~~ 738 (813)
+++ ........ ......+||.+|.++++..+...+.+.|+||++.++.|++.|..|+...... ....+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 999 43222211 1023456999999999999999999999999999999999999998644321 11111110
Q ss_pred HHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 739 AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.. ...... .....+..+.++...+-..+..++|....+...|++....
T Consensus 253 ~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PR--------KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hh--------hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00 001110 0111234555566656668999999999999998765543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=165.88 Aligned_cols=86 Identities=30% Similarity=0.662 Sum_probs=68.6
Q ss_pred EEEecCCceeEeecccccCCcceEEEEEEeeCceeEEEeecCCCCCCeEEEEcccccccccccCCCCCCCCCCCCcccCC
Q 045343 241 YILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPENICVNIGGEMGSGACGFNSICSLD 320 (813)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~W~~~~~~p~d~Cd~y~~~~~~~~CG~~g~C~~~ 320 (813)
|.|..+...++++... .+.+.++|++||.+|++|+|.|.+ ..++|.+.|++|.|+||+ |+.||+||+|+.
T Consensus 25 ~~fv~~~~e~~~t~~~--~~~s~~~r~~ld~~G~l~~~~w~~-~~~~W~~~~~~p~d~Cd~------y~~CG~~g~C~~- 94 (110)
T PF00954_consen 25 YSFVSNNEEVYYTYSL--SNSSVLSRLVLDSDGQLQRYIWNE-STQSWSVFWSAPKDQCDV------YGFCGPNGICNS- 94 (110)
T ss_pred EEEEECCCeEEEEEec--CCCceEEEEEEeeeeEEEEEEEec-CCCcEEEEEEecccCCCC------ccccCCccEeCC-
Confidence 3344444444444332 256779999999999999999965 478899999999999999 579999999964
Q ss_pred CCCCCcccCCCCCcccC
Q 045343 321 SDRRPKCACPKGYSLLD 337 (813)
Q Consensus 321 ~~~~~~C~Cl~GF~~~~ 337 (813)
+..|.|+||+||+|++
T Consensus 95 -~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 95 -NNSPKCSCLPGFEPKN 110 (110)
T ss_pred -CCCCceECCCCcCCCc
Confidence 5678999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=217.34 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=189.3
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeec-c-ccccc----hhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR-V-FQDGE----KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~-~-~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+|.|++|.|+........ ...+.|.... . ....+ ..+..|+-+-..++|+|++..+..+.+.....-+
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~---~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDL---KSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred cceeeecccCceEEEEecCCC---ccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 467999999977776654322 2222222110 0 11111 1266788888899999999888888777776666
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||++. +|..++.....+....+..++.|++.|+.|+|. .+|.|||||++|++++.++.+||+|||.+..+.....
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999999 999999888788889999999999999999994 5999999999999999999999999999988765544
Q ss_pred c--ceeecccccccccCcccccCCCCCCc-cchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 678 K--AIRTAIRGTKGYVAPEWFRNSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 678 ~--~~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
. ......+|...|+|||.+....+++. .||||.|+++..|++|+.||.....++... ...... ....+..+
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~-~~~~~~~~ 549 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYS-DQRNIFEG 549 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccc-cccccccC
Confidence 4 44566789999999999999988874 899999999999999999997655433221 000000 00111111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. .......+.+...++.++|+.+|.+|.|+++|++.
T Consensus 550 ~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 P--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred h--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 11122456677889999999999999999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=180.57 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=193.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+.+.++||+|.||+++.|+..- .+.+||||.-... ....++..|.+..+.| ..++|...+-|-.++.+-.||+|
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ceeccccccCcceeeecccccc---cCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 5677999999999999998653 5789999986542 3345778888888887 47899999988899999999999
Q ss_pred ecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-----CCCEEEeeccCccccc
Q 045343 600 FLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLT 673 (813)
Q Consensus 600 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~DfGla~~~~ 673 (813)
.+ +-||+|++. ...+++.+++..+|.|++.-++|+|+ ...|+|||||+|+||.. ...+.|+|||+|+...
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 87 668888774 56789999999999999999999995 49999999999999963 3458999999999876
Q ss_pred cCcccce-----eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 674 LNQSKAI-----RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 674 ~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
....+.. ....-||.+||+-....+...+.+.|+-|+|-++++.|-|..||.+........--+.+.+..+.-.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 5443321 22356999999999999999999999999999999999999999865433221111111111122222
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.++++. .++++..-+.-.-..+-.+-|+.+-+...+..+++
T Consensus 261 ~~Lc~g---------~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 261 EVLCEG---------FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHHHhc---------CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 222221 23444444444455677788888777766665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=188.74 Aligned_cols=258 Identities=28% Similarity=0.362 Sum_probs=195.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccC-CcceEEeEeecCCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHK-NLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~l 596 (813)
+.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEE
Confidence 456678999999999999874 67888988754333 256789999999999988 79999999977777899
Q ss_pred EEeecCCCchhhhhhccC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCcccc
Q 045343 597 VYEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLL 672 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~ 672 (813)
+++++.+++|.+++.... .+.......++.|++.++.|+|.. +++|||+||+||+++... .+++.|||+++..
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 999999999997776664 688999999999999999999954 899999999999999988 7999999999866
Q ss_pred ccCcccc----eeecccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCCcccch-hhhhhHHHHHHhhc
Q 045343 673 TLNQSKA----IRTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYR 744 (813)
Q Consensus 673 ~~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~ 744 (813)
....... ......|+..|+|||.+.. .......|+|++|++++++++|..|+...... ..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 5443221 2355679999999999987 57888999999999999999999997654421 00111111111110
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ........... ......+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 00000000000 1224577889999999999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-19 Score=172.58 Aligned_cols=261 Identities=19% Similarity=0.212 Sum_probs=194.1
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc-CCcceEEeEeecCCce
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNR 594 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~ 594 (813)
|....|.+.++||.|+||.+|.|... ..+..||||.-+.. ....++..|..+.+.++| ..|..+..|..+...-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i---~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISI---TSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeec---cCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 44456788999999999999999875 47889999987542 234467888888888875 6788888888899999
Q ss_pred EEEEeecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC---CCEEEeeccCcc
Q 045343 595 LLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDFGLAK 670 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~DfGla~ 670 (813)
.|||+.. +-+|++++. ....++.++.+-++-|++.-++|+|. .+++||||||+|+|..-+ ..+.++|||+|+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchh
Confidence 9999987 668888774 45778999999999999999999995 499999999999999643 468999999999
Q ss_pred ccccCcccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 671 LLTLNQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 671 ~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
.+....... ......||.+|.+-....+...+.+.|+-|+|.+|.++.-|..|+++........--+.+.+..-.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 875433221 123456999999988888888889999999999999999999999865543322211111111111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
-.++.+.. ..+.++...+.-|-..--++-|....+.+.+.
T Consensus 243 ~~ie~LC~---------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 243 TPIEVLCK---------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred CCHHHHhC---------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 11111111 23455666666777777777787766665553
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=193.56 Aligned_cols=218 Identities=26% Similarity=0.433 Sum_probs=164.8
Q ss_pred eeccccCCcceEEeEeecCCceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 045343 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 651 (813)
Q Consensus 573 l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~ 651 (813)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.. ...++|.....++.+|++||.|||.. +-..|+.|+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4678999999999999999999999999999999999987 56889999999999999999999963 33399999999
Q ss_pred cEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCC-------CCCCccchhhHHHHHHHHHhCCcCC
Q 045343 652 NILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-------TITAKVDVYSFGVLLLEIISCRKSF 724 (813)
Q Consensus 652 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~k~DVwS~Gvvl~elltG~~p~ 724 (813)
|.++|..+.+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876431111111222245569999998763 1467899999999999999999999
Q ss_pred Ccccchhh-hhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 725 DIEMGEEY-AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 725 ~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+....... ..+...+. . .....+.+.+.... +..+.+..++..||..+|.+||+++.|-..++.+...
T Consensus 159 ~~~~~~~~~~eii~~~~---~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVK---K--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHH---h--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 86433221 11111111 1 11112222222111 3345789999999999999999999999998876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=171.93 Aligned_cols=141 Identities=16% Similarity=0.131 Sum_probs=108.3
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc---------chhh-----------------hheeeeeeccc
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG---------EKEF-----------------KNEVVVIGQTH 577 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~---------~~~~-----------------~~E~~~l~~l~ 577 (813)
.+.||+|+||.||+|... +++.||||+++...... ...| ..|++.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999873 67899999997532111 1122 23888999998
Q ss_pred cCCcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 045343 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 657 (813)
Q Consensus 578 h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~ 657 (813)
++++.....+.. ...+|||||+++++|...+.....++.....+++.|++.+|.|||+ ..+|+||||||+|||++
T Consensus 78 ~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 TAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred HCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-
Confidence 877644333322 2348999999998876654445678899999999999999999942 34999999999999998
Q ss_pred CCCEEEeeccCccccc
Q 045343 658 YYNARISDFGLAKLLT 673 (813)
Q Consensus 658 ~~~~kl~DfGla~~~~ 673 (813)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=173.59 Aligned_cols=174 Identities=14% Similarity=0.093 Sum_probs=130.9
Q ss_pred HHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchh---------hhheeeeeeccccCCcceE
Q 045343 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE---------FKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 514 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l 584 (813)
+++....+...+.||.|+||.||.... ++..+|||.+........+. +.+|+..+.+++|++|..+
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 445566677889999999999998543 34579999996543222222 5789999999999999999
Q ss_pred EeEeecC--------CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 585 LGFCDEG--------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 585 ~g~~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
..++... ...+|||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||+++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 9886533 35789999999999988732 222 3456899999999954 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHH
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEII 718 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ell 718 (813)
.++ ++|+|||............ .+.....+..++|+|+||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 988 9999999887553221110 1233344667899999999888654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=165.46 Aligned_cols=142 Identities=16% Similarity=0.072 Sum_probs=109.6
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc--------------------------chhhhheeeeeeccc
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--------------------------EKEFKNEVVVIGQTH 577 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~ 577 (813)
.+.||+|++|.||+|... +++.||||.++...... ...+..|...+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999863 57899999987542110 011346788888999
Q ss_pred cCCcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 045343 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 657 (813)
Q Consensus 578 h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~ 657 (813)
|+++.....+... ..+|||||++++++.........++.....+++.|++.++.+||+ ..+|+||||||+|||++
T Consensus 78 ~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 78 EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 9887544444332 348999999988654443344567788899999999999999996 14999999999999999
Q ss_pred CCCEEEeeccCcccccc
Q 045343 658 YYNARISDFGLAKLLTL 674 (813)
Q Consensus 658 ~~~~kl~DfGla~~~~~ 674 (813)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.6e-19 Score=200.22 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=178.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeee--eeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVV--IGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
...+.+.||.+.|=.|.|++.. +| .|+||++-+.. .-..+.|.++++- ...++|||.+++.-.-..+.-.+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~----eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR----EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC----Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHH
Confidence 4566789999999999999874 33 48899885433 2233444443332 445689999998887767777788
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc--c
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT--L 674 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~--~ 674 (813)
|-+|..+ +|.|.|..+.-+..-+..-|+.|++.||.-+|+ .+|+|||||.+||||+.-.=+.|+||..-+... .
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 8888866 899999888877888888899999999999994 599999999999999998889999998765432 1
Q ss_pred Ccc---cceeecccccccccCcccccC----------CC-CCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHH
Q 045343 675 NQS---KAIRTAIRGTKGYVAPEWFRN----------ST-ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 739 (813)
Q Consensus 675 ~~~---~~~~~~~~gt~~y~aPE~l~~----------~~-~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 739 (813)
+.. .......+.-..|+|||.+.. .. .+++-||||+||++.||++ |+++|.... +..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a-- 246 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA-- 246 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh--
Confidence 111 111122233457999997633 12 5778999999999999988 788886321 100
Q ss_pred HHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
++.+. ....+..++.. +...+..+++.|++.||.+|.++++.++.-.++
T Consensus 247 ---Yr~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 ---YRSGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ---HhccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 01110 11111111111 123677899999999999999999999986654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-18 Score=188.89 Aligned_cols=229 Identities=22% Similarity=0.223 Sum_probs=179.3
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc--chhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEeecC
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 602 (813)
.+|+|.||.|+.+.-..+...+..+|.|.+++..... ......|..++...+ |+.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999876544444567778888886543221 113455667777776 9999999999999999999999999
Q ss_pred CCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceee
Q 045343 603 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682 (813)
Q Consensus 603 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 682 (813)
+|.|...+.....+.......+...++-++.++| ..+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 9999999998888888888888999999999999 56999999999999999999999999999987654322
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccH
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 762 (813)
.+||..|||||++. .....+|-||||++++||+||..||.. +.... +....+ ..+.
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~----------------Il~~~~--~~p~ 208 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKR----------------ILKAEL--EMPR 208 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHH----------------Hhhhcc--CCch
Confidence 27999999999998 567889999999999999999999975 11111 111011 1123
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 045343 763 KCVEKLVMVSIWCIQEDPSLRPTM 786 (813)
Q Consensus 763 ~~~~~l~~l~~~Cl~~dP~~RPt~ 786 (813)
+....+.+++..++..+|..|.-.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 445566677777888888888654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=164.74 Aligned_cols=227 Identities=22% Similarity=0.281 Sum_probs=141.6
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccc----------cCCcceEEeEe--
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTH----------HKNLVRLLGFC-- 588 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~g~~-- 588 (813)
.+.||.|+++.||.+.+. ++++..|||...... ....+++++|.-.+..+. |-.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~---~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDV---ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEETTEEEEEEEET---TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred ccccccCCceEEEEEEEc---cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 467999999999999884 467899999885432 223345666654444432 22232222221
Q ss_pred -------ecC---C-----ceEEEEeecCCCchhhhhh---ccC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 045343 589 -------DEG---Q-----NRLLVYEFLNNGTLASFLF---GNL----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHC 646 (813)
Q Consensus 589 -------~~~---~-----~~~lV~e~~~~gsL~~~l~---~~~----~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~ 646 (813)
... . ..+++|+-+ .++|.+++. ... .+....++.+..|+++.+++||.. +++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 1 235667665 567777753 222 223445667788999999999954 99999
Q ss_pred CCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccC--------CCCCCccchhhHHHHHHHHH
Q 045343 647 DIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN--------STITAKVDVYSFGVLLLEII 718 (813)
Q Consensus 647 dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvvl~ell 718 (813)
||+|+|++++.+|.++|+||+......... .....+..|.+||.... ..++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999998876544221 11334577999997643 24678999999999999999
Q ss_pred hCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCC
Q 045343 719 SCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLR 783 (813)
Q Consensus 719 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 783 (813)
+++.||.....+..... .. .... +.++.+..|+..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999985533211100 11 1123 567889999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-17 Score=159.07 Aligned_cols=185 Identities=16% Similarity=0.055 Sum_probs=135.3
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc----chhhhheeeeeeccc-cCCcceEEeEeecCCceEEEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG----EKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 598 (813)
...|++|+||+||.+.. .+..++.+.++....-. ...+.+|+++|++++ |+++++++++ +..+++|
T Consensus 7 ~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 46799999999996543 45667777776543211 124789999999995 5889999986 4579999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC-CCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDI-KPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dl-k~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+.+.+|...+.. ....++.|++++|.++|.. +|+|||| ||+|||++.++.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999998754321 1235778999999999954 9999999 79999999999999999999986553321
Q ss_pred c----c-------eeecccccccccCcccccCC-CCC-CccchhhHHHHHHHHHhCCcCCCcc
Q 045343 678 K----A-------IRTAIRGTKGYVAPEWFRNS-TIT-AKVDVYSFGVLLLEIISCRKSFDIE 727 (813)
Q Consensus 678 ~----~-------~~~~~~gt~~y~aPE~l~~~-~~~-~k~DVwS~Gvvl~elltG~~p~~~~ 727 (813)
. . .......++.|+.|+...-. ..+ ...+.++-|.-+|.++|++.+...+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 00112357778888754332 223 4578889999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=157.49 Aligned_cols=133 Identities=20% Similarity=0.221 Sum_probs=102.7
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-----ccCCcceEEeEeecCC---c-eE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-----HHKNLVRLLGFCDEGQ---N-RL 595 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~ 595 (813)
+.||+|+||.||. .+ .+. ..+||+.........+++.+|+.++.++ .||||++++|+++++. . ..
T Consensus 8 ~~LG~G~~~~Vy~--hp---~~~-~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 8 SPLGTGRHRKCYA--HP---EDA-QRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred ceecCCCceEEEE--CC---CCc-CeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 6799999999995 32 233 3468887654344566799999999999 5799999999998874 2 33
Q ss_pred EEEee--cCCCchhhhhhccCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeeCCCCCCcEEEcC----CCCEEEeeccC
Q 045343 596 LVYEF--LNNGTLASFLFGNLKPSWNLRTNIAFQIARGL-LYLHEDCSAQIIHCDIKPQNILLDD----YYNARISDFGL 668 (813)
Q Consensus 596 lV~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~DfGl 668 (813)
+|+|| +++++|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5679999999664 35544 35677888777 899965 9999999999999973 34799999544
Q ss_pred c
Q 045343 669 A 669 (813)
Q Consensus 669 a 669 (813)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.5e-16 Score=181.65 Aligned_cols=200 Identities=23% Similarity=0.209 Sum_probs=157.2
Q ss_pred HHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc---cCCcceEEeEeec
Q 045343 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDE 590 (813)
Q Consensus 514 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 590 (813)
-++....+.+.++||+|+||+||+|... +++.||+|+-+-.. .-+|.--.+++.+|+ -+-|+.+...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3444555667789999999999999875 47899999865432 223332233344444 2234444444556
Q ss_pred CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-------CCCCEEE
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-------DYYNARI 663 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-------~~~~~kl 663 (813)
.+..+||+||.+-|+|.+++...+..+|.....++.|+++.+.+||. .+|||+||||+|.||. +...++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 67789999999999999999998999999999999999999999995 4999999999999994 3456999
Q ss_pred eeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 723 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p 723 (813)
+|||-+.-+..-.........++|-.+--+|...+..++.++|.|.|..+++-||-|+..
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999766533222234566789999999999999999999999999999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.3e-17 Score=173.06 Aligned_cols=172 Identities=27% Similarity=0.372 Sum_probs=128.4
Q ss_pred ceEEEEeecCCCchhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 593 NRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
.+++.|+++...+|.+||.++ ...++...+.++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999754 356889999999999999999 38899999999999999999999999998
Q ss_pred cccccCc----ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhc
Q 045343 670 KLLTLNQ----SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 670 ~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
....... .....+...||..||+||.+.+..++.|+||||||++|+||+. -..+++..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------
Confidence 7766544 1112345679999999999999999999999999999999987 33332210
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 789 (813)
..+.++-+..+..... .....-..|+.+++.+.|.+||++.++
T Consensus 467 -~t~~d~r~g~ip~~~~-~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 -ATLTDIRDGIIPPEFL-QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -HhhhhhhcCCCChHHh-hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 0111111111110001 111233478889999999999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=155.87 Aligned_cols=143 Identities=17% Similarity=0.166 Sum_probs=109.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------------------------cchhhhheeeeeecc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------------------------GEKEFKNEVVVIGQT 576 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 576 (813)
+.+.+.||+|++|.||+|... ..++..||||.++..... ....+..|+..+.++
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~--~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDF--DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred HHhCCeeccCcceeEEEEEec--CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999721 136789999998743210 001246799999999
Q ss_pred ccCC--cceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeeCCCCCCcE
Q 045343 577 HHKN--LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ-IIHCDIKPQNI 653 (813)
Q Consensus 577 ~h~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~-ivH~dlk~~NI 653 (813)
.+.. +.+++++ ...++||||+++.+|.........+.......++.||+.++.+||+. + ++|+||||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 7533 4455543 23589999999999877664444556666788999999999999954 8 99999999999
Q ss_pred EEcCCCCEEEeeccCccccc
Q 045343 654 LLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~ 673 (813)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.4e-15 Score=152.81 Aligned_cols=134 Identities=20% Similarity=0.257 Sum_probs=111.4
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--------cchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
+.||+|++|.||+|.. .+..++||+....... ....+.+|+.++..++|+++.....++...+..++
T Consensus 2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFII 76 (211)
T ss_pred cccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence 5799999999999976 4556888876432111 11357789999999999999888888777788999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
||||+++++|.+++..... .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999999865432 788999999999999995 4999999999999999 78999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.9e-15 Score=149.87 Aligned_cols=130 Identities=20% Similarity=0.296 Sum_probs=105.2
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--------cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.||+|+||.||+|.. .+..++||+....... ...++.+|++++..++|+++.....++...+..++|
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 489999999999985 4567888886432111 124567899999999988766655566666778999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
|||+++++|.+++..... .++.+++++|.+||+ .+++|+|++|+||+++ ++.++++|||++..
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999988754321 789999999999995 5999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.5e-15 Score=170.05 Aligned_cols=133 Identities=17% Similarity=0.276 Sum_probs=107.3
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEe-ecccc-------ccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQ-------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
..+.||+|+||+||+|... +..+++|+. .+... ...+++.+|++++.+++|++++....++...+..
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~-----~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYL-----GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccceeccCCcEEEEEEeec-----CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4578999999999999874 223333332 11111 1124578999999999999999888888877888
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
++||||+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999998875 457789999999999995 499999999999999 6779999999999764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-14 Score=150.03 Aligned_cols=197 Identities=23% Similarity=0.264 Sum_probs=133.5
Q ss_pred ccCCcceEEeEee---------------------------cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHH
Q 045343 577 HHKNLVRLLGFCD---------------------------EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 629 (813)
Q Consensus 577 ~h~niv~l~g~~~---------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia 629 (813)
+|||||++.++|. ++..+++||...+. +|..++..+.. +.....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~-s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR-SYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC-chHHHHHHHHHHH
Confidence 6888888887652 22346788876644 88888876654 4455666889999
Q ss_pred HHHHHhhhcCCCCeeeCCCCCCcEEE--cCCC--CEEEeeccCccccccCc--ccc--eeecccccccccCcccccCCC-
Q 045343 630 RGLLYLHEDCSAQIIHCDIKPQNILL--DDYY--NARISDFGLAKLLTLNQ--SKA--IRTAIRGTKGYVAPEWFRNST- 700 (813)
Q Consensus 630 ~gl~yLH~~~~~~ivH~dlk~~NIll--~~~~--~~kl~DfGla~~~~~~~--~~~--~~~~~~gt~~y~aPE~l~~~~- 700 (813)
+|+.|||++ +|.|||+|+.|||| |++. .+.|+|||..---.... -.. ......|...-||||+....+
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999965 99999999999999 3443 47899999764322110 000 012234677889999886432
Q ss_pred -----CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHh
Q 045343 701 -----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWC 775 (813)
Q Consensus 701 -----~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 775 (813)
--.|+|.|+.|.+.||++....||....+ -.... ..+.+..+..+.+ .++..+.+++...
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~-----r~Yqe~qLPalp~---------~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDT-----RTYQESQLPALPS---------RVPPVARQLVFDL 493 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccch-heech-----hhhhhhhCCCCcc---------cCChHHHHHHHHH
Confidence 23589999999999999999999985221 10000 1122222222211 3456678888999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 045343 776 IQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 776 l~~dP~~RPt~~evl~~L 793 (813)
|+.||.+|++..=..+.|
T Consensus 494 L~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hcCCccccCCccHHHhHH
Confidence 999999999986655554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1e-14 Score=146.64 Aligned_cols=137 Identities=17% Similarity=0.160 Sum_probs=105.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc----------------------cchhhhheeeeeecccc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD----------------------GEKEFKNEVVVIGQTHH 578 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~h 578 (813)
+.+.+.||+|+||.||++... ++..||||++...... ....+..|+.++..+.|
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 566789999999999999763 5788999986532100 01125678888888877
Q ss_pred C--CcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 579 K--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 579 ~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
+ .++..++. ...++||||+++++|...... .....++.++++++.++|+ .+++|+||||+||+++
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD 159 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence 7 44555542 345899999999998776431 3456788999999999996 4999999999999999
Q ss_pred CCCCEEEeeccCcccccc
Q 045343 657 DYYNARISDFGLAKLLTL 674 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~ 674 (813)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-14 Score=165.53 Aligned_cols=208 Identities=23% Similarity=0.277 Sum_probs=137.8
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.++.|..|++|.||...+. ...+..|+|. .+... -.++ ++.....|.+|
T Consensus 86 ~~IklisngAygavylvrh~---~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHK---ETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ceeEeeccCCCCceeeeecc---ccccchhhcc-cccch----hhhc---cccccCCccee-------------------
Confidence 34578999999999998764 2345566633 22110 0111 22222233222
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc-----
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ----- 676 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~----- 676 (813)
|+=...++..+.++... +.+++||| +.+|+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 --gDc~tllk~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred --chhhhhcccCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 33344444444444333 67899999 5699999999999999999999999999987542111
Q ss_pred -------c-cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 677 -------S-KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 677 -------~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
. .......+||+.|+|||++..+.|...+|.|++|+|+||.+-|+.||.++.+++-.. ..+.+..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg--~visd~i----- 275 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG--QVISDDI----- 275 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--hhhhhhc-----
Confidence 0 011123579999999999999999999999999999999999999999876654221 1111110
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM 786 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 786 (813)
...+. ......++.+++.+.|+.+|..|--.
T Consensus 276 -~wpE~------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 276 -EWPEE------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred -ccccc------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 00011 11234667788889999999999643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=131.29 Aligned_cols=135 Identities=22% Similarity=0.164 Sum_probs=114.0
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc--CCcceEEeEeecCCceEEEEeec
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
.+.||+|.++.||++... +..++||....... ..++..|+.++..++| .++++++++....+..++++||+
T Consensus 3 ~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred ceecccccccceEEEEec-----CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 467999999999999873 36789998765322 4578999999999987 58999999988888899999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
+++.+..+ +......++.++++++++||.....+++|+|++|+||+++..+.+++.|||.+...
T Consensus 76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 99887654 55677788999999999999754467999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.2e-13 Score=135.65 Aligned_cols=138 Identities=20% Similarity=0.183 Sum_probs=94.3
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc--chhh----------------------hheeeeeeccccC
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEF----------------------KNEVVVIGQTHHK 579 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~--~~~~----------------------~~E~~~l~~l~h~ 579 (813)
.+.||+|+||.||+|... ++..||||++....... ...+ ..|...+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 467999999999999864 56789999876432111 1111 2334444444333
Q ss_pred --CcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 045343 580 --NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 657 (813)
Q Consensus 580 --niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~ 657 (813)
.+.+.+++ ...++||||++++.+........... .....++.+++.++.++|. ..+|+|+||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 23444433 24689999999954432211111111 5677899999999999995 15999999999999999
Q ss_pred CCCEEEeeccCccccc
Q 045343 658 YYNARISDFGLAKLLT 673 (813)
Q Consensus 658 ~~~~kl~DfGla~~~~ 673 (813)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2e-14 Score=165.74 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=187.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccc-cCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 596 (813)
.+++.+.||+|+|+.|-...... .....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~--~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSR--DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccchhhhhhhcC--CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 35566779999999998766532 244567777775443 122234455777777776 9999999999999999999
Q ss_pred EEeecCCCchhhhh-hccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCccccc
Q 045343 597 VYEFLNNGTLASFL-FGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLT 673 (813)
Q Consensus 597 V~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~ 673 (813)
+.+|..++++.+.+ .... ..+......++.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 5544 55666777889999999999993 24899999999999999999 99999999999887
Q ss_pred c-Ccccceeecccc-cccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 674 L-NQSKAIRTAIRG-TKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 674 ~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++......... ..| ....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~-----~~~~--- 247 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSW-----KSNK--- 247 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eee-----cccc---
Confidence 7 444444455678 9999999999885 45678999999999999999999987544322110 000 0000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
.. ..............++...++..+|..|.+.+++..
T Consensus 248 --~~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --GR-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cc-cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 000001122345567777888899999999888754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.7e-13 Score=136.81 Aligned_cols=135 Identities=18% Similarity=0.123 Sum_probs=102.7
Q ss_pred cccc-eeeeeeEEEEEEeccCCcceEEEEEEeeccc-------------cccchhhhheeeeeeccccCCc--ceEEeEe
Q 045343 525 EEVG-RGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-------------QDGEKEFKNEVVVIGQTHHKNL--VRLLGFC 588 (813)
Q Consensus 525 ~~LG-~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~ 588 (813)
..|| .|+.|+||++.. .+..++||+.+... ......+.+|++++.+++|++| ++.+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~-----~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEe-----CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 4677 788889998876 35678888875311 0122457889999999998875 6777775
Q ss_pred ecCCc----eEEEEeecCC-CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 589 DEGQN----RLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 589 ~~~~~----~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
..... .++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+. +|+|+||||+|||++.++.++|
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 44322 3599999997 6898887543 33433 367899999999954 9999999999999999889999
Q ss_pred eeccCcccc
Q 045343 664 SDFGLAKLL 672 (813)
Q Consensus 664 ~DfGla~~~ 672 (813)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.4e-12 Score=128.41 Aligned_cols=199 Identities=22% Similarity=0.287 Sum_probs=137.8
Q ss_pred eeccccCCcceEEeEeec-----CCceEEEEeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 045343 573 IGQTHHKNLVRLLGFCDE-----GQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQI 643 (813)
Q Consensus 573 l~~l~h~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 643 (813)
|-++-|.|||++..|..+ ..+..+++|||..|+|..+|+.. ..+......+++-||..||.|||.. .+.|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 335579999999998743 33578999999999999999753 4566777788999999999999964 8999
Q ss_pred eeCCCCCCcEEEcCCCCEEEeeccCccccccCcc---cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhC
Q 045343 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS---KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC 720 (813)
Q Consensus 644 vH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG 720 (813)
+|+++..+.|++..++-+||.- +.......... ........+-++|.+||.-...+.+..+|||+||+..+||.-+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999998888753 21111111110 0111223467899999988877888899999999999999876
Q ss_pred CcCCC-cccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 721 RKSFD-IEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 721 ~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
..-.. .....+ .++.+...+.. +. -..-..++..|++..|..||+|.+++.+.
T Consensus 279 Eiq~tnseS~~~------------~ee~ia~~i~~-le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESKVE------------VEENIANVIIG-LE-------NGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCcceee------------hhhhhhhheee-cc-------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence 54321 111100 00111111110 00 01113567789999999999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.2e-11 Score=134.25 Aligned_cols=140 Identities=21% Similarity=0.231 Sum_probs=95.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc----------------------------------------ch
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG----------------------------------------EK 564 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~ 564 (813)
+.||.|++|.||+|.+. +++.||||+.+...... +-
T Consensus 123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 46999999999999985 67899999975321100 00
Q ss_pred hhhheeeeeecc----ccCCcceEEeEe-ecCCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHH-HHHHhhh
Q 045343 565 EFKNEVVVIGQT----HHKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIAR-GLLYLHE 637 (813)
Q Consensus 565 ~~~~E~~~l~~l----~h~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~-gl~yLH~ 637 (813)
+|.+|...+.++ +|.+-+.+-..+ ......+|||||+++++|.++.... ... .+.+++..+++ .+..+|+
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence 133344444444 233333333333 2234679999999999998876432 112 24456666666 3567784
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 638 ~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
.+++|+|+||.||+++.++.++++|||++..+..
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.12 E-value=2e-10 Score=112.17 Aligned_cols=130 Identities=19% Similarity=0.132 Sum_probs=96.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcc-eEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~ 603 (813)
+.|+.|.++.||++.. .+..+++|....... ....+..|..++..+.+.+++ +++.+. ....++||||+++
T Consensus 4 ~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEE-----CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 5789999999999876 356799998754321 234567899999988766654 455443 2346899999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.++.+.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 76 ~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Ccccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 8876530 112345678999999999642 22469999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.9e-11 Score=129.55 Aligned_cols=256 Identities=23% Similarity=0.254 Sum_probs=181.3
Q ss_pred HHHHHHHHhhcccccce--eeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeecc-ccCCcceEEeE
Q 045343 513 YKELEEATDNFKEEVGR--GSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGF 587 (813)
Q Consensus 513 ~~el~~~~~~~~~~LG~--G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~ 587 (813)
..+.......+.+.+|. |.+|.||.+...+ ..+...+|+|+-+.... .....=.+|.....++ .|+|.++....
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 44566666777889999 9999999987743 35677899998554332 2233334566555566 49999998888
Q ss_pred eecCCceEEEEeecCCCchhhhhhccCC-CCHHHHHHHHHHHHH----HHHHhhhcCCCCeeeCCCCCCcEEEcCC-CCE
Q 045343 588 CDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIAR----GLLYLHEDCSAQIIHCDIKPQNILLDDY-YNA 661 (813)
Q Consensus 588 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----gl~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ 661 (813)
.++.+..++-+|++. .+|..+.+.... ++....+....+... ||.++| +..++|-|+||.||++..+ ...
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccccccee
Confidence 889999999999875 677777665433 566677777777777 999999 5699999999999999998 889
Q ss_pred EEeeccCccccccCccc-c--eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHH
Q 045343 662 RISDFGLAKLLTLNQSK-A--IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 738 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~-~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 738 (813)
++.|||+...+...... . ......|...|++||.+++ .++...|+|++|.+..+..++.+.....--..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------- 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------- 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-------
Confidence 99999999887755421 1 1122357888999998765 46788999999999999998877654321111
Q ss_pred HHHhhccCcc-cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 739 AFDCYRNEKL-DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 739 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
|...+...+ .+.++ .-..++...+..+++.+|..|++.+.+..
T Consensus 335 -W~~~r~~~ip~e~~~---------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 -WSQLRQGYIPLEFCE---------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccccccCchhhhc---------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111110 01111 11234444788899999999999877664
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.7e-10 Score=90.76 Aligned_cols=56 Identities=21% Similarity=0.378 Sum_probs=44.5
Q ss_pred eeeeeeecccCCCCCcccc-ccCChhhhHHhhcccCCeeeEEecC----ceeeeeccCCCC
Q 045343 365 FDFHELQLTNWHLSDSERF-RPYNEVQCKNSCLSDCFCAAVIFQD----DCCWFKKLPLSN 420 (813)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~A~~~~~----~~C~~~~~~l~~ 420 (813)
++|++++++.+|..+.... .++++++|+..||+||||+||+|.+ ++|++|...|.+
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 4778888888776654432 6699999999999999999999974 569999776653
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.6e-10 Score=128.14 Aligned_cols=142 Identities=15% Similarity=0.128 Sum_probs=87.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc----------------------------------cch------
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD----------------------------------GEK------ 564 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~----------------------------------~~~------ 564 (813)
+.||.|++|.||+|.+.. +++.||||+.+..... -.+
T Consensus 125 ~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~El 201 (537)
T PRK04750 125 KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDEL 201 (537)
T ss_pred hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhh
Confidence 469999999999999852 3789999998632100 011
Q ss_pred hhhheeeeeeccc----cCCcceEEeEeec-CCceEEEEeecCCCchhhhh--hccCCCCHHHHHHHHHHHHHHHHHhhh
Q 045343 565 EFKNEVVVIGQTH----HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHE 637 (813)
Q Consensus 565 ~~~~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~gl~yLH~ 637 (813)
++.+|..-+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++. .... .+. ..++...++. |+++
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~---~~la~~~v~~--~~~Q 275 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDM---KLLAERGVEV--FFTQ 275 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCH---HHHHHHHHHH--HHHH
Confidence 1233333333332 3333433333332 44678999999999998752 2221 111 1122222211 1221
Q ss_pred cCCCCeeeCCCCCCcEEEcCCC----CEEEeeccCccccccC
Q 045343 638 DCSAQIIHCDIKPQNILLDDYY----NARISDFGLAKLLTLN 675 (813)
Q Consensus 638 ~~~~~ivH~dlk~~NIll~~~~----~~kl~DfGla~~~~~~ 675 (813)
-...+++|+|+||.||+++.++ .+++.|||+...+...
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 1234999999999999999888 9999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.8e-09 Score=116.28 Aligned_cols=165 Identities=17% Similarity=0.186 Sum_probs=121.5
Q ss_pred CcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHH
Q 045343 545 TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 624 (813)
Q Consensus 545 ~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i 624 (813)
.++.+|.|...+...........+-++.|+.++||||++++...+++...|||+|.+.- |..++.... .....-.
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~---~~~v~~G 109 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG---KEEVCLG 109 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH---HHHHHHH
Confidence 46778888888765543344567778889999999999999999999999999998643 444554332 3444556
Q ss_pred HHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCc
Q 045343 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704 (813)
Q Consensus 625 ~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k 704 (813)
+.||+.||.+||+ ..+++|++|....|+++..|+.||++|.+......... ......--..|..|+.+.... -.
T Consensus 110 l~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 110 LFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cc
Confidence 8899999999997 46899999999999999999999999988754332111 011112233456666543322 35
Q ss_pred cchhhHHHHHHHHHhC
Q 045343 705 VDVYSFGVLLLEIISC 720 (813)
Q Consensus 705 ~DVwS~Gvvl~elltG 720 (813)
.|.|.||++++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 7999999999999999
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=9e-10 Score=93.90 Aligned_cols=71 Identities=18% Similarity=0.305 Sum_probs=53.8
Q ss_pred ceeeeeeecccCCCCCccccccCChhhhHHhhcccCCeeeEEecC--ceeeeeccCCCCCcccccccccccccc
Q 045343 364 LFDFHELQLTNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQD--DCCWFKKLPLSNGMTDGRLTSKAFMKY 435 (813)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~--~~C~~~~~~l~~~~~~~~~~~~~~lkl 435 (813)
.+.|+.+..+.++...... .++++++|++.|++||+|+||+|.+ ++|++|..++.+.+.........|+|+
T Consensus 11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv 83 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRL 83 (84)
T ss_pred CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEe
Confidence 3567778877777554443 6789999999999999999999974 679999887777655433345677765
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-08 Score=100.16 Aligned_cols=141 Identities=16% Similarity=0.208 Sum_probs=97.7
Q ss_pred cccceeeeeeEEEEEEecc---CCcceEEEEEEeecccc----------cc------------chhhh----heeeeeec
Q 045343 525 EEVGRGSFGIVYKGVILTT---RTSTTAVAVKKLDRVFQ----------DG------------EKEFK----NEVVVIGQ 575 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~---~~~~~~vavK~l~~~~~----------~~------------~~~~~----~E~~~l~~ 575 (813)
..||.|--+.||.|..... ...+..+|||..+.... +. .+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4688999999999975311 01346899998753210 00 11122 68888888
Q ss_pred ccc--CCcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeeCCCCCCc
Q 045343 576 THH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL-HEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 576 l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~ivH~dlk~~N 652 (813)
+.. -++.+++++ ...+|||||+.+..+..-.-....++......+..+++.+|..| |+ .+++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 853 466677765 56789999998754432222222344455677889999999999 64 499999999999
Q ss_pred EEEcCCCCEEEeeccCccccc
Q 045343 653 ILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~ 673 (813)
||+++ +.+.|+|||.+....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-CcEEEEECCCceeCC
Confidence 99974 689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-08 Score=104.10 Aligned_cols=142 Identities=18% Similarity=0.211 Sum_probs=108.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeecccc--CCcceEEeEeecCC---ceEEEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQ---NRLLVY 598 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lV~ 598 (813)
+.|+.|..+.||++... ++..+++|....... ....++..|.++++.+++ .++.+++.+..+.. ..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec----CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 56899999999998763 346789998754322 134578899999999876 44677888876643 568999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC--------------------------------------- 639 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--------------------------------------- 639 (813)
||+++.+|.+.+.. ..++...+..++.++++.|..||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988776532 34566777788888888888888420
Q ss_pred --------------CCCeeeCCCCCCcEEEcC--CCCEEEeeccCccc
Q 045343 640 --------------SAQIIHCDIKPQNILLDD--YYNARISDFGLAKL 671 (813)
Q Consensus 640 --------------~~~ivH~dlk~~NIll~~--~~~~kl~DfGla~~ 671 (813)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-09 Score=119.89 Aligned_cols=246 Identities=20% Similarity=0.207 Sum_probs=169.8
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhh--hheeeeeecc-ccCCcceEEeEeecCCceEEEE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEF--KNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 598 (813)
++...||.|.|+.|++.... ..++..+++|.+.........+. ..|+.+...+ .|.++++........+..++=-
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 44568999999999987632 24677889998865433222221 2344444444 5888888888777888888999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-CCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGla~~~~~~~~ 677 (813)
||++++++...+.-...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..+.....
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceecc
Confidence 99999998887755566778888999999999999999 6799999999999999876 8889999999875332211
Q ss_pred cceeecccccccc-cCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGY-VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y-~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....+..| .+++......+-.+.|+++||.-+.|.+++........ ....+.....
T Consensus 423 ----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------------~~~~i~~~~~ 480 (524)
T KOG0601|consen 423 ----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------------QSLTIRSGDT 480 (524)
T ss_pred ----cccccccccccchhhccccccccccccccccccccccccCcccCcccc------------------cceeeecccc
Confidence 111123333 35555566678889999999999999988765432110 0111111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.... .....+..+...++.+++..||.+.++..+.+-.
T Consensus 481 p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 PNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCCC--chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111 1124555666778899999999999888776543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.5e-08 Score=106.63 Aligned_cols=167 Identities=20% Similarity=0.254 Sum_probs=128.2
Q ss_pred eeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee----cCCceEEEEeecCC-Cch
Q 045343 532 FGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD----EGQNRLLVYEFLNN-GTL 606 (813)
Q Consensus 532 fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~e~~~~-gsL 606 (813)
-.+.||+... .+|..+.+|+++............-++.++++.|.|+|++..++. .+..+++||+|.++ ++|
T Consensus 289 ~~Ttyk~~s~---~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSN---VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeec---cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3578898774 477889999995543333333344567788999999999999885 45578999999987 578
Q ss_pred hhhhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 607 ASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 607 ~~~l~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.+.-+.. ...++...|.++.|++.||.++|+. |..-+-|.+++||++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 7765422 2356889999999999999999954 888899999999999999999999998877
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 723 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p 723 (813)
+..+.... + .-..+-|.=.||.+++.|.||...
T Consensus 443 l~~d~~~~----------------l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 443 LQEDPTEP----------------L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ecCCCCcc----------------h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 66543111 1 113467899999999999998643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.2e-08 Score=94.10 Aligned_cols=131 Identities=21% Similarity=0.344 Sum_probs=97.5
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEE-eeccccc-------cchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKK-LDRVFQD-------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+++|+-..+|.+.. -+..+++|. +++.... ..+...+|..++.+++--.|....=+..+.....|
T Consensus 2 ~~i~~GAEa~i~~~~~-----~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-----LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLI 76 (204)
T ss_pred chhhCCcceeEEeeec-----cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEE
Confidence 3578899999998855 233444543 2221111 11345678999998876666666666778888999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+|||.++-.|.+.+... +..++..+-.-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999888655 34566677777788995 4999999999999998875 99999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.5e-09 Score=122.71 Aligned_cols=242 Identities=19% Similarity=0.208 Sum_probs=163.0
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEee---ccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD---RVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.+-+|.++.++.+.-.. .+...++|... .......+....+-.++-..+||-+++..--+.-.....||++|.
T Consensus 810 ~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~ 886 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYL 886 (1205)
T ss_pred ccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHh
Confidence 467778888887654321 22222333222 222222334444444444455666665554455667889999999
Q ss_pred CCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc--------
Q 045343 602 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT-------- 673 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~-------- 673 (813)
.+++|..-|+.....+....+..+..+...++|||. ..+.|+|++|.|+++..+++.+++||+......
T Consensus 887 ~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred ccCCchhhhhcCCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 999999999887777766677777788899999994 468999999999999999999999998432210
Q ss_pred -------------cCccc--------ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhh
Q 045343 674 -------------LNQSK--------AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 732 (813)
Q Consensus 674 -------------~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~ 732 (813)
..... .......+|+.|.+||.+.+......+|.|++|++++|.++|..||.....+..
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI 1043 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh
Confidence 00000 112235689999999999999999999999999999999999999986654322
Q ss_pred hhhHHHHHHhhccCcccccccccccccc-cHHHHHHHHHHHHHhcccCCCCCCCHH
Q 045343 733 AILTDWAFDCYRNEKLDDLVEGDMEALN-DIKCVEKLVMVSIWCIQEDPSLRPTMK 787 (813)
Q Consensus 733 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 787 (813)
. +.+......... ..+...++.+++...+..+|.+|..|.
T Consensus 1044 f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 F---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 111111111111 123345566777778888999998776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.4e-07 Score=89.12 Aligned_cols=140 Identities=22% Similarity=0.298 Sum_probs=101.3
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEe-ecccc-------ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQ-------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
.+.|-+|+-+.|+++.. .++...||.- .+... -..++..+|.+.+.+++--.|.-..-++.+...-.
T Consensus 12 l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~ 86 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ 86 (229)
T ss_pred ceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence 35688999999999987 5666666642 21111 11245678999999887666655555667777788
Q ss_pred EEEeecCC-CchhhhhhccC-CCCHHHH-HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC---CEEEeeccCc
Q 045343 596 LVYEFLNN-GTLASFLFGNL-KPSWNLR-TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISDFGLA 669 (813)
Q Consensus 596 lV~e~~~~-gsL~~~l~~~~-~l~~~~~-~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGla 669 (813)
|+|||.++ -++.+++.... ....... ..++..|-+.+.-||. .+|+|+||..+||+|..++ .+.++|||++
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99999977 47888886542 2222233 6788889999999995 4999999999999996544 4689999998
Q ss_pred cc
Q 045343 670 KL 671 (813)
Q Consensus 670 ~~ 671 (813)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 65
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.6e-07 Score=84.93 Aligned_cols=76 Identities=26% Similarity=0.434 Sum_probs=60.1
Q ss_pred EEEeeCccEEEeCCC-CCEEeeeccCCC--ceeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeecC
Q 045343 102 VKLTADHGLVLNDPQ-GKQVWSSEIDIG--TVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRK 178 (813)
Q Consensus 102 l~~~~~g~l~l~~~~-~~~~wst~~~~~--~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~~ 178 (813)
+.++.||+||+++.. +.+||++++... ....+.|+++|||||++.++.++|+|=. .
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t---~------------------ 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT---T------------------ 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc---c------------------
Confidence 455689999999765 589999998633 2368899999999999998899998711 1
Q ss_pred CCCCCCCCceeEEeccCCcceecc
Q 045343 179 SETNFSRGRFQFRLLKDGNLVLNI 202 (813)
Q Consensus 179 s~~dps~G~~~~~~~~~g~~~~~~ 202 (813)
...|.|.+.|+++|+++++-
T Consensus 83 ----~~~~~~~~~L~ddGnlvl~~ 102 (114)
T smart00108 83 ----GANGNYVLVLLDDGNLVIYD 102 (114)
T ss_pred ----CCCCceEEEEeCCCCEEEEC
Confidence 13467889999999999874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.2e-07 Score=95.75 Aligned_cols=129 Identities=15% Similarity=0.081 Sum_probs=94.6
Q ss_pred EEEEEEeccCCcceEEEEEEeecccc-----------ccchhhhheeeeeeccccCC--cceEEeEeec-----CCceEE
Q 045343 535 VYKGVILTTRTSTTAVAVKKLDRVFQ-----------DGEKEFKNEVVVIGQTHHKN--LVRLLGFCDE-----GQNRLL 596 (813)
Q Consensus 535 Vykg~~~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~l 596 (813)
|.+..+ +++.+.||+...... .....+.+|...+.++...+ .++++++.+. ....+|
T Consensus 38 vvr~~~-----~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 38 TLRFEL-----AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred EEEEEE-----CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 556655 566899997643211 01113778888888885444 4455666643 234689
Q ss_pred EEeecCCC-chhhhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-------CCCEEEeec
Q 045343 597 VYEFLNNG-TLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-------YYNARISDF 666 (813)
Q Consensus 597 V~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-------~~~~kl~Df 666 (813)
|+|++++- +|.+++.. ....+...+..++.+++..+.-||+. +|+|+|++++|||++. +..+.++||
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 99999986 89998753 33445667788999999999999964 9999999999999975 468999999
Q ss_pred cCccc
Q 045343 667 GLAKL 671 (813)
Q Consensus 667 Gla~~ 671 (813)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98753
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.7e-07 Score=85.07 Aligned_cols=86 Identities=27% Similarity=0.426 Sum_probs=64.9
Q ss_pred EEEee-CccEEEeCCC-CCEEeeeccCC--CceeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeec
Q 045343 102 VKLTA-DHGLVLNDPQ-GKQVWSSEIDI--GTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSR 177 (813)
Q Consensus 102 l~~~~-~g~l~l~~~~-~~~~wst~~~~--~~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~ 177 (813)
+.++. ||+||+++.. +.+||++++.. .....+.|+++|||||++.++.++|||=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~-------------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT-------------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc--------------------
Confidence 34555 9999999765 58999999864 344689999999999999999999986421
Q ss_pred CCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeecc
Q 045343 178 KSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISG 218 (813)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 218 (813)
.+.+.+.+.|+++|+++++-... ...|.+.
T Consensus 84 -----~~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf 113 (116)
T cd00028 84 -----RVNGNYVLVLLDDGNLVLYDSDG------NFLWQSF 113 (116)
T ss_pred -----CCCCceEEEEeCCCCEEEECCCC------CEEEcCC
Confidence 03567899999999999875431 3566653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.3e-07 Score=78.59 Aligned_cols=49 Identities=16% Similarity=0.281 Sum_probs=36.3
Q ss_pred CChhhhHHhhcc---cCCeeeEEecC--ceeeeeccCC-CCCccccccccccccc
Q 045343 386 YNEVQCKNSCLS---DCFCAAVIFQD--DCCWFKKLPL-SNGMTDGRLTSKAFMK 434 (813)
Q Consensus 386 ~s~~~C~~~Cl~---nCsC~A~~~~~--~~C~~~~~~l-~~~~~~~~~~~~~~lk 434 (813)
+++++|+++|++ ||||+||+|.+ .+|++|...+ .+.+.......+.|+|
T Consensus 25 ~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 25 NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 689999999999 99999999953 5799998777 6554433323344443
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=9e-07 Score=87.06 Aligned_cols=125 Identities=23% Similarity=0.236 Sum_probs=79.6
Q ss_pred EEEEEEeccCCcceEEEEEEeeccccc------------c--------------chhhhheeeeeeccccC--CcceEEe
Q 045343 535 VYKGVILTTRTSTTAVAVKKLDRVFQD------------G--------------EKEFKNEVVVIGQTHHK--NLVRLLG 586 (813)
Q Consensus 535 Vykg~~~~~~~~~~~vavK~l~~~~~~------------~--------------~~~~~~E~~~l~~l~h~--niv~l~g 586 (813)
||.|... ++..+|||..+..... . .....+|.+.|.++... ++.++++
T Consensus 2 Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 2 VYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred EEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 7888764 6779999987532100 0 01245788888888755 5667775
Q ss_pred EeecCCceEEEEeecC--CCchhhhhhccCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 587 FCDEGQNRLLVYEFLN--NGTLASFLFGNLKPSWNLRTNIAFQIARGLLY-LHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 587 ~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~y-LH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
+. ...|||||++ +..+..+.... ++......++.+++..+.. +| ..+|+|+||.+.|||++++ .+.|
T Consensus 78 ~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 78 YN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp EE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred Ee----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence 53 4579999998 65554433222 1134456677778776665 45 4599999999999999988 9999
Q ss_pred eeccCccccc
Q 045343 664 SDFGLAKLLT 673 (813)
Q Consensus 664 ~DfGla~~~~ 673 (813)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.6e-06 Score=89.04 Aligned_cols=257 Identities=14% Similarity=0.115 Sum_probs=148.7
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEe----Ee---ecCCce
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLG----FC---DEGQNR 594 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g----~~---~~~~~~ 594 (813)
.+..||+|+-+.+|-.- +..-.+-|+.+........+...| |... .||-+-.-+. .. ......
T Consensus 15 ~gr~LgqGgea~ly~l~------e~~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLG------EVRDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecc------hhhchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 35789999999999642 222233455554433222222222 2222 3443222111 11 112225
Q ss_pred EEEEeecCCC-chhhhhhc------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 595 LLVYEFLNNG-TLASFLFG------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 595 ~lV~e~~~~g-sL~~~l~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
.+.|..+++. ...+++.. -...+|...++.+..+|.+.+-||+. |.+-+|++++|+|+++++.+.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 6677776654 23333321 23468999999999999999999965 88999999999999999999999855
Q ss_pred CccccccCcccceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhC-CcCCCcccc--hhhh----hh
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISC-RKSFDIEMG--EEYA----IL 735 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG-~~p~~~~~~--~~~~----~l 735 (813)
.-....++ ......+|...|.+||.-. +..-+...|-|.||++++++|.| ++||.+-.. .... .+
T Consensus 163 sfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 163 SFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 43332221 1133456899999999754 33456789999999999999886 999975321 1000 11
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHhcC
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQED--PSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPt~~evl~~L~~~ 796 (813)
....+..-.+ .-.....+.... .-.-....+..+..+|+... +.-|||++-.+..|..+
T Consensus 240 a~g~f~ya~~-~~~g~~p~P~~~-P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 240 AHGRFAYASD-QRRGLKPPPRSI-PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hcceeeechh-ccCCCCCCCCCC-ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0000000000 000011110000 01112344555666777543 66899999988888654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.38 E-value=2e-06 Score=86.80 Aligned_cols=107 Identities=20% Similarity=0.204 Sum_probs=86.4
Q ss_pred chhhhheeeeeecccc--CCcceEEeEeecCC----ceEEEEeecCC-CchhhhhhccCCCCHHHHHHHHHHHHHHHHHh
Q 045343 563 EKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQ----NRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635 (813)
Q Consensus 563 ~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yL 635 (813)
.....+|...+.++.. -...+.+++.+... ..+||+|++++ .+|.+++......+......++.++++.++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3457788888888854 44567777776533 35899999998 48999998755567778889999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCC---CEEEeeccCcccc
Q 045343 636 HEDCSAQIIHCDIKPQNILLDDYY---NARISDFGLAKLL 672 (813)
Q Consensus 636 H~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGla~~~ 672 (813)
|+. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 965 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.9e-06 Score=83.96 Aligned_cols=136 Identities=17% Similarity=0.123 Sum_probs=102.6
Q ss_pred cceeeeeeEEEEEEeccCCcceEEEEEEeeccc------cccchhhhheeeeeeccccC--CcceEEeEee-cC----Cc
Q 045343 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF------QDGEKEFKNEVVVIGQTHHK--NLVRLLGFCD-EG----QN 593 (813)
Q Consensus 527 LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~-~~----~~ 593 (813)
-|+||.+.|++-.+ ++..+-+|+-+... +.+...|.+|...|.++... .+.+++ ++. .. ..
T Consensus 26 ~~rgG~SgV~r~~~-----~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVER-----NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEe-----CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 36799999999776 44468888875211 23566799999999999643 344555 332 21 23
Q ss_pred eEEEEeecCC-Cchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC--EEEeeccC
Q 045343 594 RLLVYEFLNN-GTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--ARISDFGL 668 (813)
Q Consensus 594 ~~lV~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~DfGl 668 (813)
..||+|-+++ -+|.+++... .+.+...+..++.+|++.+.-||+ .++.|+|+.+.|||++.++. ++++||.-
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 6899997765 5899988653 355777888999999999999995 49999999999999986666 99999977
Q ss_pred ccc
Q 045343 669 AKL 671 (813)
Q Consensus 669 a~~ 671 (813)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.7e-07 Score=105.19 Aligned_cols=152 Identities=20% Similarity=0.283 Sum_probs=103.0
Q ss_pred HHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc-------eeecccccccccCccccc
Q 045343 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-------IRTAIRGTKGYVAPEWFR 697 (813)
Q Consensus 625 ~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~ 697 (813)
+.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+............ ......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999997 6799999999999999999999999999876544311110 011122456799999999
Q ss_pred CCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhc
Q 045343 698 NSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCI 776 (813)
Q Consensus 698 ~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 776 (813)
+...+.++|+||+|+++|-+.. |+.-+............ ...+..-......+.+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence 9888999999999999999984 55545443221111110 000000000111244677778788889
Q ss_pred ccCCCCCCCHHHHHH
Q 045343 777 QEDPSLRPTMKKVLQ 791 (813)
Q Consensus 777 ~~dP~~RPt~~evl~ 791 (813)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.4e-06 Score=83.83 Aligned_cols=136 Identities=16% Similarity=0.158 Sum_probs=93.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc----------------------cchhhhheeeeeecccc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD----------------------GEKEFKNEVVVIGQTHH 578 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~h 578 (813)
+.+.++||-|--+.||.|... .+..+|||.-+..... .....++|.+.|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 456789999999999999875 6788999965321100 01234678888888865
Q ss_pred C--CcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 579 K--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 579 ~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
. .+.+.+++ +...+||||.++-.|...-- +.+....++..|++-+..+-+ .||||+|+.+-||+++
T Consensus 169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred cCCCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 4 66666654 45689999999977654321 222233333334443333332 4899999999999999
Q ss_pred CCCCEEEeeccCcccc
Q 045343 657 DYYNARISDFGLAKLL 672 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~ 672 (813)
++|.+.++||--+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999776543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.2e-05 Score=69.67 Aligned_cols=100 Identities=27% Similarity=0.436 Sum_probs=67.4
Q ss_pred eeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeCccEEEeCCCCCEEeee
Q 045343 44 TWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSS 123 (813)
Q Consensus 44 ~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst 123 (813)
++.+.+|.+.|-|...| -|-| |. ...+++|..+... ........+.|..||||||+|..+++||++
T Consensus 13 p~~~~s~~~~L~l~~dG---------nLvl-~~--~~~~~iWss~~t~--~~~~~~~~~~L~~~GNlvl~d~~~~~lW~S 78 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDG---------NLVL-YD--SNGSVIWSSNNTS--GRGNSGCYLVLQDDGNLVLYDSSGNVLWQS 78 (114)
T ss_dssp EEEECETTEEEEEETTS---------EEEE-EE--TTTEEEEE--S-T--TSS-SSEEEEEETTSEEEEEETTSEEEEES
T ss_pred ccccccccccceECCCC---------eEEE-Ec--CCCCEEEEecccC--CccccCeEEEEeCCCCEEEEeecceEEEee
Confidence 56565589999997655 3555 33 2357799883320 111157889999999999999999999999
Q ss_pred ccCCCceeEEEEec--CcCEEEEecCCcccccccccCc
Q 045343 124 EIDIGTVAVGHMND--TGNFVLASSSSSKLWDSFSNPS 159 (813)
Q Consensus 124 ~~~~~~~~~~~l~d--~Gnlvl~~~~~~~~WqSFD~PT 159 (813)
. ...+.+.+..++ +||++ +.....+.|.|=+.|.
T Consensus 79 f-~~ptdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 F-DYPTDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp T-TSSS-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred c-CCCccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 4 335566777887 89998 7767788998877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.5e-05 Score=90.22 Aligned_cols=145 Identities=19% Similarity=0.191 Sum_probs=90.3
Q ss_pred hcc-cccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc--------------------------c--------h--
Q 045343 522 NFK-EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--------------------------E--------K-- 564 (813)
Q Consensus 522 ~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~--------------------------~--------~-- 564 (813)
+|. +.|+.++-|.||+|++. +|+.||||+.+-.-.+. . +
T Consensus 127 eF~~~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HcCCCchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 344 46999999999999996 58899999975211100 0 0
Q ss_pred ----hhhheeeeeecc----ccCCcceEEeEee-cCCceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHH
Q 045343 565 ----EFKNEVVVIGQT----HHKNLVRLLGFCD-EGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLY 634 (813)
Q Consensus 565 ----~~~~E~~~l~~l----~h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~y 634 (813)
++..|..-+.++ ++..-+++=..+. -.....|+|||++|-.+.++..- ....+.+.......++.--..+
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL 282 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 122333333333 1222223333332 34577999999999999888522 2334433322222221111112
Q ss_pred hhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 635 LH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
-| ++.|.|.+|.||+++.++.+.+.|||+...+...
T Consensus 283 ~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 RD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred hc-----CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 23 8999999999999999999999999998877543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.5e-05 Score=77.18 Aligned_cols=103 Identities=25% Similarity=0.403 Sum_probs=83.1
Q ss_pred hheeeeeecccc-CCcceEEeEeecCCceEEEEeecCCCchhhh---hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 045343 567 KNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF---LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642 (813)
Q Consensus 567 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 642 (813)
..|..+++.+++ +++++++|+| ..++|.||...+++... +.+-...+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 346677777776 6999999999 34789999998766432 222235689999999999999999999865556
Q ss_pred eeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 643 ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
+...|++++|+-+++++++|+.|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.8e-05 Score=83.71 Aligned_cols=159 Identities=19% Similarity=0.210 Sum_probs=96.9
Q ss_pred CCCCCCHHHHHHHHh------------hcc-cccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc-----------
Q 045343 507 NLPCFSYKELEEATD------------NFK-EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG----------- 562 (813)
Q Consensus 507 ~~~~~~~~el~~~~~------------~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~----------- 562 (813)
..|.++++|+.+.-. +|. +.||.-+.|.||+|.+. +++.||||+-+..-++.
T Consensus 136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~ 211 (538)
T KOG1235|consen 136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLK----NGEDVAVKVQHPGLEKLIMLDLRNLRLL 211 (538)
T ss_pred cCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEec----CCCEEEEEecCcChHHHHHHHHHHHHHH
Confidence 467777777655332 244 46999999999999996 58899999875321110
Q ss_pred --------------------ch------hhhheeeeeec----cccCCc---ceEEeEee-cCCceEEEEeecCCCchhh
Q 045343 563 --------------------EK------EFKNEVVVIGQ----THHKNL---VRLLGFCD-EGQNRLLVYEFLNNGTLAS 608 (813)
Q Consensus 563 --------------------~~------~~~~E~~~l~~----l~h~ni---v~l~g~~~-~~~~~~lV~e~~~~gsL~~ 608 (813)
.+ +|..|.+-..+ ++|-++ |.+=.++. -...+.|+||||+|..+.|
T Consensus 212 ~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~D 291 (538)
T KOG1235|consen 212 AKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKIND 291 (538)
T ss_pred HHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCC
Confidence 01 12233332222 234441 11222222 2347899999999998877
Q ss_pred hhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc----CCCCEEEeeccCcccccc
Q 045343 609 FLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD----DYYNARISDFGLAKLLTL 674 (813)
Q Consensus 609 ~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~----~~~~~kl~DfGla~~~~~ 674 (813)
...- ....+...+. ..+.++ |++.-...|++|+|=+|.||+++ .++.+.+.|||+...+..
T Consensus 292 l~~i~~~gi~~~~i~---~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 292 LDAIDKRGISPHDIL---NKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHcCCCHHHHH---HHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 6432 2233333333 222222 22222234899999999999998 367899999999876653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00015 Score=74.17 Aligned_cols=137 Identities=14% Similarity=0.174 Sum_probs=84.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeEeecCCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~ 602 (813)
++||+|..+.||+. .+...++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~-------~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe-------cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999983 1224567776532 23345788999999886544 4678888877777889999999
Q ss_pred CCc-hhhhh---------------------hcc--CCCCHHHHH-HHHH----------HHHH-HHHHhhhc-CCCCeee
Q 045343 603 NGT-LASFL---------------------FGN--LKPSWNLRT-NIAF----------QIAR-GLLYLHED-CSAQIIH 645 (813)
Q Consensus 603 ~gs-L~~~l---------------------~~~--~~l~~~~~~-~i~~----------~ia~-gl~yLH~~-~~~~ivH 645 (813)
|.. +...+ +.- ......... ++.. .+.+ ...+|... ....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21111 110 011111000 0000 0111 11222211 1345789
Q ss_pred CCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 646 CDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 646 ~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.68 E-value=8.3e-05 Score=61.92 Aligned_cols=56 Identities=18% Similarity=0.344 Sum_probs=38.9
Q ss_pred eeeeeecccCCCCCccccccCChhhhHHhhcc-cCCeeeEEec--Cceeeeec-cCCCCC
Q 045343 366 DFHELQLTNWHLSDSERFRPYNEVQCKNSCLS-DCFCAAVIFQ--DDCCWFKK-LPLSNG 421 (813)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~A~~~~--~~~C~~~~-~~l~~~ 421 (813)
.|..++...++..........++++|++.|+. +|+|.||.|. ++.|+++. ..+.+.
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~ 64 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDA 64 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccc
Confidence 34555555554332222356799999999999 9999999997 46799987 444433
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00013 Score=72.51 Aligned_cols=138 Identities=14% Similarity=0.116 Sum_probs=83.0
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhh---------hheeeeeeccccC---CcceE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEF---------KNEVVVIGQTHHK---NLVRL 584 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~h~---niv~l 584 (813)
....+...+.+-......|.+-.. ++...++|..+......++.| .+++..+.+++.. .+..+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 333344445555555666666555 566778887654222112222 2333333333322 22232
Q ss_pred EeEee-----cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC
Q 045343 585 LGFCD-----EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 659 (813)
Q Consensus 585 ~g~~~-----~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~ 659 (813)
+.+.+ -....+|+|||++|..|.+... ++. .++..+++++.-||+. |++|+|.+|.|++++++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 22221 2234579999999988876642 111 2456677888999965 99999999999999965
Q ss_pred CEEEeeccCccc
Q 045343 660 NARISDFGLAKL 671 (813)
Q Consensus 660 ~~kl~DfGla~~ 671 (813)
.+++.||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00034 Score=72.63 Aligned_cols=137 Identities=13% Similarity=0.042 Sum_probs=82.9
Q ss_pred cceeee-eeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEeecCCC
Q 045343 527 VGRGSF-GIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 527 LG~G~f-G~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
|-.|.. ..||+... .+..+.||...... ..++..|++++..+. +--+.+++++.......++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~-----~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG-----KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC-----CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444444 78898754 22467778765432 345678888888874 444667888777666789999999998
Q ss_pred chhhhh-------------------hccC----CCC--HHHHHHH-HH-------------------HHHHHHHHhhhc-
Q 045343 605 TLASFL-------------------FGNL----KPS--WNLRTNI-AF-------------------QIARGLLYLHED- 638 (813)
Q Consensus 605 sL~~~l-------------------~~~~----~l~--~~~~~~i-~~-------------------~ia~gl~yLH~~- 638 (813)
+|.... +... ... ....... .. .+.+.+..|-..
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 776432 1100 000 0000000 00 011112222111
Q ss_pred ---CCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 639 ---CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 639 ---~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....++|+|+.|.|||++++....|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 135689999999999999987789999988754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00021 Score=73.36 Aligned_cols=140 Identities=21% Similarity=0.182 Sum_probs=82.5
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeEeecC---CceEEEEe
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDEG---QNRLLVYE 599 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~---~~~~lV~e 599 (813)
+.|+.|..+.||+.... +..+++|..... .....+..|..+++.+.... +.+++.++... ...+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~-----~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD-----DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEET-----TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC-----CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 57889999999998763 257899986543 34456788888888886443 56777654322 23689999
Q ss_pred ecCCCchhh----------------hh---hcc----CCCCHHH---------HHHH------------HHHHHH-HHHH
Q 045343 600 FLNNGTLAS----------------FL---FGN----LKPSWNL---------RTNI------------AFQIAR-GLLY 634 (813)
Q Consensus 600 ~~~~gsL~~----------------~l---~~~----~~l~~~~---------~~~i------------~~~ia~-gl~y 634 (813)
++++..+.. .+ +.. ..+.+.. .... ...+.+ .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988777 11 111 0011100 0000 112222 3333
Q ss_pred hhh----cCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCccc
Q 045343 635 LHE----DCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKL 671 (813)
Q Consensus 635 LH~----~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~ 671 (813)
+++ .....++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 1356799999999999999 666668999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=1.6e-05 Score=88.63 Aligned_cols=182 Identities=17% Similarity=0.143 Sum_probs=127.3
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC-cceEEeEeecCCceEEEEeecC
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~ 602 (813)
-+.+++++.++++|..-. ..+...++.+.. .....-++++|.+++||| .+..++-+..+...+++++++.
T Consensus 247 fh~fvK~altknpKkRpt----aeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPT----AEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHhcCCCccCCC----hhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 355678899999986532 223333555432 244566788999999999 6777777777778899999988
Q ss_pred CC-c-hhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 603 NG-T-LASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 603 ~g-s-L~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
.+ + .....-....+...+...+...-++++++||.. .=+|+| ||+..+ ...|..||+.+..+.....
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~--- 386 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK--- 386 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccc---
Confidence 77 2 221111112233334445566677899999943 347888 776665 6889999999887765431
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCC
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~ 725 (813)
.....+++.++|||......+..+.|+|++|+-..++--|.+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 345668999999999999999999999999987777766766653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00062 Score=68.54 Aligned_cols=137 Identities=20% Similarity=0.196 Sum_probs=87.1
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccc---------hhh---------------hheeeeeeccc--cC
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE---------KEF---------------KNEVVVIGQTH--HK 579 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~---------~~~---------------~~E~~~l~~l~--h~ 579 (813)
.|..|--..||+|.. .++..+|||+.+....... ..| ..|..-|.++. +-
T Consensus 55 ~istGKEA~Vy~a~~----~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 55 CISTGKEANVYLAET----GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eecCCcceEEEeecc----CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 567788889999875 3678999999875322111 111 22333444442 33
Q ss_pred CcceEEeEeecCCceEEEEeecCCCchhh-hhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC
Q 045343 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLAS-FLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY 658 (813)
Q Consensus 580 niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~ 658 (813)
.+.+.+++. +-.|||||+....+-. .|.. ..+.......+..++++.+.-|-. ..++||+||..-|||+. +
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence 344444443 3479999987642111 1111 122222566677777777777764 25899999999999999 8
Q ss_pred CCEEEeeccCcccccc
Q 045343 659 YNARISDFGLAKLLTL 674 (813)
Q Consensus 659 ~~~kl~DfGla~~~~~ 674 (813)
+.+.|+|++-|....+
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8999999999986653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0017 Score=79.57 Aligned_cols=149 Identities=15% Similarity=0.219 Sum_probs=90.6
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccc-cCCc--ceEEeEeecC---CceEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNL--VRLLGFCDEG---QNRLL 596 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~l 596 (813)
.+.|+.|.+..+|+.....+. ....+++|+..... ......+.+|.++++.+. |.++ .+++.+|.+. ...++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 367899999999997654221 11356667653321 122346889999999995 6665 7888888764 35789
Q ss_pred EEeecCCCchhhh-----------------------hhccC-----------CCCH--HHHHHHH---------------
Q 045343 597 VYEFLNNGTLASF-----------------------LFGNL-----------KPSW--NLRTNIA--------------- 625 (813)
Q Consensus 597 V~e~~~~gsL~~~-----------------------l~~~~-----------~l~~--~~~~~i~--------------- 625 (813)
||||+++..+.+. |+.-. ...+ ..+..+.
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 9999988653221 11100 0001 0111111
Q ss_pred HHHHHHHHHhhhcCC--------CCeeeCCCCCCcEEEcCC-CC-EEEeeccCccccc
Q 045343 626 FQIARGLLYLHEDCS--------AQIIHCDIKPQNILLDDY-YN-ARISDFGLAKLLT 673 (813)
Q Consensus 626 ~~ia~gl~yLH~~~~--------~~ivH~dlk~~NIll~~~-~~-~kl~DfGla~~~~ 673 (813)
..+.+.+.+|..+.. ..++|+|+++.||+++.+ .. .-|.||+++..-+
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 123344566744321 359999999999999853 33 5799999886543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0015 Score=64.45 Aligned_cols=135 Identities=26% Similarity=0.331 Sum_probs=93.2
Q ss_pred cCCCCCCHHHHHHHHhhcccccceeee-eeEEEEEEeccCCcceEEEEEEeeccc-----------c----------ccc
Q 045343 506 TNLPCFSYKELEEATDNFKEEVGRGSF-GIVYKGVILTTRTSTTAVAVKKLDRVF-----------Q----------DGE 563 (813)
Q Consensus 506 ~~~~~~~~~el~~~~~~~~~~LG~G~f-G~Vykg~~~~~~~~~~~vavK~l~~~~-----------~----------~~~ 563 (813)
..+..|+... +..+|.+.||.|.- |.|||+.+ .+..+|+|..+... . ...
T Consensus 27 PKL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I-----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 98 (207)
T PF13095_consen 27 PKLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEI-----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA 98 (207)
T ss_pred CCcCCcCCCC---CcEeeeeecCCCCceeEEEEEEE-----CCeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence 3455676622 67788999999999 99999998 67799999943210 0 011
Q ss_pred hhhhheeeeeeccc---cCCc--ceEEeEeecC------------------CceEEEEeecCCCchhhhhhccCCCCHHH
Q 045343 564 KEFKNEVVVIGQTH---HKNL--VRLLGFCDEG------------------QNRLLVYEFLNNGTLASFLFGNLKPSWNL 620 (813)
Q Consensus 564 ~~~~~E~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~ 620 (813)
.-|..|.+...+|+ +.++ |+.+||..-. ..+.||.||++... . .
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~----~ 165 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------P----L 165 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------c----c
Confidence 23778888888885 4466 8888887211 12357777765533 1 1
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 621 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 621 ~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
..+-+.+|.+-|..+| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 2233456667777888 459999999999986 5689999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0013 Score=62.73 Aligned_cols=129 Identities=17% Similarity=0.295 Sum_probs=86.9
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcce-EEeEeecCCceEEEEee
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR-LLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~e~ 600 (813)
+..+.|++|++|.||+|.. .+..+|+|+-+.. .....+..|.++|..++-.++-+ ++.|-.+ .+.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-----~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-----RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec-----cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 3457899999999999987 4568999986543 33567889999999998777654 4444322 344999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC-CCcEEEcCCCCEEEeeccCccc
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIK-PQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk-~~NIll~~~~~~kl~DfGla~~ 671 (813)
..|-.|.+.-... +- +-+..+++.---|- ..+|-|+.|. |..++|..+..+.|+||.-|..
T Consensus 94 i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---DR----KHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---cH----HHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998887654322 11 22333444422233 4588888885 5555555555999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0007 Score=80.93 Aligned_cols=195 Identities=20% Similarity=0.164 Sum_probs=134.1
Q ss_pred hheeeeeeccccCCcceEEeEeecCCceE----EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 045343 567 KNEVVVIGQTHHKNLVRLLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642 (813)
Q Consensus 567 ~~E~~~l~~l~h~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 642 (813)
..|+..+.+..|+|++.+++|-.+..... +..|++..-++...+++-...+..+.+.+..++.+||.|+|.. .
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~---~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL---S 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---c
Confidence 44667777889999999999986655433 4456788888888888888889999999999999999999964 3
Q ss_pred eeeCCCCCC---cEEEcCCCCEEEe--eccCccccccCcccceeecccccccccCcccccCCCCCC--ccchhhHHHHHH
Q 045343 643 IIHCDIKPQ---NILLDDYYNARIS--DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITA--KVDVYSFGVLLL 715 (813)
Q Consensus 643 ivH~dlk~~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--k~DVwS~Gvvl~ 715 (813)
..|.-|..+ +...+..+...++ ||+.++.+...... ....-+..+.++|......... ..|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 333333333 4444556667777 88888766543221 1122355677888876665544 479999999999
Q ss_pred HHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 716 EIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 716 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.+..|..+-..... ...+.+. .....+.+....|+..++++|+...+++.+.
T Consensus 384 ~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99887654321110 0011110 0011456777889999999999999999775
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0032 Score=62.62 Aligned_cols=127 Identities=17% Similarity=0.202 Sum_probs=85.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----------------cccchhhhheeeeeeccc------cCCcc
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----------------QDGEKEFKNEVVVIGQTH------HKNLV 582 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv 582 (813)
..||+|+.=.||.-- +.....||+..... ....++..+|+.-..++. +.+|.
T Consensus 7 ~~i~~G~~R~cy~HP------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEECC------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 569999999999632 34456777775443 122355666665555544 88899
Q ss_pred eEEeEeecCCceEEEEeecCC------CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 583 RLLGFCDEGQNRLLVYEFLNN------GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 583 ~l~g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
+++|+.+++....+|+|.+.+ -+|.+++.... ++. ...+.+.+ -..||-+ ..|+.+|++|.||++.
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~~---f~~~l~~---~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALDE---FKRYLLD---HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHHH---HHHHHHH---cCCeecCCCcccEEEE
Confidence 999999999999999998754 25777774443 344 33333333 3445553 3799999999999996
Q ss_pred CC---C-CEEEee
Q 045343 657 DY---Y-NARISD 665 (813)
Q Consensus 657 ~~---~-~~kl~D 665 (813)
.. . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0049 Score=65.87 Aligned_cols=76 Identities=8% Similarity=0.006 Sum_probs=53.9
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc---CCcceEEeEeecC---CceEEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDEG---QNRLLV 597 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lV 597 (813)
.+.||.|..+.||+.... ++ .+.+|..+. ......+..|.+.|+.+.. ..+.+++++|..+ ...+||
T Consensus 19 ~~~i~~G~~~~vy~~~~~----~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYDS----QG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEcC----CC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 357999999999997542 23 355666432 1123478889999988853 4688999888543 568999
Q ss_pred EeecCCCch
Q 045343 598 YEFLNNGTL 606 (813)
Q Consensus 598 ~e~~~~gsL 606 (813)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.002 Score=66.47 Aligned_cols=137 Identities=20% Similarity=0.198 Sum_probs=75.4
Q ss_pred cccceeeee-eEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccC---CcceEEeEeecCC---ceEEE
Q 045343 525 EEVGRGSFG-IVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK---NLVRLLGFCDEGQ---NRLLV 597 (813)
Q Consensus 525 ~~LG~G~fG-~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~---~~~lV 597 (813)
+.|+.|+.. .||+.. ..+++|..+. ......+..|.+++..+... -+.++++.....+ ..+++
T Consensus 3 ~~~~~gG~~n~vy~~~--------~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG--------DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC--------CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457766666 588741 1356666443 12344688899888887532 3445555443322 34889
Q ss_pred EeecCCCchhhhh------------------hccC--C--C-------------CHHHHH--HHH-------HHHHHH-H
Q 045343 598 YEFLNNGTLASFL------------------FGNL--K--P-------------SWNLRT--NIA-------FQIARG-L 632 (813)
Q Consensus 598 ~e~~~~gsL~~~l------------------~~~~--~--l-------------~~~~~~--~i~-------~~ia~g-l 632 (813)
|++++|.++.+.. +.-. . . .|.... .+. .+.+.. +
T Consensus 73 ~~~i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 152 (235)
T cd05155 73 YRWLEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALW 152 (235)
T ss_pred EEeecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHH
Confidence 9999987764321 1100 0 0 011110 000 011111 1
Q ss_pred HH-hhh--cCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 633 LY-LHE--DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 633 ~y-LH~--~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.. ++. .....++|+|+.+.||+++++...-|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 153 EAALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred HHHhcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 111 1244589999999999999776667999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0011 Score=54.50 Aligned_cols=44 Identities=20% Similarity=0.437 Sum_probs=32.8
Q ss_pred ccCCCCCccccccCChhhhHHhhcccCCeeeEEecC--ceeeeecc
Q 045343 373 TNWHLSDSERFRPYNEVQCKNSCLSDCFCAAVIFQD--DCCWFKKL 416 (813)
Q Consensus 373 ~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~--~~C~~~~~ 416 (813)
+++...+.......+.++|++.|+.||+|.||.|.. +.|+++..
T Consensus 12 ~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 12 VDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 344444443334568999999999999999999964 56999865
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0045 Score=64.78 Aligned_cols=136 Identities=12% Similarity=0.076 Sum_probs=77.2
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEeecCCC
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~g 604 (813)
.+..|-...+|+... ++..+++|........-.-...+|..+++.+....+ .++++.+. ..+|+||++|.
T Consensus 3 ~~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe-----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 355677788998763 445677886543221111245778888888865444 34554432 36899999987
Q ss_pred chhhh-----------------hhccC----CCCHHH-HHHHHHH---------HHHHHHHhhhc-----CCCCeeeCCC
Q 045343 605 TLASF-----------------LFGNL----KPSWNL-RTNIAFQ---------IARGLLYLHED-----CSAQIIHCDI 648 (813)
Q Consensus 605 sL~~~-----------------l~~~~----~l~~~~-~~~i~~~---------ia~gl~yLH~~-----~~~~ivH~dl 648 (813)
.+... |+... .++... ......+ +.+.+..+... ....++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65421 11111 111111 1111111 11112222111 1346899999
Q ss_pred CCCcEEEcCCCCEEEeeccCccc
Q 045343 649 KPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 649 k~~NIll~~~~~~kl~DfGla~~ 671 (813)
.|.||++++++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999876 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0096 Score=61.29 Aligned_cols=140 Identities=17% Similarity=0.184 Sum_probs=79.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~ 603 (813)
+.|..|-...+|+.....+ +...+++|...... ...-....|+.++..+...++ +++++.+. ..+||||+++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCC--CCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence 4577788889998864210 14567788664322 112234578888888854444 45544432 2489999998
Q ss_pred Cchhhh-------h----------hccC-C----------CC-HHHHHHHHH----------------------HHHHHH
Q 045343 604 GTLASF-------L----------FGNL-K----------PS-WNLRTNIAF----------------------QIARGL 632 (813)
Q Consensus 604 gsL~~~-------l----------~~~~-~----------l~-~~~~~~i~~----------------------~ia~gl 632 (813)
..+... + +... . .. +..+..+.. .+.+.+
T Consensus 77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 156 (235)
T cd05157 77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI 156 (235)
T ss_pred CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence 765321 0 1100 0 11 222112211 111111
Q ss_pred HHh----hhc-CCCCeeeCCCCCCcEEEcC-CCCEEEeeccCccc
Q 045343 633 LYL----HED-CSAQIIHCDIKPQNILLDD-YYNARISDFGLAKL 671 (813)
Q Consensus 633 ~yL----H~~-~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~ 671 (813)
..| ... ....++|+|+.+.|||++. +..+.|+||..+..
T Consensus 157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111 111 2357999999999999998 57899999988754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0054 Score=65.63 Aligned_cols=139 Identities=16% Similarity=0.148 Sum_probs=83.3
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeEe------ecCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFC------DEGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~l 596 (813)
+.|..|....+|+.... +..+++|+... ....+...|++++..+.+.+ +.+++... ..++..++
T Consensus 20 ~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 20 EGISAGIENTNYFVTTD-----SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred ecccCccccceEEEEeC-----CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 46777877899987652 33578887653 22345667777787775433 44554421 22345689
Q ss_pred EEeecCCCchhh----hh----------hc---c--------CCCCHHHHH----------HHHHHHHHHHHHhhh----
Q 045343 597 VYEFLNNGTLAS----FL----------FG---N--------LKPSWNLRT----------NIAFQIARGLLYLHE---- 637 (813)
Q Consensus 597 V~e~~~~gsL~~----~l----------~~---~--------~~l~~~~~~----------~i~~~ia~gl~yLH~---- 637 (813)
|+++++|..+.. .. +. . ....|.... .....+...+.++.+
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999876532 00 10 0 001222111 011123334444443
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 638 ~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....+++|+|+.|.||+++++..+.|.||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1245799999999999999987789999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.041 Score=60.79 Aligned_cols=74 Identities=15% Similarity=0.165 Sum_probs=50.5
Q ss_pred cccceeeeeeEEEEEEeccCCcc-eEEEEEEeeccc-------cccchhhhheeeeeeccc---cCCcceEEeEeecCCc
Q 045343 525 EEVGRGSFGIVYKGVILTTRTST-TAVAVKKLDRVF-------QDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQN 593 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~ 593 (813)
++||.|.+..||++... ++ +.++||.-.... .-..+++..|.+.|..+. ..++++++.+ +.+.
T Consensus 32 ~elggGn~N~VyrV~~~----~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~ 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT----EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL 105 (401)
T ss_pred eEcCCCceEEEEEEEeC----CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC
Confidence 67999999999999874 33 478999843110 112345666777777652 2457777777 3456
Q ss_pred eEEEEeecCCC
Q 045343 594 RLLVYEFLNNG 604 (813)
Q Consensus 594 ~~lV~e~~~~g 604 (813)
.++|||++++.
T Consensus 106 ~~lVME~L~~~ 116 (401)
T PRK09550 106 AVTVMEDLSDH 116 (401)
T ss_pred CEEEEecCCCc
Confidence 78999998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.026 Score=60.52 Aligned_cols=142 Identities=23% Similarity=0.279 Sum_probs=82.2
Q ss_pred cccceeeeeeEEEEEEecc---CCcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTT---RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~ 600 (813)
+.|..|-...+|+.....+ +..+..+++|...... ........|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 4456666678998865311 1124678888865432 233456778888888854444 355665542 358999
Q ss_pred cCCCchhhh-----------------hhccC-CC--------C--HHHHHHH--------------------------HH
Q 045343 601 LNNGTLASF-----------------LFGNL-KP--------S--WNLRTNI--------------------------AF 626 (813)
Q Consensus 601 ~~~gsL~~~-----------------l~~~~-~l--------~--~~~~~~i--------------------------~~ 626 (813)
++|..+... ++... .. + |....++ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 01110 00 0 1111111 11
Q ss_pred HHHHHHHHhhh------cCCCCeeeCCCCCCcEEEcCC----CCEEEeeccCccc
Q 045343 627 QIARGLLYLHE------DCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKL 671 (813)
Q Consensus 627 ~ia~gl~yLH~------~~~~~ivH~dlk~~NIll~~~----~~~kl~DfGla~~ 671 (813)
.+.+-+..|.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222333431 135679999999999999985 8899999998854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.078 Score=57.37 Aligned_cols=139 Identities=12% Similarity=0.107 Sum_probs=75.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeE------eecCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGF------CDEGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~l 596 (813)
+.|+.|....+|+.... + ..+++|+.+. ...++...|+.++..+...+ +.+.+.. .......++
T Consensus 28 ~~l~~G~~n~~y~v~t~----~-g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT----Q-GEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred chhccccccceEEEEeC----C-CcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 45667777889987652 2 2578887652 12233444555565553222 3344431 122445789
Q ss_pred EEeecCCCchhh-----h------h---hcc-C----------CCCH-HHHHH------------HHHH-HHHHHHHhhh
Q 045343 597 VYEFLNNGTLAS-----F------L---FGN-L----------KPSW-NLRTN------------IAFQ-IARGLLYLHE 637 (813)
Q Consensus 597 V~e~~~~gsL~~-----~------l---~~~-~----------~l~~-~~~~~------------i~~~-ia~gl~yLH~ 637 (813)
++||++|..+.. . | +.. . .+.| ..... ...+ +...+..+..
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 999999875421 1 1 110 0 0111 11111 1111 1112222221
Q ss_pred ----cCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 638 ----DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 638 ----~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....+++|+|+++.||+++++...-|+||+.+..
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1345899999999999999776668999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.15 Score=54.75 Aligned_cols=140 Identities=15% Similarity=0.188 Sum_probs=79.7
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeEe------ecCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFC------DEGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~l 596 (813)
+.++.|....+|+.... ++ .+++|+.+.. ....+...|.+++..+.... +.+++... ......++
T Consensus 28 ~~~~~G~~n~~y~v~t~----~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD----VG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred cccCCccccceEEEEeC----CC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 45777777899987542 22 4667765432 12334556667777764322 44444422 12345689
Q ss_pred EEeecCCCchhhh--------------hhcc-C-----------CCCHHHHHH------------HHHHHHHHHHHhhh-
Q 045343 597 VYEFLNNGTLASF--------------LFGN-L-----------KPSWNLRTN------------IAFQIARGLLYLHE- 637 (813)
Q Consensus 597 V~e~~~~gsL~~~--------------l~~~-~-----------~l~~~~~~~------------i~~~ia~gl~yLH~- 637 (813)
++||++|..+... ++.. . ...|..... ....+.+.++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 9999988654210 1110 0 011221110 11123344555542
Q ss_pred ---cCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 638 ---DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 638 ---~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....+++|+|+++.||++++++...|.||+.+..
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2356899999999999999887778999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.094 Score=55.39 Aligned_cols=32 Identities=28% Similarity=0.484 Sum_probs=26.5
Q ss_pred CCeeeCCCCCCcEEEcCCCC-EEEeeccCcccc
Q 045343 641 AQIIHCDIKPQNILLDDYYN-ARISDFGLAKLL 672 (813)
Q Consensus 641 ~~ivH~dlk~~NIll~~~~~-~kl~DfGla~~~ 672 (813)
..++|+|+++.|||+++++. .-|.||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 569999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.16 Score=55.57 Aligned_cols=141 Identities=19% Similarity=0.177 Sum_probs=81.6
Q ss_pred ccceeeeeeEEEEEEeccC-CcceEEEEEEeeccccccchhhhheeeeeeccccCCcc-eEEeEeecCCceEEEEeecCC
Q 045343 526 EVGRGSFGIVYKGVILTTR-TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~ 603 (813)
.|-.|-.-.+|+....... ..+..+++|....... ..-....|..++..+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 4445667789987653221 1235688887654332 222336788888888655554 566665433 58999987
Q ss_pred Cchhhh-----------------hhccC------CCCHHHHHHHHHH-----------------HHHHHHHhhh-----c
Q 045343 604 GTLASF-----------------LFGNL------KPSWNLRTNIAFQ-----------------IARGLLYLHE-----D 638 (813)
Q Consensus 604 gsL~~~-----------------l~~~~------~l~~~~~~~i~~~-----------------ia~gl~yLH~-----~ 638 (813)
.+|... ++... ...|....++..+ +...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 11111 1113333333211 1112222221 1
Q ss_pred CCCCeeeCCCCCCcEEEcC-CCCEEEeeccCccc
Q 045343 639 CSAQIIHCDIKPQNILLDD-YYNARISDFGLAKL 671 (813)
Q Consensus 639 ~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~ 671 (813)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2457899999999999986 47899999988864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.15 Score=54.51 Aligned_cols=112 Identities=24% Similarity=0.327 Sum_probs=68.3
Q ss_pred hhhhheeeeeecccc--CCcceEEeEeecCC--ceEEEEeecCCCchhh------------------hhh---cc-----
Q 045343 564 KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQ--NRLLVYEFLNNGTLAS------------------FLF---GN----- 613 (813)
Q Consensus 564 ~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~------------------~l~---~~----- 613 (813)
....+|..+|+.+.- .-....++.|.++. ..+.||+|+++..+.+ +|. +-
T Consensus 66 ~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~ 145 (321)
T COG3173 66 HDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGL 145 (321)
T ss_pred hHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCC
Confidence 445667777777642 33556677787766 6799999998733221 111 00
Q ss_pred ---C---------CCCHHHHHHHH--------HHHHHHHHHhhhcC-----CCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 614 ---L---------KPSWNLRTNIA--------FQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 614 ---~---------~l~~~~~~~i~--------~~ia~gl~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
. ...|....+.+ -....-..+|++.. ...++|+|+++.||++++..-+-|.||++
T Consensus 146 ~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~ 225 (321)
T COG3173 146 PDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWEL 225 (321)
T ss_pred CCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccc
Confidence 0 00122222100 12233345555432 35699999999999999988899999999
Q ss_pred ccccccC
Q 045343 669 AKLLTLN 675 (813)
Q Consensus 669 a~~~~~~ 675 (813)
+.+.++.
T Consensus 226 ~~lGDP~ 232 (321)
T COG3173 226 ATLGDPL 232 (321)
T ss_pred cccCCcH
Confidence 9876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.14 Score=55.72 Aligned_cols=143 Identities=18% Similarity=0.245 Sum_probs=80.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcc-eEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~ 603 (813)
+.|..|=...+|+........+...+.+|....... ..-...+|..+++.+...++- ++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 345456667889886542222234678887654322 222346788888888766664 566665322 58999877
Q ss_pred Cchhh-------hh----------hccC-----CC-CHHHHHHHHHHH----------------------HHHHHHhhh-
Q 045343 604 GTLAS-------FL----------FGNL-----KP-SWNLRTNIAFQI----------------------ARGLLYLHE- 637 (813)
Q Consensus 604 gsL~~-------~l----------~~~~-----~l-~~~~~~~i~~~i----------------------a~gl~yLH~- 637 (813)
..|.. .+ +... .+ -|....++..++ .+-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65522 01 1111 01 133333222221 111222211
Q ss_pred ----cCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCcccc
Q 045343 638 ----DCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLL 672 (813)
Q Consensus 638 ----~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~~ 672 (813)
.......|+|+.+.|||+++ ++.++++||..|...
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11235899999999999975 578999999988643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.095 Score=55.48 Aligned_cols=72 Identities=21% Similarity=0.311 Sum_probs=46.4
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc---cCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.|+.|....+|+.. .++..+.||.-. ......|..|.+-|+.|. -..+.+++++....+..+||+||+
T Consensus 23 ~~v~GG~i~~a~~~~-----~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-----TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEE--SSSSEEEEEE-----TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred EecCCCChhheEEEE-----CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 568888888999865 266788999865 234457888888888773 455789999887777789999999
Q ss_pred CCC
Q 045343 602 NNG 604 (813)
Q Consensus 602 ~~g 604 (813)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.092 Score=52.06 Aligned_cols=138 Identities=17% Similarity=0.201 Sum_probs=82.4
Q ss_pred eEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHH
Q 045343 548 TAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 626 (813)
Q Consensus 548 ~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ 626 (813)
....+|++....-. ...-|.++..++++++ .|++|..= ..-...++.|+|..-.. .. ..++.
T Consensus 86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~-~N~i~ 148 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NF-SNFIT 148 (308)
T ss_pred chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------ch-hHHHH
Confidence 35567776543222 2344677777777775 35565521 33356688888744211 01 11122
Q ss_pred HHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccc
Q 045343 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVD 706 (813)
Q Consensus 627 ~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~D 706 (813)
.=++.|.-.|.+ +.+.+|+|-.|+||+-|..|.+||.|=+.-.. . +.-|.-- .....++++.
T Consensus 149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V~~vN~---~Y~~lT~~aE 210 (308)
T PF07387_consen 149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QVNMVNI---EYESLTQEAE 210 (308)
T ss_pred HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h------------eeeEEee---eccccChHHH
Confidence 224667788866 77999999999999999999999999654211 0 1111111 1234566777
Q ss_pred hhhHHHHHHHHHhC
Q 045343 707 VYSFGVLLLEIISC 720 (813)
Q Consensus 707 VwS~Gvvl~elltG 720 (813)
+-+|=.-+++++..
T Consensus 211 ~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 211 VKVFVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHHHHH
Confidence 77777777777653
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.33 Score=53.62 Aligned_cols=73 Identities=18% Similarity=0.228 Sum_probs=47.2
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----c---ccchhhhheeeeeeccc---cCCcceEEeEeecCCc
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----Q---DGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQN 593 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~---~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~ 593 (813)
.++||.|....||+... .+..++||+-.... . ....+-..|.+.|+.+. ..++.+++.++. +.
T Consensus 37 ~~eiggGn~N~VyrV~~-----~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-----SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc-----CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC
Confidence 36789999999999765 23458888764111 1 12233344455555443 357888998887 45
Q ss_pred eEEEEeecCC
Q 045343 594 RLLVYEFLNN 603 (813)
Q Consensus 594 ~~lV~e~~~~ 603 (813)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 6888999976
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.012 Score=72.47 Aligned_cols=155 Identities=12% Similarity=-0.039 Sum_probs=106.8
Q ss_pred heeeeeeccccCCcceEEeEee--cCCceEEEEeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhc--C
Q 045343 568 NEVVVIGQTHHKNLVRLLGFCD--EGQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHED--C 639 (813)
Q Consensus 568 ~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~--~ 639 (813)
.|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|-.. ..++.......-.+......-.|.. .
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444555567888765554442 334568889999999999988543 2223333332223323444444432 2
Q ss_pred CCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 045343 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719 (813)
Q Consensus 640 ~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt 719 (813)
+.-.+|++||+-|.+|..+..+|+.++|+.+...+.... .....+++-|++|++.....++.++|+|..|+-+|+.--
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 345789999999999999999999999999843332221 334567888999999988889999999999999999877
Q ss_pred CCcCC
Q 045343 720 CRKSF 724 (813)
Q Consensus 720 G~~p~ 724 (813)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77665
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.28 E-value=0.076 Score=58.86 Aligned_cols=162 Identities=22% Similarity=0.283 Sum_probs=86.8
Q ss_pred hhhheeeeeeccccCCcceEEeEeecCC-ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 045343 565 EFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 643 (813)
Q Consensus 565 ~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 643 (813)
++.-...+++.++|+|+...+.+..... ...+|+|++ +.||++++..+.. - ..... -| ++
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l-~------~~s~~------~~-----~~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL-K------DESLL------AH-----GV 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc-c------hhhhc------cc-----cc
Confidence 4455566778889999999999876544 456788876 6688888765431 1 00001 11 22
Q ss_pred eeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 045343 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 723 (813)
Q Consensus 644 vH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p 723 (813)
.|- || .+++| ...... | ....+|+|||++|.++.|+.-|...
T Consensus 89 ~~~-----~~-------~~~td----~~~t~~-----------------~-----~~~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 89 LHL-----NI-------IYITD----HFLTKY-----------------P-----SPIGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred cee-----hh-------hhccc----cccccC-----------------C-----CCCCcchhhhhHHHHHHHHHHhhHH
Confidence 221 11 22333 000000 1 0112599999999999999988765
Q ss_pred CCcccchhhhhhHHHHHHh-hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 045343 724 FDIEMGEEYAILTDWAFDC-YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789 (813)
Q Consensus 724 ~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev 789 (813)
+......++... .... ........+.... ....++.+.++++...|+-..|..||...+.
T Consensus 131 ~~~~~~s~~l~~---i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 131 EAELTESEYLEI---LLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHH---HHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 542211111110 0000 0011111111111 1223566778889999999999988865443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.052 Score=56.82 Aligned_cols=131 Identities=13% Similarity=0.096 Sum_probs=82.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc----------------c------cchhhhheeeeeecccc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ----------------D------GEKEFKNEVVVIGQTHH 578 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~----------------~------~~~~~~~E~~~l~~l~h 578 (813)
+.+.+.||-|--+-||.+... ++.+.++|.-+.... . ..-....|...|+.+.-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 557789999999999998764 567777774321100 0 00113456666666642
Q ss_pred -C-CcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 579 -K-NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 579 -~-niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
- -+.+.+++ +..++|||++.+-.|...-+-. +...+ ...+..-+.-|. ..|+||+|..-=||+++
T Consensus 170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---d~~~l---y~~lm~~Iv~la---~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE---DPPTL---YDDLMGLIVRLA---NHGLIHGDFNEFNIMVK 236 (465)
T ss_pred cCCCCCCcccc----cceeeHHHhhcccceeeeeecC---ChHHH---HHHHHHHHHHHH---HcCceecccchheeEEe
Confidence 1 23444443 4568899999887776543221 22222 223333333444 33999999999999999
Q ss_pred CCCCEEEeeccC
Q 045343 657 DYYNARISDFGL 668 (813)
Q Consensus 657 ~~~~~kl~DfGl 668 (813)
+++.++++||--
T Consensus 237 dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 237 DDDKIVVIDFPQ 248 (465)
T ss_pred cCCCEEEeechH
Confidence 999999999964
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.15 Score=55.19 Aligned_cols=62 Identities=19% Similarity=0.228 Sum_probs=43.0
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 657 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~ 657 (813)
...|+-+|+.+.++..++..... +++.+.+++.-.+.|+.-+-. --+.+|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~-pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQ-PEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcccC-hHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 34677778888898888876543 345666666655555543331 237999999999999953
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 813 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-54 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-42 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-21 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-21 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-21 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-21 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 813 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-125 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-114 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-113 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-74 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-62 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-60 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-59 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-59 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-57 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-56 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-56 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-55 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-55 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-50 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-50 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-49 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-49 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 6e-43 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 9e-42 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-41 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-40 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-40 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-40 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-40 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-39 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-39 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-39 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 5e-39 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-39 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-38 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-38 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-38 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-38 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-38 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 6e-38 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-38 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 8e-38 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-37 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-37 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-37 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-37 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-37 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-37 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-37 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-37 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-37 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-37 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-37 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-37 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-37 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-37 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 7e-37 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-36 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-36 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-36 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-36 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-36 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-36 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-36 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-36 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-36 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-36 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-36 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 7e-36 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-35 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-35 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-35 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-35 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-35 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-35 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-35 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-34 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-34 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-34 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-34 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-34 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-34 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-34 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-34 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-33 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-33 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-33 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-33 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-33 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-32 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-32 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-31 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-31 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-30 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-30 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-29 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-29 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-29 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-28 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-28 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-28 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-28 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-28 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-28 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-28 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-28 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-27 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-27 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-27 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-27 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-27 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 8e-27 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 8e-27 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 9e-27 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-26 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-26 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-26 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-26 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-26 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-26 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-26 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-26 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-26 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-26 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-25 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-25 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-25 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 9e-25 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-24 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-24 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-23 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-22 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-22 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-22 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-21 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-21 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-21 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-21 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-21 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-21 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 8e-21 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-20 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-19 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-19 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-19 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-19 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-19 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-19 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-19 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-18 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-18 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-18 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 6e-18 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-17 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-17 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-09 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 8e-17 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-16 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-16 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-16 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-16 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-16 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-16 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-16 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-16 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-15 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-15 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-14 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-14 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 9e-14 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-13 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-13 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-13 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-13 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 4e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-11 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 5e-11 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 3e-05 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 8e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 6e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 9e-11 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-10 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-10 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-10 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-09 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-07 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 1e-05 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 2e-05 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 2e-04 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 4e-05 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 4e-05 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 7e-05 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 6e-05 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 2e-04 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 4e-04 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 3e-04 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 4e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-125
Identities = 122/298 (40%), Positives = 179/298 (60%), Gaps = 14/298 (4%)
Query: 507 NLPCFSYKELEEATDNFKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKLDR-VFQDGE 563
L FS +EL+ A+DNF + +GRG FG VYKG + T VAVK+L Q GE
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL----ADGTLVAVKRLKEERTQGGE 71
Query: 564 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS----WN 619
+F+ EV +I H+NL+RL GFC RLLVY ++ NG++AS L + W
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 620 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679
R IA ARGL YLH+ C +IIH D+K NILLD+ + A + DFGLAKL+ +
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH- 190
Query: 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDI--EMGEEYAILTD 737
+ TA+RGT G++APE+ + K DV+ +GV+LLE+I+ +++FD+ ++ +L D
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795
W + +KL+ LV+ D++ + VE+L+ V++ C Q P RP M +V++MLEG
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-114
Identities = 114/309 (36%), Positives = 165/309 (53%), Gaps = 28/309 (9%)
Query: 505 ETNLPCFSYKELEEATDNFKEE--------VGRGSFGIVYKGVILTTRTSTTAVAVKKLD 556
+T FS+ EL+ T+NF E +G G FG+VYKG + + T VAVKKL
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA 63
Query: 557 RVFQD----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 612
+ +++F E+ V+ + H+NLV LLGF +G + LVY ++ NG+L L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 613 --NLKP-SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669
P SW++R IA A G+ +LHE+ IH DIK NILLD+ + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 729
+ + + I GT Y+APE R IT K D+YSFGV+LLEII+ + D
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 730 EEYAILTDWAFDCYRNEK-LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKK 788
+ L D + EK ++D ++ M D VE + V+ C+ E + RP +KK
Sbjct: 240 PQL--LLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 789 VLQMLEGVV 797
V Q+L+ +
Sbjct: 297 VQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-113
Identities = 103/308 (33%), Positives = 159/308 (51%), Gaps = 13/308 (4%)
Query: 498 SPGDGTIETNLPCFSYKELEEATDNFKEE--VGRGSFGIVYKGVILTTRTSTTAVAVKKL 555
+ +LEEAT+NF + +G G FG VYKGV+ VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL----RDGAKVALKRR 71
Query: 556 DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK 615
G +EF+ E+ + H +LV L+GFCDE +L+Y+++ NG L L+G+
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 616 P----SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671
P SW R I ARGL YLH IIH D+K NILLD+ + +I+DFG++K
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
T + T ++GT GY+ PE+F +T K DVYSFGV+L E++ R + + E
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L +WA + + N +L+ +V+ ++ + + K ++ C+ RP+M VL
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 792 MLEGVVEV 799
LE + +
Sbjct: 309 KLEYALRL 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-74
Identities = 78/309 (25%), Positives = 123/309 (39%), Gaps = 33/309 (10%)
Query: 511 FSYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFK 567
+ L + + E RG FG V+K + VAVK QD + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-----LNEYVAVKIFPI--QDKQSWQNE 66
Query: 568 NEVVVIGQTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPSWNLRTN 623
EV + H+N+++ +G G + L+ F G+L+ FL N SWN +
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCH 125
Query: 624 IAFQIARGLLYLHEDCSAQ-------IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676
IA +ARGL YLHED I H DIK +N+LL + A I+DFGLA +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 677 SKAIRTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
S GT+ Y+APE + ++D+Y+ G++L E+ S + D + E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 732 YAILTDWAFDCYRNEKLDDLVEGDM------EALNDIKCVEKLVMVSIWCIQEDPSLRPT 785
+ E + ++V + + L C D R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 786 MKKVLQMLE 794
V + +
Sbjct: 306 AGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 7e-64
Identities = 76/303 (25%), Positives = 140/303 (46%), Gaps = 47/303 (15%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEV 570
+ +L KE++G GSFG V++ + VAVK L + EF EV
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRA-----EWHGSDVAVKILMEQDFHAERVNEFLREV 85
Query: 571 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQ 627
++ + H N+V +G + N +V E+L+ G+L L + + R ++A+
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGT 687
+A+G+ YLH + I+H ++K N+L+D Y ++ DFGL++L + + GT
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGT 202
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--- 744
++APE R+ K DVYSFGV+L E+ + ++ + + ++ F C R
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-NL-NPAQVVAAVGFKCKRLEI 260
Query: 745 ----NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
N ++ ++E C +P RP+ ++ +L +++ +
Sbjct: 261 PRNLNPQVAAIIE--------------------GCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 801 LPP 803
+PP
Sbjct: 301 VPP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-62
Identities = 83/307 (27%), Positives = 145/307 (47%), Gaps = 40/307 (13%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 572
YKE+E +E VGRG+FG+V K + VA+K+++ + K F E+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKA-----KWRAKDVAIKQIES--ESERKAFIVELRQ 54
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIA 629
+ + +H N+V+L G C LV E+ G+L + L G + + Q +
Sbjct: 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
+G+ YLH +IH D+KP N+LL +I DFG A + + T +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSA 167
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748
++APE F S + K DV+S+G++L E+I+ RK FD E+G + + R +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNGTRPPLI 226
Query: 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV---SLPPNP 805
+ + + + C +DPS RP+M+++++++ ++ + P
Sbjct: 227 KN-------------LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
Query: 806 YPFSSSM 812
YP S+
Sbjct: 274 YPCQHSL 280
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-60
Identities = 76/309 (24%), Positives = 128/309 (41%), Gaps = 38/309 (12%)
Query: 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 573
+ + E +G+G FG K T R + + +K+L R ++ ++ F EV V+
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKV---THRETGEVMVMKELIRFDEETQRTFLKEVKVM 61
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGL 632
H N+++ +G + + + E++ GTL + W+ R + A IA G+
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS------------KAI 680
YLH S IIH D+ N L+ + N ++DFGLA+L+ ++ +
Sbjct: 122 AYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWA 739
R + G ++APE + KVDV+SFG++L EII + D L
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV--- 796
F + C +++ C DP RP+ K+ LE +
Sbjct: 239 F--LD-----------RYCPPN--CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
Query: 797 VEVSLPPNP 805
+ LP P
Sbjct: 284 LAGHLPLGP 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-59
Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 42/294 (14%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL----DRVFQDGEKEFKN 568
+ EL +E +G G FG VY+ VAVK D + +
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRA-----FWIGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 569 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 628
E + H N++ L G C + N LV EF G L L G + ++ N A QI
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQI 114
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR--------ISDFGLAKLLTLNQSKAI 680
ARG+ YLH++ IIH D+K NIL+ I+DFGLA+ +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTT 170
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740
+ + G ++APE R S + DV+S+GVLL E+++ F + + A+ A
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GI-DGLAVAYGVAM 228
Query: 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ C E + C DP RP+ +L L
Sbjct: 229 NKLALPIPST-------------CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 6e-59
Identities = 80/338 (23%), Positives = 126/338 (37%), Gaps = 47/338 (13%)
Query: 511 FSYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN 568
+ E DN K E +GRG +G VYKG + VAVK + F N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFS---FANRQNFIN 54
Query: 569 EVVV--IGQTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGNLKPSWNLR 621
E + + H N+ R + + LLV E+ NG+L +L + W
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSS 113
Query: 622 TNIAFQIARGLLYLHEDCSA------QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
+A + RGL YLH + I H D+ +N+L+ + ISDFGL+ LT N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 676 QSKAIR------TAIRGTKGYVAPEWFRNS-------TITAKVDVYSFGVLLLEIIS-CR 721
+ + GT Y+APE + + +VD+Y+ G++ EI C
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 722 KSFDIEMGEEYAI-LTDWAFDCYRNEKLDDLVEGD-------MEALNDIKCVEKLVMVSI 773
F E EY + + E + LV + + V L
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 774 WCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPFSSS 811
C +D R T + + + ++ N ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMM-IWERNKSVSPTA 330
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-57
Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 44/297 (14%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-------KE 565
E+E +++++G+G FG+V+KG ++ ++ VA+K L +GE +E
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSV---VAIKSLILGDSEGETEMIEKFQE 69
Query: 566 FKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNI 624
F+ EV ++ +H N+V+L G +V EF+ G L L P W+++ +
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-----YNARISDFGLAKLLTLNQSKA 679
IA G+ Y+ + + I+H D++ NI L A+++DFGL++ +
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--- 183
Query: 680 IRTAIRGTKGYVAPEWF--RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 737
+ + G ++APE + T K D YSF ++L I++ FD + +
Sbjct: 184 --SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241
Query: 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ R +D C +L V C DP RP +++ L
Sbjct: 242 IREEGLRPTIPED-------------CPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-56
Identities = 72/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEV 570
+++LE E +G+G FG VY G VA++ + +R +D K FK EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREV 80
Query: 571 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIA 629
+ QT H+N+V +G C + ++ TL S + + N IA +I
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR---TAIRG 686
+G+ YLH + I+H D+K +N+ D+ I+DFGL + + Q+ G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 687 TKGYVAPEWFRNSTI---------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 737
++APE R + + DV++ G + E+ + F E I
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII--- 252
Query: 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ K + L+ I +++ + ++C + RPT K++ MLE
Sbjct: 253 --WQMGTGMKPN---------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKN 580
+ +G GSFG VYKG VAVK L + FKNEV V+ +T H N
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
++ +G+ +V ++ +L L K +IA Q ARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
+ IIH D+K NI L + +I DFGLA + + G+ ++APE R
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 700 TI---TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756
+ + DVY+FG++L E+++ + + + I+ + L +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGRG-SLSPDLSKVRSN-- 253
Query: 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C +++ + C+++ RP+ ++L +E
Sbjct: 254 -------CPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-55
Identities = 59/298 (19%), Positives = 109/298 (36%), Gaps = 56/298 (18%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEV 570
+K+L F ++ G ++KG R + VK L ++F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKG-----RWQGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 571 VVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF 626
+ H N++ +LG C + L+ ++ G+L + L N + A
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
+ARG+ +LH I + +++++D+ ARIS +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMY 170
Query: 687 TKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743
+VAPE + T D++SF VLL E+++ F ++ I A +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DL-SNMEIGMKVALEGL 228
Query: 744 R-------NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
R + + L++ C+ EDP+ RP ++ +LE
Sbjct: 229 RPTIPPGISPHVSKLMK--------------------ICMNEDPAKRPKFDMIVPILE 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 69/305 (22%), Positives = 114/305 (37%), Gaps = 51/305 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKN 580
E VG+G +G V++G VAVK +D EK + E + H+N
Sbjct: 12 LLECVGKGRYGEVWRG-----SWQGENVAVKIFSS--RD-EKSWFRETELYNTVMLRHEN 63
Query: 581 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
++ + ++ L+ + G+L +L I IA GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLH 122
Query: 637 EDCSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIRTAIRGTKG 689
+ I H D+K +NIL+ I+D GLA + + NQ GTK
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 690 YVAPEWFRNSTITA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743
Y+APE + +VD+++FG++L E+ S I E+Y +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKP-------PF 233
Query: 744 RNEKLDDLVEGDM--------------EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
+ +D DM + L + C ++PS R T ++
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 790 LQMLE 794
+ L
Sbjct: 294 KKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 4e-49
Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 51/305 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNE--VVVIGQTHHKN 580
+E +G+G FG V++G + VAVK E+ + E + H+N
Sbjct: 46 LQESIGKGRFGEVWRG-----KWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHEN 97
Query: 581 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
++ + ++ LV ++ +G+L +L + +A A GL +LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLH 156
Query: 637 EDCSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIRTAIRGTKG 689
+ I H D+K +NIL+ I+D GLA + GTK
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 690 YVAPEWFRNSTITA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743
Y+APE +S + D+Y+ G++ EI I E+Y + Y
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQL-------PY 267
Query: 744 RNEKLDDLVEGDM--------------EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
+ D +M + + + + C + + R T ++
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 790 LQMLE 794
+ L
Sbjct: 328 KKTLS 332
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-49
Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 51/305 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKN 580
+++G+G +G V+ G + VAVK + E + E + H+N
Sbjct: 41 MVKQIGKGRYGEVWMG-----KWRGEKVAVKVFFT--TE-EASWFRETEIYQTVLMRHEN 92
Query: 581 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
++ + +G L+ ++ NG+L +L + +A+ GL +LH
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 637 EDCSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIRTAIRGTKG 689
+ + I H D+K +NIL+ I+D GLA N+ GTK
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 690 YVAPE------WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743
Y+ PE + D+YSFG++L E+ S I EEY + Y
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEYQL-------PY 262
Query: 744 RNEKLDDLVEGDM--------------EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
+ D DM + +C+ ++ + C +P+ R T +V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 790 LQMLE 794
+ L
Sbjct: 323 KKTLA 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-43
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 41/287 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNL 581
E++GRG+FG V+ G + R T VAVK + + D + +F E ++ Q H N+
Sbjct: 118 LGEQIGRGNFGEVFSGRL---RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCS 640
VRL+G C + Q +V E + G +FL + + A G+ YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---S 231
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA----IRGTKGYVAPEWF 696
IH D+ +N L+ + +ISDFG+++ A ++ T APE
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEAL 287
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD 755
+++ DV+SFG+LL E S G Y L+ N++ + VE
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSL--------GASPYPNLS--------NQQTREFVEKG 331
Query: 756 --MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
+ C + + +M W +P RP+ + Q L+ + +
Sbjct: 332 GRLPCPEL--CPDAVFRLMEQCW--AYEPGQRPSFSTIYQELQSIRK 374
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-42
Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 29/296 (9%)
Query: 514 KELEEATDNFKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 572
EE + ++G+G+FG V + VAVK+L D +++F+ E+ +
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 573 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 628
+ H +V+ G Q+ LV E+L +G L FL + + + + QI
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQI 136
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA----- 683
+G+ YL S + +H D+ +NIL++ + +I+DFGLAKLL L++ +
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 742
I APE ++ + + DV+SFGV+L E+ + C KS E+ + D
Sbjct: 194 IFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMGCERDV 247
Query: 743 YRNEKLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+L +L+E + A C ++ +M W P RP+ + L+
Sbjct: 248 PALSRLLELLEEGQRLPAPPA--CPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 69/312 (22%), Positives = 136/312 (43%), Gaps = 22/312 (7%)
Query: 495 IRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVK 553
N G + + + EE F +++G+G+FG V + VAVK
Sbjct: 17 TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 554 KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLF 611
KL ++ ++F+ E+ ++ H N+V+ G C +N L+ E+L G+L +L
Sbjct: 77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 612 GNLKPSWNLRT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669
+ K + QI +G+ YL + + IH D+ +NIL+++ +I DFGL
Sbjct: 137 KH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 670 KLLTLNQSKAIRTAIRGTKGYV---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDI 726
K+L ++ + + APE S + DV+SFGV+L E+ + +
Sbjct: 193 KVLPQDKEYY--KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250
Query: 727 EMGEEYAILTDWAFDCYRNEKLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSL 782
E ++ + L +L++ + + + C +++ +M W + +
Sbjct: 251 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQ 306
Query: 783 RPTMKKVLQMLE 794
RP+ + + ++
Sbjct: 307 RPSFRDLALRVD 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 67/292 (22%), Positives = 132/292 (45%), Gaps = 22/292 (7%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 573
+ EE F +++G+G+FG V + VAVKKL ++ ++F+ E+ ++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 574 GQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 629
H N+V+ G C +N L+ E+L G+L +L + K + QI
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQIC 124
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
+G+ YL + + IH D+ +NIL+++ +I DFGL K+L ++ +
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF--KVKEPGES 179
Query: 690 YV---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746
+ APE S + DV+SFGV+L E+ + + E ++ +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 747 KLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
L +L++ + + + C +++ +M W + + RP+ + + ++
Sbjct: 240 HLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 580
F E+GRGSF VYKG+ T T VA + ++ + + FK E ++ H N
Sbjct: 30 FDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 581 LVRLLGFC---DEGQNRLLVY-EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
+VR +G+ +++ E + +GTL ++L + + QI +GL +LH
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 637 EDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
+ IIH D+K NI + + +I D GLA L + +K A+ GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM 201
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSF-DIE-MGEEYAILTD----WAFDCYRNEKLD 749
+ VDVY+FG+ +LE+ + + + + + Y +T +FD ++
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+++E CI+++ R ++K +L
Sbjct: 261 EIIE--------------------GCIRQNKDERYSIKDLLN 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-40
Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 35/279 (12%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
K ++G G +G VY+GV + + VAVK L + +EF E V+ + H NLV
Sbjct: 224 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+LLG C ++ EF+ G L +L + + +A QI+ + YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 336
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIRTAIRGTKGYVAPEWFR 697
IH ++ +N L+ + + +++DFGL++L+T + + I+ T APE
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 392
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD-- 755
+ + K DV++FGVLL EI + S Y + ++ +L+E D
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-------PYPGID--------LSQVYELLEKDYR 437
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
ME C EK+ + C Q +PS RP+ ++ Q E
Sbjct: 438 MERPEG--CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 74/304 (24%), Positives = 131/304 (43%), Gaps = 38/304 (12%)
Query: 515 ELEEATDNFKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVV 572
E+ ++G G FG V + VAVK L + + K E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 573 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 628
+ +H+N+V+ G C D G L+ EFL +G+L +L N K NL+ A QI
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQI 135
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
+G+ YL S Q +H D+ +N+L++ + +I DFGL K + ++ T
Sbjct: 136 CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY--TVKDDRD 190
Query: 689 GYV---APEWFRNSTITAKVDVYSFGVLLLEIIS-------CRKSFDIEMGEEYAILTDW 738
V APE S DV+SFGV L E+++ F +G + +T
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT-- 248
Query: 739 AFDCYRNEKLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+L + ++ + + C +++ +M W + PS R + + +++ E
Sbjct: 249 ------VTRLVNTLKEGKRLPCPPN--CPDEVYQLMRKCW--EFQPSNRTSFQNLIEGFE 298
Query: 795 GVVE 798
+++
Sbjct: 299 ALLK 302
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 68/303 (22%), Positives = 128/303 (42%), Gaps = 43/303 (14%)
Query: 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVV 571
+F E +GRG FG VY G +L AVK L+R+ GE +F E +
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 572 VIGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 628
++ H N++ LLG C + L+V ++ +G L +F+ + ++ Q+
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQV 201
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA----- 683
A+G+ +L S + +H D+ +N +LD+ + +++DFGLA+ + + ++
Sbjct: 202 AKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 684 -IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFD 741
++ A E + T K DV+SFGVLL E+++ G Y +
Sbjct: 259 PVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVN----- 301
Query: 742 CYRNEKLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797
+ + + C + L VM+ W +RP+ +++ + +
Sbjct: 302 ---TFDITVYLLQGRRLLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIF 354
Query: 798 EVS 800
Sbjct: 355 STF 357
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 69/300 (23%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 572
+F E +GRG FG VY G +L AVK L+R+ GE +F E ++
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 573 IGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 629
+ H N++ LLG C + L+V ++ +G L +F+ + ++ Q+A
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVA 138
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL------TLNQSKAIRTA 683
+G+ YL S + +H D+ +N +LD+ + +++DFGLA+ + +++ +
Sbjct: 139 KGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDC 742
++ A E + T K DV+SFGVLL E+++ G Y +
Sbjct: 196 VKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVN------ 237
Query: 743 YRNEKLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
+ + + C + L VM+ W +RP+ +++ + +
Sbjct: 238 --TFDITVYLLQGRRLLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 30/281 (10%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ 575
NF+ +++GRG F VY+ L VA+KK+ K E+ ++ Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGV---PVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARG 631
+H N+++ E +V E + G L+ + K + Q+
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L ++H +++H DIKP N+ + ++ D GL + + + A + + GT Y+
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLV-GTPYYM 203
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
+PE + K D++S G LL E+ + + F + Y++ +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------------KI 250
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
+ D L E+L + CI DP RP + V +
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 25/311 (8%)
Query: 496 RNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVI-LTTRTSTTAVAVKK 554
+ G + P + ++G G FG V T + VAVK
Sbjct: 9 HHHHGALEVLFQGPGDP-TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 555 LDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLF 611
L +K E+ ++ +H+++++ G C + LV E++ G+L +L
Sbjct: 68 LKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 612 GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671
+ A QI G+ YLH + IH D+ +N+LLD+ +I DFGLAK
Sbjct: 128 RH-SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
Query: 672 LTLNQSKAIRTAIRGTKGYV---APEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIE 727
+ V APE + DV+SFGV L E+++ C S
Sbjct: 184 VPEGHE--YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241
Query: 728 MGEEYAILTDWAFDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLR 783
I +L +L+E + + C ++ +M + W + + S R
Sbjct: 242 TKFLELIGIA--QGQMTVLRLTELLERGERLPRPDK--CPAEVYHLMKNCW--ETEASFR 295
Query: 784 PTMKKVLQMLE 794
PT + ++ +L+
Sbjct: 296 PTFENLIPILK 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 65/285 (22%), Positives = 122/285 (42%), Gaps = 42/285 (14%)
Query: 523 FKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 580
+ +G G+FG VYKG+ I VA+K+L + KE +E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 638
+ RLLG C L+ + + G L ++ + K + + N QIA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA----IRGTKGYVAPE 694
+++H D+ +N+L+ + +I+DFGLAKLL + + I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVE 753
+ T + DV+S+GV + E+++ G + Y + ++ ++E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSILE 233
Query: 754 GD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ C + +M W D RP ++++
Sbjct: 234 KGERLPQPPI--CTIDVYMIMRKCW--MIDADSRPKFRELIIEFS 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 73/292 (25%), Positives = 137/292 (46%), Gaps = 37/292 (12%)
Query: 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 572
+E+E + + ++ +G G G V G + VA+K L + + ++ +F +E +
Sbjct: 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 630
+GQ H N++RL G G+ ++V E++ NG+L +FL + + + + +
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGA 162
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
G+ YL +H D+ +N+L+D ++SDFGL+++L + A T G K
Sbjct: 163 GMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT--TGGKIP 217
Query: 691 V---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNE 746
+ APE T ++ DV+SFGV++ E+++ GE Y +T N
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY--------GERPYWNMT--------NR 261
Query: 747 KLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ VE + A C L +M+ W +D + RP +++ +L+
Sbjct: 262 DVISSVEEGYRLPAPMG--CPHALHQLMLDCW--HKDRAQRPRFSQIVSVLD 309
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 54/300 (18%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTST-TAVAVKKLDRVFQDGEKE-FKNEVVVIGQT 576
+F+ + +GRG FG+V++ A+K++ ++ +E EV + +
Sbjct: 5 TDFEPIQCLGRGGFGVVFEA----KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 577 HHKNLVRLLG-FCDEG--------QNRLLVY---EFLNNGTLASFLF---GNLKPSWNLR 621
H +VR + ++ ++ +Y + L ++ + ++
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 622 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-- 679
+I QIA + +LH S ++H D+KP NI ++ DFGL + ++ +
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 680 --------IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
T GTK Y++PE ++ + KVD++S G++L E++ F +M
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-- 232
Query: 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
R L D+ L K + VMV + P RP +++
Sbjct: 233 ------------RVRTLTDVRNLKFPPLFTQKYPCEYVMVQ-DMLSPSPMERPEAINIIE 279
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-38
Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 47/282 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKN 580
+ +G+G FG V G + VAVK + ++ + F E V+ Q H N
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 581 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 637
LV+LLG E + L +V E++ G+L +L + + + + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 306
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR 697
+H D+ +N+L+ + A++SDFGL K + Q + ++ T APE R
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 359
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
+ K DV+SFG+LL EI S G Y + + + VE
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSF--------GRVPYPRIP--------LKDVVPRVEKGY 403
Query: 756 -MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
M+A + C + VM + W D + RPT ++ + LE
Sbjct: 404 KMDAPDG--CPPAVYDVMKNCW--HLDAATRPTFLQLREQLE 441
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 75/286 (26%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQTHHK 579
E++G GSFG+V +G T +VAVK L + +F EV + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 637
NL+RL G +V E G+L L + + + L T A Q+A G+ YL
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE- 138
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APE 694
S + IH D+ +N+LL +I DFGL + L N K APE
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPE 194
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVE 753
+ T + D + FGV L E+ + G+E + L ++ ++
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTY--------GQEPWIGLN--------GSQILHKID 238
Query: 754 GD---MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ + D C + + VMV W P RPT + L
Sbjct: 239 KEGERLPRPED--CPQDIYNVMVQCW--AHKPEDRPTFVALRDFLL 280
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 48/290 (16%)
Query: 523 FKEEVGRGSFGIVYKGV----ILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 578
F E +G+G+F ++KGV + T V +K LD+ ++ + F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYL 635
K+LV G C G +LV EF+ G+L ++L N + W L +A Q+A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL 129
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNAR--------ISDFGLAKLLTLNQSKAIRTAIRGT 687
+IH ++ +NILL + + +SD G++ + R I
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER--IPWV 184
Query: 688 KGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRN 745
PE N D +SFG L EI S G++ + L
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICS--------GGDKPLSALDS-------Q 225
Query: 746 EKLDDLVEGD-MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
KL + + A ++ + +P RP+ + +++ L
Sbjct: 226 RKLQFYEDRHQLPAPKA--AELANLINNCM--DYEPDHRPSFRAIIRDLN 271
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 65/293 (22%), Positives = 129/293 (44%), Gaps = 43/293 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 581
+G+G FG+VY G + + A+K L R+ + + F E +++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 582 VRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 638
+ L+G + + ++ +G L F+ + + ++ + Q+ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA-- 141
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA------IRGTKGYVA 692
+ +H D+ +N +LD+ + +++DFGLA+ + + +++ ++ T A
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDL 751
E + T K DV+SFGVLL E+++ G Y + L
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHID--------PFDLTHF 240
Query: 752 VE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
+ + C + L VM W + DP++RPT + ++ +E +V
Sbjct: 241 LAQGRRLPQPEY--CPDSLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVSAL 289
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-38
Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 37/279 (13%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+ ++G+G FG V+ G T T VA+K L E F E V+ + H+ LV
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLV 242
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+L E + +V E+++ G+L FL G L ++A QIA G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIRTAIRGTKGYVAPEWFR 697
+H D++ NIL+ + +++DFGLA+L+ N+ + + I+ T APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 354
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD-- 755
T K DV+SFG+LL E+ + + Y + N ++ D VE
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 399
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
M + C E L + C +++P RPT + + LE
Sbjct: 400 MPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 78/278 (28%), Positives = 120/278 (43%), Gaps = 35/278 (12%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
E+G G+FG V KG + VAVK K + + E E V+ Q + +VR
Sbjct: 24 ELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 643
++G C E ++ +LV E G L +L N + Q++ G+ YL E +
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-E--ESNF 138
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APEWFRNST 700
+H D+ +N+LL + A+ISDFGL+K L +++ A K V APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWYAPECINYYK 196
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD-MEA 758
++K DV+SFGVL+ E S G++ Y + +E L +G+ M
Sbjct: 197 FSSKSDVWSFGVLMWEAFSY--------GQKPYRGMKG-------SEVTAMLEKGERMGC 241
Query: 759 LNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
C ++ +M W D RP V L
Sbjct: 242 PAG--CPREMYDLMNLCW--TYDVENRPGFAAVELRLR 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 41/282 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
K ++G G +G VY+GV + + VAVK L + +EF E V+ + H NLV
Sbjct: 17 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+LLG C ++ EF+ G L +L + + +A QI+ + YL
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 129
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA---IRGTKGYVAPEWFR 697
IH D+ +N L+ + + +++DFGL++L+T + A A I+ T APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 185
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
+ + K DV++FGVLL EI + G Y + ++ +L+E D
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT--------YGMSPYPGID--------LSQVYELLEKDY 229
Query: 756 -MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
ME C EK+ +M + W Q +PS RP+ ++ Q E
Sbjct: 230 RMERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQAFE 267
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 40/297 (13%)
Query: 514 KELEEATDNFKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVV 571
+ +E + +G G FG V+KGV I + V +K ++ + + ++
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 572 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIA 629
IG H ++VRLLG C G + LV ++L G+L + + + + + N QIA
Sbjct: 68 AIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIA 125
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
+G+ YL E ++H ++ +N+LL +++DFG+A LL + + K
Sbjct: 126 KGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ---LLYSEAKT 179
Query: 690 YV---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRN 745
+ A E T + DV+S+GV + E+++ G E YA L
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF--------GAEPYAGLR--------L 223
Query: 746 EKLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
++ DL+E + C + VMV W D ++RPT K++ +
Sbjct: 224 AEVPDLLEKGERLAQPQI--CTIDVYMVMVKCW--MIDENIRPTFKELANEFTRMAR 276
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 80/310 (25%), Positives = 148/310 (47%), Gaps = 51/310 (16%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 579
E+G+GSFG+VY+GV + T VA+K ++ E+ EF NE V+ + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT----------NIAFQIA 629
++VRLLG +GQ L++ E + G L S+L N +A +IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
G+ YL+ + + +H D+ +N ++ + + +I DFG+ + + ++ R +G KG
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYR---KGGKG 200
Query: 690 YV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCY 743
+ +PE ++ T DV+SFGV+L EI + + E+ Y L+
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGLS------- 245
Query: 744 RNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799
NE++ V G ++ ++ C + L +M W Q +P +RP+ +++ ++ +E
Sbjct: 246 -NEQVLRFVMEGGLLDKPDN--CPDMLFELMRMCW--QYNPKMRPSFLEIISSIKEEMEP 300
Query: 800 SLPPNPYPFS 809
+ +S
Sbjct: 301 GFREVSFYYS 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-37
Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 37/279 (13%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+ ++G+G FG V+ G T T VA+K L + + F E V+ + H+ LV
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+L E + +V E+++ G+L FL G L ++A QIA G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 381
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIRTAIRGTKGYVAPEWFR 697
+H D++ NIL+ + +++DFGLA+L+ N+ + + I+ T APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 437
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD-- 755
T K DV+SFG+LL E+ + + Y + N ++ D VE
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 482
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
M + C E L + C +++P RPT + + LE
Sbjct: 483 MPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 39/283 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKN 580
K+ +G G+ G + + R VAVK++ EV ++ + H N
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNR----DVAVKRILPEC---FSFADREVQLLRESDEHPN 79
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-NIAFQIARGLLYLHEDC 639
++R + Q + + E L TL ++ L + Q GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 640 SAQIIHCDIKPQNILL-----DDYYNARISDFGLAKLLTLNQ-SKAIRTAIRGTKGYVAP 693
S I+H D+KP NIL+ A ISDFGL K L + + S + R+ + GT+G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 694 EWFRNSTI---TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNEKL 748
E T VD++S G + +IS + +L + DC L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-----L 250
Query: 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
D+ A I+ I DP RP+ K VL+
Sbjct: 251 HPEKHEDVIARELIE----------KMIAMDPQKRPSAKHVLK 283
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 77/291 (26%), Positives = 140/291 (48%), Gaps = 35/291 (12%)
Query: 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 572
KEL+ + + VG G FG V G + +VA+K L + + ++ +F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 630
+GQ H N++RL G + + ++V E++ NG+L SFL + + + + IA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIAS 158
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
G+ YL +H D+ +NIL++ ++SDFGL ++L + A T RG K
Sbjct: 159 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIP 213
Query: 691 V---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNE 746
+ +PE T+ DV+S+G++L E++S GE Y +++ +
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPYWEMSN-------QD 258
Query: 747 KLDDLVEGD-MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ + EG + D C L +M+ W Q+D + RP ++++ +L+
Sbjct: 259 VIKAVDEGYRLPPPMD--CPAALYQLMLDCW--QKDRNNRPKFEQIVSILD 305
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 83/317 (26%), Positives = 129/317 (40%), Gaps = 57/317 (17%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 579
+G G+FG VY+G + + S VAVK L V + ++ +F E ++I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-------NIAFQIARGL 632
N+VR +G + R ++ E + G L SFL + ++A IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNAR---ISDFGLAKLLTLN-----QSKAIRTAI 684
YL IH DI +N LL R I DFG+A+ + A +
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA-MLPV 209
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCY 743
+ PE F T+K D +SFGVLL EI S +G Y +
Sbjct: 210 KWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKS------- 250
Query: 744 RNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEG---- 795
N+++ + V G M+ + C + +M W Q P RP +L+ +E
Sbjct: 251 -NQEVLEFVTSGGRMDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQD 305
Query: 796 --VVEVSLPPNPYPFSS 810
V+ +LP P
Sbjct: 306 PDVINTALPIEYGPLVE 322
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 43/282 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+E+G G FG+V G VAVK + E EF E + + H LV
Sbjct: 12 LLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+ G C + +V E+++NG L ++L + + + + G+ +L S
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---S 122
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIRTAIRGTKGYVAPEWFR 697
Q IH D+ +N L+D ++SDFG+ + + +Q S + ++ + APE F
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFH 178
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
++K DV++FG+L+ E+ S +G+ Y + T N ++ V
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS--------LGKMPYDLYT--------NSEVVLKVSQGH 222
Query: 756 -MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ + + + +M S W E P RPT +++L +E
Sbjct: 223 RLYRPHL--ASDTIYQIMYSCW--HELPEKRPTFQQLLSSIE 260
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 76/305 (24%), Positives = 125/305 (40%), Gaps = 47/305 (15%)
Query: 500 GDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF 559
G + S L + +G+G FG V G + VAVK +
Sbjct: 2 GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK-----VAVKCI---- 52
Query: 560 QDG--EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP 616
++ + F E V+ Q H NLV+LLG E + L +V E++ G+L +L +
Sbjct: 53 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 617 SWNLRT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674
+ + + YL +H D+ +N+L+ + A++SDFGL K +
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169
Query: 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YA 733
Q + ++ T APE R + K DV+SFG+LL EI S G Y
Sbjct: 170 TQDTG-KLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYS--------FGRVPYP 216
Query: 734 ILTDWAFDCYRNEKLDDLVEGD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKV 789
+ + + VE M+A + C + VM + W D ++RP+ ++
Sbjct: 217 RIP--------LKDVVPRVEKGYKMDAPDG--CPPAVYEVMKNCW--HLDAAMRPSFLQL 264
Query: 790 LQMLE 794
+ LE
Sbjct: 265 REQLE 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 30/272 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 586
+G+G++GIVY G L+ + +A+K++ + E+ + HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQV---RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 587 FCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 643
E + E + G+L++ L +G LK + QI GL YLH++ QI
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 644 IHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI- 701
+H DIK N+L++ Y +ISDFG +K L GT Y+APE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRG 201
Query: 702 -TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
D++S G ++E+ + + F E+GE A + F + ++ E
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM----FKVGMFKVHPEIPESMSAEAK 256
Query: 761 D-IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
I C + DP R +L
Sbjct: 257 AFILK----------CFEPDPDKRACANDLLV 278
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 74/334 (22%), Positives = 143/334 (42%), Gaps = 52/334 (15%)
Query: 484 LSFFFIYKKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEV-----------GRGSF 532
+S++ + + T + +A F E+ G G F
Sbjct: 1 MSYYHHHHH---HDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEF 57
Query: 533 GIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLGFCDE 590
G VYKG+ ++ VA+K L + + ++ +F E ++GQ H N++RL G +
Sbjct: 58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117
Query: 591 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSAQIIHCDI 648
+ +++ E++ NG L FL +++ + IA G+ YL + +H D+
Sbjct: 118 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDL 173
Query: 649 KPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APEWFRNSTITAKV 705
+NIL++ ++SDFGL+++L + T G K + APE T+
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWTAPEAISYRKFTSAS 231
Query: 706 DVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD--MEALNDI 762
DV+SFG+++ E+++ GE Y L+ N ++ + + D
Sbjct: 232 DVWSFGIVMWEVMT--------YGERPYWELS--------NHEVMKAINDGFRLPTPMD- 274
Query: 763 KCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
C + +M+ W Q++ + RP ++ +L+
Sbjct: 275 -CPSAIYQLMMQCW--QQERARRPKFADIVSILD 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 38/282 (13%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNL 581
+G G FG VY+GV + VAVK D +++F +E V++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 639
V+L+G +E + ++ E G L +L N K S + T + QI + + YL
Sbjct: 76 VKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--- 130
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APEWF 696
S +H DI +NIL+ ++ DFGL++ + T+ + +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YKASVTRLPIKWMSPESI 186
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD 755
T DV+ F V + EI+S G++ + L + + + L +GD
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS--------FGKQPFFWLEN-------KDVIGVLEKGD 231
Query: 756 -MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ + C L +M W DPS RP +++ L
Sbjct: 232 RLPKPDL--CPPVLYTLMTRCW--DYDPSDRPRFTELVCSLS 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 43/286 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
F +E+G G FG+V+ G L VA+K + R E++F E V+ + H LV
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNK----DKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+L G C E LV EF+ +G L+ +L + + T + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA---IRGTKGYVAPEWFR 697
A +IH D+ +N L+ + ++SDFG+ + + +Q + ++ +PE F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFS 178
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
S ++K DV+SFGVL+ E+ S G+ Y + N ++ + +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS--------EGKIPYENRS--------NSEVVEDISTGF 222
Query: 756 -MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
+ + +M W +E P RP ++L+ L + E
Sbjct: 223 RLYKPRL--ASTHVYQIMNHCW--RERPEDRPAFSRLLRQLAEIAE 264
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 72/305 (23%), Positives = 131/305 (42%), Gaps = 54/305 (17%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
K E+G G+FG V+ L+ VAVK L K+F+ E ++ H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----------------I 624
+V+ G C +G ++V+E++ +G L FL + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA- 683
A QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 684 ---IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWA 739
IR PE T + DV+SFGV+L EI + G++ + L+
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTY--------GKQPWFQLS--- 240
Query: 740 FDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEG 795
N ++ + + +E C +++ VM+ W Q +P R +K++ ++L
Sbjct: 241 -----NTEVIECITQGRVLERPRV--CPKEVYDVMLGCW--QREPQQRLNIKEIYKILHA 291
Query: 796 VVEVS 800
+ + +
Sbjct: 292 LGKAT 296
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLV 582
E+G G+FG V +GV R VA+K L + +E E ++ Q + +V
Sbjct: 15 DIELGCGNFGSVRQGV-YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCS 640
RL+G C + + +LV E G L FL G + P N+ + Q++ G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL---EE 128
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APEWFR 697
+H D+ +N+LL + + A+ISDFGL+K L + S TA K + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECIN 186
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
+++ DV+S+GV + E +S G++ Y + E + + +G
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS--------YGQKPYKKMKG-------PEVMAFIEQGKR 231
Query: 756 MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
ME + C +L +M W RP V Q +
Sbjct: 232 MECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 268
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 78/297 (26%), Positives = 131/297 (44%), Gaps = 47/297 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 580
+ +G G FG V +G + ++ VAVK KLD Q +EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 581 LVRLLGFCDEGQNR-----LLVYEFLNNGTLASFL----FGNLKPSWNLRT--NIAFQIA 629
++RLLG C E ++ +++ F+ G L ++L L+T IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIRTAIR 685
G+ YL + +H D+ +N +L D ++DFGL+K + Q + + ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 686 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 744
A E + T+K DV++FGV + EI + G Y + +
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIAT--------RGMTPYPGVQNH------ 256
Query: 745 NEKLDDLVEGD-MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
E D L+ G ++ D C+++L +M S W + DP RPT + LE ++E
Sbjct: 257 -EMYDYLLHGHRLKQPED--CLDELYEIMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
++++G G FG V+ T VAVK + + + F E V+ H LV
Sbjct: 192 LEKKLGAGQFGEVWMATY----NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+L + + ++ EF+ G+L FL + L + + QIA G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APEWFR 697
IH D++ NIL+ +I+DFGLA+++ N+ TA G K + APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAIN 358
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
+ T K DV+SFG+LL+EI++ G Y +++ E + L G
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTY--------GRIPYPGMSN-------PEVIRALERGYR 403
Query: 756 MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
M + C E+L +M+ W + P RPT + + +L+
Sbjct: 404 MPRPEN--CPEELYNIMMRCW--KNRPEERPTFEYIQSVLD 440
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 43/286 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
F +E+G G FG+V G VA+K + + E EF E V+ H+ LV
Sbjct: 28 FLKELGTGQFGVVKYGKW----RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
+L G C + + ++ E++ NG L ++L + + + + + + YL S
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 138
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV---APEWFR 697
Q +H D+ +N L++D ++SDFGL++ + ++ T+ G+K V PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLM 194
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
S ++K D+++FGVL+ EI S G+ Y T N + + +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSL--------GKMPYERFT--------NSETAEHIAQGL 238
Query: 756 -MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
+ + EK+ +M S W E RPT K +L + V++
Sbjct: 239 RLYRPHL--ASEKVYTIMYSCW--HEKADERPTFKILLSNILDVMD 280
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 63/288 (21%), Positives = 116/288 (40%), Gaps = 54/288 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E +G G FG V+K +K++ ++ + EV + + H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGK---TYVIKRVKY----NNEKAEREVKALAKLDHVNIVHY 69
Query: 585 LG-FCDEGQNRL---------------LVYEFLNNGTLASFL---FGNLKPSWNLRTNIA 625
G + + + EF + GTL ++ G +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL-ELF 128
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR 685
QI +G+ Y+H S ++I+ D+KP NI L D +I DFGL L + RT +
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRTRSK 182
Query: 686 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745
GT Y++PE + +VD+Y+ G++L E++ + E + + L R+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDL--------RD 233
Query: 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793
+ D+ + + L ++ + + P RP ++L+ L
Sbjct: 234 GIISDIFDKKEKTL--LQ----------KLLSKKPEDRPNTSEILRTL 269
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 66/285 (23%), Positives = 124/285 (43%), Gaps = 42/285 (14%)
Query: 523 FKEEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 580
+ +G G+FG VYKG+ I VA+K+L + KE +E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 638
+ RLLG C L+ + + G L ++ + K + + N QIA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIRTAIRGTKGYVAPE 694
+++H D+ +N+L+ + +I+DFGLAKLL ++ + I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVE 753
+ T + DV+S+GV + E+++ G + Y + ++ ++E
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSILE 233
Query: 754 GD--MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ C + +MV W D RP ++++
Sbjct: 234 KGERLPQPPI--CTIDVYMIMVKCW--MIDADSRPKFRELIIEFS 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 83/317 (26%), Positives = 129/317 (40%), Gaps = 57/317 (17%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 579
+G G+FG VY+G + + S VAVK L V + ++ +F E ++I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-------NIAFQIARGL 632
N+VR +G + R ++ E + G L SFL + ++A IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNAR---ISDFGLAKLLTLN-----QSKAIRTAI 684
YL IH DI +N LL R I DFG+A+ + A +
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA-MLPV 250
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCY 743
+ PE F T+K D +SFGVLL EI S +G Y +
Sbjct: 251 KWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKS------- 291
Query: 744 RNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEG---- 795
N+++ + V G M+ + C + +M W Q P RP +L+ +E
Sbjct: 292 -NQEVLEFVTSGGRMDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQD 346
Query: 796 --VVEVSLPPNPYPFSS 810
V+ +LP P
Sbjct: 347 PDVINTALPIEYGPLVE 363
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 581
+G G FG V++G+ ++ AVA+K D + +F E + + Q H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 639
V+L+G E ++ E G L SFL K S +L + A+Q++ L YL
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--- 133
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIRTAIRGTKGYVAPEWF 696
S + +H DI +N+L+ ++ DFGL++ + + + + I+ APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVE-- 753
T+ DV+ FGV + EI+ G + + + N + +E
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILM--------HGVKPFQGVK--------NNDVIGRIENG 233
Query: 754 GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ + C L +M W DPS RP ++ L
Sbjct: 234 ERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 37/286 (12%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQT 576
++++ +G GS+G K + + K+LD + +EV ++ +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKI---LVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 577 HHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIAR 630
H N+VR D L +V E+ G LAS + K L + Q+
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 631 GLLYLHE--DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
L H D ++H D+KP N+ LD N ++ DFGLA++L + S A +T + GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFV-GTP 180
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748
Y++PE + K D++S G LL E+ + F L
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKEL------------A 225
Query: 749 DDLVEGDMEALNDI--KCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
+ EG + + +++ + RP+++++L+
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 72/305 (23%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 580
K E+G G+FG V+ L VAVK L + ++F+ E ++ H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------IA 625
+VR G C EG+ L+V+E++ +G L FL + + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-----QSKAI 680
Q+A G++YL +H D+ +N L+ +I DFG+++ + +
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT- 220
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWA 739
IR PE T + DV+SFGV+L EI + G++ + L+
Sbjct: 221 MLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT--------YGKQPWYQLS--- 265
Query: 740 FDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEG 795
N + D + ++E C ++ +M W Q +P R ++K V L+
Sbjct: 266 -----NTEAIDCITQGRELERPRA--CPPEVYAIMRGCW--QREPQQRHSIKDVHARLQA 316
Query: 796 VVEVS 800
+ +
Sbjct: 317 LAQAP 321
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-36
Identities = 80/302 (26%), Positives = 118/302 (39%), Gaps = 56/302 (18%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKN 580
++ +G GS G V R VAVK++ F D E+ ++ ++ H N
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCD---IALMEIKLLTESDDHPN 70
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-------NIAFQIARGLL 633
++R + + E L N L + NL+ ++ QIA G+
Sbjct: 71 VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 634 YLHEDCSAQIIHCDIKPQNILLD-------------DYYNARISDFGLAKLLTLNQSKAI 680
+LH S +IIH D+KPQNIL+ + ISDFGL K L QS
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 681 RTA--IRGTKGYVAPEWFRNSTI-------TAKVDVYSFGVLLLEIISCRKS-FDIEMGE 730
GT G+ APE S T +D++S G + I+S K F +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 731 EYAILT-DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV 789
E I+ ++ D + L+ EA + I I DP RPT KV
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIA---EATDLIS----------QMIDHDPLKRPTAMKV 293
Query: 790 LQ 791
L+
Sbjct: 294 LR 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 72/310 (23%), Positives = 130/310 (41%), Gaps = 60/310 (19%)
Query: 523 FKEEVGRGSFGIVYKG----VILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 576
+ +G G FG V + VAVK L + + + +E+ ++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 623
HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 624 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 675
+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAI 734
+ R ++ APE + T + DV+SFGVL+ EI + +G Y
Sbjct: 262 TTNG-RLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPG 308
Query: 735 LTDWAFDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVL 790
+ E+L L++ M+ + C +L +M W PS RPT K+++
Sbjct: 309 IP--------VEELFKLLKEGHRMDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLV 356
Query: 791 QMLEGVVEVS 800
+ L+ ++ ++
Sbjct: 357 EDLDRILTLT 366
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 66/298 (22%), Positives = 124/298 (41%), Gaps = 48/298 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 580
+G+G FG V + + S VAVK K D + +EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 581 LVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKPSWNLR------TNIAFQI 628
+ +L+G + + +++ F+ +G L +FL + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSKAIRTAI 684
A G+ YL S IH D+ +N +L + ++DFGL++ + Q A + +
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCY 743
+ A E ++ T DV++FGV + EI++ G+ YA + +
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENA----- 246
Query: 744 RNEKLDDLVEGD-MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
E + L+ G+ ++ + C+E++ +M W DP RP+ + LE ++
Sbjct: 247 --EIYNYLIGGNRLKQPPE--CMEEVYDLMYQCW--SADPKQRPSFTCLRMELENILG 298
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 43/282 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
E +G G FG V+ G T VAVK L + F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYY----NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
RL + + ++ E++ NG+L FL + ++A QIA G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ---SKAIRTAIRGTKGYVAPEWFR 697
IH D++ NIL+ D + +I+DFGLA+L+ N+ + + I+ T APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD- 755
T T K DV+SFG+LL EI++ G Y +T N ++ +E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT--------HGRIPYPGMT--------NPEVIQNLERGY 227
Query: 756 -MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
M ++ C E+L +M W +E P RPT + +LE
Sbjct: 228 RMVRPDN--CPEELYQLMRLCW--KERPEDRPTFDYLRSVLE 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 71/296 (23%), Positives = 115/296 (38%), Gaps = 49/296 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+G+G+FG V K A+KK+ ++ +EV+++ +H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRY---YAIKKIRHT-EEKLSTILSEVMLLASLNHQYVV 65
Query: 583 RLLGFCDEGQNRL-------------LVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQI 628
R E +N + + E+ NGTL + NL + + QI
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR--- 685
L Y+H S IIH D+KP NI +D+ N +I DFGLAK + + +
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 686 ---------GTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735
GT YVA E + K+D+YS G++ E+I S +E L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-YPFSTGMERVNILKKL 241
Query: 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + DD + + I+ I DP+ RP + +L
Sbjct: 242 RSVSIEF--PPDFDDNKMKVEKKI--IR----------LLIDHDPNKRPGARTLLN 283
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 72/314 (22%), Positives = 131/314 (41%), Gaps = 60/314 (19%)
Query: 523 FKEEVGRGSFGIVYKG----VILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 576
+ +G G+FG V + VAVK L + + + +E+ ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 623
HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 624 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 675
+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAI 734
+ R ++ APE + T + DV+SFGVL+ EI + +G Y
Sbjct: 216 TTNG-RLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPG 262
Query: 735 LTDWAFDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVL 790
+ E+L L++ M+ + C +L +M W PS RPT K+++
Sbjct: 263 IP--------VEELFKLLKEGHRMDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLV 310
Query: 791 QMLEGVVEVSLPPN 804
+ L+ ++ ++
Sbjct: 311 EDLDRILTLTTNEE 324
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 57/301 (18%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 579
F EE+G FG VYKG + T AVA+K L D+ +EF++E ++ + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 623
N+V LLG + Q +++ + ++G L FL S T+
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-----QSK 678
+ QIA G+ YL S ++H D+ +N+L+ D N +ISD GL + +
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 737
+ IR APE + D++S+GV+L E+ S G + Y +
Sbjct: 190 S-LLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS--------YGLQPYCGYS- 235
Query: 738 WAFDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQML 793
N+ + +++ + +D C + +M+ W E PS RP K + L
Sbjct: 236 -------NQDVVEMIRNRQVLPCPDD--CPAWVYALMIECW--NEFPSRRPRFKDIHSRL 284
Query: 794 E 794
Sbjct: 285 R 285
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 578
F + +G G+FG V + L + VAVK L E+ +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------- 623
N+V LLG C G L++ E+ G L +FL +T+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 624 ---IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 675
++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEE-Y 732
+ A R ++ APE N T + DV+S+G+ L E+ S S + + + Y
Sbjct: 204 KGNA-RLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 733 AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVL 790
++ + +R + ++ +M + W DP RPT K+++
Sbjct: 259 KMIKEG----FRMLSPEH-------------APAEMYDIMKTCW--DADPLKRPTFKQIV 299
Query: 791 QMLEGVVEVS 800
Q++E + S
Sbjct: 300 QLIEKQISES 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 40/283 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 581
+G G FG V++G+ ++ AVA+K D + +F E + + Q H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 639
V+L+G E ++ E G L SFL K S +L + A+Q++ L YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--- 508
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN---QSKAIRTAIRGTKGYVAPEWF 696
S + +H DI +N+L+ ++ DFGL++ + + ++ + I+ APE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVE-- 753
T+ DV+ FGV + EI+ G + + + N + +E
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMH--------GVKPFQGVK--------NNDVIGRIENG 608
Query: 754 GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ + C L +M W DPS RP ++ L
Sbjct: 609 ERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 647
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQ 575
+ + +++G GSFG +K+++ KE + EV V+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQ---YVIKEINISRMS-SKEREESRREVAVLAN 79
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAFQIARG 631
H N+V+ +E + +V ++ G L + + L QI
Sbjct: 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD--WFVQICLA 137
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L ++H +I+H DIK QNI L ++ DFG+A++L A R I GT Y+
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACI-GTPYYL 192
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
+PE N K D+++ G +L E+ + + +F+ L + +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNL------------VLKI 237
Query: 752 VEGDMEALNDI--KCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
+ G ++ + LV + +P RP++ +L+
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILEK 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-35
Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 37/297 (12%)
Query: 508 LPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL-DRVFQDGEKEF 566
L + E+G G+FG V +GV R VA+K L + +E
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGV-YRMRKKQIDVAIKVLKQGTEKADTEEM 383
Query: 567 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNI 624
E ++ Q + +VRL+G C + + +LV E G L FL G + P N+ +
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AEL 441
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
Q++ G+ YL +H ++ +N+LL + + A+ISDFGL+K L + S TA
Sbjct: 442 LHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTAR 496
Query: 685 RGTKGYV---APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAF 740
K + APE +++ DV+S+GV + E +S G++ Y +
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY--------GQKPYKKMKG--- 545
Query: 741 DCYRNEKLDDLVEGD-MEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
E + + +G ME + C +L +M W RP V Q +
Sbjct: 546 ----PEVMAFIEQGKRMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 594
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 87/354 (24%), Positives = 144/354 (40%), Gaps = 66/354 (18%)
Query: 483 GLSFFFIYKKKW------IRNSPGDGTI---ETNLPCFSYKELEEATDNFKEEVGRGSFG 533
G+ + + K K+ I + G+ T LP E F + +G G+FG
Sbjct: 1 GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFG 60
Query: 534 IVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THHKNLVRLLGFCD 589
V + L + VAVK L EK +E+ ++ H+N+V LLG C
Sbjct: 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 590 EGQNRLLVYEFLNNGTLASFL----------FGNLKPSWNLRTN----IAFQIARGLLYL 635
G L++ E+ G L +FL + T + Q+A+G+ +L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-----QSKAIRTAIRGTKGY 690
S IH D+ +N+LL + + A+I DFGLA+ + + + A R ++
Sbjct: 181 A---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA-RLPVKWM--- 233
Query: 691 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNEKL 748
APE + T + DV+S+G+LL EI S +G IL N K
Sbjct: 234 -APESIFDCVYTVQSDVWSYGILLWEIFS--------LGLNPYPGILV--------NSKF 276
Query: 749 DDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
LV+ M + + +M + W +P+ RPT +++ L+ +
Sbjct: 277 YKLVKDGYQMAQPAF--APKNIYSIMQACW--ALEPTHRPTFQQICSFLQEQAQ 326
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 76/308 (24%), Positives = 129/308 (41%), Gaps = 56/308 (18%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 578
+ +GRG+FG V + + + VAVK L E +E+ ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 579 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-------------- 623
N+V LLG C G +++ EF G L+++L +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 624 --IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-----Q 676
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAI 734
A R ++ APE + T + DV+SFGVLL EI S S +++ EE
Sbjct: 208 GDA-RLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 259
Query: 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQM 792
+ R D ++ M+ W +PS RPT ++++
Sbjct: 260 FCRRLKEGTRMRAPDY-------------TTPEMYQTMLDCW--HGEPSQRPTFSELVEH 304
Query: 793 LEGVVEVS 800
L +++ +
Sbjct: 305 LGNLLQAN 312
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 77/310 (24%), Positives = 136/310 (43%), Gaps = 60/310 (19%)
Query: 523 FKEEVGRGSFGIVYKGVIL----TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 576
+ +G G+FG V + T VAVK L + + + +E+ ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPSWNLR--- 621
HKN++ LLG C + ++ E+ + G L +L + P L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 622 -TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----- 675
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAI 734
+ R ++ APE + T + DV+SFGVLL EI + +G Y
Sbjct: 250 TTNG-RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPG 296
Query: 735 LTDWAFDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVL 790
+ E+L L++ M+ ++ C +L +M W PS RPT K+++
Sbjct: 297 VP--------VEELFKLLKEGHRMDKPSN--CTNELYMMMRDCW--HAVPSQRPTFKQLV 344
Query: 791 QMLEGVVEVS 800
+ L+ +V ++
Sbjct: 345 EDLDRIVALT 354
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 55/290 (18%), Positives = 116/290 (40%), Gaps = 54/290 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL- 581
+++G G V++ + + A+K ++ D + ++NE+ + + +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 582 -VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
+RL + Q +V E N L S+L ++ P R + + + +H
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIH-- 144
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE---- 694
I+H D+KP N L+ D ++ DFG+A + + + ++ + GT Y+ PE
Sbjct: 145 -QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 695 -------WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
S I+ K DV+S G +L + + F ++ + + L +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL---------HAI 252
Query: 748 LDDLVEGDM------EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+D E + + + +K C++ DP R ++ ++L
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLK----------CCLKRDPKQRISIPELLA 292
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 80/332 (24%), Positives = 136/332 (40%), Gaps = 60/332 (18%)
Query: 495 IRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKK 554
++ + N Y L+ F++ +G G+FG V K + A+K+
Sbjct: 1 MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKA-RIKKDGLRMDAAIKR 59
Query: 555 LDRVFQDGEK-EFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 612
+ + +F E+ V+ + HH N++ LLG C+ L E+ +G L FL
Sbjct: 60 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119
Query: 613 NLKPSWNLRTN----------------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656
+ + A +ARG+ YL Q IH D+ +NIL+
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVG 176
Query: 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV-----APEWFRNSTITAKVDVYSFG 711
+ Y A+I+DFGL S+ ++ T G + A E S T DV+S+G
Sbjct: 177 ENYVAKIADFGL--------SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 228
Query: 712 VLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLVEGD--MEALNDIKCVEKL 768
VLL EI+S +G Y +T +L + + +E + C +++
Sbjct: 229 VLLWEIVS--------LGGTPYCGMT--------CAELYEKLPQGYRLEKPLN--CDDEV 270
Query: 769 --VMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
+M W +E P RP+ ++L L ++E
Sbjct: 271 YDLMRQCW--REKPYERPSFAQILVSLNRMLE 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 77/313 (24%), Positives = 138/313 (44%), Gaps = 65/313 (20%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 579
+ +G G FG V K L R T VAVK L E + +E V+ Q +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR------------------ 621
++++L G C + LL+ E+ G+L FL + K
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 622 ------TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
+ A+QI++G+ YL +++H D+ +NIL+ + +ISDFGL++ +
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 676 QSKAIRTAIRGTKGYV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730
+ ++ ++G + A E + T + DV+SFGVLL EI++ +G
Sbjct: 204 D-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG 250
Query: 731 E-YAILTDWAFDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPT 785
Y + E+L +L++ ME ++ C E++ +M+ W +++P RP
Sbjct: 251 NPYPGIP--------PERLFNLLKTGHRMERPDN--CSEEMYRLMLQCW--KQEPDKRPV 298
Query: 786 MKKVLQMLEGVVE 798
+ + LE ++
Sbjct: 299 FADISKDLEKMMV 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/284 (20%), Positives = 117/284 (41%), Gaps = 42/284 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIG--QTHHKN 580
+++G G V++ + + A+K ++ D + ++NE+ + Q H
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
++RL + Q +V E N L S+L ++ P R + + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQ- 126
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE---- 694
I+H D+KP N L+ D ++ DFG+A + + + ++ + GT Y+ PE
Sbjct: 127 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 695 -------WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
S I+ K DV+S G +L + + F ++ + + L + E
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEF 242
Query: 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
D + + + +K C++ DP R ++ ++L
Sbjct: 243 PDIP---EKDLQDVLK----------CCLKRDPKQRISIPELLA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 54/284 (19%), Positives = 118/284 (41%), Gaps = 42/284 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL- 581
+++G G V++ + + A+K ++ D + ++NE+ + + +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 582 -VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 638
+RL + Q +V E N L S+L ++ P R + + + +H+
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQ- 173
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
I+H D+KP N L+ D ++ DFG+A + + + ++ + G Y+ PE ++
Sbjct: 174 --HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 699 ST-----------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
+ I+ K DV+S G +L + + F ++ + + L + E
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEF 289
Query: 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
D + + + +KC C++ DP R ++ ++L
Sbjct: 290 PDIP---EKDLQDVLKC----------CLKRDPKQRISIPELLA 320
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 67/313 (21%), Positives = 129/313 (41%), Gaps = 65/313 (20%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 579
+ ++G G+FG V++ L T VAVK L + +F+ E ++ + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 623
N+V+LLG C G+ L++E++ G L FL + ++
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 624 --------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
IA Q+A G+ YL + +H D+ +N L+ + +I+DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR--NIY 225
Query: 676 QSKAIRTAIRGTKGYV-----APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730
+ + + PE + T + DV+++GV+L EI S G
Sbjct: 226 SADYYK---ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--------YGL 274
Query: 731 E-YAILTDWAFDCYRNEKLDDLVE--GDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPT 785
+ Y + +E++ V + + C +L +M W + P+ RP+
Sbjct: 275 QPYYGMA--------HEEVIYYVRDGNILACPEN--CPLELYNLMRLCW--SKLPADRPS 322
Query: 786 MKKVLQMLEGVVE 798
+ ++L+ + E
Sbjct: 323 FCSIHRILQRMCE 335
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 70/358 (19%), Positives = 129/358 (36%), Gaps = 73/358 (20%)
Query: 488 FIYKKKWIRNSPGDGTIETNLPCFSYKELEEATD--------NFKEEVGRGSFGIVYKGV 539
F Y+ + + G+ + ++E E F + +G G+FG V
Sbjct: 7 FRYESQL-QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNAT 65
Query: 540 I--LTTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRL 595
++ + VAVK L E+ +E+ ++ Q H+N+V LLG C
Sbjct: 66 AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125
Query: 596 LVYEFLNNGTLASFLFGNLKPSWNLRTN-----------------------IAFQIARGL 632
L++E+ G L ++L + A+Q+A+G+
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV- 691
+L +H D+ +N+L+ +I DFGLA+ + +
Sbjct: 186 EFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMSDSNYV---VRGNARLP 237
Query: 692 ----APEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEE-YAILTDWAFDCYR 744
APE T K DV+S+G+LL EI S + I + Y ++ + ++
Sbjct: 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG----FK 293
Query: 745 NEKLDDLVEGDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
++ E++ +M S W D RP+ + L + +
Sbjct: 294 MDQPFY-------------ATEEIYIIMQSCW--AFDSRKRPSFPNLTSFLGCQLADA 336
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 58/295 (19%), Positives = 108/295 (36%), Gaps = 60/295 (20%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQ-THHKNL 581
E++G G FG V+K V A+K+ + E+ EV H ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLHE 637
VR E + L+ E+ N G+LA + N + + ++ Q+ RGL Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH- 132
Query: 638 DCSAQIIHCDIKPQNILLD-------------------DYYNARISDFGLAKLLTLNQSK 678
S ++H DIKP NI + + +I D G ++ Q +
Sbjct: 133 --SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 679 AIRTAIRGTKGYVAPE-WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 737
G ++A E N T K D+++ + ++ G+++ +
Sbjct: 191 ------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--NGDQWHEI-- 240
Query: 738 WAFDCYRNEKLDDLVEGDMEALND-IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
R +L + + + + +K I DP RP+ +++
Sbjct: 241 ------RQGRLPRIPQVLSQEFTELLK----------VMIHPDPERRPSAMALVK 279
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 65/296 (21%), Positives = 107/296 (36%), Gaps = 50/296 (16%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
F +++G G F V L A+K++ Q +E + E + +H N++
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHF---YALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 583 RLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRT----NIAFQIARGLLY 634
RL+ +C + L+ F GTL + + L + I RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL---NQSKAIRT----AIRGT 687
+H + H D+KP NILL D + D G + +A+ A R T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 688 KGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFD--IEMGEEY--AILTDWAF 740
Y APE F + I + DV+S G +L ++ +D + G+ A+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 741 --DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ L L+ + DP RP + +L LE
Sbjct: 267 PQSPRHSSALWQLLN--------------------SMMTVDPHQRPHIPLLLSQLE 302
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 60/199 (30%), Positives = 84/199 (42%), Gaps = 19/199 (9%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 583
+ VGRGSFG V++ T AVKK+ + E E+V +V
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQ---CAVKKVR--LEVFRVE---ELVACAGLSSPRIVP 114
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
L G EG + E L G+L + G L Q GL YLH +
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLH---TR 169
Query: 642 QIIHCDIKPQNILLDDY-YNARISDFGLAKLLT---LNQSKAIRTAIRGTKGYVAPEWFR 697
+I+H D+K N+LL A + DFG A L L +S I GT+ ++APE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 698 NSTITAKVDVYSFGVLLLE 716
AKVD++S ++L
Sbjct: 230 GKPCDAKVDIWSSCCMMLH 248
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 63/274 (22%), Positives = 99/274 (36%), Gaps = 37/274 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQ-THHKNL 581
+G GS+G V+K ++ AVK+ F+ EV + H
Sbjct: 63 SRLGHGSYGEVFKVR---SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
VRL +EG L E +L +G P + L +LH
Sbjct: 120 VRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLH--- 174
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
S ++H D+KP NI L ++ DFGL L + G Y+APE + S
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQGS 231
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM-EA 758
DV+S G+ +LE+ + GE + L R L +
Sbjct: 232 -YGTAADVFSLGLTILEVACNMELPH--GGEGWQQL--------RQGYLPPEFTAGLSSE 280
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792
L +++ ++ DP LR T + +L +
Sbjct: 281 LRS------VLV---MMLEPDPKLRATAEALLAL 305
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 6e-33
Identities = 41/261 (15%), Positives = 79/261 (30%), Gaps = 24/261 (9%)
Query: 495 IRNSPGDGTIETNLPCFS-YKELEEATDNF--KEEVGRGSFGIVYKGVILTTRTSTTA-- 549
+ + P + LP E + + +G G+F VY+ +
Sbjct: 38 VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97
Query: 550 VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 609
+K + + + ++ +LV E + GTL +
Sbjct: 98 FVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157
Query: 610 LFGNLKPSW-----NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA--- 661
+ L + A ++ + +H +IIH DIKP N +L + +
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214
Query: 662 --------RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVL 713
+ D G + + L I TA T G+ E N ++D +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 714 LLEIISCRKSFDIEMGEEYAI 734
+ ++ G E
Sbjct: 275 VYCMLFGTYMKVKNEGGECKP 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 62/318 (19%), Positives = 113/318 (35%), Gaps = 57/318 (17%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 582
+ + G F VY+ + + A+K+L ++ + EV + + + H N+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGRE---YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 583 RLLGFC-------DEGQNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAFQIAR 630
+ D GQ L+ L G L FL G L L+ I +Q R
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCR 147
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR----- 685
+ ++H IIH D+K +N+LL + ++ DFG A ++ + R
Sbjct: 148 AVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 686 -----GTKGYVAPE---WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT- 736
T Y PE + N I K D+++ G +L + + F E G + I+
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIVNG 264
Query: 737 --DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ L+ +Q +P R ++ +V+ L+
Sbjct: 265 KYSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304
Query: 795 GVVEVSLPPNPYPFSSSM 812
+ P + +
Sbjct: 305 EIAAARNVNPKSPITELL 322
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 525 EEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKN 580
+++G G VY + VA+K + ++ E K F+ EV Q H+N
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIK----VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+V ++ +E LV E++ TL+ ++ + S + N QI G+ + H+
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLL---TLNQSKAIRTAIRGTKGYVAPEWFR 697
+I+H DIKPQNIL+D +I DFG+AK L +L Q+ + GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT----NHVLGTVQYFSPEQAK 185
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSFD 725
D+YS G++L E++ F+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
++G GS GIV + VAVK +D Q + NEVV++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQ---VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 640
G+ ++ EFL G L + L IA + + L YLH +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLH---A 159
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+IH DIK +ILL ++SDFG ++ + K R ++ GT ++APE S
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSL 217
Query: 701 ITAKVDVYSFGVLLLEII 718
+VD++S G++++E++
Sbjct: 218 YATEVDIWSLGIMVIEMV 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E++G+G+ G VY + + T VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 640
L G +V E+L G+L + + IA + + L +LH S
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLH---S 134
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
Q+IH DIK NILL + +++DFG +T QSK R+ + GT ++APE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA 192
Query: 701 ITAKVDVYSFGVLLLEII 718
KVD++S G++ +E+I
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 580
+ +G+G+ V++G T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 581 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLY 634
+V+L +E R L+ EF G+L + L ++ L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 635 LHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
L I+H +IKP NI+ D +++DFG A+ L + + GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181
Query: 691 VAPEWFRNSTI--------TAKVDVYSFGVLLLEIIS 719
+ P+ + + + A VD++S GV +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 18/211 (8%)
Query: 525 EEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKN 580
E +G G V+ + R VAVK L F+ E +H
Sbjct: 18 EILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 581 LVRLL--GFCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
+V + G E L Y E+++ TL + + + + L +
Sbjct: 74 IVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAPE 694
H+ IIH D+KP NI++ ++ DFG+A+ + + + +T A+ GT Y++PE
Sbjct: 133 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
R ++ A+ DVYS G +L E+++ F
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 58/308 (18%), Positives = 114/308 (37%), Gaps = 41/308 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 580
+ +G+G+ V++G T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 581 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLY 634
+V+L +E R L+ EF G+L + L ++ L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 635 LHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
L I+H +IKP NI+ D +++DFG A+ L + + GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181
Query: 691 VAPEWFRNSTI--------TAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILT 736
+ P+ + + + A VD++S GV + F G Y I+T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 737 ----DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIW--CIQEDPSLRPTMKKVL 790
+ E GDM + ++++ + ++ D +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 791 QMLEGVVE 798
++
Sbjct: 302 AETSDILH 309
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVRL 584
G+G FG VY ++ +A+K L + + + G E + + EV + H N++RL
Sbjct: 18 GKGKFGNVYLAREKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCS 640
G+ + L+ E+ GT+ + L+ ++A L Y H S
Sbjct: 75 YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCH---S 127
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
++IH DIKP+N+LL +I+DFG + ++ RT + GT Y+ PE
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRM 183
Query: 701 ITAKVDVYSFGVLLLEII 718
KVD++S GVL E +
Sbjct: 184 HDEKVDLWSLGVLCYEFL 201
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 34/207 (16%)
Query: 599 EFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 655
+ L ++ + +I QIA + +LH S ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 656 DDYYNARISDFGLAKLLTLNQSKA----------IRTAIRGTKGYVAPEWFRNSTITAKV 705
++ DFGL + ++ + T GTK Y++PE + + KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 706 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCV 765
D++S G++L E++ SF +M R + D+ L K
Sbjct: 258 DIFSLGLILFELLY---SFSTQM--------------ERVRIITDVRNLKFPLLFTQKYP 300
Query: 766 EKLVMVSIWCIQEDPSLRPTMKKVLQM 792
++ +MV + P+ RP +++
Sbjct: 301 QEHMMVQ-DMLSPSPTERPEATDIIEN 326
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 43/316 (13%), Positives = 91/316 (28%), Gaps = 84/316 (26%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQ------ 575
+G+ + T S V +R + K+ K EV+ +
Sbjct: 79 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 576 -------------------THHKNLVRLLGFCDEGQ--NRLLVYEFLNN------GTLAS 608
K ++R+ + +R +Y + + L S
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 609 FLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668
+ + R + Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWF-----------RNSTITAKVDVYSFGVLLLEI 717
R ++G+ PE R + +T D ++ G+++
Sbjct: 253 LVRDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI--- 303
Query: 718 ISCRKSFDIEMGEEYAILT-DWAFDCYRNEKLDDLVEGDMEALNDI-KCVEKLVMVSIWC 775
Y I D + E + +I + V L+
Sbjct: 304 --------------YWIWCADLPIT---KDAALGGSEWIFRSCKNIPQPVRALLE---GF 343
Query: 776 IQEDPSLRPTMKKVLQ 791
++ R + ++
Sbjct: 344 LRYPKEDRLLPLQAME 359
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQ-THHKN 580
+E+GRG F +V + ++++ A K K R QD E +E+ V+
Sbjct: 34 SKELGRGKFAVVRQC---ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHED 638
++ L + +L+ E+ G + S L + + QI G+ YLH
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 639 CSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
I+H D+KPQNILL + +I DFG+++ + + +R + GT Y+APE
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEI 204
Query: 696 FRNSTITAKVDVYSFGVLL 714
IT D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 31/308 (10%), Positives = 72/308 (23%), Gaps = 60/308 (19%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHK 579
E + G +V+ + A+K + + + +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLED---FALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 580 NLV------RLLGFCDEGQ--------------------NRLLVYEFLNNGTLASFL--- 610
+ RLL D N LL+ + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181
Query: 611 ----FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 666
+ Q+ R L S ++H P N+ + + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 667 GLAKLLTLNQSKAIRTAIRGTKGYVAPEWF--RNSTITAKVDVYSFGVLLLEIISCRKSF 724
+ A Y E+ +T T ++ + G+ + + F
Sbjct: 239 SALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 725 DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM-EALNDIKCVEKLVMVSIWCIQEDPSLR 783
+ + + L + + + + + + + D R
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL--IGRF-------LNFDRRRR 344
Query: 784 PTMKKVLQ 791
+ ++
Sbjct: 345 LLPLEAME 352
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 525 EEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKL------DRVFQDGEKEFKNEVVVIGQTH 577
VGRG G VY+ + R VA+K + D VF+ + E G+
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERI----VALKLMSETLSSDPVFR---TRMQREARTAGRLQ 92
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 635
++V + F + + +N LA+ L G L P + I QI L
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDAA 150
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVAPE 694
H A H D+KP+NIL+ A + DFG+A K + GT Y+APE
Sbjct: 151 HA---AGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPE 205
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
F S T + D+Y+ +L E ++ +
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNL 581
KE +G G FG V + + T VA+K+ + +E + E+ ++ + +H N+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 582 VRLLGFCDEGQN------RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARG 631
V D Q LL E+ G L +L + L+ I+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSA 133
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
L YLHE +IIH D+KP+NI+L +I D G AK L Q + + GT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV-GTL 187
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
Y+APE T VD +SFG L E I+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 583
E++G+GSFG V+KG+ T+ VA+K +D +D ++ + E+ V+ Q + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKV---VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDC 639
G + ++ E+L G+ L G L + IA +I +GL YLH
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLDYLH--- 136
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
S + IH DIK N+LL ++ +++DFG+A LT Q K R GT ++APE + S
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQS 194
Query: 700 TITAKVDVYSFGVLLLEII 718
+K D++S G+ +E+
Sbjct: 195 AYDSKADIWSLGITAIELA 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVRL 584
G+G FG VY + +A+K L + + ++G E + + E+ + H N++R+
Sbjct: 23 GKGKFGNVYLAREKQNKFI---MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCS 640
+ + + L+ EF G L + L+ + ++A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---E 132
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
++IH DIKP+N+L+ +I+DFG + S RT GT Y+ PE T
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMC-GTLDYLPPEMIEGKT 188
Query: 701 ITAKVDVYSFGVLLLE 716
KVD++ GVL E
Sbjct: 189 HDEKVDLWCAGVLCYE 204
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 55/297 (18%), Positives = 101/297 (34%), Gaps = 58/297 (19%)
Query: 525 EEVGRGSFGIVYKGV--ILTTRTSTTAVAVKKL----DRVFQDGEKEFKNEVVVIGQTHH 578
+ G G +Y + + R V +K L D Q E + + H
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRP----VVLKGLVHSGDAEAQ---AMAMAERQFLAEVVH 138
Query: 579 KNLVRLLGFCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 633
++V++ F + +V E++ +L L + + +I L
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALS 196
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKGYVA 692
YLH +++ D+KP+NI+L + ++ D G + + GT G+ A
Sbjct: 197 YLHS---IGLVYNDLKPENIMLTE-EQLKLIDLGAVSRIN-------SFGYLYGTPGFQA 245
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752
PE R T D+Y+ G L + + + G L + + L+
Sbjct: 246 PEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPEDDPVLKTYDSYGRLL 301
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVV-EVSLPPNPYP 807
+ ++ DP R T +++ L GV+ EV P
Sbjct: 302 R---------RAIDP-----------DPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 45/201 (22%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
E++GRG FGIV++ +S K + D + K E+ ++ H+N+
Sbjct: 8 MIAEDLGRGEFGIVHRC---VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTL------ASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
+ L + + ++++EF++ + ++F + + Q+ L +L
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QVCEALQFL 118
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
H S I H DI+P+NI+ ++ +I +FG A+ L R Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAP 172
Query: 694 EWFRNSTITAKVDVYSFGVLL 714
E ++ ++ D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 575
+ EE+G G F IV K +++ A K + + +E + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKKC---REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARG 631
H N++ L + + +L+ E ++ G L F L +L T+ QI G
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDG 127
Query: 632 LLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIRTAIRGT 687
+ YLH + +I H D+KP+NI+L + ++ DFGLA + + GT
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GT 181
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLL 714
+VAPE + + D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
+ EE+G G+FG+V++ + + K ++ + + KNE+ ++ Q HH L
Sbjct: 54 DILEELGSGAFGVVHRC---VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-----NIAFQIARGLLYLH 636
+ L ++ +L+ EFL+ G LF + + N Q GL ++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNAR--ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
I+H DIKP+NI+ + + I DFGLA LN + ++ T + APE
Sbjct: 167 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPE 220
Query: 695 WFRNSTITAKVDVYSFGVLL 714
+ D+++ GVL
Sbjct: 221 IVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 30/235 (12%)
Query: 496 RNSPGDGTIETNLPCFSYKELEEATDNF--------KEEVGRGSFGIVYKGVILTTRTST 547
R S I F ++ + E +G G FG V+K +
Sbjct: 58 RTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---EETATG 114
Query: 548 TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL- 606
+A K + ++E KNE+ V+ Q H NL++L + + +LV E+++ G L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 607 -----ASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 661
S+ L QI G+ ++H I+H D+KP+NIL +
Sbjct: 175 DRIIDESYNLTELDTI-----LFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAK 226
Query: 662 RI--SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
+I DFGLA+ + ++ GT ++APE ++ D++S GV+
Sbjct: 227 QIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E++G GS+G VYK + T VA+K++ + +E E+ ++ Q ++V+
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQI---VAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAF---QIARGLLYLHEDCS 640
G + + +V E+ G+++ + K L IA +GL YLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLH---F 143
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+ IH DIK NILL+ +A+++DFG+A LT +K R + GT ++APE +
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIG 201
Query: 701 ITAKVDVYSFGVLLLEII 718
D++S G+ +E+
Sbjct: 202 YNCVADIWSLGITAIEMA 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 575
+ EE+G G F IV K +++ A K + + +E + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKKC---REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARG 631
H N++ L + + +L+ E ++ G L F L +L T+ QI G
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDG 127
Query: 632 LLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIRTAIRGT 687
+ YLH + +I H D+KP+NI+L + ++ DFGLA + + GT
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GT 181
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLL 714
+VAPE + + D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E+G G+FG VYK T A K ++ ++ +++ E+ ++ H +V+L
Sbjct: 25 GELGDGAFGKVYKAKNKETGAL---AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAF---QIARGLLYLHEDCS 640
LG ++ EF G + + + + L I Q+ L +LH S
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH---S 135
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE-----W 695
+IIH D+K N+L+ + R++DFG++ K R + GT ++APE
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCET 193
Query: 696 FRNSTITAKVDVYSFGVLLLEII 718
+++ K D++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 18/194 (9%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVRL 584
G+GSF VY+ + + VA+K +D+ +++ G + +NEV + Q H +++ L
Sbjct: 20 GKGSFAGVYRA---ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCS 640
+ ++ LV E +NG + +L +KP N A QI G+LYLH S
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLH---S 130
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
I+H D+ N+LL N +I+DFGLA L + K + GT Y++PE S
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSA 188
Query: 701 ITAKVDVYSFGVLL 714
+ DV+S G +
Sbjct: 189 HGLESDVWSLGCMF 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 575
EE+G G F IV K + + A K +L + +E + EV ++ +
Sbjct: 8 EMGEELGSGQFAIVRKC---RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
H N++ L + + +L+ E ++ G L FL + + T QI G+ YL
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 636 HEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
H S +I H D+KP+NI+L ++ DFG+A + + GT +V
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF-GTPEFV 178
Query: 692 APEWFRNSTITAKVDVYSFGVLL 714
APE + + D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---------VFQDGEKEFKNEVVVI 573
KE +GRG +V + + + AVK +D Q+ + EV ++
Sbjct: 21 PKEILGRGVSSVVRRC---IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 574 GQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 632
+ + H N+++L + LV++ + G L +L + S I + +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
LH I+H D+KP+NILLDD N +++DFG + L+ + +R GT Y+A
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVC-GTPSYLA 191
Query: 693 PEWFRNSTITA------KVDVYSFGVLL 714
PE S +VD++S GV++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
+ EE+G G+FG+V++ T R + A K + + ++ + E+ + H L
Sbjct: 160 DIHEELGTGAFGVVHRV---TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-----NIAFQIARGLLYLH 636
V L ++ +++YEF++ G L F + N + Q+ +GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
+H D+KP+NI+ + + DFGL L + ++++ GT + APE
Sbjct: 273 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTT-GTAEFAAPE 326
Query: 695 WFRNSTITAKVDVYSFGVLL 714
+ D++S GVL
Sbjct: 327 VAEGKPVGYYTDMWSVGVLS 346
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 34/277 (12%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 580
+++G G++G V + + A+K + V + EV V+ H N
Sbjct: 41 RVKKLGSGAYGEVLLC---RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+++L F ++ +N LV E G L + +K + I Q+ G+ YLH
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---K 154
Query: 641 AQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR 697
I+H D+KP+N+LL + +I DFGL+ + K ++ + GT Y+APE R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPEVLR 211
Query: 698 NSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWAFDCYRNEKLDDLVEG 754
K DV+S GV+L +++ F + + + FD + + +
Sbjct: 212 KK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE---- 266
Query: 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
A + IK +Q D R + ++ L+
Sbjct: 267 --GAKDLIKQ----------MLQFDSQRRISAQQALE 291
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 38/214 (17%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR-----------------VFQDGEKEFKNEV 570
+G F + A+KK ++ + +FKNE+
Sbjct: 40 NQGKFNKIILC-----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 571 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRT------ 622
+I ++ + G ++YE++ N ++ F F L ++
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 623 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682
I + Y+H I H D+KP NIL+D ++SDFG ++ + K I+
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG 209
Query: 683 AIRGTKGYVAPEWFRNSTIT--AKVDVYSFGVLL 714
+ RGT ++ PE+F N + AKVD++S G+ L
Sbjct: 210 S-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHH 578
+ +G+GSFG V + + AVK + + + ++ EV ++ Q H
Sbjct: 29 KGQRVLGKGSFGEVILC---KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
N+++L F ++ LV E G L + + S I Q+ G+ Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH-- 143
Query: 639 CSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
+I+H D+KP+N+LL N RI DFGL+ SK ++ I GT Y+APE
Sbjct: 144 -KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKI-GTAYYIAPEV 199
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNEKLDDLV 752
+ K DV+S GV+L ++S F+ + + + F+ + +K+ +
Sbjct: 200 LHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-- 256
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
A + I+ + PS+R + + L
Sbjct: 257 ----SAKDLIRK----------MLTYVPSMRISARDALD 281
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 41/210 (19%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
F E +G G+F V+ R + A+K + + + +NE+ V+ + H+N+
Sbjct: 12 IFMEVLGSGAFSEVFLV---KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQ 627
V L + + LV + ++ G L AS + Q
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI--------------QQ 114
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAI 684
+ + YLH I+H D+KP+N+L ++ I+DFGL+K+ Q+ + TA
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTAC 168
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
GT GYVAPE + VD +S GV+
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 20/204 (9%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVK-----KLDRVFQDGEKEFKNEVVVIGQTH 577
E +G+G F +V + R + AVK K ++ K E +
Sbjct: 28 LCEVIGKGPFSVVRRC---INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLL 633
H ++V LL +V+EF++ L + + ++ QI L
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 634 YLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
Y H IIH D+KP +LL ++ ++ FG+A L + + GT +
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRV-GTPHF 199
Query: 691 VAPEWFRNSTITAKVDVYSFGVLL 714
+APE + VDV+ GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 59/336 (17%), Positives = 132/336 (39%), Gaps = 56/336 (16%)
Query: 491 KKKWIRNSPGDGTIETNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAV 550
++ + T + + + E+ E+G G+ G+V+K + S +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-----SELGAGNGGVVFKVSH---KPSGLVM 61
Query: 551 AVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRLLVY---EFLNNGT 605
A K + + + E+ V+ + + +V G F +G+ + E ++ G+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISICMEHMDGGS 117
Query: 606 LASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 664
L L P L ++ + +GL YL E +I+H D+KP NIL++ ++
Sbjct: 118 LDQVLKKAGRIPEQILGK-VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 174
Query: 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724
DFG++ L S A + + GT+ Y++PE + + + + D++S G+ L+E+ R +
Sbjct: 175 DFGVSGQLI--DSMA-NSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR--Y 228
Query: 725 DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIW---------- 774
I + + + + + ++ ++I+
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288
Query: 775 -------------------CIQEDPSLRPTMKKVLQ 791
C+ ++P+ R +K+++
Sbjct: 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 42/212 (19%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 579
+ KEE+G+G+F +V + +T+ A K ++ ++ ++ + E + + H
Sbjct: 9 DVKEELGKGAFSVVRRC---VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 625
N+VRL E LV++ + G L AS
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------------- 111
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA---RISDFGLAKLLTLNQSKAIRT 682
QI + Y H S I+H ++KP+N+LL +++DFGLA + N S+A
Sbjct: 112 QQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHG 166
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
GT GY++PE + + VD+++ GV+L
Sbjct: 167 FA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 575
+ EE+G G F +V K +++ A K + + +E + EV ++ +
Sbjct: 14 DTGEELGSGQFAVVKKC---REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
H N++ L + + +L+ E + G L FL + T QI G+ YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 636 HEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
H S QI H D+KP+NI+L +I DFGLA + + + GT +V
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-GTPEFV 184
Query: 692 APEWFRNSTITAKVDVYSFGVLL 714
APE + + D++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVIT 207
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 33/213 (15%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVR 583
E VG G++G VYKG + T A+K +D V D E+E K E+ ++ + HH+N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQL---AAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 584 LLG-----FCDEGQNRL-LVYEFLNNGTLA----SFLFGNLKPSWNLRTNIAF---QIAR 630
G ++L LV EF G++ + LK W IA+ +I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILR 140
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
GL +LH ++IH DIK QN+LL + ++ DFG++ L + R GT +
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYW 195
Query: 691 VAPE-----WFRNSTITAKVDVYSFGVLLLEII 718
+APE ++T K D++S G+ +E+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 52/221 (23%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVIG 574
K+ +GRG +V + R + AVK ++ ++ + + E ++
Sbjct: 98 PKDVIGRGVSSVVRRC---VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 575 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWN 619
Q H +++ L+ + LV++ + G L +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-------- 206
Query: 620 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679
+ + +LH + I+H D+KP+NILLDD R+SDFG + L +
Sbjct: 207 ------RSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255
Query: 680 IRTAIRGTKGYVAPEWFRNSTITA------KVDVYSFGVLL 714
+R GT GY+APE + S +VD+++ GV+L
Sbjct: 256 LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 45/212 (21%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKN 580
KE++G GS+ + + + T AVK +D+ +D E+ ++ + H N
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATN---MEFAVKIIDKSKRDP----TEEIEILLRYGQHPN 77
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 626
++ L D+G+ +V E + G L AS + F
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL--------------F 123
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLAKLLTLNQSKAIRT 682
I + + YLH + ++H D+KP NIL + + RI DFG AK L + T
Sbjct: 124 TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMT 179
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
T +VAPE A D++S GVLL
Sbjct: 180 PC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 37/285 (12%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 584
G+G F ++ T+ A K + + + + ++E E+ + H+++V
Sbjct: 24 GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
GF ++ +V E +L + QI G YLH ++I
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
H D+K N+ L++ +I DFGLA + + + + + GT Y+APE + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 705 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDC--YRNEKLDDLVEGDMEALND 761
VDV+S G ++ ++ + F+ +E Y + + + N L++
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ-------- 247
Query: 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ---MLEGVVEVSLPP 803
+Q DP+ RPT+ ++L G + LP
Sbjct: 248 ------------KMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVI 573
+ +G G+ G V R + VA++ + + D + E+ ++
Sbjct: 138 IMSKTLGSGACGEVKLAF---ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 633
+ +H ++++ F D ++ +V E + G L + GN + +Q+ +
Sbjct: 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 634 YLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
YLH IIH D+KP+N+LL ++ +I+DFG +K+L ++ +RT GT Y
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLC-GTPTY 307
Query: 691 VAPEWFRNSTI---TAKVDVYSFGVLL 714
+APE + VD +S GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 48/196 (24%), Positives = 81/196 (41%), Gaps = 13/196 (6%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
+ +GRGS+G V + + A KK+ + F + FK E+ ++ H N+
Sbjct: 12 TLENTIGRGSWGEVKIA---VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+RL ++ + LV E G L + + I + + Y H
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KL 125
Query: 642 QIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
+ H D+KP+N L ++ DFGLA K +RT + GT YV+P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQVLEG 182
Query: 699 STITAKVDVYSFGVLL 714
+ D +S GV++
Sbjct: 183 L-YGPECDEWSAGVMM 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 580
FK ++G G+FG V+ R+S +K ++ Q ++ + E+ V+ H N
Sbjct: 25 IFKRKLGSGAFGDVHLV---EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLH 636
++++ ++ N +V E G L + L + Q+ L Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 637 EDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
S ++H D+KP+NIL + +I DFGLA+L + A GT Y+AP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAA-GTALYMAP 195
Query: 694 EWFRNSTITAKVDVYSFGVLL 714
E F+ +T K D++S GV++
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVM 215
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 60/285 (21%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 584
G+G F ++ T+ A K + + + + ++E E+ + H+++V
Sbjct: 50 GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
GF ++ +V E +L + QI G YLH ++I
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
H D+K N+ L++ +I DFGLA + + + + + GT Y+APE + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 705 VDVYSFGVLLLEIISCRKSFDIEMGEE-YA-ILT-DWAFDCYRNEKLDDLVEGDMEALND 761
VDV+S G ++ ++ + F+ +E Y I +++ + N L++
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ-------- 273
Query: 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ---MLEGVVEVSLPP 803
+Q DP+ RPT+ ++L G + LP
Sbjct: 274 ------------KMLQTDPTARPTINELLNDEFFTSGYIPARLPI 306
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 40/216 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVR 583
+ +G GSFG+VY+ + + VA+KK V QD K FKN E+ ++ + H N+VR
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGEL---VAIKK---VLQD--KRFKNRELQIMRKLDHCNIVR 111
Query: 584 LLG-FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLL 633
L F G+ + LV +++ T+ + L +Q+ R L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 634 YLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
Y+H S I H DIKPQN+LLD D ++ DFG AK L + Y+
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---------NVSYIC 218
Query: 693 PEWFR------NSTI-TAKVDVYSFGVLLLEIISCR 721
++R +T T+ +DV+S G +L E++ +
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 43/212 (20%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 579
N +G+GSFG V K R + AVK ++ EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 625
N+++L ++ + +V E G L A+ +
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-------------- 127
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRT 682
Q+ G+ Y+H I+H D+KP+NILL + + +I DFGL+ Q+ ++
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKD 182
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
I GT Y+APE R + K DV+S GV+L
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 62/292 (21%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 579
N +G+GSFG V K R + AVK ++ EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 625
N+++L ++ + +V E G L A+ I
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------------RII 127
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRT 682
Q+ G+ Y+H I+H D+KP+NILL + + +I DFGL+ Q+ ++
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKD 182
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWA 739
I GT Y+APE R + K DV+S GV+L ++S F E + T +A
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
FD + + D +A + I+ + PSLR T + L+
Sbjct: 241 FDLPQWRTISD------DAKDLIRK----------MLTFHPSLRITATQCLE 276
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 41/281 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 582
E+GRG++G+V K + +AVK++ E K ++ + + V
Sbjct: 13 MELGRGAYGVVEKM--RHVPSGQI-MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 583 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLY 634
G EG V+ E ++ +L F + + + IA I + L +
Sbjct: 70 TFYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
LH +IH D+KP N+L++ ++ DFG++ L A G K Y+APE
Sbjct: 125 LHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDA-GCKPYMAPE 179
Query: 695 ----WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750
+ K D++S G+ ++E+ R +D + T + ++L
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-------SWGTPF-------QQLKQ 225
Query: 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+VE L K + V + C++++ RPT +++Q
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-26
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 45/248 (18%)
Query: 500 GDGT-IETNLPCFSYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD 556
G G+ + N + + + D F+ G+G+FG V G +T S VA+KK
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMS---VAIKK-- 55
Query: 557 RVFQDGEKEFKN----EVVVIGQTHHKNLVRLL------GFCDEGQNRL-LVYEFLNNGT 605
V QD F+N + + HH N+V+L G D L +V E++ + T
Sbjct: 56 -VIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-T 111
Query: 606 LASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 661
L + FQ+ R + LH S + H DIKP N+L+++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170
Query: 662 -RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR------NSTI-TAKVDVYSFGVL 713
++ DFG AK L+ ++ Y+ ++R + T VD++S G +
Sbjct: 171 LKLCDFGSAKKLSPSEP---------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 714 LLEIISCR 721
E++
Sbjct: 222 FAEMMLGE 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 42/209 (20%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+ E+GRG+ IVY+ + + A+K L + +K + E+ V+ + H N++
Sbjct: 57 VESELGRGATSIVYRC---KQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNII 111
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQI 628
+L + LV E + G L A+ QI
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK--------------QI 157
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIR 685
+ YLH I+H D+KP+N+L +I+DFGL+K++ ++T
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVC- 211
Query: 686 GTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
GT GY APE R +VD++S G++
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 58/243 (23%), Positives = 88/243 (36%), Gaps = 57/243 (23%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVK-----KLDRVFQDGEKEFKNEVVVIGQTH 577
K +G+GS+G+V + TR A+K K+ ++ + K EV ++ + H
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRA---IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL------------------------------A 607
H N+ RL ++ Q LV E + G L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 608 SFLFGNLKPSWNLRTNIAF----------QIARGLLYLHEDCSAQIIHCDIKPQNILL-- 655
+ + QI L YLH + I H DIKP+N L
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFST 203
Query: 656 DDYYNARISDFGLAKLLTLNQSKAIR--TAIRGTKGYVAPEWFRNST--ITAKVDVYSFG 711
+ + ++ DFGL+K + T GT +VAPE + K D +S G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 712 VLL 714
VLL
Sbjct: 264 VLL 266
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 42/211 (19%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 580
KEE+G+G+F +V + V TT A K ++ ++ ++ + E + + H N
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 626
+VRL E LV++ + G L AS
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--------------Q 135
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA---RISDFGLAKLLTLNQSKAIRTA 683
QI + Y H S I+H ++KP+N+LL +++DFGLA + N S+A
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 190
Query: 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
GT GY++PE + + VD+++ GV+L
Sbjct: 191 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVI 573
+ +G G+ G V R + VA+K + + D + E+ ++
Sbjct: 13 IMSKTLGSGACGEVKLA---FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWN 619
+ +H ++++ F D ++ +V E + G L F
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------- 120
Query: 620 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQ 676
+Q+ + YLH IIH D+KP+N+LL ++ +I+DFG +K+L +
Sbjct: 121 ------YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--E 169
Query: 677 SKAIRTAIRGTKGYVAPEWFRNSTI---TAKVDVYSFGVLL 714
+ +RT GT Y+APE + VD +S GV+L
Sbjct: 170 TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 41/216 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVR 583
+ +G GSFG+V++ ++ + VA+KK V QD K FKN E+ ++ H N+V
Sbjct: 46 KVIGNGSFGVVFQAKLVESDE----VAIKK---VLQD--KRFKNRELQIMRIVKHPNVVD 96
Query: 584 LLGF-----CDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLL 633
L F + + L LV E++ T+ K + +Q+ R L
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 634 YLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV- 691
Y+H S I H DIKPQN+LLD ++ DFG AK+L + Y+
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---------NVSYIC 203
Query: 692 -----APEW-FRNSTITAKVDVYSFGVLLLEIISCR 721
APE F + T +D++S G ++ E++ +
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 45/288 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR-------------VFQDGEKEFKNE 569
++G G++G V + + A+K + + + +E NE
Sbjct: 40 KVRKLGSGAYGEVLLC---KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 570 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 629
+ ++ H N+++L ++ + LV EF G L + K NI QI
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
G+ YLH I+H DIKP+NILL + N +I DFGL+ ++ +R + G
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRL-G 210
Query: 687 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWAFDCY 743
T Y+APE + K DV+S GV++ ++ F + + + FD
Sbjct: 211 TAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269
Query: 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + D EA IK + D + R T ++ L
Sbjct: 270 DWKNISD------EAKELIKL----------MLTYDYNKRCTAEEALN 301
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 43/212 (20%)
Query: 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHK 579
D + +G GSF I K V + A AVK + + E + E+ + H
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQ---AFAVKIISK---RMEANTQKEITALKLCEGHP 66
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 625
N+V+L + + LV E LN G L AS I
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------------YIM 112
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRT 682
++ + ++H ++H D+KP+N+L +D +I DFG A+L + + ++T
Sbjct: 113 RKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT 168
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
T Y APE + D++S GV+L
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-25
Identities = 38/311 (12%), Positives = 86/311 (27%), Gaps = 75/311 (24%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQT----- 576
+G+ + T S V +R + K+ K EV+ +
Sbjct: 84 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140
Query: 577 -----------------HHKNLVRLLGFCDEGQNRLLVYEFL-------NNGTLASFLFG 612
+++ + ++ ++ F N T L
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200
Query: 613 NLK----PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668
+ + R + Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKS 723
+ + A + +T D ++ G+ + I C
Sbjct: 258 LVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-CADL 315
Query: 724 -FDIEMGEEYAILTDWAFDCYRN--EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDP 780
+ ++W F +N + + L+EG ++
Sbjct: 316 PNT---DDAALGGSEWIFRSCKNIPQPVRALLEG--------------------FLRYPK 352
Query: 781 SLRPTMKKVLQ 791
R + ++
Sbjct: 353 EDRLLPLQAME 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 41/211 (19%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKN 580
EE+G+G+F +V + + A ++ + ++ + E + H N
Sbjct: 15 LFEELGKGAFSVVRRC---VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 626
+VRL E + L+++ + G L AS
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI--------------Q 117
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTA 683
QI +L+ H ++H ++KP+N+LL +++DFGLA + Q +A
Sbjct: 118 QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGF 173
Query: 684 IRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
GT GY++PE R VD+++ GV+L
Sbjct: 174 A-GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 40/287 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 583
E +G G+ +V + VA+K+++ Q E E+ + Q HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEK---VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-----IAF---QIARGLLYL 635
LV + L+ G++ + + + IA ++ GL YL
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI---RTAIRGTKGYVA 692
H IH D+K NILL + + +I+DFG++ L R GT ++A
Sbjct: 138 H---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 693 PEWF-RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-----FDCYRNE 746
PE + K D++SFG I+ IE+ A + +N+
Sbjct: 195 PEVMEQVRGYDFKADIWSFG------ITA-----IELATGAAPYHKYPPMKVLMLTLQND 243
Query: 747 --KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L+ V+ K K M+S C+Q+DP RPT ++L+
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRK--MIS-LCLQKDPEKRPTAAELLR 287
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 45/315 (14%), Positives = 89/315 (28%), Gaps = 60/315 (19%)
Query: 525 EEVGRG--SFGIVYKGVILTTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKN 580
+G+G V T V V++ L+ + + E+ V +H N
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEY---VTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAF---QIARGLL 633
+V +V F+ G+ + + IA+ + + L
Sbjct: 88 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALD 142
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV-- 691
Y+H +H +K +IL+ +S + + + R K V
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ-RVVHDFPKYSVKV 198
Query: 692 ----APEWFRNSTI--TAKVDVYSFGVLLLEIISC----------RKSFDIEMGEEYAIL 735
+PE + + AK D+YS G+ E+ + + + G +L
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSI-------------------WCI 776
+ + + C+
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
Query: 777 QEDPSLRPTMKKVLQ 791
Q +P RP+ +L
Sbjct: 319 QRNPDARPSASTLLN 333
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 48/219 (21%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 582
++ +G G+ V + L T AVK +++ EV ++ Q H+N++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQ---EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQI 628
L+ F +E LV+E + G++ AS + +
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------------VVVQDV 120
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIR 685
A L +LH + I H D+KP+NIL + +I DF L + LN + +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 686 -----GTKGYVAPEWFRNSTITAK-----VDVYSFGVLL 714
G+ Y+APE + A D++S GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 582
E+GRG++G V K V + +AVK++ + E K+ ++ VV+ + +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQ---IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 583 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGL 632
+ G EG + E ++ + F + + I + L
Sbjct: 85 QFYGALFREGD----CWICMELMS-TSFDKFY-KYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
+L E+ +IIH DIKP NILLD N ++ DFG++ L S A G + Y+A
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDA-GCRPYMA 193
Query: 693 PE----WFRNSTITAKVDVYSFGVLLLEI 717
PE + DV+S G+ L E+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 28/205 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 581
E+G GSFG VY + VA+KK+ + ++ EV + + H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEV---VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 582 VRLLGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPSWNLRTNIAF---QIARGLLYLH 636
++ G LV E+ L L+ IA +GL YLH
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLH 171
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE-- 694
S +IH D+K NILL + ++ DFG A ++ + GT ++APE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----P--ANSFVGTPYWMAPEVI 222
Query: 695 -WFRNSTITAKVDVYSFGVLLLEII 718
KVDV+S G+ +E+
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA 247
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 71/310 (22%), Positives = 117/310 (37%), Gaps = 58/310 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR------VFQDGEKEFKNEVV----VIG 574
+G+G FG V+ G LT R VA+K + R EV V
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIAR 630
H ++RLL + + + +LV E LF + L + F Q+
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
+ + H S ++H DIK +NIL+D A++ DFG LL + GT+
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD-GTRV 203
Query: 690 YVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748
Y PEW V+S G+LL +++ F+ ++ + + F + +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE---RDQEILEAELHFPAHVSPDC 260
Query: 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ---MLEGVVEVSLPP-- 803
L+ C+ PS RP+++++L M +V L P
Sbjct: 261 CALIR--------------------RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSK 300
Query: 804 -NPYPFSSSM 812
P P + S+
Sbjct: 301 GGPAPLAWSL 310
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 63/279 (22%), Positives = 106/279 (37%), Gaps = 38/279 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 582
E+G G+ G V+K T +AVK++ R E K ++ VV+ +V
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGH---VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 583 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
+ G F V+ E + + + I + L YL E
Sbjct: 88 QCFGTFITNTD----VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE---- 694
+IH D+KP NILLD+ ++ DFG++ L KA + G Y+APE
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSA-GCAAYMAPERIDP 198
Query: 695 -WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753
+ DV+S G+ L+E+ + + + TD+ E L +++
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYK-------NCKTDF-------EVLTKVLQ 244
Query: 754 GDMEAL-NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ L + C+ +D RP K+L+
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 18/194 (9%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 586
G G++G V V T + VAVK +D D + K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 587 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSAQ 642
EG + L E+ + G L F ++P + A F Q+ G++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLN-QSKAIRTAIRGTKGYVAPEWFRNSTI 701
I H DIKP+N+LLD+ N +ISDFGLA + N + + + GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 702 T-AKVDVYSFGVLL 714
VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR----VFQDGEKEFKNEVVVIGQTHHKNLVR 583
G GS+G V + + T AVK L + +GE K E+ ++ + HKN+++
Sbjct: 14 GEGSYGKVKEVLDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 584 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHE 637
L+ +E + ++ +V E+ G + ++ P A F Q+ GL YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH- 126
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL-TLNQSKAIRTAIRGTKGYVAPEWF 696
S I+H DIKP N+LL +IS G+A+ L RT+ +G+ + PE
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIA 183
Query: 697 RNSTI--TAKVDVYSFGVLL 714
KVD++S GV L
Sbjct: 184 NGLDTFSGFKVDIWSAGVTL 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 62/280 (22%), Positives = 111/280 (39%), Gaps = 48/280 (17%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR------VFQDGEKEFKNEVVVIGQTHH 578
+G G FG VY G+ ++ VA+K +++ EVV++ +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 579 K--NLVRLLGFCDEGQNRLLVYEFLNN-GTLASFLF--GNLKPSWNLRTNIAFQIARGLL 633
++RLL + + + +L+ E L F+ G L+ L + +Q+ +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE--ELARSFFWQVLEAVR 163
Query: 634 YLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
+ H + ++H DIK +NIL+D + ++ DFG LL + GT+ Y
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD-GTRVYSP 216
Query: 693 PEWFRNSTITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
PEW R V+S G+LL +++ F+ +E I F + + L
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSSECQHL 273
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ WC+ PS RPT +++
Sbjct: 274 IR--------------------WCLALRPSDRPTFEEIQN 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 38/289 (13%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLL 585
G+G+F V + T VA+K +D+ + ++ EV ++ +H N+V+L
Sbjct: 24 GKGNFAKVKLARHILTGRE---VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 586 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIH 645
+ + L+ E+ + G + +L + + + QI + Y H+ I+H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVH 137
Query: 646 CDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT-AK 704
D+K +N+LLD N +I+DFG + T+ + G Y APE F+ +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFC-GAPPYAAPELFQGKKYDGPE 194
Query: 705 VDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDC--YRNEKLDDLVEGDMEALND 761
VDV+S GV+L ++S FD + + E + + Y + ++L++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK-------- 246
Query: 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ---MLEGVVEVSLPPNPYP 807
+ +P R T++++++ + G E L P P
Sbjct: 247 ------------RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEP 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 25/201 (12%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 582
K+ +G G G V + T A+K L + + EV Q + ++V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQ---KCALKLLYDS-----PKARQEVDHHWQASGGPHIV 85
Query: 583 RLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLH 636
+L + + L++ E + G L S + ++ R I I + +LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 637 EDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
S I H D+KP+N+L + +++DFG AK T N ++T T YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAP 198
Query: 694 EWFRNSTITAKVDVYSFGVLL 714
E D++S GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 35/294 (11%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 586
G G++G V V T + VAVK +D D + K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 587 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSAQ 642
EG + L E+ + G L F ++P + A F Q+ G++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTL-NQSKAIRTAIRGTKGYVAPEWFRNSTI 701
I H DIKP+N+LLD+ N +ISDFGLA + N+ + + GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 702 T-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
VDV+S G++L +++ +D + + +DW + D L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKI---DSAPLA 240
Query: 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ---MLEGVVEVSLPPNPYPFSSS 811
+ K+++ +PS R T+ + + + + + + P S
Sbjct: 241 LLH---KILVE-------NPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVS 284
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 52/216 (24%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 581
+ +G G G V + T+ A+K L + + EV + + + ++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQ---EKFALKMLQDC-----PKARREVELHWRASQCPHI 117
Query: 582 VRLLGFCDEGQNR----LLVYEFLNNGTL----------------ASFLFGNLKPSWNLR 621
VR++ + L+V E L+ G L AS
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------------- 164
Query: 622 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSK 678
I I + YLH S I H D+KP+N+L +++DFG AK T + S
Sbjct: 165 -EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 219
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLL 714
+ T T YVAPE D++S GV++
Sbjct: 220 -LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 582
+GRG FG V+ +T + A KKL R+ + + E ++ + H + +V
Sbjct: 193 LGRGGFGEVF----ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 583 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHE 637
L + E + L LV +N G + ++ + + + A F QI GL +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH- 306
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR 697
II+ D+KP+N+LLDD N RISD GLA L Q+K GT G++APE
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLL 362
Query: 698 NSTITAKVDVYSFGVLLLEII 718
VD ++ GV L E+I
Sbjct: 363 GEEYDFSVDYFALGVTLYEMI 383
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 37/291 (12%), Positives = 76/291 (26%), Gaps = 58/291 (19%)
Query: 525 EEVGRGSFGIVYKGV-ILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKN 580
G ++ + R VA+ +D + +E + + + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQ----VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 581 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+ R+L L+V E++ G+L + P +R +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHR--- 147
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
A + P + +S G L +
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------ 179
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNEKLDDLVEGDMEA 758
+ D+ G L ++ R D A +D + + A
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRP--TMKKVLQMLEGVVEVSLPPNPYP 807
+ +Q D +R T+ ++Q V + + P
Sbjct: 239 ---------VAA---RSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPID 277
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 518 EATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ 575
D+++ ++GRG + V++ + +T V VK L V +K+ K E+ ++
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVK---KKKIKREIKILEN 86
Query: 576 -THHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 632
N++ L D LV+E +NN L+ L ++R + ++I + L
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDY-DIRFYM-YEILKAL 143
Query: 633 LYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
Y H S I+H D+KP N+++D ++ R+ D+GLA+ Q +R A ++ +
Sbjct: 144 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA---SRYFK 197
Query: 692 APEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSF 724
PE + + +D++S G +L +I ++ F
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 582
VG G++G V + + VA+KKL R FQ K E++++ H+N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEK---VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 583 RLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
LL + LV F+ L + ++ + +Q+ +GL Y+H
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE-KIQ-YLVYQMLKGLKYIH 143
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
SA ++H D+KP N+ +++ +I DFGLA R A GYV W+
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWY 189
Query: 697 R-------NSTITAKVDVYSFGVLLLEIISCRKSF 724
R VD++S G ++ E+++ + F
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 55/244 (22%), Positives = 96/244 (39%), Gaps = 58/244 (23%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVR 583
+ +G GSFGIV + + + A+KK V QD +KN E+ ++ H N+++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKR---FALKK---VLQD--PRYKNRELDIMKVLDHVNIIK 64
Query: 584 LL--------------------GFCDEGQNRLLVYEFLNNGTLASFLFGNL--------- 614
L+ N + + + + N+
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 615 ----KPSWNLRTNI--------AFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNA 661
K +I +Q+ R + ++H S I H DIKPQN+L++
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181
Query: 662 RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISC 720
++ DFG AK L ++ A ++ Y APE +T T +D++S G + E+I
Sbjct: 182 KLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 721 RKSF 724
+ F
Sbjct: 239 KPLF 242
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 7e-21
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 582
+G+G FG V +T + A KKL R+ + + NE ++ + + + +V
Sbjct: 192 LGKGGFGEVC----ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 583 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDC 639
L + E ++ L LV +N G L ++ + + + A +I GL LH +
Sbjct: 248 SLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE- 305
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR-GTKGYVAPEWFRN 698
+I++ D+KP+NILLDD+ + RISD GLA + Q R GT GY+APE +N
Sbjct: 306 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKN 359
Query: 699 STITAKVDVYSFGVLLLEII 718
T D ++ G LL E+I
Sbjct: 360 ERYTFSPDWWALGCLLYEMI 379
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR--VFQDGEKEFKN------EVVVIGQT 576
+G G+FG V+ V V VK + + V +D E E+ ++ +
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIAR 630
H N++++L + LV E +G LF L L + I Q+
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDE--PLASYIFRQLVS 141
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
+ YL IIH DIK +NI++ + + ++ DFG A L + K T GT Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIEY 195
Query: 691 VAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFD 725
APE + +++++S GV L ++ F
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAV-AVKKLD--RVFQDGEKEF-KNEVVVIGQTH 577
F + +G GSF V L +T+ A+K L+ + ++ + + E V+ +
Sbjct: 33 KFGKILGEGSFSTVV----LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 578 HKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARG 631
H V+L F D+ +L + NG L ++ + F +I
Sbjct: 89 HPFFVKLYFTFQDD--EKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L YLH IIH D+KP+NILL++ + +I+DFG AK+L+ +A + GT YV
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIIS 719
+PE + D+++ G ++ ++++
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRL 584
+G G+ GIV + VA+KKL R FQ+ K E+V++ +HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 585 L------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
L +E Q+ +V E ++ L + L + + +Q+ G+ +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE-RMSY-LLYQMLCGIKHLH-- 144
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
SA IIH D+KP NI++ +I DFGLA+ + T T+ Y APE
Sbjct: 145 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILG 200
Query: 699 STITAKVDVYSFGVLLLEIISCRKSF 724
VD++S G ++ E+I F
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 13/191 (6%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 584
G G+FG V G T VAVK L+R D + K E+ + H ++++L
Sbjct: 20 GVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
+ +V E+++ G L ++ + + + QI + Y H ++
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVV 133
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT-A 703
H D+KP+N+LLD + NA+I+DFGL+ +++ + +RT+ G+ Y APE
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRLYAGP 190
Query: 704 KVDVYSFGVLL 714
+VD++S GV+L
Sbjct: 191 EVDIWSCGVIL 201
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 54/246 (21%), Positives = 100/246 (40%), Gaps = 77/246 (31%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE------------KEFKNEV 570
+++G+G++GIV+K + T VAVKK+ FQ+ E
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEV---VAVKKIFDAFQNSTDAQRTFREIMILTELSG-- 67
Query: 571 VVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEF----LNNGTLASFLFGNLKPSWNLRTN- 623
H+N+V LL + + LV+++ L+ +R N
Sbjct: 68 -------HENIVNLLNVLRADNDRDVYLVFDYMETDLHA---------------VIRANI 105
Query: 624 --------IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
+ +Q+ + + YLH S ++H D+KP NILL+ + +++DFGL++
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 676 QSKAIRTAIRGTK-------------GYVAPEWFR-------NSTITAKVDVYSFGVLLL 715
+ + + YVA W+R ++ T +D++S G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 716 EIISCR 721
EI+ +
Sbjct: 223 EILCGK 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 53/225 (23%), Positives = 83/225 (36%), Gaps = 43/225 (19%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE--FKN---------EVVVI 573
+ GS+G V GV + VA+K++ DG + E+ ++
Sbjct: 28 RFISSGSYGAVCAGV----DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 574 GQTHHKNLVRLL-----GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRTN-IAF 626
HH N++ L LV E + T LA + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
I GL LH A ++H D+ P NILL D + I DF LA+ T + +
Sbjct: 142 HILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--------- 189
Query: 687 TKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 724
YV W+R T VD++S G ++ E+ + + F
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 48/226 (21%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR-------------------------- 557
K+E+G+GS+G+V T A+K L +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 558 VFQDGEKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLK 615
+ ++ E+ ++ + H N+V+L+ D ++ L +V+E +N G + LK
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLK 132
Query: 616 PSWNLRTNIA---F-QIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671
P L + A F + +G+ YLH +IIH DIKP N+L+ + + +I+DFG++
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT---AKVDVYSFGVLL 714
+ + T GT ++APE + +DV++ GV L
Sbjct: 187 FKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 573
+ ++ ++G GS+G+V+K R + VA+KK + + E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCR---NRDTGQIVAIKK---FLESEDDPVIKKIALREIRML 56
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARG 631
Q H NLV LL + LV+E+ ++ T+ L + P ++ +I +Q +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQA 114
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673
+ + H IH D+KP+NIL+ + ++ DFG A+LLT
Sbjct: 115 VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 25/186 (13%)
Query: 496 RNSPGDGTIETNLPCFSYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVK 553
+S G NL ++ + ++ VG GS+G+V K + + VA+K
Sbjct: 7 HHSSGVDLGTENLYF-------QSMEKYENLGLVGEGSYGMVMKC---RNKDTGRIVAIK 56
Query: 554 KLDRVFQDGEKE-FKN----EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 608
K + + + K E+ ++ Q H+NLV LL C + + LV+EF+++ T+
Sbjct: 57 K---FLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILD 112
Query: 609 FLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667
L + + FQI G+ + H S IIH DIKP+NIL+ ++ DFG
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFG 169
Query: 668 LAKLLT 673
A+ L
Sbjct: 170 FARTLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 60/228 (26%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 582
+ VG G++G V V T VA+KKL R FQ K E+ ++ H+N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAK---VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 583 RLL------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTN 623
LL D+ + LV F L + ++
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY------------ 135
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683
Q+ +GL Y+H +A IIH D+KP N+ +++ +I DFGLA R A
Sbjct: 136 ---QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA-----------RQA 178
Query: 684 IRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 724
GYV W+R T VD++S G ++ E+I+ + F
Sbjct: 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 46/231 (19%), Positives = 91/231 (39%), Gaps = 51/231 (22%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKN 580
K +G G++G+V T VA+KK+ F E+ ++ H+N
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEI---VAIKKI-EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 581 LVRLL-----GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRT 622
++ + + ++ E L++ + F++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY----------- 119
Query: 623 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682
Q R + LH + +IH D+KP N+L++ + ++ DFGLA+++ + +
Sbjct: 120 ----QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 683 AIRGTK--GYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISCRKSF 724
+ + +VA W+R S + +DV+S G +L E+ R F
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 51/235 (21%), Positives = 100/235 (42%), Gaps = 44/235 (18%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKN 580
+ +G GS+G V + + VA+KK+ RVF+D + K E+ ++ + +H +
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRV---VAIKKILRVFED-LIDCKRILREIAILNRLNHDH 113
Query: 581 LVRLLGFC----DEGQNRL-LVYEFLNNGT-LASFLFGNLKPSWNLRTNIAFQIARGLLY 634
+V++L E + L +V E + + + + + + G+ Y
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK------ 688
+H SA I+H D+KP N L++ + ++ DFGLA+ + ++ + I +
Sbjct: 172 VH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 689 -------------GYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISCRKS 723
G+V W+R T +DV+S G + E+++ K
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 60/228 (26%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 582
VG G++G V T VAVKKL R FQ K E+ ++ H+N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 583 RLL------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTN 623
LL +E + LV L + + ++
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY------------ 139
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA 683
QI RGL Y+H SA IIH D+KP N+ +++ +I DFGLA R
Sbjct: 140 ---QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHT 182
Query: 684 IRGTKGYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISCRKSF 724
GYVA W+R N VD++S G ++ E+++ R F
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 7e-19
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 582
+ +G G+ GIV + VA+KKL R FQ+ K E+V++ +HKN++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 583 RLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
LL +E Q+ LV E ++ L + L + + +Q+ G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDH--ERMSYLLYQMLCGIKHLH 181
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
SA IIH D+KP NI++ +I DFGLA+ + YV ++
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---------MTPYVVTRYY 229
Query: 697 R------NSTITAKVDVYSFGVLLLEIISCRKSF 724
R VD++S G ++ E++ + F
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 57/239 (23%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL 581
K +GRGS+G VY T + VA+KK++R+F+D K E+ ++ + +
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKN---VAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 582 VRLLG-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPSWNLRTNIA---------- 625
+RL + + +V E + L +T I
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF----------KTPIFLTEEHIKTIL 135
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR 685
+ + G ++H + IIH D+KP N LL+ + ++ DFGLA+ + + I +
Sbjct: 136 YNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 686 GTK--------------GYVAPEWFR------NSTI-TAKVDVYSFGVLLLEIISCRKS 723
+ +V W+R T +D++S G + E+++ +S
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 21/205 (10%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 587
G G+FG+ T+ VAVK ++R E + E++ H N+VR
Sbjct: 29 GSGNFGVARLMRDKLTKEL---VAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEV 84
Query: 588 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSAQI 643
+ ++ E+ + G L + + + A F Q+ G+ Y H S QI
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCH---SMQI 137
Query: 644 IHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
H D+K +N LLD +I DFG +K L+ ++ + GT Y+APE
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV-GTPAYIAPEVLLRQEY 194
Query: 702 T-AKVDVYSFGVLLLEIISCRKSFD 725
DV+S GV L ++ F+
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 21/195 (10%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 584
G G+FG V G T VAVK L+R D + + E+ + H ++++L
Sbjct: 25 GVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCS 640
+ +V E+++ G L ++ N + L + F QI G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCH---R 134
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
++H D+KP+N+LLD + NA+I+DFGL+ +++ + +RT+ G+ Y APE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 191
Query: 701 -ITAKVDVYSFGVLL 714
+VD++S GV+L
Sbjct: 192 YAGPEVDIWSSGVIL 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF----KNEVVVIGQTHHK 579
+GRG FG VY + T + A+K L R+ + + + ++
Sbjct: 197 IGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 580 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
+V + + ++L + + +N G L L + S A +I GL ++H
Sbjct: 253 FIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH-- 309
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE-WFR 697
+ +++ D+KP NILLD++ + RISD GLA + + A GT GY+APE +
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQK 364
Query: 698 NSTITAKVDVYSFGVLLLEII 718
+ D +S G +L +++
Sbjct: 365 GVAYDSSADWFSLGCMLFKLL 385
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 528 GRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 584
G GSFG V T+ VA+K + R D + E+ + H ++++L
Sbjct: 18 GEGSFGKVKLATHYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCS 640
+ ++V E+ G L ++ + + + F QI + Y H
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCH---R 126
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+I+H D+KP+N+LLDD N +I+DFGL+ ++T ++T+ G+ Y APE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVINGKL 183
Query: 701 IT-AKVDVYSFGVLLLEIISCRKSFD 725
+VDV+S G++L ++ R FD
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 573
++ E++G G++G V+K R + VA+K++ R+ D + E E+ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKA---KNRETHEIVALKRV-RL--DDDDEGVPSSALREICLL 55
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGL 632
+ HKN+VRL + LV+EF + L + + + FQ+ +GL
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRG------ 686
+ H S ++H D+KPQN+L++ ++++FGLA +A +R
Sbjct: 115 GFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLA--------RAFGIPVRCYSAEVV 163
Query: 687 TKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRK 722
T Y P+ + + + +D++S G + E+ + +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 23/160 (14%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 573
+ ++ E+VG G++G+VYK R VA+K++ R+ D E E E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRI-RL--DAEDEGIPSTAIREISLL 73
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 630
+ HH N+V L+ + LV+EF+ L L L+ S ++ +Q+ R
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLR 130
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
G+ + H +I+H D+KPQN+L++ +++DFGLA+
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 573
+ + E++G G++G+VYK T A+KK + + E E E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKK---IRLEKEDEGIPSTTIREISIL 54
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 630
+ H N+V+L + +LV+E L+ L L G L+ ++ Q+
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESV-TAKS-FLLQLLN 111
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
G+ Y H +++H D+KPQN+L++ +I+DFGLA+
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 50/159 (31%), Positives = 86/159 (54%), Gaps = 19/159 (11%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 573
+NF+ E++G G++G+VYK T VA+KK+ R+ D E E E+ ++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGE---VVALKKI-RL--DTETEGVPSTAIREISLL 56
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 631
+ +H N+V+LL LV+EFL+ L F+ + L + FQ+ +G
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
L + H S +++H D+KPQN+L++ +++DFGLA+
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 41/164 (25%), Positives = 81/164 (49%), Gaps = 26/164 (15%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 573
D ++ ++G G++G VYK + T + VA+K++ R+ + E+E EV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNET---VAIKRI-RL--EHEEEGVPGTAIREVSLL 87
Query: 574 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARG 631
+ H+N++ L L++E+ N L ++ ++ +++ +Q+ G
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR-VIKS-FLYQLING 144
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNAR-----ISDFGLAK 670
+ + H S + +H D+KPQN+LL + I DFGLA+
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 582
+G+GSFG V + + T + A+K + + + E E+ ++ H LV
Sbjct: 23 IGKGSFGKVC----IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 583 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIAR 630
L F DE + +V + L G L ++L+ N+ F ++
Sbjct: 79 NLWYSFQDEE--DMFMVVDLLLGGDL----R------YHLQQNVHFKEETVKLFICELVM 126
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY 690
L YL + +IIH D+KP NILLD++ + I+DF +A +L T + GTK Y
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPY 180
Query: 691 VAPEWFRNSTI---TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
+APE F + + VD +S GV E++ R+ + I
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 33/186 (17%)
Query: 623 NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN----QSK 678
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILT 736
R ++ APE + T + DV+SFGVLL EI S S +++ EE
Sbjct: 254 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC 306
Query: 737 DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKL--VMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ R D ++ M+ W +PS RPT ++++ L
Sbjct: 307 RRLKEGTRMRAPDY-------------TTPEMYQTMLDCW--HGEPSQRPTFSELVEHLG 351
Query: 795 GVVEVS 800
+++ +
Sbjct: 352 NLLQAN 357
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 12/153 (7%)
Query: 523 FKEEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQ-THH 578
+ +GRG+FG V + + + VAVK L E + +E+ ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 579 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 637
N+V LLG C G +++ EF G L+++L + R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
I D+K + + ++ S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 53/230 (23%), Positives = 99/230 (43%), Gaps = 51/230 (22%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 582
+ +G G G+V+ V VA+KK+ V D + K E+ +I + H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKR---VAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 583 RLL--------------GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRTN---- 623
++ G E + +V E++ T LA+ L L
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG-----PLLEEHARL 124
Query: 624 IAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQSKAIR- 681
+Q+ RGL Y+H SA ++H D+KP N+ ++ +I DFGLA+++ + S
Sbjct: 125 FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 682 TAIRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 724
+ + +W+R + T +D+++ G + E+++ + F
Sbjct: 182 S------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 519 ATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV---- 572
AT ++ E+G G++G VYK + VA+K + RV + +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGH---FVALKSV-RV--PNGGGGGGGLPISTVR 60
Query: 573 -------IGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNL 620
+ H N+VRL+ + + ++ LV+E ++ L ++L P
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 621 RT--NIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678
T ++ Q RGL +LH + I+H D+KP+NIL+ +++DFGLA++ + +
Sbjct: 120 ETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA- 175
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
T + T Y APE ST VD++S G + E+
Sbjct: 176 --LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLV 582
+VGRG++G VYK + A+K+++ G E+ ++ + H N++
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKD-YALKQIEG---TGISMSACREIALLRELKHPNVI 81
Query: 583 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN---------IAFQIARG 631
L F ++ L++++ + L + + N + + +QI G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNAR----ISDFGLAKL 671
+ YLH + ++H D+KP NIL+ R I+D G A+L
Sbjct: 141 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 29/203 (14%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
+G+GSFG V+ ++ + A+K L + K E ++ + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 585 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLL 633
+ + + +L L+ +FL G L F L + F ++A L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL----F------TRLSKEVMFTEEDVKFYLAELALALD 140
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
+LH S II+ D+KP+NILLD+ + +++DFGL+K ++ KA + GT Y+AP
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAP 195
Query: 694 EWFRNSTITAKVDVYSFGVLLLE 716
E T D +SFGVL+ E
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFE 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-------------KE 565
++ E+G G++G V+K + VA+K++ RV E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRH 67
Query: 566 FKNEVVVIGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSW 618
+ H N+VRL + + +L LV+E ++ L ++L
Sbjct: 68 LE-------TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 619 NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678
++ FQ+ RGL +LH ++H D+KPQNIL+ +++DFGLA++ + +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA- 175
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS 719
T++ T Y APE S+ VD++S G + E+
Sbjct: 176 --LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFK-----NEVVVIGQT 576
++G G F V+ + T VA+K + E E K N+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 577 H--HKNLVRLLG-FCDEGQNRL---LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 628
++++LL F +G N + +V+E L L + + L I+ Q+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDD------YYNARISDFGLAKLLTLNQSKAIRT 682
GL Y+H C IIH DIKP+N+L++ +I+D G A + + +I+
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
T+ Y +PE + D++S L+ E+I+ F+
Sbjct: 198 ----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLV 582
+GRG+F V + T V A+K + + + GE F+ E V+ + +
Sbjct: 69 IGRGAFSEVA----VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 583 RLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
+L F + +N L LV E+ G L + L FG P+ R +A +I + +H
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVH--- 179
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
+H DIKP NILLD + R++DFG L + + A+ GT Y++PE +
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAV 238
Query: 700 TITAKVDVY-------SFGVLLLE 716
Y + GV E
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYE 262
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 25/163 (15%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN--------EV 570
++ + +G G F VYK T VA+KK+ ++ E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQ---IVAIKKI-KL--GHRSEAKDGINRTALREI 63
Query: 571 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQ 627
++ + H N++ LL N LV++F+ L + L PS +++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKA-YMLM 120
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
+GL YLH I+H D+KP N+LLD+ +++DFGLAK
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 20/162 (12%)
Query: 519 ATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVV 572
++ FK E++G G++ VYKG+ TT VA+K++ ++ D E+ + E+ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGV---YVALKEV-KL--DSEEGTPSTAIREISL 56
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPSWNLRT--NIAFQ 627
+ + H+N+VRL LV+EF++N + S GN L +Q
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669
+ +GL + H +I+H D+KPQN+L++ ++ DFGLA
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 28/205 (13%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLV 582
+GRG+FG V + + V A+K L + + E F+ E V+ K +
Sbjct: 82 IGRGAFGEVA----VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 583 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
L F D+ N L LV ++ G L + L K L +A F ++ + +H
Sbjct: 138 TLHYAFQDD--NNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
+H DIKP NIL+D + R++DFG L + + A+ GT Y++PE
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 248
Query: 697 RNSTITAK-----VDVYSFGVLLLE 716
+ D +S GV + E
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 56/228 (24%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 582
+G G++G+V + VA+KK+ F+ + E+ ++ + H+N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVR---VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENII 88
Query: 583 RLL-----GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTNI 624
+ ++ ++ +V + L+N + FL+
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------------- 135
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR-TA 683
QI RGL Y+H SA ++H D+KP N+LL+ + +I DFGLA++ + T
Sbjct: 136 --QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT- 189
Query: 684 IRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSF 724
YVA W+R + T +D++S G +L E++S R F
Sbjct: 190 -----EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 21/159 (13%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIG 574
+ + +++G G++ VYKG T VA+K++ ++G EV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDN---LVALKEIRLEHEEG---APCTAIREVSLLK 55
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARG 631
H N+V L ++ LV+E+L+ L +L + N++ FQ+ RG
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKL-FLFQLLRG 112
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670
L Y H +++H D+KPQN+L+++ +++DFGLA+
Sbjct: 113 LAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FKN----EVVVI 573
++ ++G+G+FG V+K T VA+KK+ + + EKE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQ---KVALKKV-LM--ENEKEGFPITALREIKIL 70
Query: 574 GQTHHKNLVRLLGFCDEGQNRL--------LVYEFLNN---GTLAS----FLFGNLKPSW 618
H+N+V L+ C + LV++F + G L++ F +K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--- 127
Query: 619 NLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678
+ + GL Y+H +I+H D+K N+L+ +++DFGLA+ +L ++
Sbjct: 128 ----RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 679 AIR--TAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIIS 719
T T Y PE +D++ G ++ E+ +
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLV 582
+GRG+FG V L ST V A+K L + + + F E ++ + +V
Sbjct: 77 IGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 583 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
+L F D+ L +V E++ G L + + P R A ++ L +H S
Sbjct: 133 QLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---S 186
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
IH D+KP N+LLD + +++DFG + TA+ GT Y++PE ++
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 701 ITAK----VDVYSFGVLLLE 716
D +S GV L E
Sbjct: 246 GDGYYGRECDWWSVGVFLYE 265
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 34/214 (15%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 582
+G+G+FG K VIL +T A+K L + + E E V+ + H L
Sbjct: 156 LGKGTFG---K-VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 583 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARG 631
L + + +RL V E+ N G L F ++L F +I
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGEL----F------FHLSRERVFSEDRARFYGAEIVSA 260
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
L YLH + + +++ D+K +N++LD + +I+DFGL K + + GT Y+
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYL 316
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
APE ++ VD + GV++ E++ R F
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 43/206 (20%), Positives = 76/206 (36%), Gaps = 53/206 (25%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 581
+ +G G G V + + + A+K L + + EV + + + ++
Sbjct: 22 TSQVLGLGINGKVLQI---FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 73
Query: 582 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIARG 631
VR++ + L+V E L+ G LF G+ + + I I
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 632 LLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
+ YLH S I H D+KP+N+L +++DFG AK T +
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------GE 173
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLL 714
Y D++S GV++
Sbjct: 174 KY-----------DKSCDMWSLGVIM 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLV 582
+G GSFG V L + A+K L +V + + E NE ++ + LV
Sbjct: 49 LGTGSFGRVM----LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHED 638
+L + N +V E++ G + F +L+ A F QI YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698
S +I+ D+KP+N+L+D +++DFG AK + K + GT +APE +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILS 212
Query: 699 STITAKVDVYSFGVLLLE 716
VD ++ GVL+ E
Sbjct: 213 KGYNKAVDWWALGVLIYE 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLV 582
+G+G+FG K VIL +T A+K L + + E E V+ T H L
Sbjct: 13 LGKGTFG---K-VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 583 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARG 631
L + + +RL V E+ N G L F ++L F +I
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGEL----F------FHLSRERVFTEERARFYGAEIVSA 117
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA-IRGTKGY 690
L YLH S +++ DIK +N++LD + +I+DFGL K S GT Y
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 171
Query: 691 VAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725
+APE ++ VD + GV++ E++ R F
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 30/201 (14%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLV 582
+G GSFG V+ L A+K L + V + + E +E +++ H ++
Sbjct: 14 LGTGSFGRVH----LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 583 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
R+ G F D ++ ++ +++ G L F L+ S +A F ++ L YLH
Sbjct: 70 RMWGTFQDA--QQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA-IRGTKGYVAPEW 695
S II+ D+KP+NILLD + +I+DFG AK + T + GT Y+APE
Sbjct: 124 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTYTLCGTPDYIAPEV 174
Query: 696 FRNSTITAKVDVYSFGVLLLE 716
+D +SFG+L+ E
Sbjct: 175 VSTKPYNKSIDWWSFGILIYE 195
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEF---KNEVVVIGQTHHKNL 581
+G+G +G V++ +T + A+K L + ++ K+ K E ++ + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFI 83
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
V L+ + + +L L+ E+L+ G L F L+ + A F +I+ L +LH
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
II+ D+KP+NI+L+ + +++DFGL K + + GT Y+APE
Sbjct: 139 ---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCGTIEYMAPEIL 193
Query: 697 RNSTITAKVDVYSFGVLLLE 716
S VD +S G L+ +
Sbjct: 194 MRSGHNRAVDWWSLGALMYD 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 581
+G+GSFG K V+L T + AVK L D + QD + E E ++ +H L
Sbjct: 31 LGKGSFG---K-VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
+L C + +RL V EF+N G L +++ S A F +I L++LH
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
II+ D+K N+LLD + +++DFG+ K N GT Y+APE
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEIL 196
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 737
+ VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 581
+G+GSFG K V+L + AVK L + + E++ +E V+ + H L
Sbjct: 46 IGKGSFG---K-VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
V L F + ++L V +++N G L F +L+ A F +IA L YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
S I++ D+KP+NILLD + ++DFGL K + S + GT Y+APE
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPEVL 211
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFD 725
VD + G +L E++ F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 581
+G+GSFG K V+L+ R T + AVK L D V QD + E E V+ L
Sbjct: 28 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
+L C + +RL V E++N G L +++ + A F +IA GL +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA-IRGTKGYVAPEW 695
II+ D+K N++LD + +I+DFG+ K N + T GT Y+APE
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIAPEI 192
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 737
VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 71/224 (31%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 581
+G+GSFG K V+L+ R T + AVK L D V QD + E E V+ L
Sbjct: 349 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
+L C + +RL V E++N G L +++ + A F +IA GL +L
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTA-IRGTKGYVAPEW 695
S II+ D+K N++LD + +I+DFG+ K N + T GT Y+APE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPDYIAPEI 513
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 737
VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 68/231 (29%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF----KNEVVVIGQTHHK 579
+G+GSFG K V L T A+K L D V D + E K V+ H
Sbjct: 25 LGKGSFG---K-VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR--VLSLAWEHP 78
Query: 580 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QI 628
L + + + L V E+LN G L +++++ F +I
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDL----M------YHIQSCHKFDLSRATFYAAEI 127
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
GL +LH I++ D+K NILLD + +I+DFG+ K L +K GT
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 182
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 737
Y+APE VD +SFGVLL E++ + F + EE ++I D
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEF--KNEVVVIGQT-HHKNL 581
+G G++G V+ ++ + A+K L + Q + + E V+ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
V L + + + +L L+ +++N G L F +L + +I L +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
II+ DIK +NILLD + ++DFGL+K ++++ GT Y+AP+
Sbjct: 177 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIV 232
Query: 697 RNSTI--TAKVDVYSFGVLLLEIISCRKSFDIE 727
R VD +S GVL+ E+++ F ++
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 581
+GRGS+ K V+L T + A+K + + V D + ++ + E V Q ++H L
Sbjct: 17 IGRGSYA---K-VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
V L C + ++RL V E++N G L +++ L A F +I+ L YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
II+ D+K N+LLD + +++D+G+ K + GT Y+APE
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEIL 182
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
R VD ++ GVL+ E+++ R FDI +
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 39/211 (18%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 579
+ +G+GSFG V K VA+K R + +E + + + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQH---VALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 580 NLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 628
N++ +L E N +YE + F S L A I
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGF-------SLPLVRKFAHSI 209
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLTLNQSKAIRTAIRG 686
+ L LH +IIHCD+KP+NILL + ++ DFG + I+
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ----- 261
Query: 687 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEI 717
++ Y APE + +D++S G +L E+
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAV-AVKKL--DRVFQDGEKEF-KNEVVVIGQ-THHKNL 581
+GRGS+ K V+L T + A++ + + V D + ++ + E V Q ++H L
Sbjct: 60 IGRGSYA---K-VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 582 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLH 636
V L C + ++RL V E++N G L +++ L A F +I+ L YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
E II+ D+K N+LLD + +++D+G+ K + GT Y+APE
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEIL 225
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731
R VD ++ GVL+ E+++ R FDI +
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 19/201 (9%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 579
+G+GSFG V K + VA+K + E + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEW---VAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 637
+V L + LV+E L+ L L +L A Q+ LL+L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 638 DCSAQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
IIHCD+KP+NILL + + +I DFG + L + I+ ++ Y +PE
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-----SRFYRSPEV 229
Query: 696 FRNSTITAKVDVYSFGVLLLE 716
+D++S G +L+E
Sbjct: 230 LLGMPYDLAIDMWSLGCILVE 250
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 35/240 (14%), Positives = 65/240 (27%), Gaps = 69/240 (28%)
Query: 519 ATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--------DRVFQDGEKEFKN 568
T+ + E++G G FG V++ T VA+K + + Q +E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT-----IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 569 EVVV---------IGQTHHKNLVRLLGFC------------------------------D 589
E+++ + + L
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 590 EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIK 649
+ +V EF G + L S +I Q+ L + H D+
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASL--RFEHRDLH 189
Query: 650 PQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGY-VAPEWFRNSTITAKVDVY 708
N+LL ++ K T+ + G V+ + S + V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVV 238
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.5 bits (153), Expect = 5e-11
Identities = 43/272 (15%), Positives = 73/272 (26%), Gaps = 40/272 (14%)
Query: 24 AQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTV 83
+P TL+AG LSP+ F + + N L I +
Sbjct: 11 GVGTSVLPAYQTLSAG---QYLLSPNQRFKLLLQ-----GDGN----LVIQDNGATVWVA 58
Query: 84 VWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGT------VAVGHMND 137
P + + + +G L+D ++VW ++ T + D
Sbjct: 59 NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQD 118
Query: 138 TGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGN 197
GN VL S + + + L G + DGN
Sbjct: 119 DGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGN 175
Query: 198 LVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESV 257
LV N A + +GT R +F G + + + +
Sbjct: 176 LVAYGPN------GAATWNAGT-----QGKGAVRAVFQGDGNLVVYGAGNAVL-WHSHT- 222
Query: 258 VPAADFYYRATLNFDGVFAQYFYPKNGNENWS 289
L +G A + W+
Sbjct: 223 --GGHASAVLRLQANGSIAIL----DEKPVWA 248
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.4 bits (106), Expect = 3e-05
Identities = 26/179 (14%), Positives = 44/179 (24%), Gaps = 10/179 (5%)
Query: 147 SSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLP 206
+ + L QT+ Q L S RF+ L DGNLV+
Sbjct: 2 AGRTRIPFNGVGTSVLPAYQTLSAGQYLLS-------PNQRFKLLLQGDGNLVIQDNGAT 54
Query: 207 TGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYR 266
A + + P + + ++ R +
Sbjct: 55 VWVA-NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTH 113
Query: 267 ATLNFDGVFAQYFYPK--NGNENWSVAWSEPENICVNIGGEMGSGACGFNSICSLDSDR 323
L DG NG + +++ + G E+ G L
Sbjct: 114 LVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQG 172
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.2 bits (95), Expect = 8e-04
Identities = 12/82 (14%), Positives = 21/82 (25%), Gaps = 7/82 (8%)
Query: 79 PAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDT 138
P W + + + D LV+ +W S AV +
Sbjct: 181 PNGAATWNAGTQGKG-----AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQAN 235
Query: 139 GNFVLASSSSSKLWDSFSNPSD 160
G+ + +W F
Sbjct: 236 GSIAILDEKP--VWARFGFQPT 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 48/211 (22%), Positives = 79/211 (37%), Gaps = 65/211 (30%)
Query: 578 HKNLVRLLG-FCDEGQN---RLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 630
+ +V+LL F G N +V+E L + L ++ P ++ I Q+ +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK-IIQQVLQ 157
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILL--DDYY----------------------------- 659
GL YLH C +IIH DIKP+NILL ++ Y
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 660 ------------------NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI 701
+I+D G A + + ++ I+ T+ Y + E S
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGY 270
Query: 702 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 732
D++S + E+ + F+ GEEY
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 20/155 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+++G G+FG + G L T VA+K + E++ + +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IP 68
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 640
++ F G+ +V E L G LF +++L+T IA Q+ + Y+H S
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---S 123
Query: 641 AQIIHCDIKPQNILLDDYYNAR-----ISDFGLAK 670
+I+ D+KP+N L+ N I DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 22/161 (13%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQT 576
++K +G GSFG++++G L VA+K E++ ++ G T
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQ---QVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLY 634
+ + F EG + +LV + L G L ++++T A Q+ +
Sbjct: 67 G---IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNAR-----ISDFGLAK 670
+H +++ DIKP N L+ + + DFG+ K
Sbjct: 122 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 47/237 (19%), Positives = 80/237 (33%), Gaps = 71/237 (29%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFK-----NEVVVIGQT 576
++G G+FG V + + AVK + + + + E
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKY---YAVKVVRNIKKYTRSAKIEADILKKIQN----DDI 93
Query: 577 HHKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 625
++ N+V+ G E G + +YE + F
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNGF-------HIEDIKLYC 143
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQSKAIRTA 683
+I + L YL + + H D+KP+NILLDD + + I+ + + + T
Sbjct: 144 IEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 684 IR----G--------------TKGYVAPE------WFRNSTITAKVDVYSFGVLLLE 716
I+ G T+ Y APE W D++SFG +L E
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 46/228 (20%), Positives = 82/228 (35%), Gaps = 57/228 (25%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 579
+G G+FG V + L + VA+K + + + E ++ + +
Sbjct: 25 GNLGEGTFGKVVE--CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 580 NLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 628
V + + + E G+N +EFL + ++A+Q+
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPY-------PLPHVRHMAYQL 132
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR------- 681
L +LHE Q+ H D+KP+NIL + + + + ++ +IR
Sbjct: 133 CHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 682 -------TAIRGTKGYVAPE------WFRNSTITAKVDVYSFGVLLLE 716
T I T+ Y PE W DV+S G +L E
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 32/165 (19%), Positives = 66/165 (40%), Gaps = 26/165 (15%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTA-----VAVK------KLDRVFQDGEKEFKNEVVVIGQ 575
R + GI+Y+ +T T + ++K +L ++ K V +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 576 THHKNLV----RLLGF-CDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRT--NIAFQ 627
+ + +GF + + R LV L G L S L + K + R+ +A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAK 670
+ L +LH + +H ++ +NI +D +++ + +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 32/173 (18%), Positives = 64/173 (36%), Gaps = 31/173 (17%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHK 579
+ +G G+FG V + + + VAVK +DR + E + +
Sbjct: 20 DTLGEGAFGKVVECIDH--KAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 580 NLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 628
V++L + + E G + Y+F+ F + +A+QI
Sbjct: 78 RCVQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLPF-------RLDHIRKMAYQI 127
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681
+ + +LH ++ H D+KP+NIL + + + + I+
Sbjct: 128 CKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 16/152 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 583
++G GSFG +Y G + VA+K + + E + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGE---EVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSA 641
+ EG ++V E L G LF ++L+T +A Q+ + Y+H S
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124
Query: 642 QIIHCDIKPQNILLDDYYNA---RISDFGLAK 670
IH D+KP N L+ I DFGLAK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 5e-09
Identities = 78/594 (13%), Positives = 171/594 (28%), Gaps = 183/594 (30%)
Query: 341 RYGSCKPDFELSCWGGGQGYKKELFDFHELQ-LTNWHLSDSERFRPYNEVQCKNSC--LS 397
+Y FE + FD ++Q + LS E + L
Sbjct: 17 QYKDILSVFE-------DAFVDN-FDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 398 DCFC-----AAVIF-----QDDCCWFKKLPLSNGMTDGRLTSKAFMKYKNK--GDDPP-- 443
F + + + P+ + ++ +++ +++ D+
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMS-PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 444 --SVPRPPDPEDKKKRKM-------------MNATG-SVLLGSSVFVNFALVCAFGLSFF 487
+V R P K ++ + + +G + + V +++ + C F
Sbjct: 128 KYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA-LDVCLSYKVQCKMD---F 182
Query: 488 FIYKKKWI----RNSPGD---------GTIETNL--PCFSYKELEEATDNFKEEVGR--- 529
I+ W+ NSP I+ N ++ + + E+ R
Sbjct: 183 KIF---WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 530 --------------------GSFGIVYKGVILTTR----------TSTTAVAVKKLDRVF 559
+F + K ++LTTR +TT +++
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCK-ILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 560 QDGE-------------KEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGT 605
E ++ EV+ T + + ++ +G ++ +N
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVL----TTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 606 LASFL---FGNLKPSWNLRTN-----IAFQ----IARGLL--------------YLHEDC 639
L + + L+P+ R + F I LL +++
Sbjct: 355 LTTIIESSLNVLEPA-EYRKMFDRLSV-FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
++ K I + Y L + L A+ +I Y P+ F +
Sbjct: 413 KYSLVEKQPKESTISIPSIY--------LELKVKLENEYALHRSIVDH--YNIPKTFDSD 462
Query: 700 TITA-KVDVYSFGVL---LLEIISCRKSFDIEMGEEYAILTDWAFDCYR--NEKL----- 748
+ +D Y + + L +IE E + D +R +K+
Sbjct: 463 DLIPPYLDQYFYSHIGHHL---------KNIEHPERMTLFRMVFLD-FRFLEQKIRHDST 512
Query: 749 -DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSL 801
+ + L +K + + DP + +L L + E +
Sbjct: 513 AWNASGSILNTLQQLKFYKPYI------CDNDPKYERLVNAILDFLPKIEENLI 560
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 5e-05
Identities = 49/320 (15%), Positives = 96/320 (30%), Gaps = 88/320 (27%)
Query: 552 VKKLD-RVFQDGEKE-FKNEVV--VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA 607
V D + QD K E + +I + L + + +V +F+
Sbjct: 30 VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI 89
Query: 608 SFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667
++ F L + R + + ++ D + Y +R+ +
Sbjct: 90 NYKF--LMSPIKTEQRQPSMMTRMYIEQRDR-----LYNDNQV----FAKYNVSRLQPYL 138
Query: 668 LAK--LLTLNQSKAIRTAIRGTKGY----VAPEWFRNSTITAKVDVYSFGVLLLEIISCR 721
+ LL L +K + I G G VA + + + K+D F + L + +C
Sbjct: 139 KLRQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMD---FKIFWLNLKNCN 193
Query: 722 KSFDI-EM------------------GEEYAILTDWAFDCYRN---EK--------LDDL 751
+ EM + R K L +
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN- 252
Query: 752 VEGDMEALN--DIKCVEKLVMVS----------------IWCIQEDPSLRPTMKKVLQML 793
V+ + +A N ++ C K+++ + I +L T +V +L
Sbjct: 253 VQ-NAKAWNAFNLSC--KILLTTRFKQVTDFLSAATTTHISLDHHSMTL--TPDEVKSLL 307
Query: 794 EGVVEVS---LPP-----NP 805
++ LP NP
Sbjct: 308 LKYLDCRPQDLPREVLTTNP 327
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 578
+ F+ ++G GSFG +Y G + T VA+K + + + E +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENV--KTKHPQLLYESKIYRILQG 61
Query: 579 KNLV-RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYL 635
+ + F EG +LV + L G LF +L+T +A Q+ + ++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNAR---ISDFGLAK 670
H S +H DIKP N L+ A I DFGLAK
Sbjct: 120 H---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 33/164 (20%), Positives = 54/164 (32%), Gaps = 27/164 (16%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFK-----NEVVVIGQTHHKNL 581
+G G FG++Y VK + E K + I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 582 VRLLGF----------CDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRT--NIAFQI 628
+ LG R +V E L G L N T + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFK--KSTVLQLGIRM 160
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAK 670
L Y+H + +H DIK N+LL ++ +D+GL+
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 29/165 (17%), Positives = 67/165 (40%), Gaps = 26/165 (15%)
Query: 527 VGRGSFGIVYKGVILTTRTSTTA--VAVKKL----------DRVFQD-GEKEFKNEVVVI 573
+G+G FG +Y + ++ + + VK + +Q + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 574 GQTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQ 627
+ + + + G +N R ++ + G+ ++ ++ +T ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAK 670
I L Y+H + +H DIK N+LL+ ++ D+GLA
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-05
Identities = 28/135 (20%), Positives = 42/135 (31%), Gaps = 30/135 (22%)
Query: 159 SDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISG 218
SD L G ++T L G + F + D NLVL N A + SG
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN-------RAVWASG 44
Query: 219 TYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQY 278
T SG + G + I + + T + Y L D Y
Sbjct: 45 TN----GKASGCVLKMQNDGNLVIYSGSRAIWASNT----NRQNGNYYLILQRDRNVVIY 96
Query: 279 FYPKNGNENWSVAWS 293
+ + + W+
Sbjct: 97 ------DNSNNAIWA 105
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-05
Identities = 18/128 (14%), Positives = 38/128 (29%), Gaps = 25/128 (19%)
Query: 33 GATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQ 92
+L G L + D + Y + VW ++
Sbjct: 7 PNSLFTGH----SLEVGPSYRLIM--------QGDCNF--VLYDS---GKPVWASNTGGL 49
Query: 93 NPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVG-HMNDTGNFVLASSSSSKL 151
G ++ L + LV+ D + +W ++ + + N V+ +
Sbjct: 50 GS----GCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI---YGPVV 102
Query: 152 WDSFSNPS 159
W + S P+
Sbjct: 103 WATGSGPA 110
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 21/98 (21%), Positives = 38/98 (38%), Gaps = 27/98 (27%)
Query: 104 LTADHGLVLNDPQGKQVWSSEID-IGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTL 162
+ D VL D GK VW+S +G+ +++ GN V+ S+ +W
Sbjct: 26 MQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIW---------- 74
Query: 163 LPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVL 200
+++TN + L +D N+V+
Sbjct: 75 ---------------QTKTNGKEDHYVLVLQQDRNVVI 97
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 31/146 (21%), Positives = 42/146 (28%), Gaps = 32/146 (21%)
Query: 159 SDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISG 218
+ LL GQT+ L + G + + NLV + S
Sbjct: 2 DNVLLSGQTLHADHSLQA---------GAYTLTIQNKCNLVKY-------QNGRQIWASN 45
Query: 219 TYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQY 278
T SG R+ G + I N + S + Y L DG F Y
Sbjct: 46 TD----RRGSGCRLTLLSDGNLVIYDHNN---NDVWGSACWGDNGKYALVLQKDGRFVIY 98
Query: 279 FYPKNGNENWSVAWSEPENICVNIGG 304
V WS N C + G
Sbjct: 99 ---------GPVLWSLGPNGCRRVNG 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 25/126 (19%), Positives = 39/126 (30%), Gaps = 22/126 (17%)
Query: 33 GATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQ 92
L A S L + + F Q D +L L Y N +W T+
Sbjct: 14 PQILHAT-ESLEILFGTHVYRFIM-QTD-----CNLVL----YDN---NNPIWATNTGGL 59
Query: 93 NPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVG-HMNDTGNFVLASSSSSKL 151
G + L D LV+ + VW S + + N V+ + L
Sbjct: 60 GN----GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA---L 112
Query: 152 WDSFSN 157
W + +
Sbjct: 113 WATQTV 118
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-05
Identities = 17/135 (12%), Positives = 40/135 (29%), Gaps = 29/135 (21%)
Query: 67 DLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEID 126
+ + S + + + + + + + D LVL D +W++
Sbjct: 1 NNIIFSKQPDDNHPQIL--HATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTG 57
Query: 127 -IGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSR 185
+G + G V+ ++ + +W +S
Sbjct: 58 GLGNGCRAVLQPDGVLVVITNENVTVW-------------------------QSPVAGKA 92
Query: 186 GRFQFRLLKDGNLVL 200
G + L D N+V+
Sbjct: 93 GHYVLVLQPDRNVVI 107
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-05
Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 7/79 (8%)
Query: 80 AKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDT 138
T VW ++ +G + L +D V+ D +G+ +W+S G V + +
Sbjct: 36 HSTSVWASN---TGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQED 92
Query: 139 GNFVLASSSSSKLWDSFSN 157
GN V+ S +W + +
Sbjct: 93 GNVVI---YGSDIWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 24/130 (18%), Positives = 37/130 (28%), Gaps = 27/130 (20%)
Query: 160 DTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT 219
+ L G+ + Q L + F + +D NLVL YD
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVL----------YDHSTSVWA 42
Query: 220 YDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYF 279
+ G + + G + G S + Y L DG Y
Sbjct: 43 SNTGILGKKGCKAVLQSDGNFVVYDAEGRSL---WASHSVRGNGNYVLVLQEDGNVVIY- 98
Query: 280 YPKNGNENWS 289
G++ WS
Sbjct: 99 ----GSDIWS 104
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 22/100 (22%), Positives = 32/100 (32%), Gaps = 28/100 (28%)
Query: 103 KLTADHGLVLNDPQGKQVWSSEIDIGTVAVGH--MNDTGNFVLASSSSSKLWDSFSNPSD 160
+ D LVL D VW+S I + GNFV+ + LW S
Sbjct: 24 IMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS------ 76
Query: 161 TLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVL 200
+ G + L +DGN+V+
Sbjct: 77 -------------------HSVRGNGNYVLVLQEDGNVVI 97
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 31/131 (23%)
Query: 159 SDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISG 218
++ LL GQT++T+ L + G F + D NLVL Y+ + S
Sbjct: 3 TNYLLSGQTLDTEGHLKN---------GDFDLVMQDDCNLVL----------YNGNWQSN 43
Query: 219 TYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQY 278
T + + ++ + G + I +G +S + Y A ++ DG +
Sbjct: 44 TAN----NGRDCKLTLTDYGELVIKNGDGSTV---WKSGAQSVKGNYAAVVHPDGRLVVF 96
Query: 279 FYPKNGNENWS 289
G +
Sbjct: 97 -----GPSVFK 102
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 18/97 (18%), Positives = 32/97 (32%), Gaps = 25/97 (25%)
Query: 104 LTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLL 163
+ D LVL D + ++ GT + G + ++ + +W S ++ S
Sbjct: 156 METDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA--- 212
Query: 164 PGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVL 200
GR+ F L D NL +
Sbjct: 213 ----------------------GRYVFVLQPDRNLAI 227
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 813 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.82 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.81 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.79 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.77 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.67 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.66 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.62 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.61 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.6 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.57 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.55 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.47 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.45 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.31 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.29 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.26 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.25 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.2 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.1 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.08 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.05 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.8 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.75 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.86 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.82 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.79 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.25 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.94 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.76 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.88 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.92 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 87.09 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 85.67 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 83.99 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.21 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=442.39 Aligned_cols=269 Identities=26% Similarity=0.388 Sum_probs=217.9
Q ss_pred CHHHHHHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEe
Q 045343 512 SYKELEEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFC 588 (813)
Q Consensus 512 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~ 588 (813)
+++|+..++.+|.++||+|+||+||+|.+.. ...+++.||||+++.... ...++|.+|+.++++++|||||+++|+|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3445556677899999999999999998743 223568899999975433 2346799999999999999999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
.+++..+||||||++|+|.++|... ..++|..+++|+.|||+||+|||+. +|+||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence 9999999999999999999999642 3578999999999999999999954 99999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
|||++++.+||+|||+|+...............||++|||||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999998765444333455679999999999999999999999999999999999 899997554322
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+.. .+..+... +.+..++..+.+|+.+||+.||.+||||.||+++|+....+
T Consensus 256 ---~~~----~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 256 ---VVE----MIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp ---HHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred ---HHH----HHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 111 11111111 11224567899999999999999999999999999986543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=441.65 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=207.2
Q ss_pred HhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+.++||+|+||+||+|.+.. ...++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34567899999999999998753 2346789999999876666667899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEE
Q 045343 598 YEFLNNGTLASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 662 (813)
||||++|+|.++|+.. ..++|..+++|+.|||+||+|||+ .+|+||||||+||||++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEE
Confidence 9999999999999653 358999999999999999999995 4999999999999999999999
Q ss_pred EeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHH
Q 045343 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 663 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......+. ...+.
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i~- 274 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDCIT- 274 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHHHH-
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHHHH-
Confidence 999999998765444333455679999999999999999999999999999999999 8999975443221 11111
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.+. +...+..+++.+.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 275 ---~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 ---QGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---cCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111 0011223467889999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=439.89 Aligned_cols=262 Identities=24% Similarity=0.438 Sum_probs=214.1
Q ss_pred HHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+.+.++||+|+||+||+|.+.. .+.++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 345678999999999999998753 224578899999987666667789999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 597 VYEFLNNGTLASFLFGN-------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
|||||++|+|.++|... ..++|..+++|+.|||+||+|||+. +|+||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 99999999999999653 3689999999999999999999964 9999999999999999999999
Q ss_pred eeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHh
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+. ...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~---- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC---- 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----
Confidence 99999987665443332334568999999999999999999999999999999999 8999976543221 111
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+..+... ..+..+++.+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 243 i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111 11223467899999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=424.15 Aligned_cols=263 Identities=28% Similarity=0.405 Sum_probs=202.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+.++||+|+||+||+|.+. ..||||+++... ....++|.+|+.+|++++|||||+++|+|.+ +..+||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESS------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 3467899999999999999763 248999986432 2334679999999999999999999999865 568999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||++|+|.++|... ..++|..+++|+.|||+||+|||+. +|+||||||+||||++++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999999764 5799999999999999999999964 99999999999999999999999999998765443
Q ss_pred ccceeecccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.........||+.|||||++.+ .+++.++|||||||+||||+||+.||.......... .....+ ...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~----~~~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRG----YAS 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTT----CCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcC----CCC
Confidence 3332455689999999999964 358999999999999999999999997544322111 111111 111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPN 804 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 804 (813)
+.+. .....+++.+.+|+.+||+.||++||||.||+++|+.+. -+.|+.
T Consensus 257 p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~-~~lpk~ 305 (307)
T 3omv_A 257 PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ-HSLPKI 305 (307)
T ss_dssp CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH-TTCCC-
T ss_pred CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh-ccCCCC
Confidence 1111 112245678899999999999999999999999998664 334544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=416.25 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=209.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
|++.++||+|+||+||+|... .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVR---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEeecCcCeEEEEEEEC---CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 667789999999999999874 46789999999876666667799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.+......
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 226 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 226 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence 999999999865 4689999999999999999999964 9999999999999999999999999999987644322
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
....+||+.|||||++.+..++.++|||||||++|||++|+.||......+.. ..+.. .. .+.+. .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~~----~~-----~~~~~--~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD----NL-----PPRLK--N 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----SS-----CCCCS--C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHc----CC-----CCCCC--c
Confidence 34578999999999999999999999999999999999999999765432211 11111 10 01111 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....++.+.+|+.+||+.||++|||+.|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12345788999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=425.04 Aligned_cols=266 Identities=25% Similarity=0.368 Sum_probs=214.6
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeecccc-ccchhhhheeeeeecccc-CCcceEEeEeecC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEG 591 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~ 591 (813)
+....+++.++||+|+||+||+|...... ...+.||||+++.... ...++|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 44456778899999999999999886432 2457899999975433 234579999999999965 8999999999764
Q ss_pred -CceEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEE
Q 045343 592 -QNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 654 (813)
Q Consensus 592 -~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIl 654 (813)
+..+||||||++|+|.++|+.. ..++|..++.++.|||+||+|||+ .+||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence 5689999999999999999642 347899999999999999999995 49999999999999
Q ss_pred EcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhh
Q 045343 655 LDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 733 (813)
Q Consensus 655 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 733 (813)
|++++.+||+|||+|+.+..+..........||+.|||||++.+..++.++|||||||+||||+| |+.||......+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999998765544433455679999999999999999999999999999999998 9999975433221
Q ss_pred hhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 734 ILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 734 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+ ...+..+.. ...+..+++++.+++.+||+.||.+|||+.||+++|+.+++.
T Consensus 297 -~----~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 -F----CRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -H----HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -H----HHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1 111111111 111123457889999999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=412.30 Aligned_cols=251 Identities=23% Similarity=0.231 Sum_probs=203.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+.+.++||+|+||+||+|... ..++.||||+++.. ....+|+.++++++|||||++++++.+++..+|||||
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~---~~g~~vAiK~i~~~-----~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDK---QTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETT-----TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEeCcEeccCCCeEEEEEEEC---CCCCEEEEEEECHH-----HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456678999999999999874 46789999999742 2335799999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~ 679 (813)
+++|+|.++|.....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++ ++||+|||+|+.+..+....
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999999999988899999999999999999999994 5999999999999999887 69999999999876543211
Q ss_pred ---eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 680 ---IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 680 ---~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....+||+.|||||++.+..++.++|||||||+||||++|+.||......+... .+. .. .. ..
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~---~~-~~------~~ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIA---SE-PP------PI 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHH---HS-CC------GG
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHH---cC-CC------Cc
Confidence 1233579999999999999999999999999999999999999997544322111 010 00 00 00
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
.......+..+.+++.+||+.||.+|||+.|++++|...
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011223467889999999999999999999999888653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=405.52 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=198.7
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeec----CCceE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRL 595 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 595 (813)
.|.++||+|+||+||+|... ..+..||||++.... ....+.|.+|+++|++++|||||++++++.+ +...+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC---CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 56678999999999999874 467899999996532 2234568999999999999999999999864 34579
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~~~~ 674 (813)
||||||++|+|.+++.....+++..+..++.||+.||+|||+. ..+|+||||||+||||+ .++.+||+|||+|+....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999999888999999999999999999999965 23499999999999998 478999999999986543
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.. ....+||+.|||||++.+ +++.++|||||||+||||+||+.||........ + ......+.....
T Consensus 185 ~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~----~~~i~~~~~~~~--- 250 (290)
T 3fpq_A 185 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVKPAS--- 250 (290)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCCCGG---
T ss_pred Cc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--H----HHHHHcCCCCCC---
Confidence 22 345689999999999875 699999999999999999999999975432211 1 111111111000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....++.+.+|+.+||+.||++|||++|++++
T Consensus 251 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111224568899999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=410.58 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=201.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCC----ceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 596 (813)
+.+.++||+|+||+||+|.+ .++.||||+++... .....+..|+..+.+++|||||+++++|.+++ ..+|
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 45678999999999999987 56789999997532 22223456777888999999999999997654 5799
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
|||||++|+|.++|+.. .++|..+.+++.|+++||+|||+++ .++|+||||||+||||+.++++||+|||+|+.
T Consensus 79 V~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999999754 5899999999999999999999642 45899999999999999999999999999987
Q ss_pred cccCccc--ceeecccccccccCcccccCC------CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh--------h
Q 045343 672 LTLNQSK--AIRTAIRGTKGYVAPEWFRNS------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--------L 735 (813)
Q Consensus 672 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~--------l 735 (813)
....... .......||+.|||||++.+. .++.++|||||||+||||+||+.|+.......... .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 7544321 112345799999999999764 36779999999999999999988875432211000 0
Q ss_pred HHHHHHhhccCcccccccccccc-cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEA-LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
........... ..++.+.. ....+..+.+.+|+.+||+.||++||||.||+++|+++.+
T Consensus 238 ~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00111111111 11122211 1233567889999999999999999999999999988754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=409.36 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=209.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|++.++||+|+||+||+|... .+++.||||++++. .....+.+.+|+++|++++|||||++++++.+++..+|
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~---~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccEEEEEEecccCeEEEEEEEC---CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3788899999999999999874 46789999999753 22344678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999999888999999999999999999999964 99999999999999999999999999999876554
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
........+||+.|||||++.+..++.++||||+||+||||++|+.||......+. ...+. ....
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~----~~~~-------- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---FAKII----KLEY-------- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HTCC--------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cCCC--------
Confidence 44334567899999999999999999999999999999999999999976543221 11111 1111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 790 (813)
.. +...++.+.+|+.+||+.||.+|||++|++
T Consensus 252 ~~--p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DF--PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC--CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC--CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 00 112346788999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=413.83 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=200.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|++.++||+|+||+||+|... .+++.||||+++... ....+++.+|+++|++++|||||++++++.+++..+||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKST---EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CEEEEEEC------CEEEEEET---TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4778899999999999999874 467899999997532 22345789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++|+|.++|... ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999999654 4568899999999999999999964 9999999999999999999999999999977543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... ....+||+.|||||++.+..++.++|||||||+||||++|+.||......+.. ..... +....
T Consensus 179 ~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i~~-~~~~~----- 244 (350)
T 4b9d_A 179 VEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV------LKIIS-GSFPP----- 244 (350)
T ss_dssp HHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH-TCCCC-----
T ss_pred ccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHHHc-CCCCC-----
Confidence 221 23467999999999999999999999999999999999999999765432211 11111 11110
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....+..+.+|+.+||+.||++|||++|++++
T Consensus 245 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 ----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112345778999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=402.68 Aligned_cols=251 Identities=24% Similarity=0.273 Sum_probs=201.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|++.++||+|+||+||+|....++..++.||||+++... .....++.+|+++|++++|||||++++++.+++..+||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4788899999999999999876655678899999997532 22344688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999999999999888999999999999999999999964 999999999999999999999999999987544322
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. ....+||+.|||||++.+..++.++|||||||+||||++|+.||......+.. ..+. ... ..
T Consensus 182 ~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~i~----~~~--------~~ 244 (304)
T 3ubd_A 182 K--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMIL----KAK--------LG 244 (304)
T ss_dssp C--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCC--------CC
T ss_pred c--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---HHHH----cCC--------CC
Confidence 2 34567999999999999999999999999999999999999999865432211 1111 111 11
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
. +...++.+.+|+.+||+.||++||| ++|++++
T Consensus 245 ~--p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 245 M--PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp C--CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred C--CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0 1123567889999999999999998 5777753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=417.05 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=209.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
|++.++||+|+||.||+|... .+++.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVR---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeeEeccCcCcEEEEEEEC---CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 667789999999999999874 46789999999876556667799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccce
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
|++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.+......
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 303 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 303 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence 999999999864 4689999999999999999999964 9999999999999999999999999999987654322
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
....+||+.|||||++.+..++.++|||||||++|||++|+.||......+.. ..+.. .. .+.+. .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~~----~~-----~~~~~--~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD----NL-----PPRLK--N 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----SC-----CCCCS--C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHc----CC-----CCCCc--c
Confidence 34578999999999999999999999999999999999999999754432211 11111 10 01111 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....+..+.+|+.+||+.||++|||+.|++++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11235778999999999999999999999885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=391.73 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=191.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..|++.++||+|+||+||+|... .+++.||||+++... ....+.+.+|++++++++|||||++++++.+++..+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT---TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT---TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 35788899999999999999864 467899999996532 223456899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+ +|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+.....
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999999 689999999888999999999999999999999964 9999999999999999999999999999876543
Q ss_pred cccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.. ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... +...+ .....
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i----~~~~~------ 229 (275)
T 3hyh_A 166 NF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNI----SNGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTCC------
T ss_pred Cc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCC------
Confidence 22 345679999999999998876 579999999999999999999997543221 11111 11110
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. +...++.+.+|+.+||+.||++|||++|++++
T Consensus 230 --~~--p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 --TL--PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 11234678899999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=383.04 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=187.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCc-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----- 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 593 (813)
.|++.+.||+|+||+||+|... .+++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEET---TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hCEEeeEEecCCCeEEEEEEEC---CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 4677899999999999999874 4678999999975432 234568999999999999999999999865442
Q ss_pred -------eEEEEeecCCCchhhhhhccCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 594 -------RLLVYEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 594 -------~~lV~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
.++||||+++|+|.+++..... .++..++.++.||++||+|||+. +|+||||||+||||+.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 6899999999999999987643 35667889999999999999964 9999999999999999999999
Q ss_pred eeccCccccccCcccc----------eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh
Q 045343 664 SDFGLAKLLTLNQSKA----------IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 733 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 733 (813)
+|||+|+.+....... .....+||+.|||||++.+..++.++|||||||++|||++ ||...... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-~~ 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-VR 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-HH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-HH
Confidence 9999999876443211 1234579999999999999999999999999999999996 67532111 00
Q ss_pred hhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 045343 734 ILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPN 804 (813)
Q Consensus 734 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 804 (813)
.+ .......... ........+.+|+.+||+.||.+|||+.|++++= =+.+++.|..
T Consensus 236 ~~-----~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~-~~~~~~~p~~ 291 (299)
T 4g31_A 236 TL-----TDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA-VFEDLDFPGK 291 (299)
T ss_dssp HH-----HHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG-GGCCC-----
T ss_pred HH-----HHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH-hhCCCCCCCc
Confidence 00 0111111110 0112345567899999999999999999998741 1234455543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=385.67 Aligned_cols=266 Identities=21% Similarity=0.317 Sum_probs=201.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeec------C
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------G 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~ 591 (813)
.|++.++||+|+||+||+|... .+++.||||+++.... ...+.+.+|+++|++++|||||++++++.. .
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~---~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRR---LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CeEEEEEEecccCeEEEEEEEC---CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3678899999999999999874 4678999999965322 223568899999999999999999998753 3
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+..+|||||++ |+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 57899999995 7899999988899999999999999999999995 4999999999999999999999999999987
Q ss_pred cccCcc--cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 672 LTLNQS--KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 672 ~~~~~~--~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
+..... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.................
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 653321 1223457899999999998875 5689999999999999999999999865443322111100000000000
Q ss_pred ccc--------cc---ccccc---cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 DDL--------VE---GDMEA---LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 ~~~--------~~---~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... +. +.... .........+.+|+.+||+.||.+|||+.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00 00000 0001224678899999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=370.25 Aligned_cols=273 Identities=35% Similarity=0.624 Sum_probs=232.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+++.+.||+|+||.||+|... ++..||||++........+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred cCccceeecCCCeeEEEEEEC----CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 445678999999999999853 5778999998766555567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 601 LNNGTLASFLFGNL----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 601 ~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999997543 588999999999999999999964 99999999999999999999999999998755433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.........+..++++..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 22223445689999999999988999999999999999999999999986655444444455555555566667777766
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
......+....+.+++.+||+.||++|||+.||+++|+.++++.
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 66666788899999999999999999999999999999887654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=376.10 Aligned_cols=202 Identities=21% Similarity=0.324 Sum_probs=170.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|++.++||+|+||+||+|........++.||||++... ....++.+|+++|.++ +|||||++++++.+.++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 367788999999999999987644456789999998653 3345688999999988 6999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-CCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGla~~~~~~~~ 677 (813)
||+++|+|.+++. .+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999984 588999999999999999999954 99999999999999876 7999999999986543211
Q ss_pred c--------------------------ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccc
Q 045343 678 K--------------------------AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMG 729 (813)
Q Consensus 678 ~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~ 729 (813)
. ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1 012345799999999999775 589999999999999999999999965443
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.79 Aligned_cols=235 Identities=20% Similarity=0.270 Sum_probs=186.7
Q ss_pred hccCCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCC----c
Q 045343 24 AQNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPR----G 99 (813)
Q Consensus 24 ~~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~----~ 99 (813)
+++.|+|++|++|++++ +|||++|+|+||||+++ ++|| |+ |.+ |||||||+. |...+ +
T Consensus 11 ~~~~~~l~~g~~l~~~~---~l~S~~g~F~lgf~~~~-------~~~l---y~--~~~-vvW~Anr~~--p~~~~~~~~~ 72 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQGDG-------NLVI---QD--NGA-TVWVANEQQ--PFSSTIPLRN 72 (276)
T ss_dssp CTTSSEECTTEEBCTTC---EEECTTSSEEEEECTTS-------CEEE---EE--TTE-EEEECSTTS--TTEEEEECCC
T ss_pred cccCCEecCCCEecCCC---EEEcCCCcEEEEEECCC-------CeEE---EC--CCC-eEEECCCCC--CcCCcccccc
Confidence 35679999999999988 99999999999999432 3677 77 777 999999993 33232 6
Q ss_pred eEEEEeeCccEEE--eCCCCCEEeeeccCC------CceeEEEEecCcCEEEEecCCcccccccccCcCcccCCCc----
Q 045343 100 SQVKLTADHGLVL--NDPQGKQVWSSEIDI------GTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQT---- 167 (813)
Q Consensus 100 ~~l~~~~~g~l~l--~~~~~~~~wst~~~~------~~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~---- 167 (813)
++|+|+.||+||| .|++|++||||+++. .++++|+|+|+|||||++ +.+|||| |||||||||||
T Consensus 73 ~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~ 148 (276)
T 3m7h_A 73 KKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLL 148 (276)
T ss_dssp TTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEE
T ss_pred eEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccc
Confidence 7899999999999 788899999999875 345789999999999998 7899999 99999999999
Q ss_pred cccccceeecCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccccCCCCCCCCceEEEeccCccEEEEecCC
Q 045343 168 METKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNG 247 (813)
Q Consensus 168 l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (813)
|..+++| ++.+||++|.|++.++++|+++++. .. ...||+++++... . ..+.++.++.+.+++.++
T Consensus 149 l~~g~~L---~S~~dps~G~fsl~l~~dGnlvLy~-~~-----~~~yW~Sgt~~~~----~-~~l~l~~dGnLvl~d~~~ 214 (276)
T 3m7h_A 149 LAPGSEL---VQGVVYGAGASKLVFQGDGNLVAYG-PN-----GAATWNAGTQGKG----A-VRAVFQGDGNLVVYGAGN 214 (276)
T ss_dssp ECSSEEE---CTTCEEEETTEEEEECTTSCEEEEC-TT-----SSEEEECCCTTTT----C-CEEEECTTSCEEEECTTS
T ss_pred cccCccc---ccCCCCCCceEEEeecCCceEEEEe-CC-----CeEEEECCCCCCc----c-EEEEEcCCCeEEEEeCCC
Confidence 6667778 5689999999999999999876642 11 2689999998641 2 567788888888887666
Q ss_pred ceeEeecccccCCcceEEEEEEeeCceeEEEeecCCCCCCeEEEEccccc-ccccc
Q 045343 248 GRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPEN-ICVNI 302 (813)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~W~~~~~~p~d-~Cd~y 302 (813)
..+..+.... ...+|++|+.||+|++|.| ...|..+|.+|+. .+.++
T Consensus 215 ~~vWsS~t~~----~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~~P~~~~~~~~ 262 (276)
T 3m7h_A 215 AVLWHSHTGG----HASAVLRLQANGSIAILDE----KPVWARFGFQPTYRHIRKI 262 (276)
T ss_dssp CEEEECSCTT----CTTCEEEECTTSCEEEEEE----EEEEESSSCCTTSCEEEEE
T ss_pred cEEEEecCCC----CCCEEEEEcCCccEEEEcC----CCeEEccCccCCcccccee
Confidence 5555444321 1247999999999999988 2458888877764 44443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.04 Aligned_cols=285 Identities=43% Similarity=0.741 Sum_probs=237.8
Q ss_pred CCCCCCHHHHHHHHhhc--ccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcce
Q 045343 507 NLPCFSYKELEEATDNF--KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVR 583 (813)
Q Consensus 507 ~~~~~~~~el~~~~~~~--~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 583 (813)
....+++.++.....+| .+.||+|+||.||+|... ++..||||++..... .....+.+|+.++++++|+||++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 35668888888877665 578999999999999743 577899999875432 23447899999999999999999
Q ss_pred EEeEeecCCceEEEEeecCCCchhhhhhccC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC
Q 045343 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNL----KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY 659 (813)
Q Consensus 584 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~ 659 (813)
+++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 9999999999999999999999999997643 489999999999999999999976555999999999999999999
Q ss_pred CEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCccc--chhhhhhHH
Q 045343 660 NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM--GEEYAILTD 737 (813)
Q Consensus 660 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~--~~~~~~l~~ 737 (813)
.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ......+..
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999998775443322 344569999999999988889999999999999999999999996322 122233445
Q ss_pred HHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
+.........+..+.+.........+..+.+.+++.+||+.||.+|||+.||+++|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 55566666677777777776667778899999999999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=393.31 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=208.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|++.++||+|+||+||+|... .+++.||||++........+.+.+|+.+|++++|||||++++++.+....+||||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~---~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTER---ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4778899999999999999874 4678999999976555556678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC--CCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY--YNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~--~~~kl~DfGla~~~~~~~ 676 (813)
||++|+|.++|.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999865 46789999999999999999999964 99999999999999854 899999999999876543
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. ....+||+.|+|||++.+..++.++|||||||+||||++|+.||......+... .+ ..... ..
T Consensus 312 ~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~---~i----~~~~~------~~ 375 (573)
T 3uto_A 312 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NV----KSCDW------NM 375 (573)
T ss_dssp E---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HH----HTTCC------CC
T ss_pred c---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HH----HhCCC------CC
Confidence 2 345679999999999999999999999999999999999999998654332111 11 00000 00
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........++.+.+|+.+||+.||.+|||+.|++++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111235678899999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=388.12 Aligned_cols=248 Identities=24% Similarity=0.272 Sum_probs=200.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhh---eeeeeeccccCCcceEEeEeecCCce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKN---EVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
+++.+.||+|+||+||+|... .+++.||||++++.. ......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 191 f~i~k~LG~G~fG~V~la~~~---~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred eEEEEEEecccCeEEEEEEEC---CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 677899999999999999874 467899999996532 122222333 46677788999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|||||++||+|.++|.....+++..+..++.||+.||.|||+ .+|+||||||+||||+.++++||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999999999988899999999999999999999994 5999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.. ....+||+.|||||++.. ..++.++|+|||||+||||++|+.||..........+..... ..
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~------- 409 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TM------- 409 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HC-------
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CC-------
Confidence 33 344689999999999964 579999999999999999999999997644322211111111 00
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
... .....+..+.+|+.+||+.||.+|++ ++||+++
T Consensus 410 -~~~--~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 -AVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -CCC--CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -CCC--CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011 01123567889999999999999998 6888764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.83 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=200.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+++.++||+|+||+||+|.. .+..||||++..... ...+++.+|++++++++|+||+++++++.+....++
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred hHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3566788999999999999976 567899999865432 223568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccC---CCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 597 VYEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQ--IIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gl~yLH~~~~~~--ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
||||+++|+|.+++.... .+++..++.++.||++||+|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999998754 389999999999999999999954 7 99999999999999999999999999986
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........... ... .....
T Consensus 189 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---~~~---~~~~~-- 258 (309)
T 3p86_A 189 KASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGF---KCKRL-- 258 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---HHH---SCCCC--
T ss_pred ccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh---cCCCC--
Confidence 5433211 2345689999999999999999999999999999999999999975543221110 000 00000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCC
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPY 806 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~ 806 (813)
.........+.+++.+||+.||.+|||+.||++.|+.+++-..||.++
T Consensus 259 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 259 -------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred -------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 011233567889999999999999999999999999988776665443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.55 Aligned_cols=267 Identities=23% Similarity=0.412 Sum_probs=214.8
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
+....+.+.+.||+|+||.||+|....+...+..||||+++... ....+++.+|+.++++++|+||+++++++.+++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 33455777899999999999999987666667789999997542 23345789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 595 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999654 5789999999999999999999964 99999999999999999999999999998775
Q ss_pred cCcccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 674 LNQSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 674 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......... . .....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~----~~~~~----- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI---S----SVEEG----- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---H----HHHTT-----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH---H----HHHcC-----
Confidence 443221 1223446788999999998899999999999999999999 99999754432211 1 11110
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSL 801 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 801 (813)
.........+..+.+++.+||+.||.+|||+.||++.|+.+++.+.
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0111122345788999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.28 Aligned_cols=269 Identities=28% Similarity=0.362 Sum_probs=206.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCc----eE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----RL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~ 595 (813)
.+++.++||+|+||+||+|.. .++.||||+++... .....+..|+.++++++||||+++++++.+... .+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQL-----LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEE-----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hchhhheecccCceEEEEEEE-----CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 466788999999999999986 46889999996532 233456679999999999999999999977543 69
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-------CCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------SAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-------~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
+||||+++|+|.+++... .+++..++.++.||++||+|||+.+ +.+|+||||||+|||++.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999999664 4899999999999999999999421 12999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHH-----
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW----- 738 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~----- 738 (813)
++...............||+.|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9877654433323446799999999999863 456688999999999999999999976443221111100
Q ss_pred ----HHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 739 ----AFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 739 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
................ ........+.+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0011111111111111 11123456789999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=355.12 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=210.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.++||+|+||+||+|... .++..||+|++........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHR---ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET---TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEEC---CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 34667789999999999999874 357889999987655556678999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++++|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999986 56789999999999999999999964 999999999999999999999999999987654322
Q ss_pred cc------------eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 678 KA------------IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 678 ~~------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------- 232 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------- 232 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------
Confidence 11 0114569999999999999999999999999999999999999986433211100
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
................+..+.+++.+||+.||++|||+.|+++.|+.+..-
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 233 ---GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000000000001123345688999999999999999999999999887543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=361.48 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=211.8
Q ss_pred HHhhcccccceeeeeeEEEEEEec----cCCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecCC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILT----TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~----~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 592 (813)
..+.+.+.||+|+||.||+|.... ....+..||||+++... ....+++.+|+.+++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 456778899999999999998753 12356789999997542 22345789999999999 8999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhccC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
..++||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 9999999999999999997542 478999999999999999999964 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhh
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 735 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l 735 (813)
.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-- 315 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-- 315 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Confidence 999999999999987654433222334557889999999999999999999999999999999 99999754332211
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
. ....... ......+...+.+++.+||+.||.+||++.|+++.|+.++.+
T Consensus 316 -~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 -K----LLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -H----HHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -H----HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 1111110 111223457889999999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.75 Aligned_cols=279 Identities=39% Similarity=0.648 Sum_probs=223.3
Q ss_pred CCCCCCHHHHHHHHhhccc--------ccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeee
Q 045343 507 NLPCFSYKELEEATDNFKE--------EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIG 574 (813)
Q Consensus 507 ~~~~~~~~el~~~~~~~~~--------~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~ 574 (813)
....|++.++..++.+|.+ .||+|+||.||+|.. .+..||||++.... ....+.+.+|+.+++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 4567999999999998864 599999999999975 46789999986532 223456889999999
Q ss_pred ccccCCcceEEeEeecCCceEEEEeecCCCchhhhhhc---cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 045343 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 651 (813)
Q Consensus 575 ~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~ 651 (813)
+++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~ 162 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA 162 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHH
Confidence 99999999999999999999999999999999999864 34689999999999999999999964 9999999999
Q ss_pred cEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh
Q 045343 652 NILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731 (813)
Q Consensus 652 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~ 731 (813)
||+++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999987654433322344579999999998875 47889999999999999999999997544322
Q ss_pred hhhhHHHHHHhh-ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 732 YAILTDWAFDCY-RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 732 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.. ..+..... ....+...++..+. .......+.+.+++.+||+.||.+|||+.+|+++|+++.
T Consensus 242 ~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 LL--LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BT--THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HH--HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11 11111111 11122223333222 234467888999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.27 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=206.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|.+.++||+|+||+||+|... .+++.||||++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBT---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceeeeeeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4567789999999999999763 4678999999976655556678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 99999999998764 588999999999999999999964 9999999999999999999999999999876644332
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........... ..... .... .
T Consensus 173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~-~~~~-------~ 237 (297)
T 3fxz_A 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNG-TPEL-------Q 237 (297)
T ss_dssp -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHC-SCCC-------S
T ss_pred -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCC-CCCC-------C
Confidence 3446799999999999999999999999999999999999999975543221110 00000 0000 0
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112345678899999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.62 Aligned_cols=280 Identities=24% Similarity=0.381 Sum_probs=208.7
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEec-cCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec--CC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQ 592 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~ 592 (813)
+....+++.++||+|+||+||+|.... ....+..||||++........+++.+|+.++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 334567788999999999999998532 234678999999986555556779999999999999999999999854 45
Q ss_pred ceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 689999999999999999765 4589999999999999999999964 999999999999999999999999999987
Q ss_pred cccCccc-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 672 LTLNQSK-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 672 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+.................+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 7543321 112334577889999999999999999999999999999999998864322110000000000000000000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.+...........+++.+.+++.+||+.||.+|||+.||++.|+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111111111223456789999999999999999999999999988754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=346.01 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=213.8
Q ss_pred CCCCHHHHHHHHhh------------cccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc
Q 045343 509 PCFSYKELEEATDN------------FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 576 (813)
Q Consensus 509 ~~~~~~el~~~~~~------------~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l 576 (813)
+.++++++..++.. +.++||+|+||.||+|... .+++.||||++........+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~---~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK---HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC---CCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 56888998888754 3457999999999999874 36789999999766555567789999999999
Q ss_pred ccCCcceEEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 577 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
+|+||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 999999999999999999999999999999998865 4689999999999999999999964 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhH
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 736 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~ 736 (813)
.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~--- 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--- 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 9999999999999876543222 23457999999999999989999999999999999999999999754332111
Q ss_pred HHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 737 DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.... ... .+... ........+.+++.+||+.||.+|||+.|++++-
T Consensus 251 ~~~~----~~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 251 KRLR----DSP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHH----HSS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHh----cCC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111 110 00010 1112356788999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=364.17 Aligned_cols=264 Identities=24% Similarity=0.423 Sum_probs=201.1
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
....+.+.+.||+|+||.||+|........+..||||+++... ....+++.+|+.++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3345667789999999999999876444567889999997542 233457899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999765 4689999999999999999999964 999999999999999999999999999987754
Q ss_pred Ccccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 675 NQSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 675 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. .. ...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~~----i~~------- 265 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---KA----VDE------- 265 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---HH----HHT-------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHc-------
Confidence 33211 1122345778999999999999999999999999999998 99999754332211 11 111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.........++..+.+++.+||+.||.+||++.+|+++|+.++..
T Consensus 266 --~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 --GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 111111223467889999999999999999999999999887543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=360.54 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=210.8
Q ss_pred HHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecCC
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 592 (813)
....+.+.++||+|+||.||+|.... ...+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 34556778899999999999998754 345678999999975422 2345689999999999 7999999999998765
Q ss_pred c-eEEEEeecCCCchhhhhhccCC--------------------------------------------------------
Q 045343 593 N-RLLVYEFLNNGTLASFLFGNLK-------------------------------------------------------- 615 (813)
Q Consensus 593 ~-~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 615 (813)
. .++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4 8999999999999999976432
Q ss_pred ----------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeeccc
Q 045343 616 ----------PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR 685 (813)
Q Consensus 616 ----------l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 685 (813)
+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...............
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 88999999999999999999964 99999999999999999999999999998765444333344566
Q ss_pred ccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHH
Q 045343 686 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKC 764 (813)
Q Consensus 686 gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 764 (813)
||+.|+|||++.+..++.++||||||+++|||++ |+.||......... . .......... .....
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~----~~~~~~~~~~---------~~~~~ 321 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGTRMR---------APDYT 321 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H----HHHHHTCCCC---------CCTTC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--H----HHHHcCCCCC---------CCCCC
Confidence 8999999999999999999999999999999998 99999754432211 0 1111110000 11123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 765 VEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 765 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
...+.+++..||+.||.+|||+.||+++|+.+++
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 4678899999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=341.52 Aligned_cols=267 Identities=25% Similarity=0.341 Sum_probs=210.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..|.+.+.||+|+||.||++... ..+..||||++..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDT---ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET---TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEEC---CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34677899999999999999864 3577899999854322 22356889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++++|.+++.....+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999998888899999999999999999999964 9999999999999999999999999999876543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...... ....
T Consensus 165 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-~~~~----- 231 (294)
T 4eqm_A 165 SLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-SVPN----- 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-CCCC-----
T ss_pred cccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-cCCC-----
Confidence 2221 23456999999999999999999999999999999999999999765432211 111111 1110
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCCCCCC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVVEVSLPPN 804 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~p~~ 804 (813)
.........++.+.+++.+||+.||.+|| +++++.+.|+.+..-.....
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 00111123457889999999999999998 99999999998876544433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=348.13 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=205.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHI---LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4677899999999999999874 367889999997542 22345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999999999998888899999999999999999999964 999999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....||+.|+|||++.+..+. .++|||||||++|||++|+.||......+.. ..+ ..+. .
T Consensus 170 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i----~~~~--------~ 231 (328)
T 3fe3_A 170 ---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR---ERV----LRGK--------Y 231 (328)
T ss_dssp ---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCC--------C
T ss_pred ---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhCC--------C
Confidence 3456799999999999888765 7899999999999999999999765432211 111 1110 0
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. +...+..+.+++.+||+.||.+|||++|++++
T Consensus 232 ~~--p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 RI--PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC--CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC--CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 11234678899999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.63 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=210.2
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
....+.+.+.||+|+||.||+|... ++..||||+++... ...+++.+|+.++.+++||||+++++++.+....++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 3445678899999999999999764 45679999997543 345678999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999765 4589999999999999999999964 9999999999999999999999999999876544
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......... .. .... ....
T Consensus 158 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~-~~~~--~~~~- 226 (268)
T 3sxs_A 158 QYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KV-SQGH--RLYR- 226 (268)
T ss_dssp CEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HH-HTTC--CCCC-
T ss_pred hhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HH-HcCC--CCCC-
Confidence 3221 233456778999999998889999999999999999999 999997554322111 00 0000 0000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
....++.+.+++.+||+.||.+|||+.|++++|+.+.+.
T Consensus 227 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 ------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 112246788999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.36 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=208.0
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
...+.+.++||+|+||.||+|... .++..||||.++.... ...+++.+|++++++++||||+++++++.+.+..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLR---ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEe---cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 345677899999999999999884 3567899999875322 234578999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999765 4689999999999999999999964 9999999999999999999999999999865433
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . ....+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~----~~~~~~------- 332 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---E----FVEKGG------- 332 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---H----HHHTTC-------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCC-------
Confidence 21111112235778999999998889999999999999999998 99999754432211 1 111110
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.......+++.+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 333 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 333 --RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 01111234567889999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=358.29 Aligned_cols=268 Identities=28% Similarity=0.389 Sum_probs=216.4
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccC----CcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEe
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTR----TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFC 588 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 588 (813)
++....+.+.++||+|+||.||+|...... ..+..||||+++.... ...+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 444567788899999999999999875322 3456899999975422 2346788999999999 899999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhccC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
.+++..++||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 99999999999999999999997543 489999999999999999999964 99999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987754433222344567889999999999999999999999999999999 999997543322
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSL 801 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 801 (813)
.. ......... .........+.+++.+||+.||.+|||+.||+++|++++....
T Consensus 302 ~~-------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 LF-------KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HH-------HHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HH-------HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11 111111100 0112345678999999999999999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=360.55 Aligned_cols=264 Identities=28% Similarity=0.392 Sum_probs=209.6
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeecCC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 592 (813)
+....+.+.++||+|+||.||+|.... ....+..||||+++.. ......++.+|+.++++++|+||+++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 334567788999999999999998653 2345678999998643 2334456889999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhcc-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC---CEE
Q 045343 593 NRLLVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NAR 662 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~---~~k 662 (813)
..++||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999999754 3578999999999999999999964 999999999999999554 599
Q ss_pred EeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHH
Q 045343 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 663 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.. ..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~~--- 298 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EF--- 298 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HH---
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH---
Confidence 999999986644332222344568999999999999999999999999999999998 99999755432211 11
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
...... .......+..+.+++.+||+.||.+|||+.||+++|+.+.+
T Consensus 299 -i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 -VTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp -HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 111110 01112335678899999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=350.25 Aligned_cols=261 Identities=24% Similarity=0.393 Sum_probs=203.3
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCC-cceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
...+.+.+.||+|+||+||+|....+.. -...||+|.++... ....+++.+|+.++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 3456778899999999999998753321 22347888885432 33456799999999999999999999999875 478
Q ss_pred EEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|+||+++|+|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999999976 46789999999999999999999965 999999999999999999999999999988765
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
...........+|..|+|||++.+..++.++||||||+++|||++ |+.||........... ....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~------- 235 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKG------- 235 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTT-------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-------HHcC-------
Confidence 544333344567889999999999999999999999999999999 9999976543321111 1110
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
........+...+.+++.+||+.||.+||++.||+++|+.+..
T Consensus 236 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111122345678899999999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.24 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=205.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------cchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
.|.+.+.||+|+||.||++... .++..||||.++..... ..+++.+|+.++++++||||+++++++.+...
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceEEeeEEeeCcCEEEEEEEEC---CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4678899999999999999874 46789999999754322 23568899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----CEEEeeccCc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFGLA 669 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~DfGla 669 (813)
.++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999998888899999999999999999999964 999999999999998776 7999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
+....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+... ........
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~-------~i~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NITAVSYD 236 (361)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHTTCCC
T ss_pred eEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhcCCC
Confidence 87654322 234579999999999999899999999999999999999999997654322110 00000000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.++. ......+.+.+++.+||+.||.+|||+.|++++
T Consensus 237 --~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 --FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 001234678899999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=338.17 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=208.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.++||+|+||.||+|... ++..||||++.... ...+++.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhceeeheecCCCccEEEEEEec----CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 34677889999999999999874 45679999997542 34567999999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999999654 5689999999999999999999964 999999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . ..... ...
T Consensus 162 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~----~~~~~--~~~----- 226 (269)
T 4hcu_A 162 TS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---E----DISTG--FRL----- 226 (269)
T ss_dssp HS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTT--CCC-----
T ss_pred cc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---H----HHhcC--ccC-----
Confidence 11 233456788999999998899999999999999999999 99999754432211 1 01110 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.........+.+++.+||+.||.+||++.|++++|+++.+
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0111235678899999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.12 Aligned_cols=248 Identities=23% Similarity=0.264 Sum_probs=205.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.+.||+|+||.||++... .+++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 4667789999999999999874 46789999999753 22334568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999999998888899999999999999999999964 99999999999999999999999999998644322
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... . .......
T Consensus 160 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~----~i~~~~~-------- 222 (337)
T 1o6l_A 160 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E----LILMEEI-------- 222 (337)
T ss_dssp CC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCC--------
T ss_pred Cc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---H----HHHcCCC--------
Confidence 21 34567999999999999999999999999999999999999999754332111 1 1001110
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
. ........+.+++.+||+.||.+|| +++||+++
T Consensus 223 ~--~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 R--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 0112356788999999999999999 89999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=346.98 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=204.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|++.+.||+|+||+||+|... .+++.||||++..... ...+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hceeeeEEecCCCEEEEEEEEC---CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3667889999999999999874 3677899999864322 23467889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+++++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999999888899999999999999999999964 9999999999999999999999999999876544333
Q ss_pred ceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+. ... ....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~----~~~---~~~~---- 229 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK----EKK---TYLN---- 229 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH----TTC---TTST----
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh----ccc---ccCC----
Confidence 32345679999999999987765 77899999999999999999999755432211 11110 000 0000
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
........+.+++.+||+.||.+|||+.|++++-
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0112356778999999999999999999998763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=345.67 Aligned_cols=262 Identities=27% Similarity=0.398 Sum_probs=212.1
Q ss_pred HHHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
...+.+.+.||+|+||.||+|..... +..+..||||+++... ....+++.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 34567789999999999999987432 2456889999997532 23346788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccC------------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 045343 595 LLVYEFLNNGTLASFLFGNL------------------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKP 650 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~ 650 (813)
++||||+++++|.+++.... .+++..++.++.||++||.|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 99999999999999997543 378999999999999999999964 999999999
Q ss_pred CcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccc
Q 045343 651 QNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMG 729 (813)
Q Consensus 651 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~ 729 (813)
+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755433322334557889999999998889999999999999999999 9999975543
Q ss_pred hhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 730 EEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 730 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
+.... ........ ......++.+.+++.+||+.||.+||++.||+++|++++.
T Consensus 259 ~~~~~-------~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ERLFN-------LLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGHHH-------HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH-------HhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22111 11111100 1112345778999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=348.86 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=210.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+.+.+.||+|+||.||+|...... ..+..||||+++.... ...+++.+|+.++++++||||+++++++.+++..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 34567789999999999999886322 3558899999975422 23457899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcc------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 045343 596 LVYEFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 651 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~ 651 (813)
+||||+++|+|.+++... ..+++..++.++.||++||.|||+. +|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcc
Confidence 999999999999999753 4688999999999999999999964 9999999999
Q ss_pred cEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccch
Q 045343 652 NILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGE 730 (813)
Q Consensus 652 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~ 730 (813)
|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 99999999999999999987654433222344568899999999998899999999999999999999 99999754332
Q ss_pred hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+.. .....+.... .....+..+.+++.+||+.||.+||++.+|+++|+++.+-
T Consensus 284 ~~~-------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 284 EVI-------YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHH-------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHH-------HHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 211 1111111111 1113456789999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.38 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=198.0
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
...+++.+.||+|+||.||+|....+...+..||||+++.... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4567788999999999999999876555677899999865322 23456889999999999999999999984 567899
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||||+++++|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999765 4689999999999999999999964 9999999999999999999999999999876543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.. ... ......
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i----~~~~~~----- 236 (281)
T 1mp8_A 170 TYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENGERL----- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----HTTCCC-----
T ss_pred cccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHH----HcCCCC-----
Confidence 2221 233456789999999998899999999999999999997 99999755432211 111 111000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
......+..+.+++.+||+.||.+|||+.|++++|+.+.+
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0112345778899999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.83 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=213.7
Q ss_pred HHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecCC
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 592 (813)
....+.+.+.||+|+||.||+|.... ....+..||||+++.... ...+.+.+|+.+++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 34457788999999999999998643 334678999999975432 2346789999999999 9999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhccC------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEE
Q 045343 593 NRLLVYEFLNNGTLASFLFGNL------------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNIL 654 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIl 654 (813)
..++||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 9999999999999999997543 488999999999999999999964 9999999999999
Q ss_pred EcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhh
Q 045343 655 LDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 733 (813)
Q Consensus 655 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 733 (813)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999988765544333344567889999999998899999999999999999999 99999754432211
Q ss_pred hhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 734 ILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 734 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
....... .. .......+..+.+++.+||+.||.+|||+.|++++|+++++
T Consensus 258 --~~~~~~~-----~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 --YKMIKEG-----FR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp --HHHHHHT-----CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHhccC-----CC--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1111110 00 01112335778999999999999999999999999988654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=364.72 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=209.8
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+....+.+.++||+|+||.||+|... .+..||||+++... ...++|.+|+.+|++++||||+++++++. .+..+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 33445677899999999999999874 45789999997542 34678999999999999999999999986 56789
Q ss_pred EEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 596 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
+||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 999999999999999764 3688999999999999999999964 99999999999999999999999999998765
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....++..|+|||++....++.++||||||++||||++ |+.||......+.. ..+.. +
T Consensus 336 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~----~------ 401 (454)
T 1qcf_A 336 DNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALER----G------ 401 (454)
T ss_dssp CHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHH----T------
T ss_pred CCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----C------
Confidence 332111 223446788999999998899999999999999999999 99999754332211 11111 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
........+++.+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 402 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 ---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 00111223467889999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.38 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=206.6
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+.+.++||+|+||.||++... .+..||||+++... ...+++.+|++++.+++|+||+++++++.+.+..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 345677899999999999999774 56679999997542 3356789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999977 56789999999999999999999964 99999999999999999999999999998765432
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... ..... .
T Consensus 175 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~~-~------- 238 (283)
T 3gen_A 175 YTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQG-L------- 238 (283)
T ss_dssp HHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHTT-C-------
T ss_pred ccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-------HHhcc-c-------
Confidence 211 223456788999999998899999999999999999998 999997554322111 00110 0
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.........+.+.+++.+||+.||.+|||+.|++++|+++.+
T Consensus 239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 000111224678899999999999999999999999988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=368.72 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=212.1
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
....+.+.++||+|+||.||+|... ..+..||||.++... ...++|.+|+.+|++++||||++++++|.+....++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEG---GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEc---CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3445677899999999999999885 346789999997542 345679999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 597 VYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999753 4688999999999999999999964 999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
..... .....++..|+|||++....++.++||||||++||||++ |+.||......+.. .. +..
T Consensus 371 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~----~~~-------- 434 (495)
T 1opk_A 371 DTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---EL----LEK-------- 434 (495)
T ss_dssp CCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HH----HHT--------
T ss_pred Cceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHc--------
Confidence 32211 223456789999999998899999999999999999999 99998754332211 11 111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.........+++.+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 435 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 435 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111111223467889999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.72 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=211.5
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 591 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 591 (813)
+....+.+.+.||+|+||.||+|..... ...+..||||.++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3345667789999999999999987432 2356789999997532 23456789999999999 899999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccC-----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNL-----------------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDI 648 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dl 648 (813)
+..++||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 99999999999999999997643 378999999999999999999964 9999999
Q ss_pred CCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcc
Q 045343 649 KPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIE 727 (813)
Q Consensus 649 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~ 727 (813)
||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987765443333344567889999999998899999999999999999998 99999755
Q ss_pred cchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 728 MGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 728 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
...... . ...... .........++.+.+++.+||+.||.+|||+.||+++|+.+...
T Consensus 279 ~~~~~~--~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVDANF--Y----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSHHH--H----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcHHHH--H----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 432211 1 111111 00111122357789999999999999999999999999886643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=341.44 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=206.8
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------cchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
...|.+.+.||+|+||.||++... .++..||||.++..... ..+++.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET---TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccceEeceEEeeCCCeEEEEEEEC---CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 456788899999999999999874 35789999998754322 245688999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----CEEEeecc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFG 667 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~DfG 667 (813)
...++||||+++++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999999998888899999999999999999999964 999999999999999877 89999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .... ..
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~----~~ 233 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NVSA----VN 233 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHH----TC
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHh----cC
Confidence 9987654322 234569999999999999899999999999999999999999997544322111 0000 00
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. . .........+..+.+++.+||+.||.+|||+.|++++
T Consensus 234 ~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 Y-E-----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C-C-----CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-C-----cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 0000011234678899999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=342.15 Aligned_cols=259 Identities=18% Similarity=0.193 Sum_probs=206.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.+.+.+.||+|+||.||+|... .+++.||||.+... ...+++.+|+.+++++ +|+||+++++++..++..++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNL---YTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEET---TTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEeeccCCceEEEEEEC---CCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 3567789999999999999863 46789999998653 3345789999999999 9999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC-----EEEeeccCcccc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-----ARISDFGLAKLL 672 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~DfGla~~~ 672 (813)
||+ +++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 9999999976 46789999999999999999999964 9999999999999998887 999999999876
Q ss_pred ccCcccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 673 TLNQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 673 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 5433211 12346799999999999999999999999999999999999999986543222111111111000000
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
...+ ....+ .+.+++..||+.||.+||++++|++.|+.+.
T Consensus 241 ~~~~---------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 241 IEVL---------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHH---------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHH---------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0000 00123 8899999999999999999999999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.83 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=203.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCC-ceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~ 598 (813)
.+.+.++||+|+||.||+|.. .+..||||.++.. ...++|.+|+.+|++++||||+++++++.+.+ ..++||
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~-----~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HeEEEeeecCcCCeeEEEEEe-----cCCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 456678999999999999987 4668999999753 35678999999999999999999999987665 789999
Q ss_pred eecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++|+|.+++.... .+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 9999999999997653 378999999999999999999964 9999999999999999999999999999864432
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .. +..+
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~----i~~~--------- 402 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PR----VEKG--------- 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HH----HHTT---------
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcC---------
Confidence 122357889999999999999999999999999999998 99999754332211 11 1111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
........++..+.+++.+||+.||.+|||+.+|++.|+.+..-
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01111223467889999999999999999999999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.91 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=204.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCc-ceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTS-TTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+.+.||+|+||.||+|....+... ...|++|.+.... ....+++.+|+.++++++|+||+++++++. ++..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 456778999999999999987543221 2347888875432 333467888999999999999999999986 5678999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+||+++|+|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999764 5789999999999999999999965 99999999999999999999999999999876554
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......+.... ..... ..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~--~~---- 236 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-------LEKGE--RL---- 236 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-------HHTTC--BC----
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-------HHcCC--CC----
Confidence 4333445668889999999998899999999999999999999 9999976543322111 11110 00
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.........+.+++.+||+.||.+||++.|++++|+.+..
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0011123457789999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=347.18 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=194.4
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCce-
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR- 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~- 594 (813)
...+.+.+.||+|+||.||+|....++.....||||+++.. .....+++.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 34577889999999999999987644433458999998653 233456789999999999999999999999877655
Q ss_pred -----EEEEeecCCCchhhhhhccC------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 595 -----LLVYEFLNNGTLASFLFGNL------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 595 -----~lV~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
++|+||+++|+|.+++.... .+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999996432 589999999999999999999964 9999999999999999999999
Q ss_pred eeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHh
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+... . .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~---~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---Y---L 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---H---H
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---H---H
Confidence 99999987655433322334557889999999999999999999999999999999 999997544322111 0 0
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
..... .......++.+.+++.+||+.||.+|||+.++++.|++++.-
T Consensus 253 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 011123457789999999999999999999999999987644
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.62 Aligned_cols=268 Identities=20% Similarity=0.251 Sum_probs=208.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCC--ceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~l 596 (813)
.|.+.+.||+|+||+||+|... .+++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CEEEEEEecCCCCeEEEEEEEC---CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3667889999999999999874 357799999997543 233456789999999999999999999987655 7799
Q ss_pred EEeecCCCchhhhhhccCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE----cCCCCEEEeeccCc
Q 045343 597 VYEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLA 669 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfGla 669 (813)
||||+++++|.+++..... +++..++.++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976543 89999999999999999999964 99999999999999 77888999999999
Q ss_pred cccccCcccceeecccccccccCccccc--------CCCCCCccchhhHHHHHHHHHhCCcCCCcccchh-hhhhHHHHH
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFR--------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAF 740 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~ 740 (813)
+....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||....... ...+.....
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 87654432 23456999999999986 5678899999999999999999999997543321 111111111
Q ss_pred HhhccCcccccc---c------cc--ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 741 DCYRNEKLDDLV---E------GD--MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 741 ~~~~~~~~~~~~---~------~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
..........+. . .. ............+.+++.+||+.||++|||++|++++..+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111111111100 0 00 11122346778899999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.59 Aligned_cols=262 Identities=18% Similarity=0.222 Sum_probs=209.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|.+.+.||+|+||.||+|... .+++.||||++... ...+++.+|+.++.++ +|+|++++++++.+....++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEEC---CCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 4677889999999999999863 46789999998643 3456788999999999 7999999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC-----EEEeeccCcccc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-----ARISDFGLAKLL 672 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~DfGla~~~ 672 (813)
||+ +++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 99999999764 458999999999999999999995 59999999999999987766 999999999877
Q ss_pred ccCccc-----ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 673 TLNQSK-----AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 673 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 644321 112345699999999999999999999999999999999999999986443221111111111100000
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
...+ ....++.+.+++.+||+.||.+||++++|++.|+++.+-
T Consensus 242 ~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 LREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000 112357889999999999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=352.40 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=205.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
...|.+.++||+|+||.||++... .++..+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~---~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV---LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET---TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC---CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 456788899999999999999874 467899999986532 223456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc---CCCCEEEeeccCcccc
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLL 672 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGla~~~ 672 (813)
+||||+++|+|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999999888899999999999999999999964 999999999999998 5678999999999876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. .....+... ..
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~-~~ 233 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-------QQIKAGAYD-FP 233 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCCC-CC
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHhCCCC-CC
Confidence 544322 23467999999999999989999999999999999999999999754432211 111111110 00
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+ .....++.+.+++.+||+.||.+|||+.|++++
T Consensus 234 ~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 011235678899999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=341.26 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=205.5
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCC----cceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRT----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
+....+.+.+.||+|+||.||+|....+.. ....||+|.+........+++.+|+.++++++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 344567788999999999999998864321 1357999999776556667899999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC--------EE
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--------AR 662 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~k 662 (813)
+..++||||+++++|.+++..... +++..++.++.||++||.|||+. +|+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999977644 89999999999999999999964 9999999999999998887 99
Q ss_pred EeeccCccccccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH
Q 045343 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 663 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|+|||++...... ....++..|+|||++.+ ..++.++||||||+++|||++|..|+.......... ... .
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--~~~-~ 232 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--QFY-E 232 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHH-H
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH--HHh-h
Confidence 9999999765432 23457889999999987 678999999999999999999655544332211110 000 0
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
...... ......+.+++.+||+.||.+|||+.|++++|+.+..
T Consensus 233 --~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 --DRHQLP------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp --TTCCCC------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred --ccCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000000 0113457899999999999999999999999998865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.22 Aligned_cols=252 Identities=31% Similarity=0.456 Sum_probs=193.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc----ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
.+.+.+.||+|+||.||+|.. .+..||||+++.... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred heeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 466778999999999999986 467899999865322 22356889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC--------CCCEEEeecc
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--------YYNARISDFG 667 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~--------~~~~kl~DfG 667 (813)
+||||+++++|.+++.. ..+++..++.++.|+++||.|||+....+|+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999864 47899999999999999999999762223999999999999986 7789999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ..... .
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~-~ 230 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAMN-K 230 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHTS-C
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhcC-C
Confidence 998665432 223468999999999999899999999999999999999999997543321110 11111 0
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
. ........++.+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 231 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 L--------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C--------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 0111123457789999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=349.04 Aligned_cols=274 Identities=25% Similarity=0.382 Sum_probs=213.4
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEecc----CCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEe
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTT----RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFC 588 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 588 (813)
++....+.+.+.||+|+||.||+|..... ..++..||||+++... ....+++.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34445677889999999999999987431 1356789999997542 22345688999999999 899999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhccC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
.+.+..++||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 99999999999999999999997643 378999999999999999999964 99999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
||++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999987664433222334457889999999988889999999999999999999 999997543322
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYP 807 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~ 807 (813)
.. ... ...... .........+.+++.+||+.||.+|||+.|+++.|++++..........
T Consensus 268 ~~---~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~ 327 (334)
T 2pvf_A 268 LF---KLL----KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327 (334)
T ss_dssp HH---HHH----HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred HH---HHH----hcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcccC
Confidence 11 111 111000 0112345678899999999999999999999999999876644443333
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=346.97 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=202.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 595 (813)
.+++.++||+|+||.||++... .+++.+|||+++... ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLK---KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4677899999999999999874 467899999997542 22344578899999887 8999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999999888899999999999999999999964 9999999999999999999999999999864322
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhh--hhhHHHHHHhhccCccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~ 753 (813)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..............
T Consensus 207 ~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------- 277 (396)
T 4dc2_A 207 GDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------- 277 (396)
T ss_dssp TCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-------
T ss_pred CCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-------
Confidence 211 3456799999999999999999999999999999999999999974332111 00011111111111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM------KKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 792 (813)
.... +......+.+++.+||+.||.+||++ .||+++
T Consensus 278 -~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 278 -QIRI--PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -CCCC--CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -ccCC--CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111 11235678899999999999999985 566654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.14 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=204.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|.+.++||+|+||.||++... .++..+|+|.++.. ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEeeeEEecCCCeEEEEEEEC---CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4667889999999999999874 46789999998643 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC--CCCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~DfGla~~~~~~~ 676 (813)
|+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999765 4789999999999999999999964 9999999999999987 7899999999998875433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+.. .... ...
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~----~~~~--~~~-- 224 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENIMN----AEYT--FDE-- 224 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHH----TCCC--CCH--
T ss_pred c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHHc----CCCC--CCh--
Confidence 2 33456899999999999888899999999999999999999999765432211 11110 0000 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
......+..+.+++.+||+.||.+|||+.|++++-
T Consensus 225 --~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred --hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 00012356788999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.19 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=198.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeec--cccCCcceEEeEeec----CC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDE----GQ 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----~~ 592 (813)
..+.+.+.||+|+||+||+|.. ++..||||++... ..+.+..|.+++.. ++||||+++++++.. ..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 4567789999999999999986 5778999998643 33455566666655 799999999998654 34
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
..++||||+++|+|.+++.. ..+++..+++++.||++||+|||... ..+|+||||||+|||++.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 57999999999999999954 46899999999999999999999321 3599999999999999999999999999
Q ss_pred CccccccCcccc--eeecccccccccCcccccCC------CCCCccchhhHHHHHHHHHhC----------CcCCCcccc
Q 045343 668 LAKLLTLNQSKA--IRTAIRGTKGYVAPEWFRNS------TITAKVDVYSFGVLLLEIISC----------RKSFDIEMG 729 (813)
Q Consensus 668 la~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~k~DVwS~Gvvl~elltG----------~~p~~~~~~ 729 (813)
+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 998765433221 12234799999999999876 445789999999999999999 777754322
Q ss_pred hhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 730 EEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 730 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
..... .. ............... ...........+.+++.+||+.||.+|||+.||++.|+++
T Consensus 239 ~~~~~-~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSF-ED-MRKVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCH-HH-HHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcch-hh-hhHHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11110 00 011111111110000 0111235678899999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.90 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=196.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+++.+.||+|+||.||+|.. .+..||||+++. ....+.+.+|++++++++||||+++++++.+ ..++|||
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKW-----RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-----TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred HeeeeeEeecCCCceEEEEEE-----CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 456778999999999999987 457899999864 2345678999999999999999999998873 5899999
Q ss_pred ecCCCchhhhhhccC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC-EEEeeccCccccccC
Q 045343 600 FLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN-ARISDFGLAKLLTLN 675 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~-~kl~DfGla~~~~~~ 675 (813)
|+++++|.+++.... .+++..++.++.||++||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999998654 4678899999999999999999643368999999999999998886 799999999765432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........... ... .......
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~----- 224 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAV-HNGTRPP----- 224 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH----HHH-HTTCCCC-----
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH----HHH-hcCCCCC-----
Confidence 2234589999999999999999999999999999999999999975433221111 011 1111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.....+..+.+++.+||+.||.+|||+.|++++|+.+.+
T Consensus 225 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 ----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp ----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111235678899999999999999999999999988654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.64 Aligned_cols=261 Identities=25% Similarity=0.430 Sum_probs=206.7
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCce-EEEEe
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR-LLVYE 599 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV~e 599 (813)
...++||+|+||+||+|....+......+|||.++.... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+|
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345889999999999999876666667899999875332 2345788999999999999999999999876665 99999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+.+++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999976 45688999999999999999999965 9999999999999999999999999999866443211
Q ss_pred --ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 679 --AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 679 --~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.......++..|+|||.+.+..++.++||||||+++|||++|..|+........ +..... ...
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~----~~~--------- 245 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLA----QGR--------- 245 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHH----TTC---------
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhh----cCC---------
Confidence 112345688999999999999999999999999999999996666543222111 111111 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
........++.+.+++.+||+.||.+|||+.++++.|+.+++..
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 00111223567899999999999999999999999998876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=359.88 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=204.1
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+.+.++||+|+||.||+|... ....||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC----CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 345677889999999999999874 34679999997543 335679999999999999999999999876 678999
Q ss_pred EeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999999753 5689999999999999999999964 9999999999999999999999999999876543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .....+
T Consensus 334 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~-------- 397 (452)
T 1fmk_A 334 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG-------- 397 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT--------
T ss_pred ceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC--------
Confidence 2211 233457789999999998899999999999999999999 99999754332211 111111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSL 801 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 801 (813)
........+++.+.+++.+||+.||++|||+++|++.|+.+.....
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0111122446788999999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=351.61 Aligned_cols=253 Identities=20% Similarity=0.217 Sum_probs=202.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+++.++||+|+||+||+|... ..++.||||+++... ......+.+|+.++.+++|+||+++++++.+.+..+||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEc---CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 455688999999999999884 357899999997532 22334588999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999987 5789999999999999999999995 499999999999999999999999999998765443
Q ss_pred ccceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .+..... .+
T Consensus 230 ~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~-----~~ 300 (437)
T 4aw2_A 230 TVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHKE-----RF 300 (437)
T ss_dssp CEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTHHH-----HC
T ss_pred Ccc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH---hhhhccc-----cc
Confidence 221 33467999999999997 4568999999999999999999999998654322111 0100000 00
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSL--RPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 792 (813)
.-+.. .....+.+.+|+.+||..+|++ ||+++|++++
T Consensus 301 ~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 301 QFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000 0123567889999999888888 9999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.82 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=200.4
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeecc-ccCCcceEEeEeecC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 591 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 591 (813)
+....+++.+.||+|+||.||+|... .+++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVK---ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEc---CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 34445778899999999999999874 45789999999753 223345678899999988 799999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+..++||||+++|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999999999888899999999999999999999964 999999999999999999999999999986
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ... ..
T Consensus 174 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~---~i~-~~----- 239 (353)
T 3txo_A 174 GICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---E---AIL-ND----- 239 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHH-HC-----
T ss_pred cccCCcc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---H---HHH-cC-----
Confidence 4432221 34567999999999999889999999999999999999999999765432211 1 111 11
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM------KKVLQ 791 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~ 791 (813)
.... .......+.+++.+||+.||.+||++ .|+++
T Consensus 240 ---~~~~--p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 ---EVVY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCC--CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1110 11234678899999999999999998 77775
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.65 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=198.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|++.++||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 4667789999999999999873 578899999865322 2235688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++ +|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 999985 777777554 5689999999999999999999964 99999999999999999999999999998765332
Q ss_pred ccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Ccccc--
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLDD-- 750 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~-- 750 (813)
.. .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ....... .....
T Consensus 174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGT
T ss_pred cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhh
Confidence 21 234568999999999876 5689999999999999999999999976544332111 1111110 00000
Q ss_pred -----------cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 751 -----------LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 751 -----------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+............+++.+++.+||+.||.+|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000011234678899999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=343.99 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=206.6
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
....|.+.+.||+|+||.||+|... .++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEEC---CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3566888999999999999999874 467899999997532 22345688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC---CCEEEeeccCccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDFGLAKL 671 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~DfGla~~ 671 (813)
++||||+++|+|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999999998888899999999999999999999964 99999999999999865 4599999999987
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+ ..+... .
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i----~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQI----KAGAYD-Y 249 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCCC-C
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HhCCCC-C
Confidence 654322 2346799999999999998999999999999999999999999975433211 1111 111110 0
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ......+..+.+++.+||+.||.+||++.|++++
T Consensus 250 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0011235678899999999999999999999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=334.48 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=195.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--------------------------ccchhhhheeeee
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--------------------------DGEKEFKNEVVVI 573 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l 573 (813)
.|.+.+.||+|+||.||+|... .+++.||||++..... ...+++.+|++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNE---NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEET---TTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ceEEEeEEeecCCEEEEEEEEC---CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4667889999999999999874 4678999999864321 1235688999999
Q ss_pred eccccCCcceEEeEeec--CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 045343 574 GQTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQ 651 (813)
Q Consensus 574 ~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~ 651 (813)
++++||||+++++++.+ ....++||||+++++|.+++. ...+++..++.++.||++||+|||+. +|+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 99999999999999976 567899999999999988764 35689999999999999999999965 9999999999
Q ss_pred cEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCCccc
Q 045343 652 NILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEM 728 (813)
Q Consensus 652 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~k~DVwS~Gvvl~elltG~~p~~~~~ 728 (813)
|||++.++.+||+|||+++........ .....||+.|+|||.+.+.. .+.++||||||+++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999876543221 34457999999999997765 3778999999999999999999997543
Q ss_pred chhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 729 GEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 729 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... .. ....... .........+.+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~---~~----~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCL---HS----KIKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHH---HH----HHHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHH---HH----HHhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 2111 01 1111110 001111235678999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.74 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=200.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.++||+|+||+||+|... .+++.||||+++..... ..+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeeeEecCCCCeEEEEEEEC---CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 567789999999999999874 35788999999754322 2356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||++++.+..+......+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9998755555555567899999999999999999999965 9999999999999999999999999999876533221
Q ss_pred ceeecccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Ccccccc--
Q 045343 679 AIRTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLDDLV-- 752 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~-- 752 (813)
.....||+.|+|||++.+.. ++.++||||||+++|||++|..|+......... + ......... +......
T Consensus 158 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~-~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-H-HHHHHHHCCCCTTTCTTGGGS
T ss_pred --ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-H-HHHHHHhCCCChhhhhhhccc
Confidence 33456899999999998765 799999999999999999988886443322111 1 111111111 0000000
Q ss_pred -c---------ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 -E---------GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 -~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+ ..............+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000000112345778899999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=329.10 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=202.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC--Cce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 594 (813)
..+.+.+.||+|+||.||+|.. .+..||||+++... ....+++.+|+.++++++||||+++++++.+. ...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-----QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred HHhHHHHHhcCCCcceEEEEEE-----CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 3567788999999999999987 46789999987532 23345789999999999999999999999877 678
Q ss_pred EEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 595 LLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
++||||+++|+|.+++.... .+++..++.++.||++||.|||+. ...|+||||||+||+++.++.++|.|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999998765 489999999999999999999954 222999999999999999999999999887643
Q ss_pred ccCcccceeecccccccccCcccccCCCCCC---ccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITA---KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
. .....||+.|+|||.+.+...+. ++||||||+++|||++|+.||......... ..........
T Consensus 164 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~~ 230 (271)
T 3kmu_A 164 Q-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEGLRP 230 (271)
T ss_dssp S-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSCCCC
T ss_pred c-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcCCCC
Confidence 2 22345899999999998765544 799999999999999999999754332211 0111111000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
......+..+.+++..||+.||.+|||+.|+++.|+.+.+
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 ---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112345678999999999999999999999999988753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=340.42 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=203.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.+.||+|+||.||+|... ..+..||||++.... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHY---KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4677899999999999999874 367789999986532 2234578899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+ +|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 789999998888899999999999999999999965 99999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
. .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ...+....
T Consensus 163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~~ 224 (336)
T 3h4j_B 163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSCV 224 (336)
T ss_dssp T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSSC
T ss_pred c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCC
Confidence 2 234569999999999988776 6899999999999999999999975432110 01111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. .....+..+.+++.+||+.||.+|||+.|++++
T Consensus 225 ~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CC--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CC--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 111235678899999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=337.94 Aligned_cols=270 Identities=21% Similarity=0.289 Sum_probs=202.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCCce-
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR- 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~- 594 (813)
..|.+.+.||+|+||.||++... .+++.||||+++..... ....+.+|+.++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDL---RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred CcEEEEEEEccCCCEEEEEEEEC---CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34677899999999999999874 46789999999754222 234688999999999999999999998765544
Q ss_pred ---EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 595 ---LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 595 ---~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
++||||+++++|.+++.....+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999998888899999999999999999999965 999999999999999999999999999987
Q ss_pred cccCccc-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 672 LTLNQSK-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 672 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~- 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP- 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC-
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCCC-
Confidence 6543222 1123456899999999999999999999999999999999999999765432211 1111111000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHH-HHHHhcCcCCCCCCCCCC
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKV-LQMLEGVVEVSLPPNPYP 807 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev-l~~L~~~~~~~~p~~p~~ 807 (813)
+ .......+..+.+++.+||+.||.+||++.++ ...|..+.....|+.|..
T Consensus 239 ---~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 239 ---P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp ---H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred ---c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 0 00011235678899999999999999965554 456666555544444433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.49 Aligned_cols=282 Identities=23% Similarity=0.342 Sum_probs=210.8
Q ss_pred CHHHHHHHHhhcccccceeeeeeEEEEEEec-cCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEee
Q 045343 512 SYKELEEATDNFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD 589 (813)
Q Consensus 512 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 589 (813)
...++....+++.++||+|+||.||+|.... +...++.||||+++... ....+.+.+|+.++++++|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3334445557788999999999999998532 23467899999997532 233467899999999999999999999998
Q ss_pred cC--CceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeec
Q 045343 590 EG--QNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDF 666 (813)
Q Consensus 590 ~~--~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 666 (813)
+. ...++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcc
Confidence 76 668999999999999999954 46789999999999999999999964 9999999999999999999999999
Q ss_pred cCccccccCccc-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 667 GLAKLLTLNQSK-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 667 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
|++......... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ......
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 249 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT-HGQMTV 249 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC-CGGGHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc-ccccCH
Confidence 999877654322 112345688889999999988899999999999999999999988643211000000000 000000
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
..+...+............++.+.+++.+||+.||.+|||+.|+++.|+.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000001111111122234578999999999999999999999999998865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=337.01 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=203.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.+.||+|+||.||++... .+++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 4667889999999999999874 467899999997532 2234567889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999999988889999999999999999999995 59999999999999999999999999999875432
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..... . ..
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~~-~--------~~ 220 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKILN-A--------EL 220 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHH-C--------CC
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-C--------CC
Confidence 23457999999999999999999999999999999999999999754332111 01111 1 11
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.. .......+.+++.+||+.||.+|| +++||+++
T Consensus 221 ~~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 RF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 10 112346788999999999999999 89999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.11 Aligned_cols=252 Identities=27% Similarity=0.497 Sum_probs=200.8
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc-------chhhhheeeeeeccccCCcceEEeEeecC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-------EKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
..+.+.+.||+|+||.||+|... .+++.||||++....... .+++.+|+.++++++|+||+++++++.+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV---KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET---TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred ccceehhccccCCceeEEEEEEc---CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45677899999999999999874 367889999986433221 15688999999999999999999998665
Q ss_pred CceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCcEEEcCCCC-----EEE
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQ--IIHCDIKPQNILLDDYYN-----ARI 663 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~--ivH~dlk~~NIll~~~~~-----~kl 663 (813)
. ++||||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 4 7999999999998888654 5789999999999999999999954 7 999999999999988776 999
Q ss_pred eeccCccccccCcccceeecccccccccCccccc--CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR--NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 741 (813)
+|||+++..... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||............. .
T Consensus 171 ~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~-- 242 (287)
T 4f0f_A 171 ADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM-I-- 242 (287)
T ss_dssp CCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-H--
T ss_pred CCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-H--
Confidence 999999754432 34467899999999984 4457889999999999999999999997554332211111 0
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
...... .......+..+.+++.+||+.||.+|||+.||++.|+++
T Consensus 243 --~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 --REEGLR--------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --HHSCCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --hccCCC--------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 001111 111123457889999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=339.46 Aligned_cols=253 Identities=21% Similarity=0.258 Sum_probs=198.6
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
...+++.+.||+|+||.||++....+...++.||||+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 345778899999999999999886555678899999997532 2234567889999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999998888899999999999999999999965 99999999999999999999999999998654
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+.. .
T Consensus 173 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~----~------- 236 (327)
T 3a62_A 173 HDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---DKILK----C------- 236 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH----T-------
T ss_pred cCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHh----C-------
Confidence 32221 33457999999999999989999999999999999999999999754432211 11110 0
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
... ........+.+++.+||+.||.+|| ++.|++++
T Consensus 237 -~~~--~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 237 -KLN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -CCC--CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CCC--CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 000 0112356788999999999999999 78888864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.93 Aligned_cols=277 Identities=25% Similarity=0.346 Sum_probs=211.8
Q ss_pred HHhhcccccceeeeeeEEEEEEec-cCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee--cCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 595 (813)
..+.+.++||+|+||.||++.... +...+..||||++........+.+.+|++++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 456778999999999999998532 23467899999997655555667999999999999999999999886 455688
Q ss_pred EEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999976 45689999999999999999999964 999999999999999999999999999987754
Q ss_pred Ccccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
..... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||.....+...... ..........+.+.+.
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHHHhh
Confidence 43221 123345888899999999888999999999999999999999998643321110000 0000000000011111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
...........++.+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111122334567899999999999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=347.55 Aligned_cols=260 Identities=25% Similarity=0.499 Sum_probs=197.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeec-CCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~ 598 (813)
+.+.+.||+|+||.||+|...........||||.++.... ...+++.+|+.++++++||||+++++++.+ +...++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 4566889999999999999865555567899999865322 334678999999999999999999998754 45789999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++|+|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999765 4578999999999999999999964 999999999999999999999999999987644322
Q ss_pred cc--eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 678 KA--IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 678 ~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |.+||......+... ... ... ..
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~----~~~--~~--- 315 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLL----QGR--RL--- 315 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHH----TTC--CC---
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHH----cCC--CC---
Confidence 11 1233457889999999999999999999999999999999 677776443322111 100 110 00
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.....++..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 316 ----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01122356789999999999999999999999999886643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=344.04 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=203.1
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-----cccchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
....|++.+.||+|+||.||+|... .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINR---ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeeEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567888999999999999999874 367899999986421 11346789999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC---EEEe
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARIS 664 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~ 664 (813)
+..++||||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEe
Confidence 9999999999999998887543 3578999999999999999999964 9999999999999986554 9999
Q ss_pred eccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 665 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+. . . ...
T Consensus 176 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~-~----~i~ 245 (351)
T 3c0i_A 176 GFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL---F-E----GII 245 (351)
T ss_dssp CCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH---H-H----HHH
T ss_pred cCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH---H-H----HHH
Confidence 99999876543221 334579999999999999899999999999999999999999997542111 1 0 000
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..... ..+. .....++.+.+++.+||+.||.+|||+.|++++
T Consensus 246 ~~~~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 246 KGKYK--MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HTCCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCC--CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01100 0000 001235678899999999999999999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=336.96 Aligned_cols=252 Identities=23% Similarity=0.255 Sum_probs=196.3
Q ss_pred CHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeecc-ccCCcceEEeEe
Q 045343 512 SYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGFC 588 (813)
Q Consensus 512 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 588 (813)
...++....+++.++||+|+||+||+|... .+++.||||++..... ....++..|+..+.++ +|+||+++++++
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSK---EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEET---TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEEC---CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 345667778889999999999999999874 3678999999864322 1223445555555555 899999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
.++...++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999999 66888887654 5689999999999999999999965 99999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
+++....... .....||++|+|||++.+ .++.++||||||+++|||++|..++..... ...+....
T Consensus 203 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~ 268 (311)
T 3p1a_A 203 LLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGY 268 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTC
T ss_pred eeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccC
Confidence 9987654322 234569999999999876 789999999999999999999777653211 01111111
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. +. ......+.+.+++.+||+.||++|||+.|++++
T Consensus 269 ~~----~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 269 LP----PE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CC----HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC----cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11 00 111235778999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=341.92 Aligned_cols=272 Identities=16% Similarity=0.171 Sum_probs=203.5
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-----------cchhhhheeeeeeccccCCcceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-----------GEKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l 584 (813)
+....|.+.++||+|+||.||+|........+..+|||+....... ..+.+.+|+.++..++|+||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3345577889999999999999998754457788999998754221 12235677788888999999999
Q ss_pred EeEeec----CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-
Q 045343 585 LGFCDE----GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY- 659 (813)
Q Consensus 585 ~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~- 659 (813)
++++.. ....++||||+ +++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 999977 67889999999 999999998877899999999999999999999964 999999999999999877
Q ss_pred -CEEEeeccCccccccCcccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh
Q 045343 660 -NARISDFGLAKLLTLNQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 733 (813)
Q Consensus 660 -~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 733 (813)
.+||+|||+++.+....... ......||..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999998775432211 113456999999999999989999999999999999999999999643222111
Q ss_pred hhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 734 ILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 734 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.. .. ...... .+...... .......++.+.+++..||+.||.+||++.+|++.|+.+.
T Consensus 270 ~~-~~-~~~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQ-TA-KTNLLD-ELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HH-HH-HHHHHH-TTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HH-HH-HHhhcc-cccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 10 00 000000 00000000 0001134568999999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.66 Aligned_cols=259 Identities=29% Similarity=0.419 Sum_probs=212.0
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
++....+.+.+.||+|+||.||+|... ..+..||||.++.. ....+++.+|+.++++++|+||+++++++.+....
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEG---GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccceeEEeecCCCCceeEEEeEec---CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 344556778899999999999999885 35788999998753 33456789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 595 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999753 4589999999999999999999965 9999999999999999999999999999876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... .. ..
T Consensus 162 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~---~~----~~------ 227 (288)
T 3kfa_A 162 TGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LL----EK------ 227 (288)
T ss_dssp CSSSSEE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HH----HT------
T ss_pred cCCcccc-ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----hc------
Confidence 6443221 334457889999999998899999999999999999999 999987544322111 11 00
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
..........++.+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 228 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 228 ---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 0011111234578899999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.05 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=205.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|.+.++||+|+||.||+|... .++..+|+|.+..........+.+|+.++++++|+||+++++++.+....++|||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEK---ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEEC---CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4778899999999999999874 3577899999876544445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC--CCCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~DfGla~~~~~~~ 676 (813)
|+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999999765 4789999999999999999999964 9999999999999974 5789999999998775433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.. .... .+.
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~i~~----~~~~--~~~-- 271 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR----CDWE--FDE-- 271 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH----CCCC--CCS--
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---HHHHh----CCCC--CCc--
Confidence 2 23456999999999999989999999999999999999999999765432111 10100 0000 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++.+||+.||.+|||+.|++++
T Consensus 272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0111235678899999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.59 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=206.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.+.||+|+||.||+|........+..||||.++... ....+++.+|+.++++++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 34667789999999999999987666667789999987542 2335678999999999999999999999865 457899
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999999764 4589999999999999999999964 99999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ... .....
T Consensus 168 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~---~~~----~~~~~------ 233 (281)
T 3cc6_A 168 YYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG---VLE----KGDRL------ 233 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH---HHH----HTCCC------
T ss_pred ccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH---HHh----cCCCC------
Confidence 221 233457889999999998899999999999999999998 999997543322111 110 00000
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.......+.+.+++.+||+.||.+||++.|++++|+.+.+
T Consensus 234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 ---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0111235678899999999999999999999999988654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.26 Aligned_cols=252 Identities=18% Similarity=0.237 Sum_probs=202.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.++||+|+||+||+|... .+++.||||+++.. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccEEEEEEEcCCCEEEEEEEEC---CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3556789999999999999874 35788999998752 22334568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999999865 4688999999999999999999964 99999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~----~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... .+. .... .
T Consensus 223 ~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i~---~~~~--~-- 291 (410)
T 3v8s_A 223 MVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---KIM---NHKN--S-- 291 (410)
T ss_dssp EEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHH---THHH--H--
T ss_pred ccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH---HHH---hccc--c--
Confidence 211 33567999999999998765 7789999999999999999999998654322111 000 0000 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSL--RPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 792 (813)
+..+.....+..+.+|+.+||+.+|.+ ||+++||+++
T Consensus 292 ---~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 ---LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000011123577889999999999988 9999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.94 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=204.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+.+.+.||+|+||.||++... ..++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKN---DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35677899999999999999874 467889999986532 233456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+.+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999999888899999999999999999999964 9999999999999999999999999999876543
Q ss_pred cccceeecccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
.. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+..... ...
T Consensus 169 ~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~----- 236 (384)
T 4fr4_A 169 TQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV----- 236 (384)
T ss_dssp CC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCC-----
T ss_pred Cc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcc-----
Confidence 22 345679999999999974 358899999999999999999999997544322211111110 000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT-MKKVLQ 791 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~ 791 (813)
. .........+.+++.+||+.||.+||+ +++|++
T Consensus 237 ---~--~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---V--TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---C--CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---c--CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 011123577899999999999999998 777765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.66 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=189.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.++||+|+||.||+|... ..++.||||+++... ..+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQK---GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEeeCCCEEEEEEEEC---CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4667789999999999999874 356789999997542 34678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGla~~~~~~~ 676 (813)
|+++++|.+++.....+++..++.++.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999999998888899999999999999999999964 9999999999999975 8899999999998765332
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... + ......... ...
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~-----~~i~~~~~~-~~~--- 272 (349)
T 2w4o_A 206 L---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-F-----RRILNCEYY-FIS--- 272 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-H-----HHHHTTCCC-CCT---
T ss_pred c---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-H-----HHHHhCCCc-cCC---
Confidence 1 23456899999999999989999999999999999999999999755433211 0 111111100 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++.+||+.||++|||+.|++++
T Consensus 273 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 --PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111345678899999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=334.51 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=190.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.++||+|+||.||+|... .++..||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNK---TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp --------------CEEEEEECS---SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEEC---CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 34677789999999999999763 4678999999875432 2346788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 598 YEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
|||++ ++|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 5999988643 3578999999999999999999964 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EK 747 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 747 (813)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.... ....... ..
T Consensus 158 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~ 232 (317)
T 2pmi_A 158 FGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPNESL 232 (317)
T ss_dssp TTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCTTT
T ss_pred cCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChhH
Confidence 6533221 2345689999999999764 689999999999999999999999986544322111 1111100 00
Q ss_pred cccc---------c----ccc----ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDL---------V----EGD----MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~---------~----~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... + ... +...........+.+++.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 0 000 0000111234678999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=338.56 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=199.6
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCc-
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN- 593 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~- 593 (813)
....+.+.+.||+|+||.||+|........+..||||+++... ....+++.+|+.++++++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3445677889999999999999987666677899999986532 2234568899999999999999999999977553
Q ss_pred ----eEEEEeecCCCchhhhhh------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 594 ----RLLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 594 ----~~lV~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
.++|+||+++++|.+++. ....+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 499999999999999984 33568999999999999999999995 59999999999999999999999
Q ss_pred eeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHh
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......... ....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~-- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---DYLL-- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHH--
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HHHH--
Confidence 99999987654432222334457889999999999999999999999999999999 88888754432211 1110
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
..... ......+..+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 264 --~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 --HGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp --TTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11000 0112345678999999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.80 Aligned_cols=249 Identities=23% Similarity=0.252 Sum_probs=196.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.++||+|+||.||+|... .++..||||+++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred HcEEeEEEeeCcCEEEEEEEEc---CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4677899999999999999874 46789999999753 22334567889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..+..++.||+.||+|||++ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999999998888899999999999999999999951 489999999999999999999999999998644332
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+ .....
T Consensus 304 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~i----~~~~~-------- 366 (446)
T 4ejn_A 304 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LI----LMEEI-------- 366 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH----HHCCC--------
T ss_pred cc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH---HH----HhCCC--------
Confidence 21 345679999999999999999999999999999999999999997554322111 10 00100
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
. ........+.+++.+||+.||.+|| +++|++++
T Consensus 367 ~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 R--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0 0112346788999999999999999 99999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.74 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=210.0
Q ss_pred HHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecCC-
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ- 592 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~- 592 (813)
...+.+.+.||+|+||.||+|.... ....++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 3456778999999999999998753 234678999999975432 2345688999999999 7999999999987755
Q ss_pred ceEEEEeecCCCchhhhhhccCC----------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLK----------------PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
..++||||+++++|.+++..... +++..++.++.||++||.|||+. +|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence 48999999999999999976543 78999999999999999999964 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhh
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 735 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l 735 (813)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-- 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--
Confidence 999999999999987655433332344567899999999999899999999999999999998 99999754432211
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
. .......... ........+.+++.+||+.||.+|||+.||+++|+.+++
T Consensus 261 ~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 261 C----RRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp H----HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----HHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 1111110000 111234678899999999999999999999999988764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.86 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=206.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...|.+.+.||+|+||.||+|... ..+..+|+|++........+.+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK---GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC---CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 345778899999999999999874 35678999999876556667899999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE---cCCCCEEEeeccCcccccc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGla~~~~~ 674 (813)
|||+++++|.+++.....+++..++.++.|++.||.|||+. +|+|+||||+||++ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999999998888899999999999999999999964 99999999999999 7889999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
... .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+... ........ ...
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~-~~~- 228 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML-------KIREGTFT-FPE- 228 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCCCC-CCH-
T ss_pred ccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhCCCC-CCc-
Confidence 332 2345689999999998764 8999999999999999999999997644322110 00111000 000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+.+++.+||+.||.+|||+.|++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 ----KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001235678899999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=339.00 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=181.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
++||+|+||.||++... .+++.||||++... ....+.+|+.++.+++ ||||+++++++.++...++||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK---KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEET---TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEEC---CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 67999999999999874 35789999998643 3456788999999997 99999999999999999999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC---CEEEeeccCccccccCcccce
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~DfGla~~~~~~~~~~~ 680 (813)
|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++........
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 99999999888899999999999999999999964 999999999999998665 8999999999876543222
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+... .....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccc
Confidence 234568999999999999999999999999999999999999997543311100001111111111110 00000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....++.+.+++.+||+.||.+|||+.|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11245778999999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=344.99 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=194.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|.+.++||+|+||+||++... ..++.||||+++... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDK---LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEET---TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEEC---CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4778899999999999999874 467799999997542 334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC--EEEeeccCccccccCcc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--ARISDFGLAKLLTLNQS 677 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~DfGla~~~~~~~~ 677 (813)
|+++|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++.......
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 999999999998888899999999999999999999964 9999999999999987765 99999999975432221
Q ss_pred cceeecccccccccCcccccCCCCCCc-cchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....||+.|+|||++.+..++.+ +||||||+++|||++|+.||......... ........ ....
T Consensus 174 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~---------~~~~ 239 (361)
T 3uc3_A 174 ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRIL---------SVKY 239 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHH---------TTCC
T ss_pred ---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHh---------cCCC
Confidence 234569999999999988887665 89999999999999999999754332111 01111111 1111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...........+.+|+.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111111235678899999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.34 Aligned_cols=261 Identities=24% Similarity=0.427 Sum_probs=201.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccC-CcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTR-TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+.+.+.||+|+||.||+|...... ..+..||||.++.... ....++.+|+.++++++|+||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 34556789999999999999876432 2356799999875422 234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999764 6789999999999999999999965 9999999999999999999999999999876543
Q ss_pred cccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 676 QSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 676 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~----~~~~~~~------ 267 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M----KAINDGF------ 267 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----HHHHTTC------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHHCCC------
Confidence 2211 1223346788999999999899999999999999999999 9999975432211 1 1111110
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
........+..+.+++.+||+.||.+||++.+|+++|+.++.
T Consensus 268 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 268 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001112345778999999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=339.65 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=200.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCc-ceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTS-TTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+.+.++||+|+||.||+|....+... ...|++|.+... .....+++.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 3467788999999999999987543221 234688887543 2334567899999999999999999999998754 889
Q ss_pred EEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|+||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999976 45789999999999999999999965 9999999999999999999999999999887554
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
..........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-------~~~~-------- 235 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKG-------- 235 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTT--------
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcC--------
Confidence 43332344557889999999999999999999999999999999 9999976543321111 1110
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
............+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 236 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 -ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 01111122356788999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.05 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=196.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|.+.++||+|+||+||+|... .+..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred chhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 567789999999999999862 56789999986432 223456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++ +|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 99985 888888754 6789999999999999999999964 999999999999999999999999999987643222
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cccccc--
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLDDL-- 751 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~-- 751 (813)
. .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+... ........ ......
T Consensus 156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGG
T ss_pred c--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhchhhhc
Confidence 1 2345689999999999764 58999999999999999999999997654322111 11111110 000000
Q ss_pred ---cccccc-------ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 ---VEGDME-------ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ---~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.++... ........+.+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00011235678899999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.52 Aligned_cols=247 Identities=25% Similarity=0.325 Sum_probs=196.7
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCC
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
.+.||+|+||.||+|... .++..||||+++.......+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~---~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET---ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEc---CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999874 35788999999865445567899999999999999999999999999999999999999
Q ss_pred Cchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE--cCCCCEEEeeccCccccccCcccce
Q 045343 604 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL--DDYYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 604 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll--~~~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 9999988654 5689999999999999999999964 99999999999999 5678999999999987754432
Q ss_pred eecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ... ... .. .... ..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i-~~~----~~-~~~~-----~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNI-LAC----RW-DLED-----EE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHH-HHT----CC-CSCS-----GG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH-Hhc----cC-CCCh-----hh
Confidence 23346999999999999889999999999999999999999999765432211 111 100 00 0000 00
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....+.+.+++.+||+.||.+|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11235778999999999999999999999973
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.60 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=202.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeecc-ccCCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 595 (813)
.+++.+.||+|+||.||++... .+++.||||+++.... ...+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLK---KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred heEEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 4667889999999999999874 4678999999975432 2234578899999887 8999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999998888899999999999999999999964 9999999999999999999999999999864332
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh--hhHHHHHHhhccCccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~ 753 (813)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .............
T Consensus 164 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------- 234 (345)
T 3a8x_A 164 GDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------- 234 (345)
T ss_dssp TCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-------
T ss_pred CCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-------
Confidence 211 34567999999999999999999999999999999999999999753221100 0001111111111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM------KKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~ 792 (813)
.... +......+.+++.+||+.||.+||++ .|++++
T Consensus 235 -~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 235 -QIRI--PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -CCCC--CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -CCCC--CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111 11235678899999999999999995 677654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=342.48 Aligned_cols=248 Identities=27% Similarity=0.333 Sum_probs=203.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 594 (813)
..+.+.+.||+|+||.||+|... .+++.||||+++... ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44667889999999999999874 467899999997532 23345677888888877 899999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999998888899999999999999999999964 999999999999999999999999999986543
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+ .... .
T Consensus 171 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i----~~~~------~ 235 (345)
T 1xjd_A 171 GDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---HSI----RMDN------P 235 (345)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCC------C
T ss_pred CCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----HhCC------C
Confidence 2221 34567999999999999999999999999999999999999999754432211 111 1010 0
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMK-KVLQ 791 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 791 (813)
.. .......+.+++.+||+.||.+||++. ||++
T Consensus 236 ~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 FY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 00 112346788999999999999999997 7764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.27 Aligned_cols=267 Identities=27% Similarity=0.419 Sum_probs=196.9
Q ss_pred CCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEe
Q 045343 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFC 588 (813)
Q Consensus 511 ~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 588 (813)
+...|+....+.+.++||+|+||+||+|... ..+|||+++... ....+.+.+|+.++++++|+||+++++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 3344566667888899999999999999752 249999986432 22345689999999999999999999975
Q ss_pred ecCCceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
.....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence 45678999999999999999964 45789999999999999999999964 99999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
+++...............||+.|+|||.+. +..++.++||||||+++|||++|+.||........ +.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~---- 239 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG---- 239 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH----
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc----
Confidence 998765432222234456999999999986 55678899999999999999999999975443221 111111
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
....... .. .....+++.+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus 240 ~~~~~~~----~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 RGSLSPD----LS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HTSCCCC----TT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccccCcc----hh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111110 00 0112345789999999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.09 Aligned_cols=249 Identities=24% Similarity=0.289 Sum_probs=203.7
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeecc-ccCCcceEEeEeecCCce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 594 (813)
..+++.+.||+|+||.||+|... .+++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET---TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 44677899999999999999874 457899999997532 23345678899999887 899999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++||||+++|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999998888899999999999999999999964 999999999999999999999999999986433
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+ . ..
T Consensus 174 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~~i---~-~~-------- 236 (353)
T 2i0e_A 174 DGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QSI---M-EH-------- 236 (353)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---H-HC--------
T ss_pred CCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH---HHH---H-hC--------
Confidence 2221 34567999999999999999999999999999999999999999754432211 111 1 11
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
.... .......+.+++.+||+.||.+||+ ++||+++
T Consensus 237 ~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 NVAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCC--CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1110 1123567889999999999999995 5777765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=334.38 Aligned_cols=260 Identities=26% Similarity=0.491 Sum_probs=201.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEee-cCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCD-EGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~ 598 (813)
+.+.+.||+|+||.||+|....+......+|||.++.... ...+++.+|+.++++++||||+++++++. .+...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5667899999999999999865555566799999875332 23456889999999999999999999864 455789999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++|+|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999764 5678999999999999999999964 999999999999999999999999999987654332
Q ss_pred c--ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 678 K--AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 678 ~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+......+.. .... . .. ..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~---~-~~--~~--- 251 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLL---Q-GR--RL--- 251 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHH---T-TC--CC---
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHh---c-CC--CC---
Confidence 1 11234557889999999999999999999999999999999 55555433322111 0000 0 00 00
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
......+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 252 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01112346789999999999999999999999999987754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.04 Aligned_cols=274 Identities=25% Similarity=0.358 Sum_probs=208.6
Q ss_pred hcccccceeeeeeEEEEEEec-cCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecC--CceEEE
Q 045343 522 NFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV 597 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 597 (813)
.+.++||+|+||+||++.... ...+++.||||+++.... ...+.+.+|++++++++|+||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 778999999999999986542 334678999999975432 2345689999999999999999999999774 567999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999765 489999999999999999999965 999999999999999999999999999988764432
Q ss_pred c-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 K-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..+.........+.+.+....
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHHHHHHHHHTTC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHHHHHHHHhccc
Confidence 1 11234557888999999998889999999999999999999999986432211000 000000000001111111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
........+..+.+++.+||+.||.+|||+.|+++.|+.+.+.-
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 12222345678999999999999999999999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.15 Aligned_cols=243 Identities=22% Similarity=0.313 Sum_probs=203.3
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--------ccchhhhheeeeeeccccCCcceEEeEee
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTHHKNLVRLLGFCD 589 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 589 (813)
...|.+.+.||+|+||.||+|... .++..||||+++.... ...+.+.+|+.++++++|+||+++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDK---EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEET---TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEEC---CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345777889999999999999874 4678999999975421 13346788999999999999999999999
Q ss_pred cCCceEEEEeecCCC-chhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 590 EGQNRLLVYEFLNNG-TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 590 ~~~~~~lV~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
+.+..++||||+.+| +|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999999877 9999999888899999999999999999999964 999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 987654432 234569999999999988776 78999999999999999999999642110
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....... .....+.+.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 11134678899999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=330.81 Aligned_cols=255 Identities=32% Similarity=0.464 Sum_probs=206.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+.+.+.||+|+||.||+|... ++..||||+++... ...+.+.+|++++++++|+||+++++++. .+..++||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 45677899999999999999864 45689999987542 34567899999999999999999999986 45689999
Q ss_pred eecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++++|.+++.... .+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999997653 689999999999999999999964 99999999999999999999999999998765432
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+.. . ......
T Consensus 164 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~----~~~~~~-------- 227 (279)
T 1qpc_A 164 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---Q----NLERGY-------- 227 (279)
T ss_dssp EEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H----HHHTTC--------
T ss_pred ccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---H----HHhccc--------
Confidence 211 233456789999999988889999999999999999999 89998754332211 1 111110
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
........++.+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 228 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 228 -RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 0011123357889999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=333.30 Aligned_cols=274 Identities=22% Similarity=0.314 Sum_probs=201.8
Q ss_pred HHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeee--eeccccCCcceEEeEeec
Q 045343 513 YKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKNLVRLLGFCDE 590 (813)
Q Consensus 513 ~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~ 590 (813)
..+.....+.+.++||+|+||.||+|.. .+..||||++.... ...+..|.++ ...++|+||+++++++..
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccceEEEeEeecCCCeEEEEEEE-----CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 3445556788899999999999999987 47889999986432 2233344444 444599999999999987
Q ss_pred C----CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCcEEEcCCCCE
Q 045343 591 G----QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYYNA 661 (813)
Q Consensus 591 ~----~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~ 661 (813)
. ...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7 6789999999999999999654 6899999999999999999999431 2299999999999999999999
Q ss_pred EEeeccCccccccCcccc--eeecccccccccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CcC
Q 045343 662 RISDFGLAKLLTLNQSKA--IRTAIRGTKGYVAPEWFRNSTITAK------VDVYSFGVLLLEIISC----------RKS 723 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~k------~DVwS~Gvvl~elltG----------~~p 723 (813)
||+|||+++......... ......||+.|+|||++.+.....+ +||||||+++|||++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999998765433221 1124569999999999988766665 9999999999999999 555
Q ss_pred CCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 724 FDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 724 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
|......... . .................. .....++.+.+.+++.+||+.||.+|||+.||+++|+.+.+..
T Consensus 262 ~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDPS-Y-EDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSCC-H-HHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCCc-h-hhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 5432211100 0 000111111111111110 1112367888999999999999999999999999999887654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.14 Aligned_cols=273 Identities=15% Similarity=0.175 Sum_probs=204.8
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeecccccc-----------chhhhheeeeeeccccCCcce
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQDG-----------EKEFKNEVVVIGQTHHKNLVR 583 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 583 (813)
....|.+.++||+|+||.||+|.+..+. ..++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 3346778899999999999999886432 135789999986532111 112334455667788999999
Q ss_pred EEeEeecC----CceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc--
Q 045343 584 LLGFCDEG----QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-- 656 (813)
Q Consensus 584 l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-- 656 (813)
+++++... ...+|||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 99998765 3489999999 99999999765 6789999999999999999999964 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh
Q 045343 657 DYYNARISDFGLAKLLTLNQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~ 731 (813)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998765432211 1133459999999999999999999999999999999999999998543321
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
... ....... ...+..+++..+. ....+..+.+++..||+.||.+||++.+|++.|+.+++.
T Consensus 269 ~~~--~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 KYV--RDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHH--HHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH--HHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 111 0011110 1112222222111 112357889999999999999999999999999876643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=328.21 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=207.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+.+.||+|+||.||++... ++..||||+++... ...+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred heeeeeEecCCCceeEEEEEec----CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 4667789999999999999874 45689999997643 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++++|.+++... ..+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999765 5689999999999999999999964 9999999999999999999999999999876433211
Q ss_pred ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . ...... . .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----~i~~~~-~-~------ 224 (267)
T 3t9t_A 161 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---E----DISTGF-R-L------ 224 (267)
T ss_dssp S-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTTC-C-C------
T ss_pred c-cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---H----HHhcCC-c-C------
Confidence 1 223457788999999998889999999999999999999 89998754332211 1 111110 0 0
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.........+.+++.+||+.||.+||++.|++++|+++.+
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 -YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111235678899999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.34 Aligned_cols=245 Identities=24% Similarity=0.218 Sum_probs=204.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.+.||+|+||.||++... .++..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEEC---CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4677889999999999999874 367899999986532 2334568889999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999998888899999999999999999999964 9999999999999999999999999999876532
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .....+..
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~~-------- 255 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------EKIVSGKV-------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC--------
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-------HHHHcCCC--------
Confidence 23456899999999999999999999999999999999999999755432111 11111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
.. .......+.+++.+||+.||.+||+ ++||+++
T Consensus 256 ~~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 RF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 00 1123567889999999999999998 8888864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=342.45 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=194.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeecccc--CCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~ 595 (813)
.|.+.+.||+|+||.||++... ++..||||++.... ....+.+.+|+.++.+++| +||+++++++.++...+
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred EEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3667899999999999999763 57789999986432 2233578899999999976 99999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||| +.+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999 57889999999888899999999999999999999965 999999999999997 578999999999887654
Q ss_pred cccceeecccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRN-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... + ...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~----~~~-- 233 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-L----HAI-- 233 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-H----HHH--
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-H----HHH--
Confidence 43333345679999999999864 66888999999999999999999999753321110 0 111
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
+++.............+.+++.+||+.||.+|||+.|++++-
T Consensus 234 -------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 -------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 111111111112245788999999999999999999999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=364.34 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=210.1
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
+....+.+.++||+|+||.||+|... ....||||+++... ...++|.+|+++|++++|+||+++++++.+ +..+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET----TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEEC----CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34455677889999999999999874 34679999997543 335679999999999999999999999876 6789
Q ss_pred EEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 596 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
|||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999999753 5689999999999999999999964 99999999999999999999999999998765
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....++..|+|||++.+..++.++||||||++||||++ |+.||......+.. . .+..+
T Consensus 415 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~----~i~~~------ 480 (535)
T 2h8h_A 415 DNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---D----QVERG------ 480 (535)
T ss_dssp CHHHHT-TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---H----HHHTT------
T ss_pred CCceec-ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcC------
Confidence 332111 223456789999999998899999999999999999999 99999754332211 1 11111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSL 801 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 801 (813)
........+.+.+.+|+.+||+.||++|||+.+|+++|+.+.....
T Consensus 481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 0011122346788999999999999999999999999999876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.08 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=210.6
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeec
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE 590 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 590 (813)
++....+.+.+.||+|+||.||+|...... .....||||.++.... ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 334455677889999999999999875432 1235799999875432 2345688999999999 89999999999999
Q ss_pred CCceEEEEeecCCCchhhhhhcc--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 591 GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 591 ~~~~~lV~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 99999999999999999998643 3578999999999999999999964 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhh
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 735 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l 735 (813)
.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-- 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-- 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--
Confidence 999999999999987655443332334557889999999998899999999999999999999 99998754332211
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
........ ........++.+.+++.+||+.||.+|||+.||+++|+.+.
T Consensus 277 ~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 YKLVKDGY-------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCC-------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111100 00011123567889999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=338.34 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=197.3
Q ss_pred hhcc-cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFK-EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|.+. +.||+|+||.||+|... .+++.||||+++.......+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINL---ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECS---SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCceecCCceEEEEEEEEc---CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4553 67999999999999863 36789999999766555566789999999885 7999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC---EEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~DfGla~~~~~~ 675 (813)
||+++++|.+++.....+++..++.++.||++||+|||+. +|+||||||+|||++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999998888899999999999999999999965 9999999999999998766 999999999866432
Q ss_pred ccc-----ceeecccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh--------hhHH
Q 045343 676 QSK-----AIRTAIRGTKGYVAPEWFRN-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTD 737 (813)
Q Consensus 676 ~~~-----~~~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~--------~l~~ 737 (813)
... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||......... ....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 211 11223458999999999875 45789999999999999999999999764321100 0000
Q ss_pred HHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
............ ... .........+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~i~~~~~~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGKYE-FPD-----KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCCCC-CCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccCcc-cCc-----hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001111111000 000 0001235678999999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.45 Aligned_cols=264 Identities=25% Similarity=0.316 Sum_probs=200.2
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-----ccchhhhheeeeeeccc---cCCcceEEeE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTH---HKNLVRLLGF 587 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~g~ 587 (813)
+....|++.++||+|+||+||+|... .+++.||||+++.... .....+.+|+.++++++ ||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECT---TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 44556788899999999999999863 4678999999874321 12345777888887775 9999999999
Q ss_pred eecCC-----ceEEEEeecCCCchhhhhhccCC--CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 588 CDEGQ-----NRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 588 ~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
+.... ..++||||+. ++|.+++..... +++..++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 97655 4789999997 599999977643 89999999999999999999965 8999999999999999999
Q ss_pred EEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH
Q 045343 661 ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 740 (813)
+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+... ...
T Consensus 159 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~ 232 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIF 232 (308)
T ss_dssp EEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH---HHH
T ss_pred EEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH
Confidence 99999999987653322 344678999999999999999999999999999999999999997654432211 111
Q ss_pred Hhhc---cCcccccc---ccccc-------ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 741 DCYR---NEKLDDLV---EGDME-------ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 741 ~~~~---~~~~~~~~---~~~~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... ........ ..... .....+..+.+.+++.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111 11000000 00000 00011345778999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=366.83 Aligned_cols=252 Identities=28% Similarity=0.394 Sum_probs=201.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 602 (813)
++||+|+||.||+|.+... ..+..||||+++.... ...+++.+|+++|++++|+|||++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCC-CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999976533 3568899999976432 234679999999999999999999999964 56899999999
Q ss_pred CCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc-cee
Q 045343 603 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK-AIR 681 (813)
Q Consensus 603 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~ 681 (813)
+|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+...... ...
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999998888899999999999999999999964 9999999999999999999999999999877544321 112
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
....+|..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..+..+.. ...
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~~---------~~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGER---------MGC 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCC---------CCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC---------CCC
Confidence 33457789999999999999999999999999999998 99999765432211 11111111 111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
...++..+.+++..||+.||++||++.+|++.|+.+.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2234678999999999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.81 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=209.7
Q ss_pred HHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
...+.+.+.||+|+||.||+|.... ....+..||||.+..... ....++.+|+.++++++|+||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 3456778999999999999998752 123567899999875322 2334688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEe
Q 045343 595 LLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 664 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 664 (813)
++||||+++|+|.+++... ..+++..+++++.||+.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEEC
Confidence 9999999999999998642 3568999999999999999999964 99999999999999999999999
Q ss_pred eccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhh
Q 045343 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 743 (813)
Q Consensus 665 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 743 (813)
|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ...
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~ 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------RFV 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------HHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH-------HHH
Confidence 9999987654432222233457889999999998899999999999999999999 88988754322111 111
Q ss_pred ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
....... .....+..+.+++.+||+.||.+|||+.|++++|+++.+
T Consensus 254 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111110 112345678899999999999999999999999988654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=339.78 Aligned_cols=257 Identities=22% Similarity=0.271 Sum_probs=206.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeeecc-ccCCcceEEeEeecCCc
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 593 (813)
..|.+.+.||+|+||.||++....+...++.||||+++... ....+.+.+|++++.++ +|+||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 35777899999999999999886555578899999986532 22345678899999999 69999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++||||+++++|.+++.....+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999999998888899999999999999999999964 99999999999999999999999999998765
Q ss_pred cCcccceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCCcccchhh-hhhHHHHHHhhccCcccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~ 750 (813)
...... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ..+.. .....
T Consensus 211 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~----- 281 (355)
T 1vzo_A 211 ADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RILKS----- 281 (355)
T ss_dssp GGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---HHHHC-----
T ss_pred cCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---HHhcc-----
Confidence 433222 334579999999999985 3478899999999999999999999975432211 11111 11100
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQML 793 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L 793 (813)
.+ .........+.+++.+||+.||.+|| +++|++++.
T Consensus 282 --~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00 01123356788999999999999999 999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.21 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=206.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.+.||+|+||.||+|... .+++.||||+++.... ...+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEEC---CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 45778899999999999999874 3567899999865332 3346788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
+||+++++|.+++.....+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999998888899999999999999999999964 999999999999999999999999999987654332
Q ss_pred cceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...+. .... ...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-----~~~~--~~~--- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-----EKKT--YLN--- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHH-----TTCT--TST---
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhh-----hccc--ccC---
Confidence 222344678999999999987665 77899999999999999999999765432111 11110 0000 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.||.+|||+.|++++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 011235678899999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=331.48 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=206.7
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------cchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
...|.+.+.||+|+||.||++... .++..||||.++..... ..+++.+|+.++++++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEEC---CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 456888999999999999999874 35788999998754322 245688999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----CEEEeecc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFG 667 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~DfG 667 (813)
...++||||+++++|.+++.....+++..++.++.||++||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999999998888899999999999999999999964 999999999999999887 79999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... .. ....
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i-~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NI-TSVS 234 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HH-HTTC
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH-Hhcc
Confidence 9987654322 234568999999999999999999999999999999999999997544322110 00 0000
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. . .++. .....++.+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~-~-~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y-D-FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C-C-CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c-c-cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 0000 001234678899999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.64 Aligned_cols=244 Identities=26% Similarity=0.288 Sum_probs=192.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeee-eeccccCCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
.+++.+.||+|+||.||++... .++..||||+++.... ...+.+..|..+ ++.++||||+++++++.+.+..+
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHK---AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEET---TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEc---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 4678899999999999999874 4678899999975432 223456667766 57789999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999998888899999999999999999999964 9999999999999999999999999999864332
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .... . .
T Consensus 193 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~---~i~~-~--------~ 255 (373)
T 2r5t_A 193 NST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---D---NILN-K--------P 255 (373)
T ss_dssp CCC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH---H---HHHH-S--------C
T ss_pred CCc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---H---HHHh-c--------c
Confidence 221 34567999999999999999999999999999999999999999754432211 1 1111 1 1
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKK 788 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 788 (813)
... .......+.+++.+||+.||.+||++.+
T Consensus 256 ~~~--~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 LQL--KPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCC--CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cCC--CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 110 1123467889999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.92 Aligned_cols=265 Identities=23% Similarity=0.309 Sum_probs=199.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|.+.++||+|+||+||+|... .+++.||||++...... ..+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNR---DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeC---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 3567789999999999999874 35789999988653222 235678899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++.....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999999998888899999999999999999999964 999999999999999999999999999987653322
Q ss_pred cceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH--------HhhccCc-
Q 045343 678 KAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNEK- 747 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~- 747 (813)
. .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ..+....
T Consensus 158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 158 Y--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 1 234568999999999876 568999999999999999999999997655433221111100 0000000
Q ss_pred cc--cccccccc---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LD--DLVEGDME---ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~--~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. .+.++... .......+..+.+++.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00000000 00011345678899999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.71 Aligned_cols=257 Identities=28% Similarity=0.386 Sum_probs=205.1
Q ss_pred Hhhccc-ccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKE-EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~-~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+.+.+ .||+|+||.||+|.... ...+..||||+++.... ...+++.+|+.++++++||||+++++++ +.+..++
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEEC-SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhccCccccccCeeeEeeeecC-CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 455666 89999999999997643 33578899999875422 2245789999999999999999999999 5677899
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++.....+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 999999999999998888899999999999999999999964 99999999999999999999999999998775443
Q ss_pred ccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 677 SKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 677 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .........
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~~----- 239 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGERM----- 239 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCCC-----
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCCC-----
Confidence 221 1122346789999999988888999999999999999999 99999754432211 111111100
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
......+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 240 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 ----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111234578899999999999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=340.60 Aligned_cols=277 Identities=23% Similarity=0.374 Sum_probs=209.5
Q ss_pred HHHhhcccccceeeeeeEEEEEEec-cCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCC--ce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~ 594 (813)
...+.+.+.||+|+||.||++.... ....+..||||++........+++.+|+.++++++|+||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3446778999999999999998532 23467899999997655555667999999999999999999999986654 78
Q ss_pred EEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 595 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
++|+||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999765 4689999999999999999999964 99999999999999999999999999998876
Q ss_pred cCcccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+.................+.+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 443221 1223457788999999998888999999999999999999999876331110000000000000000000111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
............+..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111112234678999999999999999999999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.87 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=194.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccc--cCCcceEEeEeecCCceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~l 596 (813)
|.+.+.||+|+||.||++... .+..||||++.... ....+++.+|+.++.+++ |+||+++++++..++..++
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 677889999999999999763 47789999986432 223467899999999996 5999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||| +.+++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 6788999999888889999999999999999999995 5999999999999995 5799999999998876544
Q ss_pred ccceeecccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRN-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+ ....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~----~~~~-- 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KL----HAII-- 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HH----HHHH--
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-HH----HHHh--
Confidence 3322345679999999999865 3688899999999999999999999975432111 11 1111
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
++.............+.+++.+||+.||.+|||+.||+++
T Consensus 282 -------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 -------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111124678899999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=343.08 Aligned_cols=272 Identities=15% Similarity=0.175 Sum_probs=203.6
Q ss_pred HHhhccccccee--eeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 519 ATDNFKEEVGRG--SFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G--~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
..|++.++||+| +||.||+|... .+++.||||+++... ....+.+.+|+.++++++|||||++++++.+++..
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYK---PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEc---CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 357788999999 99999999874 367899999997543 22335678899999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 595 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999765 6789999999999999999999964 9999999999999999999999999998765
Q ss_pred ccCccc-----ceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh--hHHHHHHhh
Q 045343 673 TLNQSK-----AIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--LTDWAFDCY 743 (813)
Q Consensus 673 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~--l~~~~~~~~ 743 (813)
...... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 322111 11122468999999999987 578999999999999999999999997543322110 000000000
Q ss_pred -----ccCc-------------ccccccc---------cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hh
Q 045343 744 -----RNEK-------------LDDLVEG---------DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LE 794 (813)
Q Consensus 744 -----~~~~-------------~~~~~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~ 794 (813)
..+. ....... .............+.+|+.+||+.||.+|||+.|++++ ++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 0000 0000000 00000112235678999999999999999999999976 44
Q ss_pred cC
Q 045343 795 GV 796 (813)
Q Consensus 795 ~~ 796 (813)
++
T Consensus 339 ~~ 340 (389)
T 3gni_B 339 QI 340 (389)
T ss_dssp GC
T ss_pred HH
Confidence 44
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.76 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=194.7
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCc----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN---- 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 593 (813)
..+++.+.||+|+||.||+|... .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET---TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEc---CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45677899999999999999874 367899999997533 2334678999999999999999999999865432
Q ss_pred -----------------------------------------------------eEEEEeecCCCchhhhhhccC---CCC
Q 045343 594 -----------------------------------------------------RLLVYEFLNNGTLASFLFGNL---KPS 617 (813)
Q Consensus 594 -----------------------------------------------------~~lV~e~~~~gsL~~~l~~~~---~l~ 617 (813)
.++||||+++++|.+++.... ...
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 799999999999999998653 345
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc----------ceeeccccc
Q 045343 618 WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK----------AIRTAIRGT 687 (813)
Q Consensus 618 ~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt 687 (813)
+..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 667899999999999999964 9999999999999999999999999999887654221 112345699
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHH
Q 045343 688 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEK 767 (813)
Q Consensus 688 ~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 767 (813)
+.|+|||++.+..++.++||||||+++|||++|..|+... ... .......... .........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~----~~~~~~~~~~---------~~~~~~~~~ 301 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRI----ITDVRNLKFP---------LLFTQKYPQ 301 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHH----HHHHHTTCCC---------HHHHHHCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHH----HHHhhccCCC---------cccccCChh
Confidence 9999999999999999999999999999999987654211 000 0000111000 011234466
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 768 LVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 768 l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+.+++.+||+.||.+|||+.|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=342.54 Aligned_cols=253 Identities=20% Similarity=0.202 Sum_probs=200.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.+.||+|+||.||++... .+++.||||++++.. ....+.+.+|..++.+++|+||+++++++.+.+..++
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~---~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMK---QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred hEEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3456688999999999999874 467899999997531 2234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999764 4789999999999999999999964 9999999999999999999999999999876544
Q ss_pred cccceeecccccccccCccccc-------CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFR-------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
.... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .+.....
T Consensus 216 ~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~~~~~---- 287 (412)
T 2vd5_A 216 GTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIVHYKE---- 287 (412)
T ss_dssp SCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTHHH----
T ss_pred Cccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH---HHHhccc----
Confidence 3211 23457999999999997 3568999999999999999999999997654322111 0000000
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLR---PTMKKVLQM 792 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~~ 792 (813)
.+..+.. ....+..+.+++.+||+ +|.+| |+++||+++
T Consensus 288 -~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 288 -HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0000000 11235678999999999 99998 699999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.55 Aligned_cols=259 Identities=24% Similarity=0.293 Sum_probs=202.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee----cCCce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD----EGQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~ 594 (813)
..|.+.+.||+|+||.||++... .+++.||||++........+.+.+|+.++++++||||+++++++. .....
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGL---HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEET---TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEec---CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 34677899999999999999874 367899999987655555677899999999999999999999986 34478
Q ss_pred EEEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 595 LLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
++|+||+++++|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999999875 46789999999999999999999965 99999999999999999999999999987
Q ss_pred ccccCcccc-------eeecccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH
Q 045343 671 LLTLNQSKA-------IRTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 671 ~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 740 (813)
......... ......||+.|+|||++.... ++.++||||||+++|||++|+.||......... +....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~- 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV- 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH-
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh-
Confidence 654221110 012245799999999987654 688999999999999999999999632111100 00000
Q ss_pred HhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.. .............+.+++.+||+.||.+|||+.||+++|+.+.
T Consensus 261 ---~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 ---QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ---HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ---hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 0111111234567899999999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=335.33 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=201.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 596 (813)
...|++.+.||+|+||.||++... .+++.||||.++... ....+|++++.++ +||||+++++++.+++..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK---ATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 355788899999999999999874 467899999997532 3456788888887 79999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC----CCEEEeeccCcccc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKLL 672 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~DfGla~~~ 672 (813)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+.+. +.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999998888899999999999999999999964 99999999999998543 35999999999876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........+... ...+...
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~--- 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFS--- 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCC---
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCcc---
Confidence 543322 3345789999999999888889999999999999999999999975432221111111 1111111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........++.+.+++.+||+.||.+||++.|++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111345778899999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=329.30 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=200.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc---chhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..|.+.+.||+|+||.||+|... .+++.||||++....... .+.+.+|+.++++++||||+++++++..++..+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDT---VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEET---TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEc---CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34677899999999999999874 357889999987543222 356889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+|+||+++++|.+++.....+++..++.++.||++||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999998888899999999999999999999964 9999999999999999999999999999876543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... +. ...... ... .
T Consensus 188 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~----~~~~~~-~~~---~- 254 (309)
T 2h34_A 188 KLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MG----AHINQA-IPR---P- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HH----HHHHSC-CCC---G-
T ss_pred cccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HH----HHhccC-CCC---c-
Confidence 2221 234568999999999999899999999999999999999999997543221 10 111110 000 0
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVVEVS 800 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~ 800 (813)
.......+..+.+++.+||+.||.+|| +++++++.|+..+...
T Consensus 255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 001123356788999999999999999 9999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.24 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=204.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.+.||+|+||.||+|... .+++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHE---LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEET---TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4677899999999999999874 367899999997532 1234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999999988889999999999999999999995 599999999999999999999999999998765432
Q ss_pred ccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
. .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... . ....+.
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~----~i~~~~-------- 232 (476)
T 2y94_A 171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF---K----KICDGI-------- 232 (476)
T ss_dssp C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH---H----HHHTTC--------
T ss_pred c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH---H----HHhcCC--------
Confidence 2 334579999999999988765 68999999999999999999999754432111 1 111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... .......+.+++.+||+.||.+|||+.|++++
T Consensus 233 ~~~--p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 FYT--PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cCC--CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 000 11234678899999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=360.91 Aligned_cols=251 Identities=28% Similarity=0.409 Sum_probs=200.3
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCC
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
+||+|+||.||+|..... ..+..||||+++.... ...+++.+|+++|++++|+|||++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECS-SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecC-CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 799999999999987543 2567899999976432 345679999999999999999999999976 5699999999999
Q ss_pred chhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc-eee
Q 045343 605 TLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IRT 682 (813)
Q Consensus 605 sL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~ 682 (813)
+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++.+....... ...
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999999754 5689999999999999999999964 99999999999999999999999999998775433221 112
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccccccccc
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALND 761 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 761 (813)
...++..|+|||++.+..++.++|||||||+||||++ |+.||......+.. ..+..+. .....
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~---------~~~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK---------RMECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------HHHHTTC---------CCCCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCC---------CCCCC
Confidence 2345689999999999999999999999999999998 99999765443211 1111111 01112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 762 IKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 762 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
..++..+.+++..||+.||.+||++.+|++.|+.+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 235678999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.22 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=201.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.+.||+|+||.||+|... .++..||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEEecCCCeEEEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4667789999999999999874 456789999986432 2234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999986554322
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... ...
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~----~~~-------- 224 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---ISR----VEF-------- 224 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHH----TCC--------
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH---HHh----CCC--------
Confidence 2345689999999999999999999999999999999999999975443221110 000 000
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.......+.+.+++.+||+.||.+|||+.||+++-
T Consensus 225 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred --CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00112346788999999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.39 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=194.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|.+.++||+|+||+||+|... .+++.||||+++.... ...+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDT---VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEET---TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEEC---CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4677899999999999999864 4678999999864322 2245678999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-----CCCCEEEeeccCcccc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-----DYYNARISDFGLAKLL 672 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-----~~~~~kl~DfGla~~~ 672 (813)
|||++ |+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 112 ~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99998 59999998888899999999999999999999964 999999999999994 4556999999999876
Q ss_pred ccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc---
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL--- 748 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 748 (813)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.................
T Consensus 188 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 188 GIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred CCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 533221 2345689999999999875 4899999999999999999999999765432211110000000000000
Q ss_pred ----------cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 ----------DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 ----------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.........+.+.+|+.+||+.||.+|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000001100111234678899999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.15 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=203.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|.+.++||+|+||.||+|... .++..||||++..... ...+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhcCcCCeEEEEEEEc---CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4667889999999999999874 3577899999865322 2335688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC---EEEeeccCcccccc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLTL 674 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~DfGla~~~~~ 674 (813)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999998888899999999999999999999964 9999999999999986655 99999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ........ ...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~-~~~- 228 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA-------QIKAGAYD-YPS- 228 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCC-CCT-
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH-------HHHhcccc-CCc-
Confidence 322 234568999999999999999999999999999999999999997544322111 00111110 000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++.+||+.||.+|||+.|++++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 ----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011235678899999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=334.45 Aligned_cols=271 Identities=25% Similarity=0.340 Sum_probs=195.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee-----cCCce
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD-----EGQNR 594 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----~~~~~ 594 (813)
.+.+.+.||+|+||.||+|.. +++.||||+++..... ......|+..+..++|+||+++++.+. .....
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 466778999999999999976 5689999998753211 112234445566689999999998553 23356
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------SAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
++||||+++|+|.+++.... .++..++.++.||++||.|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 89999999999999996554 489999999999999999999431 12999999999999999999999999999
Q ss_pred ccccccCcc------cceeecccccccccCcccccC-------CCCCCccchhhHHHHHHHHHhCCcCCCcccc-hhhhh
Q 045343 669 AKLLTLNQS------KAIRTAIRGTKGYVAPEWFRN-------STITAKVDVYSFGVLLLEIISCRKSFDIEMG-EEYAI 734 (813)
Q Consensus 669 a~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~-~~~~~ 734 (813)
++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+..... .+...
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987654321 111224569999999999976 3556789999999999999999877643322 11000
Q ss_pred hH----------HHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 735 LT----------DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 735 l~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.. ...............+... .......+..+.+++.+||+.||++|||+.||++.|+++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00 0000011111111111110 111234677899999999999999999999999999987754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.14 Aligned_cols=265 Identities=28% Similarity=0.397 Sum_probs=204.3
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
++....+.+.+.||+|+||.||+|.... ....+..||||++... ......++.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 3444567888999999999999998542 2346678999998643 223445788999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhcc-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCE
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNA 661 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ 661 (813)
...++||||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999754 3478999999999999999999964 9999999999999984 4569
Q ss_pred EEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHH
Q 045343 662 RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 740 (813)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~- 258 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFV- 258 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH-
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HHH-
Confidence 9999999986644332222334567899999999988899999999999999999998 99998754332211 111
Q ss_pred HhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
...... .........+.+++.+||+.||.+||++.+|+++|+.+..
T Consensus 259 ---~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 259 ---TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ---HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111000 0112335678899999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=324.33 Aligned_cols=258 Identities=24% Similarity=0.324 Sum_probs=208.5
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+.+.+.||+|+||.||+|... .++..||||++.... ....+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREK---QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhceeeheecCCCCeEEEEEEEc---CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 34677899999999999999874 357789999986532 223456889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++++|.+++.....+++..++.++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999999999888889999999999999999999995 59999999999999999999999999999765432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+... .... ..
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~-~~-------- 228 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVN-VD-------- 228 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHT-TC--------
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhc-cc--------
Confidence 2 234568999999999999899999999999999999999999997544322110 0000 00
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ--MLEGVVEVSLPP 803 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~p~ 803 (813)
.. ........+.+++.+||+.||.+||++.|+++ .+........||
T Consensus 229 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 229 LK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp CC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred cC--CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 00 01123467889999999999999999999996 344433333344
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.95 Aligned_cols=260 Identities=22% Similarity=0.346 Sum_probs=197.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.+.||+|+||.||+|... .++..||||+++... ....+++.+|+.++++++|+||+++++++.+.+..++
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEET---TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEc---CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4778899999999999999874 357899999987422 2234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 597 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
||||+++++|.+++.. ...+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999864 45689999999999999999999964 9999999999999999999999999999876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
...... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ...........
T Consensus 187 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~- 258 (310)
T 2wqm_A 187 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-----KKIEQCDYPPL- 258 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH-----HHHHTTCSCCC-
T ss_pred cCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH-----HHhhcccCCCC-
Confidence 543221 2345689999999999998999999999999999999999999975432211111 11111111111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
......+.+.+++.+||+.||.+|||+.+|+++|+++....
T Consensus 259 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 -------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11123567889999999999999999999999999886553
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.47 Aligned_cols=263 Identities=18% Similarity=0.209 Sum_probs=204.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEe-ecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~ 598 (813)
.|.+.+.||+|+||.||+|... .+++.||||++... ...+++.+|+.++++++|++++..+.++ .+....++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEEESC--SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEccCCCeEEEEEEEc---CCCcEEEEEEecCC--cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 3567789999999999999863 36789999998653 2345789999999999998877666665 5566789999
Q ss_pred eecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE---cCCCCEEEeeccCcccccc
Q 045343 599 EFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 599 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGla~~~~~ 674 (813)
||+ +++|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 999999997 346789999999999999999999965 99999999999999 4888999999999987664
Q ss_pred Ccccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 675 NQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 675 ~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 43211 1234569999999999999999999999999999999999999997643221111111111000000000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
. .....++.+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 241 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 241 V---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp H---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H---------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0 01123567899999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=333.95 Aligned_cols=256 Identities=26% Similarity=0.298 Sum_probs=198.2
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-----ccccchhhhheeeeeeccccCCcceEEeEeecCC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-----FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 592 (813)
...|++.+.||+|+||.||+|... .++..||||++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN---QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeeecCCeEEEEEEEC---CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 355778899999999999999874 46788999998653 2234467899999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhc----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 045343 593 NRLLVYEFLNNGTLASFLFG----------------------------------------NLKPSWNLRTNIAFQIARGL 632 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~~ia~gl 632 (813)
..++||||+++|+|.+++.. ...+++..++.++.||++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999999852 11235677888999999999
Q ss_pred HHhhhcCCCCeeeCCCCCCcEEEcCCC--CEEEeeccCccccccCccc--ceeecccccccccCcccccC--CCCCCccc
Q 045343 633 LYLHEDCSAQIIHCDIKPQNILLDDYY--NARISDFGLAKLLTLNQSK--AIRTAIRGTKGYVAPEWFRN--STITAKVD 706 (813)
Q Consensus 633 ~yLH~~~~~~ivH~dlk~~NIll~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~k~D 706 (813)
+|||+. +|+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999964 999999999999998766 8999999999876432221 11234569999999999975 67889999
Q ss_pred hhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 045343 707 VYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM 786 (813)
Q Consensus 707 VwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 786 (813)
|||||+++|||++|+.||......+... ...... . .. ...........+.+++.+||+.||.+||++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~-~-~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKK-L-CF-----ENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCC-C-CT-----TSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcc-c-cc-----CCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999999999999997554322111 111110 0 00 001111235678899999999999999999
Q ss_pred HHHHHH
Q 045343 787 KKVLQM 792 (813)
Q Consensus 787 ~evl~~ 792 (813)
.|++++
T Consensus 326 ~~~l~h 331 (345)
T 3hko_A 326 MRALQH 331 (345)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.03 Aligned_cols=265 Identities=23% Similarity=0.275 Sum_probs=201.3
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-----cCCcceEEeEee
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----HKNLVRLLGFCD 589 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~ 589 (813)
++....|.+.++||+|+||+||+|... .+++.||||+++.. ....+.+..|+.++++++ |+||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHI---DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEEC---CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 344556778899999999999999874 35788999998742 223445677888888886 999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC----------
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---------- 657 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---------- 657 (813)
..+..++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccch
Confidence 999999999999 999999997653 589999999999999999999954 9999999999999975
Q ss_pred ---------------CCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 045343 658 ---------------YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 722 (813)
Q Consensus 658 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~ 722 (813)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999865432 234568999999999999999999999999999999999999
Q ss_pred CCCcccchhhhhhHHHHHHhhc--------cCcccccccc-ccc-----cc---------------ccHHHHHHHHHHHH
Q 045343 723 SFDIEMGEEYAILTDWAFDCYR--------NEKLDDLVEG-DME-----AL---------------NDIKCVEKLVMVSI 773 (813)
Q Consensus 723 p~~~~~~~~~~~l~~~~~~~~~--------~~~~~~~~~~-~~~-----~~---------------~~~~~~~~l~~l~~ 773 (813)
||......+............. ........+. ... .. ......+.+.+|+.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9976543322111110000000 0000000000 000 00 00011266789999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 045343 774 WCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 774 ~Cl~~dP~~RPt~~evl~~ 792 (813)
+||+.||.+|||+.|++++
T Consensus 338 ~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCChhhCCCHHHHhcC
Confidence 9999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=325.39 Aligned_cols=262 Identities=18% Similarity=0.207 Sum_probs=203.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEe-ecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV 597 (813)
..|.+.+.||+|+||.||+|... ..++.||||++... ....++.+|+.++++++|++++..+..+ .+.+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEc---CCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 45778899999999999999864 36789999987543 2345788999999999988877777666 566678999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE---cCCCCEEEeeccCccccc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLT 673 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGla~~~~ 673 (813)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 9999999974 46789999999999999999999965 99999999999999 788999999999998775
Q ss_pred cCcccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 674 LNQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 674 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 443211 123457999999999999999999999999999999999999999764332211111111000000000
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.. .....++.+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 240 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 240 EV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh---------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 001235688999999999999999999999999988664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=336.23 Aligned_cols=266 Identities=17% Similarity=0.167 Sum_probs=205.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCC-----cceEEEEEEeeccccccchhhhheeeeeeccccCCcce----------
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRT-----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR---------- 583 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 583 (813)
..|.+.+.||+|+||.||+|....+.. .+..||||.+... +.+.+|++++++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 356778999999999999998864211 4678999998642 47889999999999999987
Q ss_pred -----EEeEeec-CCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE
Q 045343 584 -----LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 655 (813)
Q Consensus 584 -----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll 655 (813)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 5677765 67889999999 99999999875 7899999999999999999999965 99999999999999
Q ss_pred cCCC--CEEEeeccCccccccCcccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCccc
Q 045343 656 DDYY--NARISDFGLAKLLTLNQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEM 728 (813)
Q Consensus 656 ~~~~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~ 728 (813)
+.++ .+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 99999999998765432211 1233579999999999999999999999999999999999999998654
Q ss_pred chhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 729 GEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 729 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
..... +....... . .....+.+.... ....++.+.+++.+||+.||.+|||+++|++.|+++.+-
T Consensus 273 ~~~~~-~~~~~~~~-~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 273 PNTED-IMKQKQKF-V-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TCHHH-HHHHHHHH-H-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCHHH-HHHHHHhc-c-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 22111 11111110 0 011111111100 012357789999999999999999999999999887643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=340.58 Aligned_cols=271 Identities=20% Similarity=0.247 Sum_probs=209.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCC--ceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~l 596 (813)
.|.+.+.||+|+||+||+|... .+++.||||+++.... ...+.+.+|++++++++|+||+++++++.+.. ..++
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred ceEEEEEEEcCCCeEEEEEEEC---CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4667889999999999999874 3578999999975432 33456789999999999999999999997655 6799
Q ss_pred EEeecCCCchhhhhhccCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE----cCCCCEEEeeccCc
Q 045343 597 VYEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARISDFGLA 669 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~DfGla 669 (813)
||||+++|+|.+++..... +++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976533 89999999999999999999964 99999999999999 77888999999999
Q ss_pred cccccCcccceeecccccccccCcccccC--------CCCCCccchhhHHHHHHHHHhCCcCCCcccchh-hhhhHHHHH
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRN--------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAF 740 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~ 740 (813)
+....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .........
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87654332 234569999999999865 456789999999999999999999997543211 111111111
Q ss_pred HhhccCccccc---ccc------c--ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 741 DCYRNEKLDDL---VEG------D--MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 741 ~~~~~~~~~~~---~~~------~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
..........+ ... . ............+.+++.+||+.||++||+++|+++.++.+++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111111100 000 0 11112346778889999999999999999999999999887654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.85 Aligned_cols=265 Identities=20% Similarity=0.312 Sum_probs=204.5
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.++||+|+||.||++... .++..||+|+++... ....+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHK---PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEEC---CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34667789999999999999874 357889999987542 22345789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999999998888899999999999999999999952 279999999999999999999999999997654322
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH------------------
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA------------------ 739 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~------------------ 739 (813)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 187 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 187 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred ---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 23456899999999999999999999999999999999999999765432211100000
Q ss_pred -----HHhhccCcc----cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 740 -----FDCYRNEKL----DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 740 -----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......... ..+................+.+++.+||+.||.+|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000 00000101111112235678999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=323.20 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=202.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------cchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
...|.+.+.||+|+||.||++... .+++.||||.++..... ..+++.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK---GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEc---CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 456788899999999999999874 35778999998753221 245689999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----CEEEeecc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFG 667 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~DfG 667 (813)
...++||||+++++|.+++.....+++..++.++.||++||.|||+. +|+|+||||+||+++.++ .+||+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999999998888899999999999999999999964 999999999999998877 89999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+... ......
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT-------NISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH-------HhHhcc
Confidence 9987654322 234568999999999999899999999999999999999999997654322110 000000
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ... .......+.+.+++.+||+.||.+||++.|++++
T Consensus 228 ~~--~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 YD--FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CC--CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cC--Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00 000 0011234678899999999999999999999973
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=333.08 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=203.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 596 (813)
..+.+.+.||+|+||.||+|....+. ....++||.++... ....+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCC-cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 35678899999999999999875321 22246999887532 33456789999999999 89999999999999999999
Q ss_pred EEeecCCCchhhhhhccC----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC
Q 045343 597 VYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN 660 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~ 660 (813)
||||+++++|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997653 689999999999999999999964 9999999999999999999
Q ss_pred EEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHH
Q 045343 661 ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 739 (813)
Q Consensus 661 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 739 (813)
+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------- 250 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------- 250 (327)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------
T ss_pred EEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------
Confidence 99999999975432211 223457889999999988889999999999999999998 9999975433211
Q ss_pred HHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
........ ...........+.+++.+||+.||.+|||+.|++++|+.+.+-.
T Consensus 251 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 251 YEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111110 00111233567899999999999999999999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.10 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=196.5
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.++||+|+||.||++... .++..+|||++..... ...+.+.+|++++++++||||+++++++.+....++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER---SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEc---cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 56788899999999999999874 3577899999876432 2346789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE---cCCCCEEEeeccCcc
Q 045343 598 YEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAK 670 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGla~ 670 (813)
|||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999998543 6789999999999999999999964 99999999999999 456789999999998
Q ss_pred ccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
....... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||......+.... .. .......
T Consensus 176 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~---~~--~~~~~~~- 245 (285)
T 3is5_A 176 LFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK---AT--YKEPNYA- 245 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH--HCCCCCC-
T ss_pred ecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh---hc--cCCcccc-
Confidence 7654322 23456899999999886 4688999999999999999999999976543221110 00 0000000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. .....+.+.+++.+||+.||.+|||+.||+++
T Consensus 246 -~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 -VE-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -C---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -cc-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00124678899999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=329.89 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=200.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+++.+.||+|+||.||+|...........||||+++... ....+++.+|++++++++|+||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45677899999999999999876554455679999986532 233467889999999999999999999997754 89
Q ss_pred EEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|+||+++++|.+++... ..+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999764 5689999999999999999999965 999999999999999999999999999987754
Q ss_pred Ccccc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 675 NQSKA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 675 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~~----- 242 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEGE----- 242 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSCC-----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHccCC-----
Confidence 43221 1223457889999999988888999999999999999999 99999755432211 11111100
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
........+..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 243 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 ----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 001112345788999999999999999999999999988654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=322.78 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=181.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESI---HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeeeecCCCceEEEEEEEc---cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3567789999999999999874 367889999986532 1223568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|+||+++++|.+++... ..+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999865 6789999999999999999999965 9999999999999999999999999999876533
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+....
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~ 228 (278)
T 3cok_A 166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcc
Confidence 221 22356899999999999888999999999999999999999999754322110 0011111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ........+.+++.+||+.||.+|||+.+++++
T Consensus 229 ~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cC--CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 111235678899999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.15 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=196.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecC-CceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-QNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV 597 (813)
..+.+.+.||+|+||.||++.. .+..||||.++.. ...+.+.+|+.++++++|+||+++++++.+. ...++|
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 4567789999999999999976 4678999998753 3456789999999999999999999997554 478999
Q ss_pred EeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 598 YEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||+++++|.+++.... .+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999997653 378999999999999999999964 9999999999999999999999999999865432
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .......
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~~------- 231 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGY------- 231 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHTTTC-------
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCC-------
Confidence 1 22357889999999998899999999999999999998 99999754332211 0111110
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
........+..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 011112345788999999999999999999999999988653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.67 Aligned_cols=257 Identities=28% Similarity=0.390 Sum_probs=205.0
Q ss_pred hhccc-ccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKE-EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~-~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+ .||+|+||.||+|..... ..+..||||+++... ....+++.+|++++++++||||+++++++ +.+..++||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccC-CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 34445 899999999999986432 256789999997642 23356789999999999999999999999 556799999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999999654 5689999999999999999999964 999999999999999999999999999987754332
Q ss_pred cc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 678 KA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 678 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. . ........
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~----~i~~~~~~------ 232 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGKRM------ 232 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H----HHHTTCCC------
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---H----HHhcCCcC------
Confidence 21 1223456889999999988889999999999999999999 99999755432211 1 11111100
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
......+..+.+++..||+.||.+||++.+++++|+.+..
T Consensus 233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1112345788999999999999999999999999988653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.83 Aligned_cols=274 Identities=21% Similarity=0.304 Sum_probs=209.2
Q ss_pred CCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeec--cccCCcceEEeEe
Q 045343 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFC 588 (813)
Q Consensus 511 ~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~ 588 (813)
+...+.....+.+.+.||+|+||.||+|.. .++.||||++... ..+.+..|.+++.. ++||||+++++++
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 344556667888999999999999999987 4788999998643 34567778888877 7899999999999
Q ss_pred ecCC----ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCcEEEcCCC
Q 045343 589 DEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SAQIIHCDIKPQNILLDDYY 659 (813)
Q Consensus 589 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivH~dlk~~NIll~~~~ 659 (813)
.... ..++||||+++|+|.+++... .+++..++.++.||+.||.|||... ..+|+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 8776 789999999999999999654 6899999999999999999999321 34999999999999999999
Q ss_pred CEEEeeccCccccccCcccc--eeecccccccccCcccccCCC------CCCccchhhHHHHHHHHHhC----------C
Q 045343 660 NARISDFGLAKLLTLNQSKA--IRTAIRGTKGYVAPEWFRNST------ITAKVDVYSFGVLLLEIISC----------R 721 (813)
Q Consensus 660 ~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~------~~~k~DVwS~Gvvl~elltG----------~ 721 (813)
.+||+|||+++......... ......||+.|+|||++.+.. ++.++||||||+++|||++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998765443211 123456999999999997653 33689999999999999999 6
Q ss_pred cCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 722 KSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 722 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.||........ ....+ ............+.. .....+..+.+.+++.+||+.||.+|||+.||+++|+.+.+
T Consensus 265 ~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 265 LPYYDLVPSDP-SVEEM-RKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CTTTTTSCSSC-CHHHH-HHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccCcCcc-cHHHH-HHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 67754322110 00011 111111111111111 01123567889999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=336.54 Aligned_cols=247 Identities=25% Similarity=0.317 Sum_probs=198.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+...+.||+|+||.||+|... .++..||||++..... ...+++.+|++++++++||||+++++++.+++..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc---cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 44667789999999999999864 3678999999864322 22356889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+||||+. |+|.+++. ....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9999997 67877775 456789999999999999999999965 999999999999999999999999999987643
Q ss_pred CcccceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||......... ...... ....
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~-~~~~- 272 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-ESPA- 272 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-CCCC-
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CCCC-
Confidence 2 2356899999999984 567899999999999999999999999754322111 111111 0000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.......+.+.+++.+||+.||.+|||+.+++++.
T Consensus 273 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11112356788999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=326.24 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=205.0
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec----
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE---- 590 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---- 590 (813)
+.....+.+.+.||+|+||.||+|... .+++.||||+++.. .+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHR---IDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEET---TTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred chhccccceeeeeccCCceEEEEEEEc---CCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 445567788899999999999999874 35789999998653 3467899999999999999999998854
Q ss_pred ------------CCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 591 ------------GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 591 ------------~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 34579999999999999999654 5789999999999999999999964 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhH
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 736 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~ 736 (813)
.++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+.... .
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~-- 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K-- 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H--
T ss_pred CCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H--
Confidence 999999999999987654332 234568999999999999999999999999999999999998864211 0
Q ss_pred HHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 045343 737 DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSL 801 (813)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 801 (813)
.........+. ......+.+++.+||+.||.+|||+.|++++|+.+...+.
T Consensus 227 --~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 --FFTDLRDGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --HHHHHHTTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --HHHHhhccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 01111111111 1124567899999999999999999999999988765443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.78 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=197.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeec----CCce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 594 (813)
+.+.++||+|+||.||+|... ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeeccCCCCeEEEEeEec---CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456678999999999999874 467789999987532 2234568899999999999999999998865 3458
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLT 673 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~~~ 673 (813)
++||||+++++|.+++.....+++..++.++.||+.||.|||+. ..+|+|+||||+|||++ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999998888899999999999999999999964 12399999999999998 78999999999997654
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......... ............
T Consensus 184 ~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~~-- 250 (290)
T 1t4h_A 184 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPAS-- 250 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCGG--
T ss_pred ccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH------HHHHhccCCccc--
Confidence 332 234568999999998874 5899999999999999999999999754332111 111111111100
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.||.+|||+.|++++
T Consensus 251 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 ------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111223578899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.36 Aligned_cols=255 Identities=18% Similarity=0.188 Sum_probs=202.7
Q ss_pred HHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeeccccccchhhhheeeeeeccc---cCCcceEEeEeecCC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQ 592 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 592 (813)
...+.+.++||+|+||+||+|.... ....++.||||+++.. ...++..|++++.+++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3456677899999999999995322 1246788999998653 3456677777777765 999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhc-----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC----------
Q 045343 593 NRLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---------- 657 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---------- 657 (813)
..++||||+++|+|.+++.. ...+++..++.++.||++||+|||+ .+|+||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999973 4678999999999999999999995 59999999999999998
Q ss_pred -CCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhH
Q 045343 658 -YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 736 (813)
Q Consensus 658 -~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~ 736 (813)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 899999999999876533333334556799999999999999999999999999999999999999864322110
Q ss_pred HHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhcCcCC
Q 045343 737 DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLR-PTMKKVLQMLEGVVEV 799 (813)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~evl~~L~~~~~~ 799 (813)
.+..... .. ...+.+.+++..|++.+|.+| |+++++.+.|+++++-
T Consensus 294 ----------~~~~~~~----~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 ----------KPEGLFR----RL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ----------EECSCCT----TC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------eechhcc----cc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0111111 00 124567788999999999998 6888888888876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.98 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=203.9
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
...+.+.+.||+|+||.||++... .+++.||||.++.......+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR---LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEEC---CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 456788899999999999999874 36788999999865444556789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE---cCCCCEEEeeccCcccccc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGla~~~~~ 674 (813)
|||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||++ +.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999998888899999999999999999999964 99999999999999 7889999999999976543
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .... ...... .
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i----~~~~~~-~--- 226 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEKI----KEGYYE-F--- 226 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HHCCCC-C---
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HcCCCC-C---
Confidence 21 2334689999999999999999999999999999999999999975433211 1111 111000 0
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+..+.+++.+||+.||.+|||+.|++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 --ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001111335678999999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=341.42 Aligned_cols=264 Identities=22% Similarity=0.359 Sum_probs=190.3
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccc-cCCcceEEeEeecCC--
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQ-- 592 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-- 592 (813)
...|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++.++. |+||+++++++...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDR---RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEET---TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEEC---CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345778899999999999999874 467899999986432 223456788999999997 999999999997544
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++||||++ ++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 6899999998 689888865 4688999999999999999999964 9999999999999999999999999999875
Q ss_pred ccCc-------------------ccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhh
Q 045343 673 TLNQ-------------------SKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 732 (813)
Q Consensus 673 ~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~ 732 (813)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4311 1111344679999999999976 5789999999999999999999999976543222
Q ss_pred hhhHHHHHHhhccCc---cccccc------------------cccc------------ccccHHHHHHHHHHHHHhcccC
Q 045343 733 AILTDWAFDCYRNEK---LDDLVE------------------GDME------------ALNDIKCVEKLVMVSIWCIQED 779 (813)
Q Consensus 733 ~~l~~~~~~~~~~~~---~~~~~~------------------~~~~------------~~~~~~~~~~l~~l~~~Cl~~d 779 (813)
... +........ +..+.. .... ........+.+.+|+.+||+.|
T Consensus 240 ~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 240 LER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 111 111110000 000000 0000 0000123467899999999999
Q ss_pred CCCCCCHHHHHHH
Q 045343 780 PSLRPTMKKVLQM 792 (813)
Q Consensus 780 P~~RPt~~evl~~ 792 (813)
|.+|||+.|++++
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=331.17 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=194.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
|.+.++||+|+||+||+|... .++..||||+++.... .....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSK---LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred eEEEEEEcCCCCEEEEEEEEC---CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 567789999999999999874 3567899999865332 223357789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 998 5888888654 4689999999999999999999964 9999999999999999999999999999865433221
Q ss_pred ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc---
Q 045343 679 AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG--- 754 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--- 754 (813)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.......................
T Consensus 157 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 157 --YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred --cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 234568999999999876 56899999999999999999999999865543322111111000011111111100
Q ss_pred ------ccc----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 ------DME----ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ------~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 00011235678899999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=333.58 Aligned_cols=265 Identities=26% Similarity=0.354 Sum_probs=200.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|.+.+.||+|+||.||+|... .+++.||||++...... ..+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNK---DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEET---TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEEC---CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4677789999999999999874 35788999998653222 234578899999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999999988888899999999999999999999965 999999999999999999999999999987654322
Q ss_pred cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH--------HHhh-----
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCY----- 743 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~----- 743 (813)
. .....||..|+|||.+.+. .++.++||||||+++|||++|+.||......+........ ...+
T Consensus 180 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 V--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred c--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 1 2345689999999999875 6899999999999999999999999765443211100000 0000
Q ss_pred -ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 -RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 -~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.............++.+.+++.+||+.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0001111111100000112346789999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.74 Aligned_cols=250 Identities=26% Similarity=0.295 Sum_probs=204.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3566789999999999999874 367899999996532 2334568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 597 VYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++++||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999997654 489999999999999999999965 999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhh-hhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~ 753 (813)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+..... ....
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----~~~~----- 406 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EVPE----- 406 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----HCCC-----
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----cccc-----
Confidence 322 3345799999999999998999999999999999999999999986533211 11111111 0000
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.........+.+++.+||+.||.+|| +++||+++
T Consensus 407 -----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 -----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01112357789999999999999999 78999865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=342.10 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=193.7
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--------cccchhhhheeeeeeccccCCcceEEeE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTHHKNLVRLLGF 587 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~ 587 (813)
.....|.+.+.||+|+||+||+|... .+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFER---KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEEC---CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34456788899999999999999874 456899999986532 1123358899999999999999999999
Q ss_pred eecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC---CCEEEe
Q 045343 588 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARIS 664 (813)
Q Consensus 588 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~ 664 (813)
+.. +..++||||+++|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.+ ..+||+
T Consensus 209 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 209 FDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp EES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred Eec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 854 55899999999999999999888999999999999999999999964 99999999999999754 459999
Q ss_pred eccCccccccCcccceeecccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH
Q 045343 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 665 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +...
T Consensus 285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~--- 356 (419)
T 3i6u_A 285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ--- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH---
T ss_pred ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH---
Confidence 9999987654321 334679999999999863 5678899999999999999999999975432211 1000
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......... . .......+.+.+++.+||+.||.+|||+.|++++
T Consensus 357 -i~~~~~~~~-~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 -ITSGKYNFI-P-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HHTTCCCCC-H-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HhcCCCCCC-c-----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 011110000 0 0011235678999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=347.33 Aligned_cols=258 Identities=24% Similarity=0.289 Sum_probs=192.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecC------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 591 (813)
.|++.++||+|+||+||+|... ..++.||||++.... ....+++.+|+.++++++||||+++++++...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CeEEEEEeecCCCeEEEEEEEC---CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4667889999999999999874 357889999997542 23345688999999999999999999999654
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.+.++||||++++ |.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 3569999999865 5555543 488999999999999999999964 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc------
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------ 745 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------ 745 (813)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+......
T Consensus 214 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~---~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 214 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLGTPCPEFM 287 (464)
T ss_dssp ---CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSCCHHHH
T ss_pred cCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHHH
Confidence 654321 345679999999999999999999999999999999999999997654322111 01110000
Q ss_pred -------------C-c-----cccccccccc---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 -------------E-K-----LDDLVEGDME---ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 -------------~-~-----~~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. . .......... ..........+.+|+.+||+.||.+|||++|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 0000000000 00011235678999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.79 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=186.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEee--------
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCD-------- 589 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~-------- 589 (813)
..+++.++||+|+||.||+|... ..++.||||++........+.+.+|+.++.++. |+||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV---GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET---TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEEC---CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 35677899999999999999874 367789999986655555667899999999996 999999999983
Q ss_pred cCCceEEEEeecCCCchhhhhhc---cCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCcEEEcCCCCEEEe
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSAQ--IIHCDIKPQNILLDDYYNARIS 664 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~--ivH~dlk~~NIll~~~~~~kl~ 664 (813)
.....++|+||+. |+|.+++.. ...+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 3335799999996 799888864 45689999999999999999999954 6 9999999999999999999999
Q ss_pred eccCccccccCcccc----------eeecccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh
Q 045343 665 DFGLAKLLTLNQSKA----------IRTAIRGTKGYVAPEWF---RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731 (813)
Q Consensus 665 DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~ 731 (813)
|||+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432211 01134589999999998 56678899999999999999999999996432211
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+................+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus 261 -------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 -------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000011111234577899999999999999999999999887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.34 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=204.7
Q ss_pred CCHHHHHHHHhhcc-cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeecc-ccCCcceEEe
Q 045343 511 FSYKELEEATDNFK-EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLG 586 (813)
Q Consensus 511 ~~~~el~~~~~~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g 586 (813)
|...+.....|.+. ++||+|+||.||+|... .+++.||||+++.... ....++.+|+.++.++ +|+||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISK---STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 44455555666666 88999999999999874 3578999999875432 2345788999999998 4699999999
Q ss_pred EeecCCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCE
Q 045343 587 FCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNA 661 (813)
Q Consensus 587 ~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ 661 (813)
++.+....++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999998654 6789999999999999999999964 9999999999999987 7899
Q ss_pred EEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH
Q 045343 662 RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 741 (813)
||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... ...
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~ 247 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN---ISQ 247 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---HHh
Confidence 9999999987654322 2345699999999999999999999999999999999999999976543221110 000
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. .. ...........+.+.+++.+||+.||.+|||++|++++
T Consensus 248 ~----~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 V----NV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp T----CC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c----cc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00 00001112345678899999999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.54 Aligned_cols=245 Identities=23% Similarity=0.284 Sum_probs=188.0
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeec-cccCCcceEEeEeec----CCceEEEEe
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDE----GQNRLLVYE 599 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lV~e 599 (813)
+.||+|+||+||++... .++..||||+++. ...+.+|+.++.+ .+|+||+++++++.. ....++|||
T Consensus 68 ~~LG~G~~g~V~~~~~~---~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp EEEEEETTEEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeccCeEEEEEEEC---CCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 68999999999999874 4678999999863 2456778877744 489999999998865 567899999
Q ss_pred ecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCEEEeeccCcccccc
Q 045343 600 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKLLTL 674 (813)
Q Consensus 600 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGla~~~~~ 674 (813)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999999999865 3589999999999999999999964 9999999999999997 78999999999987653
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh-hhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~ 753 (813)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+ ..+... .
T Consensus 217 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~-~-- 286 (400)
T 1nxk_A 217 HNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE-F-- 286 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC-C--
T ss_pred CCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc-C--
Confidence 321 23457899999999999999999999999999999999999999754432110 000000 000000 0
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
...........+.+|+.+||+.||.+|||+.|++++-
T Consensus 287 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 287 ---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0000113457789999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=344.65 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=201.0
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
....|.+.++||+|+||+||+|... ..+..+|||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDK---VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEET---TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEEC---CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3456888999999999999999874 357789999987542 23356789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCEEEeeccCccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLAKL 671 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGla~~ 671 (813)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999999998888899999999999999999999964 9999999999999976 45599999999987
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||......+... ........ .
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~-~ 256 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR-------KVEKGKYT-F 256 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCC-C
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCCCC-C
Confidence 654322 33457999999999986 468999999999999999999999997654322111 11111100 0
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+ .....+..+.+++.+||+.||.+|||+.|++++
T Consensus 257 ~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 011235678899999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.02 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=204.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.+.||+|+||.||++... ..++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDA---DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEEC---CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4667789999999999999874 356789999986542 1234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++.....+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999999998888899999999999999999999964 99999999999999999999999999998765332
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+... .. ..... ..
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~-~~~~~------~~ 234 (294)
T 2rku_A 170 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RI-KKNEY------SI 234 (294)
T ss_dssp CC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH-HTTCC------CC
T ss_pred cc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-hhccC------CC
Confidence 22 234568999999999998889999999999999999999999997554322110 00 11100 00
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+||+.||.+|||+.|++++
T Consensus 235 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 ----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11234678899999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=341.63 Aligned_cols=237 Identities=14% Similarity=0.126 Sum_probs=185.6
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhhee---eeeeccccCCcceEE-------eE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEV---VVIGQTHHKNLVRLL-------GF 587 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~ 587 (813)
+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQ---ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC----CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred EEEcceeecCCCEEEEEEEEC---CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 456789999999999999864 35789999999743 223346788999 667777899999998 65
Q ss_pred eecCC-----------------ceEEEEeecCCCchhhhhhccCCCC-------HHHHHHHHHHHHHHHHHhhhcCCCCe
Q 045343 588 CDEGQ-----------------NRLLVYEFLNNGTLASFLFGNLKPS-------WNLRTNIAFQIARGLLYLHEDCSAQI 643 (813)
Q Consensus 588 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~l~-------~~~~~~i~~~ia~gl~yLH~~~~~~i 643 (813)
+.+.+ ..++||||+ +|+|.+++.....++ +..++.++.||++||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 689999997654343 488889999999999999965 99
Q ss_pred eeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCC-----------CCCCccchhhHHH
Q 045343 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-----------TITAKVDVYSFGV 712 (813)
Q Consensus 644 vH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~k~DVwS~Gv 712 (813)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 1344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 713 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 713 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
++|||++|+.||........ ...+... ....++.+.+++.+||+.||.+|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999964332110 1111110 0123467889999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.71 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=204.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.+.||+|+||.||++... ..++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDA---DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4667789999999999999874 356789999986542 1234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++.....+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999999998888899999999999999999999964 99999999999999999999999999998765332
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||......+... .. ..... ..
T Consensus 196 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~-~~~~~------~~ 260 (335)
T 2owb_A 196 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RI-KKNEY------SI 260 (335)
T ss_dssp CC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH-HHTCC------CC
T ss_pred cc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HH-hcCCC------CC
Confidence 22 234568999999999999889999999999999999999999997544322110 00 00000 00
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+++.+||+.||.+|||+.|++++
T Consensus 261 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 ----PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11234578899999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=340.75 Aligned_cols=260 Identities=18% Similarity=0.223 Sum_probs=204.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc-CCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~ 598 (813)
.|.+.++||+|+||.||+|... ..+..||||++... ....++..|++++..++| +++..+..++.+.+..+|||
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEET---TTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEEC---CCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 4667899999999999999874 35789999987653 234568899999999987 55666666677788889999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE---cCCCCEEEeeccCcccccc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGla~~~~~ 674 (813)
||+ +++|.+++.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 9999999974 56789999999999999999999964 99999999999999 6889999999999987764
Q ss_pred Ccccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 675 NQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 675 ~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
..... ......||..|+|||.+.+..++.++||||||++||||++|+.||.......................+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 43211 1225679999999999999999999999999999999999999998654322211111111111111111
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.+. ...++++.+++..||+.+|++||++.+|+++|+.+.
T Consensus 239 ~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 239 ALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 110 123568899999999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=342.49 Aligned_cols=265 Identities=20% Similarity=0.288 Sum_probs=185.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeec-----CC
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQ 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~ 592 (813)
.|.+.+.||+|+||+||+|... .+++.||||++..... ...+++.+|+.++++++|+||+++++++.. ..
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDK---LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp TEEECCC-------CEEEEEEC---C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CeEEeeEeeecCCeEEEEEEEC---CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4678899999999999999874 3678999999865322 234568899999999999999999999843 35
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++||||+ +++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 689999987 579999998888899999999999999999999964 9999999999999999999999999999876
Q ss_pred ccCccc-------------------------ceeecccccccccCcccc-cCCCCCCccchhhHHHHHHHHHh-------
Q 045343 673 TLNQSK-------------------------AIRTAIRGTKGYVAPEWF-RNSTITAKVDVYSFGVLLLEIIS------- 719 (813)
Q Consensus 673 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvvl~ellt------- 719 (813)
...... ......+||+.|+|||++ ....++.++|||||||+||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 532211 113445789999999976 55679999999999999999999
Q ss_pred ----CCcCCCcccch-----------------hhhhhHHHHHHhhccCc---ccc--------c---c----cccccccc
Q 045343 720 ----CRKSFDIEMGE-----------------EYAILTDWAFDCYRNEK---LDD--------L---V----EGDMEALN 760 (813)
Q Consensus 720 ----G~~p~~~~~~~-----------------~~~~l~~~~~~~~~~~~---~~~--------~---~----~~~~~~~~ 760 (813)
|+++|.+.... ........+...+.... +.. . . ...+. ..
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 365 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA-ER 365 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG-GG
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH-HH
Confidence 55555432210 00000011111111000 000 0 0 00000 00
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......+.+|+.+||+.||.+|||++|++++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11235678899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.39 Aligned_cols=267 Identities=20% Similarity=0.257 Sum_probs=198.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeec------
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------ 590 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------ 590 (813)
..|.+.++||+|+||.||+|... .+++.||||++..... .....+.+|+.++++++|+||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR---KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET---TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cceeEEEEEecCCCcEEEEEEEC---CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35778899999999999999874 3678999999864322 224467899999999999999999999876
Q ss_pred --CCceEEEEeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 591 --GQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 591 --~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
....++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999986 66666654 46789999999999999999999964 99999999999999999999999999
Q ss_pred CccccccCccc--ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 668 LAKLLTLNQSK--AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 668 la~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
+++.+...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....................
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99876532221 11234568999999999876 4579999999999999999999999986554332221111111111
Q ss_pred cCccccccccc----c----ccccc-H------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NEKLDDLVEGD----M----EALND-I------KCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~~~~~~~~~~----~----~~~~~-~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........... . ..... . .....+.+|+.+||+.||.+|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111100000 0 00000 0 113568899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=343.23 Aligned_cols=253 Identities=26% Similarity=0.323 Sum_probs=204.9
Q ss_pred HHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 517 ~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
....|++.++||+|+||+||++... .++..||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEET---TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEEC---CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 4567889999999999999999874 357889999986532 23456789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc---CCCCEEEeeccCccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKL 671 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGla~~ 671 (813)
++|+||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999999998888899999999999999999999964 999999999999995 556799999999987
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.. ..+ .......
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i----~~~~~~~- 241 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---KRV----ETGKYAF- 241 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHTCCCS-
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhCCCCC-
Confidence 654322 334569999999999876 5899999999999999999999999765432211 111 1111100
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+..+.+++.+||+.||.+|||+.|++++
T Consensus 242 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000112335678899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.60 Aligned_cols=262 Identities=26% Similarity=0.317 Sum_probs=195.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCC-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 592 (813)
.|.+.+.||+|+||.||+|... .+++.||||++..... ...+++.+|+.++++++|+||+++++++....
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDG---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp SEEEEEEC------CEEEEEET---TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred eEEEeEEeeecCCeEEEEEEEC---CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4667789999999999999874 4678999999864322 22456889999999999999999999997653
Q ss_pred -ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 593 -NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 593 -~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 8899999876 5688999999999999999999964 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc-----
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN----- 745 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 745 (813)
.... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||........... +......
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~~~~~~ 249 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE---IMKVTGTPPAEF 249 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCHHH
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCHHH
Confidence 6532 334578999999999877 6789999999999999999999999976543221110 1110000
Q ss_pred ------Cc-------ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcC
Q 045343 746 ------EK-------LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVE 798 (813)
Q Consensus 746 ------~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~ 798 (813)
.. +.......... ........+.+|+.+||+.||.+|||+.|++++ ++.+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 00 00000000000 011235678899999999999999999999985 555443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=324.10 Aligned_cols=261 Identities=24% Similarity=0.339 Sum_probs=184.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+.+.+.||+|+||.||+|... .++..||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCA---PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhheeccccceEEEEEEEC---CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34667899999999999999764 356789999986432 23456788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc--------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 598 YEFLNNGTLASFLFG--------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
|||+++++|.+++.. ...+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999863 35689999999999999999999964 9999999999999999999999999999
Q ss_pred cccccCccc---ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 670 KLLTLNQSK---AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 670 ~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
......... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhcc
Confidence 876533211 11234568999999999876 568999999999999999999999997654322111 00000
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....................+.+++.+||+.||.+||++.|++++
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 -DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000000000000111234678899999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=357.36 Aligned_cols=249 Identities=24% Similarity=0.287 Sum_probs=205.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeecc-ccCCcceEEeEeecCCce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 594 (813)
..+++.+.||+|+||.||+|... .+++.||||+++.. .....+.+..|..++..+ +|+||+++++++.+.+..
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEES---SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cceEEEEEEccCCCEEEEEEEEC---CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44677889999999999999874 46778999999753 233445678888888887 799999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+|||||+++|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+||||+.++++||+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999888899999999999999999999964 999999999999999999999999999986443
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....||+.|+|||++.+..++.++||||||++||||++|+.||......+.. ..+.. .
T Consensus 495 ~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~--------~ 557 (674)
T 3pfq_A 495 DGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------QSIME--------H 557 (674)
T ss_dssp TTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHS--------S
T ss_pred CCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH-------HHHHh--------C
Confidence 3221 34567999999999999999999999999999999999999999865432211 11111 1
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM-----KKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~~ 792 (813)
.... .......+.+|+..||+.||.+||++ +||+++
T Consensus 558 ~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 558 NVAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CCCC--CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCCC--CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1111 11235778999999999999999997 777653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=320.09 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=196.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeeeccccCCcceEEeEe--ecCCc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFC--DEGQN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~ 593 (813)
.|.+.+.||+|+||.||++... .++..||||.++... ....+.+.+|+.++++++|+||+++++++ .+...
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBT---TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ceeEeeEEecCCCeEEEEEEEC---CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4677899999999999999863 467889999987532 23346789999999999999999999998 45568
Q ss_pred eEEEEeecCCCchhhhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 594 RLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.++||||++++ |.+++.. ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999887 6666654 45689999999999999999999964 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
..............|+..|+|||++.+.. .+.++||||||+++|||++|+.||......... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------ENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------HHHhcCCC-
Confidence 65433333234566999999999997654 377999999999999999999999754322111 11111110
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ........+.+++.+||+.||.+|||+.|++++
T Consensus 231 -------~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -------A--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------C--CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------C--CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 011235678899999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=321.69 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=200.0
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
.....+.+.+.||+|+||.||+|... .++..||||.+... ...+++.+|+.++.+++|+||+++++++.+....+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK---ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET---TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC---CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 33455677889999999999999874 35789999998753 34567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
+||||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 9999999999999997 356789999999999999999999964 999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .. ........
T Consensus 178 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~~--- 245 (314)
T 3com_A 178 TMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MI-PTNPPPTF--- 245 (314)
T ss_dssp TBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-HHSCCCCC---
T ss_pred hccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HH-hcCCCccc---
Confidence 3221 234568999999999999899999999999999999999999997543221110 00 00000000
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+.+++.+||+.||.+|||+.+++++
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111235678899999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=344.65 Aligned_cols=254 Identities=26% Similarity=0.313 Sum_probs=207.2
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 592 (813)
+....|.+.+.||+|+||.||++... ..+..||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccCceEEeeEEecCCCEEEEEEEEC---CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567888999999999999999874 467899999986532 233456899999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE---cCCCCEEEeeccCc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLA 669 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~DfGla 669 (813)
..++|+||+.+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999999999888999999999999999999999965 99999999999999 56789999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.. . ........
T Consensus 177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~----~i~~~~~~ 245 (484)
T 3nyv_A 177 THFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---K----KVEKGKYT 245 (484)
T ss_dssp HHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCCC
T ss_pred EEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---H----HHHcCCCC
Confidence 87654322 234569999999999876 6899999999999999999999999765432211 1 11111110
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ........++.+.+++.+||+.||.+|||+.|++++
T Consensus 246 ~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 F------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp C------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 001112345778899999999999999999999964
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=327.69 Aligned_cols=263 Identities=24% Similarity=0.295 Sum_probs=198.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-----ccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
..|.+.+.||+|+||.||+|... .+++.||||+++.... ...+.+.+|+.++++++|+||+++++++.+...
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECS---SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred cccEEEeEEeecCCEEEEEEEEC---CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 45778899999999999999864 3578899999864321 123467899999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.++||||+++ +|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 888888654 4688999999999999999999965 9999999999999999999999999999876
Q ss_pred ccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Ccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKL 748 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~ 748 (813)
...... .....||+.|+|||.+.+. .++.++||||||+++|||++|..||......+.. ......... ...
T Consensus 163 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 163 GSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQW 237 (346)
T ss_dssp TSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTS
T ss_pred cCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCChhhh
Confidence 533221 3345689999999999764 5789999999999999999999998765432211 111111110 111
Q ss_pred ccc---cc---cc-ccc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 749 DDL---VE---GD-MEA----LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 749 ~~~---~~---~~-~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
... .+ .. ... .........+.+++.+||+.||.+|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 00 00 000 00012347889999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=329.57 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=202.6
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--------cchhhhheeeeeecc-ccCCcceEEeEe
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQT-HHKNLVRLLGFC 588 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~g~~ 588 (813)
...|.+.+.||+|+||.||+|... .++..||||+++..... ..+.+.+|+.++.++ +||||+++++++
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHR---ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhcccceEEecCCCEEEEEEEEC---CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 345667789999999999999874 35789999998653211 134578899999999 799999999999
Q ss_pred ecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 589 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 589 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
......++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999999999999998888899999999999999999999964 999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccC------CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRN------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
+..+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ...
T Consensus 247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~i--- 317 (365)
T 2y7j_A 247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML---RMI--- 317 (365)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---
T ss_pred ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH---HHH---
Confidence 987664332 234679999999999863 35788999999999999999999999754322111 111
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...... ...+. ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 318 -~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 -MEGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -HHTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HhCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011000 00000 01234678899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.94 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=195.2
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecCCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 604 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 604 (813)
..||+|+||.||+|... .++..||||.+........+.+.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDL---SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp CEEEECSSSEEEEEEET---TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEeecCcEEEEEEEEC---CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 47999999999999874 356789999997655555677999999999999999999999999999999999999999
Q ss_pred chhhhhhcc---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCccccccCcccce
Q 045343 605 TLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAI 680 (813)
Q Consensus 605 sL~~~l~~~---~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~ 680 (813)
+|.+++... ..+++..+..++.||++||.|||+. +|+|+||||+||+++. ++.+||+|||++.........
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-- 179 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-- 179 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence 999999754 3457888999999999999999964 9999999999999987 899999999999876532211
Q ss_pred eecccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 681 RTAIRGTKGYVAPEWFRNST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 681 ~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....|++.|+|||++.+.. ++.++||||||+++|||++|+.||........... .. ... . ..+.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~--~~~--~-----~~~~--- 246 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KV--GMF--K-----VHPE--- 246 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HH--HHH--C-----CCCC---
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hh--ccc--c-----cccc---
Confidence 23456899999999997643 78999999999999999999999975432221110 00 000 0 0001
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.||++||++.|++++
T Consensus 247 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 -IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111335678899999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.93 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=203.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDN---RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHhhhhcccCCeEEEEEEEC---CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 567789999999999999864 367899999987543 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++++|.+++.. ..+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 9999999999865 4689999999999999999999964 9999999999999999999999999999876543322
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... . ....... ..
T Consensus 176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~----~~~~~~~-----~~--- 239 (303)
T 3a7i_A 176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF---L----IPKNNPP-----TL--- 239 (303)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---H----HHHSCCC-----CC---
T ss_pred -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH---H----hhcCCCC-----CC---
Confidence 234568999999999999899999999999999999999999997543322111 0 0001000 01
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.......+.+++..||+.||.+|||+.|++++.
T Consensus 240 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 -EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 112346788999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=324.75 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=199.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEee--cCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 595 (813)
.|++.+.||+|+||.||++... .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++. .....+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRK---SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred heeeehhccCCCCcEEEEEEEC---CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4667789999999999999874 367899999987532 223456889999999999999999999874 466789
Q ss_pred EEEeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 596 LVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.. ..+|+|+||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999653 34899999999999999999999751 112999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
+........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. .. ....+...
T Consensus 164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~i~~~~~~ 234 (279)
T 2w5a_A 164 RILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG----KIREGKFR 234 (279)
T ss_dssp HHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHTCCC
T ss_pred eeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH----HHhhcccc
Confidence 876543211 2234689999999999998999999999999999999999999975532211 11 11111111
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
.+ ....+..+.+++.+||+.||.+||++.||++++..
T Consensus 235 ~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 RI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 11335778999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.60 Aligned_cols=251 Identities=11% Similarity=0.052 Sum_probs=180.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeecc--ccCCcceEE-------eEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT--HHKNLVRLL-------GFC 588 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~ 588 (813)
+.+.++||+|+||.||+|... .+++.||||+++.... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDV---ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred eeeeeeccCCCCEEEEEEEEC---CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 567789999999999999874 3678999999976432 2234577785544444 699988755 333
Q ss_pred ecC-----------------CceEEEEeecCCCchhhhhhcc-CCCCHHHH------HHHHHHHHHHHHHhhhcCCCCee
Q 045343 589 DEG-----------------QNRLLVYEFLNNGTLASFLFGN-LKPSWNLR------TNIAFQIARGLLYLHEDCSAQII 644 (813)
Q Consensus 589 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~gl~yLH~~~~~~iv 644 (813)
... ...++||||++ |+|.+++... ..+.+..+ +.++.||++||+|||+. +|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 322 23799999999 8999999763 34566666 78889999999999964 999
Q ss_pred eCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCc
Q 045343 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRK 722 (813)
Q Consensus 645 H~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~ 722 (813)
||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876432 224457799999999987 679999999999999999999999
Q ss_pred CCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 723 SFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 723 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
||.......... +.....................++.+.+++.+||+.||++|||+.|+++
T Consensus 292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 997653321110 0000001111111111111234678899999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.69 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=197.1
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeecc-ccCCcceEEeEeecCCce
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 594 (813)
...+.+.+.||+|+||.||+|... .+++.||||+++... .....++.+|+..+.++ +||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR---LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc---CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 456778899999999999999874 357899999987532 22345688899999998 999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-------------
Q 045343 595 LLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD------------- 657 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~------------- 657 (813)
++||||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999764 5689999999999999999999964 9999999999999984
Q ss_pred ------CCCEEEeeccCccccccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccch
Q 045343 658 ------YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730 (813)
Q Consensus 658 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~ 730 (813)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|.+++.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 4479999999998765432 23489999999999776 566899999999999999999887643211
Q ss_pred hhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 731 EYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...........+ .......+.+++.+||+.||.+|||+.|++++
T Consensus 237 ---------~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ---------WHEIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---------HHHHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------HHHHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 011111111111 11235678899999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.10 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=195.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|.+.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQ---LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEEC---CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4667789999999999999874 357789999986532 2234568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++++|.+++.....+++..+..++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999998888899999999999999999999965 99999999999999999999999999998765432
Q ss_pred ccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
. .....+++.|+|||.+.+... +.++||||||+++|||++|+.||........ .. ....... .
T Consensus 166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~~~-~----- 229 (276)
T 2h6d_A 166 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FK----KIRGGVF-Y----- 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCCC-C-----
T ss_pred c---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HH----HhhcCcc-c-----
Confidence 2 233468999999999988765 6899999999999999999999975432211 11 1111100 0
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+.+++.+||+.||.+|||+.|++++
T Consensus 230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011234678899999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=358.92 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=207.9
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
++....+.+.+.||+|+||.||+|........+..||||+++.... ...+.+.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3444567788999999999999999876555678899999875322 23467899999999999999999999985 456
Q ss_pred eEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.++||||+++|+|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 89999999999999999755 4689999999999999999999964 9999999999999999999999999999876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.. ..+. .....
T Consensus 542 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~----~~~~~-- 611 (656)
T 2j0j_A 542 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIE----NGERL-- 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH----HTCCC--
T ss_pred CCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH----cCCCC--
Confidence 5432221 233457789999999998899999999999999999997 99999754332211 1111 11000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
......+..+.+++.+||+.||.+|||+.||++.|+.++
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011234578899999999999999999999999998765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=343.21 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=200.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-------------ccchhhhheeeeeeccccCCcceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-------------DGEKEFKNEVVVIGQTHHKNLVRLL 585 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~ 585 (813)
..|.+.++||+|+||+||+|... ..+..||||++..... ...+++.+|+.++++++||||++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEK---NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEET---TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cceEEEeEecccCCeEEEEEEEC---CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34677899999999999999874 3567899999875321 2245688999999999999999999
Q ss_pred eEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC---CEE
Q 045343 586 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---NAR 662 (813)
Q Consensus 586 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~---~~k 662 (813)
+++.+....++||||+++|+|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999999998888899999999999999999999964 999999999999998765 699
Q ss_pred EeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh
Q 045343 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 663 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
|+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+... .
T Consensus 190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~ 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK-------K 258 (504)
T ss_dssp ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------H
T ss_pred EEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------H
Confidence 999999987654322 334569999999999874 68999999999999999999999998654322111 1
Q ss_pred hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........ + .......+..+.+++.+||+.||.+|||+.|++++
T Consensus 259 i~~~~~~~--~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEKGKYYF--D----FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHCCCCC--C----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCC--C----ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111000 0 00001235678999999999999999999999865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=338.23 Aligned_cols=198 Identities=26% Similarity=0.418 Sum_probs=165.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecC-----C
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----Q 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~ 592 (813)
.|.+.+.||+|+||.||+|... .+++.||||+++.... ...+.+.+|+.++++++|+||+++++++... .
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDK---NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CEEEEEEEeecCCEEEEEEEEC---CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4777899999999999999874 4678999999975322 2345788999999999999999999999766 5
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++||||+. ++|.+++.....+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 7899999986 59999999888899999999999999999999964 9999999999999999999999999999876
Q ss_pred ccCccc--------------------ceeecccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCcCC
Q 045343 673 TLNQSK--------------------AIRTAIRGTKGYVAPEWF-RNSTITAKVDVYSFGVLLLEIISCRKSF 724 (813)
Q Consensus 673 ~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvvl~elltG~~p~ 724 (813)
...... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 543211 113456799999999986 5567999999999999999999865554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.63 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=197.8
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+++.+.||+|+||.||+|... .++..||+|.+........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNK---ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEET---TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEc---CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34677889999999999999874 357789999997665556678899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++++|.+++.. ...+++..++.++.||++||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999999875 46689999999999999999999964 999999999999999999999999999765332111
Q ss_pred cceeecccccccccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWF-----RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l-----~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
. .....|+..|+|||++ ....++.++||||||+++|||++|+.||........ + ...... .....
T Consensus 173 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~-~~~~~- 242 (302)
T 2j7t_A 173 K--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAKS-DPPTL- 242 (302)
T ss_dssp C-------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHHS-CCCCC-
T ss_pred c--cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H----HHHhcc-CCccc-
Confidence 1 2335689999999998 466788999999999999999999999975433211 0 111111 00000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......+..+.+++.+||+.||.+|||+.+++++
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1112335678899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.95 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=193.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecC--------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-------- 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------- 591 (813)
.|.+.+.||+|+||.||+|... .+++.||||++... .....+|++++++++|+||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDI---ESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEET---TTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred eEEEEEEEEeccCEEEEEEEEC---CCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4677899999999999999874 46789999998643 23446799999999999999999998432
Q ss_pred ------------------------------CceEEEEeecCCCchhhhhh----ccCCCCHHHHHHHHHHHHHHHHHhhh
Q 045343 592 ------------------------------QNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHE 637 (813)
Q Consensus 592 ------------------------------~~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gl~yLH~ 637 (813)
...++||||++ ++|.+.+. ....+++..+..++.||++||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23789999998 47766664 45678999999999999999999994
Q ss_pred cCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCccccccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHH
Q 045343 638 DCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLL 715 (813)
Q Consensus 638 ~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~ 715 (813)
.+|+||||||+|||++ .++.+||+|||+++.+..... .....+|+.|+|||.+.+. .++.++|||||||++|
T Consensus 160 ---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 160 ---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp ---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred ---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 5999999999999998 688999999999987654332 2345689999999998775 4899999999999999
Q ss_pred HHHhCCcCCCcccchhhhhhHHHHHHhhcc---------------CcccccccccccccccHHHHHHHHHHHHHhcccCC
Q 045343 716 EIISCRKSFDIEMGEEYAILTDWAFDCYRN---------------EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDP 780 (813)
Q Consensus 716 elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 780 (813)
||++|+.||......+... . ....... .....+.............+..+.+|+.+||+.||
T Consensus 234 ell~g~~pf~~~~~~~~~~--~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLV--R-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHH--H-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHH--H-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999998654432211 1 1111000 00011111111111122345678999999999999
Q ss_pred CCCCCHHHHHHH
Q 045343 781 SLRPTMKKVLQM 792 (813)
Q Consensus 781 ~~RPt~~evl~~ 792 (813)
.+|||+.|++++
T Consensus 311 ~~R~t~~e~l~h 322 (383)
T 3eb0_A 311 DLRINPYEAMAH 322 (383)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=322.50 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=198.1
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--------cccchhhhheeeeeeccccCCcceEEeE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTHHKNLVRLLGF 587 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~ 587 (813)
.....|.+.+.||+|+||.||+|... .+++.||||.+.... ......+.+|+.++++++|+||++++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFER---KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEc---CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 34567888999999999999999874 367899999986431 1123458899999999999999999999
Q ss_pred eecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC---EEEe
Q 045343 588 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARIS 664 (813)
Q Consensus 588 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~ 664 (813)
+..+. .++||||+++++|.+++.....+++..++.++.||++||.|||+. +|+||||||+|||++.++. +||+
T Consensus 84 ~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 84 FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred EcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 87654 899999999999999998888899999999999999999999964 9999999999999987654 9999
Q ss_pred eccCccccccCcccceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHH
Q 045343 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741 (813)
Q Consensus 665 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 741 (813)
|||+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||........ +.....
T Consensus 160 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~- 233 (322)
T 2ycf_A 160 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT- 233 (322)
T ss_dssp CCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH-
T ss_pred cCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH-
Confidence 9999987653221 23356899999999974 56788999999999999999999999975433211 111110
Q ss_pred hhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
...... .+. ......+.+.+++.+||+.||.+||++.|+++
T Consensus 234 ---~~~~~~--~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 ---SGKYNF--IPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HTCCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---hCcccc--Cch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 011000 000 00123567899999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=340.35 Aligned_cols=249 Identities=27% Similarity=0.316 Sum_probs=201.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
+.+.+.||+|+||.||++... .+++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMK---ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 455678999999999999874 367899999997532 22345688999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 598 YEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999998753 4689999999999999999999964 99999999999999999999999999998765
Q ss_pred cCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh-hhhhHHHHHHhhccCcccccc
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~ 752 (813)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+...+ . .
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~-~------- 407 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---L-E------- 407 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---H-H-------
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---h-h-------
Confidence 44322 234579999999999999999999999999999999999999997643211 11111111 1 0
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM-----KKVLQ 791 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 791 (813)
.... .....+..+.+++.+||+.||.+||++ ++|++
T Consensus 408 -~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 -QAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -cccC--CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0000 112335778899999999999999975 66664
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=319.91 Aligned_cols=258 Identities=20% Similarity=0.295 Sum_probs=198.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeec--CCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE--GQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~ 595 (813)
..|.+.++||+|+||+||+|... .+++.||||+++. ...+.+.+|+.++++++ |+||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEEC---CCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 34677899999999999999874 3678999999864 23567899999999997 9999999999987 56789
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~~ 674 (813)
+||||+++++|.+++. .+++..++.++.||++||+|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999885 378899999999999999999964 999999999999999776 899999999987654
Q ss_pred CcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH--------HHhhcc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRN 745 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~ 745 (813)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .... ......
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HHHHHHHCHHHHHHHHHH
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH-HHHHHhcCCchhhhHHHH
Confidence 432 234568999999999877 678999999999999999999999996443321110 0000 000000
Q ss_pred Cc------c--------cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EK------L--------DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~------~--------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. . ...................+.+++.+||+.||.+|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0 00000000111112246788999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=336.18 Aligned_cols=198 Identities=24% Similarity=0.319 Sum_probs=169.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc------ccCCcceEEeEeecCC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT------HHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~ 592 (813)
..|++.++||+|+||+||+|... ..++.||||+++.. ....+++.+|+.+++.+ +|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~---~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDH---KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEEC---CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 34777899999999999999874 35789999999753 22335677788877776 5779999999999999
Q ss_pred ceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC--EEEeeccC
Q 045343 593 NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN--ARISDFGL 668 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~DfGl 668 (813)
..++||||+. ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999996 6898888765 3589999999999999999999965 9999999999999999887 99999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 729 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~ 729 (813)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9765432 2345789999999999999999999999999999999999999976544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.08 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=202.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC------cceEEeEeecCC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN------LVRLLGFCDEGQ 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~ 592 (813)
..|.+.+.||+|+||.||+|... ...+..||||+++.. ....+.+.+|+.++++++|++ ++++++++.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDH--KAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET--TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEec--CCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 45778899999999999999863 235789999998753 233456888999999987765 999999999999
Q ss_pred ceEEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-------------
Q 045343 593 NRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD------------- 657 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~------------- 657 (813)
..++||||+ +++|.+++.... .+++..++.++.||++||+|||+. +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999997654 678999999999999999999964 9999999999999987
Q ss_pred ------CCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchh
Q 045343 658 ------YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731 (813)
Q Consensus 658 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~ 731 (813)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999875432 234568999999999999999999999999999999999999997654433
Q ss_pred hhhhHHHHHHhhccC-----ccccc---------------------ccccc-cccccHHHHHHHHHHHHHhcccCCCCCC
Q 045343 732 YAILTDWAFDCYRNE-----KLDDL---------------------VEGDM-EALNDIKCVEKLVMVSIWCIQEDPSLRP 784 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~-----~~~~~---------------------~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 784 (813)
............... ..... ..+.. .........+.+.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 221111110000000 00000 00000 0011234578899999999999999999
Q ss_pred CHHHHHHH
Q 045343 785 TMKKVLQM 792 (813)
Q Consensus 785 t~~evl~~ 792 (813)
|+.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999865
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.62 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=183.6
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--cchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
..+++.++||+|+||+||++... .+++.||||+++..... ..+.+.++...++.++||||+++++++.+++..++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHV---PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEec---CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 45677899999999999999874 36789999998653221 12234455555788899999999999999999999
Q ss_pred EEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 597 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
||||++ |+|.+++.. ...+++..++.++.||+.||.|||+. .+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 588777653 46789999999999999999999952 38999999999999999999999999999876
Q ss_pred ccCcccceeecccccccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWF----RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||......... +. ...... .
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~----~~~~~~-~ 231 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LK----QVVEEP-S 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HH----HHHHSC-C
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HH----HHhccC-C
Confidence 54322 2334689999999996 5567889999999999999999999999753322111 11 111110 0
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
.. ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQ--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00 111123567899999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.34 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=202.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---------ccchhhhheeeeeeccc-cCCcceEEeEee
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---------DGEKEFKNEVVVIGQTH-HKNLVRLLGFCD 589 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 589 (813)
.|.+.+.||+|+||.||+|... .+++.||||.++.... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ccceeeeecCCCceEEEEEEEc---CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4667789999999999999874 4678999999865321 12345788999999995 999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+....++||||+++++|.+++.....+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999998888899999999999999999999964 9999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhh
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFR------NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 743 (813)
........ .....+++.|+|||++. ...++.++||||||+++|||++|+.||......... ...
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~---- 241 (298)
T 1phk_A 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RMI---- 241 (298)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----
T ss_pred hhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH---HHH----
Confidence 87654322 23456899999999885 456788999999999999999999999754332111 100
Q ss_pred ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...... . ........+..+.+++.+||+.||.+|||+.|++++
T Consensus 242 ~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 011100 0 001112345778999999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=334.21 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=191.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecC----C--c
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG----Q--N 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----~--~ 593 (813)
.|.+.+.||+|+||.||+|... ..++.||||++... .+.+.+|++++++++|+|||++++++... + .
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEEC---CCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3667789999999999999884 35789999998643 23456799999999999999999988432 1 2
Q ss_pred eEEEEeecCCCchhhhhh----ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-CCEEEeeccC
Q 045343 594 RLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-YNARISDFGL 668 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~DfGl 668 (813)
.++||||+++ +|.+.+. ....+++..++.++.||++||+|||+ .+|+||||||+||||+.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999986 5555543 35678999999999999999999995 599999999999999955 6789999999
Q ss_pred ccccccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc--
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-- 745 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 745 (813)
++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .... ..+..
T Consensus 204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~-~~lg~p~ 277 (420)
T 1j1b_A 204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEII-KVLGTPT 277 (420)
T ss_dssp CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH-HHHCSCC
T ss_pred hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHhCCCC
Confidence 987654322 2345789999999998765 7899999999999999999999999865432211 1111 11000
Q ss_pred --------Cccccccccccc-----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 --------EKLDDLVEGDME-----ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 --------~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....+...+.+. ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000111011110 00111235788999999999999999999999965
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.11 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=196.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+.+.||+|+||.||+|... ..+|||+++... ....+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWH------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEES------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred HeEEeeEeccCCceEEEEEEEc------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 4567799999999999999863 248999886432 23346788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
+||+++++|.+++.... .+++..++.++.||++||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999998754 689999999999999999999965 999999999999998 6799999999987653221
Q ss_pred c---cceeecccccccccCcccccC---------CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 677 S---KAIRTAIRGTKGYVAPEWFRN---------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 677 ~---~~~~~~~~gt~~y~aPE~l~~---------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
. ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.....+... .. ..
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~-~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------WQ-MG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH------HH-HH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-hc
Confidence 1 111233458999999999864 34788999999999999999999999755432211 01 11
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
........ ....+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 257 ~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 257 TGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred cCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 112245688999999999999999999999999988755
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=329.60 Aligned_cols=257 Identities=26% Similarity=0.333 Sum_probs=180.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecC------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------ 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 591 (813)
.|.+.+.||+|+||.||+|... .++..||||++..... ...+.+.+|+.++++++|+||+++++++...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp TEEEEEECC----CCEEEEEET---TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEeeEEeecCCeEEEEEEEC---CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4667789999999999999864 4678999999865322 2345688999999999999999999998654
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
...++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 5679999998 7899998865 5689999999999999999999954 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EK 747 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 747 (813)
.... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||........... +...... +.
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~~ 253 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAEL 253 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHH
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHH
Confidence 5432 234578999999999877 6789999999999999999999999976543221111 1111100 00
Q ss_pred cccc--------ccc--ccccc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDDL--------VEG--DMEAL----NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~~--------~~~--~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
+..+ +.. ..... ........+.+|+.+||+.||.+|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 000 00000 001224678899999999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.91 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=194.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCc------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN------ 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 593 (813)
.|.+.+.||+|+||+||+|... ....+|+|++... .....+|++++++++|+||+++++++.....
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~----~~~~~aikk~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLV----ESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEET----TTEEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred eEEEeEEEeeCCCeEEEEEEEC----CCCeEEEEEEecC----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4677899999999999999874 3345899987542 2234579999999999999999999854433
Q ss_pred eEEEEeecCCCchhhhh---hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCc
Q 045343 594 RLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLA 669 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla 669 (813)
.++||||++++.+.... .....+++..++.++.||++||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 78999999886554433 2356789999999999999999999964 999999999999999 7999999999999
Q ss_pred cccccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH--------
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-------- 740 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-------- 740 (813)
+....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+.........
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 87654332 2345689999999998765 58999999999999999999999998655432211100000
Q ss_pred Hh----hccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 045343 741 DC----YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV 796 (813)
Q Consensus 741 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 796 (813)
.. ........+................+.+|+.+||+.||.+|||+.|++++ ++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00 00001111111111111112245688999999999999999999999976 4444
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.45 Aligned_cols=257 Identities=20% Similarity=0.333 Sum_probs=202.5
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccc-----------------hhhhheeeeeeccccCCc
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-----------------KEFKNEVVVIGQTHHKNL 581 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~-----------------~~~~~E~~~l~~l~h~ni 581 (813)
..|.+.+.||+|+||.||+|.. ++..||||++........ +.+.+|+.++++++||||
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred CceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3467789999999999999987 678999999975422211 678999999999999999
Q ss_pred ceEEeEeecCCceEEEEeecCCCchhhh------hhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 582 VRLLGFCDEGQNRLLVYEFLNNGTLASF------LFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 582 v~l~g~~~~~~~~~lV~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
+++++++.+.+..++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ ..+|+|+||||+||
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence 9999999999999999999999999999 665 5678999999999999999999996 15999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCC-CCCC-ccchhhHHHHHHHHHhCCcCCCcccchh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITA-KVDVYSFGVLLLEIISCRKSFDIEMGEE 731 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-k~DVwS~Gvvl~elltG~~p~~~~~~~~ 731 (813)
+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999876543 13446689999999999877 5666 9999999999999999999997654311
Q ss_pred hhhhHHHHHHhhccCccccc------ccc---cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 732 YAILTDWAFDCYRNEKLDDL------VEG---DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~------~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. +. ........... ..+ .............+.+++.+||+.||.+|||+.|++++
T Consensus 260 ~--~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 E--LF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp H--HH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H--HH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 11 11111111000 000 00000012345788999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.48 Aligned_cols=269 Identities=21% Similarity=0.261 Sum_probs=201.6
Q ss_pred CHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc--------cCCcce
Q 045343 512 SYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH--------HKNLVR 583 (813)
Q Consensus 512 ~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~ 583 (813)
...++....|.+.++||+|+||+||+|... .+++.||||+++.. ....+.+.+|+.++++++ |+||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDI---QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEec---CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 333444566888899999999999999874 36789999999743 233457889999999986 788999
Q ss_pred EEeEee----cCCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 045343 584 LLGFCD----EGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 657 (813)
Q Consensus 584 l~g~~~----~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~ 657 (813)
+++++. +....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+. .+|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~ 182 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEec
Confidence 999987 566889999999 45555555433 5689999999999999999999952 28999999999999987
Q ss_pred CC-------------------------------------------------CEEEeeccCccccccCcccceeecccccc
Q 045343 658 YY-------------------------------------------------NARISDFGLAKLLTLNQSKAIRTAIRGTK 688 (813)
Q Consensus 658 ~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 688 (813)
++ .+||+|||++...... .....||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~ 257 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR 257 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence 75 7999999999876543 23346899
Q ss_pred cccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh---hhHHHHHHhhcc-------------------C
Q 045343 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCYRN-------------------E 746 (813)
Q Consensus 689 ~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~---~l~~~~~~~~~~-------------------~ 746 (813)
.|+|||++.+..++.++|||||||++|||++|+.||......+.. ............ .
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 999999999999999999999999999999999999765432211 001111111100 0
Q ss_pred ccccccccc---------ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDDLVEGD---------MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+..+.+.. .......+....+.+|+.+||+.||.+|||+.||+++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000 0011234567889999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.82 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=192.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeec------CC
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE------GQ 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~ 592 (813)
.+.+.+.||+|+||.||+|... .+++.||||++... ....+++.+|+.++.++ +|+||+++++++.. ..
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred cEEEEEEeccCCCEEEEEEEEC---CCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3567789999999999999874 35678999998753 33456789999999999 79999999999976 45
Q ss_pred ceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 593 NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 789999999999999999754 5688999999999999999999964 99999999999999999999999999998
Q ss_pred ccccCcccceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 671 LLTLNQSKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 671 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
........ .....|++.|+|||++. +..++.++||||||+++|||++|+.||.......... .. ..
T Consensus 178 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~ 248 (326)
T 2x7f_A 178 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI-PR 248 (326)
T ss_dssp ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-HH
T ss_pred ecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------Hh-hc
Confidence 76533211 23456899999999987 5568899999999999999999999997543221110 00 00
Q ss_pred CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...... ........+.+++.+||+.||.+||++.+++++
T Consensus 249 ~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 249 NPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111 111235678899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.86 Aligned_cols=258 Identities=24% Similarity=0.291 Sum_probs=189.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 592 (813)
.|.+.+.||+|+||.||+|... ..+..||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred heeEeeeeEecCCEEEEEEEEC---CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4667789999999999999874 367889999987532 223456889999999999999999999997654
Q ss_pred -ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 593 -NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 593 -~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 67999999975 7877775 3578999999999999999999964 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc-------
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR------- 744 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------- 744 (813)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.....
T Consensus 177 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 177 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN---KVIEQLGTPCPEFM 250 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHC-CCCCCHHHH
T ss_pred cccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHH
Confidence 653321 234578999999999999999999999999999999999999997654321110 0000000
Q ss_pred ------------c-C-----cccccccccc---cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 ------------N-E-----KLDDLVEGDM---EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ------------~-~-----~~~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. . .......... ...........+.+|+.+||+.||.+|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 0 0000000000 000012336788999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.66 Aligned_cols=266 Identities=21% Similarity=0.232 Sum_probs=186.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCc-----
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----- 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 593 (813)
..+.+.+.||+|+||.||+|... .++..||||++... ......+.+|++.+..++|+||+++++++.....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEK---STGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp TTEEEC----------CEEEEET---TTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred cceEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 44667789999999999999874 35789999998653 2334456777888888999999999999865433
Q ss_pred --eEEEEeecCCCchh---hhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeecc
Q 045343 594 --RLLVYEFLNNGTLA---SFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFG 667 (813)
Q Consensus 594 --~~lV~e~~~~gsL~---~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfG 667 (813)
.++||||++++.+. .++.....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++. ++.+||+|||
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 78999999875333 2334556788999999999999999999943 459999999999999996 8999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH-------
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA------- 739 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~------- 739 (813)
+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...............
T Consensus 178 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 178 SAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp TCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 9987664332 2345689999999998665 4899999999999999999999999865432211110000
Q ss_pred -HHhhccCcc-ccccc-c-----cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 740 -FDCYRNEKL-DDLVE-G-----DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 740 -~~~~~~~~~-~~~~~-~-----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......... ....+ . .............+.+|+.+||+.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 00000 0 00001112346789999999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=321.64 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=193.5
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccc--cCCcceEEeEeecCCce
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 594 (813)
..|.+.+.||+|+||.||++... ++..||||++.... ....+.+.+|+.++.+++ |+||+++++++.+++..
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34677889999999999999763 47789999986432 223467899999999997 59999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++||| +.+++|.+++.....+++..++.++.||++||.|||+. +|+||||||+|||+++ +.+||+|||+++....
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99999 67889999999888899999999999999999999964 9999999999999975 7999999999987765
Q ss_pred CcccceeecccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhh
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 743 (813)
...........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... + ....
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~----~~~~ 253 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-L----HAII 253 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-H----HHHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-H----HHHH
Confidence 433322344568999999999875 46788999999999999999999999754322111 0 1111
Q ss_pred ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 045343 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQML 793 (813)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 793 (813)
.. ...........+.+.+++.+||+.||.+||++.|++++-
T Consensus 254 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 254 DP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11 111011111246788999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=332.56 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=182.6
Q ss_pred hhc-ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee--cCCceEEE
Q 045343 521 DNF-KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRLLV 597 (813)
Q Consensus 521 ~~~-~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV 597 (813)
+++ .++||+|+||+||+|..... ..+..||||+++.. .....+.+|+.++++++||||+++++++. .....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDG-KDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSS-SCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccC-CCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 444 45899999999999987432 35678999998643 33457889999999999999999999994 46688999
Q ss_pred EeecCCCchhhhhhcc---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE----cCCCCEEEe
Q 045343 598 YEFLNNGTLASFLFGN---------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL----DDYYNARIS 664 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~ 664 (813)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999874 777777422 2488999999999999999999964 99999999999999 678899999
Q ss_pred eccCccccccCccc-ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchh------hhhhH
Q 045343 665 DFGLAKLLTLNQSK-AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILT 736 (813)
Q Consensus 665 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~------~~~l~ 736 (813)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999876543221 113346789999999999874 58999999999999999999999997543311 00011
Q ss_pred HHHHHhhcc---Ccccccc-------------cccccc--------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 737 DWAFDCYRN---EKLDDLV-------------EGDMEA--------LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 737 ~~~~~~~~~---~~~~~~~-------------~~~~~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+...+.. .....+. ...... .........+.+|+.+||+.||.+|||+.|++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111110 0000000 000000 0000114567899999999999999999999986
Q ss_pred H
Q 045343 793 L 793 (813)
Q Consensus 793 L 793 (813)
=
T Consensus 335 p 335 (405)
T 3rgf_A 335 P 335 (405)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=316.83 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=199.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeecc---ccCCcceEEeEee-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT---HHKNLVRLLGFCD----- 589 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~----- 589 (813)
.|.+.+.||+|+||.||+|.... .+++.||||+++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred ceeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46678899999999999998732 3568899999865332 2234677888888777 8999999999986
Q ss_pred cCCceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
.....++||||+. |+|.+++... ..+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence 5567899999998 6999998764 3489999999999999999999964 99999999999999999999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc--
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-- 745 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 745 (813)
+++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||......... .........
T Consensus 166 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~ 239 (326)
T 1blx_A 166 LARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPG 239 (326)
T ss_dssp SCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCC
T ss_pred ccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCC
Confidence 9987653321 23456899999999999989999999999999999999999999765432211 111111100
Q ss_pred -Ccccc-------ccc---ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 -EKLDD-------LVE---GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 -~~~~~-------~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..... ... ..............+.+++.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000 000000112345778899999999999999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.63 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=198.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecC-----Cc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 593 (813)
.|.+.+.||+|+||.||+|... .++..||||++..... ...+.+.+|++++.+++|+||+++++++... ..
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDN---LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cEEEEEEeecCCCeEEEEEEEC---CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4677899999999999999874 4678899999874322 2235688999999999999999999998654 36
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++|+||+. ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999997 589988865 4589999999999999999999964 99999999999999999999999999998765
Q ss_pred cCcccc-eeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC---cc
Q 045343 674 LNQSKA-IRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE---KL 748 (813)
Q Consensus 674 ~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~ 748 (813)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ........ .+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCCCCHHHH
Confidence 443221 1234579999999998754 4589999999999999999999999976543322111 11100000 00
Q ss_pred ccc------------cccc-cc-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 DDL------------VEGD-ME-ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 ~~~------------~~~~-~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+ .... .. ..........+.+++.+||+.||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000 00 00001234678899999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.07 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=193.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCce---
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR--- 594 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 594 (813)
.|.+.+.||+|+||.||+|... .+++.||||++..... ...+++.+|+.++++++|+||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDK---RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cEEEEeEEecCCCeEEEEEEEC---CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4567789999999999999874 4678999999975322 2245688999999999999999999999877655
Q ss_pred ---EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 595 ---LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 595 ---~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 688887743 489999999999999999999965 999999999999999999999999999986
Q ss_pred cccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cc
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EK 747 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 747 (813)
.... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ....... +.
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~ 265 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTGVPGTEF 265 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHH
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCcHHH
Confidence 5432 234568999999999987 6789999999999999999999999976543221110 0000000 00
Q ss_pred ccc------------ccccccc--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 748 LDD------------LVEGDME--ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 748 ~~~------------~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... +...... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 0000000 00011235788999999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.87 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=204.6
Q ss_pred HHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecC
Q 045343 514 KELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG 591 (813)
Q Consensus 514 ~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 591 (813)
.+.....|.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEc---CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 3445567888999999999999999874 3567899999865432 3345788999999999999999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC---CCEEEeeccC
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY---YNARISDFGL 668 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~DfGl 668 (813)
...++|+||+++++|.+++.....+++..++.++.||+.||.|||+. +|+|+||||+||+++.+ +.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999999999998888899999999999999999999964 99999999999999754 4799999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
+........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......... . ....+..
T Consensus 171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~----~~~~~~~ 239 (287)
T 2wei_A 171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---K----RVETGKY 239 (287)
T ss_dssp GGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCC
T ss_pred ceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHcCCC
Confidence 987654322 223458899999999876 4889999999999999999999999754332111 1 1111111
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ........+..+.+++.+||+.||.+|||+.|++++
T Consensus 240 ~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 240 AF------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CC------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CC------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 000011235678899999999999999999999973
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=323.43 Aligned_cols=200 Identities=27% Similarity=0.336 Sum_probs=169.1
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cC-----CcceEEeEeecCC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HK-----NLVRLLGFCDEGQ 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~ 592 (813)
..|.+.+.||+|+||+||+|... .+++.||||+++.. .....++..|+.+++.++ |+ +|+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDR---VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEc---CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 45677889999999999999874 36788999999743 223456777888888775 44 4999999999999
Q ss_pred ceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc--CCCCEEEeeccC
Q 045343 593 NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGL 668 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~DfGl 668 (813)
..++||||+. ++|.+++... ..+++..++.++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 5999998765 4689999999999999999999953 46899999999999994 578899999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 729 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~ 729 (813)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9876432 2345689999999999999999999999999999999999999986543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.83 Aligned_cols=257 Identities=23% Similarity=0.278 Sum_probs=188.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccccc-----------chhhhheeeeeeccccCCcceEEeEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-----------EKEFKNEVVVIGQTHHKNLVRLLGFCD 589 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~~~ 589 (813)
|.+.+.||+|+||.||+|... .+..||||++....... .+.+.+|+.++++++||||+++++++.
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred eEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 556789999999999999763 47889999986532221 256889999999999999999999984
Q ss_pred c-----CCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 590 E-----GQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 590 ~-----~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
. ....++||||+. |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEE
Confidence 3 335799999998 5777777654 4789999999999999999999965 9999999999999999999999
Q ss_pred eeccCccccccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
+|||+++....... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... .....
T Consensus 176 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~ 249 (362)
T 3pg1_A 176 CDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN---KIVEV 249 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHH
T ss_pred EecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHH
Confidence 99999986543322 234568999999999877 678999999999999999999999997654322111 01111
Q ss_pred hcc-------------------CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRN-------------------EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... ........... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 00000000000 00111235678899999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.39 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=191.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEee----------
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD---------- 589 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------- 589 (813)
.|.+.+.||+|+||.||+|... ..++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDN---DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TEEEEEECC-----CEEEEEET---TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred ceeEEEEeccCCCeEEEEEEEC---CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4567789999999999999874 357899999987655555677899999999999999999999873
Q ss_pred ----cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEe
Q 045343 590 ----EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARIS 664 (813)
Q Consensus 590 ----~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~ 664 (813)
+....++||||++ |+|.+++.. ..+++..++.++.||++||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3457899999998 699998864 4688999999999999999999964 999999999999997 56799999
Q ss_pred eccCccccccCccc-ceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHh
Q 045343 665 DFGLAKLLTLNQSK-AIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742 (813)
Q Consensus 665 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 742 (813)
|||+++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+.... ....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL---ILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHh
Confidence 99999876533221 11233457899999998865 6789999999999999999999999986543221110 0000
Q ss_pred hcc---C-------ccccccccccc------ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 743 YRN---E-------KLDDLVEGDME------ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 743 ~~~---~-------~~~~~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... + .+......... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000 0 00000000000 00011235778999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.70 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=192.9
Q ss_pred CCHHHHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc------ccchhhhheeeeeecc----ccCC
Q 045343 511 FSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQT----HHKN 580 (813)
Q Consensus 511 ~~~~el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~n 580 (813)
....+.....|.+.+.||+|+||.||+|... .+++.||||+++.... .....+.+|+.++.++ +|+|
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRL---TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp ----------CEEEEEEEEETTEEEEEEECT---TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred ccchhhhhhceEEeeEEEcCCCEEEEEEEEc---cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence 3344566677889999999999999999763 3677999999865322 1234567788888888 8999
Q ss_pred cceEEeEeecCCceEEEEee-cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CC
Q 045343 581 LVRLLGFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DY 658 (813)
Q Consensus 581 iv~l~g~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~ 658 (813)
|+++++++.+.+..++|+|+ +.+++|.+++.....+++..++.++.||++||.|||+. +|+||||||+||+++ .+
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR 176 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence 99999999999999999999 78999999998888899999999999999999999965 999999999999999 88
Q ss_pred CCEEEeeccCccccccCcccceeecccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCCCcccchhhhhhHH
Q 045343 659 YNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 737 (813)
Q Consensus 659 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~ 737 (813)
+.+||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||..... .
T Consensus 177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-- 245 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I-- 245 (312)
T ss_dssp TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H--
T ss_pred CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H--
Confidence 999999999998765432 2345689999999998776654 589999999999999999999964211 0
Q ss_pred HHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 738 WAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ... . ........+.+++.+||+.||++|||+.|++++
T Consensus 246 --~~----~~~--------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 --LE----AEL--------H--FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HH----TCC--------C--CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hh----hcc--------C--CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000 0 011234678899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=318.89 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=199.3
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC------cceEEeEeecC
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN------LVRLLGFCDEG 591 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~ 591 (813)
...|.+.+.||+|+||.||+|..... .+..||||+++.. ....+.+.+|+.++++++|++ ++.+.+++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34677889999999999999987422 3478999998753 233456888999999998766 89999999999
Q ss_pred CceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE--------------
Q 045343 592 QNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL-------------- 655 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll-------------- 655 (813)
...++||||+ +++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 55666666543 468999999999999999999995 599999999999999
Q ss_pred -----cCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccch
Q 045343 656 -----DDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 730 (813)
Q Consensus 656 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~ 730 (813)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 66889999999999865432 23456899999999999999999999999999999999999999865443
Q ss_pred hhhhhHHHHHHhhcc-----Ccccc-ccccc---------------------ccccccHHHHHHHHHHHHHhcccCCCCC
Q 045343 731 EYAILTDWAFDCYRN-----EKLDD-LVEGD---------------------MEALNDIKCVEKLVMVSIWCIQEDPSLR 783 (813)
Q Consensus 731 ~~~~l~~~~~~~~~~-----~~~~~-~~~~~---------------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 783 (813)
+.............. ..... ..... ............+.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 221111111000000 00000 00000 0001122446789999999999999999
Q ss_pred CCHHHHHHH
Q 045343 784 PTMKKVLQM 792 (813)
Q Consensus 784 Pt~~evl~~ 792 (813)
||+.|++++
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.13 Aligned_cols=242 Identities=24% Similarity=0.423 Sum_probs=199.7
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------cchhhhheeeeeeccc--cCCcceEEeEee
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTH--HKNLVRLLGFCD 589 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~ 589 (813)
...|.+.+.||+|+||.||+|... .+++.||||+++..... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEET---TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 345778899999999999999874 46789999999754322 2356788999999996 599999999999
Q ss_pred cCCceEEEEeecCC-CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeecc
Q 045343 590 EGQNRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFG 667 (813)
Q Consensus 590 ~~~~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfG 667 (813)
+.+..++|+|++.+ ++|.+++.....+++..++.++.||++||+|||+. +|+||||||+|||++ +++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999986 89999998888899999999999999999999964 999999999999999 78999999999
Q ss_pred CccccccCcccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccC
Q 045343 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNE 746 (813)
Q Consensus 668 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 746 (813)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ...
T Consensus 196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------~~~- 258 (320)
T 3a99_A 196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IRG- 258 (320)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HHC-
T ss_pred ccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------------hcc-
Confidence 998765432 234568999999999987665 67899999999999999999999643110 000
Q ss_pred cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 747 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. .. .....+.+.+++.+||+.||.+|||+.||+++
T Consensus 259 ~~--~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 QV--FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CC--CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc--cc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 11234678899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.80 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=193.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCc----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN---- 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 593 (813)
.|.+.+.||+|+||.||+|... .++..||||++..... ...+++.+|+.++++++||||+++++++.....
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDK---RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred eEEEeeeEecCCCeEEEEEEEC---CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3567789999999999999874 4678999999865322 224568899999999999999999999977654
Q ss_pred --eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 594 --RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 594 --~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.++||||+. ++|.+++.. .+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 688888754 488999999999999999999965 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc-----
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN----- 745 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 745 (813)
.... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ........
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~ 247 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEF 247 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH---HHHHHHCBCCHHH
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHH
Confidence 5432 234568999999999877 678999999999999999999999997654322111 00000000
Q ss_pred ------C-------cccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 ------E-------KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ------~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. .+......... .........+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000000000 0112346788999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=320.23 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=196.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecC-----Cc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 593 (813)
.+.+.+.||+|+||.||+|... .+++.||||+++.... ....++.+|+.++++++|+||+++++++... ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHK---PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ceEEeeEEcCCCCeEEEEEEEC---CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4667789999999999999874 3578999999864322 2245678999999999999999999988654 67
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 899999997 689988865 4689999999999999999999964 99999999999999999999999999998765
Q ss_pred cCcccc--------eeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhc
Q 045343 674 LNQSKA--------IRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 674 ~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||........... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHhC
Confidence 332111 0123468999999998764 6789999999999999999999999976543221111 111110
Q ss_pred cC----cccccc---------------cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NE----KLDDLV---------------EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~----~~~~~~---------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ....+. ...+. .........+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000000 00000 0011345678899999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=311.53 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=190.4
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec--------
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-------- 590 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 590 (813)
..+++.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA---LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEc---CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 45677899999999999999874 36789999998653 3345678899999999999999999998854
Q ss_pred -----CCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEe
Q 045343 591 -----GQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 664 (813)
Q Consensus 591 -----~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 664 (813)
....++||||+++++|.+++... ..+++..++.++.||++||+|||+. +|+|+||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 34679999999999999999754 4678899999999999999999965 99999999999999999999999
Q ss_pred eccCccccccCcc------------cceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchh
Q 045343 665 DFGLAKLLTLNQS------------KAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 731 (813)
Q Consensus 665 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~ 731 (813)
|||++........ ........|++.|+|||.+.+. .++.++||||||+++|||++ |+......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~- 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER- 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence 9999987643210 1112345689999999999765 68999999999999999998 44322111
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... ....... ..............+.+++.+||+.||.+|||+.|++++
T Consensus 235 -~~~~----~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 -VNIL----KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHH----HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHH----Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111 1111100 011111122345678899999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.72 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=174.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheee-eeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+.+.||+|+||.||+|... .+++.||||+++.... ....++..|+. +++.++||||+++++++.+.+..++|
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHK---PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEET---TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhehheeccCCCEEEEEEEEc---CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3456788999999999999874 3578999999975422 22334555555 77788999999999999999999999
Q ss_pred EeecCCCchhhhhhc-----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 598 YEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
|||+++ +|.+++.. ...+++..+..++.|+++||.|||+. .+|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999985 78777753 56789999999999999999999952 38999999999999999999999999999876
Q ss_pred ccCcccceeecccccccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWF----RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .+
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~ 239 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------------QL 239 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------------HH
Confidence 54322 2234689999999998 456789999999999999999999999974322100 00
Q ss_pred ccccc---ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 749 DDLVE---GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 749 ~~~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
..+.. +.+...........+.+++.+||+.||.+|||+.||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111 11111111234578899999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=320.94 Aligned_cols=271 Identities=20% Similarity=0.294 Sum_probs=201.0
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-----------cCCcceE
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----------HKNLVRL 584 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l 584 (813)
+....|.+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.++++++ |+||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEec---CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 34456788899999999999999874 46789999998743 223456788998888886 8999999
Q ss_pred EeEeecCC----ceEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc--
Q 045343 585 LGFCDEGQ----NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-- 656 (813)
Q Consensus 585 ~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-- 656 (813)
++++.... ..++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. .+|+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEecc
Confidence 99987544 689999999 89999999753 4589999999999999999999952 2899999999999994
Q ss_pred ----CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhh
Q 045343 657 ----DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 732 (813)
Q Consensus 657 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~ 732 (813)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 4457999999999876533 2334689999999999999999999999999999999999999975542111
Q ss_pred ----hhhHHHHHHhhcc-------------------Cccccccccc---------ccccccHHHHHHHHHHHHHhcccCC
Q 045343 733 ----AILTDWAFDCYRN-------------------EKLDDLVEGD---------MEALNDIKCVEKLVMVSIWCIQEDP 780 (813)
Q Consensus 733 ----~~l~~~~~~~~~~-------------------~~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dP 780 (813)
..+.. ....... +....+.... ..........+.+.+|+.+||+.||
T Consensus 244 ~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 244 TKDDDHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp -CHHHHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred CChHHHHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 11111 1110000 0000000000 0011234567889999999999999
Q ss_pred CCCCCHHHHHHH--HhcCcCC
Q 045343 781 SLRPTMKKVLQM--LEGVVEV 799 (813)
Q Consensus 781 ~~RPt~~evl~~--L~~~~~~ 799 (813)
.+|||+.||+++ +.+....
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTTC
T ss_pred cccCCHHHHhhChhhhcccCc
Confidence 999999999984 4544433
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=293.93 Aligned_cols=211 Identities=21% Similarity=0.255 Sum_probs=159.6
Q ss_pred ccCCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEE
Q 045343 25 QNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKL 104 (813)
Q Consensus 25 ~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~ 104 (813)
++.|+|.+|++|++++ +| ++|.|+|||+.++ . +.+ |.. +|+||+|||+. | .++.|+|
T Consensus 6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~g----n-----l~l-y~~---~~~vW~an~~~---~--~~~~l~l 62 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDC----N-----LVL-FDS---DVRVWASNTAG---A--TGCRAVL 62 (236)
T ss_dssp CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTS----C-----EEE-EES---SSEEECCCCCS---C--SCCBCCB
T ss_pred eccceeCCCCEECCCC---EE--EcCCEEEEECCCC----c-----EEE-EEC---CEEEEECCCCC---C--CCeEEEE
Confidence 4569999999999998 78 4999999998654 1 223 443 79999999983 3 5778999
Q ss_pred eeCccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccccccCcCcc----------cCCCccccc-c
Q 045343 105 TADHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTL----------LPGQTMETK-Q 172 (813)
Q Consensus 105 ~~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTl----------Lpg~~l~~~-~ 172 (813)
+.||||||+|++|++||+|++... +..+|+|+|+|||||++. ++||||||||||+ +||||++.+ +
T Consensus 63 ~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~ 139 (236)
T 1dlp_A 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQ 139 (236)
T ss_dssp CSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCC
T ss_pred cCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccc
Confidence 999999999999999999998643 345899999999999954 8999999998665 677766543 4
Q ss_pred ceeecCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccccCCCCCCCCceEEEeccCccEEEEecCCceeEe
Q 045343 173 GLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDL 252 (813)
Q Consensus 173 ~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (813)
+|+| .+||++|.|++.++++|++.++ +.. ..||++++|... ......++.++.++++..++..+..
T Consensus 140 ~L~s---~~d~s~G~~~l~l~~dG~LvL~--~~~-----~~~W~s~~~~~~----~~~~~~L~~~Gnl~ly~~~~~~vw~ 205 (236)
T 1dlp_A 140 TLHA---TQSLQLSPYRLSMETDCNLVLF--DRD-----DRVWSTNTAGKG----TGCRAVLQPNGRMDVLTNQNIAVWT 205 (236)
T ss_dssp EECS---SCCCBCSSCEEEEETTTEEEEE--BTT-----BCCSCCCCCSSC----SSCEEEEETTTEEEEEETTTEEEEE
T ss_pred eEEc---CcEeecCcEEEEECCCCcEEEE--cCC-----EeEEeCCCcCCC----CceEEEECCCCcEEEEeCCCcEEEE
Confidence 6774 7899999999999999976554 322 479999988532 2234456677777777655554444
Q ss_pred ecccccCCcceEEEEEEeeCceeEEE
Q 045343 253 TTESVVPAADFYYRATLNFDGVFAQY 278 (813)
Q Consensus 253 ~~~~~~~~~~~~~r~~L~~dG~l~~y 278 (813)
+.... . ...+|++|+.||++++|
T Consensus 206 s~~~~--~-~~~~rl~Ld~dG~l~ly 228 (236)
T 1dlp_A 206 SGNSR--S-AGRYVFVLQPDRNLAIY 228 (236)
T ss_dssp CCCCC--S-SSCCEEEECSSSCEEEE
T ss_pred eCCCC--C-CCCEEEEEcCCCcEEEe
Confidence 43221 1 23579999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=325.01 Aligned_cols=246 Identities=28% Similarity=0.332 Sum_probs=183.7
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEeec
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
..+.||+|+||+||.+.. .+++.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 19 ~~~~LG~G~~g~V~~~~~----~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGS----FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp EEEEEEECSTTCEEEEEE----SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCeEeeCCCeEEEEEEE----ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 357899999999986543 26789999998643 234678899999876 8999999999999999999999999
Q ss_pred CCCchhhhhhccCCC-------CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCC-------------CCE
Q 045343 602 NNGTLASFLFGNLKP-------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDY-------------YNA 661 (813)
Q Consensus 602 ~~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~-------------~~~ 661 (813)
. |+|.+++...... ++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999765322 3345678999999999999964 99999999999999754 489
Q ss_pred EEeeccCccccccCcccc--eeecccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 662 RISDFGLAKLLTLNQSKA--IRTAIRGTKGYVAPEWFRN-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999876543221 1234579999999999975 568899999999999999999 999997543322
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
... ...... . +.............+.+++.+||+.||.+|||+.||++
T Consensus 248 ~~i----~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNI----IRGIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH----HHTCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH----hcCCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 111101 0 11111223456788999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.25 Aligned_cols=250 Identities=20% Similarity=0.216 Sum_probs=169.6
Q ss_pred Hhhcc-cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec----CCce
Q 045343 520 TDNFK-EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNR 594 (813)
Q Consensus 520 ~~~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 594 (813)
.|.+. +.||+|+||.||+|... .+++.||||++.... +...+....+..++|+||+++++++.. +...
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHR---RTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEEC---CCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 35564 46999999999999874 357899999986521 112222233556789999999999865 4458
Q ss_pred EEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCEEEeeccCc
Q 045343 595 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLA 669 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGla 669 (813)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999999765 3689999999999999999999965 9999999999999976 455999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||........... ........
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~--- 248 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLG--- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcc---
Confidence 8655322 2345689999999999888899999999999999999999999975433211000 00000000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
............+..+.+++.+||+.||.+|||+.|++++
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111112345778999999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=307.58 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=176.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-c-chhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-G-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+.+.||+|+||.||+|... .+++.||||++...... . .+.+.++..+++.++|+||+++++++.+.+..++|
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFR---KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GEEEEEEC------CEEEEEET---TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cccccceeeecCCeeEEEEEEe---cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4566789999999999999874 35779999999754221 1 22344455567788999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+ ++.+..+... ...+++..++.++.||++||.|||+. .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9999 4555555443 46789999999999999999999951 289999999999999999999999999997765432
Q ss_pred ccceeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
. .....+++.|+|||++. ...++.++||||||+++|||++|+.||........ .+ ...... ....+
T Consensus 180 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~----~~~~~~-~~~~~ 250 (318)
T 2dyl_A 180 A---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VL----TKVLQE-EPPLL 250 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HH----HHHHHS-CCCCC
T ss_pred c---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HH----HHHhcc-CCCCC
Confidence 2 23456899999999994 45688899999999999999999999975332211 11 011111 00000
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ........+.+++.+||+.||.+||++.|++++
T Consensus 251 -----~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 -----P--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -----C--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----C--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 011235678899999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=318.26 Aligned_cols=246 Identities=26% Similarity=0.323 Sum_probs=183.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 599 (813)
+.+.+.||+|+||+|+.... .+++.||||++... ....+.+|+.+++++ +|||||++++++.+....++|||
T Consensus 26 y~~~~~LG~G~~G~V~~~~~----~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGM----FDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEE----SSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EecCCeeecCcCEEEEEEEE----eCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 45568899999999654332 26788999998642 234577899999998 79999999999999999999999
Q ss_pred ecCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-----CCCEEEeeccCccccc
Q 045343 600 FLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLT 673 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~DfGla~~~~ 673 (813)
|+. |+|.+++.... ...+..++.++.||++||.|||+. +|+||||||+|||++. ...+||+|||+++...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 996 69999997653 455667789999999999999964 9999999999999953 3468899999998775
Q ss_pred cCccc-ceeecccccccccCccccc---CCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 674 LNQSK-AIRTAIRGTKGYVAPEWFR---NSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 674 ~~~~~-~~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... .......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------HhccCCc
Confidence 43221 1134467999999999997 4567889999999999999999 999986433221110 1111111
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
.. .. ........+.+++.+||+.||.+|||+.||++
T Consensus 248 ~~-~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DC-LH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TT-SC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-cC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 10 00 11234566889999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=337.64 Aligned_cols=244 Identities=21% Similarity=0.284 Sum_probs=192.9
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
++....|.+.+.||+|+||.||+|..... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 33445678889999999999999987521 46889999986432 2234568899999999999999999999987665
Q ss_pred -----eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 594 -----RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 594 -----~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
.+|||||+++++|.+++.. .+++..++.++.||++||.|||+. +|+||||||+|||++.+ .+||+|||+
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999998765 689999999999999999999964 99999999999999986 999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
++..... ....||++|+|||++.+.. +.++||||||++++||++|..|+......
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------ 282 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------ 282 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------
T ss_pred chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------
Confidence 9876532 3356999999999987654 88999999999999999998887532110
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGV 796 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 796 (813)
.+.. ..........+.+++.+||+.||.+|| +++++.+.|.++
T Consensus 283 -~~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 283 -GLPE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -SCCT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -cccc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000 001122346788999999999999999 566666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=330.92 Aligned_cols=272 Identities=24% Similarity=0.278 Sum_probs=200.7
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeec------C
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------G 591 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~ 591 (813)
..|.+.++||+|+||.||+|... .++..||||+++.. .....+.+.+|+.++++++||||+++++++.. +
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~---~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQ---DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCT---TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 56888899999999999998763 46788999998653 22334568899999999999999999999765 6
Q ss_pred CceEEEEeecCCCchhhhhhccC---CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCC---EEEee
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYN---ARISD 665 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~D 665 (813)
+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 67899999999999999997643 588999999999999999999964 9999999999999997665 99999
Q ss_pred ccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhh--hhH-HHHHHh
Q 045343 666 FGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILT-DWAFDC 742 (813)
Q Consensus 666 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~--~l~-~~~~~~ 742 (813)
||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .+. ......
T Consensus 168 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 168 LGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 999987654332 23457999999999999999999999999999999999999999754221100 000 000000
Q ss_pred hccCccccc--ccccc--cccccHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHhcCcCC
Q 045343 743 YRNEKLDDL--VEGDM--EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKK-----VLQMLEGVVEV 799 (813)
Q Consensus 743 ~~~~~~~~~--~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e-----vl~~L~~~~~~ 799 (813)
......... ..... ........+..+.+++.+||+.||.+|||+.| ..+.++.+++.
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000000 00000 11123346788999999999999999999977 44555554443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=297.09 Aligned_cols=234 Identities=13% Similarity=0.061 Sum_probs=183.3
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 592 (813)
+....|.+.+.||+|+||.||+|... ..++.||||++...... ..+++.+|+.++.+++|+||+++++++.+.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDT---ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEET---TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred EecCcEEEEEEEcccCCeEEEEEEec---CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence 33445788899999999999999874 35789999999754322 2367899999999999999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++||||+++++|.+++... .......+++.||++||.|||+. +|+||||||+|||++.++.+||++++
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred cEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999999999653 35557888999999999999965 99999999999999999999997443
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
|++ .++.++||||||+++|||++|+.||.......... ......
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~ 218 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDT 218 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCT
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHh
Confidence 333 36889999999999999999999997654321000 000000
Q ss_pred ccccc--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 753 EGDME--ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 753 ~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
..... .......++.+.+++.+||+.||.+| |+.|+++.|+++...
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00000 00112345678999999999999999 999999999886654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=290.57 Aligned_cols=232 Identities=21% Similarity=0.276 Sum_probs=177.8
Q ss_pred hhcc-cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeee-eccccCCcceEEeEeec----CCce
Q 045343 521 DNFK-EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI-GQTHHKNLVRLLGFCDE----GQNR 594 (813)
Q Consensus 521 ~~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~ 594 (813)
|.+. +.||+|+||.||++... .+++.||||+++. ...+.+|+.++ +..+|+||+++++++.. ....
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEc---CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4444 67999999999999874 3578999999864 34567788887 55689999999999876 6678
Q ss_pred EEEEeecCCCchhhhhhccC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCEEEeeccCc
Q 045343 595 LLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGLA 669 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGla 669 (813)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999997653 689999999999999999999964 9999999999999998 789999999998
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
.... +..++.++||||||+++|||++|+.||......... .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 6533 134577899999999999999999999754321100 00001
Q ss_pred cccccccccc--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcC
Q 045343 750 DLVEGDMEAL--NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVE 798 (813)
Q Consensus 750 ~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~ 798 (813)
.+........ ........+.+++.+||+.||.+|||+.|++++ +.+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 1111111100 012345788999999999999999999999974 444433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-33 Score=302.40 Aligned_cols=246 Identities=16% Similarity=0.149 Sum_probs=184.1
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--------ccchhhhheeeeeeccc---------c
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTH---------H 578 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---------h 578 (813)
+....|.+.++||+|+||+||+|.. +++.||||+++.... ...+.+.+|+.++++++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred cccccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 3456788899999999999999986 468999999975422 12266888999988886 7
Q ss_pred CCcceEEeEe-----------------e-------------cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHH
Q 045343 579 KNLVRLLGFC-----------------D-------------EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 628 (813)
Q Consensus 579 ~niv~l~g~~-----------------~-------------~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i 628 (813)
+|||++.+.+ . +....++||||+++|++.+.+.. ..+++..++.++.||
T Consensus 92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL 170 (336)
T ss_dssp CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence 7777776653 2 26789999999999977666644 567999999999999
Q ss_pred HHHHHHhh-hcCCCCeeeCCCCCCcEEEcCCC--------------------CEEEeeccCccccccCcccceeeccccc
Q 045343 629 ARGLLYLH-EDCSAQIIHCDIKPQNILLDDYY--------------------NARISDFGLAKLLTLNQSKAIRTAIRGT 687 (813)
Q Consensus 629 a~gl~yLH-~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt 687 (813)
+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt 240 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC 240 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence 99999999 65 999999999999999887 8999999999876532 24689
Q ss_pred ccccCcccccCCCCCCccchhhHHHH-HHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHH
Q 045343 688 KGYVAPEWFRNSTITAKVDVYSFGVL-LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVE 766 (813)
Q Consensus 688 ~~y~aPE~l~~~~~~~k~DVwS~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 766 (813)
+.|+|||++.+.. +.++|||||+++ .+++++|..||...... ..+.. ......... ...........++
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~---~~~~~~~~~----~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTD---KMLKQMTFK----TKCNTPAMKQIKR 310 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHH---HHHHTCCCS----SCCCSHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHH---hhhhhhccC----cccchhhhhhcCH
Confidence 9999999998776 889999998777 77788899887421000 00000 111000000 0011111235678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH-HH
Q 045343 767 KLVMVSIWCIQEDPSLRPTMKKVL-QM 792 (813)
Q Consensus 767 ~l~~l~~~Cl~~dP~~RPt~~evl-~~ 792 (813)
.+.+|+.+||+.| |+.|++ ++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 8999999999976 999988 53
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=303.54 Aligned_cols=235 Identities=14% Similarity=0.097 Sum_probs=173.2
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeecccc-CCcc---------e-----
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHH-KNLV---------R----- 583 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv---------~----- 583 (813)
.+.+.||+|+||.||+|... .+++.||||+++.... ...+.+.+|+.+++.++| +|.. .
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQ---ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEETTEEEEEEEET---TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred EEecccccCCCEEEEEEEec---CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34578999999999999874 3577999999873322 235678899999999877 2211 1
Q ss_pred -------EEeEeec-----CCceEEEEeecCCCchhhhhhc-------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 045343 584 -------LLGFCDE-----GQNRLLVYEFLNNGTLASFLFG-------NLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644 (813)
Q Consensus 584 -------l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iv 644 (813)
+..++.. ....+++|++ .+++|.+++.. ...+++..++.++.||++||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1111111 1234566665 46899988841 23467889999999999999999954 999
Q ss_pred eCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccc----------cCCCCCCccchhhHHHHH
Q 045343 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF----------RNSTITAKVDVYSFGVLL 714 (813)
Q Consensus 645 H~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~k~DVwS~Gvvl 714 (813)
||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999875432 234567 999999999 555688899999999999
Q ss_pred HHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 045343 715 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790 (813)
Q Consensus 715 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 790 (813)
|||++|+.||........ ...++... ...++.+.+++.+||+.||.+||++.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~---------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG---------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC---------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhh---------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999975432111 11111110 12246789999999999999999976664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-27 Score=271.65 Aligned_cols=185 Identities=19% Similarity=0.105 Sum_probs=129.8
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----------cccchhhhheeeeeecc-ccCCcceEEeEeecCCce
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----------QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 594 (813)
.++.|++|.+.++... -.+..++||.+.... +...++|.+|+++|+++ +|+||++++++++++...
T Consensus 241 ~~~~~~~~~h~~~rr~---~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY---FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp C-C--------CCEEE---EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred ccccCCcccccccccc---cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 4566666655544322 246678999986431 12235699999999999 799999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
||||||++|++|.++|.....++.. +|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999999988877654 5889999999999965 999999999999999999999999999987754
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 722 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~ 722 (813)
+... ....+||++|+|||++.+. ...++|+|++|++++++.++..
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCcc--ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 4332 3456799999999999764 5678999999999988766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-24 Score=244.03 Aligned_cols=183 Identities=18% Similarity=0.256 Sum_probs=143.9
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc--------cchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
.+.||+|+||.||+|.. .+..+++|+....... ..+++.+|++++++++|+||+++..++...+..+
T Consensus 341 ~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 46899999999999954 4567888876432111 1244789999999999999997766666778889
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
|||||+++++|.+++.. +..++.||++||.|||+. +|+||||||+|||++. .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999999876 568999999999999964 9999999999999999 9999999999987653
Q ss_pred cccc-----eeecccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCC
Q 045343 676 QSKA-----IRTAIRGTKGYVAPEWFRN--STITAKVDVYSFGVLLLEIISCRKSF 724 (813)
Q Consensus 676 ~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvvl~elltG~~p~ 724 (813)
.... ......||+.|+|||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3211 1235679999999999976 56788899999998888888776655
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.4e-20 Score=161.99 Aligned_cols=103 Identities=20% Similarity=0.382 Sum_probs=87.5
Q ss_pred CCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeC
Q 045343 28 GTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (813)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~ 107 (813)
|+|.+||.|.+|+ +|+| |.|.|.|...| .|.|+. ..++||+|||+ .|...++.|+|+.|
T Consensus 2 n~L~~g~~L~~g~---~L~s--g~y~l~~q~Dg---------NLvly~----~~~~vW~ant~---~~~~~~~~L~l~~d 60 (105)
T 4h3o_A 2 NILDNNEGLYAGQ---SLDV--EPYHFIMQDDC---------NLVLYD----HSTSTWASNTE---IGGKSGCSAVLQSD 60 (105)
T ss_dssp CEECTTEEECTTC---EEEE--TTEEEEECTTS---------CEEEEE----TTEEEEECCCC---CTTCCSCEEEECTT
T ss_pred CCcCCCCEEcCCC---EEEE--CCEEEEECCCC---------eEEEEE----CCEEEEEecCC---CCCCccEEEEEeCC
Confidence 6899999999999 8988 88999998765 366654 35899999998 44556789999999
Q ss_pred ccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccc
Q 045343 108 HGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDS 154 (813)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqS 154 (813)
|||||+|++|++||+|++... +..+|+|+|+|||||++. .||||
T Consensus 61 GnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 61 GNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp SCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred ccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 999999999999999998754 346899999999999964 69998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=8.5e-20 Score=164.65 Aligned_cols=108 Identities=19% Similarity=0.249 Sum_probs=91.4
Q ss_pred ccCCCcCCCceeeecCCCceee--cCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEE
Q 045343 25 QNNGTVPVGATLTAGTNSSTWL--SPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQV 102 (813)
Q Consensus 25 ~~~~~~~~~~~l~~~~~~~~lv--S~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l 102 (813)
++.|+|.+|++|.+|+ +|+ |++|.|+|+|+.+|. . +||++ +++||+||++. + +.++.|
T Consensus 6 ~~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~~dgn-------l---vly~~---~~~vW~sn~~~---~-~~~~~l 65 (119)
T 1b2p_A 6 SKQPDDNHPQILHATE---SLEILFGTHVYRFIMQTDCN-------L---VLYDN---NNPIWATNTGG---L-GNGCRA 65 (119)
T ss_dssp CSCSSSCCCCEEETTC---EEEEEETTEEEEEEECTTSC-------E---EEEET---TEEEEECCCTT---S-CSSCEE
T ss_pred ecCcccCCCCEEcCCC---EEEEeCCCCCEEEEEecCCC-------E---EEEEC---CEEEEeCCCcc---C-CCceEE
Confidence 3568999999999999 999 999999999997651 2 57875 79999999982 2 346789
Q ss_pred EEeeCccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCccccccc
Q 045343 103 KLTADHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDSF 155 (813)
Q Consensus 103 ~~~~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqSF 155 (813)
+|+.||||||+|.+|++||+|.+... +...++|+|+|||||++ .++|||=
T Consensus 66 ~l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~Sg 116 (119)
T 1b2p_A 66 VLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQ 116 (119)
T ss_dssp EECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECC
T ss_pred EEccCCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCCC
Confidence 99999999999999999999997643 45689999999999998 3899983
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=8.8e-20 Score=162.48 Aligned_cols=109 Identities=16% Similarity=0.324 Sum_probs=91.7
Q ss_pred CCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEee
Q 045343 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (813)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~ 106 (813)
+|+|.+|+.|.+|+ +|+ ++|.|+|+|+.+|. | +||+ .+++||.||++. + +.++.|+|..
T Consensus 1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGn---------l-vl~~---~~~~vW~sn~~~---~-~~~~~l~l~~ 59 (110)
T 3a0c_A 1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCN---------F-VLYD---SGKPVWASNTGG---L-GSGCRLTLHN 59 (110)
T ss_dssp CCEEETTCEECTTC---EEE-ETTTEEEEECTTSC---------E-EEEE---TTEEEEECCCTT---S-CSSCEEEECT
T ss_pred CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCc---------E-EEEE---CCEEEEECCCCC---C-CCcEEEEEeC
Confidence 37899999999999 899 99999999987651 2 5676 379999999973 2 2467899999
Q ss_pred CccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccccccCc
Q 045343 107 DHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDSFSNPS 159 (813)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PT 159 (813)
||||||+|.+|++||+|.+... +...++|+|+|||||++. .+||||+||.
T Consensus 60 dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 60 NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 9999999999999999998744 345899999999999975 7999999983
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-20 Score=197.31 Aligned_cols=142 Identities=13% Similarity=0.088 Sum_probs=112.5
Q ss_pred cccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc------------------ccchhhhheeeeeeccccCCcceE
Q 045343 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ------------------DGEKEFKNEVVVIGQTHHKNLVRL 584 (813)
Q Consensus 523 ~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l 584 (813)
+.+.||+|+||.||+|.. .++..||||.++.... .....+.+|+.++++++ | +++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~----~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS----EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp EEEEEEECSSEEEEEEEE----TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred ecCEeccCCCceEEEEEe----CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 558999999999999987 2578999999864221 12345889999999999 4 566
Q ss_pred EeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEe
Q 045343 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARIS 664 (813)
Q Consensus 585 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 664 (813)
.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+. +|+||||||+|||++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence 665433 56799999999999998 421 23457999999999999954 999999999999999 9999999
Q ss_pred eccCccccccCcccceeecccccccccCcccccC
Q 045343 665 DFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRN 698 (813)
Q Consensus 665 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 698 (813)
|||+++.. ..+.|||++..
T Consensus 235 DFG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp CCTTCEET---------------TSTTHHHHHHH
T ss_pred ECCCCeEC---------------CCCCHHHHHHH
Confidence 99998642 34678887743
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=5.2e-19 Score=159.09 Aligned_cols=109 Identities=20% Similarity=0.346 Sum_probs=90.4
Q ss_pred CCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEee
Q 045343 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (813)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~ 106 (813)
.|+|.+||+|.+++ +|+ +|.|+|+|+.+| +.+ +|+ ..++||+||++. + ..++.|+|+.
T Consensus 2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dg-------nlv---ly~---~~~~vW~sn~~~---~-~~~~~l~l~~ 59 (115)
T 2dpf_A 2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKC-------NLV---KYQ---NGRQIWASNTDR---R-GSGCRLTLLS 59 (115)
T ss_dssp CCEEETTCEEETTE---EEE--ETTEEEEECTTS-------CEE---EEE---TTEEEEECSCTT---S-CSSCEEEECT
T ss_pred CCEeCCCCEECCCC---EEE--CCCEEEEEcCCC-------cEE---EEe---CCEEEEeCCCCC---C-CCceEEEECC
Confidence 58999999999998 898 799999998654 133 365 379999999983 2 2467899999
Q ss_pred CccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccccccCcC
Q 045343 107 DHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDSFSNPSD 160 (813)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTD 160 (813)
||||||+|.++++||+|++..+ +..+++|+|+|||||++. ++||||.+++.
T Consensus 60 ~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 60 DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 9999999999999999998643 346899999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-19 Score=157.47 Aligned_cols=109 Identities=19% Similarity=0.423 Sum_probs=91.0
Q ss_pred CCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEee
Q 045343 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (813)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~ 106 (813)
+|||.+||.|.+|+ +| ++|.|+|+|+.+|. . +||.+ +++||+||++. . +.++.|+|..
T Consensus 1 tdtl~~gq~L~~g~---~L--~~~~~~L~~~~dgn-------l---vl~~~---~~~vW~sn~~~---~-~~~~~l~l~~ 58 (112)
T 1xd5_A 1 SDRLNSGHQLDTGG---SL--AEGGYLFIIQNDCN-------L---VLYDN---NRAVWASGTNG---K-ASGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECTTC---EE--EETTEEEEECTTSC-------E---EEEET---TEEEEECCCTT---S-CSSEEEEECT
T ss_pred CCCCCCCCEECCCC---EE--eCCCEEEEEcCCCc-------E---EEEEC---CEEEEeCCCcC---C-CCCEEEEEeC
Confidence 48999999999998 88 57999999998751 2 35764 68999999872 1 3467899999
Q ss_pred CccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccccccC
Q 045343 107 DHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDSFSNP 158 (813)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~P 158 (813)
||||||+| ++.+||+|.+... +...++|+++|||||++..+.++||||+|.
T Consensus 59 ~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 59 DGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp TSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred CCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 99999999 8889999987643 345899999999999997788999999984
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=148.60 Aligned_cols=103 Identities=20% Similarity=0.384 Sum_probs=85.3
Q ss_pred CCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeC
Q 045343 28 GTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (813)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~ 107 (813)
+||.+||.|.+|+ +|+ +|.|+|+|+.+| +.+| |.. .++||++|+.. + +.++.|+|..|
T Consensus 2 ntL~~gq~L~~g~---~L~--~g~~~L~~q~dG-------nLvl---y~~---~~~vW~snt~~---~-~~~~~l~l~~d 59 (109)
T 3dzw_A 2 NILYSGETLSPGE---FLN--NGRYVFIMQEDC-------NLVL---YDV---DKPIWATNTGG---L-DRRCHLSMQSD 59 (109)
T ss_dssp CEEETTEEECTTC---EEE--ETTEEEEECTTS-------CEEE---EET---TEEEEECCCTT---S-SSSCEEEECTT
T ss_pred CCcCCCCEeCCCC---EEE--CCCEEEEEcCCC-------cEEE---EeC---CEEEEECCccc---C-CCCEEEEEeCC
Confidence 6899999999998 886 799999998765 1333 654 58999999873 2 34678999999
Q ss_pred ccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCccccccc
Q 045343 108 HGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSF 155 (813)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSF 155 (813)
|||||+|.+++++|+|++.... ..+|+|+|+|||||+++ .+|||=
T Consensus 60 GNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 60 GNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp SCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred CCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 9999999999999999986544 36899999999999984 799984
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=6.7e-17 Score=168.19 Aligned_cols=137 Identities=17% Similarity=0.138 Sum_probs=104.3
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceE--EEEEEeeccccc------------------------cchhhhheeeeeec
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTA--VAVKKLDRVFQD------------------------GEKEFKNEVVVIGQ 575 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~ 575 (813)
.+.+.||+|+||.||+|... .++.. ||||.++..... ....+.+|+.++.+
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~---~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGV---FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEE---ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEc---CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 46688999999999999873 25667 999987532111 01257889999999
Q ss_pred cccCCc--ceEEeEeecCCceEEEEeecCC-C----chhhhhhccCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeeCC
Q 045343 576 THHKNL--VRLLGFCDEGQNRLLVYEFLNN-G----TLASFLFGNLKPSWNLRTNIAFQIARGLLYLH-EDCSAQIIHCD 647 (813)
Q Consensus 576 l~h~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~ivH~d 647 (813)
++|+++ +.++.+ ...+|||||+.+ | +|.++... .++.....++.||+.+|.||| +. +|+|||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 998864 445543 367899999942 4 56655432 235577889999999999999 64 999999
Q ss_pred CCCCcEEEcCCCCEEEeeccCccccc
Q 045343 648 IKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 648 lk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
|||+|||++. .++|+|||+|....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999998 99999999997643
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=140.93 Aligned_cols=104 Identities=16% Similarity=0.221 Sum_probs=83.9
Q ss_pred ccCCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEE
Q 045343 25 QNNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKL 104 (813)
Q Consensus 25 ~~~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~ 104 (813)
.++|+|.+||.|..|+ +|+| |.|.|-|...| .|.| |.. ++||.+|+.. .+.++.|+|
T Consensus 4 ~~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dG---------nLvl-~~~----~~vW~snt~~----~~~~~~l~l 60 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDC---------NLVL-YGG----KYGWQSNTHG----NGEHCFLRL 60 (110)
T ss_dssp CBTTEEETTCEEETTE---EEEC--SSCEEEECTTS---------CEEE-ECS----SSCEECCCTT----SSSSCEEEE
T ss_pred cccCEECCCCEecCCC---EEEe--CCEEEEEcCCC---------eEEE-ECC----eEEEECCCcC----CCcCEEEEE
Confidence 3679999999999998 8998 56999776543 1444 653 4899999873 234578999
Q ss_pred eeCccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccc
Q 045343 105 TADHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDS 154 (813)
Q Consensus 105 ~~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqS 154 (813)
+.||||||+|.+|.++|++++... +..+|+|+|+|||||++ ..+|+|
T Consensus 61 ~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 61 NHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp CTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred eCCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 999999999999999999998643 33689999999999998 479987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-15 Score=136.04 Aligned_cols=106 Identities=13% Similarity=0.160 Sum_probs=85.9
Q ss_pred cCCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEe
Q 045343 26 NNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLT 105 (813)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~ 105 (813)
+.|+|.+||.|.+++ .|.+ |.|.|-|...| .|.++.. ...++||.+|+.. + +.++.|.|.
T Consensus 5 ~~~tL~~gq~L~~g~---~L~~--g~~~L~~q~dG---------NLvL~~~--~~~~~vWssnt~~---~-~~~~~l~l~ 64 (113)
T 3mez_B 5 VRNVLFSSQVMYDNA---QLAT--RDYSLVMRDDC---------NLVLTKG--SKTNIVWESGTSG---R-GQHCFMRLG 64 (113)
T ss_dssp CSSEEETTCEEETTC---EEEE--TTEEEEECTTS---------CEEEEET--TTTEEEEECCCTT---S-CSSCEEEEC
T ss_pred cCCEeCCCCEECCCC---EeEc--CCEEEEEcCCC---------EEEEEEC--CCCEEEEECCccc---C-CcCEEEEEe
Confidence 468999999999998 8864 89999997654 2555432 1368999999873 1 245789999
Q ss_pred eCccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccc
Q 045343 106 ADHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDS 154 (813)
Q Consensus 106 ~~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqS 154 (813)
.||||||+|.+|+++|+|++... +..+|+|+|+|||||++ ..+|+|
T Consensus 65 ~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 65 HSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp TTSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 99999999999999999998643 33689999999999997 689987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=7.9e-16 Score=136.87 Aligned_cols=88 Identities=23% Similarity=0.368 Sum_probs=74.5
Q ss_pred CceEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceee
Q 045343 98 RGSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFS 176 (813)
Q Consensus 98 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S 176 (813)
...+|.|+.||||||++ .+++||++++...+ ..+++|+|+|||||++.++.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t-------------------- 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT-------------------- 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC--------------------
Confidence 35789999999999998 58999999986543 368999999999999998999999993
Q ss_pred cCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeecccc
Q 045343 177 RKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTY 220 (813)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 220 (813)
++++|.|++.++++|+++++. ..||+++++
T Consensus 79 -----~~~~g~~~l~l~~dGnlvl~~---------~~~W~S~~~ 108 (110)
T 3a0c_A 79 -----NGKEDHYVLVLQQDRNVVIYG---------PVVWATGSG 108 (110)
T ss_dssp -----CCSSSCCEEEECTTSCEEEEC---------SEEEECSCC
T ss_pred -----CCCCCCEEEEEeCCccEEEEC---------CCEecCCCc
Confidence 457899999999999977752 169998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=135.67 Aligned_cols=92 Identities=28% Similarity=0.393 Sum_probs=76.5
Q ss_pred CceEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceee
Q 045343 98 RGSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFS 176 (813)
Q Consensus 98 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S 176 (813)
...+|.|+.||||+|++. +++||++++...+ ..+|+|+++|||||++ ++.++||||+
T Consensus 19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~-------------------- 76 (112)
T 1xd5_A 19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT-------------------- 76 (112)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc--------------------
Confidence 357899999999999987 7899999986433 4689999999999999 7889999994
Q ss_pred cCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccccCC
Q 045343 177 RKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDP 222 (813)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (813)
+|++|.|++.++++|+++++.. . ...||++++|.+
T Consensus 77 -----~~~~g~~~l~l~~dGnlvl~~~-~-----~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----NRQNGNYYLILQRDRNVVIYDN-S-----NNAIWATHTNVG 111 (112)
T ss_dssp -----CCSCCCCEEEECTTSCEEEECT-T-----SCEEEECCCCCC
T ss_pred -----cCCCCCEEEEEeCCCcEEEECC-C-----CceEEECCCccC
Confidence 4567999999999999777531 1 258999999864
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-15 Score=136.28 Aligned_cols=86 Identities=21% Similarity=0.317 Sum_probs=73.5
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeec
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSR 177 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~ 177 (813)
..+|.|..||||+|++. +++||++++...+ ...|+|+|+|||||++.+++++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~---------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS----------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC----------------------
Confidence 46799999999999987 8999999986543 36899999999999999899999999
Q ss_pred CCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccc
Q 045343 178 KSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT 219 (813)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 219 (813)
+||++|.|++.++++|+++++. ..||++++
T Consensus 88 ---~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp ---CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred ---CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCC
Confidence 3567899999999999977653 26999876
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.2e-15 Score=131.15 Aligned_cols=107 Identities=21% Similarity=0.379 Sum_probs=84.9
Q ss_pred cCCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEe
Q 045343 26 NNGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLT 105 (813)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~ 105 (813)
+.|||.+||.|.+|+ +| .+|.|.|.|...|. |-+ |.. +|.+|+.. . +.++.|+|+
T Consensus 2 ~~dtL~~gq~L~~g~---~L--~~g~~~L~~q~dGN---------Lvl-~~~------~Wssnt~~---~-~~~~~l~l~ 56 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEG---HL--KNGDFDLVMQDDCN---------LVL-YNG------NWQSNTAN---N-GRDCKLTLT 56 (109)
T ss_dssp CCSEEETTCEECTTC---EE--EETTEEEEECTTSC---------EEE-ETT------TEECCCTT---S-CSSCEEEEC
T ss_pred ccCCcCCCCCcCCCC---Ee--ECCCEEEEEecCCe---------EEE-EeC------eEEcCCCC---C-CCcEEEEEc
Confidence 569999999999998 78 57999999976541 222 432 69998772 1 346789999
Q ss_pred eCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCC
Q 045343 106 ADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPG 165 (813)
Q Consensus 106 ~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg 165 (813)
.||||||+|.+++++|+|++.... ..+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 57 ~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 57 DYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 999999999999999999986433 4589999999999997 679997 555554
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=8.1e-15 Score=131.59 Aligned_cols=89 Identities=21% Similarity=0.359 Sum_probs=75.7
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeec
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSR 177 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~ 177 (813)
...|.|+.||||+|++ .+++||++++.... ...++|+++|||||++.++.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~-------------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW-------------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC--------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC--------------------
Confidence 4679999999999998 57899999986543 3689999999999999888999999997
Q ss_pred CCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccccCC
Q 045343 178 KSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDP 222 (813)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (813)
+++|.|++.++++|+++++. ..||++++|..
T Consensus 80 -----~~~g~~~l~l~~dGnlvl~~---------~~~W~S~~~~~ 110 (115)
T 2dpf_A 80 -----GDNGKYALVLQKDGRFVIYG---------PVLWSLGPNGC 110 (115)
T ss_dssp -----CSSSCCEEEECTTSCEEEEC---------SEEECSSTTCB
T ss_pred -----CCCCCEEEEEeCCCeEEEEC---------CCEEECCCCCC
Confidence 36789999999999977752 16999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-14 Score=157.69 Aligned_cols=140 Identities=11% Similarity=0.023 Sum_probs=94.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-----cchhh---------hheeeeeeccccCCcceEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-----GEKEF---------KNEVVVIGQTHHKNLVRLLG 586 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-----~~~~~---------~~E~~~l~~l~h~niv~l~g 586 (813)
|.+.++||+|++|.||+|... +++.||||+++..... ...++ ..+.++.....|+||++++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 567789999999999999763 6789999987632110 00011 11111111223444444332
Q ss_pred Eee------cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-
Q 045343 587 FCD------EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY- 659 (813)
Q Consensus 587 ~~~------~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~- 659 (813)
... .....+|||||+++++|..+.. ......++.||+.+|.|||+. +||||||||.|||+++++
T Consensus 173 ~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 173 EGFPVPEPIAQSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TTCSCCCEEEEETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred cCCCCCeeeeccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence 111 1123479999999999876543 223456889999999999965 999999999999998776
Q ss_pred ---------CEEEeeccCccccc
Q 045343 660 ---------NARISDFGLAKLLT 673 (813)
Q Consensus 660 ---------~~kl~DfGla~~~~ 673 (813)
.+.|+||+-+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999886543
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=122.30 Aligned_cols=102 Identities=11% Similarity=0.231 Sum_probs=80.2
Q ss_pred CCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEee
Q 045343 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (813)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~ 106 (813)
+|+|.+||.|.+|+ .| .+|.|.|.|...| -|.+ |.. .. ||.+|+..+ +.+..|.|..
T Consensus 2 ~~~l~~gq~L~~g~---~L--~~g~~~L~~q~dG---------nLvl-~~~---~~-vW~snt~~~----~~~~~l~l~~ 58 (111)
T 3mez_A 2 NNVLLTGDVIHTDN---QL--SYESAAFVMQGDC---------NLVL-YNE---AG-GFQSNTHGR----GVDCTLRLNN 58 (111)
T ss_dssp TTEEETTCEECTTC---EE--EETTEEEEECTTS---------CEEE-ECS---SC-CEECCCTTS----CSSCEEEECT
T ss_pred cCEeCCCCEeCCCC---EE--ecCCEEEEEccCC---------eEEE-ECC---CC-EEECCcccC----CcCEEEEEcC
Confidence 58899999999998 78 4799999997654 1333 542 23 999998732 3357899999
Q ss_pred CccEEEeCCCCC-EEeeeccCC---CceeEEEEecCcCEEEEecCCcccccc
Q 045343 107 DHGLVLNDPQGK-QVWSSEIDI---GTVAVGHMNDTGNFVLASSSSSKLWDS 154 (813)
Q Consensus 107 ~g~l~l~~~~~~-~~wst~~~~---~~~~~~~l~d~Gnlvl~~~~~~~~WqS 154 (813)
||||||+|.++. +||+|++.. .+..+++|+++|||||++ ..+|+|
T Consensus 59 dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 59 RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 999999998876 599999632 234689999999999997 679987
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.31 E-value=5.2e-12 Score=112.15 Aligned_cols=87 Identities=21% Similarity=0.291 Sum_probs=70.3
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCce-eEEEEecCcCEEEEecCCc-ccccccccCcCcccCCCccccccceee
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGTV-AVGHMNDTGNFVLASSSSS-KLWDSFSNPSDTLLPGQTMETKQGLFS 176 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~-~~~~l~d~Gnlvl~~~~~~-~~WqSFD~PTDTlLpg~~l~~~~~L~S 176 (813)
...|.++.||||||++.++ +|++++...+. ..++|+++|||||++.+++ ++|||.-+
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------- 79 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence 5789999999999999876 99999875433 6899999999999998776 49998731
Q ss_pred cCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccc
Q 045343 177 RKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT 219 (813)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 219 (813)
.....|.|.+.+++||+++++. .++|.+++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred ----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1114578999999999999984 46888765
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.2e-12 Score=111.70 Aligned_cols=88 Identities=17% Similarity=0.249 Sum_probs=70.9
Q ss_pred CceEEEEeeCccEEEeCC-CCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCcccccccee
Q 045343 98 RGSQVKLTADHGLVLNDP-QGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLF 175 (813)
Q Consensus 98 ~~~~l~~~~~g~l~l~~~-~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~ 175 (813)
...+|.++.||||||++. .++++|++++...+ ...++|+++|||||++.+++++|||=.+-
T Consensus 24 g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~----------------- 86 (113)
T 3mez_B 24 RDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVG----------------- 86 (113)
T ss_dssp TTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCC-----------------
T ss_pred CCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcC-----------------
Confidence 457899999999999998 48999999987543 46899999999999998889999974310
Q ss_pred ecCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccc
Q 045343 176 SRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT 219 (813)
Q Consensus 176 S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 219 (813)
..|.|.+.+++||+++++. ...|.+++
T Consensus 87 --------~~~~~~~~L~~dGnlvly~---------~~~W~s~~ 113 (113)
T 3mez_B 87 --------QEGDYVLILQINGQAVVYG---------PAVWSTAA 113 (113)
T ss_dssp --------SSSCCEEEECTTSCEEEEC---------SEEEESCC
T ss_pred --------CCCCEEEEEcCCceEEEec---------CCEecCCC
Confidence 1356899999999999873 35787653
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=109.62 Aligned_cols=86 Identities=27% Similarity=0.381 Sum_probs=69.4
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeec
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSR 177 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~ 177 (813)
...|.|+.||||||++. +++||++++...+ ...++|+++|||||++.++.++|||..+.
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence 47799999999999987 7899999986543 36899999999999998889999986421
Q ss_pred CCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccc
Q 045343 178 KSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT 219 (813)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 219 (813)
..+.|.+.++++|+++++. .+.|.+++
T Consensus 80 ------~~~~~~~~L~ddGNlvly~---------~~~W~s~t 106 (109)
T 3dzw_A 80 ------ENGNYVCVLQKDRNVVIYG---------TARWATGT 106 (109)
T ss_dssp ------SSSCEEEEECTTSCEEEEE---------SCCCCCCC
T ss_pred ------CCCCEEEEEeCCCEEEEEC---------CCEEeCCC
Confidence 2256889999999999874 24676654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=126.98 Aligned_cols=115 Identities=15% Similarity=0.271 Sum_probs=86.7
Q ss_pred ccCCCcCCCce----eeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCce
Q 045343 25 QNNGTVPVGAT----LTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGS 100 (813)
Q Consensus 25 ~~~~~~~~~~~----l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~ 100 (813)
..+||+.||+. |..|+ .|+|+ ..++.|+|...-.. .. ..+ + |.+ ..+++|.+++.++ . ..
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~---~L~S~-~dps~G~fsl~l~~-dG-nlv--L-y~~--~~~~yW~Sgt~~~---~--~~ 197 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGS---ELVQG-VVYGAGASKLVFQG-DG-NLV--A-YGP--NGAATWNAGTQGK---G--AV 197 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSE---EECTT-CEEEETTEEEEECT-TS-CEE--E-ECT--TSSEEEECCCTTT---T--CC
T ss_pred ccccccccccccccccccCc---ccccC-CCCCCceEEEeecC-Cc-eEE--E-EeC--CCeEEEECCCCCC---c--cE
Confidence 35699999999 87776 78654 56777777653111 12 233 3 432 2589999988732 1 26
Q ss_pred EEEEeeCccEEEeCCCCCEEeeeccCCCceeEEEEecCcCEEEEecCCccccccccc
Q 045343 101 QVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLWDSFSN 157 (813)
Q Consensus 101 ~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~ 157 (813)
.|.++.||+|+++|.++.++|++++......+|+|+++|||||++. +.+||||||
T Consensus 198 ~l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 198 RAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp EEEECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred EEEEcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 8999999999999998899999998755557899999999999986 689999997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.20 E-value=3.2e-11 Score=106.85 Aligned_cols=84 Identities=23% Similarity=0.354 Sum_probs=67.7
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCce-eEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeec
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGTV-AVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSR 177 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~-~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~ 177 (813)
...|.|+.||||||++. +++|++++...+. ..++|+++|||||++.++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence 46799999999999986 6899999875433 5899999999999998889999986411
Q ss_pred CCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeecc
Q 045343 178 KSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISG 218 (813)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 218 (813)
..|.|.+.+++||+++++. ...|.++
T Consensus 84 ------~~~~~~~~L~~dGNlvly~---------~~~W~t~ 109 (110)
T 3r0e_B 84 ------KQGEYVLILQDDGFGVIYG---------PAIFETS 109 (110)
T ss_dssp ------SSSCCEEEECTTSCEEEEC---------SEEEESC
T ss_pred ------CCCCEEEEEcCCccEEEec---------CCEecCC
Confidence 2345889999999999874 2567765
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.10 E-value=2.9e-10 Score=115.91 Aligned_cols=77 Identities=22% Similarity=0.336 Sum_probs=65.2
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCceeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeecC
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRK 178 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~~ 178 (813)
.-.|.|..||||+|++. +++||++++.......++|+++|||||+|.++++||+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~--------------------- 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK--------------------- 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC---------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc---------------------
Confidence 46788889999999986 78999999875555689999999999999999999999975
Q ss_pred CCCCCCCCceeEEeccCCcceec
Q 045343 179 SETNFSRGRFQFRLLKDGNLVLN 201 (813)
Q Consensus 179 s~~dps~G~~~~~~~~~g~~~~~ 201 (813)
.++|.|.+.++++|+++++
T Consensus 85 ----~~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 85 ----GSIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp ----CCSSCCEEEECSSSCEEEE
T ss_pred ----ccCCcEEEEEeCCCCEEEe
Confidence 1346788999999998886
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.8e-10 Score=100.56 Aligned_cols=85 Identities=20% Similarity=0.312 Sum_probs=68.8
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeec
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSR 177 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~ 177 (813)
...|.|+.||||||+++ +|+|++...+ ...++|+++|||||++.++.++|+|-.+
T Consensus 22 ~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~-------------------- 77 (109)
T 3r0e_A 22 DFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ-------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC--------------------
T ss_pred CEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc--------------------
Confidence 57899999999999984 8999987543 3689999999999999888999975210
Q ss_pred CCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccccC
Q 045343 178 KSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYD 221 (813)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (813)
...+.|.+.+++||+++++. .+.|.+++|.
T Consensus 78 -----~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~~ 107 (109)
T 3r0e_A 78 -----SVKGNYAAVVHPDGRLVVFG---------PSVFKIDPWV 107 (109)
T ss_dssp -----CSSSCCEEEEETTTEEEEEC---------SEEEEECTTS
T ss_pred -----CCCcCEEEEEcCCCeEEEEe---------cCEECCCCcc
Confidence 12367889999999999874 3689998874
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.05 E-value=4.4e-10 Score=98.49 Aligned_cols=77 Identities=31% Similarity=0.560 Sum_probs=63.2
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCC--ceeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceee
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIG--TVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFS 176 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~--~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S 176 (813)
.-+|.+..||||||++ .+++||++++... ....+.|+++|||||+|.+++++|+|-.
T Consensus 20 ~y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t-------------------- 78 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS-------------------- 78 (105)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CEEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC--------------------
Confidence 3579999999999998 4589999998643 3468999999999999999999998621
Q ss_pred cCCCCCCCCCceeEEeccCCcceec
Q 045343 177 RKSETNFSRGRFQFRLLKDGNLVLN 201 (813)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~ 201 (813)
....+.|.+.|+++|+++++
T Consensus 79 -----~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 -----TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp -----CCCSSCEEEEECTTSCEEEE
T ss_pred -----CCCCCCEEEEEeCCCeEEEE
Confidence 11456789999999999987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=5.1e-10 Score=116.25 Aligned_cols=141 Identities=15% Similarity=0.041 Sum_probs=109.8
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 599 (813)
+.+...++.|+.+.||+... .+..+++|............+.+|..+++.+. |..+.++++++.+....++|||
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 44566788888899999864 35689999986532233457899999999884 6778899999988888999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED----------------------------------------- 638 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------------------------------------- 638 (813)
|++|.+|.+.+. +......++.+++++|..||..
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999987632 2233457889999999999971
Q ss_pred ---------------CCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 639 ---------------CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 639 ---------------~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....++|+|+++.||+++++..+.|+||+.+..
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766677999988754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.80 E-value=5.3e-09 Score=108.10 Aligned_cols=131 Identities=15% Similarity=0.053 Sum_probs=96.7
Q ss_pred ccc-eeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeEeecCCceEEEEeecC
Q 045343 526 EVG-RGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 526 ~LG-~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~ 602 (813)
.++ .|..+.||++... ++..++||..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++
T Consensus 26 ~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp ECSCTTSSCEEEEEECT----TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred ecccCCCCceEEEEecC----CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 344 5556999998542 4567899986542 3356788999999986545 4568998888888999999999
Q ss_pred CCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------------
Q 045343 603 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------------------------------------------- 639 (813)
Q Consensus 603 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------------- 639 (813)
+.+|. ... . ....++.++++.|..||...
T Consensus 99 G~~l~--~~~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 99 GQDLL--SSH---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp SEETT--TSC---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CcccC--cCc---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 99884 211 1 12356778888888888531
Q ss_pred ------------CCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 640 ------------SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 640 ------------~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.9e-08 Score=109.43 Aligned_cols=142 Identities=16% Similarity=0.206 Sum_probs=105.6
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEee--ccc-cccchhhhheeeeeeccc--cCCcceEEeEeecCC---ceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVF-QDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQ---NRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~---~~~l 596 (813)
+.|+.|.++.||+... .+..+++|+.. ... ......+.+|..+++.+. +..++++++++.+.+ ..++
T Consensus 44 ~~l~~G~sn~~y~v~~-----~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVT-----PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEEC-----SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEE-----CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 5789999999999865 23567888765 221 122457888999999987 456889999987763 4799
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------------------------------------- 639 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------- 639 (813)
||||+++..+.+... ..++...+..++.++++.|+.||...
T Consensus 119 vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999988754222 23567788899999999999999620
Q ss_pred ------------------CCCeeeCCCCCCcEEEcCCCC--EEEeeccCccccc
Q 045343 640 ------------------SAQIIHCDIKPQNILLDDYYN--ARISDFGLAKLLT 673 (813)
Q Consensus 640 ------------------~~~ivH~dlk~~NIll~~~~~--~kl~DfGla~~~~ 673 (813)
...++|+|+++.|||++.++. +.|+||+.+....
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 257999999999999997753 6899999987543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=5e-08 Score=103.52 Aligned_cols=186 Identities=19% Similarity=0.158 Sum_probs=118.8
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCC--cceEEeEeecCC---ceEEEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKN--LVRLLGFCDEGQ---NRLLVY 598 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~ 598 (813)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..++||
T Consensus 26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN--------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST--------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC--------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 458899999999742 35788875432 23456888999998873 333 445665554433 347899
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED---------------------------------------- 638 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~---------------------------------------- 638 (813)
|+++|..|.+... ..++...+..++.++++.++.||..
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988875432 2356667777888888888888851
Q ss_pred ---------------CCCCeeeCCCCCCcEEEcC--CCCEEEeeccCccccccCcccceeec------------cccccc
Q 045343 639 ---------------CSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQSKAIRTA------------IRGTKG 689 (813)
Q Consensus 639 ---------------~~~~ivH~dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~gt~~ 689 (813)
....++|+|+++.||++++ ...+.|+||+.+....+...-..... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1245899999999999998 55688999999876433211000000 000001
Q ss_pred ccC-cccccCCCCCCccchhhHHHHHHHHHhCCcCC
Q 045343 690 YVA-PEWFRNSTITAKVDVYSFGVLLLEIISCRKSF 724 (813)
Q Consensus 690 y~a-PE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~ 724 (813)
... |+.... .....+.|+++.+++++.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 121111 011258899999999999998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=3.6e-05 Score=83.24 Aligned_cols=84 Identities=7% Similarity=-0.006 Sum_probs=56.2
Q ss_pred ccc-ceeeeeeEEEEEEeccCC---cceEEEEEEeeccc---cccchhhhheeeeeecccc---CCcceEEeEeecCC--
Q 045343 525 EEV-GRGSFGIVYKGVILTTRT---STTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDEGQ-- 592 (813)
Q Consensus 525 ~~L-G~G~fG~Vykg~~~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~-- 592 (813)
+.| +.|....+|+........ ++..+++|...... ......+..|..+++.+.. ..+.++++++.+.+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 888899999876531000 15567888754322 1123567889999988853 35778888886653
Q ss_pred -ceEEEEeecCCCchhh
Q 045343 593 -NRLLVYEFLNNGTLAS 608 (813)
Q Consensus 593 -~~~lV~e~~~~gsL~~ 608 (813)
..++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 4689999999877653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=3.2e-05 Score=80.02 Aligned_cols=136 Identities=17% Similarity=0.116 Sum_probs=92.7
Q ss_pred ccceeeee-eEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEeecCC
Q 045343 526 EVGRGSFG-IVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 526 ~LG~G~fG-~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
.+..|..| .||+.... .++..+.+|+-... ...++.+|...|+.+. +--+.++++++.+++..++|||++++
T Consensus 31 ~~~~G~S~~~v~rl~~~---~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK---PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECC---TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEec---CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 68886542 24556888876432 3456788888888774 44477899999988899999999999
Q ss_pred CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 045343 604 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED--------------------------------------------- 638 (813)
Q Consensus 604 gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~--------------------------------------------- 638 (813)
.++.+..... ......+..++++.|.-||..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8876654221 122334445555555555531
Q ss_pred ----------CCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 639 ----------CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 639 ----------~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=6.1e-05 Score=79.63 Aligned_cols=136 Identities=18% Similarity=0.192 Sum_probs=89.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccC---CcceEEeEee-cCCceEEEEee
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK---NLVRLLGFCD-EGQNRLLVYEF 600 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~e~ 600 (813)
+.++.|....||+. +..++||+-.. ......+..|.++|+.+.+. .+.+++.++. .....++|||+
T Consensus 25 ~~l~~G~~n~v~~v--------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV--------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE--------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE--------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788888899986 23477777432 22345688999999998653 3567777774 44567899999
Q ss_pred cCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 045343 601 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED------------------------------------------ 638 (813)
Q Consensus 601 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~------------------------------------------ 638 (813)
++|..|.+.... .++...+..++.++++.|+.||..
T Consensus 95 i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999888653211 123333344444444444444421
Q ss_pred ---------------CCCCeeeCCCCCCcEEEcC---CCC-EEEeeccCcccc
Q 045343 639 ---------------CSAQIIHCDIKPQNILLDD---YYN-ARISDFGLAKLL 672 (813)
Q Consensus 639 ---------------~~~~ivH~dlk~~NIll~~---~~~-~kl~DfGla~~~ 672 (813)
....++|+|+++.||+++. ++. ..|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2346799999999999987 455 489999988653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00038 Score=76.34 Aligned_cols=75 Identities=15% Similarity=0.092 Sum_probs=47.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-------ccchhhhheeeeeecccc--C-CcceEEeEeecCCce
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-------DGEKEFKNEVVVIGQTHH--K-NLVRLLGFCDEGQNR 594 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~ 594 (813)
+.||.|..+.||++.... .+..++||....... .....+..|.++++.+.. + .+.+++.+ +.+..
T Consensus 36 ~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 579999999999986531 346789997642111 123446778888887742 3 34456654 34456
Q ss_pred EEEEeecCCC
Q 045343 595 LLVYEFLNNG 604 (813)
Q Consensus 595 ~lV~e~~~~g 604 (813)
++|||++++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00057 Score=73.05 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=78.8
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc--CCcceEEeE------eecCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLGF------CDEGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~------~~~~~~~~l 596 (813)
+.|+.|..+.||+.... +..+++|+.... ..++..|..+++.+.. -.+.+++.. .......++
T Consensus 38 ~~l~gG~~n~~~~v~~~-----~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-----SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEET-----TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeC-----CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 35666778899998652 234888887642 2334455566665532 123444431 123456789
Q ss_pred EEeecCCCchh-----------h---hhhcc------C--------CCCHHHHH--------------------------
Q 045343 597 VYEFLNNGTLA-----------S---FLFGN------L--------KPSWNLRT-------------------------- 622 (813)
Q Consensus 597 V~e~~~~gsL~-----------~---~l~~~------~--------~l~~~~~~-------------------------- 622 (813)
|+||++|..+. . .++.. . ...|....
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 0 11110 0 01232110
Q ss_pred -----HHHHHHHHHHHHhhh----------cCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 623 -----NIAFQIARGLLYLHE----------DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 623 -----~i~~~ia~gl~yLH~----------~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
.+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123345666653 1257899999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0012 Score=69.56 Aligned_cols=134 Identities=18% Similarity=0.131 Sum_probs=88.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc---cCCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.|+.|....+|+... ++..++||..... ....+..|...|+.+. ...+.++++++......++||||+
T Consensus 42 ~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-----EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEECCSSSSEEEEEES-----SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred EEeCCccceeeeEEEE-----CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 5688999999999764 3457888876532 2456888988888884 356889999988778899999999
Q ss_pred CCCchhh--------h---hhcc---C-------------------CCCHHHHH---HHH----------------HHHH
Q 045343 602 NNGTLAS--------F---LFGN---L-------------------KPSWNLRT---NIA----------------FQIA 629 (813)
Q Consensus 602 ~~gsL~~--------~---l~~~---~-------------------~l~~~~~~---~i~----------------~~ia 629 (813)
++..+.. . |+.. . .-+|.... ++. ..++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 9876521 1 1111 0 01344321 111 1111
Q ss_pred HHH-HHhh-hcCCCCeeeCCCCCCcEEEcCCCCEEEeecc
Q 045343 630 RGL-LYLH-EDCSAQIIHCDIKPQNILLDDYYNARISDFG 667 (813)
Q Consensus 630 ~gl-~yLH-~~~~~~ivH~dlk~~NIll~~~~~~kl~DfG 667 (813)
+-+ ..|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 2332 12357899999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0017 Score=71.76 Aligned_cols=80 Identities=9% Similarity=0.018 Sum_probs=47.4
Q ss_pred CCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCC---CCCccchhhHHHHHHH
Q 045343 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST---ITAKVDVYSFGVLLLE 716 (813)
Q Consensus 640 ~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~k~DVwS~Gvvl~e 716 (813)
...++|+|+++.|||++.++ ++|+||+.+....+...-. .....-...|.+|+...... .....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 56899999999999998876 9999999987644221100 00000012455655443111 1112445577777777
Q ss_pred HHhCC
Q 045343 717 IISCR 721 (813)
Q Consensus 717 lltG~ 721 (813)
..+++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0028 Score=65.99 Aligned_cols=74 Identities=18% Similarity=0.201 Sum_probs=53.1
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc---CCcceEEeEeecCCceEEEEeec
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDEGQNRLLVYEFL 601 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lV~e~~ 601 (813)
+.+|.|..+.||+..+. +++.+.||+-..........|..|...|+.+.. --+.+++++. ..++||||+
T Consensus 21 ~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA----DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEETTEEEEEEEET----TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred EecCCCCCeEEEEEEEC----CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 56899999999999874 678899998654433334567889988888742 2355666553 347899998
Q ss_pred CCCch
Q 045343 602 NNGTL 606 (813)
Q Consensus 602 ~~gsL 606 (813)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.015 Score=56.82 Aligned_cols=101 Identities=13% Similarity=0.007 Sum_probs=66.0
Q ss_pred Cchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccceee
Q 045343 604 GTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT 682 (813)
Q Consensus 604 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 682 (813)
-+|.++|.. ..+++++++|.++.|.++.|.-+-.. ... ..+=+.|..|+|..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc------------
Confidence 478999975 46889999999999999998776211 011 1333456999999999998864 1110
Q ss_pred cccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 045343 683 AIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 722 (813)
Q Consensus 683 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~ 722 (813)
.....+.|||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123466888764 345678899999999999886443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0049 Score=64.55 Aligned_cols=136 Identities=15% Similarity=0.152 Sum_probs=75.6
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEeec-
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFL- 601 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~- 601 (813)
.+.|+.|....+|+. ..+++|....... .......|..+++.+....+ .++++++ .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE---------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee---------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 467888989999987 2477777653211 12234568878877754444 4666553 33457899999
Q ss_pred CCCchhhh------------------hhccC-CC----C-HHHHHHHHH--------------HHHHHHH----Hhh-hc
Q 045343 602 NNGTLASF------------------LFGNL-KP----S-WNLRTNIAF--------------QIARGLL----YLH-ED 638 (813)
Q Consensus 602 ~~gsL~~~------------------l~~~~-~l----~-~~~~~~i~~--------------~ia~gl~----yLH-~~ 638 (813)
++..|... ++... .+ + +.....+.. .+.+.+. .|. ..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 65554320 01110 01 1 111111110 0111111 111 11
Q ss_pred CCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 639 CSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 639 ~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
....++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 2456899999999999 56678899999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.01 E-value=0.0072 Score=63.84 Aligned_cols=140 Identities=13% Similarity=0.107 Sum_probs=78.4
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeEe------ecCCceEE
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFC------DEGQNRLL 596 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~l 596 (813)
+.|+.|....+|+.... ++ .+++|..... ....++..|..++..+.... +.+++... ......++
T Consensus 28 ~~i~~G~~n~~~~v~~~----~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT----KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEECC---EEEEEEEES----SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eccCCCcccceEEEEeC----Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 34677888899998653 22 5778887542 12345667777777775323 33444221 12345689
Q ss_pred EEeecCCCchhh----h----------hhcc------CC------CCHHHHHH------------HHHHHHHHHHHhhhc
Q 045343 597 VYEFLNNGTLAS----F----------LFGN------LK------PSWNLRTN------------IAFQIARGLLYLHED 638 (813)
Q Consensus 597 V~e~~~~gsL~~----~----------l~~~------~~------l~~~~~~~------------i~~~ia~gl~yLH~~ 638 (813)
+++|++|..+.. . ++.. .. ..|..... +...+.+.+..+++.
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999999865421 0 1110 00 01322111 011234455555532
Q ss_pred ----CCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 639 ----CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 639 ----~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 235799999999999999876668999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0093 Score=65.89 Aligned_cols=76 Identities=13% Similarity=0.198 Sum_probs=49.5
Q ss_pred cccceeeeeeEEEEEEeccC----CcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEe
Q 045343 525 EEVGRGSFGIVYKGVILTTR----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 599 (813)
+.|+.|-...+|+....... .++..+.+|+.... .....+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 56788888999998764211 12456888876331 111456678888888864444 577776653 38999
Q ss_pred ecCCCch
Q 045343 600 FLNNGTL 606 (813)
Q Consensus 600 ~~~~gsL 606 (813)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.016 Score=61.53 Aligned_cols=34 Identities=29% Similarity=0.277 Sum_probs=28.8
Q ss_pred CCCeeeCCCCCCcEEEcCC----CCEEEeeccCccccc
Q 045343 640 SAQIIHCDIKPQNILLDDY----YNARISDFGLAKLLT 673 (813)
Q Consensus 640 ~~~ivH~dlk~~NIll~~~----~~~kl~DfGla~~~~ 673 (813)
...++|+|+.+.||+++.+ ..+.|+||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 4589999999999999874 689999999886543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.029 Score=62.25 Aligned_cols=74 Identities=15% Similarity=0.122 Sum_probs=46.4
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEeecCC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~ 603 (813)
+.|+.|-...+|+..... .+..+++|+..... ...-....|..++..+...++ .++++.+.. .+|+||+++
T Consensus 114 ~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---KQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETT---TTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECC---CCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 568888889999987631 23567788764321 111123578888888865555 577777632 359999987
Q ss_pred Cch
Q 045343 604 GTL 606 (813)
Q Consensus 604 gsL 606 (813)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.02 Score=61.94 Aligned_cols=142 Identities=17% Similarity=0.207 Sum_probs=82.9
Q ss_pred cccceeeeeeEEEEEEecc----CCcceEEEEEEeeccccccchhhhheeeeeeccccCC-cceEEeEeecCCceEEEEe
Q 045343 525 EEVGRGSFGIVYKGVILTT----RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e 599 (813)
+.|..|-...+|+.....+ ..++..+.+|+.... ......+.+|..+++.+...+ ..++++++.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 4566787888999876321 113457888875321 223445678999988885333 3577777654 29999
Q ss_pred ecCCCchhhh-----------------hhcc-----CCCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 045343 600 FLNNGTLASF-----------------LFGN-----LKPS--WNLRTNIAFQIAR-------------------GLLYLH 636 (813)
Q Consensus 600 ~~~~gsL~~~-----------------l~~~-----~~l~--~~~~~~i~~~ia~-------------------gl~yLH 636 (813)
|+++..|..- |+.. .... |..+.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 1111 1112 3444445443321 233332
Q ss_pred h-----cCCCCeeeCCCCCCcEEEcCC----CCEEEeeccCccc
Q 045343 637 E-----DCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKL 671 (813)
Q Consensus 637 ~-----~~~~~ivH~dlk~~NIll~~~----~~~kl~DfGla~~ 671 (813)
+ .....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123579999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.48 E-value=0.033 Score=60.04 Aligned_cols=77 Identities=14% Similarity=0.110 Sum_probs=44.2
Q ss_pred cccceeeeeeEEEEEEeccC-----CcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEE
Q 045343 525 EEVGRGSFGIVYKGVILTTR-----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ 598 (813)
+.|+.|....+|+....... ..+..+++|...... ........|..+++.+...++ .++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 46778888899998764210 012567777764321 111234678888888864444 46776542 37899
Q ss_pred eecCCCch
Q 045343 599 EFLNNGTL 606 (813)
Q Consensus 599 e~~~~gsL 606 (813)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.79 E-value=0.036 Score=58.50 Aligned_cols=138 Identities=12% Similarity=0.035 Sum_probs=76.6
Q ss_pred ccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCC--cceEEeE-----eecCCceEEEE
Q 045343 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGF-----CDEGQNRLLVY 598 (813)
Q Consensus 526 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lV~ 598 (813)
.|+ |....||+.... ++..+++|..... .....++..|..++..+.... +++++.. ...+...++|+
T Consensus 33 ~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE----DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEECCT----TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEEcC----CCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 355 777789986542 3456889987532 112345677887777774322 3444443 11133457899
Q ss_pred eecCCCchhh-----h---------hhc---c------CCCCHHHH----HHH---------------HHHHHHHHHHhh
Q 045343 599 EFLNNGTLAS-----F---------LFG---N------LKPSWNLR----TNI---------------AFQIARGLLYLH 636 (813)
Q Consensus 599 e~~~~gsL~~-----~---------l~~---~------~~l~~~~~----~~i---------------~~~ia~gl~yLH 636 (813)
|++++..+.. . ++. . ...++... ..+ ...+.+.+..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9998865421 0 111 0 01121110 001 111112222332
Q ss_pred hc----CCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 637 ED----CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 637 ~~----~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+. ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11 245689999999999999 4 899999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.88 E-value=0.22 Score=52.84 Aligned_cols=33 Identities=24% Similarity=0.307 Sum_probs=28.7
Q ss_pred CCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 640 ~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
...++|+|+.+.||++++++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 457999999999999998888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.92 E-value=0.19 Score=55.06 Aligned_cols=142 Identities=15% Similarity=0.151 Sum_probs=83.3
Q ss_pred cccceeeeeeEEEEEEeccCCc----ceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEe
Q 045343 525 EEVGRGSFGIVYKGVILTTRTS----TTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 599 (813)
+.|..|-...+|+........+ +..+++|+..... ...-...+|..+++.+...++ .++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 4577777889999876422111 4678888754322 222234678888888854344 46665442 378999
Q ss_pred ecCCCchhhh-----------------hhc------------cCCC-CHHHHHHHHHHH-------------------HH
Q 045343 600 FLNNGTLASF-----------------LFG------------NLKP-SWNLRTNIAFQI-------------------AR 630 (813)
Q Consensus 600 ~~~~gsL~~~-----------------l~~------------~~~l-~~~~~~~i~~~i-------------------a~ 630 (813)
|+++..|..- |+. .... -|..+.++..++ .+
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998664210 011 0011 133333333221 22
Q ss_pred HHHHhhh---------------------cCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 631 GLLYLHE---------------------DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 631 gl~yLH~---------------------~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.+..|.+ .....++|+|+.+.||+ +.++.+.|+||..+...
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 3333321 11346899999999999 88889999999988643
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=87.09 E-value=0.45 Score=38.42 Aligned_cols=33 Identities=18% Similarity=0.481 Sum_probs=28.4
Q ss_pred ccCChhhhHHhhcccCCeeeEEecC--ceeeeecc
Q 045343 384 RPYNEVQCKNSCLSDCFCAAVIFQD--DCCWFKKL 416 (813)
Q Consensus 384 ~~~s~~~C~~~Cl~nCsC~A~~~~~--~~C~~~~~ 416 (813)
..+++++|++.|+.+=.|+||.|+. .-|+++..
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 4579999999999999999999975 45999864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=85.67 E-value=3.1 Score=42.28 Aligned_cols=67 Identities=13% Similarity=0.083 Sum_probs=33.7
Q ss_pred CCCeeEEEecCCCCCC---CCCCceEEEEeeC-ccEEEeCCC-CCEEeeeccCC-C-----ceeEEEEecCcCEEEEe
Q 045343 79 PAKTVVWYTDNKDQNP---AVPRGSQVKLTAD-HGLVLNDPQ-GKQVWSSEIDI-G-----TVAVGHMNDTGNFVLAS 145 (813)
Q Consensus 79 ~~~tvvWvanr~~~~~---~~~~~~~l~~~~~-g~l~l~~~~-~~~~wst~~~~-~-----~~~~~~l~d~Gnlvl~~ 145 (813)
+...++|...+...+. ....+-.+....+ +.++.+|.+ |+++|+..... . ....+.++.+||+++.+
T Consensus 153 ~~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 153 PNGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp TTSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred CCCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 3356777765542111 0112223333333 246666666 77777765321 1 13456667777777765
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=83.99 E-value=37 Score=34.00 Aligned_cols=74 Identities=14% Similarity=0.271 Sum_probs=43.5
Q ss_pred EEEEEeeccCCCeeEEEecCCCCCCCC----CCceEEEEeeCccEEEeCCCCCEEeeeccCC-CceeEEEEecCcCEEEE
Q 045343 70 LLSIFYSNIPAKTVVWYTDNKDQNPAV----PRGSQVKLTADHGLVLNDPQGKQVWSSEIDI-GTVAVGHMNDTGNFVLA 144 (813)
Q Consensus 70 ~lgiw~~~~~~~tvvWvanr~~~~~~~----~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~-~~~~~~~l~d~Gnlvl~ 144 (813)
.+.||= .....++|.........+. ..++.+-++.++.+..+|.+|+.+|...... .....+..+.+||+++.
T Consensus 16 ~v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~ 93 (276)
T 3no2_A 16 KIAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVA 93 (276)
T ss_dssp EEEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEE
T ss_pred EEEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEE
Confidence 344552 2245778877654210111 1233444466666777888999999988642 23345677778887775
Q ss_pred e
Q 045343 145 S 145 (813)
Q Consensus 145 ~ 145 (813)
+
T Consensus 94 ~ 94 (276)
T 3no2_A 94 W 94 (276)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.97 E-value=3.7 Score=40.03 Aligned_cols=114 Identities=11% Similarity=0.113 Sum_probs=76.9
Q ss_pred ccCCcceEEeEeecCCceEEEEeecCCC-chhhhhhccCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeeeCCCCCCcEE
Q 045343 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNG-TLASFLFGNLKPSWNLRTNIAFQIARGLL-YLHEDCSAQIIHCDIKPQNIL 654 (813)
Q Consensus 577 ~h~niv~l~g~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gl~-yLH~~~~~~ivH~dlk~~NIl 654 (813)
.||++ -...-.+++...+.|+.-+++ ++..+ ...+...+++++.+|+.... +++ .-+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 57777 444446777777777765443 33322 45678889999999988776 666 5588899999999
Q ss_pred EcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCC
Q 045343 655 LDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFD 725 (813)
Q Consensus 655 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~ 725 (813)
++.++.++|.-.|+-.. ++|.-+ ++.-=.-.+=+++..++.++..|+
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987665332 233221 111223356677888888877664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=80.21 E-value=1.3 Score=48.02 Aligned_cols=30 Identities=27% Similarity=0.361 Sum_probs=25.5
Q ss_pred CeeeCCCCCCcEEE------cCCCCEEEeeccCccc
Q 045343 642 QIIHCDIKPQNILL------DDYYNARISDFGLAKL 671 (813)
Q Consensus 642 ~ivH~dlk~~NIll------~~~~~~kl~DfGla~~ 671 (813)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 813 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-69 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-69 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-20 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-09 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-05 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-09 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-04 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-07 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-06 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-04 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 0.004 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 229 bits (584), Expect = 2e-69
Identities = 71/304 (23%), Positives = 137/304 (45%), Gaps = 34/304 (11%)
Query: 511 FSYKELEEATDNFKEEV-----------GRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF 559
F++++ EA F +E+ G G FG V G + VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 560 -QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-S 617
+ ++F +E ++GQ H N++ L G + +++ EF+ NG+L SFL N +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 618 WNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677
+ IA G+ YL + +H D+ +NIL++ ++SDFGL++ L + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 678 KAIRTA---IRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 734
T+ + + APE + T+ DV+S+G+++ E++S +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233
Query: 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ N+ + + +E D + C L + + C Q+D + RP +++ L+
Sbjct: 234 -----YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 795 GVVE 798
++
Sbjct: 289 KMIR 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 3e-69
Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 24/284 (8%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+ +G GSFG VYKG AV + + + FKNEV V+ +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKG----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+G+ Q +V ++ +L L K +IA Q A+G+ YLH
Sbjct: 68 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR---N 698
IIH D+K NI L + +I DFGLA + + + G+ ++APE R
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
+ + + DVY+FG++L E+++ + + + + Y + L +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSKVRSN---- 237
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLP 802
C + + + C+++ RP ++L +E + SLP
Sbjct: 238 -----CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR-SLP 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-64
Identities = 68/293 (23%), Positives = 129/293 (44%), Gaps = 23/293 (7%)
Query: 517 EEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQ 575
+F E +GRG FG VY G +L AVK L+R+ GE +F E +++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 576 THHKNLVRLLGFCDEGQNR-LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLL 633
H N++ LLG C + L+V ++ +G L +F+ P+ Q+A+G
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-- 142
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI--RTAIRGTKGYV 691
+ S + +H D+ +N +LD+ + +++DFGLA+ + + ++ +T + ++
Sbjct: 143 -MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
A E + T K DV+SFGVLL E+++ ++ D + +L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQ- 255
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPN 804
C + L V + C +RP+ +++ + + + +
Sbjct: 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 2e-64
Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 27/274 (9%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
E +G G FG V+ G T VAVK L + F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMG----YYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCS 640
RL + ++ E++ NG+L FL +K + N ++A QIA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
IH D++ NIL+ D + +I+DFGLA+L+ N+ A R + + APE T
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGT 186
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
T K DV+SFG+LL EI++ + + N ++ +E +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVR 231
Query: 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C E+L + C +E P RPT + +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 7e-64
Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 26/287 (9%)
Query: 514 KELEEATDNFK---EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE-KEFKNE 569
K+L DN E+G G+FG V +GV + VA+K L + + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMRE 59
Query: 570 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQI 628
++ Q + +VRL+G C + + +LV E G L FL G + + + Q+
Sbjct: 60 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS-KAIRTAIRGT 687
+ G+ YL E +H D+ +N+LL + + A+ISDFGL+K L + S R+A +
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
+ APE +++ DV+S+GV + E +S + + + +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPE 220
Query: 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
+ +E +C +L + C RP V Q +
Sbjct: 221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 8e-63
Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 25/278 (8%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
F +E+G G FG+V+ G L VA+K + E++F E V+ + H L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDK----VAIKTIREGAMS-EEDFIEEAEVMMKLSHPKL 62
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 640
V+L G C E LV+EF+ +G L+ +L + + + G+ YL E C
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+IH D+ +N L+ + ++SDFG+ + + +Q + + + +PE F S
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSR 178
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
++K DV+SFGVL+ E+ S K ++ N ++ + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYK 223
Query: 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
+ + C +E P RP ++L+ L + E
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-62
Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 581
F +E+G G FG+V G VA+K + E EF E V+ H+ L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYD----VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKL 61
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 640
V+L G C + + ++ E++ NG L ++L + + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+H D+ +N L++D ++SDFGL++ + + + + PE S
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
++K D+++FGVL+ EI S K ++ + N + + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
EK+ + C E RPT K +L +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-61
Identities = 58/306 (18%), Positives = 121/306 (39%), Gaps = 39/306 (12%)
Query: 516 LEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVV 572
+E D+F+ E+G G+ G+V+K + +A K + + + E+ V
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGL---VMARKLIHLEIKPAIRNQIIRELQV 57
Query: 573 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 632
+ + + +V G + E ++ G+L L + + ++ + +GL
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
YL E I+H D+KP NIL++ ++ DFG++ L + + + GT+ Y++
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMS 171
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL----------------- 735
PE + + + + D++S G+ L+E+ R +E ++
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 736 ----------TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT 785
D E LD +V L + C+ ++P+ R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 786 MKKVLQ 791
+K+++
Sbjct: 292 LKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 2e-61
Identities = 77/317 (24%), Positives = 129/317 (40%), Gaps = 39/317 (12%)
Query: 506 TNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTA--VAVKKLDR-VFQDG 562
T LP E +F + +G G+FG V + S A VAVK L
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69
Query: 563 EKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----- 616
+ +E+ V+ +H N+V LLG C G L++ E+ G L +FL
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 617 -------------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663
+ ++Q+A+G+ +L S IH D+ +NILL +I
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKI 186
Query: 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKS 723
DFGLA+ + + + ++ R ++APE N T + DV+S+G+ L E+ S S
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 724 FDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLR 783
+ K +++ L+ ++ + C DP R
Sbjct: 247 --------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 784 PTMKKVLQMLEGVVEVS 800
PT K+++Q++E + S
Sbjct: 293 PTFKQIVQLIEKQISES 309
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 2e-61
Identities = 73/316 (23%), Positives = 131/316 (41%), Gaps = 47/316 (14%)
Query: 512 SYKELEEATDNFK--EEVGRGSFGIVYKGVI--LTTRTSTTAVAVKKLDR-VFQDGEKEF 566
LE +N + ++G G+FG V++ L T VAVK L D + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 567 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---------- 616
+ E ++ + + N+V+LLG C G+ L++E++ G L FL
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 617 --------------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNAR 662
S + IA Q+A G+ YL E +H D+ +N L+ + +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 663 ISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK 722
I+DFGL++ + ++ PE + T + DV+++GV+L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 723 SFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSL 782
M E E + + +G++ A + C +L + C + P+
Sbjct: 241 QPYYGMAHE--------------EVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPAD 285
Query: 783 RPTMKKVLQMLEGVVE 798
RP+ + ++L+ + E
Sbjct: 286 RPSFCSIHRILQRMCE 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-60
Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 23/272 (8%)
Query: 526 EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVR 583
E+G G+FG V KG + T VAVK L D E E V+ Q + +VR
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKT-VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQI 643
++G C E ++ +LV E G L +L N + Q++ G+ YL E +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 644 IHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IRTAIRGTKGYVAPEWFRNSTIT 702
+H D+ +N+LL + A+ISDFGL+K L +++ +T + + APE +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 703 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762
+K DV+SFGVL+ E S + + + ++ ++E
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 763 KCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C ++ + C D RP V L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-60
Identities = 57/298 (19%), Positives = 114/298 (38%), Gaps = 29/298 (9%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+E +G+G FG V++G + VAVK ++ + E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRG-----KWRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENIL 60
Query: 583 RLLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 638
+ ++ LV ++ +G+L +L + +A A GL +LH +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHME 119
Query: 639 CSAQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL--TLNQSKAIRTAIRGTKGYV 691
I H D+K +NIL+ I+D GLA + GTK Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 692 APEWFRNS------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY----AILTDWAFD 741
APE +S + D+Y+ G++ EI I + + +D + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 742 CYRNEKLDDLVEGDM-EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
R + + ++ + + + + C + + R T ++ + L + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 8e-60
Identities = 65/299 (21%), Positives = 118/299 (39%), Gaps = 44/299 (14%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTA--VAVKKLDRVFQDGEKE-FKNEVVVIGQ-THH 578
F + +G G+FG V + + VAVK L E+E +E+ ++ Q H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---------------------- 616
+N+V LLG C L++E+ G L ++L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 617 -SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
++ A+Q+A+G+ +L +H D+ +N+L+ +I DFGLA+ + +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735
+ +R R ++APE T K DV+S+G+LL EI S + + +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD---- 273
Query: 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
L++ + E++ ++ C D RP+ + L
Sbjct: 274 ----------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 1e-59
Identities = 79/293 (26%), Positives = 133/293 (45%), Gaps = 27/293 (9%)
Query: 512 SYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNE 569
+Y + E + ++G G +G VY+GV + + VAVK L + E EF E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 570 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQ 627
V+ + H NLV+LLG C ++ EF+ G L +L + S + +A Q
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 628 IARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGT 687
I+ + YL IH D+ +N L+ + + +++DFGL++L+T + A +
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFP 179
Query: 688 KGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747
+ APE + + K DV++FGVLL EI + S + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224
Query: 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
+ +L+E D C EK+ + C Q +PS RP+ ++ Q E + + S
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-59
Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 29/299 (9%)
Query: 509 PCFSYKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEF 566
+ E ++ + ++G+G FG V+ G T TT VA+K L + F
Sbjct: 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMS-PEAF 59
Query: 567 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS--WNLRTNI 624
E V+ + H+ LV+L + +V E+++ G+L FL G ++
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 625 AFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAI 684
A QIA G+ Y+ +H D++ NIL+ + +++DFGLA+L+ N+ A R
Sbjct: 119 AAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGA 174
Query: 685 RGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 744
+ + APE T K DV+SFG+LL E+ + + +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMV 219
Query: 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPP 803
N ++ D VE +C E L + C +++P RPT + + LE + P
Sbjct: 220 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-59
Identities = 67/277 (24%), Positives = 112/277 (40%), Gaps = 33/277 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
+ +G+G FG V G VAVK + + F E V+ Q H NLV
Sbjct: 11 LLQTIGKGEFGDVMLG-----DYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 583 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDC 639
+LLG E + L +V E++ G+L +L + + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
+H D+ +N+L+ + A++SDFGL K + Q + + APE R
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 175
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759
+ K DV+SFG+LL EI S + + + + VE +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVP---------------YPRIPLKDVVPRVEKGYKMD 220
Query: 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796
C + V C D ++RP+ ++ + LE +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-58
Identities = 77/311 (24%), Positives = 133/311 (42%), Gaps = 45/311 (14%)
Query: 506 TNLPCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEK 564
T P + +++ F++ +G G+FG V K I A+K++ +D +
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHR 55
Query: 565 EFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------- 616
+F E+ V+ + HH N++ LLG C+ L E+ +G L FL +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 617 ---------SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFG 667
S + A +ARG+ YL Q IH D+ +NIL+ + Y A+I+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172
Query: 668 LAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE 727
L++ + K T R ++A E S T DV+S+GVLL EI+S +
Sbjct: 173 LSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--- 226
Query: 728 MGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMK 787
+ +L + + + C +++ + C +E P RP+
Sbjct: 227 ------------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 788 KVLQMLEGVVE 798
++L L ++E
Sbjct: 275 QILVSLNRMLE 285
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-58
Identities = 61/279 (21%), Positives = 113/279 (40%), Gaps = 21/279 (7%)
Query: 519 ATD-NFKEEVGRGSFGIVYKGVILTT-RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQ 575
T+ + +G G+FG VYKG+ + VA+K+L KE +E V+
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
+ ++ RLLG C +L+ L N QIA+G+ YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
+++H D+ +N+L+ + +I+DFGLAKLL + + + ++A E
Sbjct: 128 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
+ T + DV+S+GV + E+++ +D ++ ++E
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKG 229
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C + M+ + C D RP ++++
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-58
Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 24/275 (8%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTH 577
+++ + +G G++G V V T AVAVK +D + D + K E+ + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 637
H+N+V+ G EG + L E+ + G L + ++ Q+ G++YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR 697
I H DIKP+N+LLD+ N +ISDFGLA + N + + + GT YVAPE +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 698 NSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756
VDV+S G++L +++ +D + + +DW + D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKI---DS 234
Query: 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L + + E+PS R T+ + +
Sbjct: 235 APLALLH----------KILVENPSARITIPDIKK 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 30/276 (10%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 580
F E+GRGSF VYKG+ T T VA +L ++ + + FK E ++ H N
Sbjct: 13 FDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 581 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
+VR + +LV E + +GTL ++L + + QI +GL +LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 637 EDCSAQIIHCDIKPQNILLDD-YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
IIH D+K NI + + +I D GLA L + + A+ GT ++APE
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM 184
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
+ VDVY+FG+ +LE+ + + + + G
Sbjct: 185 YEEK-YDESVDVYAFGMCMLEMATSEYPYS--------------ECQNAAQIYRRVTSGV 229
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
A D + ++ + CI+++ R ++K +L
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 8e-58
Identities = 62/285 (21%), Positives = 124/285 (43%), Gaps = 24/285 (8%)
Query: 521 DNFKEE--VGRGSFGIVYKGVILTTRTST-TAVAVKKLDRVF-QDGEKEFKNEVVVIGQT 576
+ +G G FG VYKG++ T+ VA+K L + + +F E ++GQ
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYL 635
H N++RL G + + +++ E++ NG L FL S + IA G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI-RTAIRGTKGYVAPE 694
+H D+ +NIL++ ++SDFGL+++L + + + + APE
Sbjct: 127 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754
T+ DV+SFG+++ E+++ + + N ++ +
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMKAIND 228
Query: 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799
+ C + + + C Q++ + RP ++ +L+ ++
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 22/278 (7%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNL 581
+G G FG V++G+ ++ AVA+K D +E F E + + Q H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 640
V+L+G E ++ E G L SFL A+Q++ L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 641 AQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNST 700
+H DI +N+L+ ++ DFGL++ + + + + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185
Query: 701 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
T+ DV+ FGV + EI+ + + + + G+ +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------------DVIGRIENGERLPMP 231
Query: 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
C L + C DPS RP ++ L ++E
Sbjct: 232 P-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-57
Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 33/283 (11%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQT 576
++++ +G GS+G K + + K+LD + +EV ++ +
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGK---ILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 577 HHKNLVRLLGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKP----SWNLRTNIAFQIAR 630
H N+VR + N L V E+ G LAS + K + Q+
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 631 GLLYLHE--DCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
L H D ++H D+KP N+ LD N ++ DFGLA++L + S A A GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748
Y++PE + K D++S G LL E+ + F + E
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---------------AFSQKELA 223
Query: 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ EG + + ++L + + RP+++++L+
Sbjct: 224 GKIREGKFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 1e-57
Identities = 63/273 (23%), Positives = 100/273 (36%), Gaps = 33/273 (12%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 581
E+G GSFG VY + VA+KK+ + ++ EV + + H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSE---VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
++ G LV E+ + +GL YLH S
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 642 QIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFR---N 698
+IH D+K NILL + ++ DFG A ++ S GT ++APE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDE 188
Query: 699 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758
KVDV+S G+ +E+ + F+ L + + + A
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL---------------FNMNAMSALYHIAQNESPA 233
Query: 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
L E C+Q+ P RPT + +L+
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-57
Identities = 70/281 (24%), Positives = 111/281 (39%), Gaps = 25/281 (8%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 575
+ + E++G GSFG+V +G T +VAVK L + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLY 634
H+NL+RL G + +V E G+L L + + A Q+A G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR-TAIRGTKGYVAP 693
L IH D+ +N+LL +I DFGL + L N + + + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753
E + T + D + FGV L E+ + + I + IL + R + +D
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPED--- 239
Query: 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
C + + V + C P RPT + L
Sbjct: 240 ----------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-57
Identities = 70/279 (25%), Positives = 120/279 (43%), Gaps = 38/279 (13%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 575
++F+ +G+G FG VY ++ +A+K L + E + + EV +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
H N++RL G+ + L+ E+ GT+ L K ++A L Y
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H S ++IH DIKP+N+LL +I+DFG + ++ RT + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNEKLDDLV 752
KVD++S GVL E + + F+ +E I ++ F + E DL+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
++ +PS RP +++VL+
Sbjct: 236 S--------------------RLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 68/269 (25%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 584
E++G+G+ G VY + + T VA+++++ Q ++ NE++V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQ---EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 585 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQII 644
L G +V E+L G+L + + + + L +LH S Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 645 HCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAK 704
H DIK NILL + +++DFG +T QSK R+ + GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 705 VDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDI 762
VD++S G++ +E+I + + + Y I T+ + EKL + +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA------IFRDFL 250
Query: 763 KCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
C+ D R + K++LQ
Sbjct: 251 N----------RCLDMDVEKRGSAKELLQ 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-55
Identities = 62/281 (22%), Positives = 112/281 (39%), Gaps = 32/281 (11%)
Query: 520 TDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 577
D ++ E+G G+FG VYK T A K +D ++ +++ E+ ++
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSV---LAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 578 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLH 636
H N+V+LL N ++ EF G + + + +P + + + Q L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
+IIH D+K NIL + +++DFG++ T + R + GT ++APE
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVV 182
Query: 697 RNST-----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
T K DV+S G+ L+E+ + L +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH---------------ELNPMRVLLKI 227
Query: 752 VEGDMEALNDIKCV-EKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + L C++++ R T ++LQ
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-53
Identities = 76/300 (25%), Positives = 128/300 (42%), Gaps = 40/300 (13%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTST----TAVAVKKLDR-VFQDGEKEFKNEVVVIGQ-T 576
+ +G G+FG V + T VAVK L + + +E+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----------------SWNL 620
HKN++ LLG C + ++ E+ + G L +L P S
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 621 RTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAI 680
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 681 RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 740
T R ++APE + T + DV+SFGVLL EI + S +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---------------Y 238
Query: 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
E+L L++ C +L M+ C PS RPT K++++ L+ +V ++
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 71/289 (24%), Positives = 130/289 (44%), Gaps = 31/289 (10%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTT--AVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHK 579
E+G+GSFG+VY+GV VA+K ++ EF NE V+ + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIA 629
++VRLLG +GQ L++ E + G L S+L PS + +A +IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKG 689
G+ YL + + +H D+ +N ++ + + +I DFG+ + +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 690 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749
+++PE ++ T DV+SFGV+L EI + + + E + L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------------QVLR 246
Query: 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798
++EG + D C + L + C Q +P +RP+ +++ ++ +E
Sbjct: 247 FVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 4e-52
Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 38/299 (12%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTA--VAVKKLDR-VFQDGEKEFKNEVVVIGQT-HH 578
+ +GRG+FG V + + T VAVK L + +E+ ++ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 579 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKP----------------SWNLR 621
N+V LLG C G +++ EF G L+++L +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 622 TNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIR 681
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + +
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 741
R ++APE + T + DV+SFGVLL EI S S + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCR 248
Query: 742 CYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800
+ + ++ + C +PS RPT ++++ L +++ +
Sbjct: 249 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 5e-50
Identities = 62/275 (22%), Positives = 113/275 (41%), Gaps = 31/275 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
EE+G G+FG+V++ T + A K + + ++ + E+ + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNN---FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSA 641
L ++ +++YEF++ G L + S + Q+ +GL ++HE
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---N 143
Query: 642 QIIHCDIKPQNILLDDYYNARI--SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
+H D+KP+NI+ + + DFGL L QS GT + APE
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK 200
Query: 700 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNEKLDDLVEGDM 756
+ D++S GVL ++S F E +E + + DW D + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE------ 254
Query: 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + I+ + DP+ R T+ + L+
Sbjct: 255 DGKDFIR----------KLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 34/282 (12%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQ 575
++FK + +G GSF V L T A+K L++ + ++ E V+ +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSRE---YAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
H V+L + + + NG L ++ +I L YL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H IIH D+KP+NILL++ + +I+DFG AK+L+ +A + GT YV+PE
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNEKLDDLV 752
+ D+++ G ++ ++++ F I+ ++ F K DLV
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794
E + D + R +++
Sbjct: 242 E--------------------KLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 1e-48
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 34/288 (11%)
Query: 513 YKELEEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR-VFQDGEKEFKNE 569
+K+ E+ D + + +G G+F V T+ VA+K + + + E +NE
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQK---LVAIKCIAKKALEGKEGSMENE 57
Query: 570 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 629
+ V+ + H N+V L + G + L+ + ++ G L + + + + FQ+
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117
Query: 630 RGLLYLHEDCSAQIIHCDIKPQNILL---DDYYNARISDFGLAKLLTLNQSKAIRTAIRG 686
+ YLH+ I+H D+KP+N+L D+ ISDFGL+K+ + + G
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171
Query: 687 TKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCY 743
T GYVAPE + VD +S GV+ ++ F E + IL ++ FD
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + D A + I+ +++DP R T ++ LQ
Sbjct: 232 YWDDISD------SAKDFIR----------HLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (433), Expect = 1e-47
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 33/279 (11%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 578
D + EE+G G+FG+V++ V T K ++ + + KNE+ ++ Q HH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRV---FVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 579 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHE 637
L+ L ++ +L+ EFL+ G L + S N Q GL ++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH- 144
Query: 638 DCSAQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
I+H DIKP+NI+ + + + DFGLA L ++ I T + APE
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEI 199
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNEKLDDLV 752
+ D+++ GVL ++S F E E + DW FD +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP-- 257
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
EA + IK +Q++P R T+ L+
Sbjct: 258 ----EAKDFIK----------NLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 56/283 (19%), Positives = 122/283 (43%), Gaps = 34/283 (12%)
Query: 517 EEATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 574
+E + + E++GRG FGIV++ V +++ + K + D + K E+ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKT---YMAKFVKVKGTD-QVLVKKEISILN 56
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLL 633
H+N++ L + + ++++EF++ + + + + + Q+ L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 634 YLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYV 691
+LH S I H DI+P+NI+ +I +FG A+ L + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNEKL 748
APE ++ ++ D++S G L+ ++S F E ++ I+ ++ FD +++
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
EA++ + + ++ R T + LQ
Sbjct: 231 SI------EAMDFVD----------RLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (405), Expect = 1e-44
Identities = 59/289 (20%), Positives = 111/289 (38%), Gaps = 40/289 (13%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLD---------RVFQDGEKEFKNE 569
+N++ E +GRG +V + + T AVK +D Q+ + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 570 VVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 628
V ++ + H N+++L + LV++ + G L +L + S I +
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
+ LH I+H D+KP+NILLDD N +++DFG + L + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 689 GYVAPEWFRNST------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 742
Y+APE S +VD++S GV++ +++ F + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMIMSG 230
Query: 743 YRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + + + + P R T ++ L
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS----------RFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 5e-44
Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 36/291 (12%)
Query: 520 TDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIG 574
+D ++ E +G G V+ L VAVK L F+ E
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 575 QTHHKNLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 630
+H +V + G +V E+++ TL + + + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 631 GLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRT-AIRGTKG 689
L + IIH D+KP NI++ ++ DFG+A+ + + + +T A+ GT
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 690 YVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCYRNE 746
Y++PE R ++ A+ DVYS G +L E+++ F + A + D R+E
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 747 KLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGV 796
L L+ + V K + ++P R T ++ L V
Sbjct: 240 GLS-------ADLDAV--VLK-------ALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 7e-44
Identities = 54/295 (18%), Positives = 94/295 (31%), Gaps = 26/295 (8%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
++G GSFG +Y G + VA+K + + E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEE---VAIKLECV--KTKHPQLHIESKIYKMMQGGVGI 65
Query: 583 RLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+ +C EG ++V E L F F + K S +A Q+ + Y+H S
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122
Query: 642 QIIHCDIKPQNIL---LDDYYNARISDFGLAKLLTLNQSKAI-----RTAIRGTKGYVAP 693
IH D+KP N L I DFGLAK ++ + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753
+ + D+ S G +L+ + + + + ++ L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPF 808
G +C +P + Q+ + Y F
Sbjct: 243 GYPSEFATYLN---------FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 2e-43
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVI-- 573
++F +GRG FG VY T A+K LD+ + GE NE +++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKM---YAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 574 -GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 632
+V + + + +N G L L + S A +I GL
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 633 LYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
++H +++ D+KP NILLD++ + RISD GLA + + A GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMA 173
Query: 693 PEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
PE + + D +S G +L +++ F ++ + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELP 229
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM 786
E + ++ +Q D + R
Sbjct: 230 DSFSPELRSLLE----------GLLQRDVNRRLGC 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 6e-43
Identities = 70/276 (25%), Positives = 110/276 (39%), Gaps = 31/276 (11%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQ 575
++F + +G+GSFG V+ T A+K L + + D + E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ---FFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 576 T-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 634
H L + +N V E+LN G L + K + T A +I GL +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
LH I++ D+K NILLD + +I+DFG+ K L +K GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPE 173
Query: 695 WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754
VD +SFGVLL E++ + F + EE F R +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFYPRWL 226
Query: 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790
+ EA + + +P R ++ +
Sbjct: 227 EKEAKDLLV----------KLFVREPEKRLGVRGDI 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-42
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 44/280 (15%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKL------DRVFQDGEKEFKNEVVVIGQ- 575
+G G FG VY G+ ++ VA+K + D EVV++ +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 576 -THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLL 633
+ ++RLL + + + +L+ E L + +Q+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 634 YLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
+ H ++H DIK +NIL+D + ++ DFG LL T GT+ Y
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177
Query: 693 PEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
PEW R V+S G+LL +++ F+ +E I F + + L
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSSECQHL 234
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ WC+ PS RPT +++
Sbjct: 235 IR--------------------WCLALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (385), Expect = 1e-41
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 39/273 (14%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 575
+F+ +G GSFG V+ A+K L + + +E +++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRY---YAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
H ++R+ G + Q ++ +++ G L S L + + + A ++ L YL
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H II+ D+KP+NILLD + +I+DFG AK + + + GT Y+APE
Sbjct: 121 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWAFDCYRNEKLDDLV 752
+D +SFG+L+ E+++ F M IL + F + NE + DL+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT 785
I D S R
Sbjct: 233 SR--------------------LITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 62/285 (21%), Positives = 107/285 (37%), Gaps = 25/285 (8%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 579
+ +G G F VYK T VA+KK+ + K+ E+ ++ + H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQ---IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 580 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 639
N++ LL N LV++F+ +L + + +GL YLH+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNS 699
I+H D+KP N+LLD+ +++DFGLAK + T T+ Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 700 T-ITAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNEKL 748
VD+++ G +L E++ I W C + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 749 DDLVEGDMEALNDIKCVEKLVMVSI-WCIQEDPSLRPTMKKVLQM 792
+ + ++ I +P R T + L+M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-41
Identities = 58/278 (20%), Positives = 109/278 (39%), Gaps = 33/278 (11%)
Query: 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 582
+ +G G G V + T+ A+K L + + EV + + + ++V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEK---FALKMLQDC-----PKARREVELHWRASQCPHIV 68
Query: 583 RLLGFCD----EGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLH 636
R++ + + L+V E L+ G L S + G+ + + I I + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 637 EDCSAQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
S I H D+KP+N+L +++DFG AK T + S T T YVAP
Sbjct: 129 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAP 182
Query: 694 EWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753
E D++S GV++ ++ F ++ R +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQY----- 234
Query: 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + E++ M+ ++ +P+ R T+ + +
Sbjct: 235 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 6e-41
Identities = 55/287 (19%), Positives = 110/287 (38%), Gaps = 24/287 (8%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT 576
+ + E++G G++G+VYK T A+KK+ +D E+ ++ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
H N+V+L + +LV+E L+ + Q+ G+ Y H
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
+++H D+KPQN+L++ +I+DFGLA+ + K I
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDVLM 173
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNEKLDDL 751
+ + +D++S G + E+++ F + + IL + N
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 752 VEGDMEALNDIKCVEKLVMVSI-------WCIQEDPSLRPTMKKVLQ 791
+ + + L + ++ DP+ R T K+ L+
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 7e-41
Identities = 47/297 (15%), Positives = 95/297 (31%), Gaps = 28/297 (9%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 581
+G GSFG++++G L VA+K R + + ++E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQ---VAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 582 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSA 641
+ F EG + +LV + L K S A Q+ + +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EK 120
Query: 642 QIIHCDIKPQNILLDDYYN-----ARISDFGLAKLLTLNQSKAI-----RTAIRGTKGYV 691
+++ DIKP N L+ + + DFG+ K +K + + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 692 APEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
+ + + D+ + G + + + + + + ++ L +L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPPNPYPF 808
G E+ + P + + V+E F
Sbjct: 241 CAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 65/279 (23%), Positives = 110/279 (39%), Gaps = 32/279 (11%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE------KEFKNEVVVIGQT 576
EE+G G F +V K +T A K + + ++ + EV ++ +
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
H N++ L + + +L+ E + G L FL + T QI G ++
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VY 127
Query: 637 EDCSAQIIHCDIKPQNILLDDY----YNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVA 692
S QI H D+KP+NI+L D +I DFGLA + I GT +VA
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVA 184
Query: 693 PEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752
PE + + D++S GV+ ++S F + +E + +E +
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
A + I+ + +DP R T++ LQ
Sbjct: 245 A---LAKDFIR----------RLLVKDPKKRMTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 31/296 (10%)
Query: 519 ATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVV-- 572
A ++ E+G G++G V+K L + VA+K++ + EV V
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDL--KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 573 -IGQTHHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIA 625
+ H N+VRL C D LV+E ++ ++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 626 FQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIR 685
FQ+ RGL +LH S +++H D+KPQNIL+ +++DFGLA++ + + T++
Sbjct: 123 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVV 176
Query: 686 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWA 739
T Y APE S+ VD++S G + E+ + F + I
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 740 FDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSI----WCIQEDPSLRPTMKKVLQ 791
D R+ L A K V + + C+ +P+ R + L
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 26/289 (8%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQT 576
+NF+ E++G G++G+VYK T VA+KK+ D + E+ ++ +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYL 635
+H N+V+LL LV+EFL+ L L + FQ+ +GL +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H ++H D+KPQN+L++ +++DFGLA+ + T T Y APE
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEI 173
Query: 696 FRNS-TITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAIL--------TDWAFDCYR 744
+ VD++S G + E+++ R F D E+ + + I W
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 745 NEKLDDLVEGDMEALNDI--KCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791
+ + + + + E + + DP+ R + K L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-39
Identities = 66/320 (20%), Positives = 124/320 (38%), Gaps = 31/320 (9%)
Query: 518 EATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIG 574
+ + +G G++G+V + VA+KK+ Q + E+ ++
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKV---RVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 575 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARG 631
+ H+N++ + + +L + + L+ LK S + +QI RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 632 LLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK-AIRTAIRGTKGY 690
L Y+H SA ++H D+KP N+LL+ + +I DFGLA++ + T T+ Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 691 VAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYR 744
APE NS T +D++S G +L E++S R F + + IL + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSI---------WCIQEDPSLRPTMKKVLQ---M 792
+ + K + + + +P R +++ L +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
Query: 793 LEGVVEVSLPPNPYPFSSSM 812
+ P PF M
Sbjct: 299 EQYYDPSDEPIAEAPFKFDM 318
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 53/295 (17%), Positives = 108/295 (36%), Gaps = 34/295 (11%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLV 582
++G+G+FG V+K T VA+KK+ + E+ ++ H+N+V
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQK---VALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 583 RLLGFCDEGQNR--------LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 634
L+ C + LV++F + +K + + + + GL
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL-- 130
Query: 635 LHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS--KAIRTAIRGTKGYVA 692
+ +I+H D+K N+L+ +++DFGLA+ +L ++ T T Y
Sbjct: 131 -YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 693 PEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIE--------MGEEYAILTDWAFDCY 743
PE +D++ G ++ E+ + + + +T +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIW-------CIQEDPSLRPTMKKVLQ 791
N +L + +E +K K + + + DP+ R L
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 62/305 (20%), Positives = 114/305 (37%), Gaps = 34/305 (11%)
Query: 509 PCFSYKELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKN 568
P +E + + +G GSFG+VY+ + + VA+KK+ + ++
Sbjct: 10 PGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE---LVAIKKVLQ----DKRFKNR 62
Query: 569 EVVVIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKP---SWN 619
E+ ++ + H N+VRL F + LV +++ +
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 620 LRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSK 678
+Q+ R L Y+H S I H DIKPQN+LLD D ++ DFG AK L + +
Sbjct: 123 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGE 177
Query: 679 AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIE----------- 727
+ I F + T+ +DV+S G +L E++ + F +
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 728 -MGEEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTM 786
+G Y K + + + + + + ++ P+ R T
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 787 KKVLQ 791
+
Sbjct: 298 LEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 53/282 (18%), Positives = 108/282 (38%), Gaps = 22/282 (7%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 582
E++G G++G V+K T VA+K++ D E+ ++ + HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 583 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQ 642
RL + LV+EF + F N + + FQ+ +GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 643 IIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTIT 702
++H D+KPQN+L++ ++++FGLA+ + + F +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYS 180
Query: 703 AKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760
+D++S G + E+ + + ++ ++ + + D +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 761 DIKCVEKLVMVSI-----------WCIQEDPSLRPTMKKVLQ 791
LV V ++ +P R + ++ LQ
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 60/276 (21%), Positives = 100/276 (36%), Gaps = 36/276 (13%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 575
++F + +G+G+FG V T A+K L + +D E V+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRY---YAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
T H L L V E+ N G L L + +I L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL--- 118
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
S +++ DIK +N++LD + +I+DFGL K + + GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNEKLDDLV 752
++ VD + GV++ E++ R F + E IL + F + + L+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236
Query: 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKK 788
G +++DP R
Sbjct: 237 AG--------------------LLKKDPKQRLGGGP 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 78/333 (23%), Positives = 130/333 (39%), Gaps = 44/333 (13%)
Query: 511 FSYKELEEATDNFK------EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE- 563
F +E+ + + + VG G++G V V T VA+KKL R FQ
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA---KVAIKKLYRPFQSELF 60
Query: 564 -KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKP 616
K E+ ++ H+N++ LL + LV F+ GT L + K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKL 118
Query: 617 SWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676
+ + +Q+ +GL Y+H +A IIH D+KP N+ +++ +I DFGLA+ Q
Sbjct: 119 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 170
Query: 677 SKAIRTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 735
+ + T T+ Y APE N T VD++S G ++ E+I+ + F +
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 736 TDWAFDCYRNEKLDDLV-EGDMEALNDIKCVEKLVMVSIW-------------CIQEDPS 781
E + L + + + +EK SI + D
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 782 LRPTMKKVLQM--LEGVVEVSLPPNPYPFSSSM 812
R T + L E + + P + S
Sbjct: 291 QRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 8e-34
Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 38/281 (13%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ 575
D F + +G GSFG V + A+K LD+ K+ NE ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGN---HYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 576 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
+ LV+L + N +V E++ G + S L + S A QI YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 636 HEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEW 695
H S +I+ D+KP+N+L+D +++DFG AK + K + GT +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 696 FRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755
+ VD ++ GVL+ E+ + F + + ++ + K+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFS 262
Query: 756 MEALNDIKCVEKLVMVSIWCIQEDP-----SLRPTMKKVLQ 791
+ + ++ +Q D +L+ + +
Sbjct: 263 SDLKDLLR----------NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 9e-34
Identities = 59/277 (21%), Positives = 111/277 (40%), Gaps = 26/277 (9%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIG 574
+NF+ + +G G++G V+ ++ + A+K L + + + E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 575 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 633
LV L L+ +++N G L + L + + + +I L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 634 YLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAP 693
+LH+ II+ DIK +NILLD + ++DFGL+K ++++ GT Y+AP
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAP 199
Query: 694 EWFR--NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751
+ R +S VD +S GVL+ E+++ F ++ + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256
Query: 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKK 788
E A + I+ + +DP R
Sbjct: 257 QEMSALAKDLIQ----------RLLMKDPKKRLGCGP 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 70/329 (21%), Positives = 125/329 (37%), Gaps = 57/329 (17%)
Query: 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 582
+ +G G+ GIV + VA+KKL R FQ+ K E+V++ +HKN++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 583 RLLGFC------DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 636
LL +E Q+ LV E ++ + + + +Q+ G+ +LH
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH 136
Query: 637 EDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWF 696
IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 697 RNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756
VD++S G ++ E++ + F G +Y + + + + +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILF---PGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 757 EALNDIKCVEKLVMVSI----------------------------WCIQEDPSLRPTMKK 788
N ++ K ++ + DP+ R ++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 789 VLQ-----MLEGVVEVSLPPNPYPFSSSM 812
LQ + EV PP P + +
Sbjct: 308 ALQHPYINVWYDPAEVEAPP-PQIYDKQL 335
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (315), Expect = 4e-32
Identities = 57/299 (19%), Positives = 117/299 (39%), Gaps = 43/299 (14%)
Query: 521 DNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-TH 577
D+++ ++GRG + V++ + +T V VK L V +K+ K E+ ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVK---KKKIKREIKILENLRG 88
Query: 578 HKNLVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 635
N++ L + +R LV+E +NN + ++I + L Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYC 145
Query: 636 HEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPE 694
H I+H D+KP N+++D ++ R+ D+GLA+ Q ++ + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 695 -WFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-------TDWAFDCYRNE 746
+D++S G +L +I ++ F ++ T+ +D
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 747 KLD-DLVEGDMEALNDIKCVEKLVMVSIW-------------CIQEDPSLRPTMKKVLQ 791
++ D D+ + K E+ V ++ D R T ++ ++
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-32
Identities = 73/334 (21%), Positives = 125/334 (37%), Gaps = 42/334 (12%)
Query: 509 PCFSYKELE----EATDNFK--EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDG 562
P F +EL E + ++ VG G++G V T VAVKKL R FQ
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL---RVAVKKLSRPFQSI 58
Query: 563 E--KEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGNLK 615
K E+ ++ H+N++ LL + N + + L L + + K
Sbjct: 59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-K 117
Query: 616 PSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675
+ + + +QI RGL Y+H IIH D+KP N+ +++ +I DFGLA
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA-----R 169
Query: 676 QSKAIRTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYA 733
+ T T+ Y APE N VD++S G ++ E+++ R F ++
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 734 ILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIW-------------CIQEDP 780
++ E + + + K+ +++ + D
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
Query: 781 SLRPTMKKVLQM--LEGVVEVSLPPNPYPFSSSM 812
R T + L + P P+ S
Sbjct: 290 DKRITAAQALAHAYFAQYHDPDDEPVADPYDQSF 323
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 1e-26
Identities = 53/317 (16%), Positives = 103/317 (32%), Gaps = 54/317 (17%)
Query: 523 FKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 582
++G G F V+ + T VA+K + + + ++E+ ++ + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTH---VAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72
Query: 583 RLLGFCDEGQNRLLVY----------------EFLNNGTLASFLFGNLKPSWNLRTNIAF 626
+ +LL + N + + I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 627 QIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTLNQSKAIRTAIR 685
Q+ GL Y+H C IIH DIKP+N+L++ + +A L T
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 686 GTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-----------AI 734
T+ Y +PE + D++S L+ E+I+ F+ + G Y +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 735 LTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSI--------------------W 774
L + RN K L +I ++ + +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 775 CIQEDPSLRPTMKKVLQ 791
+Q DP R ++
Sbjct: 311 MLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 7e-20
Identities = 29/208 (13%), Positives = 59/208 (28%), Gaps = 30/208 (14%)
Query: 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVK----------KLDRVFQDGEKEFKNEV 570
D + +G G V+ VK K+ G+ F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE----CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 571 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--IAFQI 628
+ + + L +L G Y + N L + + + I
Sbjct: 58 IRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMI 112
Query: 629 ARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTK 688
+ + I+H D+ N+L+ + I DF + + + R +
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV--EVGEEGWREILERDVR 166
Query: 689 GYVAPEWFRNSTITAKVDVYSFGVLLLE 716
+F + + D+ S +L+
Sbjct: 167 --NIITYFSRTY-RTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.8 bits (129), Expect = 2e-09
Identities = 24/129 (18%), Positives = 41/129 (31%), Gaps = 27/129 (20%)
Query: 72 SIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVA 131
SI YS T + Q ++ + D LVL D + ++ GT
Sbjct: 11 SILYSTQGNDNHPQ-TLHATQ-SLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGC 68
Query: 132 VGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFR 191
+ G + ++ + +W S + + S GR+ F
Sbjct: 69 RAVLQPNGRMDVLTNQNIAVWTSGN-------------------------SRSAGRYVFV 103
Query: 192 LLKDGNLVL 200
L D NL +
Sbjct: 104 LQPDRNLAI 112
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 42.6 bits (100), Expect = 2e-05
Identities = 27/144 (18%), Positives = 43/144 (29%), Gaps = 35/144 (24%)
Query: 135 MNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLK 194
+ + GN +L S+ + N TL Q+ ++ +
Sbjct: 5 VANNGNSILYSTQGND------NHPQTLHATQS---------------LQLSPYRLSMET 43
Query: 195 DGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTT 254
D NLVL D D + + T +G R + +G M +L
Sbjct: 44 DCNLVLF-------DRDDRVWSTNTA----GKGTGCRAVLQPNGRMDVLTNQNIA---VW 89
Query: 255 ESVVPAADFYYRATLNFDGVFAQY 278
S + Y L D A Y
Sbjct: 90 TSGNSRSAGRYVFVLQPDRNLAIY 113
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 53.0 bits (127), Expect = 3e-09
Identities = 26/126 (20%), Positives = 46/126 (36%), Gaps = 25/126 (19%)
Query: 33 GATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQ 92
G L AG + + F +L L Y + T VW ++
Sbjct: 7 GEGLYAGQSLD-----VEPYHFIM------QEDCNLVL----YDH---STSVWASNT--- 45
Query: 93 NPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKL 151
+G + L +D V+ D +G+ +W+S G V + + GN V+ S +
Sbjct: 46 GILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---I 102
Query: 152 WDSFSN 157
W + +
Sbjct: 103 WSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 39.2 bits (91), Expect = 2e-04
Identities = 20/119 (16%), Positives = 32/119 (26%), Gaps = 22/119 (18%)
Query: 160 DTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT 219
+ L G+ + Q L + F + +D NLVL D + + S T
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLY-------DHSTSVWASNT 45
Query: 220 YDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQY 278
+ + G + S + Y L DG Y
Sbjct: 46 GILGKKG---CKAVLQSDGNFVVYDAE---GRSLWASHSVRGNGNYVLVLQEDGNVVIY 98
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.8 bits (116), Expect = 1e-07
Identities = 21/129 (16%), Positives = 39/129 (30%), Gaps = 28/129 (21%)
Query: 72 SIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVA 131
+I + + T + Q + + +D LVL D +VW+S T
Sbjct: 2 NILFGLSHEGSHPQ-TLHAAQ-SLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGC 58
Query: 132 VGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFR 191
+ G V+ ++ ++ W S T S G +
Sbjct: 59 RAVLQSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLV 93
Query: 192 LLKDGNLVL 200
L D + +
Sbjct: 94 LQPDRTVTI 102
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 45.9 bits (108), Expect = 1e-06
Identities = 29/141 (20%), Positives = 43/141 (30%), Gaps = 30/141 (21%)
Query: 159 SDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISG 218
SD L G ++T L G + F + D NLVL D A + SG
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLY-------DNNRAVWASG 44
Query: 219 TYDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQY 278
T SG + G + I + S + Y L D Y
Sbjct: 45 TNGK----ASGCVLKMQNDGNLVIYSGSRA----IWASNTNRQNGNYYLILQRDRNVVIY 96
Query: 279 FYPKNGNENWSVAWSEPENIC 299
+ + + W+ N+
Sbjct: 97 ------DNSNNAIWATHTNVG 111
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 44.4 bits (104), Expect = 3e-06
Identities = 21/132 (15%), Positives = 42/132 (31%), Gaps = 22/132 (16%)
Query: 29 TVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTD 88
+ G L G + + G + F + N + Y N VW +
Sbjct: 3 RLNSGHQLDTGGSLA-----EGGYLFII---QNDCNL-------VLYDN---NRAVWASG 44
Query: 89 NKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASSSS 148
+ G +K+ D LV+ S+ + N V+ +S+
Sbjct: 45 TNGKA----SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN 100
Query: 149 SKLWDSFSNPSD 160
+ +W + +N +
Sbjct: 101 NAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 40.0 bits (93), Expect = 1e-04
Identities = 24/130 (18%), Positives = 39/130 (30%), Gaps = 28/130 (21%)
Query: 160 DTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGT 219
+ L G+T+ T + L G F F + +D NLVL D + + T
Sbjct: 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVLY-------DVDKPIWATNT 45
Query: 220 YDPANSSNSGYRVMFNESGYMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYF 279
+ S + G + + S + Y L D Y
Sbjct: 46 GGLSRSC----FLSMQTDGNLVVY---NPSNKPIWASNTGGQNGNYVCILQKDRNVVIY- 97
Query: 280 YPKNGNENWS 289
G + W+
Sbjct: 98 ----GTDRWA 103
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 35.4 bits (81), Expect = 0.004
Identities = 24/132 (18%), Positives = 48/132 (36%), Gaps = 26/132 (19%)
Query: 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWY 86
+ + G TL+ G + G F F + + N L ++ + P +W
Sbjct: 1 DNILYSGETLSTGEFLN-----YGSFVFIMQ-----EDCN----LVLYDVDKP----IWA 42
Query: 87 TDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVA-VGHMNDTGNFVLAS 145
T+ + R + + D LV+ +P K +W+S V + N V+
Sbjct: 43 TNTGGLS----RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG 98
Query: 146 SSSSKLWDSFSN 157
+ W + ++
Sbjct: 99 TD---RWATGTH 107
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 813 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.82 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.71 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.63 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.52 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.28 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.13 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.12 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.09 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.03 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.9 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.3 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.08 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.85 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.15 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=414.18 Aligned_cols=271 Identities=24% Similarity=0.442 Sum_probs=208.3
Q ss_pred CCCCHHHHHHHHhhc-----------ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeecc
Q 045343 509 PCFSYKELEEATDNF-----------KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT 576 (813)
Q Consensus 509 ~~~~~~el~~~~~~~-----------~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l 576 (813)
..++|+++..++.+| .++||+|+||+||+|.+..+......||||++.... ....++|.+|+++|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 456777777777665 357999999999999986555556689999986532 33446799999999999
Q ss_pred ccCCcceEEeEeecCCceEEEEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE
Q 045343 577 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILL 655 (813)
Q Consensus 577 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll 655 (813)
+|||||+++|+|.+++..++||||+++|+|.+++... ..++|..+++++.|||+||.|||+ .+|+||||||+||||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILV 161 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEE
Confidence 9999999999999999999999999999999988764 578999999999999999999996 499999999999999
Q ss_pred cCCCCEEEeeccCccccccCcccce---eecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchh
Q 045343 656 DDYYNARISDFGLAKLLTLNQSKAI---RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE 731 (813)
Q Consensus 656 ~~~~~~kl~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 731 (813)
+.++.+||+|||+++.+........ .....||+.|+|||.+.+..++.++|||||||+||||+| |+.||......+
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998765433211 122457899999999999999999999999999999998 899997543322
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
. ...+ ..+ .......++++.+.+|+.+||+.||.+||||.||++.|+.+++
T Consensus 242 ~---~~~i----~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 242 V---INAI----EQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp H---HHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H---HHHH----HcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 1111 111 1111223456788999999999999999999999999998765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=401.88 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=197.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
+++.++||+|+||+||+|.+. ++..||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 567889999999999999874 4567999999753 33456899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
+++|+|.+++... ..+++..+++++.|||+||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999998754 5688999999999999999999964 99999999999999999999999999998775443322
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....||..|+|||++.+..++.++|||||||++|||+|+..|+....... .+...+.... .. .
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~~~------~~-------~ 222 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGF------RL-------Y 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHHHTC------CC-------C
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHHHhcC------CC-------C
Confidence 334568999999999999999999999999999999999544443322211 1111111110 01 1
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.+..+++++.+++.+||+.||++||||+||+++|+++.+
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 112335678999999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=397.49 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=205.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
|++.++||+|+||+||+|... .+++.||||+++... ....+++.+|++++++++|||||++++++.+++..+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 677899999999999999874 357899999986532 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++|+|.+++.....+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999998888999999999999999999999964 99999999999999999999999999999876554433
Q ss_pred eeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... .. ....... .
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~----~~~~~~~---------~ 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD----WKEKKTY---------L 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH----HHTTCTT---------S
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH----HhcCCCC---------C
Confidence 3456789999999999988776 578999999999999999999997544322111 00 0000000 0
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......++.+.+|+.+||+.||++|||++|++++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111234677899999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=402.68 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=200.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.+.+.++||+|+||+||+|... ..||||+++.. .....++|.+|+.++++++|||||++++++.+ ...++|
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 4567789999999999999752 24999998643 23345679999999999999999999999865 568999
Q ss_pred EeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++|+|.+++... ..+++..++.++.|||+||+|||+ .+|+||||||+||||+.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999754 568999999999999999999995 499999999999999999999999999998876544
Q ss_pred ccceeecccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.........||+.|+|||++.+. .++.++|||||||+||||+||+.||.......... .........
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~-------- 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYLS-------- 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTSCC--------
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCCCC--------
Confidence 33334556799999999998643 47899999999999999999999997544322111 111111111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
+... .....+++.+.+++.+||+.||.+||||+||+++|+.+.+
T Consensus 229 p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 PDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Ccch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1110 1122346789999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-48 Score=406.35 Aligned_cols=261 Identities=29% Similarity=0.435 Sum_probs=213.5
Q ss_pred HHHHHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCce
Q 045343 515 ELEEATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 515 el~~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
|+....+++.++||+|+||+||+|... ..++.||||+++.. ....++|.+|+++|++++|||||+++++|.+++..
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEG---GGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEEC---CCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 444556778899999999999999884 35788999999754 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 595 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
++||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||||+.++.+||+|||+|+..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999653 5789999999999999999999964 9999999999999999999999999999987
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
..+.... .....|++.|+|||++.+..++.++|||||||++|||++|..|+........ + ......+
T Consensus 166 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~----~~~i~~~------ 232 (287)
T d1opja_ 166 TGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLEKD------ 232 (287)
T ss_dssp CSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H----HHHHHTT------
T ss_pred CCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--H----HHHHhcC------
Confidence 6543322 3345688999999999999999999999999999999998777654332211 1 1111111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.........++.+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 233 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111122345789999999999999999999999999988754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=401.62 Aligned_cols=253 Identities=32% Similarity=0.469 Sum_probs=204.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+++.++||+|+||+||+|.+. ++..||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 45677899999999999999874 4678999999754 3345679999999999999999999998855 5679999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++|+|.+++... ..+++..+++|+.||++||.|||+. +|+||||||+||||++++.+||+|||+|+.+....
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999988654 3689999999999999999999964 99999999999999999999999999999876543
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
... .....||+.|+|||++.+..++.++|||||||++|||+||..|+........ +... +..+ .
T Consensus 164 ~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~----i~~~---------~ 227 (272)
T d1qpca_ 164 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN----LERG---------Y 227 (272)
T ss_dssp EEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----HHTT---------C
T ss_pred ccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHhc---------C
Confidence 222 3445789999999999998999999999999999999997666543322211 1111 1111 0
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
....+...++.+.+|+.+||+.||++||||+||+++|+.+
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1111123456789999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=387.73 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=209.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
++|.++||+|+||+||+|... ++..||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred CEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 457899999999999999973 5678999999864 33457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
+++|+|.+++.. ...+++..+++++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999765 46788999999999999999999964 99999999999999999999999999998766543322
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEA 758 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 758 (813)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.. . .+.... .+
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~----~i~~~~--~~------- 220 (258)
T d1k2pa_ 158 -SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---E----HIAQGL--RL------- 220 (258)
T ss_dssp -CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---H----HHHTTC--CC-------
T ss_pred -ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH---H----HHHhCC--CC-------
Confidence 334668999999999999999999999999999999998 89999765433211 1 111110 01
Q ss_pred cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 759 LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 759 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
..+...++.+.+++.+||+.||++|||++||+++|.++
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11123356889999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=389.10 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=206.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|++.++||+|+||+||+|... .+++.||||++.... ....+++.+|++++++++|||||++++++.+++..++
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEEC---CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 3778899999999999999874 467899999986432 2334578899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999999988889999999999999999999995 499999999999999999999999999998765432
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||......+.. ........
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~-------- 221 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRVEF-------- 221 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCC--------
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC--------
Confidence 34467999999999999999999999999999999999999999755432211 11111110
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQ 791 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 791 (813)
. .+...++.+.+|+.+||+.||.+|||++|+++
T Consensus 222 ~--~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 T--FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C--CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 01123567889999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=394.00 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=207.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|++.++||+|+||+||+|... .+++.||||+++.......+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~---~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBT---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEEC---CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 3677789999999999999863 4678999999986655556679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 600 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 600 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
|+++|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.+......
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence 9999999998765 4689999999999999999999964 9999999999999999999999999999987544322
Q ss_pred eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEAL 759 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 759 (813)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....... .. . .
T Consensus 173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~-~~-----~--~ 237 (293)
T d1yhwa1 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT-PE-----L--Q 237 (293)
T ss_dssp -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS-CC-----C--S
T ss_pred -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC-CC-----C--C
Confidence 345679999999999999999999999999999999999999997544322111 1111100 00 0 1
Q ss_pred ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 760 NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 760 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.....++.+.+|+.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112345778899999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=394.02 Aligned_cols=250 Identities=29% Similarity=0.404 Sum_probs=201.9
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEeecC
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 602 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 602 (813)
++||+|+||+||+|.+... ..++.||||+++.... ...++|.+|+++|++++|||||+++++|.+ +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccC-CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 4699999999999987543 3567899999965322 234579999999999999999999999965 56789999999
Q ss_pred CCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc-ee
Q 045343 603 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA-IR 681 (813)
Q Consensus 603 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~ 681 (813)
+|+|.+++.....+++..+++++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++.+....... ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999999888999999999999999999999964 99999999999999999999999999999876543322 12
Q ss_pred ecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccccccc
Q 045343 682 TAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDMEALN 760 (813)
Q Consensus 682 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 760 (813)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +.. .+..+.. ...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~----~i~~~~~---------~~~ 231 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----MLEKGER---------MGC 231 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTTCC---------CCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHH----HHHcCCC---------CCC
Confidence 34568999999999999999999999999999999998 899997543322 111 1111111 111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 045343 761 DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEG 795 (813)
Q Consensus 761 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 795 (813)
+..+++.+.+|+.+||+.||++|||+++|+++|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 22345788999999999999999999999998875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=404.86 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=208.7
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCC--cceEEEEEEeecc-ccccchhhhheeeeeecc-ccCCcceEEeEeecCCc
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRT--STTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 593 (813)
...+++.++||+|+||+||+|....... ....||||++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3456788999999999999999864332 2457999998643 233456789999999998 89999999999999999
Q ss_pred eEEEEeecCCCchhhhhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 045343 594 RLLVYEFLNNGTLASFLFGN-----------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKP 650 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~ 650 (813)
.++||||+++|+|.++|... ..+++..++.++.||++||+|||+. +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 99999999999999999654 2478999999999999999999964 999999999
Q ss_pred CcEEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccc
Q 045343 651 QNILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMG 729 (813)
Q Consensus 651 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~ 729 (813)
+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999988766554433445678999999999999999999999999999999998 8999975443
Q ss_pred hhhhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 045343 730 EEYAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLE 794 (813)
Q Consensus 730 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 794 (813)
... +.. .... ......+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~~--~~~----~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN--FYK----LIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH--HHH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HHH----HHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 111 1111 1111122234678999999999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=389.00 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=198.2
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeec----CCceE
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRL 595 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 595 (813)
+|.++||+|+||+||+|... .++..||||++.... ....+.+.+|+++|++++|||||++++++.+ ....+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~---~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC---CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 56788999999999999874 356789999986532 2234568999999999999999999999864 34579
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCCEEEeeccCcccccc
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD-DYYNARISDFGLAKLLTL 674 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~DfGla~~~~~ 674 (813)
+||||+++|+|.+++.....+++..++.++.||++||+|||+. ..+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999999888999999999999999999999965 23499999999999996 578999999999986543
Q ss_pred CcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.. .....||+.|+|||++.+ +++.++|||||||++|||++|+.||........ + ......+....
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~----~~~i~~~~~~~---- 232 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVKPA---- 232 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCCCG----
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H----HHHHHcCCCCc----
Confidence 32 335679999999999875 599999999999999999999999975433211 1 11111111100
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
. ......+.+.+|+.+||+.||++|||++|++++
T Consensus 233 ~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 S----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp G----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0 111234568899999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=404.08 Aligned_cols=266 Identities=20% Similarity=0.298 Sum_probs=206.8
Q ss_pred HHHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 518 EATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 518 ~~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
...|++.++||+|+||+||+|... .++..||||+++.... ...+++.+|+.+|++++|||||+++++|.++++.++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHK---PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEET---TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345677899999999999999874 4678999999975432 234578999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. .+|+||||||+||||+.++.+||+|||+|+......
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 999999999999999888899999999999999999999952 389999999999999999999999999998765432
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHH-HHhh------------
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-FDCY------------ 743 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-~~~~------------ 743 (813)
....+||+.|+|||++.+.+++.++||||+||++|||++|+.||......+........ ....
T Consensus 160 ----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 23468999999999999999999999999999999999999999765432211100000 0000
Q ss_pred --cc--------Ccccc----cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 --RN--------EKLDD----LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 --~~--------~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ....+ +.............+.++.+++.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00 00000 000000000111234678899999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=397.23 Aligned_cols=261 Identities=24% Similarity=0.433 Sum_probs=201.7
Q ss_pred hhcccccceeeeeeEEEEEEeccC-CcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTR-TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
+.+.+.||+|+||+||+|.+..+. .....||||+++.... ...++|.+|++++++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 456788999999999999986433 2235799999865332 23456899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+.+++|.+++... ..++|..+++++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999987654 6789999999999999999999964 999999999999999999999999999998754432
Q ss_pred cc-eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KA-IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+........ +. ..+..+ .
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~----~~i~~~---------~ 230 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VM----KAINDG---------F 230 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----HHHHTT---------C
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HH----HHHhcc---------C
Confidence 21 12345689999999999999999999999999999999997666654332211 11 111111 1
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
+...+..++..+.+|+.+||+.||++||||.||+++|+.+++.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1112223457889999999999999999999999999987754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=392.35 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=205.9
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
|++.++||+|+||+||+|... .++..||||+++.......+++.+|+++|++++|||||++++++.+++..++||||
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNK---ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEeeCCCcEEEEEEEC---CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 677889999999999999874 46788999999876666678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcccc
Q 045343 601 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSKA 679 (813)
Q Consensus 601 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 679 (813)
+++|+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~- 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccc-
Confidence 999999999765 45689999999999999999999965 9999999999999999999999999999865433211
Q ss_pred eeecccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccc
Q 045343 680 IRTAIRGTKGYVAPEWFR-----NSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEG 754 (813)
Q Consensus 680 ~~~~~~gt~~y~aPE~l~-----~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 754 (813)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .... .....+
T Consensus 167 -~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~------~i~~-~~~~~~--- 235 (288)
T d2jfla1 167 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------KIAK-SEPPTL--- 235 (288)
T ss_dssp -HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHH-SCCCCC---
T ss_pred -ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH------HHHc-CCCCCC---
Confidence 23467999999999984 4567899999999999999999999997654322110 1111 111111
Q ss_pred cccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 755 DMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 755 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......++.+.+|+.+||+.||.+|||++|++++
T Consensus 236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112345788999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=394.90 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=204.2
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
..+++.++||+|+||+||+|.+. ++..||||+++.. ....++|.+|+.++++++|+|||+++++|.+ +..++||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~----~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC----CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 35788899999999999999874 4457999999754 3445689999999999999999999999854 5689999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++|+|.+++... ..++|..++.++.||++||+|||+. +|+||||||+||||+.++++||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999988653 5689999999999999999999965 99999999999999999999999999998775443
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
... .....||+.|+|||++....++.++||||||+++|||++|..|+........ +...+. .+ .
T Consensus 168 ~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~----~~---------~ 231 (285)
T d1fmka3 168 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE----RG---------Y 231 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHH----TT---------C
T ss_pred cee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hc---------C
Confidence 322 3445689999999999999999999999999999999997766654332211 111111 11 0
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVSLPP 803 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~ 803 (813)
..+.....++++.+++.+||+.||++||+|++|+++|+.......|+
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 11112234578899999999999999999999999999877665444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=392.84 Aligned_cols=248 Identities=22% Similarity=0.281 Sum_probs=203.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|++.+.||+|+||+||+|... .+++.||||+++... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 3788899999999999999874 357889999987432 2334568999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999999999888999999999999999999999964 99999999999999999999999999999876544
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~-------- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------QKIIKLEY-------- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTTCC--------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-------HHHHcCCC--------
Confidence 333344567999999999999999999999999999999999999999865332211 11111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVL 790 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 790 (813)
. .+...++.+.+|+.+||+.||.+|||++|++
T Consensus 228 ~--~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 D--FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp C--CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred C--CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 0 0112356788999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=389.30 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=204.3
Q ss_pred hccc-ccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 522 NFKE-EVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 522 ~~~~-~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.+.+ +||+|+||+||+|..... .++..||||+++.... ...++|.+|+++|++++|||||+++|++.+ +..+||||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred EECCcEEecccCeEEEEEEEecC-CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 3445 599999999999987533 2456899999975432 335679999999999999999999999865 56899999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|+++|+|.+++.. +..+++..+++++.|||+||+|||+ .+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 9999999999765 4678999999999999999999995 49999999999999999999999999999987654322
Q ss_pred -ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 679 -AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 679 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..+..+...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~~~~------- 231 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKRM------- 231 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTCCC-------
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCC-------
Confidence 11234568999999999999999999999999999999998 99999755432211 111111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
..+...++.+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 232 --~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223457889999999999999999999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=387.12 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=192.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeec--CCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 595 (813)
.|++.+.||+|+||+||+|... .+++.||||+++... +...+.+.+|++++++++|||||++++++.+ +...+
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRK---SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hCEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 3678899999999999999874 467899999986542 2234568899999999999999999999864 45689
Q ss_pred EEEeecCCCchhhhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 596 LVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC--SAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.. ..+|+||||||+||||+.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 357899999999999999999999752 235999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
+.+..+... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .. ........
T Consensus 162 ~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~----~i~~~~~~ 232 (269)
T d2java1 162 RILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG----KIREGKFR 232 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH----HHHHTCCC
T ss_pred eecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HH----HHHcCCCC
Confidence 987644322 3456799999999999999999999999999999999999999975443221 11 11111111
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+ +...++.+.+|+.+||+.||.+|||++|++++
T Consensus 233 ~~---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 RI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 11345678999999999999999999999763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-45 Score=390.82 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=210.1
Q ss_pred HhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.++||+|+||+||+|.... ...++..||||+++..... ..++|.+|++++++++|+||++++++|.+.+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 35678999999999999998753 2345678999999754332 34679999999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhcc------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 045343 597 VYEFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQN 652 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~N 652 (813)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 99999999999998642 237899999999999999999995 499999999999
Q ss_pred EEEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCCCcccchh
Q 045343 653 ILLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEE 731 (813)
Q Consensus 653 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~-~p~~~~~~~~ 731 (813)
|||+.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++|. +||......+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 999999999999999998776554443344567899999999999999999999999999999999986 5665443322
Q ss_pred hhhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 732 YAILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 732 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.. ..+..+.... .+...+.++.+|+.+||+.||.+||||.||+++|+++.+
T Consensus 251 ~~-------~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 VI-------YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HH-------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH-------HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 1111111111 112345678999999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-45 Score=390.09 Aligned_cols=247 Identities=24% Similarity=0.303 Sum_probs=202.9
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc---ccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..|+..++||+|+||+||+|... .+++.||||+++.... ...+++.+|+.+|++++|||||++++++.+++..+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEEC---CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 34677889999999999999874 4678999999875432 22356889999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|..++.....+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999999988888888899999999999999999999964 9999999999999999999999999999875432
Q ss_pred cccceeecccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRN---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. + ..... .....
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~----~~i~~-~~~~~-- 233 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIAQ-NESPA-- 233 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHH-SCCCC--
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--H----HHHHh-CCCCC--
Confidence 33569999999999864 4588999999999999999999999975432211 1 11111 11111
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......++.+.+|+.+||+.||.+|||++|++++
T Consensus 234 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1112345788999999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-45 Score=387.09 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=191.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.|++.++||+|+||+||+|... .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDK---RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEET---TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4788899999999999999874 357889999987533 233456889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc---CCCCEEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGla~~~~~~ 675 (813)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999999888999999999999999999999964 999999999999994 5789999999999876543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ... ....
T Consensus 164 ~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~---i~~-~~~~------ 227 (307)
T d1a06a_ 164 SV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQ---ILK-AEYE------ 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HH---HHT-TCCC------
T ss_pred Ce---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HH---Hhc-cCCC------
Confidence 22 33467999999999999999999999999999999999999999754432211 11 111 1100
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........++.+.+|+.+||+.||.+|||++|++++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0011112345778999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=387.32 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=198.8
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-cchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
..+++.+.||+|+||+||+|.....+..+..||||+++..... ..+.|.+|+.++++++|||||++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 4577889999999999999998766556778999998654333 3456999999999999999999999996 4678999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+++|+|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999998765 45789999999999999999999964 99999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....||+.|+|||.+.+..++.++|||||||++|||++ |.+||......+.. ..+ ..+...
T Consensus 163 ~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i----~~~~~~------ 228 (273)
T d1mp8a_ 163 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENGERL------ 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----HTTCCC------
T ss_pred cee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHH----HcCCCC------
Confidence 222 344568999999999999999999999999999999998 88888755432211 111 111111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
......++.+.+|+.+||+.||++|||+.||+++|+.++
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112234578999999999999999999999999998765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=381.20 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=195.6
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeec-CCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~ 598 (813)
.+++.++||+|+||.||+|.. .+..||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+..++||
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HeEEeEEEecCCCeEEEEEEE-----CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 356789999999999999987 4568999999753 445779999999999999999999999865 45689999
Q ss_pred eecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 599 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 599 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||+++|+|.++|... ..++|..+++++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 999999999999754 358999999999999999999995 49999999999999999999999999999875533
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+....... +...+ ..+.
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~~-------- 217 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGY-------- 217 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTTC--------
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCC--------
Confidence 223457899999999999999999999999999999998 677776543322 11111 1111
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
........++++.+|+.+||+.||.+||||.||+++|+.+.
T Consensus 218 -~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 218 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11112234578899999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=387.66 Aligned_cols=261 Identities=25% Similarity=0.479 Sum_probs=206.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeecC-CceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-QNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~ 598 (813)
.+|.++||+|+||+||+|.+..++.....||||+++.. .....++|.+|+++|++++|||||+++|++.+. ...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 35678899999999999998765545567999999753 333456799999999999999999999998754 5789999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+++|+|.+++... ...++..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999998765 467788999999999999999995 4999999999999999999999999999998765432
Q ss_pred cc--eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 678 KA--IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 678 ~~--~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .+...+. .+. ...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~----~g~--~~~--- 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL----QGR--RLL--- 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTC--CCC---
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----cCC--CCC---
Confidence 21 1234568999999999999999999999999999999999888876433211 1111111 111 011
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
.+...++.+.+|+.+||+.||++||+|.||+++|+.+.+-
T Consensus 255 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122356789999999999999999999999999987643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-44 Score=389.50 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=207.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|++.++||+|+||+||+|... .++..||||++........+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTER---ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5788899999999999999874 4678999999976555556678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc--CCCCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~DfGla~~~~~~~ 676 (813)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999864 46799999999999999999999964 999999999999996 46789999999998876443
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.. .... .
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i~~----~~~~------~ 244 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NVKS----CDWN------M 244 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHH----TCCC------S
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHh----CCCC------C
Confidence 2 345679999999999999999999999999999999999999997554322111 1110 0000 0
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........++.+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111235678899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-44 Score=387.42 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=207.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 599 (813)
.|++.++||+|+||+||+|... .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEK---ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4788899999999999999874 4678999999976544455678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc--CCCCEEEeeccCccccccCc
Q 045343 600 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD--DYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 600 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~DfGla~~~~~~~ 676 (813)
|+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999887655 4689999999999999999999964 999999999999998 67899999999999876543
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+. ..... .
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~----~~~~~------~ 247 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVK----RCDWE------F 247 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----HCCCC------C
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCCC------C
Confidence 2 34467999999999999999999999999999999999999999755432211 1111 00000 0
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112345678899999999999999999999885
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=387.91 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=199.3
Q ss_pred HHhhcccccceeeeeeEEEEEEeccC--CcceEEEEEEeeccc-cccchhhhheeeeeecc-ccCCcceEEeEeecC-Cc
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-QN 593 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 593 (813)
..+++.++||+|+||.||+|...... ..++.||||+++... ....+++..|..++.++ +|+|||.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 45778899999999999999976432 345789999997532 23345677888888777 689999999998664 46
Q ss_pred eEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 045343 594 RLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD 657 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~ 657 (813)
.++||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||||+.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 89999999999999999643 2478999999999999999999954 9999999999999999
Q ss_pred CCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCCCcccchhhhhhH
Q 045343 658 YYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILT 736 (813)
Q Consensus 658 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~-~p~~~~~~~~~~~l~ 736 (813)
++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. .||......+. +.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence 9999999999998776554433344567999999999999999999999999999999999975 56754432211 11
Q ss_pred HHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 737 DWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
..+..+.... .....++.+.+++.+||+.||++|||++||+++|+.+++
T Consensus 248 ----~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 ----RRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111111111 111235678999999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=379.87 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=199.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.+++.+.||+|+||+||+|...........||||+++... .+..++|.+|+.+|++++|||||+++|+|.+ ...++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 4677899999999999999987655566789999986532 2334579999999999999999999999965 46789
Q ss_pred EEeecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
||||+++|+|.+++... ..+++..+++++.|||+||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999999887654 5789999999999999999999964 9999999999999999999999999999987654
Q ss_pred cccce-eecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 676 QSKAI-RTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 676 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
..... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+.. . ......
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~---~i~~~~------- 231 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H---KIDKEG------- 231 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---HHHTSC-------
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---H---HHHhCC-------
Confidence 43221 233568889999999999999999999999999999998 89999754432211 1 111111
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGV 796 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 796 (813)
...+.....+..+.+++.+||+.||++||||.||++.|++.
T Consensus 232 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 --ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111223456789999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=378.99 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=205.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc------ccchhhhheeeeeeccccCCcceEEeEeecCCc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 593 (813)
.|++.++||+|+||+||+|... .+++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+++.
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~---~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CEEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4788899999999999999874 4678999999865322 123568999999999999999999999999999
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----CEEEeeccCc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY----NARISDFGLA 669 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~DfGla 669 (813)
.+|||||+++|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999999888999999999999999999999964 999999999999998776 5999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD 749 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 749 (813)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... . .......
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~-i~~~~~~ 234 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------N-VSAVNYE 234 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHTTCCC
T ss_pred hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH------H-HHhcCCC
Confidence 88754432 234568999999999999999999999999999999999999998654322110 0 0010000
Q ss_pred ccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 DLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.........+..+.+|+.+||+.||.+|||++|++++
T Consensus 235 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 ------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000111235678899999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=386.62 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=202.2
Q ss_pred hhcccccceeeeeeEEEEEEeccC-CcceEEEEEEeecc-ccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTR-TSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.++||+|+||+||+|....+. .....||||+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 677899999999999999875432 12346899998653 334456899999999999999999999999864 577889
Q ss_pred eecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 599 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 599 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
||+.+|+|.+++.. ...+++..+++++.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999999888765 46789999999999999999999964 999999999999999999999999999998765544
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.. ..+.. + .
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~---~~i~~----~---------~ 230 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK----G---------E 230 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH---HHHHH----T---------C
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc----C---------C
Confidence 433445578999999999999999999999999999999999 78888754432211 11111 1 1
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
....+..+++.+.+++.+||+.||.+|||+.||+++|+.+.
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11112234578899999999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=386.04 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=212.8
Q ss_pred HHHHHhhcccccceeeeeeEEEEEEec--cCCcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecC
Q 045343 516 LEEATDNFKEEVGRGSFGIVYKGVILT--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG 591 (813)
Q Consensus 516 l~~~~~~~~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 591 (813)
+....+++.++||+|+||.||+|.+.. ....++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 444567888999999999999998753 234678999999975432 2345688999999999 699999999999999
Q ss_pred CceEEEEeecCCCchhhhhhccC------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 045343 592 QNRLLVYEFLNNGTLASFLFGNL------------------KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNI 653 (813)
Q Consensus 592 ~~~~lV~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NI 653 (813)
+..++||||+++|+|.+++.... .+++..+++++.||++||+|||.+ +|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999986432 578999999999999999999965 999999999999
Q ss_pred EEcCCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCCCcccchhh
Q 045343 654 LLDDYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEY 732 (813)
Q Consensus 654 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG-~~p~~~~~~~~~ 732 (813)
|++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+ .+|+......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999987655444434556799999999999999999999999999999999995 454543332211
Q ss_pred hhhHHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 733 AILTDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 733 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
+...+.. ..........++.+.+|+.+||+.||.+||||.||+++|++++
T Consensus 257 --~~~~i~~-------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 --FYKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp --HHHHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHhc-------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1111111 1111112234578999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=382.91 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=203.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc-ccccchhhhheeeeeecc-ccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 597 (813)
.+++.++||+|+||+||+|.+..+. ....||||+++.. .....++|.+|+++|+++ +|||||+++++|.+++..++|
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCC-eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 3466789999999999999986432 3346889988643 334556799999999998 799999999999999999999
Q ss_pred EeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCE
Q 045343 598 YEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNA 661 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 661 (813)
|||+++|+|.++|+.. ..+++..+++++.|||+||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999643 5689999999999999999999964 99999999999999999999
Q ss_pred EEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCc-CCCcccchhhhhhHHHHH
Q 045343 662 RISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTDWAF 740 (813)
Q Consensus 662 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~ 740 (813)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+ +.
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~---- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---- 236 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH----
Confidence 9999999986553322 233468999999999999999999999999999999999765 565332211 11
Q ss_pred HhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 045343 741 DCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEVS 800 (813)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 800 (813)
..+..+. ........++++.+|+.+||+.||++||||+||+++|+++++-.
T Consensus 237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 237 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111110 01112234578999999999999999999999999999887543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=382.55 Aligned_cols=262 Identities=28% Similarity=0.409 Sum_probs=208.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccC----CcceEEEEEEeecccc-ccchhhhheeeeeecc-ccCCcceEEeEeecCC
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTR----TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ 592 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 592 (813)
..+++.++||+|+||.||+|...... ..+..||||+++.... ....++.+|...+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 35778899999999999999875432 2346899999976433 3346788899999888 7999999999999999
Q ss_pred ceEEEEeecCCCchhhhhhcc----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 045343 593 NRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD 656 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~ 656 (813)
..++||||+++|+|.++|... ..+++..+++++.||+.||+|||+. +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 999999999999999999644 3579999999999999999999964 999999999999999
Q ss_pred CCCCEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCCCcccchhhhhh
Q 045343 657 DYYNARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 735 (813)
Q Consensus 657 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l 735 (813)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||....... +
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---H
Confidence 999999999999998776554443455679999999999999999999999999999999998 677876443221 1
Q ss_pred HHHHHHhhccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 045343 736 TDWAFDCYRNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVEV 799 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 799 (813)
...+..+.. .......++.+.+|+.+||+.||++|||+.||++.|++++.+
T Consensus 247 ----~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 ----FKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ----HHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111111111 111122356789999999999999999999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=379.12 Aligned_cols=248 Identities=23% Similarity=0.263 Sum_probs=207.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc---ccccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|++.+.||+|+||.||+|... .+++.||||++++. .....+++.+|+.+|++++|||||++++++.+++..++
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 3678899999999999999874 46789999999753 22334668899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
||||+++|+|.+++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999998899999999999999999999995 499999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .......
T Consensus 160 ~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~----~i~~~~~-------- 222 (337)
T d1o6la_ 160 AT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E----LILMEEI-------- 222 (337)
T ss_dssp CC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCC--------
T ss_pred cc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH---H----HHhcCCC--------
Confidence 22 34567999999999999999999999999999999999999999865432211 1 1111111
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
.. +...+.++.+|+.+||+.||.+||+ ++|++++
T Consensus 223 ~~--p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 RF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC--CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 10 1123567889999999999999995 8888874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=380.62 Aligned_cols=267 Identities=21% Similarity=0.276 Sum_probs=200.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCC----ceEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRLL 596 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 596 (813)
+-+.++||+|+||+||+|.+ ++..||||+++... .....+..|+..+.+++|||||+++++|.+.+ ..++
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 45678999999999999986 57799999986432 11222445667777889999999999997654 5789
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED-----CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
||||+++|+|.++|+.. .++|..+++++.|+|.||+|||+. ..++|+||||||+||||+.++.+||+|||+++.
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999999764 689999999999999999999953 146999999999999999999999999999998
Q ss_pred cccCccc--ceeecccccccccCcccccCCC------CCCccchhhHHHHHHHHHhCCcCCCcccchhhhh--------h
Q 045343 672 LTLNQSK--AIRTAIRGTKGYVAPEWFRNST------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--------L 735 (813)
Q Consensus 672 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~------~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~--------l 735 (813)
....... .......||+.|+|||++.... ++.++|||||||+||||+||..|+.......... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7544321 1133467999999999987643 5678999999999999999998875432211000 0
Q ss_pred HHHHHHhhccCccccccccccc-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 736 TDWAFDCYRNEKLDDLVEGDME-ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
..........+. ..+.+. .....+....+.+++.+||+.||.+||||.||+++|+++.+
T Consensus 238 ~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 011111111111 111111 11233566789999999999999999999999999987653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-43 Score=376.03 Aligned_cols=244 Identities=24% Similarity=0.314 Sum_probs=205.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
|++.++||+|+||+||+|... .+++.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEEC---CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 678899999999999999874 467899999997532 23346788999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCcc
Q 045343 598 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 677 (813)
|||+++|+|..++.....+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999999999899999999999999999999994 59999999999999999999999999999876533
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .... .. ..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~i~~-~~--------~~ 219 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---E---KILN-AE--------LR 219 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H---HHHH-CC--------CC
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH---H---HHHc-CC--------CC
Confidence 23467999999999999999999999999999999999999999765432211 0 1111 10 00
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
.+...++.+.+++.+||+.||.+|+ |++|++++
T Consensus 220 --~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0112346788999999999999996 89999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=372.94 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=199.4
Q ss_pred ccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc-----cchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 524 KEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 524 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
.+.||+|+||+||+|... .+++.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 3 l~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEEETTEEEEEEECS---SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred ceEeccCcCeEEEEEEEC---CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 478999999999999864 46789999998643221 2356889999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+.++++..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9999999888887788899999999999999999999964 9999999999999999999999999999876544322
Q ss_pred ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cccccccc-
Q 045343 679 AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLDDLVE- 753 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~- 753 (813)
.....||+.|+|||++... .++.++|||||||++|||++|+.||......+... .+...... +.......
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSS
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhcc
Confidence 3345799999999998654 57999999999999999999999997654432211 11111110 00000000
Q ss_pred ------cccccc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 754 ------GDMEAL----NDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 754 ------~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
...... ......+.+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 001234678999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=379.27 Aligned_cols=261 Identities=27% Similarity=0.450 Sum_probs=209.5
Q ss_pred HHhhcccccceeeeeeEEEEEEecc--CCcceEEEEEEeeccc-cccchhhhheeeeeeccccCCcceEEeEeecCCceE
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 595 (813)
..+++.++||+|+||+||+|.+... ...+..||||+++... ......|.+|++++++++|||||+++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 4557789999999999999987432 2245789999997532 223346899999999999999999999999999999
Q ss_pred EEEeecCCCchhhhhhcc----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEee
Q 045343 596 LVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISD 665 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 665 (813)
+||||+++|+|.+++... ..+++..+.+++.|+|+||.|||+. +|+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999998632 2468999999999999999999964 999999999999999999999999
Q ss_pred ccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCCCcccchhhhhhHHHHHHhhc
Q 045343 666 FGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYR 744 (813)
Q Consensus 666 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 744 (813)
||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .|+......+.. ....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~-------~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------RFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------HHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHH
Confidence 99999876544433334456899999999999999999999999999999999985 556543222111 1111
Q ss_pred cCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 045343 745 NEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVVE 798 (813)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 798 (813)
.+.... ....+++.+.+++.+||+.||++||||.+|+++|++.++
T Consensus 250 ~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 112345789999999999999999999999999988654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-43 Score=364.72 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=205.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---------cchhhhheeeeeeccc-cCCcceEEeEee
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---------GEKEFKNEVVVIGQTH-HKNLVRLLGFCD 589 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 589 (813)
.|++.+.||+|+||+||+|... .+++.||||+++..... ..+.+.+|+.++++++ |||||++++++.
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~---~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCEEceEEecCcCeEEEEEEEC---CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 3677899999999999999864 46789999999754321 1235788999999997 999999999999
Q ss_pred cCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCc
Q 045343 590 EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLA 669 (813)
Q Consensus 590 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla 669 (813)
+++..+|||||+++|+|.++|.....+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999999888999999999999999999999964 9999999999999999999999999999
Q ss_pred cccccCcccceeecccccccccCcccccC------CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhh
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRN------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 743 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 743 (813)
+.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ...
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i 227 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMI 227 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHH
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHH
Confidence 98765332 344679999999999853 34688999999999999999999999865432211 111
Q ss_pred ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 744 RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+... .........++++.+++.+||+.||.+|||++||+++
T Consensus 228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111110 0111122345789999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.2e-43 Score=366.85 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=202.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc---cchhhhheeeeeeccccCCcceEEeEeecCCc---
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN--- 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--- 593 (813)
.|++.+.||+|+||+||+|... .+++.||||+++..... ..+.+.+|+.++++++|||||++++++...+.
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDL---RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred eeEEeEEEeeCCCeEEEEEEEC---CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3678899999999999999874 46789999999754322 23468999999999999999999999876543
Q ss_pred -eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 594 -RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 594 -~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
.+|||||+++++|.+++.....+++..++.++.||++||+|||+. +|+||||||+|||++.++..+|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 789999999999999998888999999999999999999999964 9999999999999999999999999998766
Q ss_pred ccCccc-ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccc
Q 045343 673 TLNQSK-AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDL 751 (813)
Q Consensus 673 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 751 (813)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ...........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~-- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP-- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC--
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCC--
Confidence 433221 123446799999999999999999999999999999999999999975543221 11111111110
Q ss_pred ccccccccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCc
Q 045343 752 VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-TMKKVLQMLEGVV 797 (813)
Q Consensus 752 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~ 797 (813)
........++.+.+++.+||+.||.+|| |++++++.|.++.
T Consensus 234 -----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0011113457889999999999999999 8999999887653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-42 Score=374.92 Aligned_cols=245 Identities=24% Similarity=0.216 Sum_probs=205.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeeeccccCCcceEEeEeecCCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 596 (813)
.|++.++||+|+||.||+|... .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+....++
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~---~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEEC---CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 4778899999999999999874 467899999986432 2334568899999999999999999999999999999
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|+||+.+|+|..++.....+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999999998888999999999999999999999954 9999999999999999999999999999886533
Q ss_pred ccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccccccc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDM 756 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 756 (813)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+ .... .
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i----~~~~--------~ 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---EKI----VSGK--------V 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCC--------C
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---HHH----hcCC--------C
Confidence 23457999999999999999999999999999999999999999754332111 111 1111 0
Q ss_pred cccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 757 EALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 757 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
. .....+..+.+++.+||+.||.+|+ |++|++++
T Consensus 256 ~--~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 R--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C--CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0 0112356788999999999999994 89999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-42 Score=374.93 Aligned_cols=248 Identities=24% Similarity=0.261 Sum_probs=199.5
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhh---eeeeeeccccCCcceEEeEeecCCce
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKN---EVVVIGQTHHKNLVRLLGFCDEGQNR 594 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~ 594 (813)
|++.++||+|+||.||+|... .+++.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~---~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred CeeeeEEecCCCeEEEEEEEC---CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 667899999999999999874 467899999986421 122223444 46777788899999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++||||+++|+|.++|.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999888899999999999999999999964 999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVE 753 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 753 (813)
.. .....||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+. .... .
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~--------~ 223 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL--------T 223 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSS--------S
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhcc--------c
Confidence 42 334579999999999975 56899999999999999999999999765433221111 1000 0
Q ss_pred ccccccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 045343 754 GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPT-----MKKVLQM 792 (813)
Q Consensus 754 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 792 (813)
.... .....++.+.+|+.+||+.||.+||| ++|++++
T Consensus 224 ~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 MAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCC--CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCC--CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0000 01123567899999999999999999 6888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=371.55 Aligned_cols=247 Identities=27% Similarity=0.335 Sum_probs=202.8
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc---cccchhhhheeeeee-ccccCCcceEEeEeecCCceE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIG-QTHHKNLVRLLGFCDEGQNRL 595 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~ 595 (813)
.|++.++||+|+||+||+|... .+++.||||+++... ....+.+..|..++. .++|||||++++++.+++..+
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~---~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CeEEeeEEecCCCcEEEEEEEC---CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 3678899999999999999874 467899999997532 233345667777665 689999999999999999999
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
+||||+++|+|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999999888899999999999999999999964 9999999999999999999999999999876543
Q ss_pred cccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccc
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGD 755 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 755 (813)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... +.
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~------~~ 221 (320)
T d1xjda_ 157 DAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDN------PF 221 (320)
T ss_dssp TCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC------CC
T ss_pred ccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC------CC
Confidence 322 34567999999999999999999999999999999999999999865432211 1111110 00
Q ss_pred ccccccHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 045343 756 MEALNDIKCVEKLVMVSIWCIQEDPSLRPTMK-KVLQ 791 (813)
Q Consensus 756 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 791 (813)
. +...+..+.+|+.+||+.||.+||++. |+++
T Consensus 222 ~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 112356788999999999999999995 7764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=370.33 Aligned_cols=248 Identities=23% Similarity=0.268 Sum_probs=196.6
Q ss_pred Hhhcc-cccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecc-ccCCcceEEeEeec----CCc
Q 045343 520 TDNFK-EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE----GQN 593 (813)
Q Consensus 520 ~~~~~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~ 593 (813)
.|.+. +.||+|+||+||+|... .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ...
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~---~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEEC---CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35555 45999999999999874 3678999999864 34677899887655 89999999999865 456
Q ss_pred eEEEEeecCCCchhhhhhcc--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC---CCCEEEeeccC
Q 045343 594 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD---YYNARISDFGL 668 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~DfGl 668 (813)
.++||||+++|+|.++|... ..+++..++.++.||+.||+|||+. +|+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 89999999999999999764 4689999999999999999999954 9999999999999985 56799999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
|+....... .....||+.|+|||++.+..++.++|||||||+||||+||+.||.......... ...
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~-------- 226 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMK-------- 226 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHH--------
Confidence 987765432 344679999999999999999999999999999999999999997544322110 000
Q ss_pred cccccccc--cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 DDLVEGDM--EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 ~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
..+..... ........++++.+|+.+||+.||.+|||+.|++++
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111111 111112446789999999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=369.10 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=203.0
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecCCceEEEEee
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 600 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 600 (813)
|.+.++||+|+||+||+|... .+++.||||.++... .....+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~---~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 678899999999999999874 367889999997542 2344688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhccC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC--CCCEEEeeccCccccccCcc
Q 045343 601 LNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD--YYNARISDFGLAKLLTLNQS 677 (813)
Q Consensus 601 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~ 677 (813)
+++|+|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++. ...+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999998764 78999999999999999999995 49999999999999984 45899999999987654332
Q ss_pred cceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccccccccccc
Q 045343 678 KAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLVEGDME 757 (813)
Q Consensus 678 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 757 (813)
.....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. . .... .... .+.
T Consensus 160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---~---~i~~-~~~~--~~~--- 224 (321)
T d1tkia_ 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---E---NIMN-AEYT--FDE--- 224 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H---HHHH-TCCC--CCH---
T ss_pred ---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH---H---HHHh-CCCC--CCh---
Confidence 33456899999999999999999999999999999999999999765432211 0 1100 0000 000
Q ss_pred ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 758 ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 758 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
......++++.+|+.+||+.||.+|||++|++++
T Consensus 225 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 -EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001235678899999999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=359.65 Aligned_cols=269 Identities=22% Similarity=0.284 Sum_probs=200.4
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 597 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 597 (813)
.|.+.++||+|+||+||+|... .+++.||||+++... ....+++.+|++++++++|||||++++++.++.+.++|
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3566789999999999999874 357789999996532 22356789999999999999999999999999999999
Q ss_pred EeecCCCchhhhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCc
Q 045343 598 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQ 676 (813)
Q Consensus 598 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~ 676 (813)
|||+.++.+...... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 999976655444333 45689999999999999999999964 99999999999999999999999999998765433
Q ss_pred ccceeecccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc---cc
Q 045343 677 SKAIRTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD---LV 752 (813)
Q Consensus 677 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~ 752 (813)
.. .....||+.|+|||.+.... .+.++|||||||++|||++|+.||......+.............+..... ..
T Consensus 157 ~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp BC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 22 33457999999999877665 57899999999999999999999976543221110000000000000000 00
Q ss_pred cc-----cc-c---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 045343 753 EG-----DM-E---ALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV 796 (813)
Q Consensus 753 ~~-----~~-~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 796 (813)
+. .. . ........+.+.+|+.+||+.||.+|||++|++++ ++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 00 0 00011234678899999999999999999999987 5443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=358.96 Aligned_cols=240 Identities=24% Similarity=0.428 Sum_probs=197.2
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------cchhhhheeeeeeccc--cCCcceEEeEeecC
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTH--HKNLVRLLGFCDEG 591 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~ 591 (813)
.|++.++||+|+||+||+|... .+++.||||+++..... ...++.+|+.++++++ |||||++++++.+.
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred eEEEeEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4778899999999999999874 36789999998753221 2345778999999986 89999999999999
Q ss_pred CceEEEEeecCC-CchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-CCCEEEeeccCc
Q 045343 592 QNRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-YYNARISDFGLA 669 (813)
Q Consensus 592 ~~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~DfGla 669 (813)
+..++||||+.+ +++.+++.....+++..++.++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999999976 6888888888889999999999999999999995 49999999999999985 579999999999
Q ss_pred cccccCcccceeecccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcc
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKL 748 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 748 (813)
+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... + . .. ..
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i----~---~~-~~ 221 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I----I---RG-QV 221 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H----H---HC-CC
T ss_pred eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H----h---hc-cc
Confidence 8754332 345679999999999987765 5679999999999999999999974311 0 0 00 00
Q ss_pred cccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 749 DDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 749 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
... ...++++.+++.+||+.||.+|||++|++++
T Consensus 222 --~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 --FFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CCS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCC--------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011 1234678899999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-41 Score=356.56 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=200.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.++||+|+||+||+|... +++.||||+++... ....+++.+|+.+|++++|||||++++++.+++..++++
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 567789999999999999873 56889999996532 233567899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
||+.++.+..+......+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 9999988888888888999999999999999999999964 9999999999999999999999999999876543222
Q ss_pred ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Cccc-----
Q 045343 679 AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKLD----- 749 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~----- 749 (813)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+... . ....... ....
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~--~-i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--R-IFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H-HHHHHCCCCTTTSTTGGGS
T ss_pred --cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH--H-HHHhhCCCChhhccchhhh
Confidence 2345689999999998754 56899999999999999999999997554322111 1 1111000 0000
Q ss_pred -cc------ccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 750 -DL------VEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 750 -~~------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ..+...........+.+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000001112235678899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=355.21 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=198.3
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeecc---ccCCcceEEeEeec----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT---HHKNLVRLLGFCDE---- 590 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~---- 590 (813)
.|++.++||+|+||+||+|.... ..++.||||+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CEEEEEEEecccCeEEEEEEEEC--CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46778999999999999998742 2467899999865322 2334567888887776 79999999999843
Q ss_pred -CCceEEEEeecCCCchhhhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 591 -GQNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 591 -~~~~~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
....++++||+.++.+..... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 346799999999988765544 346789999999999999999999964 999999999999999999999999999
Q ss_pred ccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---
Q 045343 669 AKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN--- 745 (813)
Q Consensus 669 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--- 745 (813)
++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... .......
T Consensus 163 ~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~ 236 (305)
T d1blxa_ 163 ARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGE 236 (305)
T ss_dssp CCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCG
T ss_pred hhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCch
Confidence 987654322 3456799999999999999999999999999999999999999986544322111 1111100
Q ss_pred Cccc------c-ccc---ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLD------D-LVE---GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~------~-~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.... . ... ............+.+.+|+.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0 000 000000111235678899999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=353.00 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=207.0
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc----cccchhhhheeeeeecccc-CCcceEEeEeecCCce
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNR 594 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~ 594 (813)
.|++.++||+|+||+||+|....++.+++.||||.++... ....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 3788899999999999999987666678999999986432 2234578899999999976 8999999999999999
Q ss_pred EEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccccc
Q 045343 595 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTL 674 (813)
Q Consensus 595 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~ 674 (813)
++|+||+.+|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999999988888999999999999999999995 4999999999999999999999999999987654
Q ss_pred CcccceeecccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccccc
Q 045343 675 NQSKAIRTAIRGTKGYVAPEWFRNS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDDLV 752 (813)
Q Consensus 675 ~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 752 (813)
..... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... .......
T Consensus 182 ~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~------- 250 (322)
T d1vzoa_ 182 DETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILK------- 250 (322)
T ss_dssp GGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHH-------
T ss_pred ccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhccc-------
Confidence 43332 3446799999999999764 468899999999999999999999976543321111 0000000
Q ss_pred cccccccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 045343 753 EGDMEALNDIKCVEKLVMVSIWCIQEDPSLRP-----TMKKVLQM 792 (813)
Q Consensus 753 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 792 (813)
... ......++++.+++.+||+.||.+|| |++|++++
T Consensus 251 -~~~--~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 -SEP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -CCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -CCC--CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 000 01123467889999999999999999 58999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=351.21 Aligned_cols=268 Identities=19% Similarity=0.222 Sum_probs=200.0
Q ss_pred HHhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecc--ccccchhhhheeeeeeccccCCcceEEeEeec------
Q 045343 519 ATDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------ 590 (813)
Q Consensus 519 ~~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------ 590 (813)
..|.+.++||+|+||+||+|... .+++.||||++... .....+++.+|+++|++++|+||+++++.+..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR---KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCEEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 35677899999999999999874 46789999998543 23345668899999999999999999998854
Q ss_pred --CCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccC
Q 045343 591 --GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGL 668 (813)
Q Consensus 591 --~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGl 668 (813)
....++||||+.++.+..+......++...+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 346899999999988887777778889999999999999999999954 999999999999999999999999999
Q ss_pred ccccccCccc--ceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc
Q 045343 669 AKLLTLNQSK--AIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 745 (813)
Q Consensus 669 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 745 (813)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876543221 112335699999999998765 6899999999999999999999999765443322221111111111
Q ss_pred Ccccccc--------cccccccc-------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 746 EKLDDLV--------EGDMEALN-------DIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 746 ~~~~~~~--------~~~~~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
....... ........ .......+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1111100 00000000 01123467789999999999999999999977
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=345.71 Aligned_cols=261 Identities=18% Similarity=0.177 Sum_probs=196.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceE-EeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL-LGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~g~~~~~~~~~lV~ 598 (813)
.|++.++||+|+||+||+|... .+++.||||.+... ...+++..|++++++++|+|++.. .++..+++..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEEC---CCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 3778899999999999999874 35789999988653 334578899999999987775555 45557777889999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc---CCCCEEEeeccCccccccC
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLD---DYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~DfGla~~~~~~ 675 (813)
||+.++.+..+......+++..+..++.|+++||+|||+. +|+||||||+|||++ .+..+||+|||+|+.+...
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9995544444445567899999999999999999999964 999999999999985 4567999999999987543
Q ss_pred ccc-----ceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCcccc
Q 045343 676 QSK-----AIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLDD 750 (813)
Q Consensus 676 ~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 750 (813)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 321 112345799999999999999999999999999999999999999976543221111100000000000000
Q ss_pred cccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 751 LVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 751 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
.....++++.+++..||+.+|++||++.++.+.|+.+.
T Consensus 240 ---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 240 ---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ---------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 01123577899999999999999999999998887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=353.99 Aligned_cols=264 Identities=23% Similarity=0.278 Sum_probs=195.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCcceEEeEeecC------Cc
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------QN 593 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 593 (813)
+|...++||+|+||+||+|... .+++.||||+++.. ...+.+|+++|++++|+||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC----SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEEC---CCCCEEEEEEECcc----chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 4666789999999999999874 46789999998653 23456799999999999999999998432 24
Q ss_pred eEEEEeecCCCchhhhh---hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCc
Q 045343 594 RLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLA 669 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla 669 (813)
.+|||||++++.+..+. .....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccch
Confidence 68999999877544433 345678999999999999999999994 5999999999999999765 8999999999
Q ss_pred cccccCcccceeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHH---------HH
Q 045343 670 KLLTLNQSKAIRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD---------WA 739 (813)
Q Consensus 670 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~ 739 (813)
+....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+...... ..
T Consensus 171 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 87754432 334579999999998765 468999999999999999999999997654322111000 00
Q ss_pred HHhh---ccCcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 045343 740 FDCY---RNEKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV 796 (813)
Q Consensus 740 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 796 (813)
.... ......................+.+.+|+.+||+.||++|||+.|++++ ++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 0001111111111111112345678999999999999999999999975 5544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-39 Score=340.28 Aligned_cols=260 Identities=18% Similarity=0.220 Sum_probs=204.7
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc-CCcceEEeEeecCCceEEEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~ 598 (813)
.|.+.++||+|+||+||+|... .+++.||||.++.. ....++.+|+++++.++| +|++.+++++.++...++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 4678899999999999999874 36789999988653 334568889999999975 89999999999999999999
Q ss_pred eecCCCchhhhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-----CCCEEEeeccCcccc
Q 045343 599 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDD-----YYNARISDFGLAKLL 672 (813)
Q Consensus 599 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~DfGla~~~ 672 (813)
||+ +++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+.+
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 998 68998888654 478999999999999999999994 59999999999999974 578999999999987
Q ss_pred ccCcccc-----eeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCc
Q 045343 673 TLNQSKA-----IRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEK 747 (813)
Q Consensus 673 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 747 (813)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 5432211 12345799999999999999999999999999999999999999976543322111111111110001
Q ss_pred ccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 045343 748 LDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQMLEGVV 797 (813)
Q Consensus 748 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 797 (813)
..++ ....++++.+++..|++.+|++||+++.+.+.|++++
T Consensus 237 ~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 237 LREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111 0123467889999999999999999999999887754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=350.99 Aligned_cols=266 Identities=25% Similarity=0.298 Sum_probs=193.9
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeecCC-----
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----- 592 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 592 (813)
.|++.++||+|+||+||+|... .+++.||||+++... ....+.+.+|+.+|++++|||||++++++...+
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDG---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp SEEEEEEC------CEEEEEET---TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cEEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4667789999999999999874 467899999997532 222456889999999999999999999997654
Q ss_pred -ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 593 -NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 593 -~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
+.++||||+ +.+|..++. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 569999999 556766654 45789999999999999999999954 999999999999999999999999999987
Q ss_pred cccCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHH--------Hh
Q 045343 672 LTLNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DC 742 (813)
Q Consensus 672 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~ 742 (813)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||................ ..
T Consensus 171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 6543 3445799999999998764 56899999999999999999999997654322111100000 00
Q ss_pred hcc-------CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCC
Q 045343 743 YRN-------EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVEV 799 (813)
Q Consensus 743 ~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~ 799 (813)
... ..+.+........ ........+.+|+.+||+.||.+|||++|++++ ++.+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 000 0000000000000 011234677899999999999999999999987 6665543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-39 Score=340.14 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=204.1
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeecCCceEEEE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 598 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 598 (813)
|++.++||+|+||+||+|... .+++.||||+++.... ...+++.+|+.++++++|+||+++++++.+....++|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEeeeEEecCcCeEEEEEEEC---CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 567799999999999999874 4678899999865332 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccCccc
Q 045343 599 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLNQSK 678 (813)
Q Consensus 599 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 678 (813)
|++.+++|..++.....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||.++........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999999999998888899999999999999999999964 9999999999999999999999999999876544322
Q ss_pred ceeecccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc---Ccc---ccc
Q 045343 679 AIRTAIRGTKGYVAPEWFRNST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---EKL---DDL 751 (813)
Q Consensus 679 ~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~---~~~ 751 (813)
.....++..|+|||.+.... ++.++|||||||++|||++|+.||.......... ..+...... ... ...
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH--HHHHHHHCCCCTTTCTTGGGS
T ss_pred --ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH--HHHHhhcCCCChhhhhhhhhc
Confidence 23345788899999987665 6899999999999999999999975433322111 111111110 000 000
Q ss_pred cc---------ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 752 VE---------GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 752 ~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.+ ............+.+.+|+.+||+.||.+|||++||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000011112335678899999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=348.09 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=196.4
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc-ccchhhhheeeeeeccccCCcceEEeEeecCC----ceE
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRL 595 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 595 (813)
|++.++||+|+||+||+|... .+++.||||+++.... ...+++.+|+.+|++++||||+++++++.... ..+
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDN---VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp EEEEEECC---CCCEEEEEET---TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred eEEEEEEeeccCeEEEEEEEC---CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 667799999999999999864 4678999999975332 23457889999999999999999999996543 335
Q ss_pred EEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccccC
Q 045343 596 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLTLN 675 (813)
Q Consensus 596 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~~~ 675 (813)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 566777899999999654 689999999999999999999964 9999999999999999999999999999876544
Q ss_pred cccc-eeecccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhccCccc----
Q 045343 676 QSKA-IRTAIRGTKGYVAPEWFRN-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNEKLD---- 749 (813)
Q Consensus 676 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---- 749 (813)
.... ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+..................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 3221 1344669999999999855 457889999999999999999999997654322211111000000000000
Q ss_pred ----c-c--ccccccc---cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 045343 750 ----D-L--VEGDMEA---LNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGV 796 (813)
Q Consensus 750 ----~-~--~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 796 (813)
. . ....... ........++.+|+.+||+.||.+|||+.|++++ |+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0 0 0000000 0001223568899999999999999999999986 5543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-38 Score=338.71 Aligned_cols=258 Identities=20% Similarity=0.324 Sum_probs=196.5
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeec--CCceEE
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE--GQNRLL 596 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~l 596 (813)
.|++.++||+|+||+||+|... .+++.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5778899999999999999874 46789999998643 3467889999999995 9999999999864 456899
Q ss_pred EEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-CEEEeeccCccccccC
Q 045343 597 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY-NARISDFGLAKLLTLN 675 (813)
Q Consensus 597 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~DfGla~~~~~~ 675 (813)
||||+.+++|..+. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999998764 4589999999999999999999954 999999999999998654 6999999999877654
Q ss_pred cccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhh--hHHH-----HHHhh---c
Q 045343 676 QSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--LTDW-----AFDCY---R 744 (813)
Q Consensus 676 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~--l~~~-----~~~~~---~ 744 (813)
.. .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... +... ..... .
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 3445689999999998765 47999999999999999999999997654322111 0000 00000 0
Q ss_pred cC---ccccccc--------ccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 745 NE---KLDDLVE--------GDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 745 ~~---~~~~~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.. ....... ............+++.+|+.+||+.||.+|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000 000111112345678899999999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-38 Score=340.46 Aligned_cols=260 Identities=24% Similarity=0.278 Sum_probs=187.3
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccc--cccchhhhheeeeeeccccCCcceEEeEeec------CC
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQ 592 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 592 (813)
|++.++||+|+||+||+|... .+++.||||++.... ....+++.+|+.++++++|||||++++++.. ..
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~---~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp EEEEEECSCC--CEEEEEEET---TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCcCeEEEEEEEC---CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 567789999999999999874 367899999997542 2233468899999999999999999999853 35
Q ss_pred ceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCcccc
Q 045343 593 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLL 672 (813)
Q Consensus 593 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~ 672 (813)
..++||||+.++.+..+ . ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence 78999999977655543 2 4578999999999999999999964 9999999999999999999999999998876
Q ss_pred ccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhH----------------
Q 045343 673 TLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT---------------- 736 (813)
Q Consensus 673 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~---------------- 736 (813)
..... .....+|+.|+|||++.+..++.++||||+||+++||++|+.||............
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 54332 34456899999999999999999999999999999999999999754322111000
Q ss_pred HHHHHhhccC------cccccccccc---cccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 045343 737 DWAFDCYRNE------KLDDLVEGDM---EALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM 792 (813)
Q Consensus 737 ~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 792 (813)
.......... .......... ...........+.+|+.+||+.||++|||++||+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 0000000000 011123456788999999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-38 Score=340.85 Aligned_cols=275 Identities=25% Similarity=0.284 Sum_probs=199.2
Q ss_pred hhcccccceeeeeeEEEEEEeccCCcceEEEEEEeecccc--ccchhhhheeeeeeccccCCcceEEeEeec-----CCc
Q 045343 521 DNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQN 593 (813)
Q Consensus 521 ~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~ 593 (813)
|++.++||+|+||+||+|... .+++.||||+++.... ...+++.+|+.+|++++|+|||++++++.. ...
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEET---TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred eEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 677899999999999999874 4678999999975422 233568899999999999999999999853 334
Q ss_pred eEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEEeeccCccccc
Q 045343 594 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARISDFGLAKLLT 673 (813)
Q Consensus 594 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~~~ 673 (813)
.+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 5777888899999999865 4689999999999999999999954 99999999999999999999999999997654
Q ss_pred cCcccceeecccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCCCcccchhhhhhHHHHHHhhcc-------
Q 045343 674 LNQSKAIRTAIRGTKGYVAPEWFRNS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------- 745 (813)
Q Consensus 674 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 745 (813)
.. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.....................
T Consensus 173 ~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 173 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp GG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred cc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 32 2345689999999987665 4688999999999999999999999765432211111000000000
Q ss_pred --------CcccccccccccccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCCCCCCCC
Q 045343 746 --------EKLDDLVEGDMEALNDIKCVEKLVMVSIWCIQEDPSLRPTMKKVLQM--LEGVVEVSLPPNPYPF 808 (813)
Q Consensus 746 --------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~p~~p~~~ 808 (813)
............. ........+.+|+.+||+.||.+|||++|++++ +.+..+.+..|.+.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~ 319 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred chhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence 0000000000000 001234678899999999999999999999984 5555443333333333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-33 Score=304.03 Aligned_cols=274 Identities=20% Similarity=0.257 Sum_probs=192.1
Q ss_pred HhhcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-----------cCCcceEEeEe
Q 045343 520 TDNFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----------HKNLVRLLGFC 588 (813)
Q Consensus 520 ~~~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~ 588 (813)
.|++.++||+|+||+||+|... .+++.||||+++... ...+.+.+|+.++++++ |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~---~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4788999999999999999874 467899999997532 22345677888777764 57899999987
Q ss_pred ecC--CceEEEEeecCCCchhhh-h--hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----
Q 045343 589 DEG--QNRLLVYEFLNNGTLASF-L--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYY---- 659 (813)
Q Consensus 589 ~~~--~~~~lV~e~~~~gsL~~~-l--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~---- 659 (813)
... ...+++++++..+..... . .....+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 543 456667776655443222 2 234577899999999999999999996 25899999999999998654
Q ss_pred --CEEEeeccCccccccCcccceeecccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCCCcccchhh----h
Q 045343 660 --NARISDFGLAKLLTLNQSKAIRTAIRGTKGYVAPEWFRNSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY----A 733 (813)
Q Consensus 660 --~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvvl~elltG~~p~~~~~~~~~----~ 733 (813)
.++++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||........ .
T Consensus 168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 3999999999865432 2345699999999999999999999999999999999999999975433111 0
Q ss_pred hhHHHHHHhhc------------------cC-ccccccccc---------ccccccHHHHHHHHHHHHHhcccCCCCCCC
Q 045343 734 ILTDWAFDCYR------------------NE-KLDDLVEGD---------MEALNDIKCVEKLVMVSIWCIQEDPSLRPT 785 (813)
Q Consensus 734 ~l~~~~~~~~~------------------~~-~~~~~~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 785 (813)
.+.... ..+. .. ....+.... ............+.+|+.+||+.||.+|||
T Consensus 243 ~~~~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 243 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111100 0000 00 000000000 011123456788999999999999999999
Q ss_pred HHHHHHH--HhcC---cCCCCCCCC
Q 045343 786 MKKVLQM--LEGV---VEVSLPPNP 805 (813)
Q Consensus 786 ~~evl~~--L~~~---~~~~~p~~p 805 (813)
++|++++ +++. .++..|+.|
T Consensus 322 a~e~L~Hp~f~~~~~~~~~~~p~~~ 346 (362)
T d1q8ya_ 322 AGGLVNHPWLKDTLGMEEIRVPDRE 346 (362)
T ss_dssp HHHHHTCGGGTTCTTCTTCCCTTSC
T ss_pred HHHHhcCcccCCCCCcccCCCCCcc
Confidence 9999986 5533 233444444
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.82 E-value=1.7e-20 Score=165.77 Aligned_cols=111 Identities=18% Similarity=0.366 Sum_probs=92.3
Q ss_pred CCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEee
Q 045343 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (813)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~ 106 (813)
+|+|.+||.|.+|+ +|+| |.|.|+|+.+| .|.|++ ..++||.||++ .+ ..++.|.|+.
T Consensus 1 tDtL~~gq~L~~g~---~l~~--g~~~l~~q~DG---------NLvly~----~~~~vW~s~~~---~~-~~~~~l~l~~ 58 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG---SLAE--GGYLFIIQNDC---------NLVLYD----NNRAVWASGTN---GK-ASGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECTTC---EEEE--TTEEEEECTTS---------CEEEEE----TTEEEEECCCT---TS-CSSEEEEECT
T ss_pred CCEecCCCEecCCC---EEEE--CCEEEEEcCCC---------CEEEEc----CCcEEEEccCc---cC-CCCcEEEEec
Confidence 48999999999999 8875 99999998765 255654 35899999987 22 3457899999
Q ss_pred CccEEEeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccccccCcC
Q 045343 107 DHGLVLNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDSFSNPSD 160 (813)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTD 160 (813)
||+|+|++. +.++|+++++.. +..+|+|+|+|||||++.+++++|||+.+|+|
T Consensus 59 dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 59 DGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp TSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred cccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 999999996 567888776644 44689999999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=2.1e-20 Score=183.06 Aligned_cols=162 Identities=13% Similarity=0.107 Sum_probs=117.3
Q ss_pred hcccccceeeeeeEEEEEEeccCCcceEEEEEEeeccccc------------------cchhhhheeeeeeccccCCcce
Q 045343 522 NFKEEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRVFQD------------------GEKEFKNEVVVIGQTHHKNLVR 583 (813)
Q Consensus 522 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~ 583 (813)
.+.++||+|+||+||+|... +++.||||.++..... .......|...+.++.|.+++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~ 78 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred hhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcce
Confidence 45789999999999999863 5788999987531110 0112345777888899999999
Q ss_pred EEeEeecCCceEEEEeecCCCchhhhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCCEEE
Q 045343 584 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSAQIIHCDIKPQNILLDDYYNARI 663 (813)
Q Consensus 584 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 663 (813)
.+++. ..+++|||+++..+.+ ++.....+++.|++++|+|||+. +|+||||||+|||++++ .++|
T Consensus 79 ~~~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 79 VYAWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EEEEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred EEEec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 88764 2379999999876543 34455678999999999999964 99999999999999965 5899
Q ss_pred eeccCccccccCcccceeecccccccccCc------ccccCCCCCCccchhhHHHH
Q 045343 664 SDFGLAKLLTLNQSKAIRTAIRGTKGYVAP------EWFRNSTITAKVDVYSFGVL 713 (813)
Q Consensus 664 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~~~k~DVwS~Gvv 713 (813)
+|||+|+........ .|+.. |. ....++.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 999999776433221 11111 11 13457788999996543
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.79 E-value=1.2e-19 Score=158.61 Aligned_cols=106 Identities=21% Similarity=0.369 Sum_probs=88.1
Q ss_pred CCCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEee
Q 045343 27 NGTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTA 106 (813)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~ 106 (813)
+|+|.+||.|.+|+ +|. +|.|.|.|+.+| .|.|+.. .++||.||++. + +..+.|.|+.
T Consensus 1 ~~~L~~g~~L~~G~---~l~--ng~~~l~~q~DG---------NLvly~~----~~~vW~s~~~~---~-~~~~~l~l~~ 58 (108)
T d1jpca_ 1 DNILYSGETLSTGE---FLN--YGSFVFIMQEDC---------NLVLYDV----DKPIWATNTGG---L-SRSCFLSMQT 58 (108)
T ss_dssp CCEEETTEEECTTC---EEE--ETTEEEEECTTS---------CEEEEET----TEEEEECCCTT---S-CSSCEEEECT
T ss_pred CCCccCCCEecCCC---EEE--cCCEEEEECCCC---------eEEEEeC----CceeeEeCCCC---C-CCccEEEEec
Confidence 47899999999998 785 699999999876 2666543 58899999883 2 3466899999
Q ss_pred CccEEEeCCCCCEEeeeccCCCce-eEEEEecCcCEEEEecCCccccccccc
Q 045343 107 DHGLVLNDPQGKQVWSSEIDIGTV-AVGHMNDTGNFVLASSSSSKLWDSFSN 157 (813)
Q Consensus 107 ~g~l~l~~~~~~~~wst~~~~~~~-~~~~l~d~Gnlvl~~~~~~~~WqSFD~ 157 (813)
||+|+|++++|++||+|++..... .+|+|+|+|||||++. .+||||+|
T Consensus 59 ~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 59 DGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred cceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 999999999999999999764433 5789999999999964 59999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.79 E-value=1.5e-19 Score=157.86 Aligned_cols=106 Identities=22% Similarity=0.360 Sum_probs=88.1
Q ss_pred CCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeC
Q 045343 28 GTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (813)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~ 107 (813)
|+|.+|+.|.+|+ +|++ |.|.|+|+..| .|.++. ..++||+||++ .+....+.|.|+.|
T Consensus 2 ~~L~~g~~L~~g~---~l~~--g~~~l~~q~dg---------nLvl~~----~~~~vW~ant~---~~~~~~~~l~l~~d 60 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQ---SLDV--EPYHFIMQEDC---------NLVLYD----HSTSVWASNTG---ILGKKGCKAVLQSD 60 (109)
T ss_dssp CEEETTCEEETTC---EEEE--TTEEEEECTTS---------CEEEEE----TTEEEEECCCC---CTTCCCCEEEECTT
T ss_pred CCccCCCEEeCCC---EEEe--CCEEEEecCCC---------eEEEEe----CCEEEEEeCCC---CCCceeEEEEEcCC
Confidence 7899999999998 8864 89999998765 255543 35889999998 44556788999999
Q ss_pred ccEEEeCCCCCEEeeeccCC-CceeEEEEecCcCEEEEecCCccccccccc
Q 045343 108 HGLVLNDPQGKQVWSSEIDI-GTVAVGHMNDTGNFVLASSSSSKLWDSFSN 157 (813)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~-~~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~ 157 (813)
|+|||+|++|++||+|+++. .+..+|+|+|+|||||+++ .+|||+-|
T Consensus 61 GnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 61 GNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred ceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 99999999999999999864 4456899999999999964 59999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.71 E-value=7.2e-18 Score=149.54 Aligned_cols=101 Identities=22% Similarity=0.294 Sum_probs=85.8
Q ss_pred EEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCccc
Q 045343 73 IFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKL 151 (813)
Q Consensus 73 iw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~ 151 (813)
|||.++++++.+|++|++. +......+|.|+.||||+|++. +.+||++++...+ ...|.|+++|||||++.++++|
T Consensus 12 il~~~~~~~~~~~~l~~~q--~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~l 88 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQ--SLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAV 88 (120)
T ss_dssp ECCCC--CCCCCCEECSSC--CCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEE
T ss_pred EEEcCCCCCCcccEEcCCC--eeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEE
Confidence 8999999999999999993 4445567899999999999985 6889999987654 3689999999999999999999
Q ss_pred ccccccCcCcccCCCccccccceeecCCCCCCCCCceeEEeccCCcceec
Q 045343 152 WDSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLN 201 (813)
Q Consensus 152 WqSFD~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 201 (813)
||||+ +.++|.|.+.|++||++++|
T Consensus 89 W~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 89 WTSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EEeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 99984 34678999999999999987
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=5.1e-17 Score=142.42 Aligned_cols=111 Identities=19% Similarity=0.223 Sum_probs=92.6
Q ss_pred EEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeCccEEEeCCCCCEEeeeccCCCceeEEEEecCcCEEEEecCCcccc
Q 045343 73 IFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIGTVAVGHMNDTGNFVLASSSSSKLW 152 (813)
Q Consensus 73 iw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~l~d~Gnlvl~~~~~~~~W 152 (813)
|||.--++.+..|..+.++ +......+|.|+.||||||++ .+.++|++++.+..++.+.|+|+|||||++.++++||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~--~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vW 79 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQ--SLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRW 79 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTC--EECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSC
T ss_pred EEEecCCCCCCcceecCCC--cEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEE
Confidence 6777667778888888873 444567789999999999998 5789999998877778999999999999999999999
Q ss_pred cccccCcCcccCCCccccccceeecCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeecccc
Q 045343 153 DSFSNPSDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTY 220 (813)
Q Consensus 153 qSFD~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 220 (813)
||+. +.++|.|.+.|++||++++|. .++|.+++.
T Consensus 80 sS~t-------------------------~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt~ 113 (115)
T d1dlpa1 80 SSGT-------------------------KGSIGNYVLVLQPDRTVTIYG---------PGLWDSGTS 113 (115)
T ss_dssp CCCC-------------------------CCCSSCCEEEECSSSCEEEEC---------SEEEECSCC
T ss_pred EcCC-------------------------CCCCCCEEEEECCCCcEEEeC---------CCeecCCCC
Confidence 9873 346899999999999998862 468988764
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=1.6e-14 Score=127.28 Aligned_cols=102 Identities=20% Similarity=0.292 Sum_probs=78.9
Q ss_pred CCcCCCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeC
Q 045343 28 GTVPVGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTAD 107 (813)
Q Consensus 28 ~~~~~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~ 107 (813)
++|.++|+| .+++..|.|.|.|..+|. |.+ |. ..++||.+|+.. + +....|.|+.|
T Consensus 15 ~~l~~~q~l-------~~~~~~~~y~l~mQ~DGN---------LVL-y~---~~~~vWssnt~~---~-~~~~~l~l~~d 70 (119)
T d1b2pa_ 15 QILHATESL-------EILFGTHVYRFIMQTDCN---------LVL-YD---NNNPIWATNTGG---L-GNGCRAVLQPD 70 (119)
T ss_dssp CEEETTCEE-------EEEETTEEEEEEECTTSC---------EEE-EE---TTEEEEECCCTT---S-CSSCEEEECTT
T ss_pred CEEeCCCeE-------EEecCCceEEEEECCCCc---------EEE-EE---CCeEEEEecCCC---C-CcceEEEEEeC
Confidence 455555555 346789999999998761 444 43 258899999872 2 34578999999
Q ss_pred ccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccc
Q 045343 108 HGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFS 156 (813)
Q Consensus 108 g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD 156 (813)
|+|+|+|.+|.+||++++.... ..+|+|+|||||||++ ..+|||-.
T Consensus 71 GnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 71 GVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp SCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CCEEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 9999999999999999986543 4579999999999996 46999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.28 E-value=1.3e-12 Score=113.88 Aligned_cols=87 Identities=23% Similarity=0.298 Sum_probs=68.5
Q ss_pred CCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeCccEEEeCCCCCEEeeeccCCC
Q 045343 49 SGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLVLNDPQGKQVWSSEIDIG 128 (813)
Q Consensus 49 ~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~ 128 (813)
+|.|.|.|..+| -|.|+. ...+||.+|.. ....+++.|..||||||+|.++++||++.+...
T Consensus 25 ~g~~~l~~q~DG---------NLvL~~----~~~~vW~s~t~-----~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~ 86 (115)
T d1dlpa1 25 LSSFRFTMQSDC---------NLVLFD----SDVRVWASNTA-----GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGS 86 (115)
T ss_dssp STTEEEEECTTS---------CEEEEE----SSSEEECCCCC-----SCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC
T ss_pred cCCEEEEECCCC---------eEEEEc----CCeeEEEcccC-----CCCceEEEEeccCCEEEEccCCCEEEEcCCCCC
Confidence 588999998776 255643 25789988754 234677899999999999999999999998743
Q ss_pred -ceeEEEEecCcCEEEEecCCcccccccc
Q 045343 129 -TVAVGHMNDTGNFVLASSSSSKLWDSFS 156 (813)
Q Consensus 129 -~~~~~~l~d~Gnlvl~~~~~~~~WqSFD 156 (813)
+..+++|++||||||++ ..+|+|-.
T Consensus 87 ~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 87 IGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp SSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred CCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 34579999999999995 46999854
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.13 E-value=6.6e-11 Score=103.69 Aligned_cols=86 Identities=21% Similarity=0.322 Sum_probs=69.5
Q ss_pred eEEEEeeCccEEEeCCCCCEEeeeccCCCc-eeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeecC
Q 045343 100 SQVKLTADHGLVLNDPQGKQVWSSEIDIGT-VAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSRK 178 (813)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~~ 178 (813)
=+|.+..||||||++. +.+||++++.+.+ .+.+.|+++|||||++.++.+||+|.-
T Consensus 32 y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t---------------------- 88 (119)
T d1b2pa_ 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV---------------------- 88 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC----------------------
T ss_pred EEEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC----------------------
Confidence 3688999999999975 5789999987554 468999999999999999999997632
Q ss_pred CCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeecccc
Q 045343 179 SETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTY 220 (813)
Q Consensus 179 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 220 (813)
.-+.|.|.+.|++||+++++. .+.|.+++.
T Consensus 89 ---~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T~ 118 (119)
T d1b2pa_ 89 ---AGKAGHYVLVLQPDRNVVIYG---------DALWATQTV 118 (119)
T ss_dssp ---CCCSSCEEEEECTTSCEEEEE---------SEEEECCCC
T ss_pred ---cCCCCceEEEEcCCCCEEEEC---------CCEeccCCc
Confidence 124578999999999999873 357887653
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.12 E-value=7.3e-11 Score=101.99 Aligned_cols=77 Identities=27% Similarity=0.405 Sum_probs=64.4
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCCce-eEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceeec
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIGTV-AVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFSR 177 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~-~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S~ 177 (813)
.-+|.+..||||||++ .+.+||++++...+. ..+.|+++|||||++.++++||+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS----------------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS----------------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc-----------------------
Confidence 3578999999999997 558999999876543 589999999999999999999986
Q ss_pred CCCCCCCCCceeEEeccCCcceec
Q 045343 178 KSETNFSRGRFQFRLLKDGNLVLN 201 (813)
Q Consensus 178 ~s~~dps~G~~~~~~~~~g~~~~~ 201 (813)
.+...++.|.+.|++||+++++
T Consensus 76 --~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 --NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp --CCCCSCSCEEEEECTTSCEEEE
T ss_pred --cccCCCCcEEEEEcCCCCEEEe
Confidence 1222557889999999999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.09 E-value=1.3e-10 Score=100.34 Aligned_cols=87 Identities=29% Similarity=0.494 Sum_probs=69.0
Q ss_pred ceEEEEeeCccEEEeCCCCCEEeeeccCCC--ceeEEEEecCcCEEEEecCCcccccccccCcCcccCCCccccccceee
Q 045343 99 GSQVKLTADHGLVLNDPQGKQVWSSEIDIG--TVAVGHMNDTGNFVLASSSSSKLWDSFSNPSDTLLPGQTMETKQGLFS 176 (813)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~--~~~~~~l~d~Gnlvl~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~L~S 176 (813)
.-.|.|..||||||++ .+.+||++++... ....+.|+++|||||++++++++|+|=
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~--------------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH--------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC---------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe---------------------
Confidence 3568899999999987 5689999998643 346799999999999999999999871
Q ss_pred cCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeecccc
Q 045343 177 RKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTY 220 (813)
Q Consensus 177 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 220 (813)
+..+.|.|.+.|++||+++++- ...|.++++
T Consensus 78 ----t~~~~~~~~l~L~ddGNlvly~---------~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ----SVRGNGNYVLVLQEDGNVVIYG---------SDIWSTGTY 108 (109)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC---------CEEEECCCC
T ss_pred ----eECCCCCEEEEEeCCCcEEEEC---------CCEecCCCc
Confidence 1124577899999999999872 347877654
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.03 E-value=3.1e-10 Score=99.67 Aligned_cols=98 Identities=18% Similarity=0.246 Sum_probs=71.9
Q ss_pred CCceeeecCCCceeecCCCcEEEeeeecCCCCCCCCcEEEEEEeeccCCCeeEEEecCCCCCCCCCCceEEEEeeCccEE
Q 045343 32 VGATLTAGTNSSTWLSPSGDFAFGFRQVDEENNTNDLFLLSIFYSNIPAKTVVWYTDNKDQNPAVPRGSQVKLTADHGLV 111 (813)
Q Consensus 32 ~~~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgiw~~~~~~~tvvWvanr~~~~~~~~~~~~l~~~~~g~l~ 111 (813)
+.+.|..++ +| ..|.|.|.|...| .|.|+. ...+||.++.. ..+....+.|..+||||
T Consensus 22 ~~~~l~~~q---~l--~~g~y~L~~q~DG---------NLvL~~----~~~~vW~s~t~----~~~~~~~~~l~~~GnLv 79 (120)
T d1dlpa2 22 HPQTLHATQ---SL--QLSPYRLSMETDC---------NLVLFD----RDDRVWSTNTA----GKGTGCRAVLQPNGRMD 79 (120)
T ss_dssp CCCEECSSC---CC--BCSSCEEEEETTT---------EEEEEB----TTBCCSCCCCC----SSCSSCEEEEETTTEEE
T ss_pred cccEEcCCC---ee--EcCCEEEEEcCCC---------cEEEec----CCcEEEEEccc----cCCCcEEEEEeCCeeEE
Confidence 345555555 44 3477999887655 466643 24678977643 22456789999999999
Q ss_pred EeCCCCCEEeeeccCCC-ceeEEEEecCcCEEEEecCCcccccc
Q 045343 112 LNDPQGKQVWSSEIDIG-TVAVGHMNDTGNFVLASSSSSKLWDS 154 (813)
Q Consensus 112 l~~~~~~~~wst~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqS 154 (813)
|+|.++++||+|++... +...+.|++||||||++ ..+|.|
T Consensus 80 l~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 80 VLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp EEETTTEEEEECCCCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred EEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence 99999999999998643 44579999999999995 468976
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.81 E-value=7e-09 Score=90.05 Aligned_cols=111 Identities=25% Similarity=0.321 Sum_probs=78.0
Q ss_pred cCcccCCCccccccceeecCCCCCCCCCceeEEeccCCcceeccccCCCCCCCCceeeccccCCCCCCCCceEEEeccCc
Q 045343 159 SDTLLPGQTMETKQGLFSRKSETNFSRGRFQFRLLKDGNLVLNIANLPTGDAYDAYYISGTYDPANSSNSGYRVMFNESG 238 (813)
Q Consensus 159 TDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (813)
||||+|||.|..++.|++ |.|+|.++.||+|+++... .++|.++.... .....+.++.++
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~~-------~~vW~s~~~~~----~~~~~l~l~~dG 60 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN-------RAVWASGTNGK----ASGCVLKMQNDG 60 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEETT-------EEEEECCCTTS----CSSEEEEECTTS
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcCC-------cEEEEccCccC----CCCcEEEEeccc
Confidence 899999999999999975 9999999999999987421 46887765432 234567888888
Q ss_pred cEEEEecCCceeEeecccccCCcceEEEEEEeeCceeEEEeecCCCCCCeEEEEccccccc
Q 045343 239 YMYILRRNGGRFDLTTESVVPAADFYYRATLNFDGVFAQYFYPKNGNENWSVAWSEPENIC 299 (813)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~W~~~~~~p~d~C 299 (813)
.+.++...+. +-.+.. ......++++|..||+|++|. .. ....|+...+.|
T Consensus 61 nLvl~~~~~~-~w~s~t---~~~~~~~~l~L~ddGNlvly~--~~----~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 61 NLVIYSGSRA-IWASNT---NRQNGNYYLILQRDRNVVIYD--NS----NNAIWATHTNVG 111 (112)
T ss_dssp CEEEEETTEE-EEECCC---CCSCCCCEEEECTTSCEEEEC--TT----SCEEEECCCCCC
T ss_pred cEEEEecCCe-EEEEee---ccCCCceEEEEcCCCCEEEEC--CC----CcEEecCCCccC
Confidence 8887765332 222211 122234689999999999983 11 245687665544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.94 E-value=1.1e-05 Score=80.78 Aligned_cols=132 Identities=16% Similarity=0.063 Sum_probs=89.4
Q ss_pred eeeeeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccc-cCCcceEEeEeecCCceEEEEeecCCCchhh
Q 045343 530 GSFGIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 608 (813)
Q Consensus 530 G~fG~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 608 (813)
++...||+... ++..+.||+...........+.+|...+..+. +--+.+++.+..+++..++||+++++..+.+
T Consensus 25 ~s~~~v~rv~~-----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 25 MSPAKVYKLVG-----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CSSSEEEEEEC-----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred CCCCcEEEEEe-----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence 34468998753 45567888876554444556778888877764 4446788888888888999999999988765
Q ss_pred hhhccCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------------
Q 045343 609 FLFGNLKPSWNLRTNIAFQIARGLLYLHED-------------------------------------------------- 638 (813)
Q Consensus 609 ~l~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------------------------------------------------- 638 (813)
..... .....++.++++.++.||+.
T Consensus 100 ~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 100 EYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp HTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 43211 11222344444444444421
Q ss_pred ---C---CCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 639 ---C---SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 639 ---~---~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
. ...++|+|+.|.|||++++...-|+||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 12379999999999999876677999988754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.34 E-value=0.00014 Score=71.75 Aligned_cols=138 Identities=15% Similarity=0.052 Sum_probs=82.2
Q ss_pred cceeee-eeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeecccc--CCcceEEeEeecCCceEEEEeecCC
Q 045343 527 VGRGSF-GIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNN 603 (813)
Q Consensus 527 LG~G~f-G~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~ 603 (813)
+..|.. ..||+.... .+..+.+|.-.. .....+..|...++.+.. -.+.+++++..++...++||+++++
T Consensus 18 ~~~G~s~~~v~r~~~~----~~~~~vlK~~~~---~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----GRPVLFVKTDLS---GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECT----TSCCEEEEEECS---CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeC----CCCEEEEEeCCc---cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 444443 578987642 445577776543 233457778888877743 3356788888888889999999988
Q ss_pred Cchhhhh-----------------hcc----CCCC--HHHHHHHH--------------------HHHHHHHHHhhhc--
Q 045343 604 GTLASFL-----------------FGN----LKPS--WNLRTNIA--------------------FQIARGLLYLHED-- 638 (813)
Q Consensus 604 gsL~~~l-----------------~~~----~~l~--~~~~~~i~--------------------~~ia~gl~yLH~~-- 638 (813)
..+.+.. +.. .... +.....-. ......+..+.+.
T Consensus 91 ~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (255)
T d1nd4a_ 91 QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP 170 (255)
T ss_dssp EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred cccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence 7664321 000 0000 00000000 0011223333321
Q ss_pred --CCCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 639 --CSAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 639 --~~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 123489999999999999887778999988754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.01 E-value=0.00077 Score=71.09 Aligned_cols=76 Identities=16% Similarity=0.139 Sum_probs=46.8
Q ss_pred cccceeeeeeEEEEEEeccCCcceEEEEEEeecc-------ccccchhhhheeeeeeccc-c--CCcceEEeEeecCCce
Q 045343 525 EEVGRGSFGIVYKGVILTTRTSTTAVAVKKLDRV-------FQDGEKEFKNEVVVIGQTH-H--KNLVRLLGFCDEGQNR 594 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~ 594 (813)
++||.|....||+.... ..++.++||.-... ......+...|.+.|+.+. + ..+.+++.+ +++..
T Consensus 32 ~eig~G~~N~vfrV~~~---~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~ 106 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ---EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 106 (392)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEeCCCceEeEEEEEeC---CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCC
Confidence 57899999999998753 23567888864321 0112233456777776663 2 345566655 34567
Q ss_pred EEEEeecCCCc
Q 045343 595 LLVYEFLNNGT 605 (813)
Q Consensus 595 ~lV~e~~~~gs 605 (813)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 89999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.01 E-value=0.018 Score=60.27 Aligned_cols=76 Identities=13% Similarity=0.205 Sum_probs=49.3
Q ss_pred cccceeeeeeEEEEEEeccC----CcceEEEEEEeeccccccchhhhheeeeeeccccCCc-ceEEeEeecCCceEEEEe
Q 045343 525 EEVGRGSFGIVYKGVILTTR----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYE 599 (813)
Q Consensus 525 ~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 599 (813)
+.|+.|-.-.+|+....... .....|.++.... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 56788888899998875432 1234455555432 2233456678888888854455 478887754 68999
Q ss_pred ecCCCch
Q 045343 600 FLNNGTL 606 (813)
Q Consensus 600 ~~~~gsL 606 (813)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.90 E-value=0.016 Score=58.72 Aligned_cols=132 Identities=15% Similarity=0.085 Sum_probs=73.5
Q ss_pred eeEEEEEEeccCCcceEEEEEEeeccccccchhhhheeeeeeccccCCc--ceEEe-----EeecCCceEEEEeecCCCc
Q 045343 533 GIVYKGVILTTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL--VRLLG-----FCDEGQNRLLVYEFLNNGT 605 (813)
Q Consensus 533 G~Vykg~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~e~~~~gs 605 (813)
-.||++.+. ++..+++|..+.. ....+++..|...+..|....+ +..+. ....+...+.++++++|..
T Consensus 36 N~vy~v~~~----dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDE----DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCT----TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcC----CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 479988763 6777899986532 2245667788888877753332 11211 1233445788999987654
Q ss_pred hhh-----h------h---h----c-----cCCCCHH-------------------HHHHHHHHHHHHHHHhh----hcC
Q 045343 606 LAS-----F------L---F----G-----NLKPSWN-------------------LRTNIAFQIARGLLYLH----EDC 639 (813)
Q Consensus 606 L~~-----~------l---~----~-----~~~l~~~-------------------~~~~i~~~ia~gl~yLH----~~~ 639 (813)
+.. + + + . ....++. .+..+...+.+.+..+. +..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 321 0 0 0 0 0111111 11112222222333332 223
Q ss_pred CCCeeeCCCCCCcEEEcCCCCEEEeeccCccc
Q 045343 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAKL 671 (813)
Q Consensus 640 ~~~ivH~dlk~~NIll~~~~~~kl~DfGla~~ 671 (813)
..+++|+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4679999999999999754 45899988754
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.71 E-value=0.021 Score=35.54 Aligned_cols=32 Identities=25% Similarity=0.618 Sum_probs=24.2
Q ss_pred cccccccCCCCCCCCCCCCcccCCCCCCCcccCCCCCccc
Q 045343 297 NICVNIGGEMGSGACGFNSICSLDSDRRPKCACPKGYSLL 336 (813)
Q Consensus 297 d~Cd~y~~~~~~~~CG~~g~C~~~~~~~~~C~Cl~GF~~~ 336 (813)
|.|.+ -..|| ||-|+. ....-.|.|-+||+|.
T Consensus 2 dECsi------gnpCG-nGTCtN-viGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKN-VIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEE-CSSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-Cceeee-cccceEEeecCCcCCC
Confidence 56877 57898 889974 2334479999999985
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.30 E-value=0.2 Score=49.90 Aligned_cols=31 Identities=26% Similarity=0.315 Sum_probs=27.8
Q ss_pred CCCeeeCCCCCCcEEEcCCCCEEEeeccCcc
Q 045343 640 SAQIIHCDIKPQNILLDDYYNARISDFGLAK 670 (813)
Q Consensus 640 ~~~ivH~dlk~~NIll~~~~~~kl~DfGla~ 670 (813)
..+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5689999999999999998777899999874
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.08 E-value=0.17 Score=33.63 Aligned_cols=28 Identities=25% Similarity=0.666 Sum_probs=20.7
Q ss_pred CCCCCCCCcccCCCCCCCcccCCCCCcccC
Q 045343 308 SGACGFNSICSLDSDRRPKCACPKGYSLLD 337 (813)
Q Consensus 308 ~~~CG~~g~C~~~~~~~~~C~Cl~GF~~~~ 337 (813)
+..|. +++|.. +-.+-.|.|++||.+..
T Consensus 9 ~~~C~-~~~C~N-t~Gsy~C~C~~Gy~l~~ 36 (42)
T d1lmja2 9 PLLCR-GGVCHN-TEGSYRCECPPGHQLSP 36 (42)
T ss_dssp SSTTT-TSEEEE-ETTEEEEESCTTSCCCS
T ss_pred CCCCC-CCEeEC-CCCCeEEeCCCCCeECc
Confidence 67885 789974 33344799999999753
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.85 E-value=0.21 Score=33.18 Aligned_cols=26 Identities=23% Similarity=0.625 Sum_probs=20.7
Q ss_pred CCCCCCCCcccCCCCCCCcccCCCCCc
Q 045343 308 SGACGFNSICSLDSDRRPKCACPKGYS 334 (813)
Q Consensus 308 ~~~CG~~g~C~~~~~~~~~C~Cl~GF~ 334 (813)
+..|..+|.|.. ...+-.|.|++||+
T Consensus 10 ~~pC~n~g~C~n-~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCIN-TLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEE-CSSSEEEECCTTEE
T ss_pred CCCCCCCcEeEC-CCCCEEeECCCCCc
Confidence 468999999974 33445899999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.15 E-value=0.52 Score=31.31 Aligned_cols=26 Identities=31% Similarity=0.612 Sum_probs=19.5
Q ss_pred CCCCCCCcccCCCCCCCcccCCCCCcc
Q 045343 309 GACGFNSICSLDSDRRPKCACPKGYSL 335 (813)
Q Consensus 309 ~~CG~~g~C~~~~~~~~~C~Cl~GF~~ 335 (813)
..|+.++.|.. +..+-.|.|++||+.
T Consensus 11 ~~~~~~~~C~N-t~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 11 PDVCKHGQCIN-TDGSYRCECPFGYIL 36 (43)
T ss_dssp TTSCSSSCCCC-CSSCCCCCCCTTEEE
T ss_pred cCCCCCCEeEC-CCCCeEeECCCCccc
Confidence 45667899974 344558999999986
|